The table below lists the options of the executed module.
| Option | Value |
|---|---|
| analyze.sites | yes |
| region.types | cpgislands, genes, promoters, tiling, tiling1kb, gencode22promoters, ensembleRegBuildBPall |
| differential.permutations | 0 |
| differential.comparison.columns | TISSUE_TYPE, DONOR_SEX, cmp_mono_vs_neut, cmpV_mono_vs_neut, cmpC_mono_vs_neut, cmpV_mono_vs_Mf, cmpV_mono_vs_Mf0, cmpV_mono_vs_Mf1, cmpV_mono_vs_Mf2, cmpV_Mf0_vs_Mf1, cmpV_Mf0_vs_Mf2, cmpV_Mf1_vs_Mf2, cmpV_Tcells, cmpV_Tcells_vs_NK, cmpV_Tcells_vs_Bnaive, cmpV_TCD4_vs_NK, cmpV_TCD8_vs_NK, cmp_Bnaive_vs_Bmem, cmp_Bnaive_vs_plasma, cmp_plasma_vs_Bmem, cmpV_Bnaive_vs_NK |
| differential.comparison.columns.all.pairwise | default |
| columns.pairing | default |
| differential.site.test.method | limma |
| covariate.adjustment.columns | TISSUE_TYPE, DONOR_SEX |
| differential.adjustment.sva | yes |
| differential.adjustment.celltype | yes |
| differential.enrichment | yes |
Differential methylation analysis was conducted on site and region level according to the sample groups specified in the analysis.
The following comparisons were made:
The table below summarizes information on the comparisons.
| comparison | adjustment | covariateTable | |
| 1 | Bone marrow vs. non.Bone marrow (based on TISSUE_TYPE) | csv | |
| 2 | Cord blood vs. non.Cord blood (based on TISSUE_TYPE) | csv | |
| 3 | Tonsil vs. non.Tonsil (based on TISSUE_TYPE) | csv | |
| 4 | Venous blood vs. non.Venous blood (based on TISSUE_TYPE) | csv | |
| 5 | Female vs. Male (based on DONOR_SEX) | TISSUE_TYPE | csv |
| 6 | mono vs. neut (based on cmp_mono_vs_neut) | TISSUE_TYPE,DONOR_SEX | csv |
| 7 | mono vs. neut (based on cmpV_mono_vs_neut) | DONOR_SEX | csv |
| 8 | mono vs. neut (based on cmpC_mono_vs_neut) | DONOR_SEX | csv |
| 9 | Mf vs. mono (based on cmpV_mono_vs_Mf) | DONOR_SEX | csv |
| 10 | Mf0 vs. mono (based on cmpV_mono_vs_Mf0) | DONOR_SEX | csv |
| 11 | Mf1 vs. mono (based on cmpV_mono_vs_Mf1) | DONOR_SEX | csv |
| 12 | Mf2 vs. mono (based on cmpV_mono_vs_Mf2) | DONOR_SEX | csv |
| 13 | Mf0 vs. Mf1 (based on cmpV_Mf0_vs_Mf1) | DONOR_SEX | csv |
| 14 | Mf0 vs. Mf2 (based on cmpV_Mf0_vs_Mf2) | DONOR_SEX | csv |
| 15 | Mf1 vs. Mf2 (based on cmpV_Mf1_vs_Mf2) | DONOR_SEX | csv |
| 16 | CD4 vs. CD8 (based on cmpV_Tcells) | DONOR_SEX | csv |
| 17 | NK vs. Tcell (based on cmpV_Tcells_vs_NK) | DONOR_SEX | csv |
| 18 | Bnaive vs. Tcell (based on cmpV_Tcells_vs_Bnaive) | DONOR_SEX | csv |
| 19 | NK vs. TCD4 (based on cmpV_TCD4_vs_NK) | DONOR_SEX | csv |
| 20 | NK vs. TCD8 (based on cmpV_TCD8_vs_NK) | DONOR_SEX | csv |
| 21 | Bmem vs. Bnaive (based on cmp_Bnaive_vs_Bmem) | TISSUE_TYPE,DONOR_SEX | csv |
| 22 | Bnaive vs. plasma (based on cmp_Bnaive_vs_plasma) | TISSUE_TYPE | csv |
| 23 | Bmem vs. plasma (based on cmp_plasma_vs_Bmem) | csv | |
| 24 | Bnaive vs. NK (based on cmpV_Bnaive_vs_NK) | DONOR_SEX | csv |
In the following anlyses, p-values on the site level were computed using the limma method. I.e. hierarchical linear models from the limma package were employed and fitted using an empirical Bayes approach on derived M-values.
Differential methylation on the site level was computed based on a variety of metrics. Of particular interest for the following plots and analyses are the following quantities for each site: a) the difference in mean methylation levels of the two groups being compared, b) the quotient in mean methylation and c) a statistical test (limma or t-test depending on the settings) assessing whether the methylation values in the two groups originate from distinct distributions. Additionally each site was assigned a rank based on each of these three criteria. A combined rank is computed as the maximum (i.e. worst) rank among the three ranks. The smaller the combined rank for a site, the more evidence for differential methylation it exhibits. This section includes scatterplots of the site group means as well as volcano plots of each pairwise comparison colored according to the combined ranks or p-values of a given site.
The following rank cutfoffs have been automatically selected for the analysis of differentially methylated sites:
| Rank Cutoff | |
| Bone marrow vs. non.Bone marrow (based on TISSUE_TYPE) | 315526 |
| Cord blood vs. non.Cord blood (based on TISSUE_TYPE) | 365793 |
| Tonsil vs. non.Tonsil (based on TISSUE_TYPE) | 2897925 |
| Venous blood vs. non.Venous blood (based on TISSUE_TYPE) | 116653 |
| Female vs. Male (based on DONOR_SEX) | 1789 |
| mono vs. neut (based on cmp_mono_vs_neut) | 2075148 |
| mono vs. neut (based on cmpV_mono_vs_neut) | 751016 |
| mono vs. neut (based on cmpC_mono_vs_neut) | 1945917 |
| Mf vs. mono (based on cmpV_mono_vs_Mf) | 2297046 |
| Mf0 vs. mono (based on cmpV_mono_vs_Mf0) | 2894612 |
| Mf1 vs. mono (based on cmpV_mono_vs_Mf1) | 2297046 |
| Mf2 vs. mono (based on cmpV_mono_vs_Mf2) | 3546039 |
| Mf0 vs. Mf1 (based on cmpV_Mf0_vs_Mf1) | 3017788 |
| Mf0 vs. Mf2 (based on cmpV_Mf0_vs_Mf2) | 2822127 |
| Mf1 vs. Mf2 (based on cmpV_Mf1_vs_Mf2) | 3321182 |
| CD4 vs. CD8 (based on cmpV_Tcells) | 5141962 |
| NK vs. Tcell (based on cmpV_Tcells_vs_NK) | 2697870 |
| Bnaive vs. Tcell (based on cmpV_Tcells_vs_Bnaive) | 2270374 |
| NK vs. TCD4 (based on cmpV_TCD4_vs_NK) | 4797460 |
| NK vs. TCD8 (based on cmpV_TCD8_vs_NK) | 2326117 |
| Bmem vs. Bnaive (based on cmp_Bnaive_vs_Bmem) | 2798392 |
| Bnaive vs. plasma (based on cmp_Bnaive_vs_plasma) | 2323463 |
| Bmem vs. plasma (based on cmp_plasma_vs_Bmem) | 5636418 |
| Bnaive vs. NK (based on cmpV_Bnaive_vs_NK) | 3247137 |
| comparison | |
| differential methylation measure |
Scatterplot for differential methylation (sites). If the selected criterion is not rankGradient:
The transparency corresponds to point density. If the number of points exceeds 2e+06 then the number of points for density estimation is reduced to that number by random sampling.The1% of the points in the sparsest populated plot regions are drawn explicitly (up to a maximum of 10000 points).Additionally, the colored points represent differentially methylated sites (according to the selected criterion).
If the selected criterion is rankGradient: median combined ranks accross hexagonal bins are shown
as a gradient according to the color legend.
| comparison | |
| difference metric | |
| significance metric |
Volcano plot for differential methylation quantified by various metrics. Color scale according to combined ranking.
A tabular overview of measures for differential methylation on the site level for the individual comparisons are provided in this section. Below, a brief explanation of the different columns can be found:
The tables for the individual comparisons can be found here:
Differential methylation on the region level was computed based on a variety of metrics. Of particular interest for the following plots and analyses are the following quantities for each region: the mean difference in means across all sites in a region of the two groups being compared and the mean of quotients in mean methylation as well as a combined p-value calculated from all site p-values in the region [1]. Additionally each region was assigned a rank based on each of these three criteria. A combined rank is computed as the maximum (i.e. worst) value among the three ranks. The smaller the combined rank for a region, the more evidence for differential methylation it exhibits. Regions were defined based on the region types specified in the analysis. This section includes scatterplots of the region group means as well as volcano plots of each pairwise comparison colored according to the combined rank of a given region.
The following rank cutfoffs have been automatically selected for the analysis of differentially methylated regions:
| cpgislands | genes | promoters | tiling | tiling1kb | gencode22promoters | ensembleRegBuildBPall | |
| Bone marrow vs. non.Bone marrow (based on TISSUE_TYPE) | 3922 | 1846 | 1302 | 53 | 18287 | 1302 | 7918 |
| Cord blood vs. non.Cord blood (based on TISSUE_TYPE) | 3990 | 1183 | 3028 | 888 | 15990 | 3039 | 13614 |
| Tonsil vs. non.Tonsil (based on TISSUE_TYPE) | 1236 | 688 | 248 | 1187 | 34102 | 253 | 7405 |
| Venous blood vs. non.Venous blood (based on TISSUE_TYPE) | 223 | 67 | 65 | 18 | 3187 | 65 | 4944 |
| Female vs. Male (based on DONOR_SEX) | 913 | 3600 | 2745 | 18236 | 175539 | 2765 | 43734 |
| mono vs. neut (based on cmp_mono_vs_neut) | 52 | 94 | 81 | 85 | 7239 | 74 | 6571 |
| mono vs. neut (based on cmpV_mono_vs_neut) | 94 | 108 | 97 | 167 | 2947 | 97 | 2452 |
| mono vs. neut (based on cmpC_mono_vs_neut) | 899 | 714 | 438 | 2370 | 39457 | 437 | 7982 |
| Mf vs. mono (based on cmpV_mono_vs_Mf) | 359 | 651 | 467 | 2634 | 36126 | 448 | 5921 |
| Mf0 vs. mono (based on cmpV_mono_vs_Mf0) | 295 | 760 | 430 | 2239 | 35380 | 437 | 8038 |
| Mf1 vs. mono (based on cmpV_mono_vs_Mf1) | 359 | 651 | 467 | 2634 | 36126 | 448 | 5921 |
| Mf2 vs. mono (based on cmpV_mono_vs_Mf2) | 391 | 676 | 324 | 1040 | 22735 | 307 | 7619 |
| Mf0 vs. Mf1 (based on cmpV_Mf0_vs_Mf1) | 995 | 2652 | 3215 | 10303 | 82802 | 3131 | 24680 |
| Mf0 vs. Mf2 (based on cmpV_Mf0_vs_Mf2) | 581 | 2438 | 1435 | 7932 | 72538 | 1440 | 20766 |
| Mf1 vs. Mf2 (based on cmpV_Mf1_vs_Mf2) | 709 | 2775 | 2558 | 12440 | 83486 | 2526 | 24745 |
| CD4 vs. CD8 (based on cmpV_Tcells) | 2111 | 5273 | 4508 | 23646 | 319479 | 4529 | 63688 |
| NK vs. Tcell (based on cmpV_Tcells_vs_NK) | 511 | 1235 | 317 | 1466 | 59103 | 331 | 11513 |
| Bnaive vs. Tcell (based on cmpV_Tcells_vs_Bnaive) | 238 | 543 | 156 | 707 | 13775 | 169 | 3664 |
| NK vs. TCD4 (based on cmpV_TCD4_vs_NK) | 846 | 4123 | 1444 | 14124 | 299600 | 1447 | 51835 |
| NK vs. TCD8 (based on cmpV_TCD8_vs_NK) | 2505 | 2343 | 846 | 4316 | 87393 | 837 | 16413 |
| Bmem vs. Bnaive (based on cmp_Bnaive_vs_Bmem) | 1667 | 1497 | 1428 | 6347 | 110909 | 1418 | 22316 |
| Bnaive vs. plasma (based on cmp_Bnaive_vs_plasma) | 4493 | 2187 | 3447 | 6692 | 107816 | 3463 | 17611 |
| Bmem vs. plasma (based on cmp_plasma_vs_Bmem) | 1786 | 1972 | 1806 | 9035 | 189019 | 1845 | 31052 |
| Bnaive vs. NK (based on cmpV_Bnaive_vs_NK) | 752 | 1341 | 349 | 2005 | 74738 | 352 | 13441 |
| comparison | |
| regions | |
| differential methylation measure |
Scatterplot for differential methylation (regions). If the selected criterion is not rankGradient:
The transparency corresponds to point density. The 1% of the points in the sparsest populated plot regions are drawn explicitly.
Additionally, the colored points represent differentially methylated regions (according to the selected criterion).
If the selected criterion is rankGradient: median combined ranks accross hexagonal bins are shown
as a gradient according to the color legend.
| comparison | |
| regions | |
| difference metric | |
| significance metric |
Volcano plot for differential methylation quantified by various metrics. Color scale according to combined ranking.
A tabular overview of measures for differential methylation on the region level for the individual comparisons are provided in this section.
The tables for the individual comparisons can be found here:
| cpgislands | genes | promoters | tiling | tiling1kb | gencode22promoters | ensembleRegBuildBPall | |
| Bone marrow vs. non.Bone marrow (based on TISSUE_TYPE) | csv | csv | csv | csv | csv | csv | csv |
| Cord blood vs. non.Cord blood (based on TISSUE_TYPE) | csv | csv | csv | csv | csv | csv | csv |
| Tonsil vs. non.Tonsil (based on TISSUE_TYPE) | csv | csv | csv | csv | csv | csv | csv |
| Venous blood vs. non.Venous blood (based on TISSUE_TYPE) | csv | csv | csv | csv | csv | csv | csv |
| Female vs. Male (based on DONOR_SEX) | csv | csv | csv | csv | csv | csv | csv |
| mono vs. neut (based on cmp_mono_vs_neut) | csv | csv | csv | csv | csv | csv | csv |
| mono vs. neut (based on cmpV_mono_vs_neut) | csv | csv | csv | csv | csv | csv | csv |
| mono vs. neut (based on cmpC_mono_vs_neut) | csv | csv | csv | csv | csv | csv | csv |
| Mf vs. mono (based on cmpV_mono_vs_Mf) | csv | csv | csv | csv | csv | csv | csv |
| Mf0 vs. mono (based on cmpV_mono_vs_Mf0) | csv | csv | csv | csv | csv | csv | csv |
| Mf1 vs. mono (based on cmpV_mono_vs_Mf1) | csv | csv | csv | csv | csv | csv | csv |
| Mf2 vs. mono (based on cmpV_mono_vs_Mf2) | csv | csv | csv | csv | csv | csv | csv |
| Mf0 vs. Mf1 (based on cmpV_Mf0_vs_Mf1) | csv | csv | csv | csv | csv | csv | csv |
| Mf0 vs. Mf2 (based on cmpV_Mf0_vs_Mf2) | csv | csv | csv | csv | csv | csv | csv |
| Mf1 vs. Mf2 (based on cmpV_Mf1_vs_Mf2) | csv | csv | csv | csv | csv | csv | csv |
| CD4 vs. CD8 (based on cmpV_Tcells) | csv | csv | csv | csv | csv | csv | csv |
| NK vs. Tcell (based on cmpV_Tcells_vs_NK) | csv | csv | csv | csv | csv | csv | csv |
| Bnaive vs. Tcell (based on cmpV_Tcells_vs_Bnaive) | csv | csv | csv | csv | csv | csv | csv |
| NK vs. TCD4 (based on cmpV_TCD4_vs_NK) | csv | csv | csv | csv | csv | csv | csv |
| NK vs. TCD8 (based on cmpV_TCD8_vs_NK) | csv | csv | csv | csv | csv | csv | csv |
| Bmem vs. Bnaive (based on cmp_Bnaive_vs_Bmem) | csv | csv | csv | csv | csv | csv | csv |
| Bnaive vs. plasma (based on cmp_Bnaive_vs_plasma) | csv | csv | csv | csv | csv | csv | csv |
| Bmem vs. plasma (based on cmp_plasma_vs_Bmem) | csv | csv | csv | csv | csv | csv | csv |
| Bnaive vs. NK (based on cmpV_Bnaive_vs_NK) | csv | csv | csv | csv | csv | csv | csv |
Enrichment Analysis was conducted. The wordclouds and tables below contains significant GO terms as determined by a hypergeometric test.
| comparison | |
| Hypermethylation/hypomethylation | |
| ontology | |
| regions | |
| differential methylation measure |
Wordclouds for GO enrichment terms.
| comparison | |
| Hypermethylation/hypomethylation | |
| ontology | |
| regions | |
| differential methylation measure |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0032501 | 0 | 5.8201 | 16.334 | 32 | 6280 | multicellular organismal process |
| GO:0048699 | 0 | 6.1488 | 2.9879 | 13 | 1205 | generation of neurons |
| GO:0007198 | 0 | Inf | 0.0052 | 2 | 2 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
| GO:0072272 | 0 | Inf | 0.0052 | 2 | 2 | proximal/distal pattern formation involved in metanephric nephron development |
| GO:0007275 | 0 | 4.7454 | 8.6631 | 21 | 3771 | multicellular organismal development |
| GO:0048663 | 0 | 25.3267 | 0.1847 | 4 | 71 | neuron fate commitment |
| GO:0034654 | 0 | 3.7665 | 9.8316 | 22 | 3780 | nucleobase-containing compound biosynthetic process |
| GO:0048513 | 0 | 4.2294 | 6.3112 | 17 | 2680 | organ development |
| GO:0072086 | 0 | 403.6053 | 0.0104 | 2 | 4 | specification of loop of Henle identity |
| GO:0021510 | 1e-04 | 19.2563 | 0.2393 | 4 | 92 | spinal cord development |
| GO:0021797 | 1e-04 | 201.7763 | 0.0156 | 2 | 6 | forebrain anterior/posterior pattern specification |
| GO:0065007 | 1e-04 | 6.2813 | 26.5297 | 37 | 10200 | biological regulation |
| GO:0060255 | 1e-04 | 3.4068 | 13.1712 | 25 | 5064 | regulation of macromolecule metabolic process |
| GO:0030900 | 2e-04 | 8.3626 | 0.8401 | 6 | 323 | forebrain development |
| GO:0061004 | 2e-04 | 115.2782 | 0.0234 | 2 | 9 | pattern specification involved in kidney development |
| GO:0060284 | 3e-04 | 5.6225 | 1.7192 | 8 | 661 | regulation of cell development |
| GO:0021521 | 4e-04 | 89.6491 | 0.0286 | 2 | 11 | ventral spinal cord interneuron specification |
| GO:0050885 | 4e-04 | 22.9505 | 0.1483 | 3 | 57 | neuromuscular process controlling balance |
| GO:0007409 | 4e-04 | 5.8583 | 1.4123 | 7 | 543 | axonogenesis |
| GO:0007399 | 6e-04 | 4.3029 | 3.044 | 10 | 1365 | nervous system development |
| GO:0016331 | 6e-04 | 11.8073 | 0.3823 | 4 | 147 | morphogenesis of embryonic epithelium |
| GO:0045934 | 6e-04 | 4.14 | 2.9989 | 10 | 1153 | negative regulation of nucleobase-containing compound metabolic process |
| GO:0006837 | 6e-04 | 67.2237 | 0.0364 | 2 | 14 | serotonin transport |
| GO:0022010 | 6e-04 | 67.2237 | 0.0364 | 2 | 14 | central nervous system myelination |
| GO:0051960 | 7e-04 | 5.4564 | 1.5112 | 7 | 581 | regulation of nervous system development |
| GO:0060581 | 7e-04 | 62.0486 | 0.039 | 2 | 15 | cell fate commitment involved in pattern specification |
| GO:0045892 | 7e-04 | 4.3533 | 2.5177 | 9 | 968 | negative regulation of transcription, DNA-templated |
| GO:0032502 | 7e-04 | 3.6479 | 6.7455 | 15 | 3247 | developmental process |
| GO:0021782 | 8e-04 | 18.7629 | 0.1795 | 3 | 69 | glial cell development |
| GO:0007379 | 8e-04 | 57.6128 | 0.0416 | 2 | 16 | segment specification |
| GO:0003002 | 8e-04 | 7.8172 | 0.7354 | 5 | 305 | regionalization |
| GO:0014013 | 9e-04 | 17.9436 | 0.1873 | 3 | 72 | regulation of gliogenesis |
| GO:0048709 | 9e-04 | 17.9436 | 0.1873 | 3 | 72 | oligodendrocyte differentiation |
| GO:0000904 | 9e-04 | 4.6226 | 2.0678 | 8 | 795 | cell morphogenesis involved in differentiation |
| GO:0021514 | 9e-04 | 53.7684 | 0.0442 | 2 | 17 | ventral spinal cord interneuron differentiation |
| GO:0061333 | 9e-04 | 17.6861 | 0.1899 | 3 | 73 | renal tubule morphogenesis |
| GO:0072088 | 9e-04 | 17.6861 | 0.1899 | 3 | 73 | nephron epithelium morphogenesis |
| GO:1902679 | 0.001 | 4.1452 | 2.6348 | 9 | 1013 | negative regulation of RNA biosynthetic process |
| GO:0009890 | 0.001 | 3.844 | 3.2096 | 10 | 1234 | negative regulation of biosynthetic process |
| GO:0035640 | 0.001 | 50.4046 | 0.0468 | 2 | 18 | exploration behavior |
| GO:0045596 | 0.001 | 5.0871 | 1.6152 | 7 | 621 | negative regulation of cell differentiation |
| GO:0007610 | 0.001 | 5.0358 | 1.6308 | 7 | 627 | behavior |
| GO:0034645 | 0.0011 | 2.8101 | 11.3167 | 21 | 4351 | cellular macromolecule biosynthetic process |
| GO:0097659 | 0.0011 | 3.5935 | 4.6501 | 12 | 2129 | nucleic acid-templated transcription |
| GO:0072079 | 0.0011 | 47.4365 | 0.0494 | 2 | 19 | nephron tubule formation |
| GO:0061053 | 0.0011 | 16.2834 | 0.2055 | 3 | 79 | somite development |
| GO:0060322 | 0.0011 | 4.9525 | 1.6568 | 7 | 637 | head development |
| GO:0001708 | 0.0012 | 15.8638 | 0.2107 | 3 | 81 | cell fate specification |
| GO:0031290 | 0.0012 | 44.7982 | 0.052 | 2 | 20 | retinal ganglion cell axon guidance |
| GO:0007218 | 0.0013 | 15.2733 | 0.2185 | 3 | 84 | neuropeptide signaling pathway |
| GO:0051241 | 0.0014 | 4.2828 | 2.2212 | 8 | 854 | negative regulation of multicellular organismal process |
| GO:0050768 | 0.0014 | 9.1516 | 0.489 | 4 | 188 | negative regulation of neurogenesis |
| GO:0006355 | 0.0014 | 3.465 | 4.7949 | 12 | 2229 | regulation of transcription, DNA-templated |
| GO:2001141 | 0.0015 | 3.4577 | 4.8034 | 12 | 2226 | regulation of RNA biosynthetic process |
| GO:0002089 | 0.0015 | 40.3132 | 0.0572 | 2 | 22 | lens morphogenesis in camera-type eye |
| GO:0060993 | 0.0016 | 14.2144 | 0.2341 | 3 | 90 | kidney morphogenesis |
| GO:0072080 | 0.0017 | 14.0519 | 0.2367 | 3 | 91 | nephron tubule development |
| GO:0045686 | 0.0018 | 36.6435 | 0.0624 | 2 | 24 | negative regulation of glial cell differentiation |
| GO:0090304 | 0.0018 | 2.6689 | 11.7381 | 21 | 4513 | nucleic acid metabolic process |
| GO:0044699 | 0.0018 | 9.49 | 32.1893 | 39 | 12376 | single-organism process |
| GO:0007268 | 0.0018 | 4.5518 | 1.7947 | 7 | 690 | synaptic transmission |
| GO:0045944 | 0.0019 | 4.0733 | 2.3278 | 8 | 895 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0021513 | 0.0019 | 35.0481 | 0.065 | 2 | 25 | spinal cord dorsal/ventral patterning |
| GO:0046483 | 0.0019 | 2.6357 | 13.5926 | 23 | 5226 | heterocycle metabolic process |
| GO:0006725 | 0.002 | 2.6242 | 13.6316 | 23 | 5241 | cellular aromatic compound metabolic process |
| GO:0050793 | 0.0025 | 3.0497 | 4.947 | 12 | 1902 | regulation of developmental process |
| GO:0009888 | 0.0025 | 3.1814 | 4.2786 | 11 | 1645 | tissue development |
| GO:0032812 | 0.0026 | Inf | 0.0026 | 1 | 1 | positive regulation of epinephrine secretion |
| GO:0035332 | 0.0026 | Inf | 0.0026 | 1 | 1 | positive regulation of hippo signaling |
| GO:0048561 | 0.0026 | Inf | 0.0026 | 1 | 1 | establishment of organ orientation |
| GO:0097402 | 0.0026 | Inf | 0.0026 | 1 | 1 | neuroblast migration |
| GO:2001111 | 0.0026 | Inf | 0.0026 | 1 | 1 | positive regulation of lens epithelial cell proliferation |
| GO:0009954 | 0.0026 | 29.5541 | 0.0761 | 2 | 30 | proximal/distal pattern formation |
| GO:1903508 | 0.0029 | 3.49 | 3.0873 | 9 | 1187 | positive regulation of nucleic acid-templated transcription |
| GO:0046883 | 0.003 | 7.364 | 0.6034 | 4 | 232 | regulation of hormone secretion |
| GO:0019219 | 0.0031 | 3.1541 | 5.2488 | 12 | 2489 | regulation of nucleobase-containing compound metabolic process |
| GO:0032228 | 0.0031 | 26.8579 | 0.0832 | 2 | 32 | regulation of synaptic transmission, GABAergic |
| GO:0048048 | 0.0031 | 26.8579 | 0.0832 | 2 | 32 | embryonic eye morphogenesis |
| GO:0032989 | 0.0033 | 3.4115 | 3.1524 | 9 | 1212 | cellular component morphogenesis |
| GO:1901360 | 0.0035 | 2.4717 | 14.1726 | 23 | 5449 | organic cyclic compound metabolic process |
| GO:0035295 | 0.0036 | 4.5476 | 1.5059 | 6 | 579 | tube development |
| GO:0050433 | 0.0037 | 24.4115 | 0.091 | 2 | 35 | regulation of catecholamine secretion |
| GO:0023061 | 0.0038 | 5.3491 | 1.0508 | 5 | 404 | signal release |
| GO:0072175 | 0.0038 | 10.4588 | 0.3147 | 3 | 121 | epithelial tube formation |
| GO:0090596 | 0.0038 | 6.8739 | 0.645 | 4 | 248 | sensory organ morphogenesis |
| GO:0048858 | 0.0039 | 3.9328 | 2.06 | 7 | 792 | cell projection morphogenesis |
| GO:0045664 | 0.0041 | 5.2544 | 1.069 | 5 | 411 | regulation of neuron differentiation |
| GO:0031175 | 0.0041 | 3.8961 | 2.0782 | 7 | 799 | neuron projection development |
| GO:0051254 | 0.0042 | 3.2866 | 3.2616 | 9 | 1254 | positive regulation of RNA metabolic process |
| GO:0009889 | 0.0044 | 2.9962 | 5.474 | 12 | 2581 | regulation of biosynthetic process |
| GO:0050794 | 0.0045 | 3.8082 | 9.6009 | 16 | 5083 | regulation of cellular process |
| GO:0034641 | 0.0045 | 2.4066 | 14.4171 | 23 | 5543 | cellular nitrogen compound metabolic process |
| GO:0072006 | 0.0045 | 9.7896 | 0.3355 | 3 | 129 | nephron development |
| GO:0031076 | 0.0046 | 21.7667 | 0.1014 | 2 | 39 | embryonic camera-type eye development |
| GO:0031032 | 0.0049 | 9.4859 | 0.3459 | 3 | 133 | actomyosin structure organization |
| GO:0072001 | 0.005 | 6.3692 | 0.6945 | 4 | 267 | renal system development |
| GO:0014062 | 0.0051 | 403.5789 | 0.0051 | 1 | 2 | regulation of serotonin secretion |
| GO:0021983 | 0.0051 | 20.6478 | 0.1066 | 2 | 41 | pituitary gland development |
| GO:0003404 | 0.0052 | 393.2821 | 0.0052 | 1 | 2 | optic vesicle morphogenesis |
| GO:0042706 | 0.0052 | 393.2821 | 0.0052 | 1 | 2 | eye photoreceptor cell fate commitment |
| GO:0043503 | 0.0052 | 393.2821 | 0.0052 | 1 | 2 | skeletal muscle fiber adaptation |
| GO:0061386 | 0.0052 | 393.2821 | 0.0052 | 1 | 2 | closure of optic fissure |
| GO:2000854 | 0.0052 | 393.2821 | 0.0052 | 1 | 2 | positive regulation of corticosterone secretion |
| GO:0072073 | 0.0055 | 9.1315 | 0.3589 | 3 | 138 | kidney epithelium development |
| GO:0009914 | 0.0062 | 5.9758 | 0.7387 | 4 | 284 | hormone transport |
| GO:0042127 | 0.0074 | 2.9841 | 3.5607 | 9 | 1369 | regulation of cell proliferation |
| GO:0051937 | 0.0075 | 16.7664 | 0.13 | 2 | 50 | catecholamine transport |
| GO:0010557 | 0.0075 | 2.9769 | 3.5685 | 9 | 1372 | positive regulation of macromolecule biosynthetic process |
| GO:0048522 | 0.0077 | 2.3123 | 10.474 | 18 | 4027 | positive regulation of cellular process |
| GO:0009946 | 0.0078 | 196.6282 | 0.0078 | 1 | 3 | proximal/distal axis specification |
| GO:0014016 | 0.0078 | 196.6282 | 0.0078 | 1 | 3 | neuroblast differentiation |
| GO:0014063 | 0.0078 | 196.6282 | 0.0078 | 1 | 3 | negative regulation of serotonin secretion |
| GO:0021912 | 0.0078 | 196.6282 | 0.0078 | 1 | 3 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification |
| GO:0033693 | 0.0078 | 196.6282 | 0.0078 | 1 | 3 | neurofilament bundle assembly |
| GO:0061074 | 0.0078 | 196.6282 | 0.0078 | 1 | 3 | regulation of neural retina development |
| GO:0070093 | 0.0078 | 196.6282 | 0.0078 | 1 | 3 | negative regulation of glucagon secretion |
| GO:0070253 | 0.0078 | 196.6282 | 0.0078 | 1 | 3 | somatostatin secretion |
| GO:0071502 | 0.0078 | 196.6282 | 0.0078 | 1 | 3 | cellular response to temperature stimulus |
| GO:0006928 | 0.0079 | 2.8035 | 4.2656 | 10 | 1640 | movement of cell or subcellular component |
| GO:0050877 | 0.0081 | 3.1406 | 2.9625 | 8 | 1139 | neurological system process |
| GO:0007405 | 0.0084 | 15.7771 | 0.1379 | 2 | 53 | neuroblast proliferation |
| GO:1901576 | 0.0085 | 2.2393 | 14.144 | 22 | 5438 | organic substance biosynthetic process |
| GO:0007187 | 0.0087 | 7.6921 | 0.424 | 3 | 163 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
| GO:0051492 | 0.0087 | 15.4727 | 0.1405 | 2 | 54 | regulation of stress fiber assembly |
| GO:0010628 | 0.009 | 2.886 | 3.6699 | 9 | 1411 | positive regulation of gene expression |
| GO:0033993 | 0.0091 | 3.7071 | 1.8285 | 6 | 703 | response to lipid |
| GO:0001654 | 0.0092 | 5.2995 | 0.8297 | 4 | 319 | eye development |
| GO:0030278 | 0.0093 | 7.5025 | 0.4344 | 3 | 167 | regulation of ossification |
| GO:0045669 | 0.0099 | 14.3637 | 0.1509 | 2 | 58 | positive regulation of osteoblast differentiation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0051279 | 6e-04 | 67.1579 | 0.0384 | 2 | 59 | regulation of release of sequestered calcium ion into cytosol |
| GO:0071228 | 7e-04 | Inf | 7e-04 | 1 | 1 | cellular response to tumor cell |
| GO:0002361 | 0.0013 | 1707.5556 | 0.0013 | 1 | 2 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation |
| GO:0002522 | 0.0013 | 1707.5556 | 0.0013 | 1 | 2 | leukocyte migration involved in immune response |
| GO:0032796 | 0.0013 | 1707.5556 | 0.0013 | 1 | 2 | uropod organization |
| GO:0033277 | 0.0013 | 1707.5556 | 0.0013 | 1 | 2 | abortive mitotic cell cycle |
| GO:0051283 | 0.0014 | 45.4911 | 0.0559 | 2 | 86 | negative regulation of sequestering of calcium ion |
| GO:1903649 | 0.0014 | 17.8172 | 0.2367 | 3 | 364 | regulation of cytoplasmic transport |
| GO:0050864 | 0.0016 | 41.9725 | 0.0605 | 2 | 93 | regulation of B cell activation |
| GO:0002694 | 0.0016 | 17.0428 | 0.2471 | 3 | 380 | regulation of leukocyte activation |
| GO:0070489 | 0.0018 | 16.3743 | 0.2568 | 3 | 395 | T cell aggregation |
| GO:0070486 | 0.0019 | 16.0382 | 0.262 | 3 | 403 | leukocyte aggregation |
| GO:0051250 | 0.002 | 37.4191 | 0.0676 | 2 | 104 | negative regulation of lymphocyte activation |
| GO:0060402 | 0.0022 | 35 | 0.0722 | 2 | 111 | calcium ion transport into cytosol |
| GO:0061502 | 0.0026 | 569.1111 | 0.0026 | 1 | 4 | early endosome to recycling endosome transport |
| GO:0030216 | 0.0027 | 31.5041 | 0.08 | 2 | 123 | keratinocyte differentiation |
| GO:0042129 | 0.0029 | 30.7359 | 0.0819 | 2 | 126 | regulation of T cell proliferation |
| GO:0043409 | 0.003 | 30.0039 | 0.0839 | 2 | 129 | negative regulation of MAPK cascade |
| GO:0031339 | 0.0032 | 426.8056 | 0.0033 | 1 | 5 | negative regulation of vesicle fusion |
| GO:0050859 | 0.0032 | 426.8056 | 0.0033 | 1 | 5 | negative regulation of B cell receptor signaling pathway |
| GO:0051534 | 0.0032 | 426.8056 | 0.0033 | 1 | 5 | negative regulation of NFAT protein import into nucleus |
| GO:0050851 | 0.0033 | 28.6391 | 0.0878 | 2 | 135 | antigen receptor-mediated signaling pathway |
| GO:0050866 | 0.0034 | 28.2111 | 0.0891 | 2 | 137 | negative regulation of cell activation |
| GO:0002924 | 0.0039 | 341.4222 | 0.0039 | 1 | 6 | negative regulation of humoral immune response mediated by circulating immunoglobulin |
| GO:0051126 | 0.0039 | 341.4222 | 0.0039 | 1 | 6 | negative regulation of actin nucleation |
| GO:2000021 | 0.0046 | 23.9151 | 0.1047 | 2 | 161 | regulation of ion homeostasis |
| GO:0032944 | 0.0052 | 22.6205 | 0.1105 | 2 | 170 | regulation of mononuclear cell proliferation |
| GO:0001845 | 0.0052 | 243.8413 | 0.0052 | 1 | 8 | phagolysosome assembly |
| GO:0070372 | 0.0052 | 22.4852 | 0.1112 | 2 | 171 | regulation of ERK1 and ERK2 cascade |
| GO:0006955 | 0.0053 | 8.2734 | 0.7954 | 4 | 1359 | immune response |
| GO:0050870 | 0.0057 | 21.4576 | 0.1164 | 2 | 179 | positive regulation of T cell activation |
| GO:0051924 | 0.0058 | 21.2151 | 0.1177 | 2 | 181 | regulation of calcium ion transport |
| GO:0002713 | 0.0058 | 213.3472 | 0.0059 | 1 | 9 | negative regulation of B cell mediated immunity |
| GO:0038180 | 0.0058 | 213.3472 | 0.0059 | 1 | 9 | nerve growth factor signaling pathway |
| GO:0042355 | 0.0058 | 213.3472 | 0.0059 | 1 | 9 | L-fucose catabolic process |
| GO:0022409 | 0.008 | 17.9597 | 0.1385 | 2 | 213 | positive regulation of cell-cell adhesion |
| GO:0050860 | 0.0084 | 142.1944 | 0.0085 | 1 | 13 | negative regulation of T cell receptor signaling pathway |
| GO:0098602 | 0.0087 | 9.0898 | 0.4519 | 3 | 695 | single organism cell adhesion |
| GO:0006606 | 0.0093 | 16.602 | 0.1496 | 2 | 230 | protein import into nucleus |
| GO:0051480 | 0.0093 | 16.5284 | 0.1502 | 2 | 231 | cytosolic calcium ion homeostasis |
| GO:0046651 | 0.0095 | 16.3831 | 0.1515 | 2 | 233 | lymphocyte proliferation |
| GO:0051170 | 0.0096 | 16.3114 | 0.1522 | 2 | 234 | nuclear import |
| GO:0035855 | 0.0097 | 121.8651 | 0.0098 | 1 | 15 | megakaryocyte development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0070988 | 0 | 67.136 | 0.0585 | 3 | 60 | demethylation |
| GO:0000723 | 1e-04 | 48.9936 | 0.079 | 3 | 81 | telomere maintenance |
| GO:0035574 | 1e-04 | 181.6686 | 0.0146 | 2 | 15 | histone H4-K20 demethylation |
| GO:0044728 | 1e-04 | 41.9588 | 0.0917 | 3 | 94 | DNA methylation or demethylation |
| GO:0071285 | 1e-04 | 168.6813 | 0.0156 | 2 | 16 | cellular response to lithium ion |
| GO:0045653 | 1e-04 | 147.5769 | 0.0176 | 2 | 18 | negative regulation of megakaryocyte differentiation |
| GO:1902679 | 2e-04 | 9.5048 | 0.988 | 6 | 1013 | negative regulation of RNA biosynthetic process |
| GO:0031497 | 3e-04 | 29.0706 | 0.1307 | 3 | 134 | chromatin assembly |
| GO:0065004 | 4e-04 | 25.8793 | 0.1463 | 3 | 150 | protein-DNA complex assembly |
| GO:0016577 | 4e-04 | 81.3528 | 0.0302 | 2 | 31 | histone demethylation |
| GO:0006335 | 4e-04 | 78.6359 | 0.0312 | 2 | 32 | DNA replication-dependent nucleosome assembly |
| GO:0008214 | 5e-04 | 76.0943 | 0.0322 | 2 | 33 | protein dealkylation |
| GO:0045934 | 5e-04 | 8.2633 | 1.1246 | 6 | 1153 | negative regulation of nucleobase-containing compound metabolic process |
| GO:0032776 | 5e-04 | 73.7115 | 0.0332 | 2 | 34 | DNA methylation on cytosine |
| GO:0051290 | 5e-04 | 69.3665 | 0.0351 | 2 | 36 | protein heterotetramerization |
| GO:0000183 | 6e-04 | 65.5043 | 0.0371 | 2 | 38 | chromatin silencing at rDNA |
| GO:0034080 | 7e-04 | 62.0486 | 0.039 | 2 | 40 | CENP-A containing nucleosome assembly |
| GO:1901532 | 7e-04 | 62.0486 | 0.039 | 2 | 40 | regulation of hematopoietic progenitor cell differentiation |
| GO:0009890 | 7e-04 | 7.6743 | 1.2036 | 6 | 1234 | negative regulation of biosynthetic process |
| GO:0002502 | 0.001 | Inf | 0.001 | 1 | 1 | peptide antigen assembly with MHC class I protein complex |
| GO:0032918 | 0.001 | Inf | 0.001 | 1 | 1 | spermidine acetylation |
| GO:0032919 | 0.001 | Inf | 0.001 | 1 | 1 | spermine acetylation |
| GO:0032920 | 0.001 | Inf | 0.001 | 1 | 1 | putrescine acetylation |
| GO:0046204 | 0.001 | Inf | 0.001 | 1 | 1 | nor-spermidine metabolic process |
| GO:0071228 | 0.001 | Inf | 0.001 | 1 | 1 | cellular response to tumor cell |
| GO:0034724 | 0.0011 | 49.0897 | 0.0488 | 2 | 50 | DNA replication-independent nucleosome organization |
| GO:0071103 | 0.0012 | 17.0518 | 0.2195 | 3 | 225 | DNA conformation change |
| GO:0045892 | 0.0017 | 7.4772 | 0.9441 | 5 | 968 | negative regulation of transcription, DNA-templated |
| GO:0010038 | 0.0019 | 14.6376 | 0.2546 | 3 | 261 | response to metal ion |
| GO:0009447 | 0.0019 | 1097.3571 | 0.002 | 1 | 2 | putrescine catabolic process |
| GO:0033274 | 0.0019 | 1097.3571 | 0.002 | 1 | 2 | response to vitamin B2 |
| GO:0043044 | 0.002 | 35.1251 | 0.0673 | 2 | 69 | ATP-dependent chromatin remodeling |
| GO:0007049 | 0.0024 | 5.9076 | 1.5255 | 6 | 1564 | cell cycle |
| GO:0006305 | 0.0028 | 29.7663 | 0.079 | 2 | 81 | DNA alkylation |
| GO:0002376 | 0.0031 | 5.1346 | 2.1887 | 7 | 2244 | immune system process |
| GO:0030099 | 0.0035 | 11.6786 | 0.317 | 3 | 325 | myeloid cell differentiation |
| GO:0042542 | 0.0038 | 25.2622 | 0.0927 | 2 | 95 | response to hydrogen peroxide |
| GO:0032355 | 0.0039 | 24.7271 | 0.0946 | 2 | 97 | response to estradiol |
| GO:0050911 | 0.0043 | 10.8833 | 0.3394 | 3 | 348 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0048545 | 0.0047 | 10.5091 | 0.3511 | 3 | 360 | response to steroid hormone |
| GO:0002396 | 0.0049 | 274.2857 | 0.0049 | 1 | 5 | MHC protein complex assembly |
| GO:2000510 | 0.0049 | 274.2857 | 0.0049 | 1 | 5 | positive regulation of dendritic cell chemotaxis |
| GO:1901654 | 0.0054 | 20.9505 | 0.1112 | 2 | 114 | response to ketone |
| GO:0045814 | 0.0055 | 20.7638 | 0.1122 | 2 | 115 | negative regulation of gene expression, epigenetic |
| GO:0071241 | 0.0057 | 20.2228 | 0.1151 | 2 | 118 | cellular response to inorganic substance |
| GO:0042493 | 0.0059 | 9.6495 | 0.3814 | 3 | 391 | response to drug |
| GO:1903707 | 0.0061 | 19.5436 | 0.119 | 2 | 122 | negative regulation of hemopoiesis |
| GO:0051054 | 0.0062 | 19.3808 | 0.12 | 2 | 123 | positive regulation of DNA metabolic process |
| GO:0010605 | 0.0071 | 4.6597 | 1.8815 | 6 | 1929 | negative regulation of macromolecule metabolic process |
| GO:0009593 | 0.0074 | 8.8519 | 0.4145 | 3 | 425 | detection of chemical stimulus |
| GO:0016458 | 0.0075 | 17.6183 | 0.1317 | 2 | 135 | gene silencing |
| GO:0042592 | 0.0075 | 5.182 | 1.3236 | 5 | 1357 | homeostatic process |
| GO:0022417 | 0.0078 | 156.7041 | 0.0078 | 1 | 8 | protein maturation by protein folding |
| GO:0034975 | 0.0078 | 156.7041 | 0.0078 | 1 | 8 | protein folding in endoplasmic reticulum |
| GO:0038166 | 0.0078 | 156.7041 | 0.0078 | 1 | 8 | angiotensin-activated signaling pathway |
| GO:0050906 | 0.0078 | 8.6826 | 0.4223 | 3 | 433 | detection of stimulus involved in sensory perception |
| GO:0007606 | 0.0091 | 8.2104 | 0.4457 | 3 | 457 | sensory perception of chemical stimulus |
| GO:0045945 | 0.0097 | 121.8651 | 0.0098 | 1 | 10 | positive regulation of transcription from RNA polymerase III promoter |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0021509 | 0.001 | Inf | 0.001 | 1 | 1 | roof plate formation |
| GO:0042502 | 0.001 | Inf | 0.001 | 1 | 1 | tyrosine phosphorylation of Stat2 protein |
| GO:2001051 | 0.001 | Inf | 0.001 | 1 | 1 | positive regulation of tendon cell differentiation |
| GO:0035483 | 0.0021 | 1024.1333 | 0.0021 | 1 | 2 | gastric emptying |
| GO:0048866 | 0.0021 | 1024.1333 | 0.0021 | 1 | 2 | stem cell fate specification |
| GO:0031064 | 0.0042 | 341.3333 | 0.0042 | 1 | 4 | negative regulation of histone deacetylation |
| GO:0035992 | 0.0042 | 341.3333 | 0.0042 | 1 | 4 | tendon formation |
| GO:0051461 | 0.0042 | 341.3333 | 0.0042 | 1 | 4 | positive regulation of corticotropin secretion |
| GO:0060214 | 0.0042 | 341.3333 | 0.0042 | 1 | 4 | endocardium formation |
| GO:0060455 | 0.0042 | 341.3333 | 0.0042 | 1 | 4 | negative regulation of gastric acid secretion |
| GO:1903365 | 0.0042 | 341.3333 | 0.0042 | 1 | 4 | regulation of fear response |
| GO:2000987 | 0.0042 | 341.3333 | 0.0042 | 1 | 4 | positive regulation of behavioral fear response |
| GO:0060836 | 0.0062 | 204.7733 | 0.0062 | 1 | 6 | lymphatic endothelial cell differentiation |
| GO:0060956 | 0.0062 | 204.7733 | 0.0062 | 1 | 6 | endocardial cell differentiation |
| GO:0006334 | 0.0065 | 18.7771 | 0.1228 | 2 | 118 | nucleosome assembly |
| GO:0042756 | 0.0073 | 170.6333 | 0.0073 | 1 | 7 | drinking behavior |
| GO:0060452 | 0.0073 | 170.6333 | 0.0073 | 1 | 7 | positive regulation of cardiac muscle contraction |
| GO:2000252 | 0.0073 | 170.6333 | 0.0073 | 1 | 7 | negative regulation of feeding behavior |
| GO:0007586 | 0.0081 | 16.7396 | 0.1373 | 2 | 132 | digestion |
| GO:0043117 | 0.0083 | 146.2476 | 0.0083 | 1 | 8 | positive regulation of vascular permeability |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0045065 | 0.0029 | 548.6429 | 0.0029 | 1 | 3 | cytotoxic T cell differentiation |
| GO:2000467 | 0.0049 | 274.2857 | 0.0049 | 1 | 5 | positive regulation of glycogen (starch) synthase activity |
| GO:0010666 | 0.0068 | 182.8333 | 0.0068 | 1 | 7 | positive regulation of cardiac muscle cell apoptotic process |
| GO:0048552 | 0.0097 | 121.8651 | 0.0098 | 1 | 10 | regulation of metalloenzyme activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042742 | 0 | 108.8602 | 0.0865 | 4 | 190 | defense response to bacterium |
| GO:0042089 | 0 | 119.3438 | 0.0451 | 3 | 99 | cytokine biosynthetic process |
| GO:0006909 | 1e-04 | 61.9076 | 0.0851 | 3 | 187 | phagocytosis |
| GO:0031640 | 1e-04 | 236.0923 | 0.0127 | 2 | 28 | killing of cells of other organism |
| GO:0051707 | 1e-04 | 28.5878 | 0.3136 | 4 | 689 | response to other organism |
| GO:0009607 | 1e-04 | 27.2524 | 0.3282 | 4 | 721 | response to biotic stimulus |
| GO:0032602 | 3e-04 | 105.6138 | 0.0273 | 2 | 60 | chemokine production |
| GO:0032644 | 5e-04 | Inf | 5e-04 | 1 | 1 | regulation of fractalkine production |
| GO:0050725 | 5e-04 | Inf | 5e-04 | 1 | 1 | positive regulation of interleukin-1 beta biosynthetic process |
| GO:0050754 | 5e-04 | Inf | 5e-04 | 1 | 1 | positive regulation of fractalkine biosynthetic process |
| GO:0070947 | 5e-04 | Inf | 5e-04 | 1 | 1 | neutrophil mediated killing of fungus |
| GO:0035821 | 6e-04 | 73.6819 | 0.0387 | 2 | 85 | modification of morphology or physiology of other organism |
| GO:0045360 | 9e-04 | 2561.8333 | 9e-04 | 1 | 2 | regulation of interleukin-1 biosynthetic process |
| GO:0042221 | 0.001 | 19.3385 | 1.6595 | 6 | 3646 | response to chemical |
| GO:0045079 | 0.0014 | 1280.8333 | 0.0014 | 1 | 3 | negative regulation of chemokine biosynthetic process |
| GO:0050756 | 0.0014 | 1280.8333 | 0.0014 | 1 | 3 | fractalkine metabolic process |
| GO:0050920 | 0.0016 | 45.4866 | 0.0619 | 2 | 136 | regulation of chemotaxis |
| GO:0043901 | 0.0016 | 44.8118 | 0.0628 | 2 | 138 | negative regulation of multi-organism process |
| GO:0001878 | 0.0018 | 853.8333 | 0.0018 | 1 | 4 | response to yeast |
| GO:0045415 | 0.0018 | 853.8333 | 0.0018 | 1 | 4 | negative regulation of interleukin-8 biosynthetic process |
| GO:0006952 | 0.0022 | 12.8901 | 0.6577 | 4 | 1445 | defense response |
| GO:0070942 | 0.0023 | 640.3333 | 0.0023 | 1 | 5 | neutrophil mediated cytotoxicity |
| GO:0042330 | 0.0025 | 16.6918 | 0.3022 | 3 | 664 | taxis |
| GO:0045416 | 0.0027 | 512.2333 | 0.0027 | 1 | 6 | positive regulation of interleukin-8 biosynthetic process |
| GO:0051873 | 0.0032 | 426.8333 | 0.0032 | 1 | 7 | killing by host of symbiont cells |
| GO:0045073 | 0.0035 | 384.05 | 0.0035 | 1 | 9 | regulation of chemokine biosynthetic process |
| GO:0042117 | 0.0036 | 365.8333 | 0.0036 | 1 | 8 | monocyte activation |
| GO:0045348 | 0.0036 | 365.8333 | 0.0036 | 1 | 8 | positive regulation of MHC class II biosynthetic process |
| GO:0001774 | 0.0045 | 284.5 | 0.0046 | 1 | 10 | microglial cell activation |
| GO:0042535 | 0.0045 | 284.5 | 0.0046 | 1 | 10 | positive regulation of tumor necrosis factor biosynthetic process |
| GO:0051818 | 0.005 | 256.0333 | 0.005 | 1 | 11 | disruption of cells of other organism involved in symbiotic interaction |
| GO:0050755 | 0.0051 | 255.9667 | 0.0051 | 1 | 13 | chemokine metabolic process |
| GO:0032496 | 0.0055 | 23.7129 | 0.117 | 2 | 257 | response to lipopolysaccharide |
| GO:0050930 | 0.0064 | 196.9103 | 0.0064 | 1 | 14 | induction of positive chemotaxis |
| GO:0002438 | 0.0073 | 170.6333 | 0.0073 | 1 | 16 | acute inflammatory response to antigenic stimulus |
| GO:0044130 | 0.0073 | 170.6333 | 0.0073 | 1 | 16 | negative regulation of growth of symbiont in host |
| GO:0044144 | 0.0073 | 170.6333 | 0.0073 | 1 | 16 | modulation of growth of symbiont involved in interaction with host |
| GO:0050900 | 0.0082 | 19.2447 | 0.1434 | 2 | 315 | leukocyte migration |
| GO:0044110 | 0.0091 | 134.6754 | 0.0091 | 1 | 20 | growth involved in symbiotic interaction |
| GO:0001819 | 0.0095 | 17.7917 | 0.1548 | 2 | 340 | positive regulation of cytokine production |
| GO:0002227 | 0.01 | 121.8333 | 0.01 | 1 | 22 | innate immune response in mucosa |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042742 | 0 | 108.8602 | 0.0865 | 4 | 190 | defense response to bacterium |
| GO:0042089 | 0 | 119.3438 | 0.0451 | 3 | 99 | cytokine biosynthetic process |
| GO:0006909 | 1e-04 | 61.9076 | 0.0851 | 3 | 187 | phagocytosis |
| GO:0031640 | 1e-04 | 236.0923 | 0.0127 | 2 | 28 | killing of cells of other organism |
| GO:0051707 | 1e-04 | 28.5878 | 0.3136 | 4 | 689 | response to other organism |
| GO:0009607 | 1e-04 | 27.2524 | 0.3282 | 4 | 721 | response to biotic stimulus |
| GO:0032602 | 3e-04 | 105.6138 | 0.0273 | 2 | 60 | chemokine production |
| GO:0032644 | 5e-04 | Inf | 5e-04 | 1 | 1 | regulation of fractalkine production |
| GO:0050725 | 5e-04 | Inf | 5e-04 | 1 | 1 | positive regulation of interleukin-1 beta biosynthetic process |
| GO:0050754 | 5e-04 | Inf | 5e-04 | 1 | 1 | positive regulation of fractalkine biosynthetic process |
| GO:0070947 | 5e-04 | Inf | 5e-04 | 1 | 1 | neutrophil mediated killing of fungus |
| GO:0035821 | 6e-04 | 73.6819 | 0.0387 | 2 | 85 | modification of morphology or physiology of other organism |
| GO:0045360 | 9e-04 | 2561.8333 | 9e-04 | 1 | 2 | regulation of interleukin-1 biosynthetic process |
| GO:0045079 | 0.0014 | 1280.8333 | 0.0014 | 1 | 3 | negative regulation of chemokine biosynthetic process |
| GO:0050756 | 0.0014 | 1280.8333 | 0.0014 | 1 | 3 | fractalkine metabolic process |
| GO:0050920 | 0.0016 | 45.4866 | 0.0619 | 2 | 136 | regulation of chemotaxis |
| GO:0006955 | 0.0017 | 13.7706 | 0.6195 | 4 | 1361 | immune response |
| GO:0001878 | 0.0018 | 853.8333 | 0.0018 | 1 | 4 | response to yeast |
| GO:0045415 | 0.0018 | 853.8333 | 0.0018 | 1 | 4 | negative regulation of interleukin-8 biosynthetic process |
| GO:0006952 | 0.0022 | 12.8901 | 0.6577 | 4 | 1445 | defense response |
| GO:0070942 | 0.0023 | 640.3333 | 0.0023 | 1 | 5 | neutrophil mediated cytotoxicity |
| GO:0042330 | 0.0025 | 16.6918 | 0.3022 | 3 | 664 | taxis |
| GO:0045416 | 0.0027 | 512.2333 | 0.0027 | 1 | 6 | positive regulation of interleukin-8 biosynthetic process |
| GO:0051873 | 0.0032 | 426.8333 | 0.0032 | 1 | 7 | killing by host of symbiont cells |
| GO:0045073 | 0.0035 | 384.05 | 0.0035 | 1 | 9 | regulation of chemokine biosynthetic process |
| GO:0042117 | 0.0036 | 365.8333 | 0.0036 | 1 | 8 | monocyte activation |
| GO:0045348 | 0.0036 | 365.8333 | 0.0036 | 1 | 8 | positive regulation of MHC class II biosynthetic process |
| GO:0001774 | 0.0045 | 284.5 | 0.0046 | 1 | 10 | microglial cell activation |
| GO:0042535 | 0.0045 | 284.5 | 0.0046 | 1 | 10 | positive regulation of tumor necrosis factor biosynthetic process |
| GO:0051818 | 0.005 | 256.0333 | 0.005 | 1 | 11 | disruption of cells of other organism involved in symbiotic interaction |
| GO:0050755 | 0.0051 | 255.9667 | 0.0051 | 1 | 13 | chemokine metabolic process |
| GO:0032496 | 0.0055 | 23.7129 | 0.117 | 2 | 257 | response to lipopolysaccharide |
| GO:0050930 | 0.0064 | 196.9103 | 0.0064 | 1 | 14 | induction of positive chemotaxis |
| GO:0002438 | 0.0073 | 170.6333 | 0.0073 | 1 | 16 | acute inflammatory response to antigenic stimulus |
| GO:0044130 | 0.0073 | 170.6333 | 0.0073 | 1 | 16 | negative regulation of growth of symbiont in host |
| GO:0044144 | 0.0073 | 170.6333 | 0.0073 | 1 | 16 | modulation of growth of symbiont involved in interaction with host |
| GO:0050900 | 0.0082 | 19.2447 | 0.1434 | 2 | 315 | leukocyte migration |
| GO:0044110 | 0.0091 | 134.6754 | 0.0091 | 1 | 20 | growth involved in symbiotic interaction |
| GO:0001819 | 0.0095 | 17.7917 | 0.1548 | 2 | 340 | positive regulation of cytokine production |
| GO:0002227 | 0.01 | 121.8333 | 0.01 | 1 | 22 | innate immune response in mucosa |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042742 | 0 | 81.6398 | 0.0988 | 4 | 190 | defense response to bacterium |
| GO:0051852 | 0 | 1024.4 | 0.0036 | 2 | 7 | disruption by host of symbiont cells |
| GO:0051707 | 0 | 35.787 | 0.3584 | 5 | 689 | response to other organism |
| GO:0051883 | 0 | 568.963 | 0.0057 | 2 | 11 | killing of cells in other organism involved in symbiotic interaction |
| GO:0044130 | 0 | 365.6429 | 0.0083 | 2 | 16 | negative regulation of growth of symbiont in host |
| GO:0044144 | 0 | 365.6429 | 0.0083 | 2 | 16 | modulation of growth of symbiont involved in interaction with host |
| GO:0044110 | 0 | 284.3148 | 0.0104 | 2 | 20 | growth involved in symbiotic interaction |
| GO:0050832 | 1e-04 | 255.7833 | 0.0118 | 2 | 26 | defense response to fungus |
| GO:0002446 | 1e-04 | 243.6508 | 0.012 | 2 | 23 | neutrophil mediated immunity |
| GO:0051702 | 2e-04 | 121.6587 | 0.0229 | 2 | 44 | interaction with symbiont |
| GO:0051817 | 5e-04 | 78.4923 | 0.0349 | 2 | 67 | modification of morphology or physiology of other organism involved in symbiotic interaction |
| GO:0010963 | 5e-04 | Inf | 5e-04 | 1 | 1 | regulation of L-arginine import |
| GO:0070946 | 5e-04 | Inf | 5e-04 | 1 | 1 | neutrophil mediated killing of gram-positive bacterium |
| GO:0070947 | 5e-04 | Inf | 5e-04 | 1 | 1 | neutrophil mediated killing of fungus |
| GO:0001909 | 7e-04 | 67.0833 | 0.0406 | 2 | 78 | leukocyte mediated cytotoxicity |
| GO:0009607 | 0.001 | 25.6655 | 0.2261 | 3 | 574 | response to biotic stimulus |
| GO:0032496 | 0.0011 | 57.7023 | 0.0523 | 2 | 133 | response to lipopolysaccharide |
| GO:0042089 | 0.0011 | 52.488 | 0.0515 | 2 | 99 | cytokine biosynthetic process |
| GO:0032963 | 0.0015 | 45.4137 | 0.0593 | 2 | 114 | collagen metabolic process |
| GO:0009605 | 0.0015 | 11.1553 | 1.0419 | 5 | 2003 | response to external stimulus |
| GO:0045079 | 0.0016 | 1097.7857 | 0.0016 | 1 | 3 | negative regulation of chemokine biosynthetic process |
| GO:0090467 | 0.0016 | 1097.7857 | 0.0016 | 1 | 3 | arginine import |
| GO:1902023 | 0.0016 | 1097.7857 | 0.0016 | 1 | 3 | L-arginine transport |
| GO:0022617 | 0.0017 | 41.6639 | 0.0645 | 2 | 124 | extracellular matrix disassembly |
| GO:0071222 | 0.0017 | 41.6639 | 0.0645 | 2 | 124 | cellular response to lipopolysaccharide |
| GO:0070943 | 0.0018 | 853.7778 | 0.0018 | 1 | 4 | neutrophil mediated killing of symbiont cell |
| GO:0044236 | 0.002 | 39.0795 | 0.0687 | 2 | 132 | multicellular organismal metabolic process |
| GO:0001878 | 0.0021 | 731.8095 | 0.0021 | 1 | 4 | response to yeast |
| GO:0045415 | 0.0021 | 731.8095 | 0.0021 | 1 | 4 | negative regulation of interleukin-8 biosynthetic process |
| GO:0043901 | 0.0022 | 37.3407 | 0.0718 | 2 | 138 | negative regulation of multi-organism process |
| GO:0071216 | 0.0024 | 35.0023 | 0.0765 | 2 | 147 | cellular response to biotic stimulus |
| GO:0010269 | 0.0026 | 548.8214 | 0.0026 | 1 | 5 | response to selenium ion |
| GO:0045416 | 0.0031 | 439.0286 | 0.0031 | 1 | 6 | positive regulation of interleukin-8 biosynthetic process |
| GO:0042221 | 0.0032 | 9.6684 | 1.8966 | 6 | 3646 | response to chemical |
| GO:0006909 | 0.0039 | 27.3622 | 0.0973 | 2 | 187 | phagocytosis |
| GO:0006952 | 0.004 | 9.6669 | 0.7517 | 4 | 1445 | defense response |
| GO:0009635 | 0.0042 | 313.551 | 0.0042 | 1 | 8 | response to herbicide |
| GO:0051597 | 0.0042 | 313.551 | 0.0042 | 1 | 8 | response to methylmercury |
| GO:0006527 | 0.0047 | 274.3393 | 0.0047 | 1 | 9 | arginine catabolic process |
| GO:0060056 | 0.0047 | 274.3393 | 0.0047 | 1 | 9 | mammary gland involution |
| GO:0045926 | 0.0049 | 24.2997 | 0.1092 | 2 | 210 | negative regulation of growth |
| GO:0002003 | 0.0052 | 243.8413 | 0.0052 | 1 | 10 | angiotensin maturation |
| GO:0000050 | 0.0057 | 219.4429 | 0.0057 | 1 | 11 | urea cycle |
| GO:0015802 | 0.0057 | 219.4429 | 0.0057 | 1 | 11 | basic amino acid transport |
| GO:0060177 | 0.0057 | 219.4429 | 0.0057 | 1 | 11 | regulation of angiotensin metabolic process |
| GO:0010042 | 0.0062 | 199.4805 | 0.0062 | 1 | 12 | response to manganese ion |
| GO:0033197 | 0.0062 | 199.4805 | 0.0062 | 1 | 12 | response to vitamin E |
| GO:0043092 | 0.0062 | 199.4805 | 0.0062 | 1 | 12 | L-amino acid import |
| GO:0031640 | 0.0066 | 191.825 | 0.0066 | 1 | 17 | killing of cells of other organism |
| GO:0033189 | 0.0067 | 182.8452 | 0.0068 | 1 | 13 | response to vitamin A |
| GO:0035821 | 0.007 | 179.8706 | 0.0071 | 1 | 18 | modification of morphology or physiology of other organism |
| GO:0071941 | 0.0073 | 168.7692 | 0.0073 | 1 | 14 | nitrogen cycle metabolic process |
| GO:0043603 | 0.0077 | 19.2226 | 0.1373 | 2 | 264 | cellular amide metabolic process |
| GO:0002438 | 0.0083 | 146.2476 | 0.0083 | 1 | 16 | acute inflammatory response to antigenic stimulus |
| GO:0050755 | 0.0083 | 146.2476 | 0.0083 | 1 | 16 | chemokine metabolic process |
| GO:0001991 | 0.0088 | 137.0982 | 0.0088 | 1 | 17 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin |
| GO:0070207 | 0.0088 | 137.0982 | 0.0088 | 1 | 17 | protein homotrimerization |
| GO:0071549 | 0.0093 | 129.0252 | 0.0094 | 1 | 18 | cellular response to dexamethasone stimulus |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0014739 | 0.001 | Inf | 0.001 | 1 | 1 | positive regulation of muscle hyperplasia |
| GO:0006955 | 0.0012 | 6.8925 | 1.3275 | 6 | 1361 | immune response |
| GO:0060350 | 0.0014 | 42.8224 | 0.0556 | 2 | 57 | endochondral bone morphogenesis |
| GO:0007165 | 0.0014 | 5.7154 | 4.8787 | 11 | 5002 | signal transduction |
| GO:0071672 | 0.0019 | 1097.3571 | 0.002 | 1 | 2 | negative regulation of smooth muscle cell chemotaxis |
| GO:0071673 | 0.0019 | 1097.3571 | 0.002 | 1 | 2 | positive regulation of smooth muscle cell chemotaxis |
| GO:0071315 | 0.0029 | 548.6429 | 0.0029 | 1 | 3 | cellular response to morphine |
| GO:2000172 | 0.0029 | 548.6429 | 0.0029 | 1 | 3 | regulation of branching morphogenesis of a nerve |
| GO:0023052 | 0.0032 | 4.994 | 5.3323 | 11 | 5467 | signaling |
| GO:0048584 | 0.0036 | 5.4374 | 1.6425 | 6 | 1684 | positive regulation of response to stimulus |
| GO:0002682 | 0.0037 | 6.2209 | 1.1197 | 5 | 1148 | regulation of immune system process |
| GO:0051249 | 0.0037 | 11.4604 | 0.3228 | 3 | 331 | regulation of lymphocyte activation |
| GO:0050852 | 0.0045 | 23.0196 | 0.1014 | 2 | 104 | T cell receptor signaling pathway |
| GO:0051534 | 0.0049 | 274.2857 | 0.0049 | 1 | 5 | negative regulation of NFAT protein import into nucleus |
| GO:0009838 | 0.0058 | 219.4143 | 0.0059 | 1 | 6 | abscission |
| GO:0048743 | 0.0058 | 219.4143 | 0.0059 | 1 | 6 | positive regulation of skeletal muscle fiber development |
| GO:0071447 | 0.0058 | 219.4143 | 0.0059 | 1 | 6 | cellular response to hydroperoxide |
| GO:0050865 | 0.0068 | 9.1642 | 0.4009 | 3 | 411 | regulation of cell activation |
| GO:0032466 | 0.0068 | 182.8333 | 0.0068 | 1 | 7 | negative regulation of cytokinesis |
| GO:2000045 | 0.007 | 18.1694 | 0.1278 | 2 | 131 | regulation of G1/S transition of mitotic cell cycle |
| GO:0035630 | 0.0078 | 156.7041 | 0.0078 | 1 | 8 | bone mineralization involved in bone maturation |
| GO:0002274 | 0.0083 | 16.6099 | 0.1395 | 2 | 143 | myeloid leukocyte activation |
| GO:0003376 | 0.0087 | 137.1071 | 0.0088 | 1 | 9 | sphingosine-1-phosphate signaling pathway |
| GO:0050790 | 0.0091 | 4.3889 | 1.9819 | 6 | 2032 | regulation of catalytic activity |
| GO:0045936 | 0.0092 | 8.1732 | 0.4477 | 3 | 459 | negative regulation of phosphate metabolic process |
| GO:0051174 | 0.0093 | 4.9023 | 1.3918 | 5 | 1427 | regulation of phosphorus metabolic process |
| GO:0010564 | 0.0096 | 8.0459 | 0.4545 | 3 | 466 | regulation of cell cycle process |
| GO:0001774 | 0.0097 | 121.8651 | 0.0098 | 1 | 10 | microglial cell activation |
| GO:0051546 | 0.0097 | 121.8651 | 0.0098 | 1 | 10 | keratinocyte migration |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0002376 | 3e-04 | 10.2724 | 1.605 | 7 | 2244 | immune system process |
| GO:0045576 | 5e-04 | 75.6691 | 0.0336 | 2 | 47 | mast cell activation |
| GO:0042326 | 0.0017 | 16.2331 | 0.2503 | 3 | 350 | negative regulation of phosphorylation |
| GO:0019220 | 0.0019 | 8.243 | 1.0128 | 5 | 1416 | regulation of phosphate metabolic process |
| GO:2000172 | 0.0021 | 768.3 | 0.0021 | 1 | 3 | regulation of branching morphogenesis of a nerve |
| GO:0044700 | 0.0023 | 8.1752 | 3.9089 | 9 | 5465 | single organism signaling |
| GO:0042110 | 0.0024 | 14.3265 | 0.2825 | 3 | 395 | T cell activation |
| GO:0001775 | 0.0024 | 9.628 | 0.6187 | 4 | 865 | cell activation |
| GO:0071593 | 0.0024 | 14.2519 | 0.284 | 3 | 397 | lymphocyte aggregation |
| GO:0007154 | 0.0026 | 7.9628 | 3.9754 | 9 | 5558 | cell communication |
| GO:0007159 | 0.0031 | 13.0586 | 0.309 | 3 | 432 | leukocyte cell-cell adhesion |
| GO:0051534 | 0.0036 | 384.1 | 0.0036 | 1 | 5 | negative regulation of NFAT protein import into nucleus |
| GO:0010563 | 0.0036 | 12.2632 | 0.3283 | 3 | 459 | negative regulation of phosphorus metabolic process |
| GO:0034109 | 0.0037 | 12.208 | 0.3297 | 3 | 461 | homotypic cell-cell adhesion |
| GO:0009966 | 0.004 | 6.2122 | 1.7839 | 6 | 2494 | regulation of signal transduction |
| GO:0048743 | 0.0043 | 307.26 | 0.0043 | 1 | 6 | positive regulation of skeletal muscle fiber development |
| GO:0051716 | 0.0052 | 6.9535 | 4.3252 | 9 | 6047 | cellular response to stimulus |
| GO:0002366 | 0.007 | 18.9638 | 0.1287 | 2 | 180 | leukocyte activation involved in immune response |
| GO:0042113 | 0.0086 | 17.0258 | 0.1431 | 2 | 200 | B cell activation |
| GO:0060272 | 0.0093 | 127.9667 | 0.0093 | 1 | 13 | embryonic skeletal joint morphogenesis |
| GO:0060326 | 0.0093 | 16.2759 | 0.1495 | 2 | 209 | cell chemotaxis |
| GO:0034097 | 0.0095 | 8.5877 | 0.4621 | 3 | 646 | response to cytokine |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0014739 | 0.001 | Inf | 0.001 | 1 | 1 | positive regulation of muscle hyperplasia |
| GO:0006955 | 0.0012 | 6.8925 | 1.3275 | 6 | 1361 | immune response |
| GO:0060350 | 0.0014 | 42.8224 | 0.0556 | 2 | 57 | endochondral bone morphogenesis |
| GO:0007165 | 0.0014 | 5.7154 | 4.8787 | 11 | 5002 | signal transduction |
| GO:0071672 | 0.0019 | 1097.3571 | 0.002 | 1 | 2 | negative regulation of smooth muscle cell chemotaxis |
| GO:0071673 | 0.0019 | 1097.3571 | 0.002 | 1 | 2 | positive regulation of smooth muscle cell chemotaxis |
| GO:0071315 | 0.0029 | 548.6429 | 0.0029 | 1 | 3 | cellular response to morphine |
| GO:2000172 | 0.0029 | 548.6429 | 0.0029 | 1 | 3 | regulation of branching morphogenesis of a nerve |
| GO:0023052 | 0.0032 | 4.994 | 5.3323 | 11 | 5467 | signaling |
| GO:0048584 | 0.0036 | 5.4374 | 1.6425 | 6 | 1684 | positive regulation of response to stimulus |
| GO:0002682 | 0.0037 | 6.2209 | 1.1197 | 5 | 1148 | regulation of immune system process |
| GO:0051249 | 0.0037 | 11.4604 | 0.3228 | 3 | 331 | regulation of lymphocyte activation |
| GO:0050852 | 0.0045 | 23.0196 | 0.1014 | 2 | 104 | T cell receptor signaling pathway |
| GO:0051534 | 0.0049 | 274.2857 | 0.0049 | 1 | 5 | negative regulation of NFAT protein import into nucleus |
| GO:0009838 | 0.0058 | 219.4143 | 0.0059 | 1 | 6 | abscission |
| GO:0048743 | 0.0058 | 219.4143 | 0.0059 | 1 | 6 | positive regulation of skeletal muscle fiber development |
| GO:0071447 | 0.0058 | 219.4143 | 0.0059 | 1 | 6 | cellular response to hydroperoxide |
| GO:0050865 | 0.0068 | 9.1642 | 0.4009 | 3 | 411 | regulation of cell activation |
| GO:0032466 | 0.0068 | 182.8333 | 0.0068 | 1 | 7 | negative regulation of cytokinesis |
| GO:2000045 | 0.007 | 18.1694 | 0.1278 | 2 | 131 | regulation of G1/S transition of mitotic cell cycle |
| GO:0035630 | 0.0078 | 156.7041 | 0.0078 | 1 | 8 | bone mineralization involved in bone maturation |
| GO:0002274 | 0.0083 | 16.6099 | 0.1395 | 2 | 143 | myeloid leukocyte activation |
| GO:0003376 | 0.0087 | 137.1071 | 0.0088 | 1 | 9 | sphingosine-1-phosphate signaling pathway |
| GO:0050790 | 0.0091 | 4.3889 | 1.9819 | 6 | 2032 | regulation of catalytic activity |
| GO:0045936 | 0.0092 | 8.1732 | 0.4477 | 3 | 459 | negative regulation of phosphate metabolic process |
| GO:0051174 | 0.0093 | 4.9023 | 1.3918 | 5 | 1427 | regulation of phosphorus metabolic process |
| GO:0010564 | 0.0096 | 8.0459 | 0.4545 | 3 | 466 | regulation of cell cycle process |
| GO:0001774 | 0.0097 | 121.8651 | 0.0098 | 1 | 10 | microglial cell activation |
| GO:0051546 | 0.0097 | 121.8651 | 0.0098 | 1 | 10 | keratinocyte migration |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006264 | 0.0039 | 365.7381 | 0.0039 | 1 | 15 | mitochondrial DNA replication |
| GO:0000002 | 0.007 | 196.7821 | 0.007 | 1 | 27 | mitochondrial genome maintenance |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0002376 | 0.0012 | 8.8009 | 1.4591 | 6 | 2244 | immune system process |
| GO:0010193 | 0.0032 | 426.8056 | 0.0033 | 1 | 5 | response to ozone |
| GO:0051534 | 0.0032 | 426.8056 | 0.0033 | 1 | 5 | negative regulation of NFAT protein import into nucleus |
| GO:0016098 | 0.0039 | 341.4222 | 0.0039 | 1 | 6 | monoterpenoid metabolic process |
| GO:0042113 | 0.0071 | 19.1553 | 0.13 | 2 | 200 | B cell activation |
| GO:0034097 | 0.0071 | 9.8152 | 0.4201 | 3 | 646 | response to cytokine |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0051534 | 0.0019 | 768.45 | 0.002 | 1 | 5 | negative regulation of NFAT protein import into nucleus |
| GO:0042113 | 0.0024 | 38.3207 | 0.078 | 2 | 200 | B cell activation |
| GO:0002376 | 0.0053 | 11.7259 | 0.8755 | 4 | 2244 | immune system process |
| GO:0033141 | 0.007 | 180.6588 | 0.007 | 1 | 18 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
| GO:0042326 | 0.0073 | 21.5876 | 0.1365 | 2 | 350 | negative regulation of phosphorylation |
| GO:0030511 | 0.0086 | 146.2095 | 0.0086 | 1 | 22 | positive regulation of transforming growth factor beta receptor signaling pathway |
| GO:0045343 | 0.0086 | 146.2095 | 0.0086 | 1 | 22 | regulation of MHC class I biosynthetic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:2000502 | 0 | 5123.3333 | 0.0016 | 2 | 3 | negative regulation of natural killer cell chemotaxis |
| GO:2000402 | 0 | 1024.4 | 0.0036 | 2 | 7 | negative regulation of lymphocyte migration |
| GO:0002689 | 0 | 640.125 | 0.0052 | 2 | 10 | negative regulation of leukocyte chemotaxis |
| GO:0045954 | 0 | 365.6429 | 0.0083 | 2 | 16 | positive regulation of natural killer cell mediated cytotoxicity |
| GO:1901623 | 0 | 301.0588 | 0.0099 | 2 | 19 | regulation of lymphocyte chemotaxis |
| GO:0034260 | 0 | 284.3148 | 0.0104 | 2 | 20 | negative regulation of GTPase activity |
| GO:0002715 | 1e-04 | 204.6133 | 0.014 | 2 | 27 | regulation of natural killer cell mediated immunity |
| GO:0045089 | 1e-04 | 43.5273 | 0.1103 | 3 | 212 | positive regulation of innate immune response |
| GO:0031343 | 2e-04 | 131.0427 | 0.0213 | 2 | 41 | positive regulation of cell killing |
| GO:0048521 | 2e-04 | 127.7583 | 0.0218 | 2 | 42 | negative regulation of behavior |
| GO:0002443 | 2e-04 | 36.1434 | 0.1321 | 3 | 254 | leukocyte mediated immunity |
| GO:0001910 | 3e-04 | 111.0507 | 0.025 | 2 | 48 | regulation of leukocyte mediated cytotoxicity |
| GO:0050776 | 3e-04 | 19.5495 | 0.3912 | 4 | 752 | regulation of immune response |
| GO:0002708 | 5e-04 | 78.4923 | 0.0349 | 2 | 67 | positive regulation of lymphocyte mediated immunity |
| GO:0031295 | 5e-04 | 76.1393 | 0.0359 | 2 | 69 | T cell costimulation |
| GO:0030101 | 6e-04 | 75.0147 | 0.0364 | 2 | 70 | natural killer cell activation |
| GO:0070489 | 9e-04 | 22.927 | 0.2055 | 3 | 395 | T cell aggregation |
| GO:0070486 | 9e-04 | 22.4565 | 0.2096 | 3 | 403 | leukocyte aggregation |
| GO:1902530 | 0.001 | 2195.7143 | 0.001 | 1 | 2 | positive regulation of protein linear polyubiquitination |
| GO:0045065 | 0.0016 | 1097.7857 | 0.0016 | 1 | 3 | cytotoxic T cell differentiation |
| GO:0002685 | 0.0016 | 43.0876 | 0.0624 | 2 | 120 | regulation of leukocyte migration |
| GO:0031347 | 0.0019 | 17.1017 | 0.2726 | 3 | 524 | regulation of defense response |
| GO:0002699 | 0.0021 | 37.903 | 0.0707 | 2 | 136 | positive regulation of immune effector process |
| GO:0050920 | 0.0021 | 37.903 | 0.0707 | 2 | 136 | regulation of chemotaxis |
| GO:0070424 | 0.0031 | 439.0286 | 0.0031 | 1 | 6 | regulation of nucleotide-binding oligomerization domain containing signaling pathway |
| GO:0030336 | 0.0034 | 29.2832 | 0.091 | 2 | 175 | negative regulation of cell migration |
| GO:0045321 | 0.0035 | 13.8329 | 0.334 | 3 | 642 | leukocyte activation |
| GO:0016337 | 0.0037 | 13.5668 | 0.3402 | 3 | 654 | single organismal cell-cell adhesion |
| GO:1903039 | 0.0037 | 28.2905 | 0.0942 | 2 | 181 | positive regulation of leukocyte cell-cell adhesion |
| GO:0034112 | 0.0038 | 27.9742 | 0.0952 | 2 | 183 | positive regulation of homotypic cell-cell adhesion |
| GO:1902914 | 0.0042 | 313.551 | 0.0042 | 1 | 8 | regulation of protein polyubiquitination |
| GO:0051271 | 0.0042 | 26.4921 | 0.1004 | 2 | 193 | negative regulation of cellular component movement |
| GO:0060326 | 0.0049 | 24.4187 | 0.1087 | 2 | 209 | cell chemotaxis |
| GO:0040013 | 0.0051 | 23.8349 | 0.1113 | 2 | 214 | negative regulation of locomotion |
| GO:0043086 | 0.0052 | 11.9137 | 0.3849 | 3 | 740 | negative regulation of catalytic activity |
| GO:0097341 | 0.0052 | 243.8413 | 0.0052 | 1 | 10 | zymogen inhibition |
| GO:1990001 | 0.0052 | 243.8413 | 0.0052 | 1 | 10 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0032102 | 0.0056 | 22.7462 | 0.1165 | 2 | 224 | negative regulation of response to external stimulus |
| GO:2000353 | 0.0057 | 219.4429 | 0.0057 | 1 | 11 | positive regulation of endothelial cell apoptotic process |
| GO:0051251 | 0.0058 | 22.3378 | 0.1186 | 2 | 228 | positive regulation of lymphocyte activation |
| GO:0060033 | 0.0067 | 182.8452 | 0.0068 | 1 | 13 | anatomical structure regression |
| GO:0050863 | 0.0069 | 20.3266 | 0.13 | 2 | 250 | regulation of T cell activation |
| GO:0048584 | 0.007 | 8.1494 | 0.876 | 4 | 1684 | positive regulation of response to stimulus |
| GO:0050867 | 0.0075 | 19.5258 | 0.1352 | 2 | 260 | positive regulation of cell activation |
| GO:0055070 | 0.0078 | 156.7041 | 0.0078 | 1 | 15 | copper ion homeostasis |
| GO:0048535 | 0.0088 | 137.0982 | 0.0088 | 1 | 17 | lymph node development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0070489 | 0 | 115.5424 | 0.2055 | 6 | 395 | T cell aggregation |
| GO:0070486 | 0 | 113.1537 | 0.2096 | 6 | 403 | leukocyte aggregation |
| GO:0098602 | 0 | 63.9274 | 0.3615 | 6 | 695 | single organism cell adhesion |
| GO:0001775 | 0 | 50.6822 | 0.45 | 6 | 865 | cell activation |
| GO:0050863 | 0 | 222.4412 | 0.028 | 3 | 71 | regulation of T cell activation |
| GO:0048007 | 0 | 1024.4 | 0.0036 | 2 | 7 | antigen processing and presentation, exogenous lipid antigen via MHC class Ib |
| GO:0033077 | 0 | 133.0609 | 0.0375 | 3 | 72 | T cell differentiation in thymus |
| GO:0030098 | 0 | 55.511 | 0.1436 | 4 | 276 | lymphocyte differentiation |
| GO:0022407 | 0 | 128.5726 | 0.0475 | 3 | 120 | regulation of cell-cell adhesion |
| GO:0022610 | 0 | 32.0669 | 0.6872 | 6 | 1321 | biological adhesion |
| GO:0002475 | 0 | 568.963 | 0.0057 | 2 | 11 | antigen processing and presentation via MHC class Ib |
| GO:0002429 | 1e-04 | 45.9788 | 0.1046 | 3 | 201 | immune response-activating cell surface receptor signaling pathway |
| GO:0030097 | 2e-04 | 21.5381 | 0.3569 | 4 | 686 | hemopoiesis |
| GO:0006955 | 2e-04 | 17.2259 | 0.708 | 5 | 1361 | immune response |
| GO:0002520 | 4e-04 | 19.2784 | 0.3964 | 4 | 762 | immune system development |
| GO:0021773 | 5e-04 | Inf | 5e-04 | 1 | 1 | striatal medium spiny neuron differentiation |
| GO:0030887 | 5e-04 | Inf | 5e-04 | 1 | 1 | positive regulation of myeloid dendritic cell activation |
| GO:0038115 | 5e-04 | Inf | 5e-04 | 1 | 1 | chemokine (C-C motif) ligand 19 signaling pathway |
| GO:0038116 | 5e-04 | Inf | 5e-04 | 1 | 1 | chemokine (C-C motif) ligand 21 signaling pathway |
| GO:0071678 | 5e-04 | Inf | 5e-04 | 1 | 1 | olfactory bulb axon guidance |
| GO:0097022 | 5e-04 | Inf | 5e-04 | 1 | 1 | lymphocyte migration into lymph node |
| GO:2000522 | 5e-04 | Inf | 5e-04 | 1 | 1 | positive regulation of immunological synapse formation |
| GO:2000526 | 5e-04 | Inf | 5e-04 | 1 | 1 | positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation |
| GO:0031294 | 6e-04 | 75.0147 | 0.0364 | 2 | 70 | lymphocyte costimulation |
| GO:0032649 | 7e-04 | 66.2078 | 0.0411 | 2 | 79 | regulation of interferon-gamma production |
| GO:0002694 | 7e-04 | 77.4987 | 0.0433 | 2 | 131 | regulation of leukocyte activation |
| GO:0050852 | 8e-04 | 64.2947 | 0.0442 | 2 | 97 | T cell receptor signaling pathway |
| GO:0002253 | 8e-04 | 23.2927 | 0.2024 | 3 | 389 | activation of immune response |
| GO:2000525 | 0.001 | 2195.7143 | 0.001 | 1 | 2 | positive regulation of T cell costimulation |
| GO:0002764 | 0.0012 | 20.1716 | 0.2325 | 3 | 447 | immune response-regulating signaling pathway |
| GO:0050707 | 0.0015 | 45.4137 | 0.0593 | 2 | 114 | regulation of cytokine secretion |
| GO:2000547 | 0.0016 | 1097.7857 | 0.0016 | 1 | 3 | regulation of dendritic cell dendrite assembly |
| GO:0046649 | 0.0018 | 56.4106 | 0.0702 | 2 | 265 | lymphocyte activation |
| GO:0001766 | 0.0021 | 731.8095 | 0.0021 | 1 | 4 | membrane raft polarization |
| GO:0002408 | 0.0021 | 731.8095 | 0.0021 | 1 | 4 | myeloid dendritic cell chemotaxis |
| GO:0097029 | 0.0021 | 731.8095 | 0.0021 | 1 | 4 | mature conventional dendritic cell differentiation |
| GO:1902715 | 0.0021 | 731.8095 | 0.0021 | 1 | 4 | positive regulation of interferon-gamma secretion |
| GO:0002274 | 0.0023 | 36.0047 | 0.0744 | 2 | 143 | myeloid leukocyte activation |
| GO:0002568 | 0.0026 | 548.8214 | 0.0026 | 1 | 5 | somatic diversification of T cell receptor genes |
| GO:0002885 | 0.0026 | 548.8214 | 0.0026 | 1 | 5 | positive regulation of hypersensitivity |
| GO:0033153 | 0.0026 | 548.8214 | 0.0026 | 1 | 5 | T cell receptor V(D)J recombination |
| GO:0051665 | 0.0026 | 548.8214 | 0.0026 | 1 | 5 | membrane raft localization |
| GO:0072610 | 0.0026 | 548.8214 | 0.0026 | 1 | 5 | interleukin-12 secretion |
| GO:2000510 | 0.0026 | 548.8214 | 0.0026 | 1 | 5 | positive regulation of dendritic cell chemotaxis |
| GO:0001768 | 0.0031 | 439.0286 | 0.0031 | 1 | 6 | establishment of T cell polarity |
| GO:0050870 | 0.0036 | 28.6139 | 0.0931 | 2 | 179 | positive regulation of T cell activation |
| GO:0002606 | 0.0036 | 365.8333 | 0.0036 | 1 | 7 | positive regulation of dendritic cell antigen processing and presentation |
| GO:0021902 | 0.0036 | 365.8333 | 0.0036 | 1 | 7 | commitment of neuronal cell to specific neuron type in forebrain |
| GO:0031077 | 0.0036 | 365.8333 | 0.0036 | 1 | 7 | post-embryonic camera-type eye development |
| GO:0050862 | 0.0036 | 365.8333 | 0.0036 | 1 | 7 | positive regulation of T cell receptor signaling pathway |
| GO:0002863 | 0.0047 | 274.3393 | 0.0047 | 1 | 9 | positive regulation of inflammatory response to antigenic stimulus |
| GO:0003334 | 0.0047 | 274.3393 | 0.0047 | 1 | 9 | keratinocyte development |
| GO:0022409 | 0.0051 | 23.9494 | 0.1108 | 2 | 213 | positive regulation of cell-cell adhesion |
| GO:0002696 | 0.0052 | 24.5935 | 0.1129 | 2 | 248 | positive regulation of leukocyte activation |
| GO:0002864 | 0.0052 | 243.8413 | 0.0052 | 1 | 10 | regulation of acute inflammatory response to antigenic stimulus |
| GO:0045059 | 0.0052 | 243.8413 | 0.0052 | 1 | 10 | positive thymic T cell selection |
| GO:2000484 | 0.0052 | 243.8413 | 0.0052 | 1 | 10 | positive regulation of interleukin-8 secretion |
| GO:0045058 | 0.0055 | 235.9385 | 0.0055 | 1 | 14 | T cell selection |
| GO:0002922 | 0.0057 | 219.4429 | 0.0057 | 1 | 11 | positive regulation of humoral immune response |
| GO:0045060 | 0.0057 | 219.4429 | 0.0057 | 1 | 11 | negative thymic T cell selection |
| GO:0043368 | 0.0064 | 196.7821 | 0.0064 | 1 | 14 | positive T cell selection |
| GO:0031274 | 0.0067 | 182.8452 | 0.0068 | 1 | 13 | positive regulation of pseudopodium assembly |
| GO:0019216 | 0.0071 | 20.0797 | 0.1316 | 2 | 253 | regulation of lipid metabolic process |
| GO:0071731 | 0.0073 | 168.7692 | 0.0073 | 1 | 14 | response to nitric oxide |
| GO:0032940 | 0.0075 | 10.3532 | 0.4396 | 3 | 845 | secretion by cell |
| GO:0034695 | 0.0078 | 156.7041 | 0.0078 | 1 | 15 | response to prostaglandin E |
| GO:1903020 | 0.0078 | 156.7041 | 0.0078 | 1 | 15 | positive regulation of glycoprotein metabolic process |
| GO:0002577 | 0.0083 | 146.2476 | 0.0083 | 1 | 16 | regulation of antigen processing and presentation |
| GO:0031579 | 0.0083 | 146.2476 | 0.0083 | 1 | 16 | membrane raft organization |
| GO:0031268 | 0.0088 | 137.0982 | 0.0088 | 1 | 17 | pseudopodium organization |
| GO:0021544 | 0.0098 | 121.8492 | 0.0099 | 1 | 19 | subpallium development |
| GO:0090023 | 0.0098 | 121.8492 | 0.0099 | 1 | 19 | positive regulation of neutrophil chemotaxis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0070489 | 0 | 58.2047 | 0.3853 | 9 | 395 | T cell aggregation |
| GO:0098602 | 0 | 42.8584 | 0.6779 | 10 | 695 | single organism cell adhesion |
| GO:0007159 | 0 | 85.7328 | 0.1982 | 7 | 251 | leukocyte cell-cell adhesion |
| GO:0034109 | 0 | 77.0413 | 0.2195 | 7 | 278 | homotypic cell-cell adhesion |
| GO:0022610 | 0 | 21.4386 | 1.2884 | 10 | 1321 | biological adhesion |
| GO:0046649 | 0 | 48.3127 | 0.2479 | 6 | 313 | lymphocyte activation |
| GO:0022407 | 0 | 30.6565 | 0.3248 | 6 | 333 | regulation of cell-cell adhesion |
| GO:0002694 | 0 | 26.7201 | 0.3706 | 6 | 380 | regulation of leukocyte activation |
| GO:0006955 | 0 | 15.5459 | 1.3275 | 9 | 1361 | immune response |
| GO:0001775 | 0 | 29.0664 | 0.4402 | 6 | 605 | cell activation |
| GO:0002521 | 0 | 24.134 | 0.4087 | 6 | 419 | leukocyte differentiation |
| GO:0002568 | 0 | 787.7436 | 0.0049 | 2 | 5 | somatic diversification of T cell receptor genes |
| GO:0033153 | 0 | 787.7436 | 0.0049 | 2 | 5 | T cell receptor V(D)J recombination |
| GO:0050863 | 0 | 78.75 | 0.0529 | 3 | 67 | regulation of T cell activation |
| GO:0002429 | 0 | 27.9963 | 0.196 | 4 | 201 | immune response-activating cell surface receptor signaling pathway |
| GO:0048534 | 0 | 13.6188 | 0.7052 | 6 | 723 | hematopoietic or lymphoid organ development |
| GO:0031295 | 0 | 57.947 | 0.0673 | 3 | 69 | T cell costimulation |
| GO:0050867 | 1e-04 | 21.4602 | 0.2536 | 4 | 260 | positive regulation of cell activation |
| GO:0035455 | 1e-04 | 157.4256 | 0.0166 | 2 | 17 | response to interferon-alpha |
| GO:0050852 | 1e-04 | 37.7797 | 0.1014 | 3 | 104 | T cell receptor signaling pathway |
| GO:0046597 | 1e-04 | 147.5769 | 0.0176 | 2 | 18 | negative regulation of viral entry into host cell |
| GO:0035456 | 2e-04 | 138.8869 | 0.0185 | 2 | 19 | response to interferon-beta |
| GO:0007166 | 2e-04 | 7.6447 | 3.1172 | 10 | 3196 | cell surface receptor signaling pathway |
| GO:0002684 | 4e-04 | 11.0831 | 0.6722 | 5 | 738 | positive regulation of immune system process |
| GO:0002253 | 4e-04 | 14.1478 | 0.3794 | 4 | 389 | activation of immune response |
| GO:1903039 | 7e-04 | 21.3287 | 0.1765 | 3 | 181 | positive regulation of leukocyte cell-cell adhesion |
| GO:0034112 | 7e-04 | 21.0889 | 0.1785 | 3 | 183 | positive regulation of homotypic cell-cell adhesion |
| GO:0002764 | 7e-04 | 12.2479 | 0.436 | 4 | 447 | immune response-regulating signaling pathway |
| GO:0030217 | 8e-04 | 59.1852 | 0.0426 | 2 | 59 | T cell differentiation |
| GO:0071593 | 8e-04 | 2995.4 | 8e-04 | 1 | 2 | lymphocyte aggregation |
| GO:0045071 | 9e-04 | 54.8157 | 0.0439 | 2 | 45 | negative regulation of viral genome replication |
| GO:0021773 | 0.001 | Inf | 0.001 | 1 | 1 | striatal medium spiny neuron differentiation |
| GO:0030887 | 0.001 | Inf | 0.001 | 1 | 1 | positive regulation of myeloid dendritic cell activation |
| GO:0071678 | 0.001 | Inf | 0.001 | 1 | 1 | olfactory bulb axon guidance |
| GO:0002562 | 0.0011 | 47.12 | 0.0507 | 2 | 52 | somatic diversification of immune receptors via germline recombination within a single locus |
| GO:0042127 | 0.0012 | 6.8481 | 1.3353 | 6 | 1369 | regulation of cell proliferation |
| GO:0051251 | 0.0013 | 16.8211 | 0.2224 | 3 | 228 | positive regulation of lymphocyte activation |
| GO:0046632 | 0.0022 | 33.6132 | 0.0702 | 2 | 72 | alpha-beta T cell differentiation |
| GO:0030260 | 0.0025 | 31.3621 | 0.0751 | 2 | 77 | entry into host cell |
| GO:0051828 | 0.0025 | 31.3621 | 0.0751 | 2 | 77 | entry into other organism involved in symbiotic interaction |
| GO:0052126 | 0.0025 | 31.3621 | 0.0751 | 2 | 77 | movement in host environment |
| GO:0032649 | 0.0026 | 30.5435 | 0.0771 | 2 | 79 | regulation of interferon-gamma production |
| GO:0060337 | 0.0027 | 30.1499 | 0.078 | 2 | 80 | type I interferon signaling pathway |
| GO:0034340 | 0.0028 | 29.7663 | 0.079 | 2 | 81 | response to type I interferon |
| GO:0048525 | 0.0029 | 29.0275 | 0.081 | 2 | 83 | negative regulation of viral process |
| GO:0002669 | 0.0029 | 548.6429 | 0.0029 | 1 | 3 | positive regulation of T cell anergy |
| GO:0045590 | 0.0029 | 548.6429 | 0.0029 | 1 | 3 | negative regulation of regulatory T cell differentiation |
| GO:0044700 | 0.0032 | 4.9968 | 5.3303 | 11 | 5465 | single organism signaling |
| GO:0045785 | 0.0037 | 11.4248 | 0.3238 | 3 | 332 | positive regulation of cell adhesion |
| GO:0007154 | 0.0038 | 4.8669 | 5.421 | 11 | 5558 | cell communication |
| GO:0045580 | 0.0038 | 24.9918 | 0.0936 | 2 | 96 | regulation of T cell differentiation |
| GO:0001766 | 0.0039 | 365.7381 | 0.0039 | 1 | 4 | membrane raft polarization |
| GO:0030538 | 0.0039 | 365.7381 | 0.0039 | 1 | 4 | embryonic genitalia morphogenesis |
| GO:0048619 | 0.0039 | 365.7381 | 0.0039 | 1 | 4 | embryonic hindgut morphogenesis |
| GO:1902715 | 0.0039 | 365.7381 | 0.0039 | 1 | 4 | positive regulation of interferon-gamma secretion |
| GO:0044336 | 0.0049 | 274.2857 | 0.0049 | 1 | 5 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process |
| GO:0051665 | 0.0049 | 274.2857 | 0.0049 | 1 | 5 | membrane raft localization |
| GO:0019722 | 0.0051 | 21.5314 | 0.1083 | 2 | 111 | calcium-mediated signaling |
| GO:0002911 | 0.0058 | 219.4143 | 0.0059 | 1 | 6 | regulation of lymphocyte anergy |
| GO:0042129 | 0.0065 | 18.9082 | 0.1229 | 2 | 126 | regulation of T cell proliferation |
| GO:0034341 | 0.0067 | 18.6056 | 0.1248 | 2 | 128 | response to interferon-gamma |
| GO:0021902 | 0.0068 | 182.8333 | 0.0068 | 1 | 7 | commitment of neuronal cell to specific neuron type in forebrain |
| GO:0031077 | 0.0068 | 182.8333 | 0.0068 | 1 | 7 | post-embryonic camera-type eye development |
| GO:0048007 | 0.0068 | 182.8333 | 0.0068 | 1 | 7 | antigen processing and presentation, exogenous lipid antigen via MHC class Ib |
| GO:0007172 | 0.0078 | 156.7041 | 0.0078 | 1 | 8 | signal complex assembly |
| GO:0051716 | 0.008 | 4.2498 | 5.898 | 11 | 6047 | cellular response to stimulus |
| GO:0002274 | 0.0083 | 16.6099 | 0.1395 | 2 | 143 | myeloid leukocyte activation |
| GO:0002645 | 0.0087 | 137.1071 | 0.0088 | 1 | 9 | positive regulation of tolerance induction |
| GO:0003334 | 0.0087 | 137.1071 | 0.0088 | 1 | 9 | keratinocyte development |
| GO:0061525 | 0.0087 | 137.1071 | 0.0088 | 1 | 9 | hindgut development |
| GO:0045061 | 0.0091 | 131.1624 | 0.0091 | 1 | 10 | thymic T cell selection |
| GO:0002664 | 0.0097 | 121.8651 | 0.0098 | 1 | 10 | regulation of T cell tolerance induction |
| GO:0010310 | 0.0097 | 121.8651 | 0.0098 | 1 | 10 | regulation of hydrogen peroxide metabolic process |
| GO:0045059 | 0.0097 | 121.8651 | 0.0098 | 1 | 10 | positive thymic T cell selection |
| GO:2000484 | 0.0097 | 121.8651 | 0.0098 | 1 | 10 | positive regulation of interleukin-8 secretion |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0002694 | 0 | 66.6489 | 0.1977 | 5 | 380 | regulation of leukocyte activation |
| GO:0070489 | 0 | 64.0214 | 0.2055 | 5 | 395 | T cell aggregation |
| GO:0070486 | 0 | 62.701 | 0.2096 | 5 | 403 | leukocyte aggregation |
| GO:0051251 | 0 | 67.6205 | 0.1186 | 4 | 228 | positive regulation of lymphocyte activation |
| GO:0050863 | 0 | 61.4837 | 0.13 | 4 | 250 | regulation of T cell activation |
| GO:0031295 | 0 | 139.1364 | 0.0359 | 3 | 69 | T cell costimulation |
| GO:0050867 | 0 | 59.043 | 0.1352 | 4 | 260 | positive regulation of cell activation |
| GO:0030098 | 0 | 55.511 | 0.1436 | 4 | 276 | lymphocyte differentiation |
| GO:0098602 | 0 | 35.4614 | 0.3615 | 5 | 695 | single organism cell adhesion |
| GO:0022407 | 0 | 45.7204 | 0.1732 | 4 | 333 | regulation of cell-cell adhesion |
| GO:0002520 | 0 | 32.1753 | 0.3964 | 5 | 762 | immune system development |
| GO:1903039 | 1e-04 | 51.2124 | 0.0942 | 3 | 181 | positive regulation of leukocyte cell-cell adhesion |
| GO:0034112 | 1e-04 | 50.6367 | 0.0952 | 3 | 183 | positive regulation of homotypic cell-cell adhesion |
| GO:0022610 | 2e-04 | 17.8002 | 0.6872 | 5 | 1321 | biological adhesion |
| GO:0030097 | 2e-04 | 21.5381 | 0.3569 | 4 | 686 | hemopoiesis |
| GO:0006955 | 2e-04 | 17.2259 | 0.708 | 5 | 1361 | immune response |
| GO:0002684 | 3e-04 | 19.6878 | 0.3886 | 4 | 747 | positive regulation of immune system process |
| GO:0045785 | 5e-04 | 27.4322 | 0.1727 | 3 | 332 | positive regulation of cell adhesion |
| GO:0021773 | 5e-04 | Inf | 5e-04 | 1 | 1 | striatal medium spiny neuron differentiation |
| GO:0071678 | 5e-04 | Inf | 5e-04 | 1 | 1 | olfactory bulb axon guidance |
| GO:0033077 | 6e-04 | 72.8619 | 0.0375 | 2 | 72 | T cell differentiation in thymus |
| GO:0002376 | 7e-04 | Inf | 0.0531 | 2 | 358 | immune system process |
| GO:0050864 | 0.001 | 55.9707 | 0.0484 | 2 | 93 | regulation of B cell activation |
| GO:0045590 | 0.0016 | 1097.7857 | 0.0016 | 1 | 3 | negative regulation of regulatory T cell differentiation |
| GO:0050851 | 0.0021 | 38.1905 | 0.0702 | 2 | 135 | antigen receptor-mediated signaling pathway |
| GO:0002568 | 0.0026 | 548.8214 | 0.0026 | 1 | 5 | somatic diversification of T cell receptor genes |
| GO:0033153 | 0.0026 | 548.8214 | 0.0026 | 1 | 5 | T cell receptor V(D)J recombination |
| GO:0050670 | 0.0032 | 30.3473 | 0.0879 | 2 | 169 | regulation of lymphocyte proliferation |
| GO:0070663 | 0.0035 | 29.113 | 0.0916 | 2 | 176 | regulation of leukocyte proliferation |
| GO:0021902 | 0.0036 | 365.8333 | 0.0036 | 1 | 7 | commitment of neuronal cell to specific neuron type in forebrain |
| GO:0031077 | 0.0036 | 365.8333 | 0.0036 | 1 | 7 | post-embryonic camera-type eye development |
| GO:0048007 | 0.0036 | 365.8333 | 0.0036 | 1 | 7 | antigen processing and presentation, exogenous lipid antigen via MHC class Ib |
| GO:0003334 | 0.0047 | 274.3393 | 0.0047 | 1 | 9 | keratinocyte development |
| GO:0002313 | 0.0052 | 243.8413 | 0.0052 | 1 | 10 | mature B cell differentiation involved in immune response |
| GO:0045059 | 0.0052 | 243.8413 | 0.0052 | 1 | 10 | positive thymic T cell selection |
| GO:0002475 | 0.0057 | 219.4429 | 0.0057 | 1 | 11 | antigen processing and presentation via MHC class Ib |
| GO:0002517 | 0.0057 | 219.4429 | 0.0057 | 1 | 11 | T cell tolerance induction |
| GO:0032943 | 0.0061 | 21.6567 | 0.1222 | 2 | 235 | mononuclear cell proliferation |
| GO:0043368 | 0.0064 | 196.7821 | 0.0064 | 1 | 14 | positive T cell selection |
| GO:0030889 | 0.0073 | 168.7692 | 0.0073 | 1 | 14 | negative regulation of B cell proliferation |
| GO:0001775 | 0.0091 | 24.0663 | 0.1601 | 2 | 605 | cell activation |
| GO:0021544 | 0.0098 | 121.8492 | 0.0099 | 1 | 19 | subpallium development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030887 | 5e-04 | Inf | 5e-04 | 1 | 1 | positive regulation of myeloid dendritic cell activation |
| GO:0070489 | 5e-04 | 28.6607 | 0.1798 | 3 | 395 | T cell aggregation |
| GO:0070486 | 6e-04 | 28.0725 | 0.1834 | 3 | 403 | leukocyte aggregation |
| GO:0046649 | 0.0014 | 20.6794 | 0.2462 | 3 | 541 | lymphocyte activation |
| GO:0022610 | 0.0015 | 14.2293 | 0.6013 | 4 | 1321 | biological adhesion |
| GO:0002274 | 0.0017 | 43.2085 | 0.0651 | 2 | 143 | myeloid leukocyte activation |
| GO:0001766 | 0.0018 | 853.8333 | 0.0018 | 1 | 4 | membrane raft polarization |
| GO:1902715 | 0.0018 | 853.8333 | 0.0018 | 1 | 4 | positive regulation of interferon-gamma secretion |
| GO:0051665 | 0.0023 | 640.3333 | 0.0023 | 1 | 5 | membrane raft localization |
| GO:0098602 | 0.0028 | 15.9104 | 0.3163 | 3 | 695 | single organism cell adhesion |
| GO:0030217 | 0.003 | 32.4813 | 0.086 | 2 | 189 | T cell differentiation |
| GO:0048007 | 0.0032 | 426.8333 | 0.0032 | 1 | 7 | antigen processing and presentation, exogenous lipid antigen via MHC class Ib |
| GO:0002520 | 0.0036 | 14.4397 | 0.3468 | 3 | 762 | immune system development |
| GO:0002376 | 0.0038 | 26.641 | 0.4056 | 3 | 1482 | immune system process |
| GO:2000484 | 0.0045 | 284.5 | 0.0046 | 1 | 10 | positive regulation of interleukin-8 secretion |
| GO:0002475 | 0.005 | 256.0333 | 0.005 | 1 | 11 | antigen processing and presentation via MHC class Ib |
| GO:2000353 | 0.005 | 256.0333 | 0.005 | 1 | 11 | positive regulation of endothelial cell apoptotic process |
| GO:0001775 | 0.0052 | 12.6247 | 0.3937 | 3 | 865 | cell activation |
| GO:0050863 | 0.0052 | 24.3935 | 0.1138 | 2 | 250 | regulation of T cell activation |
| GO:0060033 | 0.0059 | 213.3333 | 0.0059 | 1 | 13 | anatomical structure regression |
| GO:0031579 | 0.0073 | 170.6333 | 0.0073 | 1 | 16 | membrane raft organization |
| GO:0048535 | 0.0077 | 159.9583 | 0.0077 | 1 | 17 | lymph node development |
| GO:0022407 | 0.0091 | 18.1764 | 0.1516 | 2 | 333 | regulation of cell-cell adhesion |
| GO:0045730 | 0.01 | 121.8333 | 0.01 | 1 | 22 | respiratory burst |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007389 | 0 | 25.278 | 0.809 | 12 | 429 | pattern specification process |
| GO:0009954 | 0 | 84.5297 | 0.0622 | 4 | 33 | proximal/distal pattern formation |
| GO:0009952 | 0 | 20.0658 | 0.3828 | 6 | 203 | anterior/posterior pattern specification |
| GO:0007399 | 0 | 6.4821 | 3.6695 | 14 | 1946 | nervous system development |
| GO:0007198 | 0 | Inf | 0.0038 | 2 | 2 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
| GO:0009889 | 0 | 5.7831 | 7.1939 | 19 | 3815 | regulation of biosynthetic process |
| GO:0032501 | 0 | 6.9775 | 11.8421 | 24 | 6280 | multicellular organismal process |
| GO:0006355 | 0 | 5.4216 | 6.0285 | 17 | 3197 | regulation of transcription, DNA-templated |
| GO:0043009 | 0 | 9.6321 | 1.1163 | 8 | 592 | chordate embryonic development |
| GO:2001141 | 0 | 5.3325 | 6.1077 | 17 | 3239 | regulation of RNA biosynthetic process |
| GO:0048736 | 0 | 19.4108 | 0.3168 | 5 | 168 | appendage development |
| GO:0009790 | 0 | 11.1331 | 0.8658 | 7 | 540 | embryo development |
| GO:0034654 | 0 | 5.0405 | 7.1279 | 18 | 3780 | nucleobase-containing compound biosynthetic process |
| GO:0009887 | 0 | 7.5541 | 1.6443 | 9 | 872 | organ morphogenesis |
| GO:0009953 | 0 | 23.9184 | 0.1999 | 4 | 106 | dorsal/ventral pattern formation |
| GO:0035113 | 1e-04 | 19.488 | 0.2433 | 4 | 129 | embryonic appendage morphogenesis |
| GO:0001764 | 1e-04 | 19.3321 | 0.2451 | 4 | 130 | neuron migration |
| GO:0032502 | 1e-04 | 4.4297 | 9.7075 | 20 | 5148 | developmental process |
| GO:0035108 | 2e-04 | 16.7779 | 0.281 | 4 | 149 | limb morphogenesis |
| GO:0021872 | 2e-04 | 31.5124 | 0.1113 | 3 | 59 | forebrain generation of neurons |
| GO:0001501 | 2e-04 | 8.3322 | 0.89 | 6 | 472 | skeletal system development |
| GO:0016070 | 2e-04 | 3.9753 | 7.637 | 17 | 4050 | RNA metabolic process |
| GO:0006837 | 3e-04 | 94.679 | 0.0264 | 2 | 14 | serotonin transport |
| GO:0034641 | 3e-04 | 3.954 | 10.4524 | 20 | 5543 | cellular nitrogen compound metabolic process |
| GO:0060255 | 3e-04 | 3.881 | 9.5491 | 19 | 5064 | regulation of macromolecule metabolic process |
| GO:0097659 | 4e-04 | 4.7908 | 3.7057 | 11 | 2317 | nucleic acid-templated transcription |
| GO:0019219 | 5e-04 | 4.732 | 3.8491 | 11 | 2489 | regulation of nucleobase-containing compound metabolic process |
| GO:0046483 | 5e-04 | 3.7011 | 9.8546 | 19 | 5226 | heterocycle metabolic process |
| GO:0006725 | 5e-04 | 3.685 | 9.8829 | 19 | 5241 | cellular aromatic compound metabolic process |
| GO:0009888 | 6e-04 | 4.4149 | 3.102 | 10 | 1645 | tissue development |
| GO:0034645 | 6e-04 | 3.6008 | 8.2046 | 17 | 4351 | cellular macromolecule biosynthetic process |
| GO:0035282 | 7e-04 | 19.5641 | 0.1754 | 3 | 93 | segmentation |
| GO:0048704 | 7e-04 | 19.1363 | 0.1791 | 3 | 95 | embryonic skeletal system morphogenesis |
| GO:0007420 | 8e-04 | 6.4691 | 1.1333 | 6 | 601 | brain development |
| GO:0032355 | 8e-04 | 18.7267 | 0.1829 | 3 | 97 | response to estradiol |
| GO:0048699 | 8e-04 | 5.724 | 1.6412 | 7 | 1085 | generation of neurons |
| GO:1901360 | 9e-04 | 3.4711 | 10.2751 | 19 | 5449 | organic cyclic compound metabolic process |
| GO:0048568 | 9e-04 | 7.6683 | 0.775 | 5 | 411 | embryonic organ development |
| GO:0021884 | 0.001 | 49.3623 | 0.0471 | 2 | 25 | forebrain neuron development |
| GO:0045165 | 0.0012 | 9.8645 | 0.4695 | 4 | 249 | cell fate commitment |
| GO:0001662 | 0.0013 | 43.6581 | 0.0528 | 2 | 28 | behavioral fear response |
| GO:0048666 | 0.0013 | 5.0138 | 1.7405 | 7 | 923 | neuron development |
| GO:0002009 | 0.0014 | 6.9619 | 0.8504 | 5 | 451 | morphogenesis of an epithelium |
| GO:0048665 | 0.0015 | 39.1341 | 0.0585 | 2 | 31 | neuron fate specification |
| GO:0071312 | 0.0016 | 37.8272 | 0.0603 | 2 | 32 | cellular response to alkaloid |
| GO:0033993 | 0.0017 | 5.4842 | 1.3256 | 6 | 703 | response to lipid |
| GO:0071383 | 0.0018 | 14.0538 | 0.2414 | 3 | 128 | cellular response to steroid hormone stimulus |
| GO:0014070 | 0.0018 | 5.411 | 1.3426 | 6 | 712 | response to organic cyclic compound |
| GO:0035150 | 0.0018 | 13.8307 | 0.2451 | 3 | 130 | regulation of tube size |
| GO:0035115 | 0.0019 | 35.4583 | 0.0641 | 2 | 34 | embryonic forelimb morphogenesis |
| GO:0002878 | 0.0019 | Inf | 0.0019 | 1 | 1 | negative regulation of acute inflammatory response to non-antigenic stimulus |
| GO:0009956 | 0.0019 | Inf | 0.0019 | 1 | 1 | radial pattern formation |
| GO:0014739 | 0.0019 | Inf | 0.0019 | 1 | 1 | positive regulation of muscle hyperplasia |
| GO:0090274 | 0.0019 | Inf | 0.0019 | 1 | 1 | positive regulation of somatostatin secretion |
| GO:0007188 | 0.0021 | 13.1022 | 0.2583 | 3 | 137 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
| GO:0009566 | 0.0026 | 12.2703 | 0.2753 | 3 | 146 | fertilization |
| GO:0003018 | 0.0026 | 12.1843 | 0.2772 | 3 | 147 | vascular process in circulatory system |
| GO:0021532 | 0.0027 | 29.0807 | 0.0773 | 2 | 41 | neural tube patterning |
| GO:0051966 | 0.003 | 27.6585 | 0.0811 | 2 | 43 | regulation of synaptic transmission, glutamatergic |
| GO:1901576 | 0.003 | 2.998 | 10.2544 | 18 | 5438 | organic substance biosynthetic process |
| GO:0051171 | 0.0034 | 27.7969 | 0.089 | 2 | 95 | regulation of nitrogen compound metabolic process |
| GO:0021953 | 0.0035 | 10.9543 | 0.3074 | 3 | 163 | central nervous system neuron differentiation |
| GO:0022414 | 0.0035 | 4.175 | 2.0629 | 7 | 1094 | reproductive process |
| GO:0048754 | 0.0036 | 10.8177 | 0.3111 | 3 | 165 | branching morphogenesis of an epithelial tube |
| GO:0014062 | 0.0036 | 568.4074 | 0.0036 | 1 | 2 | regulation of serotonin secretion |
| GO:0021568 | 0.0038 | 548.1786 | 0.0038 | 1 | 2 | rhombomere 2 development |
| GO:0060738 | 0.0038 | 548.1786 | 0.0038 | 1 | 2 | epithelial-mesenchymal signaling involved in prostate gland development |
| GO:0060849 | 0.0038 | 548.1786 | 0.0038 | 1 | 2 | regulation of transcription involved in lymphatic endothelial cell fate commitment |
| GO:0071672 | 0.0038 | 548.1786 | 0.0038 | 1 | 2 | negative regulation of smooth muscle cell chemotaxis |
| GO:0071673 | 0.0038 | 548.1786 | 0.0038 | 1 | 2 | positive regulation of smooth muscle cell chemotaxis |
| GO:0072272 | 0.0038 | 548.1786 | 0.0038 | 1 | 2 | proximal/distal pattern formation involved in metanephric nephron development |
| GO:0065007 | 0.004 | 4.4091 | 19.234 | 26 | 10200 | biological regulation |
| GO:0009725 | 0.004 | 4.587 | 1.5689 | 6 | 832 | response to hormone |
| GO:0035295 | 0.0042 | 5.363 | 1.0918 | 5 | 579 | tube development |
| GO:0008285 | 0.0046 | 5.2303 | 1.1182 | 5 | 593 | negative regulation of cell proliferation |
| GO:0045934 | 0.0047 | 3.9437 | 2.1742 | 7 | 1153 | negative regulation of nucleobase-containing compound metabolic process |
| GO:0050795 | 0.0049 | 9.67 | 0.347 | 3 | 184 | regulation of behavior |
| GO:0010467 | 0.0052 | 3.3424 | 5.0755 | 11 | 3267 | gene expression |
| GO:0014063 | 0.0056 | 274.0714 | 0.0057 | 1 | 3 | negative regulation of serotonin secretion |
| GO:0060741 | 0.0056 | 274.0714 | 0.0057 | 1 | 3 | prostate gland stromal morphogenesis |
| GO:0071315 | 0.0056 | 274.0714 | 0.0057 | 1 | 3 | cellular response to morphine |
| GO:0071502 | 0.0056 | 274.0714 | 0.0057 | 1 | 3 | cellular response to temperature stimulus |
| GO:0071651 | 0.0056 | 274.0714 | 0.0057 | 1 | 3 | positive regulation of chemokine (C-C motif) ligand 5 production |
| GO:0008015 | 0.0058 | 6.2358 | 0.7316 | 4 | 388 | blood circulation |
| GO:0048608 | 0.0058 | 6.2192 | 0.7335 | 4 | 389 | reproductive structure development |
| GO:0042733 | 0.0059 | 19.1977 | 0.115 | 2 | 61 | embryonic digit morphogenesis |
| GO:0031327 | 0.0063 | 3.7183 | 2.2949 | 7 | 1217 | negative regulation of cellular biosynthetic process |
| GO:0010629 | 0.0064 | 3.7149 | 2.2968 | 7 | 1218 | negative regulation of gene expression |
| GO:0000122 | 0.0066 | 4.7884 | 1.2163 | 5 | 645 | negative regulation of transcription from RNA polymerase II promoter |
| GO:0015696 | 0.0067 | 17.9647 | 0.123 | 2 | 70 | ammonium transport |
| GO:0001763 | 0.0069 | 8.5244 | 0.3922 | 3 | 208 | morphogenesis of a branching structure |
| GO:0033555 | 0.007 | 17.4188 | 0.1263 | 2 | 67 | multicellular organismal response to stress |
| GO:0060359 | 0.0072 | 17.1538 | 0.1282 | 2 | 68 | response to ammonium ion |
| GO:0060284 | 0.0073 | 4.6665 | 1.2464 | 5 | 661 | regulation of cell development |
| GO:0002865 | 0.0075 | 182.7024 | 0.0075 | 1 | 4 | negative regulation of acute inflammatory response to antigenic stimulus |
| GO:0021555 | 0.0075 | 182.7024 | 0.0075 | 1 | 4 | midbrain-hindbrain boundary morphogenesis |
| GO:0035726 | 0.0075 | 182.7024 | 0.0075 | 1 | 4 | common myeloid progenitor cell proliferation |
| GO:0060528 | 0.0075 | 182.7024 | 0.0075 | 1 | 4 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development |
| GO:0060743 | 0.0075 | 182.7024 | 0.0075 | 1 | 4 | epithelial cell maturation involved in prostate gland development |
| GO:0070445 | 0.0075 | 182.7024 | 0.0075 | 1 | 4 | regulation of oligodendrocyte progenitor proliferation |
| GO:0072086 | 0.0075 | 182.7024 | 0.0075 | 1 | 4 | specification of loop of Henle identity |
| GO:0072078 | 0.0077 | 16.6471 | 0.132 | 2 | 70 | nephron tubule morphogenesis |
| GO:0042310 | 0.0079 | 16.4047 | 0.1339 | 2 | 71 | vasoconstriction |
| GO:1901700 | 0.008 | 3.5489 | 2.3948 | 7 | 1270 | response to oxygen-containing compound |
| GO:0021536 | 0.0081 | 16.1693 | 0.1358 | 2 | 72 | diencephalon development |
| GO:0007268 | 0.0087 | 4.4602 | 1.3011 | 5 | 690 | synaptic transmission |
| GO:0072028 | 0.0087 | 15.5018 | 0.1414 | 2 | 75 | nephron morphogenesis |
| GO:0038170 | 0.0094 | 137.0179 | 0.0094 | 1 | 5 | somatostatin signaling pathway |
| GO:0060040 | 0.0094 | 137.0179 | 0.0094 | 1 | 5 | retinal bipolar neuron differentiation |
| GO:1903507 | 0.0097 | 3.7717 | 1.8838 | 6 | 999 | negative regulation of nucleic acid-templated transcription |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006955 | 0 | 22.836 | 1.416 | 11 | 1361 | immune response |
| GO:0051707 | 0 | 16.7428 | 0.7168 | 7 | 689 | response to other organism |
| GO:0009607 | 0 | 15.9575 | 0.7501 | 7 | 721 | response to biotic stimulus |
| GO:0007166 | 0 | 11.4752 | 3.3251 | 12 | 3196 | cell surface receptor signaling pathway |
| GO:0051607 | 1e-04 | 24.5259 | 0.2185 | 4 | 210 | defense response to virus |
| GO:0048525 | 1e-04 | 44.0856 | 0.0864 | 3 | 83 | negative regulation of viral process |
| GO:0006952 | 1e-04 | 10.0701 | 1.2699 | 7 | 1390 | defense response |
| GO:0035455 | 1e-04 | 146.1714 | 0.0177 | 2 | 17 | response to interferon-alpha |
| GO:0046597 | 2e-04 | 137.0268 | 0.0187 | 2 | 18 | negative regulation of viral entry into host cell |
| GO:0035456 | 2e-04 | 128.958 | 0.0198 | 2 | 19 | response to interferon-beta |
| GO:0019722 | 2e-04 | 32.5962 | 0.1155 | 3 | 111 | calcium-mediated signaling |
| GO:0044700 | 2e-04 | 7.8774 | 5.6857 | 13 | 5465 | single organism signaling |
| GO:0007154 | 3e-04 | 7.6726 | 5.7824 | 13 | 5558 | cell communication |
| GO:0019835 | 4e-04 | 81.1429 | 0.0302 | 2 | 29 | cytolysis |
| GO:1903900 | 7e-04 | 20.9986 | 0.1769 | 3 | 170 | regulation of viral life cycle |
| GO:0044764 | 7e-04 | 9.1509 | 0.7616 | 5 | 732 | multi-organism cellular process |
| GO:0051716 | 8e-04 | 6.6996 | 6.2912 | 13 | 6047 | cellular response to stimulus |
| GO:0044419 | 9e-04 | 8.5097 | 0.8157 | 5 | 784 | interspecies interaction between organisms |
| GO:0045071 | 0.001 | 50.897 | 0.0468 | 2 | 45 | negative regulation of viral genome replication |
| GO:0043903 | 0.0011 | 17.6748 | 0.2091 | 3 | 201 | regulation of symbiosis, encompassing mutualism through parasitism |
| GO:0006968 | 0.0014 | 42.0632 | 0.0562 | 2 | 54 | cellular defense response |
| GO:2001239 | 0.0016 | 39.761 | 0.0593 | 2 | 57 | regulation of extrinsic apoptotic signaling pathway in absence of ligand |
| GO:0016525 | 0.0018 | 37.0557 | 0.0635 | 2 | 61 | negative regulation of angiogenesis |
| GO:0002282 | 0.0021 | 1024.1333 | 0.0021 | 1 | 2 | microglial cell activation involved in immune response |
| GO:0002357 | 0.0021 | 1024.1333 | 0.0021 | 1 | 2 | defense response to tumor cell |
| GO:0007200 | 0.0021 | 34.1496 | 0.0687 | 2 | 66 | phospholipase C-activating G-protein coupled receptor signaling pathway |
| GO:1901343 | 0.0022 | 33.622 | 0.0697 | 2 | 67 | negative regulation of vasculature development |
| GO:0038096 | 0.0023 | 32.6141 | 0.0718 | 2 | 69 | Fc-gamma receptor signaling pathway involved in phagocytosis |
| GO:0009605 | 0.0025 | 5.2087 | 2.0839 | 7 | 2003 | response to external stimulus |
| GO:0030260 | 0.0028 | 29.12 | 0.0801 | 2 | 77 | entry into host cell |
| GO:0051828 | 0.0028 | 29.12 | 0.0801 | 2 | 77 | entry into other organism involved in symbiotic interaction |
| GO:0052126 | 0.0028 | 29.12 | 0.0801 | 2 | 77 | movement in host environment |
| GO:0002252 | 0.0029 | 13.1037 | 0.2998 | 3 | 379 | immune effector process |
| GO:0060337 | 0.0031 | 27.9945 | 0.0832 | 2 | 80 | type I interferon signaling pathway |
| GO:0048388 | 0.0031 | 512.0333 | 0.0031 | 1 | 3 | endosomal lumen acidification |
| GO:0034340 | 0.0031 | 27.6383 | 0.0843 | 2 | 81 | response to type I interferon |
| GO:0040012 | 0.0034 | 7.8341 | 0.6565 | 4 | 631 | regulation of locomotion |
| GO:0038034 | 0.0034 | 26.2995 | 0.0884 | 2 | 85 | signal transduction in absence of ligand |
| GO:0045321 | 0.0037 | 7.6933 | 0.6679 | 4 | 642 | leukocyte activation |
| GO:1903749 | 0.0039 | 24.7971 | 0.0936 | 2 | 90 | positive regulation of establishment of protein localization to mitochondrion |
| GO:0050900 | 0.0039 | 11.1324 | 0.3277 | 3 | 315 | leukocyte migration |
| GO:0035556 | 0.004 | 4.7363 | 2.2618 | 7 | 2174 | intracellular signal transduction |
| GO:0008626 | 0.0052 | 255.9833 | 0.0052 | 1 | 5 | granzyme-mediated apoptotic signaling pathway |
| GO:0023041 | 0.0052 | 255.9833 | 0.0052 | 1 | 5 | neuronal signal transduction |
| GO:0030644 | 0.0052 | 255.9833 | 0.0052 | 1 | 5 | cellular chloride ion homeostasis |
| GO:2000503 | 0.0052 | 255.9833 | 0.0052 | 1 | 5 | positive regulation of natural killer cell chemotaxis |
| GO:2001233 | 0.0055 | 9.7842 | 0.3714 | 3 | 357 | regulation of apoptotic signaling pathway |
| GO:0046666 | 0.0062 | 204.7733 | 0.0062 | 1 | 6 | retinal cell programmed cell death |
| GO:0097527 | 0.0062 | 204.7733 | 0.0062 | 1 | 6 | necroptotic signaling pathway |
| GO:0034341 | 0.0076 | 17.2755 | 0.1332 | 2 | 128 | response to interferon-gamma |
| GO:0001771 | 0.0083 | 146.2476 | 0.0083 | 1 | 8 | immunological synapse formation |
| GO:0010822 | 0.0083 | 16.4838 | 0.1394 | 2 | 134 | positive regulation of mitochondrion organization |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031424 | 1e-04 | 319.3125 | 0.013 | 2 | 50 | keratinization |
| GO:0009913 | 7e-04 | 88.9123 | 0.045 | 2 | 173 | epidermal cell differentiation |
| GO:0060429 | 0.0011 | 42 | 0.2674 | 3 | 1028 | epithelium development |
| GO:0043588 | 0.0014 | 65.2716 | 0.0609 | 2 | 234 | skin development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048663 | 0 | 32.138 | 0.1893 | 5 | 71 | neuron fate commitment |
| GO:0001708 | 0 | 29.4653 | 0.2055 | 5 | 79 | cell fate specification |
| GO:0072272 | 0 | Inf | 0.0053 | 2 | 2 | proximal/distal pattern formation involved in metanephric nephron development |
| GO:0019219 | 0 | 3.7481 | 9.7095 | 22 | 3642 | regulation of nucleobase-containing compound metabolic process |
| GO:0072086 | 0 | 393.2308 | 0.0107 | 2 | 4 | specification of loop of Henle identity |
| GO:0034645 | 0 | 3.5925 | 11.5996 | 24 | 4351 | cellular macromolecule biosynthetic process |
| GO:0034654 | 1e-04 | 3.568 | 10.0774 | 22 | 3780 | nucleobase-containing compound biosynthetic process |
| GO:0009889 | 1e-04 | 3.5244 | 10.1707 | 22 | 3815 | regulation of biosynthetic process |
| GO:2001141 | 1e-04 | 3.5856 | 8.6351 | 20 | 3239 | regulation of RNA biosynthetic process |
| GO:0021510 | 1e-04 | 18.7346 | 0.2453 | 4 | 92 | spinal cord development |
| GO:0097659 | 1e-04 | 3.4809 | 8.8377 | 20 | 3315 | nucleic acid-templated transcription |
| GO:0009790 | 2e-04 | 4.9354 | 2.5353 | 10 | 951 | embryo development |
| GO:0009653 | 2e-04 | 3.5265 | 6.3237 | 16 | 2372 | anatomical structure morphogenesis |
| GO:0061004 | 2e-04 | 112.315 | 0.024 | 2 | 9 | pattern specification involved in kidney development |
| GO:0007423 | 3e-04 | 6.3592 | 1.301 | 7 | 488 | sensory organ development |
| GO:0010454 | 4e-04 | 87.3447 | 0.0293 | 2 | 11 | negative regulation of cell fate commitment |
| GO:0021521 | 4e-04 | 87.3447 | 0.0293 | 2 | 11 | ventral spinal cord interneuron specification |
| GO:0050885 | 5e-04 | 22.345 | 0.152 | 3 | 57 | neuromuscular process controlling balance |
| GO:0060581 | 7e-04 | 60.4536 | 0.04 | 2 | 15 | cell fate commitment involved in pattern specification |
| GO:0048468 | 7e-04 | 3.4123 | 4.9321 | 13 | 1850 | cell development |
| GO:1901576 | 7e-04 | 2.8649 | 14.4976 | 25 | 5438 | organic substance biosynthetic process |
| GO:0033555 | 7e-04 | 18.8413 | 0.1786 | 3 | 67 | multicellular organismal response to stress |
| GO:0007379 | 8e-04 | 56.1319 | 0.0427 | 2 | 16 | segment specification |
| GO:0021514 | 9e-04 | 52.3863 | 0.0453 | 2 | 17 | ventral spinal cord interneuron differentiation |
| GO:0046483 | 0.0011 | 2.7508 | 13.9324 | 24 | 5226 | heterocycle metabolic process |
| GO:0006725 | 0.0011 | 2.7388 | 13.9724 | 24 | 5241 | cellular aromatic compound metabolic process |
| GO:0072079 | 0.0012 | 46.2172 | 0.0507 | 2 | 19 | nephron tubule formation |
| GO:0007399 | 0.0012 | 3.2197 | 5.188 | 13 | 1946 | nervous system development |
| GO:0031290 | 0.0013 | 43.6467 | 0.0533 | 2 | 20 | retinal ganglion cell axon guidance |
| GO:0048699 | 0.0015 | 3.9045 | 2.8134 | 9 | 1129 | generation of neurons |
| GO:0016070 | 0.0017 | 2.6723 | 10.7972 | 20 | 4050 | RNA metabolic process |
| GO:0060255 | 0.0019 | 2.6101 | 13.5005 | 23 | 5064 | regulation of macromolecule metabolic process |
| GO:0021513 | 0.002 | 34.1472 | 0.0666 | 2 | 25 | spinal cord dorsal/ventral patterning |
| GO:1901360 | 0.0021 | 2.5797 | 14.5269 | 24 | 5449 | organic cyclic compound metabolic process |
| GO:0006357 | 0.0022 | 3.2155 | 4.2149 | 11 | 1581 | regulation of transcription from RNA polymerase II promoter |
| GO:0045909 | 0.0023 | 31.4113 | 0.072 | 2 | 27 | positive regulation of vasodilation |
| GO:0010467 | 0.0024 | 2.5577 | 11.9569 | 21 | 4485 | gene expression |
| GO:0001662 | 0.0025 | 30.2012 | 0.0746 | 2 | 28 | behavioral fear response |
| GO:0001712 | 0.0027 | Inf | 0.0027 | 1 | 1 | ectodermal cell fate commitment |
| GO:0019428 | 0.0027 | Inf | 0.0027 | 1 | 1 | allantoin biosynthetic process |
| GO:0019628 | 0.0027 | Inf | 0.0027 | 1 | 1 | urate catabolic process |
| GO:0021723 | 0.0027 | Inf | 0.0027 | 1 | 1 | medullary reticular formation development |
| GO:0042502 | 0.0027 | Inf | 0.0027 | 1 | 1 | tyrosine phosphorylation of Stat2 protein |
| GO:0042666 | 0.0027 | Inf | 0.0027 | 1 | 1 | negative regulation of ectodermal cell fate specification |
| GO:0048894 | 0.0027 | Inf | 0.0027 | 1 | 1 | efferent axon development in a lateral line nerve |
| GO:0048925 | 0.0027 | Inf | 0.0027 | 1 | 1 | lateral line system development |
| GO:0061452 | 0.0027 | Inf | 0.0027 | 1 | 1 | retrotrapezoid nucleus neuron differentiation |
| GO:0071881 | 0.0027 | Inf | 0.0027 | 1 | 1 | adenylate cyclase-inhibiting adrenergic receptor signaling pathway |
| GO:0071882 | 0.0027 | Inf | 0.0027 | 1 | 1 | phospholipase C-activating adrenergic receptor signaling pathway |
| GO:2000383 | 0.0027 | Inf | 0.0027 | 1 | 1 | regulation of ectoderm development |
| GO:0034641 | 0.0027 | 2.5117 | 14.7775 | 24 | 5543 | cellular nitrogen compound metabolic process |
| GO:0010470 | 0.0031 | 27.0716 | 0.0826 | 2 | 31 | regulation of gastrulation |
| GO:0044707 | 0.0031 | 2.6187 | 14.2849 | 23 | 5863 | single-multicellular organism process |
| GO:0009954 | 0.0035 | 25.3218 | 0.088 | 2 | 33 | proximal/distal pattern formation |
| GO:0044057 | 0.0036 | 5.4087 | 1.0371 | 5 | 389 | regulation of system process |
| GO:0021522 | 0.0037 | 24.5288 | 0.0906 | 2 | 34 | spinal cord motor neuron differentiation |
| GO:0050880 | 0.0049 | 9.5313 | 0.3439 | 3 | 129 | regulation of blood vessel size |
| GO:0001764 | 0.005 | 9.4557 | 0.3466 | 3 | 130 | neuron migration |
| GO:0021545 | 0.0051 | 20.6478 | 0.1066 | 2 | 40 | cranial nerve development |
| GO:0060429 | 0.0051 | 3.403 | 2.7406 | 8 | 1028 | epithelium development |
| GO:0007586 | 0.0052 | 9.3078 | 0.3519 | 3 | 132 | digestion |
| GO:0007198 | 0.0053 | 383.425 | 0.0053 | 1 | 2 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
| GO:0021934 | 0.0053 | 383.425 | 0.0053 | 1 | 2 | hindbrain tangential cell migration |
| GO:0035483 | 0.0053 | 383.425 | 0.0053 | 1 | 2 | gastric emptying |
| GO:0042706 | 0.0053 | 383.425 | 0.0053 | 1 | 2 | eye photoreceptor cell fate commitment |
| GO:0043503 | 0.0053 | 383.425 | 0.0053 | 1 | 2 | skeletal muscle fiber adaptation |
| GO:0048866 | 0.0053 | 383.425 | 0.0053 | 1 | 2 | stem cell fate specification |
| GO:0070473 | 0.0053 | 383.425 | 0.0053 | 1 | 2 | negative regulation of uterine smooth muscle contraction |
| GO:0007605 | 0.0058 | 8.9576 | 0.3652 | 3 | 137 | sensory perception of sound |
| GO:0006355 | 0.0059 | 3.2432 | 3.5136 | 9 | 1616 | regulation of transcription, DNA-templated |
| GO:0043010 | 0.0063 | 5.9216 | 0.7438 | 4 | 279 | camera-type eye development |
| GO:0048592 | 0.0064 | 8.6325 | 0.3786 | 3 | 142 | eye morphogenesis |
| GO:0006937 | 0.0065 | 8.5703 | 0.3812 | 3 | 143 | regulation of muscle contraction |
| GO:0048562 | 0.0066 | 5.8565 | 0.7518 | 4 | 282 | embryonic organ morphogenesis |
| GO:0016331 | 0.007 | 8.33 | 0.3919 | 3 | 147 | morphogenesis of embryonic epithelium |
| GO:0003002 | 0.0073 | 5.6976 | 0.7751 | 4 | 305 | regionalization |
| GO:0007186 | 0.008 | 3.1409 | 2.9512 | 8 | 1107 | G-protein coupled receptor signaling pathway |
| GO:0003358 | 0.008 | 191.7 | 0.008 | 1 | 3 | noradrenergic neuron development |
| GO:0021912 | 0.008 | 191.7 | 0.008 | 1 | 3 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification |
| GO:0071878 | 0.008 | 191.7 | 0.008 | 1 | 3 | negative regulation of adrenergic receptor signaling pathway |
| GO:0071883 | 0.008 | 191.7 | 0.008 | 1 | 3 | activation of MAPK activity by adrenergic receptor signaling pathway |
| GO:0050877 | 0.0094 | 3.0452 | 3.0365 | 8 | 1139 | neurological system process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0071228 | 7e-04 | Inf | 7e-04 | 1 | 1 | cellular response to tumor cell |
| GO:0007165 | 0.0011 | 9.3506 | 3.5777 | 9 | 5002 | signal transduction |
| GO:0060337 | 0.0014 | 43.5613 | 0.0572 | 2 | 80 | type I interferon signaling pathway |
| GO:0033277 | 0.0014 | 1536.7 | 0.0014 | 1 | 2 | abortive mitotic cell cycle |
| GO:0034340 | 0.0015 | 43.007 | 0.0579 | 2 | 81 | response to type I interferon |
| GO:0006955 | 0.0016 | 8.6111 | 0.9735 | 5 | 1361 | immune response |
| GO:0050864 | 0.0019 | 37.3065 | 0.0665 | 2 | 93 | regulation of B cell activation |
| GO:1901164 | 0.0021 | 768.3 | 0.0021 | 1 | 3 | negative regulation of trophoblast cell migration |
| GO:0023052 | 0.0023 | 8.1706 | 3.9103 | 9 | 5467 | signaling |
| GO:0051250 | 0.0024 | 33.2593 | 0.0744 | 2 | 104 | negative regulation of lymphocyte activation |
| GO:0050859 | 0.0036 | 384.1 | 0.0036 | 1 | 5 | negative regulation of B cell receptor signaling pathway |
| GO:0051534 | 0.0036 | 384.1 | 0.0036 | 1 | 5 | negative regulation of NFAT protein import into nucleus |
| GO:0034341 | 0.0036 | 26.8818 | 0.0916 | 2 | 128 | response to interferon-gamma |
| GO:0043409 | 0.0037 | 26.6684 | 0.0923 | 2 | 129 | negative regulation of MAPK cascade |
| GO:0050851 | 0.004 | 25.4553 | 0.0966 | 2 | 135 | antigen receptor-mediated signaling pathway |
| GO:0050866 | 0.0041 | 25.0749 | 0.098 | 2 | 137 | negative regulation of cell activation |
| GO:0002924 | 0.0043 | 307.26 | 0.0043 | 1 | 6 | negative regulation of humoral immune response mediated by circulating immunoglobulin |
| GO:0048518 | 0.0052 | 5.981 | 3.3953 | 8 | 4747 | positive regulation of biological process |
| GO:0007565 | 0.0063 | 20.1058 | 0.1216 | 2 | 170 | female pregnancy |
| GO:0070372 | 0.0063 | 19.9855 | 0.1223 | 2 | 171 | regulation of ERK1 and ERK2 cascade |
| GO:0002713 | 0.0064 | 192 | 0.0064 | 1 | 9 | negative regulation of B cell mediated immunity |
| GO:0002682 | 0.0067 | 7.1049 | 0.8211 | 4 | 1148 | regulation of immune system process |
| GO:2000146 | 0.0071 | 18.8566 | 0.1295 | 2 | 181 | negative regulation of cell motility |
| GO:0048552 | 0.0071 | 170.6556 | 0.0072 | 1 | 10 | regulation of metalloenzyme activity |
| GO:0007162 | 0.0075 | 18.2378 | 0.1338 | 2 | 187 | negative regulation of cell adhesion |
| GO:0050860 | 0.0093 | 127.9667 | 0.0093 | 1 | 13 | negative regulation of T cell receptor signaling pathway |
| GO:0007204 | 0.0096 | 16.0402 | 0.1516 | 2 | 212 | positive regulation of cytosolic calcium ion concentration |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0002263 | 1e-04 | 64.0197 | 0.0824 | 3 | 181 | cell activation involved in immune response |
| GO:1902106 | 5e-04 | 83.8301 | 0.0341 | 2 | 75 | negative regulation of leukocyte differentiation |
| GO:0002694 | 5e-04 | 29.8309 | 0.173 | 3 | 380 | regulation of leukocyte activation |
| GO:1903901 | 6e-04 | 77.4329 | 0.0369 | 2 | 81 | negative regulation of viral life cycle |
| GO:0042100 | 6e-04 | 75.5111 | 0.0378 | 2 | 83 | B cell proliferation |
| GO:0030183 | 9e-04 | 61.7091 | 0.046 | 2 | 101 | B cell differentiation |
| GO:2000552 | 9e-04 | 2561.8333 | 9e-04 | 1 | 2 | negative regulation of T-helper 2 cell cytokine production |
| GO:0070374 | 0.0013 | 50.4165 | 0.056 | 2 | 123 | positive regulation of ERK1 and ERK2 cascade |
| GO:0002285 | 0.0013 | 50 | 0.0564 | 2 | 124 | lymphocyte activation involved in immune response |
| GO:0043901 | 0.0016 | 44.8118 | 0.0628 | 2 | 138 | negative regulation of multi-organism process |
| GO:0006959 | 0.0019 | 41.4286 | 0.0678 | 2 | 149 | humoral immune response |
| GO:0043308 | 0.0023 | 640.3333 | 0.0023 | 1 | 5 | eosinophil degranulation |
| GO:2000503 | 0.0023 | 640.3333 | 0.0023 | 1 | 5 | positive regulation of natural killer cell chemotaxis |
| GO:0043307 | 0.0027 | 512.2333 | 0.0027 | 1 | 6 | eosinophil activation |
| GO:0043615 | 0.0027 | 512.2333 | 0.0027 | 1 | 6 | astrocyte cell migration |
| GO:0051707 | 0.0027 | 16.0561 | 0.3136 | 3 | 689 | response to other organism |
| GO:0050792 | 0.0028 | 33.9508 | 0.0824 | 2 | 181 | regulation of viral process |
| GO:0042742 | 0.0031 | 32.3064 | 0.0865 | 2 | 190 | defense response to bacterium |
| GO:0009607 | 0.0031 | 15.3071 | 0.3282 | 3 | 721 | response to biotic stimulus |
| GO:0048534 | 0.0031 | 15.2625 | 0.3291 | 3 | 723 | hematopoietic or lymphoid organ development |
| GO:0035743 | 0.0032 | 426.8333 | 0.0032 | 1 | 7 | CD4-positive, alpha-beta T cell cytokine production |
| GO:0002684 | 0.0034 | 14.746 | 0.34 | 3 | 747 | positive regulation of immune system process |
| GO:0071360 | 0.0036 | 365.8333 | 0.0036 | 1 | 8 | cellular response to exogenous dsRNA |
| GO:0002313 | 0.0045 | 284.5 | 0.0046 | 1 | 10 | mature B cell differentiation involved in immune response |
| GO:0048245 | 0.0045 | 284.5 | 0.0046 | 1 | 10 | eosinophil chemotaxis |
| GO:0042327 | 0.0046 | 13.2926 | 0.3751 | 3 | 824 | positive regulation of phosphorylation |
| GO:0032943 | 0.0046 | 25.9897 | 0.107 | 2 | 235 | mononuclear cell proliferation |
| GO:0002710 | 0.005 | 256.0333 | 0.005 | 1 | 11 | negative regulation of T cell mediated immunity |
| GO:0050863 | 0.0052 | 24.3935 | 0.1138 | 2 | 250 | regulation of T cell activation |
| GO:0002443 | 0.0054 | 24 | 0.1156 | 2 | 254 | leukocyte mediated immunity |
| GO:0043922 | 0.0055 | 232.7424 | 0.0055 | 1 | 12 | negative regulation by host of viral transcription |
| GO:0035458 | 0.0059 | 213.3333 | 0.0059 | 1 | 13 | cellular response to interferon-beta |
| GO:0002724 | 0.0064 | 196.9103 | 0.0064 | 1 | 14 | regulation of T cell cytokine production |
| GO:0030502 | 0.0064 | 196.9103 | 0.0064 | 1 | 14 | negative regulation of bone mineralization |
| GO:0090280 | 0.0064 | 196.9103 | 0.0064 | 1 | 14 | positive regulation of calcium ion import |
| GO:0010562 | 0.0065 | 11.6468 | 0.4247 | 3 | 933 | positive regulation of phosphorus metabolic process |
| GO:0031349 | 0.0069 | 21.0993 | 0.1311 | 2 | 288 | positive regulation of defense response |
| GO:1903706 | 0.0069 | 21.0244 | 0.1315 | 2 | 289 | regulation of hemopoiesis |
| GO:0010818 | 0.0077 | 159.9583 | 0.0077 | 1 | 17 | T cell chemotaxis |
| GO:0002719 | 0.0082 | 150.5392 | 0.0082 | 1 | 18 | negative regulation of cytokine production involved in immune response |
| GO:0033141 | 0.0082 | 150.5392 | 0.0082 | 1 | 18 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
| GO:0071407 | 0.0086 | 18.7551 | 0.147 | 2 | 323 | cellular response to organic cyclic compound |
| GO:0050718 | 0.0086 | 142.1667 | 0.0086 | 1 | 19 | positive regulation of interleukin-1 beta secretion |
| GO:1901623 | 0.0086 | 142.1667 | 0.0086 | 1 | 19 | regulation of lymphocyte chemotaxis |
| GO:0002683 | 0.009 | 18.2894 | 0.1507 | 2 | 331 | negative regulation of immune system process |
| GO:0070723 | 0.0091 | 134.6754 | 0.0091 | 1 | 20 | response to cholesterol |
| GO:0022407 | 0.0091 | 18.1764 | 0.1516 | 2 | 333 | regulation of cell-cell adhesion |
| GO:0045671 | 0.0095 | 127.9333 | 0.0096 | 1 | 21 | negative regulation of osteoclast differentiation |
| GO:0052472 | 0.0095 | 127.9333 | 0.0096 | 1 | 21 | modulation by host of symbiont transcription |
| GO:0045343 | 0.01 | 121.8333 | 0.01 | 1 | 22 | regulation of MHC class I biosynthetic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0002263 | 1e-04 | 64.0197 | 0.0824 | 3 | 181 | cell activation involved in immune response |
| GO:1902106 | 5e-04 | 83.8301 | 0.0341 | 2 | 75 | negative regulation of leukocyte differentiation |
| GO:0002694 | 5e-04 | 29.8309 | 0.173 | 3 | 380 | regulation of leukocyte activation |
| GO:1903901 | 6e-04 | 77.4329 | 0.0369 | 2 | 81 | negative regulation of viral life cycle |
| GO:0042100 | 6e-04 | 75.5111 | 0.0378 | 2 | 83 | B cell proliferation |
| GO:0030183 | 9e-04 | 61.7091 | 0.046 | 2 | 101 | B cell differentiation |
| GO:2000552 | 9e-04 | 2561.8333 | 9e-04 | 1 | 2 | negative regulation of T-helper 2 cell cytokine production |
| GO:0070374 | 0.0013 | 50.4165 | 0.056 | 2 | 123 | positive regulation of ERK1 and ERK2 cascade |
| GO:0002285 | 0.0013 | 50 | 0.0564 | 2 | 124 | lymphocyte activation involved in immune response |
| GO:0043901 | 0.0016 | 44.8118 | 0.0628 | 2 | 138 | negative regulation of multi-organism process |
| GO:0006959 | 0.0019 | 41.4286 | 0.0678 | 2 | 149 | humoral immune response |
| GO:0043308 | 0.0023 | 640.3333 | 0.0023 | 1 | 5 | eosinophil degranulation |
| GO:2000503 | 0.0023 | 640.3333 | 0.0023 | 1 | 5 | positive regulation of natural killer cell chemotaxis |
| GO:0043307 | 0.0027 | 512.2333 | 0.0027 | 1 | 6 | eosinophil activation |
| GO:0043615 | 0.0027 | 512.2333 | 0.0027 | 1 | 6 | astrocyte cell migration |
| GO:0050792 | 0.0028 | 33.9508 | 0.0824 | 2 | 181 | regulation of viral process |
| GO:0048534 | 0.0031 | 15.2625 | 0.3291 | 3 | 723 | hematopoietic or lymphoid organ development |
| GO:0035743 | 0.0032 | 426.8333 | 0.0032 | 1 | 7 | CD4-positive, alpha-beta T cell cytokine production |
| GO:0002684 | 0.0034 | 14.746 | 0.34 | 3 | 747 | positive regulation of immune system process |
| GO:0071360 | 0.0036 | 365.8333 | 0.0036 | 1 | 8 | cellular response to exogenous dsRNA |
| GO:0002313 | 0.0045 | 284.5 | 0.0046 | 1 | 10 | mature B cell differentiation involved in immune response |
| GO:0048245 | 0.0045 | 284.5 | 0.0046 | 1 | 10 | eosinophil chemotaxis |
| GO:0042327 | 0.0046 | 13.2926 | 0.3751 | 3 | 824 | positive regulation of phosphorylation |
| GO:0032943 | 0.0046 | 25.9897 | 0.107 | 2 | 235 | mononuclear cell proliferation |
| GO:0002710 | 0.005 | 256.0333 | 0.005 | 1 | 11 | negative regulation of T cell mediated immunity |
| GO:0050863 | 0.0052 | 24.3935 | 0.1138 | 2 | 250 | regulation of T cell activation |
| GO:0002443 | 0.0054 | 24 | 0.1156 | 2 | 254 | leukocyte mediated immunity |
| GO:0043922 | 0.0055 | 232.7424 | 0.0055 | 1 | 12 | negative regulation by host of viral transcription |
| GO:0035458 | 0.0059 | 213.3333 | 0.0059 | 1 | 13 | cellular response to interferon-beta |
| GO:0002724 | 0.0064 | 196.9103 | 0.0064 | 1 | 14 | regulation of T cell cytokine production |
| GO:0030502 | 0.0064 | 196.9103 | 0.0064 | 1 | 14 | negative regulation of bone mineralization |
| GO:0090280 | 0.0064 | 196.9103 | 0.0064 | 1 | 14 | positive regulation of calcium ion import |
| GO:0010562 | 0.0065 | 11.6468 | 0.4247 | 3 | 933 | positive regulation of phosphorus metabolic process |
| GO:0031349 | 0.0069 | 21.0993 | 0.1311 | 2 | 288 | positive regulation of defense response |
| GO:1903706 | 0.0069 | 21.0244 | 0.1315 | 2 | 289 | regulation of hemopoiesis |
| GO:0010818 | 0.0077 | 159.9583 | 0.0077 | 1 | 17 | T cell chemotaxis |
| GO:0002719 | 0.0082 | 150.5392 | 0.0082 | 1 | 18 | negative regulation of cytokine production involved in immune response |
| GO:0033141 | 0.0082 | 150.5392 | 0.0082 | 1 | 18 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
| GO:0071407 | 0.0086 | 18.7551 | 0.147 | 2 | 323 | cellular response to organic cyclic compound |
| GO:0050718 | 0.0086 | 142.1667 | 0.0086 | 1 | 19 | positive regulation of interleukin-1 beta secretion |
| GO:1901623 | 0.0086 | 142.1667 | 0.0086 | 1 | 19 | regulation of lymphocyte chemotaxis |
| GO:0002683 | 0.009 | 18.2894 | 0.1507 | 2 | 331 | negative regulation of immune system process |
| GO:0070723 | 0.0091 | 134.6754 | 0.0091 | 1 | 20 | response to cholesterol |
| GO:0022407 | 0.0091 | 18.1764 | 0.1516 | 2 | 333 | regulation of cell-cell adhesion |
| GO:0045671 | 0.0095 | 127.9333 | 0.0096 | 1 | 21 | negative regulation of osteoclast differentiation |
| GO:0052472 | 0.0095 | 127.9333 | 0.0096 | 1 | 21 | modulation by host of symbiont transcription |
| GO:0045343 | 0.01 | 121.8333 | 0.01 | 1 | 22 | regulation of MHC class I biosynthetic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0019835 | 0.0038 | 548.1786 | 0.0038 | 1 | 29 | cytolysis |
| GO:0001895 | 0.008 | 251.082 | 0.0081 | 1 | 62 | retina homeostasis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030502 | 0 | 365.6667 | 0.0082 | 2 | 14 | negative regulation of bone mineralization |
| GO:0042221 | 1e-04 | 25.7988 | 2.1337 | 8 | 3646 | response to chemical |
| GO:0007187 | 1e-04 | 47.5312 | 0.0954 | 3 | 163 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
| GO:0045637 | 1e-04 | 44.7059 | 0.1012 | 3 | 173 | regulation of myeloid cell differentiation |
| GO:0002573 | 1e-04 | 43.4143 | 0.1042 | 3 | 178 | myeloid leukocyte differentiation |
| GO:1902105 | 2e-04 | 36.6256 | 0.1229 | 3 | 210 | regulation of leukocyte differentiation |
| GO:0051716 | 2e-04 | Inf | 3.5388 | 9 | 6047 | cellular response to stimulus |
| GO:0045670 | 3e-04 | 108.6383 | 0.0255 | 2 | 49 | regulation of osteoclast differentiation |
| GO:0042330 | 4e-04 | 17.8303 | 0.3886 | 4 | 664 | taxis |
| GO:0007166 | 4e-04 | 13.3689 | 1.8703 | 7 | 3196 | cell surface receptor signaling pathway |
| GO:0006955 | 5e-04 | 12.9185 | 0.7965 | 5 | 1361 | immune response |
| GO:0007193 | 6e-04 | 72.9048 | 0.0363 | 2 | 62 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway |
| GO:0070167 | 7e-04 | 67.2747 | 0.0392 | 2 | 67 | regulation of biomineral tissue development |
| GO:0006952 | 7e-04 | 12.092 | 0.8456 | 5 | 1445 | defense response |
| GO:0002688 | 0.001 | 55.302 | 0.0474 | 2 | 81 | regulation of leukocyte chemotaxis |
| GO:0002687 | 0.0012 | 50.1905 | 0.0521 | 2 | 89 | positive regulation of leukocyte migration |
| GO:0050729 | 0.0012 | 50.1905 | 0.0521 | 2 | 89 | positive regulation of inflammatory response |
| GO:0002879 | 0.0012 | 1921.125 | 0.0012 | 1 | 2 | positive regulation of acute inflammatory response to non-antigenic stimulus |
| GO:0050921 | 0.0016 | 42.7675 | 0.0609 | 2 | 104 | positive regulation of chemotaxis |
| GO:0030003 | 0.0018 | 16.7697 | 0.2622 | 3 | 448 | cellular cation homeostasis |
| GO:0070374 | 0.0022 | 36.0071 | 0.072 | 2 | 123 | positive regulation of ERK1 and ERK2 cascade |
| GO:0002682 | 0.0029 | 9.9483 | 0.6718 | 4 | 1148 | regulation of immune system process |
| GO:0043308 | 0.0029 | 480.1875 | 0.0029 | 1 | 5 | eosinophil degranulation |
| GO:0090383 | 0.0029 | 480.1875 | 0.0029 | 1 | 5 | phagosome acidification |
| GO:2000503 | 0.0029 | 480.1875 | 0.0029 | 1 | 5 | positive regulation of natural killer cell chemotaxis |
| GO:0002274 | 0.003 | 30.8592 | 0.0837 | 2 | 143 | myeloid leukocyte activation |
| GO:0098771 | 0.0031 | 13.811 | 0.316 | 3 | 540 | inorganic ion homeostasis |
| GO:0055082 | 0.0034 | 13.3219 | 0.3271 | 3 | 559 | cellular chemical homeostasis |
| GO:0043307 | 0.0035 | 384.125 | 0.0035 | 1 | 6 | eosinophil activation |
| GO:0043615 | 0.0035 | 384.125 | 0.0035 | 1 | 6 | astrocyte cell migration |
| GO:2001204 | 0.0035 | 384.125 | 0.0035 | 1 | 6 | regulation of osteoclast development |
| GO:2001275 | 0.0035 | 384.125 | 0.0035 | 1 | 6 | positive regulation of glucose import in response to insulin stimulus |
| GO:0002252 | 0.0039 | 12.6143 | 0.3447 | 3 | 589 | immune effector process |
| GO:0030278 | 0.004 | 26.329 | 0.0977 | 2 | 167 | regulation of ossification |
| GO:0033860 | 0.0041 | 320.0833 | 0.0041 | 1 | 7 | regulation of NAD(P)H oxidase activity |
| GO:0032101 | 0.0045 | 12.0163 | 0.3611 | 3 | 617 | regulation of response to external stimulus |
| GO:0002366 | 0.0046 | 24.3852 | 0.1053 | 2 | 180 | leukocyte activation involved in immune response |
| GO:0002281 | 0.0047 | 274.3393 | 0.0047 | 1 | 8 | macrophage activation involved in immune response |
| GO:0051924 | 0.0047 | 24.2474 | 0.1059 | 2 | 181 | regulation of calcium ion transport |
| GO:0050795 | 0.0048 | 23.843 | 0.1077 | 2 | 184 | regulation of behavior |
| GO:0043270 | 0.0053 | 22.7061 | 0.1129 | 2 | 193 | positive regulation of ion transport |
| GO:0002283 | 0.0058 | 213.3472 | 0.0059 | 1 | 10 | neutrophil activation involved in immune response |
| GO:0048245 | 0.0058 | 213.3472 | 0.0059 | 1 | 10 | eosinophil chemotaxis |
| GO:0030097 | 0.0061 | 10.7518 | 0.4015 | 3 | 686 | hemopoiesis |
| GO:0060326 | 0.0062 | 20.9289 | 0.1223 | 2 | 209 | cell chemotaxis |
| GO:0007204 | 0.0064 | 20.6259 | 0.1241 | 2 | 212 | positive regulation of cytosolic calcium ion concentration |
| GO:0014061 | 0.007 | 174.5341 | 0.007 | 1 | 12 | regulation of norepinephrine secretion |
| GO:0043922 | 0.007 | 174.5341 | 0.007 | 1 | 12 | negative regulation by host of viral transcription |
| GO:0090026 | 0.007 | 174.5341 | 0.007 | 1 | 12 | positive regulation of monocyte chemotaxis |
| GO:0002520 | 0.0081 | 9.6252 | 0.4459 | 3 | 762 | immune system development |
| GO:0090280 | 0.0082 | 147.6635 | 0.0082 | 1 | 14 | positive regulation of calcium ion import |
| GO:0015874 | 0.0093 | 127.9583 | 0.0094 | 1 | 16 | norepinephrine transport |
| GO:0002548 | 0.0099 | 121.754 | 0.0099 | 1 | 19 | monocyte chemotaxis |
| GO:0010818 | 0.0099 | 119.9531 | 0.0099 | 1 | 17 | T cell chemotaxis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0002761 | 1e-04 | 308.6263 | 0.0197 | 2 | 101 | regulation of myeloid leukocyte differentiation |
| GO:0002263 | 4e-04 | 169.7989 | 0.0353 | 2 | 181 | cell activation involved in immune response |
| GO:0043308 | 0.001 | 1921.5 | 0.001 | 1 | 5 | eosinophil degranulation |
| GO:2000503 | 0.001 | 1921.5 | 0.001 | 1 | 5 | positive regulation of natural killer cell chemotaxis |
| GO:1903706 | 0.001 | 105.1498 | 0.0564 | 2 | 289 | regulation of hemopoiesis |
| GO:0043307 | 0.0012 | 1537.1 | 0.0012 | 1 | 6 | eosinophil activation |
| GO:0043615 | 0.0012 | 1537.1 | 0.0012 | 1 | 6 | astrocyte cell migration |
| GO:2001204 | 0.0012 | 1537.1 | 0.0012 | 1 | 6 | regulation of osteoclast development |
| GO:0002281 | 0.0016 | 1097.7857 | 0.0016 | 1 | 8 | macrophage activation involved in immune response |
| GO:0002283 | 0.0019 | 853.7222 | 0.002 | 1 | 10 | neutrophil activation involved in immune response |
| GO:0048245 | 0.0019 | 853.7222 | 0.002 | 1 | 10 | eosinophil chemotaxis |
| GO:0002521 | 0.0022 | 71.7458 | 0.0817 | 2 | 419 | leukocyte differentiation |
| GO:0043922 | 0.0023 | 698.4091 | 0.0023 | 1 | 12 | negative regulation by host of viral transcription |
| GO:0036230 | 0.0026 | 808 | 0.0026 | 1 | 20 | granulocyte activation |
| GO:0030502 | 0.0027 | 590.8846 | 0.0027 | 1 | 14 | negative regulation of bone mineralization |
| GO:0090280 | 0.0027 | 590.8846 | 0.0027 | 1 | 14 | positive regulation of calcium ion import |
| GO:0010818 | 0.0033 | 480 | 0.0033 | 1 | 17 | T cell chemotaxis |
| GO:0050718 | 0.0037 | 426.6111 | 0.0037 | 1 | 19 | positive regulation of interleukin-1 beta secretion |
| GO:1901623 | 0.0037 | 426.6111 | 0.0037 | 1 | 19 | regulation of lymphocyte chemotaxis |
| GO:0070723 | 0.0039 | 404.1316 | 0.0039 | 1 | 20 | response to cholesterol |
| GO:0045671 | 0.0041 | 383.9 | 0.0041 | 1 | 21 | negative regulation of osteoclast differentiation |
| GO:0052472 | 0.0041 | 383.9 | 0.0041 | 1 | 21 | modulation by host of symbiont transcription |
| GO:0048246 | 0.0045 | 348.9545 | 0.0045 | 1 | 23 | macrophage chemotaxis |
| GO:0050704 | 0.0047 | 333.7609 | 0.0047 | 1 | 24 | regulation of interleukin-1 secretion |
| GO:0050850 | 0.0049 | 319.8333 | 0.0049 | 1 | 25 | positive regulation of calcium-mediated signaling |
| GO:0051930 | 0.0051 | 307.02 | 0.0051 | 1 | 26 | regulation of sensory perception of pain |
| GO:0045321 | 0.0051 | 46.05 | 0.1252 | 2 | 642 | leukocyte activation |
| GO:0014808 | 0.0053 | 295.1923 | 0.0053 | 1 | 27 | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum |
| GO:0098751 | 0.0053 | 295.1923 | 0.0053 | 1 | 27 | bone cell development |
| GO:1903513 | 0.0053 | 295.1923 | 0.0053 | 1 | 27 | endoplasmic reticulum to cytosol transport |
| GO:0042330 | 0.0054 | 44.4532 | 0.1295 | 2 | 664 | taxis |
| GO:0002275 | 0.0055 | 373.6585 | 0.0055 | 1 | 42 | myeloid cell activation involved in immune response |
| GO:0032732 | 0.0056 | 274.0714 | 0.0057 | 1 | 29 | positive regulation of interleukin-1 production |
| GO:0002548 | 0.006 | 255.7667 | 0.006 | 1 | 31 | monocyte chemotaxis |
| GO:0048534 | 0.0064 | 40.6519 | 0.141 | 2 | 723 | hematopoietic or lymphoid organ development |
| GO:0032651 | 0.0074 | 207.2838 | 0.0074 | 1 | 38 | regulation of interleukin-1 beta production |
| GO:0051208 | 0.0074 | 207.2838 | 0.0074 | 1 | 38 | sequestering of calcium ion |
| GO:0030316 | 0.0078 | 259.2712 | 0.0078 | 1 | 60 | osteoclast differentiation |
| GO:0032760 | 0.0086 | 178.2907 | 0.0086 | 1 | 44 | positive regulation of tumor necrosis factor production |
| GO:0051702 | 0.0086 | 178.2907 | 0.0086 | 1 | 44 | interaction with symbiont |
| GO:0031663 | 0.0088 | 174.2273 | 0.0088 | 1 | 45 | lipopolysaccharide-mediated signaling pathway |
| GO:0007600 | 0.0089 | 34.0094 | 0.167 | 2 | 856 | sensory perception |
| GO:0043525 | 0.0091 | 166.6304 | 0.0092 | 1 | 47 | positive regulation of neuron apoptotic process |
| GO:0045087 | 0.0091 | 33.5926 | 0.1689 | 2 | 866 | innate immune response |
| GO:0071347 | 0.0093 | 163.0745 | 0.0094 | 1 | 48 | cellular response to interleukin-1 |
| GO:0031644 | 0.0099 | 153.26 | 0.0099 | 1 | 51 | regulation of neurological system process |
| GO:0050918 | 0.0099 | 153.26 | 0.0099 | 1 | 51 | positive chemotaxis |
| GO:0061515 | 0.0099 | 153.26 | 0.0099 | 1 | 51 | myeloid cell development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030502 | 0 | 365.6667 | 0.0082 | 2 | 14 | negative regulation of bone mineralization |
| GO:0042221 | 1e-04 | 25.7988 | 2.1337 | 8 | 3646 | response to chemical |
| GO:0007187 | 1e-04 | 47.5312 | 0.0954 | 3 | 163 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
| GO:0045637 | 1e-04 | 44.7059 | 0.1012 | 3 | 173 | regulation of myeloid cell differentiation |
| GO:0002573 | 1e-04 | 43.4143 | 0.1042 | 3 | 178 | myeloid leukocyte differentiation |
| GO:1902105 | 2e-04 | 36.6256 | 0.1229 | 3 | 210 | regulation of leukocyte differentiation |
| GO:0051716 | 2e-04 | Inf | 3.5388 | 9 | 6047 | cellular response to stimulus |
| GO:0045670 | 3e-04 | 108.6383 | 0.0255 | 2 | 49 | regulation of osteoclast differentiation |
| GO:0042330 | 4e-04 | 17.8303 | 0.3886 | 4 | 664 | taxis |
| GO:0007166 | 4e-04 | 13.3689 | 1.8703 | 7 | 3196 | cell surface receptor signaling pathway |
| GO:0006955 | 5e-04 | 12.9185 | 0.7965 | 5 | 1361 | immune response |
| GO:0007193 | 6e-04 | 72.9048 | 0.0363 | 2 | 62 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway |
| GO:0070167 | 7e-04 | 67.2747 | 0.0392 | 2 | 67 | regulation of biomineral tissue development |
| GO:0006952 | 7e-04 | 12.092 | 0.8456 | 5 | 1445 | defense response |
| GO:0002688 | 0.001 | 55.302 | 0.0474 | 2 | 81 | regulation of leukocyte chemotaxis |
| GO:0002687 | 0.0012 | 50.1905 | 0.0521 | 2 | 89 | positive regulation of leukocyte migration |
| GO:0050729 | 0.0012 | 50.1905 | 0.0521 | 2 | 89 | positive regulation of inflammatory response |
| GO:0002879 | 0.0012 | 1921.125 | 0.0012 | 1 | 2 | positive regulation of acute inflammatory response to non-antigenic stimulus |
| GO:0050921 | 0.0016 | 42.7675 | 0.0609 | 2 | 104 | positive regulation of chemotaxis |
| GO:0030003 | 0.0018 | 16.7697 | 0.2622 | 3 | 448 | cellular cation homeostasis |
| GO:0070374 | 0.0022 | 36.0071 | 0.072 | 2 | 123 | positive regulation of ERK1 and ERK2 cascade |
| GO:0002682 | 0.0029 | 9.9483 | 0.6718 | 4 | 1148 | regulation of immune system process |
| GO:0043308 | 0.0029 | 480.1875 | 0.0029 | 1 | 5 | eosinophil degranulation |
| GO:0090383 | 0.0029 | 480.1875 | 0.0029 | 1 | 5 | phagosome acidification |
| GO:2000503 | 0.0029 | 480.1875 | 0.0029 | 1 | 5 | positive regulation of natural killer cell chemotaxis |
| GO:0002274 | 0.003 | 30.8592 | 0.0837 | 2 | 143 | myeloid leukocyte activation |
| GO:0098771 | 0.0031 | 13.811 | 0.316 | 3 | 540 | inorganic ion homeostasis |
| GO:0055082 | 0.0034 | 13.3219 | 0.3271 | 3 | 559 | cellular chemical homeostasis |
| GO:0043307 | 0.0035 | 384.125 | 0.0035 | 1 | 6 | eosinophil activation |
| GO:0043615 | 0.0035 | 384.125 | 0.0035 | 1 | 6 | astrocyte cell migration |
| GO:2001204 | 0.0035 | 384.125 | 0.0035 | 1 | 6 | regulation of osteoclast development |
| GO:2001275 | 0.0035 | 384.125 | 0.0035 | 1 | 6 | positive regulation of glucose import in response to insulin stimulus |
| GO:0002252 | 0.0039 | 12.6143 | 0.3447 | 3 | 589 | immune effector process |
| GO:0030278 | 0.004 | 26.329 | 0.0977 | 2 | 167 | regulation of ossification |
| GO:0033860 | 0.0041 | 320.0833 | 0.0041 | 1 | 7 | regulation of NAD(P)H oxidase activity |
| GO:0032101 | 0.0045 | 12.0163 | 0.3611 | 3 | 617 | regulation of response to external stimulus |
| GO:0002366 | 0.0046 | 24.3852 | 0.1053 | 2 | 180 | leukocyte activation involved in immune response |
| GO:0002281 | 0.0047 | 274.3393 | 0.0047 | 1 | 8 | macrophage activation involved in immune response |
| GO:0051924 | 0.0047 | 24.2474 | 0.1059 | 2 | 181 | regulation of calcium ion transport |
| GO:0050795 | 0.0048 | 23.843 | 0.1077 | 2 | 184 | regulation of behavior |
| GO:0043270 | 0.0053 | 22.7061 | 0.1129 | 2 | 193 | positive regulation of ion transport |
| GO:0002283 | 0.0058 | 213.3472 | 0.0059 | 1 | 10 | neutrophil activation involved in immune response |
| GO:0048245 | 0.0058 | 213.3472 | 0.0059 | 1 | 10 | eosinophil chemotaxis |
| GO:0030097 | 0.0061 | 10.7518 | 0.4015 | 3 | 686 | hemopoiesis |
| GO:0060326 | 0.0062 | 20.9289 | 0.1223 | 2 | 209 | cell chemotaxis |
| GO:0007204 | 0.0064 | 20.6259 | 0.1241 | 2 | 212 | positive regulation of cytosolic calcium ion concentration |
| GO:0014061 | 0.007 | 174.5341 | 0.007 | 1 | 12 | regulation of norepinephrine secretion |
| GO:0043922 | 0.007 | 174.5341 | 0.007 | 1 | 12 | negative regulation by host of viral transcription |
| GO:0090026 | 0.007 | 174.5341 | 0.007 | 1 | 12 | positive regulation of monocyte chemotaxis |
| GO:0002520 | 0.0081 | 9.6252 | 0.4459 | 3 | 762 | immune system development |
| GO:0090280 | 0.0082 | 147.6635 | 0.0082 | 1 | 14 | positive regulation of calcium ion import |
| GO:0015874 | 0.0093 | 127.9583 | 0.0094 | 1 | 16 | norepinephrine transport |
| GO:0002548 | 0.0099 | 121.754 | 0.0099 | 1 | 19 | monocyte chemotaxis |
| GO:0010818 | 0.0099 | 119.9531 | 0.0099 | 1 | 17 | T cell chemotaxis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007596 | 4e-04 | 41.9294 | 0.1736 | 3 | 534 | blood coagulation |
| GO:0050878 | 8e-04 | 32.766 | 0.2198 | 3 | 676 | regulation of body fluid levels |
| GO:0002366 | 0.0013 | 56.9139 | 0.0585 | 2 | 180 | leukocyte activation involved in immune response |
| GO:0002322 | 0.0016 | 960.625 | 0.0016 | 1 | 5 | B cell proliferation involved in immune response |
| GO:2001204 | 0.0019 | 768.45 | 0.002 | 1 | 6 | regulation of osteoclast development |
| GO:0009611 | 0.0022 | 22.5219 | 0.3131 | 3 | 963 | response to wounding |
| GO:0031666 | 0.0023 | 640.3333 | 0.0023 | 1 | 7 | positive regulation of lipopolysaccharide-mediated signaling pathway |
| GO:0002281 | 0.0026 | 548.8214 | 0.0026 | 1 | 8 | macrophage activation involved in immune response |
| GO:0002283 | 0.0032 | 426.8056 | 0.0033 | 1 | 10 | neutrophil activation involved in immune response |
| GO:0050900 | 0.004 | 32.0788 | 0.1024 | 2 | 315 | leukocyte migration |
| GO:0007567 | 0.0045 | 295.4038 | 0.0046 | 1 | 14 | parturition |
| GO:0045595 | 0.0058 | 15.6841 | 0.4373 | 3 | 1345 | regulation of cell differentiation |
| GO:2000026 | 0.0061 | 15.4193 | 0.4441 | 3 | 1366 | regulation of multicellular organismal development |
| GO:0007166 | 0.0078 | 15.2657 | 1.0391 | 4 | 3196 | cell surface receptor signaling pathway |
| GO:0040011 | 0.0083 | 13.6817 | 0.4948 | 3 | 1522 | locomotion |
| GO:0036230 | 0.0084 | 153.49 | 0.0085 | 1 | 26 | granulocyte activation |
| GO:0098751 | 0.0087 | 147.5769 | 0.0088 | 1 | 27 | bone cell development |
| GO:0001501 | 0.0088 | 21.1404 | 0.1535 | 2 | 472 | skeletal system development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0014739 | 3e-04 | Inf | 3e-04 | 1 | 1 | positive regulation of muscle hyperplasia |
| GO:0071228 | 3e-04 | Inf | 3e-04 | 1 | 1 | cellular response to tumor cell |
| GO:0071672 | 7e-04 | 3843.25 | 7e-04 | 1 | 2 | negative regulation of smooth muscle cell chemotaxis |
| GO:0071673 | 7e-04 | 3843.25 | 7e-04 | 1 | 2 | positive regulation of smooth muscle cell chemotaxis |
| GO:0071315 | 0.001 | 1921.5 | 0.001 | 1 | 3 | cellular response to morphine |
| GO:0071447 | 0.0019 | 768.45 | 0.002 | 1 | 6 | cellular response to hydroperoxide |
| GO:0001774 | 0.0032 | 426.8056 | 0.0033 | 1 | 10 | microglial cell activation |
| GO:0090026 | 0.0039 | 349.1591 | 0.0039 | 1 | 12 | positive regulation of monocyte chemotaxis |
| GO:0006979 | 0.0045 | 30.2981 | 0.1083 | 2 | 333 | response to oxidative stress |
| GO:1900087 | 0.0062 | 213.2778 | 0.0062 | 1 | 19 | positive regulation of G1/S transition of mitotic cell cycle |
| GO:2000406 | 0.0062 | 213.2778 | 0.0062 | 1 | 19 | positive regulation of T cell migration |
| GO:0006911 | 0.0068 | 191.925 | 0.0068 | 1 | 21 | phagocytosis, engulfment |
| GO:0097178 | 0.0081 | 159.8958 | 0.0081 | 1 | 25 | ruffle assembly |
| GO:0014072 | 0.0084 | 153.49 | 0.0085 | 1 | 26 | response to isoquinoline alkaloid |
| GO:0048662 | 0.0094 | 137.0179 | 0.0094 | 1 | 29 | negative regulation of smooth muscle cell proliferation |
| GO:0016601 | 0.0097 | 132.2845 | 0.0098 | 1 | 30 | Rac protein signal transduction |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:2001275 | 0.0012 | 1537.1 | 0.0012 | 1 | 6 | positive regulation of glucose import in response to insulin stimulus |
| GO:0010759 | 0.0014 | 1280.8333 | 0.0014 | 1 | 7 | positive regulation of macrophage chemotaxis |
| GO:0071674 | 0.0027 | 590.8846 | 0.0027 | 1 | 14 | mononuclear cell migration |
| GO:0010828 | 0.0066 | 232.4697 | 0.0066 | 1 | 34 | positive regulation of glucose transport |
| GO:0048566 | 0.007 | 219.1571 | 0.007 | 1 | 36 | embryonic digestive tract development |
| GO:0050873 | 0.007 | 219.1571 | 0.007 | 1 | 36 | brown fat cell differentiation |
| GO:0038032 | 0.0076 | 201.8158 | 0.0076 | 1 | 39 | termination of G-protein coupled receptor signaling pathway |
| GO:0045600 | 0.0082 | 187.0122 | 0.0082 | 1 | 42 | positive regulation of fat cell differentiation |
| GO:0050994 | 0.0086 | 178.2907 | 0.0086 | 1 | 44 | regulation of lipid catabolic process |
| GO:0046324 | 0.0099 | 153.26 | 0.0099 | 1 | 51 | regulation of glucose import |
| GO:1900076 | 0.0099 | 153.26 | 0.0099 | 1 | 51 | regulation of cellular response to insulin stimulus |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006264 | 0.0039 | 365.7381 | 0.0039 | 1 | 15 | mitochondrial DNA replication |
| GO:0000002 | 0.007 | 196.7821 | 0.007 | 1 | 27 | mitochondrial genome maintenance |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0035574 | 0 | 393.7949 | 0.0078 | 2 | 15 | histone H4-K20 demethylation |
| GO:0045653 | 0 | 319.8958 | 0.0094 | 2 | 18 | negative regulation of megakaryocyte differentiation |
| GO:0016577 | 1e-04 | 176.3448 | 0.0161 | 2 | 31 | histone demethylation |
| GO:0006335 | 1e-04 | 170.4556 | 0.0166 | 2 | 32 | DNA replication-dependent nucleosome assembly |
| GO:0008214 | 1e-04 | 164.9462 | 0.0172 | 2 | 33 | protein dealkylation |
| GO:0032776 | 1e-04 | 159.7812 | 0.0177 | 2 | 34 | DNA methylation on cytosine |
| GO:0051290 | 1e-04 | 150.3627 | 0.0187 | 2 | 36 | protein heterotetramerization |
| GO:0000183 | 2e-04 | 141.9907 | 0.0198 | 2 | 38 | chromatin silencing at rDNA |
| GO:0034080 | 2e-04 | 134.5 | 0.0208 | 2 | 40 | CENP-A containing nucleosome assembly |
| GO:1901532 | 2e-04 | 134.5 | 0.0208 | 2 | 40 | regulation of hematopoietic progenitor cell differentiation |
| GO:0034724 | 3e-04 | 106.4097 | 0.026 | 2 | 50 | DNA replication-independent nucleosome organization |
| GO:0070988 | 4e-04 | 88.0057 | 0.0312 | 2 | 60 | demethylation |
| GO:0043044 | 5e-04 | 76.1393 | 0.0359 | 2 | 69 | ATP-dependent chromatin remodeling |
| GO:0000723 | 8e-04 | 64.5232 | 0.0421 | 2 | 81 | telomere maintenance |
| GO:0006305 | 8e-04 | 64.5232 | 0.0421 | 2 | 81 | DNA alkylation |
| GO:0044728 | 0.001 | 55.3587 | 0.0489 | 2 | 94 | DNA methylation or demethylation |
| GO:0007186 | 0.0015 | 12.9356 | 0.5759 | 4 | 1107 | G-protein coupled receptor signaling pathway |
| GO:0045814 | 0.0015 | 45.0088 | 0.0598 | 2 | 115 | negative regulation of gene expression, epigenetic |
| GO:0002682 | 0.0017 | 12.4362 | 0.5972 | 4 | 1148 | regulation of immune system process |
| GO:1903707 | 0.0017 | 42.3639 | 0.0635 | 2 | 122 | negative regulation of hemopoiesis |
| GO:0031497 | 0.002 | 38.4823 | 0.0697 | 2 | 134 | chromatin assembly |
| GO:0016458 | 0.0021 | 38.1905 | 0.0702 | 2 | 135 | gene silencing |
| GO:0001920 | 0.0021 | 731.8095 | 0.0021 | 1 | 4 | negative regulation of receptor recycling |
| GO:0065004 | 0.0025 | 34.286 | 0.078 | 2 | 150 | protein-DNA complex assembly |
| GO:0045637 | 0.0034 | 29.6296 | 0.09 | 2 | 173 | regulation of myeloid cell differentiation |
| GO:0050862 | 0.0036 | 365.8333 | 0.0036 | 1 | 7 | positive regulation of T cell receptor signaling pathway |
| GO:0048534 | 0.0049 | 12.2092 | 0.3761 | 3 | 723 | hematopoietic or lymphoid organ development |
| GO:0002313 | 0.0052 | 243.8413 | 0.0052 | 1 | 10 | mature B cell differentiation involved in immune response |
| GO:0071103 | 0.0056 | 22.6428 | 0.117 | 2 | 225 | DNA conformation change |
| GO:0043414 | 0.0061 | 21.7514 | 0.1217 | 2 | 234 | macromolecule methylation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0002252 | 0 | 38.1738 | 0.3817 | 6 | 587 | immune effector process |
| GO:0002366 | 0 | 49.3247 | 0.1287 | 4 | 180 | leukocyte activation involved in immune response |
| GO:0006968 | 0 | 112.625 | 0.0386 | 3 | 54 | cellular defense response |
| GO:0001775 | 0 | 20.2687 | 0.6187 | 6 | 865 | cell activation |
| GO:0002283 | 0 | 426.6667 | 0.0072 | 2 | 10 | neutrophil activation involved in immune response |
| GO:0019722 | 1e-04 | 52.9861 | 0.0794 | 3 | 111 | calcium-mediated signaling |
| GO:0036230 | 1e-04 | 213.125 | 0.013 | 2 | 20 | granulocyte activation |
| GO:0048246 | 1e-04 | 162.4021 | 0.0165 | 2 | 23 | macrophage chemotaxis |
| GO:0060326 | 4e-04 | 27.6007 | 0.1495 | 3 | 209 | cell chemotaxis |
| GO:0032760 | 4e-04 | 81.0899 | 0.0315 | 2 | 44 | positive regulation of tumor necrosis factor production |
| GO:0001805 | 7e-04 | Inf | 7e-04 | 1 | 1 | positive regulation of type III hypersensitivity |
| GO:0030593 | 8e-04 | 57.661 | 0.0436 | 2 | 61 | neutrophil chemotaxis |
| GO:0042330 | 9e-04 | 12.7342 | 0.4749 | 4 | 664 | taxis |
| GO:0050900 | 9e-04 | 20.8161 | 0.2036 | 3 | 313 | leukocyte migration |
| GO:0002444 | 0.001 | 53.1389 | 0.0472 | 2 | 66 | myeloid leukocyte mediated immunity |
| GO:0007200 | 0.001 | 53.1389 | 0.0472 | 2 | 66 | phospholipase C-activating G-protein coupled receptor signaling pathway |
| GO:0043207 | 0.001 | 12.2486 | 0.4928 | 4 | 689 | response to external biotic stimulus |
| GO:0045055 | 0.0012 | 48.5651 | 0.0515 | 2 | 72 | regulated secretory pathway |
| GO:0002431 | 0.0012 | 47.2099 | 0.0529 | 2 | 74 | Fc receptor mediated stimulatory signaling pathway |
| GO:0001798 | 0.0014 | 1536.7 | 0.0014 | 1 | 2 | positive regulation of type IIa hypersensitivity |
| GO:0001812 | 0.0014 | 1536.7 | 0.0014 | 1 | 2 | positive regulation of type I hypersensitivity |
| GO:0002282 | 0.0014 | 1536.7 | 0.0014 | 1 | 2 | microglial cell activation involved in immune response |
| GO:0002357 | 0.0014 | 1536.7 | 0.0014 | 1 | 2 | defense response to tumor cell |
| GO:0002361 | 0.0014 | 1536.7 | 0.0014 | 1 | 2 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation |
| GO:0002522 | 0.0014 | 1536.7 | 0.0014 | 1 | 2 | leukocyte migration involved in immune response |
| GO:0002892 | 0.0014 | 1536.7 | 0.0014 | 1 | 2 | regulation of type II hypersensitivity |
| GO:0032765 | 0.0014 | 1536.7 | 0.0014 | 1 | 2 | positive regulation of mast cell cytokine production |
| GO:0030316 | 0.0015 | 43.007 | 0.0579 | 2 | 81 | osteoclast differentiation |
| GO:0097530 | 0.0015 | 41.9396 | 0.0594 | 2 | 83 | granulocyte migration |
| GO:1903555 | 0.0016 | 41.4255 | 0.0601 | 2 | 84 | regulation of tumor necrosis factor superfamily cytokine production |
| GO:0006821 | 0.0016 | 40.9237 | 0.0608 | 2 | 85 | chloride transport |
| GO:0007229 | 0.0016 | 40.9237 | 0.0608 | 2 | 85 | integrin-mediated signaling pathway |
| GO:0050729 | 0.0018 | 39.0319 | 0.0637 | 2 | 89 | positive regulation of inflammatory response |
| GO:0002351 | 0.0021 | 768.3 | 0.0021 | 1 | 3 | serotonin production involved in inflammatory response |
| GO:0002554 | 0.0021 | 768.3 | 0.0021 | 1 | 3 | serotonin secretion by platelet |
| GO:0033026 | 0.0021 | 768.3 | 0.0021 | 1 | 3 | negative regulation of mast cell apoptotic process |
| GO:0002761 | 0.0023 | 34.2738 | 0.0722 | 2 | 101 | regulation of myeloid leukocyte differentiation |
| GO:0045087 | 0.0024 | 9.6162 | 0.6194 | 4 | 866 | innate immune response |
| GO:0002521 | 0.0028 | 13.4784 | 0.2997 | 3 | 419 | leukocyte differentiation |
| GO:0033023 | 0.0029 | 512.1667 | 0.0029 | 1 | 4 | mast cell homeostasis |
| GO:0009617 | 0.0031 | 12.9653 | 0.3111 | 3 | 435 | response to bacterium |
| GO:0006950 | 0.0033 | 6.2901 | 2.3976 | 7 | 3352 | response to stress |
| GO:0071222 | 0.0034 | 27.7705 | 0.0887 | 2 | 124 | cellular response to lipopolysaccharide |
| GO:0023041 | 0.0036 | 384.1 | 0.0036 | 1 | 5 | neuronal signal transduction |
| GO:0043308 | 0.0036 | 384.1 | 0.0036 | 1 | 5 | eosinophil degranulation |
| GO:2000503 | 0.0036 | 384.1 | 0.0036 | 1 | 5 | positive regulation of natural killer cell chemotaxis |
| GO:0002281 | 0.0039 | 341.3778 | 0.0039 | 1 | 6 | macrophage activation involved in immune response |
| GO:0002866 | 0.0043 | 307.26 | 0.0043 | 1 | 6 | positive regulation of acute inflammatory response to antigenic stimulus |
| GO:0043307 | 0.0043 | 307.26 | 0.0043 | 1 | 6 | eosinophil activation |
| GO:0043615 | 0.0043 | 307.26 | 0.0043 | 1 | 6 | astrocyte cell migration |
| GO:2001204 | 0.0043 | 307.26 | 0.0043 | 1 | 6 | regulation of osteoclast development |
| GO:0071216 | 0.0047 | 23.3303 | 0.1051 | 2 | 147 | cellular response to biotic stimulus |
| GO:0006820 | 0.0056 | 10.4781 | 0.3819 | 3 | 534 | anion transport |
| GO:0001771 | 0.0057 | 219.4429 | 0.0057 | 1 | 8 | immunological synapse formation |
| GO:0002524 | 0.0057 | 219.4429 | 0.0057 | 1 | 8 | hypersensitivity |
| GO:0042355 | 0.0064 | 192 | 0.0064 | 1 | 9 | L-fucose catabolic process |
| GO:0048870 | 0.0066 | 7.1183 | 0.8197 | 4 | 1146 | cell motility |
| GO:0002682 | 0.0067 | 7.1049 | 0.8211 | 4 | 1148 | regulation of immune system process |
| GO:0001820 | 0.0071 | 170.6556 | 0.0072 | 1 | 10 | serotonin secretion |
| GO:0002418 | 0.0071 | 170.6556 | 0.0072 | 1 | 10 | immune response to tumor cell |
| GO:0035589 | 0.0071 | 170.6556 | 0.0072 | 1 | 10 | G-protein coupled purinergic nucleotide receptor signaling pathway |
| GO:0048245 | 0.0071 | 170.6556 | 0.0072 | 1 | 10 | eosinophil chemotaxis |
| GO:0071318 | 0.0071 | 170.6556 | 0.0072 | 1 | 10 | cellular response to ATP |
| GO:0006909 | 0.0075 | 18.2378 | 0.1338 | 2 | 187 | phagocytosis |
| GO:0001973 | 0.0086 | 139.6091 | 0.0086 | 1 | 12 | adenosine receptor signaling pathway |
| GO:0043306 | 0.0086 | 139.6091 | 0.0086 | 1 | 12 | positive regulation of mast cell degranulation |
| GO:0043922 | 0.0086 | 139.6091 | 0.0086 | 1 | 12 | negative regulation by host of viral transcription |
| GO:0032879 | 0.0093 | 5.4878 | 1.4527 | 5 | 2031 | regulation of localization |
| GO:0038093 | 0.0098 | 15.8112 | 0.1538 | 2 | 215 | Fc receptor signaling pathway |
| GO:0030502 | 0.01 | 118.1154 | 0.01 | 1 | 14 | negative regulation of bone mineralization |
| GO:0033005 | 0.01 | 118.1154 | 0.01 | 1 | 14 | positive regulation of mast cell activation |
| GO:0090280 | 0.01 | 118.1154 | 0.01 | 1 | 14 | positive regulation of calcium ion import |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0002642 | 2e-04 | Inf | 2e-04 | 1 | 1 | positive regulation of immunoglobulin biosynthetic process |
| GO:2001274 | 6e-04 | 3843.5 | 6e-04 | 1 | 3 | negative regulation of glucose import in response to insulin stimulus |
| GO:0032119 | 0.0016 | 1097.7857 | 0.0016 | 1 | 8 | sequestering of zinc ion |
| GO:0010829 | 0.0029 | 548.6429 | 0.0029 | 1 | 15 | negative regulation of glucose transport |
| GO:0033622 | 0.0029 | 548.6429 | 0.0029 | 1 | 15 | integrin activation |
| GO:0055069 | 0.0039 | 404.1316 | 0.0039 | 1 | 20 | zinc ion homeostasis |
| GO:0006829 | 0.0053 | 295.1923 | 0.0053 | 1 | 27 | zinc II ion transport |
| GO:0002637 | 0.0072 | 213.0556 | 0.0072 | 1 | 37 | regulation of immunoglobulin production |
| GO:0046324 | 0.0099 | 153.26 | 0.0099 | 1 | 51 | regulation of glucose import |
| GO:1900076 | 0.0099 | 153.26 | 0.0099 | 1 | 51 | regulation of cellular response to insulin stimulus |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006355 | 0 | 9.7762 | 8.1074 | 28 | 3197 | regulation of transcription, DNA-templated |
| GO:2001141 | 0 | 9.615 | 8.2139 | 28 | 3239 | regulation of RNA biosynthetic process |
| GO:0007389 | 0 | 21.3156 | 0.873 | 12 | 394 | pattern specification process |
| GO:0019219 | 0 | 9.4128 | 9.2358 | 29 | 3642 | regulation of nucleobase-containing compound metabolic process |
| GO:0034654 | 0 | 8.9598 | 9.5858 | 29 | 3780 | nucleobase-containing compound biosynthetic process |
| GO:0009790 | 0 | 10.7175 | 2.4117 | 16 | 951 | embryo development |
| GO:0009954 | 0 | 80.4202 | 0.0837 | 5 | 33 | proximal/distal pattern formation |
| GO:0046483 | 0 | 6.5076 | 13.2527 | 30 | 5226 | heterocycle metabolic process |
| GO:0006725 | 0 | 6.4792 | 13.2908 | 30 | 5241 | cellular aromatic compound metabolic process |
| GO:0048699 | 0 | 8.4299 | 2.5913 | 14 | 1129 | generation of neurons |
| GO:0048729 | 0 | 10.2734 | 1.4607 | 11 | 576 | tissue morphogenesis |
| GO:0060255 | 0 | 5.9354 | 12.8419 | 29 | 5064 | regulation of macromolecule metabolic process |
| GO:1901360 | 0 | 6.1026 | 13.8183 | 30 | 5449 | organic cyclic compound metabolic process |
| GO:0048736 | 0 | 20.6236 | 0.426 | 7 | 168 | appendage development |
| GO:0034641 | 0 | 5.9417 | 14.0566 | 30 | 5543 | cellular nitrogen compound metabolic process |
| GO:1901576 | 0 | 5.3244 | 13.7904 | 29 | 5438 | organic substance biosynthetic process |
| GO:0009889 | 0 | 7.2072 | 4.7441 | 16 | 2581 | regulation of biosynthetic process |
| GO:0030900 | 0 | 12.3093 | 0.8191 | 8 | 323 | forebrain development |
| GO:0097659 | 0 | 8.5548 | 2.6171 | 12 | 1549 | nucleic acid-templated transcription |
| GO:0035108 | 0 | 19.3223 | 0.3779 | 6 | 149 | limb morphogenesis |
| GO:0060322 | 0 | 8.0916 | 1.6154 | 10 | 637 | head development |
| GO:0000122 | 0 | 7.9853 | 1.6357 | 10 | 645 | negative regulation of transcription from RNA polymerase II promoter |
| GO:0051172 | 0 | 6.1007 | 2.9797 | 13 | 1175 | negative regulation of nitrogen compound metabolic process |
| GO:1903507 | 0 | 6.4631 | 2.5334 | 12 | 999 | negative regulation of nucleic acid-templated transcription |
| GO:0009890 | 0 | 5.7817 | 3.1293 | 13 | 1234 | negative regulation of biosynthetic process |
| GO:0007198 | 0 | Inf | 0.0051 | 2 | 2 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
| GO:0072272 | 0 | Inf | 0.0051 | 2 | 2 | proximal/distal pattern formation involved in metanephric nephron development |
| GO:0060581 | 0 | 106.4444 | 0.038 | 3 | 15 | cell fate commitment involved in pattern specification |
| GO:0051253 | 0 | 6.1111 | 2.6678 | 12 | 1052 | negative regulation of RNA metabolic process |
| GO:0045944 | 0 | 6.4244 | 2.2697 | 11 | 895 | positive regulation of transcription from RNA polymerase II promoter |
| GO:2000113 | 0 | 5.8859 | 2.7616 | 12 | 1089 | negative regulation of cellular macromolecule biosynthetic process |
| GO:0021514 | 0 | 91.2262 | 0.0431 | 3 | 17 | ventral spinal cord interneuron differentiation |
| GO:1903508 | 0 | 5.3579 | 3.0101 | 12 | 1187 | positive regulation of nucleic acid-templated transcription |
| GO:0021510 | 0 | 28.0147 | 0.1687 | 4 | 70 | spinal cord development |
| GO:0010629 | 0 | 5.2088 | 3.0888 | 12 | 1218 | negative regulation of gene expression |
| GO:0048869 | 0 | 3.9003 | 9.0101 | 21 | 3553 | cellular developmental process |
| GO:0014013 | 0 | 25.6672 | 0.1826 | 4 | 72 | regulation of gliogenesis |
| GO:0021513 | 0 | 58.0227 | 0.0634 | 3 | 25 | spinal cord dorsal/ventral patterning |
| GO:0009953 | 0 | 24.7419 | 0.1899 | 4 | 81 | dorsal/ventral pattern formation |
| GO:0072086 | 0 | 414.5405 | 0.0101 | 2 | 4 | specification of loop of Henle identity |
| GO:0051254 | 0 | 5.0449 | 3.1801 | 12 | 1254 | positive regulation of RNA metabolic process |
| GO:0021915 | 0 | 14.8922 | 0.3931 | 5 | 155 | neural tube development |
| GO:0034645 | 0 | 4.9352 | 6.1648 | 16 | 3263 | cellular macromolecule biosynthetic process |
| GO:0014003 | 1e-04 | 43.9971 | 0.0811 | 3 | 32 | oligodendrocyte development |
| GO:0016070 | 1e-04 | 5.6872 | 3.7159 | 12 | 2183 | RNA metabolic process |
| GO:0045595 | 1e-04 | 4.6702 | 3.4108 | 12 | 1345 | regulation of cell differentiation |
| GO:0009952 | 1e-04 | 12.7218 | 0.4599 | 5 | 191 | anterior/posterior pattern specification |
| GO:0048704 | 1e-04 | 19.151 | 0.2409 | 4 | 95 | embryonic skeletal system morphogenesis |
| GO:0010557 | 1e-04 | 4.5686 | 3.4793 | 12 | 1372 | positive regulation of macromolecule biosynthetic process |
| GO:0010628 | 1e-04 | 4.4289 | 3.5782 | 12 | 1411 | positive regulation of gene expression |
| GO:0021983 | 2e-04 | 33.557 | 0.104 | 3 | 41 | pituitary gland development |
| GO:0065007 | 2e-04 | 6.111 | 25.8664 | 36 | 10200 | biological regulation |
| GO:0001501 | 2e-04 | 6.9976 | 1.197 | 7 | 472 | skeletal system development |
| GO:0010467 | 2e-04 | 5.0243 | 4.1167 | 12 | 2375 | gene expression |
| GO:0031328 | 2e-04 | 4.1715 | 3.776 | 12 | 1489 | positive regulation of cellular biosynthetic process |
| GO:0051173 | 2e-04 | 4.1622 | 3.7836 | 12 | 1492 | positive regulation of nitrogen compound metabolic process |
| GO:0060253 | 2e-04 | 118.4015 | 0.0228 | 2 | 9 | negative regulation of glial cell proliferation |
| GO:0061004 | 2e-04 | 118.4015 | 0.0228 | 2 | 9 | pattern specification involved in kidney development |
| GO:0035113 | 3e-04 | 13.9109 | 0.3271 | 4 | 129 | embryonic appendage morphogenesis |
| GO:0001764 | 3e-04 | 13.7995 | 0.3297 | 4 | 130 | neuron migration |
| GO:0060562 | 3e-04 | 13.6583 | 0.336 | 4 | 146 | epithelial tube morphogenesis |
| GO:0010454 | 3e-04 | 92.0781 | 0.0279 | 2 | 11 | negative regulation of cell fate commitment |
| GO:0021521 | 3e-04 | 92.0781 | 0.0279 | 2 | 11 | ventral spinal cord interneuron specification |
| GO:0010720 | 3e-04 | 7.3157 | 0.9586 | 6 | 378 | positive regulation of cell development |
| GO:0050885 | 4e-04 | 23.5895 | 0.1445 | 3 | 57 | neuromuscular process controlling balance |
| GO:0021903 | 4e-04 | 82.8649 | 0.0304 | 2 | 12 | rostrocaudal neural tube patterning |
| GO:0007519 | 4e-04 | 12.5896 | 0.3601 | 4 | 142 | skeletal muscle tissue development |
| GO:0007267 | 5e-04 | 4.2429 | 2.9493 | 10 | 1163 | cell-cell signaling |
| GO:0016331 | 5e-04 | 12.1455 | 0.3728 | 4 | 147 | morphogenesis of embryonic epithelium |
| GO:0072001 | 5e-04 | 8.4632 | 0.6771 | 5 | 267 | renal system development |
| GO:0048762 | 5e-04 | 11.8935 | 0.3804 | 4 | 150 | mesenchymal cell differentiation |
| GO:0006837 | 6e-04 | 69.045 | 0.0355 | 2 | 14 | serotonin transport |
| GO:0007379 | 7e-04 | 59.1737 | 0.0406 | 2 | 16 | segment specification |
| GO:0061333 | 8e-04 | 18.1786 | 0.1851 | 3 | 73 | renal tubule morphogenesis |
| GO:0072088 | 8e-04 | 18.1786 | 0.1851 | 3 | 73 | nephron epithelium morphogenesis |
| GO:0031324 | 9e-04 | 3.3757 | 5.0516 | 13 | 1992 | negative regulation of cellular metabolic process |
| GO:0044707 | 9e-04 | 4.428 | 8.2805 | 16 | 5627 | single-multicellular organism process |
| GO:0072079 | 0.001 | 48.7218 | 0.0482 | 2 | 19 | nephron tubule formation |
| GO:0048665 | 0.001 | 48.6127 | 0.0482 | 2 | 20 | neuron fate specification |
| GO:0031290 | 0.0012 | 46.012 | 0.0507 | 2 | 20 | retinal ganglion cell axon guidance |
| GO:0050768 | 0.0013 | 9.4137 | 0.4768 | 4 | 188 | negative regulation of neurogenesis |
| GO:0051962 | 0.0013 | 6.8806 | 0.8267 | 5 | 326 | positive regulation of nervous system development |
| GO:0007423 | 0.0013 | 5.6047 | 1.2375 | 6 | 488 | sensory organ development |
| GO:0022414 | 0.0014 | 3.9415 | 2.7743 | 9 | 1094 | reproductive process |
| GO:0002089 | 0.0014 | 41.4054 | 0.0558 | 2 | 22 | lens morphogenesis in camera-type eye |
| GO:0010719 | 0.0014 | 41.4054 | 0.0558 | 2 | 22 | negative regulation of epithelial to mesenchymal transition |
| GO:0021516 | 0.0014 | 41.4054 | 0.0558 | 2 | 22 | dorsal spinal cord development |
| GO:0061138 | 0.0015 | 8.9694 | 0.4996 | 4 | 197 | morphogenesis of a branching epithelium |
| GO:0060993 | 0.0015 | 14.6102 | 0.2282 | 3 | 90 | kidney morphogenesis |
| GO:0072080 | 0.0016 | 14.4432 | 0.2308 | 3 | 91 | nephron tubule development |
| GO:0001656 | 0.0016 | 14.28 | 0.2333 | 3 | 92 | metanephros development |
| GO:0015698 | 0.0016 | 8.7849 | 0.5097 | 4 | 201 | inorganic anion transport |
| GO:0021879 | 0.0016 | 37.9975 | 0.0602 | 2 | 25 | forebrain neuron differentiation |
| GO:0033993 | 0.0017 | 4.6026 | 1.7828 | 7 | 703 | response to lipid |
| GO:0021884 | 0.0018 | 35.9976 | 0.0634 | 2 | 25 | forebrain neuron development |
| GO:0032355 | 0.0019 | 13.516 | 0.246 | 3 | 97 | response to estradiol |
| GO:0048666 | 0.0019 | 4.0684 | 2.3407 | 8 | 923 | neuron development |
| GO:0044238 | 0.0019 | 3.1833 | 23.0135 | 32 | 9075 | primary metabolic process |
| GO:0001662 | 0.0023 | 31.8378 | 0.071 | 2 | 28 | behavioral fear response |
| GO:0045687 | 0.0023 | 31.8378 | 0.071 | 2 | 28 | positive regulation of glial cell differentiation |
| GO:0060487 | 0.0023 | 31.8378 | 0.071 | 2 | 28 | lung epithelial cell differentiation |
| GO:0035295 | 0.0023 | 6.0781 | 0.9469 | 5 | 424 | tube development |
| GO:0001828 | 0.0025 | Inf | 0.0025 | 1 | 1 | inner cell mass cellular morphogenesis |
| GO:0002878 | 0.0025 | Inf | 0.0025 | 1 | 1 | negative regulation of acute inflammatory response to non-antigenic stimulus |
| GO:0003142 | 0.0025 | Inf | 0.0025 | 1 | 1 | cardiogenic plate morphogenesis |
| GO:0003327 | 0.0025 | Inf | 0.0025 | 1 | 1 | type B pancreatic cell fate commitment |
| GO:0009956 | 0.0025 | Inf | 0.0025 | 1 | 1 | radial pattern formation |
| GO:0021759 | 0.0025 | Inf | 0.0025 | 1 | 1 | globus pallidus development |
| GO:0035332 | 0.0025 | Inf | 0.0025 | 1 | 1 | positive regulation of hippo signaling |
| GO:0060580 | 0.0025 | Inf | 0.0025 | 1 | 1 | ventral spinal cord interneuron fate determination |
| GO:0060807 | 0.0025 | Inf | 0.0025 | 1 | 1 | regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification |
| GO:0090274 | 0.0025 | Inf | 0.0025 | 1 | 1 | positive regulation of somatostatin secretion |
| GO:2001111 | 0.0025 | Inf | 0.0025 | 1 | 1 | positive regulation of lens epithelial cell proliferation |
| GO:0045666 | 0.0026 | 7.6775 | 0.5807 | 4 | 229 | positive regulation of neuron differentiation |
| GO:0043009 | 0.0027 | 5.89 | 0.976 | 5 | 437 | chordate embryonic development |
| GO:0007399 | 0.0028 | 5.1105 | 1.4772 | 6 | 881 | nervous system development |
| GO:0048608 | 0.0029 | 5.7276 | 0.9865 | 5 | 389 | reproductive structure development |
| GO:0051093 | 0.0031 | 4.1167 | 1.9806 | 7 | 781 | negative regulation of developmental process |
| GO:0060441 | 0.0031 | 26.694 | 0.0837 | 2 | 33 | epithelial tube branching involved in lung morphogenesis |
| GO:0021522 | 0.0033 | 25.8581 | 0.0862 | 2 | 34 | spinal cord motor neuron differentiation |
| GO:0035115 | 0.0033 | 25.8581 | 0.0862 | 2 | 34 | embryonic forelimb morphogenesis |
| GO:0072175 | 0.0035 | 10.75 | 0.3068 | 3 | 121 | epithelial tube formation |
| GO:0007417 | 0.0037 | 4.5928 | 1.5327 | 6 | 710 | central nervous system development |
| GO:0048663 | 0.0037 | 24.362 | 0.0912 | 2 | 40 | neuron fate commitment |
| GO:0031128 | 0.0037 | 24.3339 | 0.0913 | 2 | 36 | developmental induction |
| GO:0071383 | 0.0041 | 10.1433 | 0.3246 | 3 | 128 | cellular response to steroid hormone stimulus |
| GO:0050880 | 0.0042 | 10.0622 | 0.3271 | 3 | 129 | regulation of blood vessel size |
| GO:0072006 | 0.0042 | 10.0622 | 0.3271 | 3 | 129 | nephron development |
| GO:0009725 | 0.0045 | 3.8487 | 2.1099 | 7 | 832 | response to hormone |
| GO:0048864 | 0.0045 | 6.5771 | 0.6746 | 4 | 266 | stem cell development |
| GO:0021545 | 0.0046 | 21.7667 | 0.1014 | 2 | 40 | cranial nerve development |
| GO:0014062 | 0.0049 | 414.5135 | 0.0049 | 1 | 2 | regulation of serotonin secretion |
| GO:0007188 | 0.005 | 9.4565 | 0.3474 | 3 | 137 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
| GO:0003326 | 0.0051 | 403.6579 | 0.0051 | 1 | 2 | pancreatic A cell fate commitment |
| GO:0003329 | 0.0051 | 403.6579 | 0.0051 | 1 | 2 | pancreatic PP cell fate commitment |
| GO:0007493 | 0.0051 | 403.6579 | 0.0051 | 1 | 2 | endodermal cell fate determination |
| GO:0021568 | 0.0051 | 403.6579 | 0.0051 | 1 | 2 | rhombomere 2 development |
| GO:0048866 | 0.0051 | 403.6579 | 0.0051 | 1 | 2 | stem cell fate specification |
| GO:0060738 | 0.0051 | 403.6579 | 0.0051 | 1 | 2 | epithelial-mesenchymal signaling involved in prostate gland development |
| GO:0060849 | 0.0051 | 403.6579 | 0.0051 | 1 | 2 | regulation of transcription involved in lymphatic endothelial cell fate commitment |
| GO:0061386 | 0.0051 | 403.6579 | 0.0051 | 1 | 2 | closure of optic fissure |
| GO:2000043 | 0.0051 | 403.6579 | 0.0051 | 1 | 2 | regulation of cardiac cell fate specification |
| GO:2000026 | 0.0051 | 3.2029 | 3.3707 | 9 | 1364 | regulation of multicellular organismal development |
| GO:0072073 | 0.0051 | 9.3858 | 0.35 | 3 | 138 | kidney epithelium development |
| GO:0055123 | 0.0052 | 9.3162 | 0.3525 | 3 | 139 | digestive system development |
| GO:0043010 | 0.0053 | 6.2608 | 0.7075 | 4 | 279 | camera-type eye development |
| GO:0048483 | 0.0053 | 20.1701 | 0.109 | 2 | 43 | autonomic nervous system development |
| GO:0051966 | 0.0053 | 20.1701 | 0.109 | 2 | 43 | regulation of synaptic transmission, glutamatergic |
| GO:0010721 | 0.0054 | 19.9078 | 0.1106 | 2 | 48 | negative regulation of cell development |
| GO:0048592 | 0.0055 | 9.1133 | 0.3601 | 3 | 142 | eye morphogenesis |
| GO:0002067 | 0.0058 | 19.2294 | 0.1141 | 2 | 45 | glandular epithelial cell differentiation |
| GO:0030520 | 0.0058 | 19.2294 | 0.1141 | 2 | 45 | intracellular estrogen receptor signaling pathway |
| GO:0009566 | 0.006 | 8.8561 | 0.3702 | 3 | 146 | fertilization |
| GO:0050794 | 0.0068 | 3.3261 | 15.3893 | 22 | 7999 | regulation of cellular process |
| GO:0048646 | 0.0069 | 3.5492 | 2.2938 | 7 | 950 | anatomical structure formation involved in morphogenesis |
| GO:0014032 | 0.0074 | 16.8682 | 0.1293 | 2 | 51 | neural crest cell development |
| GO:0014063 | 0.0076 | 201.8158 | 0.0076 | 1 | 3 | negative regulation of serotonin secretion |
| GO:0021530 | 0.0076 | 201.8158 | 0.0076 | 1 | 3 | spinal cord oligodendrocyte cell fate specification |
| GO:0021912 | 0.0076 | 201.8158 | 0.0076 | 1 | 3 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification |
| GO:0060741 | 0.0076 | 201.8158 | 0.0076 | 1 | 3 | prostate gland stromal morphogenesis |
| GO:0061010 | 0.0076 | 201.8158 | 0.0076 | 1 | 3 | gall bladder development |
| GO:0071502 | 0.0076 | 201.8158 | 0.0076 | 1 | 3 | cellular response to temperature stimulus |
| GO:0071651 | 0.0076 | 201.8158 | 0.0076 | 1 | 3 | positive regulation of chemokine (C-C motif) ligand 5 production |
| GO:2000035 | 0.0076 | 201.8158 | 0.0076 | 1 | 3 | regulation of stem cell division |
| GO:0048546 | 0.008 | 16.2046 | 0.1344 | 2 | 53 | digestive tract morphogenesis |
| GO:0030855 | 0.0082 | 4.4277 | 1.2702 | 5 | 527 | epithelial cell differentiation |
| GO:0014070 | 0.0085 | 3.7687 | 1.8056 | 6 | 712 | response to organic cyclic compound |
| GO:0048645 | 0.0085 | 15.591 | 0.1395 | 2 | 55 | organ formation |
| GO:0060537 | 0.0086 | 5.4161 | 0.814 | 4 | 321 | muscle tissue development |
| GO:0048562 | 0.0088 | 7.6758 | 0.4282 | 3 | 187 | embryonic organ morphogenesis |
| GO:0031018 | 0.0089 | 15.3013 | 0.142 | 2 | 56 | endocrine pancreas development |
| GO:0007517 | 0.0091 | 5.3303 | 0.8267 | 4 | 326 | muscle organ development |
| GO:0009887 | 0.0092 | 5.4138 | 0.8386 | 4 | 432 | organ morphogenesis |
| GO:0072503 | 0.0096 | 5.247 | 0.8394 | 4 | 331 | cellular divalent inorganic cation homeostasis |
| GO:0009653 | 0.0097 | 4.4544 | 1.3562 | 5 | 815 | anatomical structure morphogenesis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0014036 | 4e-04 | Inf | 4e-04 | 1 | 1 | neural crest cell fate specification |
| GO:0033693 | 0.0012 | 1537.1 | 0.0012 | 1 | 3 | neurofilament bundle assembly |
| GO:0021915 | 0.0015 | 49.7386 | 0.0605 | 2 | 155 | neural tube development |
| GO:0014029 | 0.0019 | 768.45 | 0.002 | 1 | 5 | neural crest formation |
| GO:0019896 | 0.0019 | 768.45 | 0.002 | 1 | 5 | axon transport of mitochondrion |
| GO:0031133 | 0.0019 | 768.45 | 0.002 | 1 | 5 | regulation of axon diameter |
| GO:0008090 | 0.0023 | 614.72 | 0.0023 | 1 | 6 | retrograde axon cargo transport |
| GO:0014012 | 0.0023 | 614.72 | 0.0023 | 1 | 6 | peripheral nervous system axon regeneration |
| GO:0045109 | 0.0066 | 191.9625 | 0.0066 | 1 | 17 | intermediate filament organization |
| GO:0023019 | 0.0086 | 146.2095 | 0.0086 | 1 | 22 | signal transduction involved in regulation of gene expression |
| GO:0042474 | 0.0086 | 146.2095 | 0.0086 | 1 | 22 | middle ear morphogenesis |
| GO:0051412 | 0.0086 | 146.2095 | 0.0086 | 1 | 22 | response to corticosterone |
| GO:0008089 | 0.0089 | 139.5545 | 0.009 | 1 | 23 | anterograde axon cargo transport |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0019827 | 0.0092 | Inf | 0.0092 | 1 | 142 | stem cell maintenance |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005534 | 0.0026 | 551.4286 | 0.0026 | 1 | 5 | galactose binding |
| GO:0046920 | 0.0041 | 315.0408 | 0.0041 | 1 | 8 | alpha-(1->3)-fucosyltransferase activity |
| GO:0001784 | 0.0067 | 183.7143 | 0.0067 | 1 | 13 | phosphotyrosine binding |
| GO:0030246 | 0.0074 | 19.6202 | 0.1346 | 2 | 260 | carbohydrate binding |
| GO:0005001 | 0.0088 | 137.75 | 0.0088 | 1 | 17 | transmembrane receptor protein tyrosine phosphatase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0035575 | 1e-04 | 182.5325 | 0.0146 | 2 | 15 | histone demethylase activity (H4-K20 specific) |
| GO:0032451 | 5e-04 | 69.6968 | 0.0349 | 2 | 36 | demethylase activity |
| GO:0046982 | 6e-04 | 13.2613 | 0.4038 | 4 | 416 | protein heterodimerization activity |
| GO:0004145 | 0.001 | Inf | 0.001 | 1 | 1 | diamine N-acetyltransferase activity |
| GO:0008311 | 0.001 | Inf | 0.001 | 1 | 1 | double-stranded DNA 3'-5' exodeoxyribonuclease activity |
| GO:0016890 | 0.0019 | 1102.5714 | 0.0019 | 1 | 2 | site-specific endodeoxyribonuclease activity, specific for altered base |
| GO:0003677 | 0.0033 | 5.0675 | 2.2133 | 7 | 2280 | DNA binding |
| GO:0004844 | 0.0039 | 367.4762 | 0.0039 | 1 | 4 | uracil DNA N-glycosylase activity |
| GO:0004945 | 0.0039 | 367.4762 | 0.0039 | 1 | 4 | angiotensin type II receptor activity |
| GO:0004984 | 0.0042 | 10.9688 | 0.3368 | 3 | 347 | olfactory receptor activity |
| GO:0004528 | 0.0048 | 275.5893 | 0.0049 | 1 | 5 | phosphodiesterase I activity |
| GO:0004930 | 0.0049 | 7.151 | 0.729 | 4 | 751 | G-protein coupled receptor activity |
| GO:0004523 | 0.0058 | 220.4571 | 0.0058 | 1 | 6 | RNA-DNA hybrid ribonuclease activity |
| GO:0001849 | 0.0068 | 183.7024 | 0.0068 | 1 | 7 | complement component C1q binding |
| GO:0042393 | 0.0095 | 15.4706 | 0.1495 | 2 | 154 | histone binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0046811 | 0.0018 | 1187.4615 | 0.0018 | 1 | 2 | histone deacetylase inhibitor activity |
| GO:0005111 | 0.0036 | 395.7692 | 0.0036 | 1 | 4 | type 2 fibroblast growth factor receptor binding |
| GO:0016520 | 0.0036 | 395.7692 | 0.0036 | 1 | 4 | growth hormone-releasing hormone receptor activity |
| GO:0051430 | 0.0036 | 395.7692 | 0.0036 | 1 | 4 | corticotropin-releasing hormone receptor 1 binding |
| GO:0051431 | 0.0036 | 395.7692 | 0.0036 | 1 | 4 | corticotropin-releasing hormone receptor 2 binding |
| GO:0005105 | 0.0045 | 296.8077 | 0.0045 | 1 | 5 | type 1 fibroblast growth factor receptor binding |
| GO:0001849 | 0.0063 | 197.8462 | 0.0063 | 1 | 7 | complement component C1q binding |
| GO:0008083 | 0.0082 | 16.8731 | 0.1386 | 2 | 153 | growth factor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:2001069 | 8e-04 | Inf | 8e-04 | 1 | 1 | glycogen binding |
| GO:0031720 | 0.0025 | 643.2083 | 0.0025 | 1 | 3 | haptoglobin binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008201 | 0.0017 | 43.7286 | 0.0643 | 2 | 142 | heparin binding |
| GO:0004252 | 0.0017 | 43.4156 | 0.0648 | 2 | 143 | serine-type endopeptidase activity |
| GO:0017171 | 0.0023 | 37.2707 | 0.0752 | 2 | 166 | serine hydrolase activity |
| GO:0015643 | 0.0045 | 285.8519 | 0.0045 | 1 | 10 | toxic substance binding |
| GO:0050786 | 0.005 | 257.25 | 0.005 | 1 | 11 | RAGE receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008201 | 0.0023 | 36.4381 | 0.0735 | 2 | 142 | heparin binding |
| GO:0004252 | 0.0023 | 36.1773 | 0.074 | 2 | 143 | serine-type endopeptidase activity |
| GO:0017171 | 0.0031 | 31.0569 | 0.0859 | 2 | 166 | serine hydrolase activity |
| GO:0015643 | 0.0052 | 245 | 0.0052 | 1 | 10 | toxic substance binding |
| GO:0019864 | 0.0057 | 220.4857 | 0.0057 | 1 | 11 | IgG binding |
| GO:0050786 | 0.0057 | 220.4857 | 0.0057 | 1 | 11 | RAGE receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004053 | 0.001 | 2206.1429 | 0.001 | 1 | 2 | arginase activity |
| GO:0070011 | 0.0022 | 16.4652 | 0.2827 | 3 | 546 | peptidase activity, acting on L-amino acid peptides |
| GO:0008201 | 0.0023 | 36.4381 | 0.0735 | 2 | 142 | heparin binding |
| GO:0004252 | 0.0023 | 36.1773 | 0.074 | 2 | 143 | serine-type endopeptidase activity |
| GO:0017171 | 0.0031 | 31.0569 | 0.0859 | 2 | 166 | serine hydrolase activity |
| GO:0050786 | 0.0057 | 220.4857 | 0.0057 | 1 | 11 | RAGE receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0052731 | 9e-04 | Inf | 9e-04 | 1 | 1 | phosphocholine phosphatase activity |
| GO:0052732 | 9e-04 | Inf | 9e-04 | 1 | 1 | phosphoethanolamine phosphatase activity |
| GO:0001632 | 0.0018 | 1187.4615 | 0.0018 | 1 | 2 | leukotriene B4 receptor activity |
| GO:0038036 | 0.0054 | 237.4308 | 0.0054 | 1 | 6 | sphingosine-1-phosphate receptor activity |
| GO:0043208 | 0.0072 | 169.5714 | 0.0072 | 1 | 8 | glycosphingolipid binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008009 | 5e-04 | 76.0296 | 0.0335 | 2 | 47 | chemokine activity |
| GO:0005126 | 6e-04 | 23.1631 | 0.1773 | 3 | 249 | cytokine receptor binding |
| GO:0019210 | 9e-04 | 55.1219 | 0.0456 | 2 | 64 | kinase inhibitor activity |
| GO:0004861 | 0.0085 | 140.2727 | 0.0085 | 1 | 12 | cyclin-dependent protein serine/threonine kinase inhibitor activity |
| GO:0005095 | 0.0099 | 118.6769 | 0.01 | 1 | 14 | GTPase inhibitor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0052731 | 9e-04 | Inf | 9e-04 | 1 | 1 | phosphocholine phosphatase activity |
| GO:0052732 | 9e-04 | Inf | 9e-04 | 1 | 1 | phosphoethanolamine phosphatase activity |
| GO:0001632 | 0.0018 | 1187.4615 | 0.0018 | 1 | 2 | leukotriene B4 receptor activity |
| GO:0038036 | 0.0054 | 237.4308 | 0.0054 | 1 | 6 | sphingosine-1-phosphate receptor activity |
| GO:0043208 | 0.0072 | 169.5714 | 0.0072 | 1 | 8 | glycosphingolipid binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004523 | 0.0016 | 1029.5333 | 0.0016 | 1 | 6 | RNA-DNA hybrid ribonuclease activity |
| GO:0045236 | 0.0044 | 321.5 | 0.0044 | 1 | 17 | CXCR chemokine receptor binding |
| GO:0016893 | 0.0085 | 160.5833 | 0.0085 | 1 | 33 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0019864 | 0 | 428.6944 | 0.0071 | 2 | 11 | IgG binding |
| GO:0032403 | 0.0013 | 11.8725 | 0.5339 | 4 | 825 | protein complex binding |
| GO:0019763 | 0.0039 | 343.0444 | 0.0039 | 1 | 6 | immunoglobulin receptor activity |
| GO:0005068 | 0.0058 | 214.3611 | 0.0058 | 1 | 9 | transmembrane receptor protein tyrosine kinase adaptor activity |
| GO:0004861 | 0.0077 | 155.8687 | 0.0078 | 1 | 12 | cyclin-dependent protein serine/threonine kinase inhibitor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005068 | 0.0035 | 385.95 | 0.0035 | 1 | 9 | transmembrane receptor protein tyrosine kinase adaptor activity |
| GO:0004861 | 0.0047 | 280.6364 | 0.0047 | 1 | 12 | cyclin-dependent protein serine/threonine kinase inhibitor activity |
| GO:0005132 | 0.0066 | 192.875 | 0.0066 | 1 | 17 | type I interferon receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030246 | 2e-04 | 44.323 | 0.1178 | 3 | 260 | carbohydrate binding |
| GO:0042288 | 0.0054 | 233.8485 | 0.0054 | 1 | 12 | MHC class I protein binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030883 | 0 | 1470.4762 | 0.0029 | 2 | 5 | endogenous lipid antigen binding |
| GO:0030884 | 0 | 1470.4762 | 0.0029 | 2 | 5 | exogenous lipid antigen binding |
| GO:0071723 | 0 | 882.1714 | 0.0041 | 2 | 7 | lipopeptide binding |
| GO:0030881 | 0 | 735.0952 | 0.0047 | 2 | 8 | beta-2-microglobulin binding |
| GO:0035757 | 6e-04 | Inf | 6e-04 | 1 | 1 | chemokine (C-C motif) ligand 19 binding |
| GO:0035758 | 6e-04 | Inf | 6e-04 | 1 | 1 | chemokine (C-C motif) ligand 21 binding |
| GO:0038117 | 6e-04 | Inf | 6e-04 | 1 | 1 | C-C motif chemokine 19 receptor activity |
| GO:0038121 | 6e-04 | Inf | 6e-04 | 1 | 1 | C-C motif chemokine 21 receptor activity |
| GO:0003823 | 8e-04 | 60.996 | 0.0431 | 2 | 74 | antigen binding |
| GO:0019956 | 0.0064 | 192.9125 | 0.0064 | 1 | 11 | chemokine binding |
| GO:0033218 | 0.0066 | 20.2365 | 0.1264 | 2 | 217 | amide binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030883 | 0.0048 | 275.5893 | 0.0049 | 1 | 5 | endogenous lipid antigen binding |
| GO:0030884 | 0.0048 | 275.5893 | 0.0049 | 1 | 5 | exogenous lipid antigen binding |
| GO:0042608 | 0.0068 | 183.7024 | 0.0068 | 1 | 7 | T cell receptor binding |
| GO:0071723 | 0.0068 | 183.7024 | 0.0068 | 1 | 7 | lipopeptide binding |
| GO:0030881 | 0.0077 | 157.449 | 0.0078 | 1 | 8 | beta-2-microglobulin binding |
| GO:0005057 | 0.0084 | 16.571 | 0.1398 | 2 | 144 | receptor signaling protein activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008142 | 0.0023 | 643.375 | 0.0023 | 1 | 5 | oxysterol binding |
| GO:0030883 | 0.0023 | 643.375 | 0.0023 | 1 | 5 | endogenous lipid antigen binding |
| GO:0030884 | 0.0023 | 643.375 | 0.0023 | 1 | 5 | exogenous lipid antigen binding |
| GO:0071723 | 0.0032 | 428.8611 | 0.0032 | 1 | 7 | lipopeptide binding |
| GO:0030881 | 0.0036 | 367.5714 | 0.0036 | 1 | 8 | beta-2-microglobulin binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030883 | 0.0019 | 772.1 | 0.0019 | 1 | 5 | endogenous lipid antigen binding |
| GO:0030884 | 0.0019 | 772.1 | 0.0019 | 1 | 5 | exogenous lipid antigen binding |
| GO:0071723 | 0.0027 | 514.6667 | 0.0027 | 1 | 7 | lipopeptide binding |
| GO:0030881 | 0.0031 | 441.1143 | 0.0031 | 1 | 8 | beta-2-microglobulin binding |
| GO:0005095 | 0.0054 | 237.4308 | 0.0054 | 1 | 14 | GTPase inhibitor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0043565 | 0 | 16.2711 | 1.437 | 13 | 793 | sequence-specific DNA binding |
| GO:0003676 | 1e-04 | 4.3414 | 6.5959 | 16 | 3640 | nucleic acid binding |
| GO:0004993 | 4e-04 | 84.6703 | 0.029 | 2 | 16 | serotonin receptor activity |
| GO:0000981 | 0.0017 | 6.6395 | 0.8952 | 5 | 494 | sequence-specific DNA binding RNA polymerase II transcription factor activity |
| GO:0016521 | 0.0018 | Inf | 0.0018 | 1 | 1 | pituitary adenylate cyclase activating polypeptide activity |
| GO:0031858 | 0.0018 | Inf | 0.0018 | 1 | 1 | pituitary adenylate cyclase-activating polypeptide receptor binding |
| GO:0001071 | 0.002 | 4.6924 | 1.8664 | 7 | 1030 | nucleic acid binding transcription factor activity |
| GO:0005277 | 0.0036 | 571.2222 | 0.0036 | 1 | 2 | acetylcholine transmembrane transporter activity |
| GO:0004994 | 0.009 | 142.7778 | 0.0091 | 1 | 5 | somatostatin receptor activity |
| GO:0005499 | 0.009 | 142.7778 | 0.0091 | 1 | 5 | vitamin D binding |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0016495 | 0.001 | Inf | 0.001 | 1 | 1 | C-X3-C chemokine receptor activity |
| GO:0004872 | 0.002 | 6.0107 | 1.4569 | 6 | 1407 | receptor activity |
| GO:0001607 | 0.0021 | 1029 | 0.0021 | 1 | 2 | neuromedin U receptor activity |
| GO:0045031 | 0.0021 | 1029 | 0.0021 | 1 | 2 | ATP-activated nucleotide receptor activity |
| GO:0030594 | 0.0023 | 32.7697 | 0.0714 | 2 | 69 | neurotransmitter receptor activity |
| GO:0004888 | 0.0041 | 5.9531 | 1.139 | 5 | 1100 | transmembrane signaling receptor activity |
| GO:0004871 | 0.0057 | 5.6691 | 1.2529 | 5 | 1370 | signal transducer activity |
| GO:0008528 | 0.0062 | 19.3717 | 0.1191 | 2 | 115 | G-protein coupled peptide receptor activity |
| GO:0031726 | 0.0062 | 205.7467 | 0.0062 | 1 | 6 | CCR1 chemokine receptor binding |
| GO:0031730 | 0.0072 | 171.4444 | 0.0072 | 1 | 7 | CCR5 chemokine receptor binding |
| GO:0005068 | 0.0093 | 128.5667 | 0.0093 | 1 | 9 | transmembrane receptor protein tyrosine kinase adaptor activity |
| GO:0005057 | 0.0095 | 15.3863 | 0.1491 | 2 | 144 | receptor signaling protein activity |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005164 | 0.0036 | 571.2222 | 0.0036 | 1 | 28 | tumor necrosis factor receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030246 | 5e-04 | 25.3224 | 0.1683 | 3 | 260 | carbohydrate binding |
| GO:0004871 | 0.0015 | 9.2333 | 0.9798 | 5 | 1514 | signal transducer activity |
| GO:0005094 | 0.0019 | 857.7778 | 0.0019 | 1 | 3 | Rho GDP-dissociation inhibitor activity |
| GO:0005534 | 0.0032 | 428.8333 | 0.0032 | 1 | 5 | galactose binding |
| GO:0001784 | 0.0084 | 142.8704 | 0.0084 | 1 | 13 | phosphotyrosine binding |
| GO:0005096 | 0.0088 | 17.0617 | 0.1456 | 2 | 225 | GTPase activator activity |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004698 | 0.0014 | 1286.9167 | 0.0014 | 1 | 3 | calcium-dependent protein kinase C activity |
| GO:0008142 | 0.0023 | 643.375 | 0.0023 | 1 | 5 | oxysterol binding |
| GO:0031726 | 0.0027 | 514.6667 | 0.0027 | 1 | 6 | CCR1 chemokine receptor binding |
| GO:0031730 | 0.0032 | 428.8611 | 0.0032 | 1 | 7 | CCR5 chemokine receptor binding |
| GO:0005125 | 0.0038 | 29.019 | 0.096 | 2 | 212 | cytokine activity |
| GO:0003796 | 0.0041 | 321.6042 | 0.0041 | 1 | 9 | lysozyme activity |
| GO:0016004 | 0.0041 | 321.6042 | 0.0041 | 1 | 9 | phospholipase activator activity |
| GO:0010857 | 0.0045 | 285.8519 | 0.0045 | 1 | 10 | calcium-dependent protein kinase activity |
| GO:0005132 | 0.0077 | 160.7188 | 0.0077 | 1 | 17 | type I interferon receptor binding |
| GO:0042802 | 0.0095 | 10.0658 | 0.4865 | 3 | 1074 | identical protein binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004698 | 0.0014 | 1286.9167 | 0.0014 | 1 | 3 | calcium-dependent protein kinase C activity |
| GO:0008142 | 0.0023 | 643.375 | 0.0023 | 1 | 5 | oxysterol binding |
| GO:0031726 | 0.0027 | 514.6667 | 0.0027 | 1 | 6 | CCR1 chemokine receptor binding |
| GO:0031730 | 0.0032 | 428.8611 | 0.0032 | 1 | 7 | CCR5 chemokine receptor binding |
| GO:0005125 | 0.0038 | 29.019 | 0.096 | 2 | 212 | cytokine activity |
| GO:0016004 | 0.0041 | 321.6042 | 0.0041 | 1 | 9 | phospholipase activator activity |
| GO:0010857 | 0.0045 | 285.8519 | 0.0045 | 1 | 10 | calcium-dependent protein kinase activity |
| GO:0005132 | 0.0077 | 160.7188 | 0.0077 | 1 | 17 | type I interferon receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0003796 | 0.0017 | 965.0625 | 0.0017 | 1 | 9 | lysozyme activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004872 | 3e-04 | 16.6928 | 0.7284 | 5 | 1407 | receptor activity |
| GO:0004930 | 3e-04 | 19.6747 | 0.3888 | 4 | 751 | G-protein coupled receptor activity |
| GO:0004871 | 4e-04 | 15.391 | 0.7838 | 5 | 1514 | signal transducer activity |
| GO:0035717 | 5e-04 | Inf | 5e-04 | 1 | 1 | chemokine (C-C motif) ligand 7 binding |
| GO:0071791 | 0.001 | 2206.1429 | 0.001 | 1 | 2 | chemokine (C-C motif) ligand 5 binding |
| GO:0001653 | 0.0015 | 44.4319 | 0.0606 | 2 | 117 | peptide receptor activity |
| GO:0004698 | 0.0016 | 1103 | 0.0016 | 1 | 3 | calcium-dependent protein kinase C activity |
| GO:0004982 | 0.0016 | 1103 | 0.0016 | 1 | 3 | N-formyl peptide receptor activity |
| GO:0031726 | 0.0031 | 441.1143 | 0.0031 | 1 | 6 | CCR1 chemokine receptor binding |
| GO:0031730 | 0.0036 | 367.5714 | 0.0036 | 1 | 7 | CCR5 chemokine receptor binding |
| GO:0016004 | 0.0047 | 275.6429 | 0.0047 | 1 | 9 | phospholipase activator activity |
| GO:0010857 | 0.0052 | 245 | 0.0052 | 1 | 10 | calcium-dependent protein kinase activity |
| GO:0019956 | 0.0057 | 220.4857 | 0.0057 | 1 | 11 | chemokine binding |
| GO:0016493 | 0.0062 | 200.4286 | 0.0062 | 1 | 12 | C-C chemokine receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004698 | 6e-04 | 3861.75 | 6e-04 | 1 | 3 | calcium-dependent protein kinase C activity |
| GO:0031726 | 0.0012 | 1544.4 | 0.0012 | 1 | 6 | CCR1 chemokine receptor binding |
| GO:0031730 | 0.0014 | 1286.9167 | 0.0014 | 1 | 7 | CCR5 chemokine receptor binding |
| GO:0016004 | 0.0017 | 965.0625 | 0.0017 | 1 | 9 | phospholipase activator activity |
| GO:0010857 | 0.0019 | 857.7778 | 0.0019 | 1 | 10 | calcium-dependent protein kinase activity |
| GO:0042056 | 0.0047 | 335.3478 | 0.0047 | 1 | 24 | chemoattractant activity |
| GO:0008009 | 0.0091 | 167.4239 | 0.0091 | 1 | 47 | chemokine activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004872 | 3e-04 | 16.6928 | 0.7284 | 5 | 1407 | receptor activity |
| GO:0004930 | 3e-04 | 19.6747 | 0.3888 | 4 | 751 | G-protein coupled receptor activity |
| GO:0004871 | 4e-04 | 15.391 | 0.7838 | 5 | 1514 | signal transducer activity |
| GO:0035717 | 5e-04 | Inf | 5e-04 | 1 | 1 | chemokine (C-C motif) ligand 7 binding |
| GO:0071791 | 0.001 | 2206.1429 | 0.001 | 1 | 2 | chemokine (C-C motif) ligand 5 binding |
| GO:0001653 | 0.0015 | 44.4319 | 0.0606 | 2 | 117 | peptide receptor activity |
| GO:0004698 | 0.0016 | 1103 | 0.0016 | 1 | 3 | calcium-dependent protein kinase C activity |
| GO:0004982 | 0.0016 | 1103 | 0.0016 | 1 | 3 | N-formyl peptide receptor activity |
| GO:0031726 | 0.0031 | 441.1143 | 0.0031 | 1 | 6 | CCR1 chemokine receptor binding |
| GO:0031730 | 0.0036 | 367.5714 | 0.0036 | 1 | 7 | CCR5 chemokine receptor binding |
| GO:0016004 | 0.0047 | 275.6429 | 0.0047 | 1 | 9 | phospholipase activator activity |
| GO:0010857 | 0.0052 | 245 | 0.0052 | 1 | 10 | calcium-dependent protein kinase activity |
| GO:0019956 | 0.0057 | 220.4857 | 0.0057 | 1 | 11 | chemokine binding |
| GO:0016493 | 0.0062 | 200.4286 | 0.0062 | 1 | 12 | C-C chemokine receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005057 | 8e-04 | 71.8545 | 0.0466 | 2 | 144 | receptor signaling protein activity |
| GO:0005068 | 0.0029 | 482.4688 | 0.0029 | 1 | 9 | transmembrane receptor protein tyrosine kinase adaptor activity |
| GO:0005102 | 0.0052 | 16.3923 | 0.42 | 3 | 1298 | receptor binding |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004523 | 0.0016 | 1029.5333 | 0.0016 | 1 | 6 | RNA-DNA hybrid ribonuclease activity |
| GO:0045236 | 0.0044 | 321.5 | 0.0044 | 1 | 17 | CXCR chemokine receptor binding |
| GO:0016893 | 0.0085 | 160.5833 | 0.0085 | 1 | 33 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0035575 | 0 | 395.6667 | 0.0078 | 2 | 15 | histone demethylase activity (H4-K20 specific) |
| GO:0032451 | 1e-04 | 151.0784 | 0.0186 | 2 | 36 | demethylase activity |
| GO:0004930 | 3e-04 | 19.6747 | 0.3888 | 4 | 751 | G-protein coupled receptor activity |
| GO:0038023 | 0.002 | 11.9347 | 0.6202 | 4 | 1198 | signaling receptor activity |
| GO:0008142 | 0.0026 | 551.4286 | 0.0026 | 1 | 5 | oxysterol binding |
| GO:0042393 | 0.0027 | 33.5351 | 0.0797 | 2 | 154 | histone binding |
| GO:0005068 | 0.0047 | 275.6429 | 0.0047 | 1 | 9 | transmembrane receptor protein tyrosine kinase adaptor activity |
| GO:0060089 | 0.0074 | 8 | 0.8905 | 4 | 1720 | molecular transducer activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0019864 | 0 | 342.9111 | 0.0085 | 2 | 11 | IgG binding |
| GO:0016495 | 8e-04 | Inf | 8e-04 | 1 | 1 | C-X3-C chemokine receptor activity |
| GO:0030594 | 0.0013 | 45.8896 | 0.0536 | 2 | 69 | neurotransmitter receptor activity |
| GO:0001607 | 0.0016 | 1403.5455 | 0.0016 | 1 | 2 | neuromedin U receptor activity |
| GO:0045031 | 0.0016 | 1403.5455 | 0.0016 | 1 | 2 | ATP-activated nucleotide receptor activity |
| GO:0004698 | 0.0023 | 701.7273 | 0.0023 | 1 | 3 | calcium-dependent protein kinase C activity |
| GO:0019767 | 0.0023 | 701.7273 | 0.0023 | 1 | 3 | IgE receptor activity |
| GO:0008528 | 0.0035 | 27.1274 | 0.0893 | 2 | 115 | G-protein coupled peptide receptor activity |
| GO:0019863 | 0.0039 | 350.8182 | 0.0039 | 1 | 5 | IgE binding |
| GO:0004871 | 0.0039 | 6.5942 | 1.1758 | 5 | 1514 | signal transducer activity |
| GO:0031726 | 0.0047 | 280.6364 | 0.0047 | 1 | 6 | CCR1 chemokine receptor binding |
| GO:0031730 | 0.0054 | 233.8485 | 0.0054 | 1 | 7 | CCR5 chemokine receptor binding |
| GO:0046920 | 0.0062 | 200.4286 | 0.0062 | 1 | 8 | alpha-(1->3)-fucosyltransferase activity |
| GO:0016004 | 0.007 | 175.3636 | 0.007 | 1 | 9 | phospholipase activator activity |
| GO:0010857 | 0.0077 | 155.8687 | 0.0078 | 1 | 10 | calcium-dependent protein kinase activity |
| GO:0045028 | 0.0077 | 155.8687 | 0.0078 | 1 | 10 | G-protein coupled purinergic nucleotide receptor activity |
| GO:0004888 | 0.008 | 6.5438 | 0.8543 | 4 | 1100 | transmembrane signaling receptor activity |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031726 | 0 | 514.3667 | 0.0066 | 2 | 6 | CCR1 chemokine receptor binding |
| GO:0008009 | 0 | 74.9562 | 0.0517 | 3 | 47 | chemokine activity |
| GO:0031730 | 0 | 411.4667 | 0.0077 | 2 | 7 | CCR5 chemokine receptor binding |
| GO:0019864 | 1e-04 | 228.5333 | 0.0121 | 2 | 11 | IgG binding |
| GO:0005126 | 1e-04 | 19.0769 | 0.2739 | 4 | 249 | cytokine receptor binding |
| GO:0004872 | 4e-04 | 7.0175 | 1.548 | 7 | 1407 | receptor activity |
| GO:0016495 | 0.0011 | Inf | 0.0011 | 1 | 1 | C-X3-C chemokine receptor activity |
| GO:0001664 | 0.002 | 14.0422 | 0.2585 | 3 | 235 | G-protein coupled receptor binding |
| GO:0001607 | 0.0022 | 964.625 | 0.0022 | 1 | 2 | neuromedin U receptor activity |
| GO:0045031 | 0.0022 | 964.625 | 0.0022 | 1 | 2 | ATP-activated nucleotide receptor activity |
| GO:0030594 | 0.0026 | 30.5831 | 0.0759 | 2 | 69 | neurotransmitter receptor activity |
| GO:0004698 | 0.0033 | 482.2812 | 0.0033 | 1 | 3 | calcium-dependent protein kinase C activity |
| GO:0019767 | 0.0033 | 482.2812 | 0.0033 | 1 | 3 | IgE receptor activity |
| GO:0004888 | 0.0054 | 5.4566 | 1.2102 | 5 | 1100 | transmembrane signaling receptor activity |
| GO:0019863 | 0.0055 | 241.1094 | 0.0055 | 1 | 5 | IgE binding |
| GO:0038036 | 0.0066 | 192.875 | 0.0066 | 1 | 6 | sphingosine-1-phosphate receptor activity |
| GO:0008528 | 0.0069 | 18.0791 | 0.1265 | 2 | 115 | G-protein coupled peptide receptor activity |
| GO:0046920 | 0.0088 | 137.75 | 0.0088 | 1 | 8 | alpha-(1->3)-fucosyltransferase activity |
| GO:0016004 | 0.0099 | 120.5234 | 0.0099 | 1 | 9 | phospholipase activator activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008009 | 1e-04 | 228.1778 | 0.0152 | 2 | 47 | chemokine activity |
| GO:0045031 | 6e-04 | 3861.5 | 6e-04 | 1 | 2 | ATP-activated nucleotide receptor activity |
| GO:0004698 | 0.001 | 1930.625 | 0.001 | 1 | 3 | calcium-dependent protein kinase C activity |
| GO:0031726 | 0.0019 | 772.1 | 0.0019 | 1 | 6 | CCR1 chemokine receptor binding |
| GO:0001664 | 0.0022 | 43.5308 | 0.076 | 2 | 235 | G-protein coupled receptor binding |
| GO:0031730 | 0.0023 | 643.375 | 0.0023 | 1 | 7 | CCR5 chemokine receptor binding |
| GO:0005126 | 0.0025 | 41.0256 | 0.0806 | 2 | 249 | cytokine receptor binding |
| GO:0046920 | 0.0026 | 551.4286 | 0.0026 | 1 | 8 | alpha-(1->3)-fucosyltransferase activity |
| GO:0016004 | 0.0029 | 482.4688 | 0.0029 | 1 | 9 | phospholipase activator activity |
| GO:0010857 | 0.0032 | 428.8333 | 0.0032 | 1 | 10 | calcium-dependent protein kinase activity |
| GO:0045028 | 0.0032 | 428.8333 | 0.0032 | 1 | 10 | G-protein coupled purinergic nucleotide receptor activity |
| GO:0016502 | 0.0055 | 241.1094 | 0.0055 | 1 | 17 | nucleotide receptor activity |
| GO:0035586 | 0.0068 | 192.8375 | 0.0068 | 1 | 21 | purinergic receptor activity |
| GO:0042056 | 0.0077 | 167.6522 | 0.0078 | 1 | 24 | chemoattractant activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042169 | 0.0019 | Inf | 0.0019 | 1 | 29 | SH2 domain binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0043565 | 0.0024 | 18.5519 | 0.3079 | 3 | 793 | sequence-specific DNA binding |
| GO:0043274 | 0.0054 | 237.4308 | 0.0054 | 1 | 14 | phospholipase binding |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007268 | 0 | 10.2985 | 2.3745 | 17 | 686 | synaptic transmission |
| GO:0071805 | 0 | 13.0342 | 0.533 | 6 | 154 | potassium ion transmembrane transport |
| GO:0006813 | 0 | 10.5169 | 0.6542 | 6 | 189 | potassium ion transport |
| GO:0034765 | 1e-04 | 7.196 | 1.118 | 7 | 323 | regulation of ion transmembrane transport |
| GO:0098655 | 1e-04 | 5.3196 | 1.9868 | 9 | 574 | cation transmembrane transport |
| GO:0098660 | 2e-04 | 5.8831 | 1.5892 | 8 | 483 | inorganic ion transmembrane transport |
| GO:0001508 | 5e-04 | 11.8956 | 0.3738 | 4 | 108 | action potential |
| GO:0048167 | 8e-04 | 10.5648 | 0.4188 | 4 | 121 | regulation of synaptic plasticity |
| GO:0051049 | 0.0017 | 2.9636 | 5.2647 | 13 | 1521 | regulation of transport |
| GO:0044700 | 0.0034 | 2.1904 | 18.8781 | 29 | 5454 | single organism signaling |
| GO:0003220 | 0.0035 | Inf | 0.0035 | 1 | 1 | left ventricular cardiac muscle tissue morphogenesis |
| GO:0019694 | 0.0035 | Inf | 0.0035 | 1 | 1 | alkanesulfonate metabolic process |
| GO:0035332 | 0.0035 | Inf | 0.0035 | 1 | 1 | positive regulation of hippo signaling |
| GO:0048561 | 0.0035 | Inf | 0.0035 | 1 | 1 | establishment of organ orientation |
| GO:0051615 | 0.0035 | Inf | 0.0035 | 1 | 1 | histamine uptake |
| GO:0086094 | 0.0035 | Inf | 0.0035 | 1 | 1 | positive regulation of ryanodine-sensitive calcium-release channel activity by adrenergic receptor signaling pathway involved in positive regulation of cardiac muscle contraction |
| GO:1901896 | 0.0035 | Inf | 0.0035 | 1 | 1 | positive regulation of calcium-transporting ATPase activity |
| GO:2001111 | 0.0035 | Inf | 0.0035 | 1 | 1 | positive regulation of lens epithelial cell proliferation |
| GO:0007611 | 0.0043 | 6.5795 | 0.6611 | 4 | 191 | learning or memory |
| GO:0002090 | 0.0045 | 22.1235 | 0.1004 | 2 | 29 | regulation of receptor internalization |
| GO:0007154 | 0.0045 | 2.1331 | 19.2 | 29 | 5547 | cell communication |
| GO:0071407 | 0.0049 | 4.9258 | 1.1111 | 5 | 321 | cellular response to organic cyclic compound |
| GO:0007610 | 0.0056 | 3.5991 | 2.1668 | 7 | 626 | behavior |
| GO:0031635 | 0.0069 | 293.4231 | 0.0069 | 1 | 2 | adenylate cyclase-inhibiting opioid receptor signaling pathway |
| GO:0033590 | 0.0069 | 293.4231 | 0.0069 | 1 | 2 | response to cobalamin |
| GO:0043006 | 0.0069 | 293.4231 | 0.0069 | 1 | 2 | activation of phospholipase A2 activity by calcium-mediated signaling |
| GO:0048143 | 0.0069 | 293.4231 | 0.0069 | 1 | 2 | astrocyte activation |
| GO:0051284 | 0.0069 | 293.4231 | 0.0069 | 1 | 2 | positive regulation of sequestering of calcium ion |
| GO:0061386 | 0.0069 | 293.4231 | 0.0069 | 1 | 2 | closure of optic fissure |
| GO:0098904 | 0.0069 | 293.4231 | 0.0069 | 1 | 2 | regulation of AV node cell action potential |
| GO:0098907 | 0.0069 | 293.4231 | 0.0069 | 1 | 2 | regulation of SA node cell action potential |
| GO:1900452 | 0.0069 | 293.4231 | 0.0069 | 1 | 2 | regulation of long term synaptic depression |
| GO:0098661 | 0.0075 | 8.0421 | 0.4015 | 3 | 116 | inorganic anion transmembrane transport |
| GO:0051896 | 0.0079 | 7.9012 | 0.4084 | 3 | 118 | regulation of protein kinase B signaling |
| GO:0044765 | 0.0089 | 2.0878 | 11.952 | 20 | 3453 | single-organism transport |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008347 | 0.002 | 34.2312 | 0.0663 | 2 | 29 | glial cell migration |
| GO:0015862 | 0.0023 | Inf | 0.0023 | 1 | 1 | uridine transport |
| GO:1901264 | 0.0039 | 23.6799 | 0.0937 | 2 | 41 | carbohydrate derivative transport |
| GO:0051966 | 0.0041 | 23.0864 | 0.096 | 2 | 42 | regulation of synaptic transmission, glutamatergic |
| GO:0006682 | 0.0046 | 449.2941 | 0.0046 | 1 | 2 | galactosylceramide biosynthetic process |
| GO:0021568 | 0.0046 | 449.2941 | 0.0046 | 1 | 2 | rhombomere 2 development |
| GO:0021658 | 0.0046 | 449.2941 | 0.0046 | 1 | 2 | rhombomere 3 morphogenesis |
| GO:0035087 | 0.0046 | 449.2941 | 0.0046 | 1 | 2 | siRNA loading onto RISC involved in RNA interference |
| GO:0035483 | 0.0046 | 449.2941 | 0.0046 | 1 | 2 | gastric emptying |
| GO:0030423 | 0.0068 | 224.6324 | 0.0069 | 1 | 3 | targeting of mRNA for destruction involved in RNA interference |
| GO:0032513 | 0.0068 | 224.6324 | 0.0069 | 1 | 3 | negative regulation of protein phosphatase type 2B activity |
| GO:0035284 | 0.0068 | 224.6324 | 0.0069 | 1 | 3 | brain segmentation |
| GO:1903365 | 0.0068 | 224.6324 | 0.0069 | 1 | 3 | regulation of fear response |
| GO:2000172 | 0.0068 | 224.6324 | 0.0069 | 1 | 3 | regulation of branching morphogenesis of a nerve |
| GO:2000766 | 0.0068 | 224.6324 | 0.0069 | 1 | 3 | negative regulation of cytoplasmic translation |
| GO:2000987 | 0.0068 | 224.6324 | 0.0069 | 1 | 3 | positive regulation of behavioral fear response |
| GO:0031064 | 0.0091 | 149.7451 | 0.0091 | 1 | 4 | negative regulation of histone deacetylation |
| GO:0051461 | 0.0091 | 149.7451 | 0.0091 | 1 | 4 | positive regulation of corticotropin secretion |
| GO:0060455 | 0.0091 | 149.7451 | 0.0091 | 1 | 4 | negative regulation of gastric acid secretion |
| GO:0070885 | 0.0091 | 149.7451 | 0.0091 | 1 | 4 | negative regulation of calcineurin-NFAT signaling cascade |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050832 | 0 | 169.6556 | 0.0347 | 4 | 28 | defense response to fungus |
| GO:0051707 | 0 | 15.6289 | 0.8537 | 8 | 688 | response to other organism |
| GO:0009607 | 0 | 14.8938 | 0.8934 | 8 | 720 | response to biotic stimulus |
| GO:0031640 | 0 | 110.0986 | 0.036 | 3 | 29 | killing of cells of other organism |
| GO:0006954 | 0 | 11.9651 | 0.7123 | 6 | 574 | inflammatory response |
| GO:0045087 | 0 | 9.8505 | 1.0696 | 7 | 862 | innate immune response |
| GO:0035821 | 2e-04 | 34.3599 | 0.1067 | 3 | 86 | modification of morphology or physiology of other organism |
| GO:0016045 | 2e-04 | 119.8275 | 0.0211 | 2 | 17 | detection of bacterium |
| GO:0044110 | 3e-04 | 99.8366 | 0.0248 | 2 | 20 | growth involved in symbiotic interaction |
| GO:0044117 | 3e-04 | 99.8366 | 0.0248 | 2 | 20 | growth of symbiont in host |
| GO:0009605 | 3e-04 | 6.0199 | 2.4792 | 9 | 1998 | response to external stimulus |
| GO:0098581 | 4e-04 | 85.5574 | 0.0285 | 2 | 23 | detection of external biotic stimulus |
| GO:0019731 | 7e-04 | 61.9229 | 0.0385 | 2 | 31 | antibacterial humoral response |
| GO:0010043 | 0.001 | 49.8595 | 0.0472 | 2 | 38 | response to zinc ion |
| GO:0010963 | 0.0012 | Inf | 0.0012 | 1 | 1 | regulation of L-arginine import |
| GO:0044356 | 0.0012 | Inf | 0.0012 | 1 | 1 | clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine |
| GO:0035872 | 0.0016 | 38.9949 | 0.0596 | 2 | 48 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway |
| GO:0006950 | 0.0018 | 4.4932 | 3.9249 | 10 | 3337 | response to stress |
| GO:0070301 | 0.0019 | 35.1603 | 0.0658 | 2 | 53 | cellular response to hydrogen peroxide |
| GO:0070988 | 0.0023 | 32.0105 | 0.072 | 2 | 58 | demethylation |
| GO:0050830 | 0.0024 | 31.7333 | 0.0729 | 2 | 62 | defense response to Gram-positive bacterium |
| GO:0070488 | 0.0025 | 849.5556 | 0.0025 | 1 | 2 | neutrophil aggregation |
| GO:0070946 | 0.0025 | 849.5556 | 0.0025 | 1 | 2 | neutrophil mediated killing of gram-positive bacterium |
| GO:0071557 | 0.0025 | 849.5556 | 0.0025 | 1 | 2 | histone H3-K27 demethylation |
| GO:0051716 | 0.0026 | 4.3154 | 7.4848 | 14 | 6032 | cellular response to stimulus |
| GO:0032496 | 0.0037 | 11.1462 | 0.3177 | 3 | 256 | response to lipopolysaccharide |
| GO:0090467 | 0.0037 | 424.75 | 0.0037 | 1 | 3 | arginine import |
| GO:1902023 | 0.0037 | 424.75 | 0.0037 | 1 | 3 | L-arginine transport |
| GO:0002376 | 0.0039 | 5.3203 | 1.6747 | 6 | 1644 | immune system process |
| GO:0001816 | 0.0041 | 7.2161 | 0.6812 | 4 | 549 | cytokine production |
| GO:0032827 | 0.005 | 283.1481 | 0.005 | 1 | 4 | negative regulation of natural killer cell differentiation involved in immune response |
| GO:0070269 | 0.005 | 283.1481 | 0.005 | 1 | 4 | pyroptosis |
| GO:0031349 | 0.0051 | 9.9091 | 0.3561 | 3 | 287 | positive regulation of defense response |
| GO:0002252 | 0.0052 | 6.7284 | 0.7284 | 4 | 587 | immune effector process |
| GO:0006919 | 0.0052 | 20.803 | 0.1092 | 2 | 88 | activation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0042742 | 0.0058 | 20.0358 | 0.1162 | 2 | 118 | defense response to bacterium |
| GO:0010269 | 0.0062 | 212.3472 | 0.0062 | 1 | 5 | response to selenium ion |
| GO:0070383 | 0.0062 | 212.3472 | 0.0062 | 1 | 5 | DNA cytosine deamination |
| GO:1901565 | 0.0063 | 9.1224 | 0.3859 | 3 | 311 | organonitrogen compound catabolic process |
| GO:0032815 | 0.0074 | 169.8667 | 0.0074 | 1 | 6 | negative regulation of natural killer cell activation |
| GO:0070943 | 0.0074 | 169.8667 | 0.0074 | 1 | 6 | neutrophil mediated killing of symbiont cell |
| GO:0030307 | 0.0077 | 17.0174 | 0.1328 | 2 | 107 | positive regulation of cell growth |
| GO:0009253 | 0.0087 | 141.5463 | 0.0087 | 1 | 7 | peptidoglycan catabolic process |
| GO:0031638 | 0.0089 | 15.6646 | 0.1439 | 2 | 116 | zymogen activation |
| GO:0051092 | 0.0092 | 15.3925 | 0.1464 | 2 | 118 | positive regulation of NF-kappaB transcription factor activity |
| GO:0009635 | 0.0099 | 121.3175 | 0.0099 | 1 | 8 | response to herbicide |
| GO:0032119 | 0.0099 | 121.3175 | 0.0099 | 1 | 8 | sequestering of zinc ion |
| GO:0051597 | 0.0099 | 121.3175 | 0.0099 | 1 | 8 | response to methylmercury |
| GO:0051852 | 0.0099 | 121.3175 | 0.0099 | 1 | 8 | disruption by host of symbiont cells |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050832 | 0 | 149.6765 | 0.0384 | 4 | 28 | defense response to fungus |
| GO:0051707 | 0 | 13.2226 | 0.9436 | 8 | 688 | response to other organism |
| GO:0009607 | 0 | 12.6007 | 0.9875 | 8 | 720 | response to biotic stimulus |
| GO:0006954 | 0 | 12.9841 | 0.7872 | 7 | 574 | inflammatory response |
| GO:0031640 | 0 | 97.8526 | 0.0398 | 3 | 29 | killing of cells of other organism |
| GO:0045087 | 1e-04 | 8.4421 | 1.1822 | 7 | 862 | innate immune response |
| GO:0035821 | 2e-04 | 30.5382 | 0.1179 | 3 | 86 | modification of morphology or physiology of other organism |
| GO:0016045 | 2e-04 | 107.2 | 0.0233 | 2 | 17 | detection of bacterium |
| GO:0044110 | 3e-04 | 89.3158 | 0.0274 | 2 | 20 | growth involved in symbiotic interaction |
| GO:0044117 | 3e-04 | 89.3158 | 0.0274 | 2 | 20 | growth of symbiont in host |
| GO:0098581 | 4e-04 | 76.5414 | 0.0315 | 2 | 23 | detection of external biotic stimulus |
| GO:0006950 | 5e-04 | 4.7837 | 4.5876 | 12 | 3345 | response to stress |
| GO:0009605 | 7e-04 | 5.0158 | 2.7402 | 9 | 1998 | response to external stimulus |
| GO:0019731 | 8e-04 | 55.3975 | 0.0425 | 2 | 31 | antibacterial humoral response |
| GO:0010043 | 0.0012 | 44.6053 | 0.0521 | 2 | 38 | response to zinc ion |
| GO:0010963 | 0.0014 | Inf | 0.0014 | 1 | 1 | regulation of L-arginine import |
| GO:0044356 | 0.0014 | Inf | 0.0014 | 1 | 1 | clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine |
| GO:0035872 | 0.0019 | 34.8856 | 0.0658 | 2 | 48 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway |
| GO:0070301 | 0.0024 | 31.4551 | 0.0727 | 2 | 53 | cellular response to hydrogen peroxide |
| GO:0070488 | 0.0027 | 764.5 | 0.0027 | 1 | 2 | neutrophil aggregation |
| GO:0070946 | 0.0027 | 764.5 | 0.0027 | 1 | 2 | neutrophil mediated killing of gram-positive bacterium |
| GO:0071557 | 0.0027 | 764.5 | 0.0027 | 1 | 2 | histone H3-K27 demethylation |
| GO:0070988 | 0.0028 | 28.6372 | 0.0795 | 2 | 58 | demethylation |
| GO:0050830 | 0.0029 | 28.2037 | 0.081 | 2 | 62 | defense response to Gram-positive bacterium |
| GO:0051716 | 0.003 | 3.8532 | 8.2727 | 15 | 6032 | cellular response to stimulus |
| GO:0090467 | 0.0041 | 382.225 | 0.0041 | 1 | 3 | arginine import |
| GO:1902023 | 0.0041 | 382.225 | 0.0041 | 1 | 3 | L-arginine transport |
| GO:0032496 | 0.0049 | 9.9065 | 0.3511 | 3 | 256 | response to lipopolysaccharide |
| GO:0032827 | 0.0055 | 254.8 | 0.0055 | 1 | 4 | negative regulation of natural killer cell differentiation involved in immune response |
| GO:0070269 | 0.0055 | 254.8 | 0.0055 | 1 | 4 | pyroptosis |
| GO:0001816 | 0.006 | 6.3663 | 0.7529 | 4 | 549 | cytokine production |
| GO:0006919 | 0.0064 | 18.6108 | 0.1207 | 2 | 88 | activation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0031349 | 0.0067 | 8.8069 | 0.3936 | 3 | 287 | positive regulation of defense response |
| GO:0010269 | 0.0068 | 191.0875 | 0.0069 | 1 | 5 | response to selenium ion |
| GO:0070383 | 0.0068 | 191.0875 | 0.0069 | 1 | 5 | DNA cytosine deamination |
| GO:0042742 | 0.0075 | 17.3621 | 0.1316 | 2 | 118 | defense response to bacterium |
| GO:0002252 | 0.0076 | 5.936 | 0.8051 | 4 | 587 | immune effector process |
| GO:0002376 | 0.008 | 4.3523 | 1.898 | 6 | 1644 | immune system process |
| GO:0032815 | 0.0082 | 152.86 | 0.0082 | 1 | 6 | negative regulation of natural killer cell activation |
| GO:0070943 | 0.0082 | 152.86 | 0.0082 | 1 | 6 | neutrophil mediated killing of symbiont cell |
| GO:1901565 | 0.0084 | 8.1077 | 0.4265 | 3 | 311 | organonitrogen compound catabolic process |
| GO:0030307 | 0.0093 | 15.2241 | 0.1467 | 2 | 107 | positive regulation of cell growth |
| GO:0009253 | 0.0096 | 127.375 | 0.0096 | 1 | 7 | peptidoglycan catabolic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0070301 | 0 | 60.976 | 0.0623 | 3 | 53 | cellular response to hydrogen peroxide |
| GO:0009635 | 0 | 318.5 | 0.0094 | 2 | 8 | response to herbicide |
| GO:0016045 | 2e-04 | 127.325 | 0.02 | 2 | 17 | detection of bacterium |
| GO:0070207 | 2e-04 | 127.325 | 0.02 | 2 | 17 | protein homotrimerization |
| GO:0098581 | 3e-04 | 90.9107 | 0.027 | 2 | 23 | detection of external biotic stimulus |
| GO:0051707 | 9e-04 | 8.2278 | 0.8088 | 5 | 688 | response to other organism |
| GO:0000302 | 0.001 | 18.0071 | 0.201 | 3 | 171 | response to reactive oxygen species |
| GO:0034599 | 0.0011 | 17.4809 | 0.2069 | 3 | 176 | cellular response to oxidative stress |
| GO:0009607 | 0.0012 | 7.8424 | 0.8464 | 5 | 720 | response to biotic stimulus |
| GO:0010963 | 0.0012 | Inf | 0.0012 | 1 | 1 | regulation of L-arginine import |
| GO:0061015 | 0.0012 | Inf | 0.0012 | 1 | 1 | snRNA import into nucleus |
| GO:0042742 | 0.0014 | 15.9841 | 0.2257 | 3 | 192 | defense response to bacterium |
| GO:0035872 | 0.0014 | 41.4348 | 0.0564 | 2 | 48 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway |
| GO:0071557 | 0.0023 | 899.5882 | 0.0024 | 1 | 2 | histone H3-K27 demethylation |
| GO:0045087 | 0.0026 | 6.4792 | 1.0133 | 5 | 862 | innate immune response |
| GO:0015891 | 0.0035 | 449.7647 | 0.0035 | 1 | 3 | siderophore transport |
| GO:0070682 | 0.0035 | 449.7647 | 0.0035 | 1 | 3 | proteasome regulatory particle assembly |
| GO:0090467 | 0.0035 | 449.7647 | 0.0035 | 1 | 3 | arginine import |
| GO:1902023 | 0.0035 | 449.7647 | 0.0035 | 1 | 3 | L-arginine transport |
| GO:0006954 | 0.0039 | 7.3805 | 0.6748 | 4 | 574 | inflammatory response |
| GO:0032827 | 0.0047 | 299.8235 | 0.0047 | 1 | 4 | negative regulation of natural killer cell differentiation involved in immune response |
| GO:0070269 | 0.0047 | 299.8235 | 0.0047 | 1 | 4 | pyroptosis |
| GO:0010269 | 0.0059 | 224.8529 | 0.0059 | 1 | 5 | response to selenium ion |
| GO:0032815 | 0.007 | 179.8706 | 0.0071 | 1 | 6 | negative regulation of natural killer cell activation |
| GO:0009253 | 0.0082 | 149.8824 | 0.0082 | 1 | 7 | peptidoglycan catabolic process |
| GO:0071222 | 0.009 | 15.6746 | 0.1446 | 2 | 123 | cellular response to lipopolysaccharide |
| GO:0051597 | 0.0094 | 128.4622 | 0.0094 | 1 | 8 | response to methylmercury |
| GO:0043933 | 0.0094 | 3.7915 | 2.5921 | 7 | 2205 | macromolecular complex subunit organization |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:2000502 | 0 | 1799.0588 | 0.0037 | 2 | 3 | negative regulation of natural killer cell chemotaxis |
| GO:2000402 | 0 | 359.7176 | 0.0087 | 2 | 7 | negative regulation of lymphocyte migration |
| GO:0002689 | 1e-04 | 224.7794 | 0.0124 | 2 | 10 | negative regulation of leukocyte chemotaxis |
| GO:0030101 | 1e-04 | 43.9269 | 0.0844 | 3 | 68 | natural killer cell activation |
| GO:0045954 | 2e-04 | 128.395 | 0.0199 | 2 | 16 | positive regulation of natural killer cell mediated cytotoxicity |
| GO:0034260 | 2e-04 | 105.7163 | 0.0236 | 2 | 19 | negative regulation of GTPase activity |
| GO:1901623 | 2e-04 | 105.7163 | 0.0236 | 2 | 19 | regulation of lymphocyte chemotaxis |
| GO:0002685 | 4e-04 | 24.3205 | 0.1489 | 3 | 120 | regulation of leukocyte migration |
| GO:0002715 | 5e-04 | 71.8494 | 0.0335 | 2 | 27 | regulation of natural killer cell mediated immunity |
| GO:0050920 | 6e-04 | 21.3722 | 0.1688 | 3 | 136 | regulation of chemotaxis |
| GO:0031343 | 0.0012 | 46.0151 | 0.0509 | 2 | 41 | positive regulation of cell killing |
| GO:0048521 | 0.0012 | 44.8618 | 0.0521 | 2 | 42 | negative regulation of behavior |
| GO:0035644 | 0.0012 | Inf | 0.0012 | 1 | 1 | phosphoanandamide dephosphorylation |
| GO:1901751 | 0.0012 | Inf | 0.0012 | 1 | 1 | leukotriene A4 metabolic process |
| GO:2001306 | 0.0012 | Inf | 0.0012 | 1 | 1 | lipoxin B4 biosynthetic process |
| GO:0050865 | 0.0014 | 9.8277 | 0.5063 | 4 | 408 | regulation of cell activation |
| GO:0001910 | 0.0016 | 38.9949 | 0.0596 | 2 | 48 | regulation of leukocyte mediated cytotoxicity |
| GO:0060326 | 0.002 | 13.8 | 0.2581 | 3 | 208 | cell chemotaxis |
| GO:0034109 | 0.0021 | 8.716 | 0.5683 | 4 | 458 | homotypic cell-cell adhesion |
| GO:0033274 | 0.0025 | 849.5556 | 0.0025 | 1 | 2 | response to vitamin B2 |
| GO:0070829 | 0.0025 | 849.5556 | 0.0025 | 1 | 2 | heterochromatin maintenance |
| GO:2001303 | 0.0025 | 849.5556 | 0.0025 | 1 | 2 | lipoxin A4 biosynthetic process |
| GO:0032102 | 0.0025 | 12.7873 | 0.278 | 3 | 224 | negative regulation of response to external stimulus |
| GO:0002708 | 0.0031 | 27.562 | 0.0831 | 2 | 67 | positive regulation of lymphocyte mediated immunity |
| GO:0031295 | 0.0032 | 27.1426 | 0.0844 | 2 | 68 | T cell costimulation |
| GO:0050863 | 0.0034 | 11.4688 | 0.309 | 3 | 249 | regulation of T cell activation |
| GO:2000145 | 0.0048 | 6.888 | 0.7123 | 4 | 574 | regulation of cell motility |
| GO:0032237 | 0.0062 | 212.3472 | 0.0062 | 1 | 5 | activation of store-operated calcium channel activity |
| GO:0051122 | 0.0062 | 212.3472 | 0.0062 | 1 | 5 | hepoxilin biosynthetic process |
| GO:0002683 | 0.0074 | 8.6083 | 0.4082 | 3 | 329 | negative regulation of immune system process |
| GO:0043045 | 0.0074 | 169.8667 | 0.0074 | 1 | 6 | DNA methylation involved in embryo development |
| GO:1901339 | 0.0074 | 169.8667 | 0.0074 | 1 | 6 | regulation of store-operated calcium channel activity |
| GO:0045785 | 0.0075 | 8.5547 | 0.4107 | 3 | 331 | positive regulation of cell adhesion |
| GO:0032817 | 0.0087 | 141.5463 | 0.0087 | 1 | 7 | regulation of natural killer cell proliferation |
| GO:0035999 | 0.0087 | 141.5463 | 0.0087 | 1 | 7 | tetrahydrofolate interconversion |
| GO:0090331 | 0.0087 | 141.5463 | 0.0087 | 1 | 7 | negative regulation of platelet aggregation |
| GO:2001300 | 0.0087 | 141.5463 | 0.0087 | 1 | 7 | lipoxin metabolic process |
| GO:0022408 | 0.0091 | 15.5274 | 0.1452 | 2 | 117 | negative regulation of cell-cell adhesion |
| GO:0098602 | 0.0093 | 5.6695 | 0.8574 | 4 | 691 | single organism cell adhesion |
| GO:0051901 | 0.0099 | 121.3175 | 0.0099 | 1 | 8 | positive regulation of mitochondrial depolarization |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0051460 | 0.002 | Inf | 0.002 | 1 | 1 | negative regulation of corticotropin secretion |
| GO:1900011 | 0.002 | Inf | 0.002 | 1 | 1 | negative regulation of corticotropin-releasing hormone receptor activity |
| GO:0030999 | 0.0039 | 526.931 | 0.0039 | 1 | 2 | linear element assembly |
| GO:0070946 | 0.0039 | 526.931 | 0.0039 | 1 | 2 | neutrophil mediated killing of gram-positive bacterium |
| GO:0071314 | 0.0039 | 526.931 | 0.0039 | 1 | 2 | cellular response to cocaine |
| GO:0060359 | 0.0078 | 16.4675 | 0.1332 | 2 | 68 | response to ammonium ion |
| GO:0002125 | 0.0078 | 175.6207 | 0.0078 | 1 | 4 | maternal aggressive behavior |
| GO:0050886 | 0.0085 | 15.7484 | 0.1391 | 2 | 71 | endocrine process |
| GO:0002322 | 0.0098 | 131.7069 | 0.0098 | 1 | 5 | B cell proliferation involved in immune response |
| GO:0006824 | 0.0098 | 131.7069 | 0.0098 | 1 | 5 | cobalt ion transport |
| GO:0007386 | 0.0098 | 131.7069 | 0.0098 | 1 | 5 | compartment pattern specification |
| GO:0014719 | 0.0098 | 131.7069 | 0.0098 | 1 | 5 | skeletal muscle satellite cell activation |
| GO:0015889 | 0.0098 | 131.7069 | 0.0098 | 1 | 5 | cobalamin transport |
| GO:0097211 | 0.0098 | 131.7069 | 0.0098 | 1 | 5 | cellular response to gonadotropin-releasing hormone |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0002418 | 1e-04 | 191.025 | 0.0144 | 2 | 10 | immune response to tumor cell |
| GO:0002717 | 3e-04 | 95.4625 | 0.0259 | 2 | 18 | positive regulation of natural killer cell mediated immunity |
| GO:0042269 | 6e-04 | 63.6083 | 0.0374 | 2 | 26 | regulation of natural killer cell mediated cytotoxicity |
| GO:0001912 | 0.0012 | 44.8706 | 0.0517 | 2 | 36 | positive regulation of leukocyte mediated cytotoxicity |
| GO:0006952 | 0.0013 | 5.4112 | 1.8169 | 7 | 1386 | defense response |
| GO:0002355 | 0.0014 | Inf | 0.0014 | 1 | 1 | detection of tumor cell |
| GO:0015782 | 0.0014 | Inf | 0.0014 | 1 | 1 | CMP-N-acetylneuraminate transport |
| GO:0045321 | 0.0018 | 6.8215 | 0.9152 | 5 | 637 | leukocyte activation |
| GO:0042110 | 0.0021 | 8.5349 | 0.5632 | 4 | 392 | T cell activation |
| GO:0071593 | 0.0022 | 8.49 | 0.5661 | 4 | 394 | lymphocyte aggregation |
| GO:0006968 | 0.0027 | 29.3038 | 0.0776 | 2 | 54 | cellular defense response |
| GO:0007165 | 0.0028 | 3.623 | 7.1753 | 14 | 4994 | signal transduction |
| GO:0031341 | 0.0028 | 28.7491 | 0.079 | 2 | 55 | regulation of cell killing |
| GO:0002357 | 0.0029 | 728.0476 | 0.0029 | 1 | 2 | defense response to tumor cell |
| GO:0006478 | 0.0029 | 728.0476 | 0.0029 | 1 | 2 | peptidyl-tyrosine sulfation |
| GO:0071393 | 0.0029 | 728.0476 | 0.0029 | 1 | 2 | cellular response to progesterone stimulus |
| GO:0086098 | 0.0029 | 728.0476 | 0.0029 | 1 | 2 | angiotensin-activated signaling pathway involved in heart process |
| GO:0007159 | 0.003 | 7.7725 | 0.6164 | 4 | 429 | leukocyte cell-cell adhesion |
| GO:0009607 | 0.0031 | 5.9955 | 1.0345 | 5 | 720 | response to biotic stimulus |
| GO:0034109 | 0.0038 | 7.2619 | 0.658 | 4 | 458 | homotypic cell-cell adhesion |
| GO:0031295 | 0.0042 | 23.0667 | 0.0977 | 2 | 68 | T cell costimulation |
| GO:0010641 | 0.0043 | 364 | 0.0043 | 1 | 3 | positive regulation of platelet-derived growth factor receptor signaling pathway |
| GO:0045065 | 0.0043 | 364 | 0.0043 | 1 | 3 | cytotoxic T cell differentiation |
| GO:0060468 | 0.0043 | 364 | 0.0043 | 1 | 3 | prevention of polyspermy |
| GO:2000502 | 0.0043 | 364 | 0.0043 | 1 | 3 | negative regulation of natural killer cell chemotaxis |
| GO:0015748 | 0.0047 | 21.7429 | 0.1034 | 2 | 72 | organophosphate ester transport |
| GO:0050715 | 0.0051 | 20.8452 | 0.1078 | 2 | 75 | positive regulation of cytokine secretion |
| GO:0002443 | 0.0055 | 9.4605 | 0.3649 | 3 | 254 | leukocyte mediated immunity |
| GO:0050778 | 0.0056 | 6.4795 | 0.7342 | 4 | 511 | positive regulation of immune response |
| GO:0002051 | 0.0057 | 242.6508 | 0.0057 | 1 | 4 | osteoblast fate commitment |
| GO:0033625 | 0.0057 | 242.6508 | 0.0057 | 1 | 4 | positive regulation of integrin activation |
| GO:0051902 | 0.0057 | 242.6508 | 0.0057 | 1 | 4 | negative regulation of mitochondrial depolarization |
| GO:1903532 | 0.0064 | 8.9181 | 0.3865 | 3 | 269 | positive regulation of secretion by cell |
| GO:0023052 | 0.0069 | 3.1669 | 7.8391 | 14 | 5456 | signaling |
| GO:0090383 | 0.0072 | 181.9762 | 0.0072 | 1 | 5 | phagosome acidification |
| GO:2001223 | 0.0072 | 181.9762 | 0.0072 | 1 | 5 | negative regulation of neuron migration |
| GO:2001286 | 0.0072 | 181.9762 | 0.0072 | 1 | 5 | regulation of caveolin-mediated endocytosis |
| GO:0009615 | 0.0073 | 8.5263 | 0.4037 | 3 | 281 | response to virus |
| GO:0002855 | 0.0086 | 145.5714 | 0.0086 | 1 | 6 | regulation of natural killer cell mediated immune response to tumor cell |
| GO:0002860 | 0.0086 | 145.5714 | 0.0086 | 1 | 6 | positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target |
| GO:0015780 | 0.0086 | 145.5714 | 0.0086 | 1 | 6 | nucleotide-sugar transport |
| GO:0032463 | 0.0086 | 145.5714 | 0.0086 | 1 | 6 | negative regulation of protein homooligomerization |
| GO:0050847 | 0.0086 | 145.5714 | 0.0086 | 1 | 6 | progesterone receptor signaling pathway |
| GO:0071803 | 0.0086 | 145.5714 | 0.0086 | 1 | 6 | positive regulation of podosome assembly |
| GO:0002706 | 0.0086 | 15.8271 | 0.1408 | 2 | 98 | regulation of lymphocyte mediated immunity |
| GO:0044763 | 0.0088 | 7.8154 | 16.0402 | 21 | 11164 | single-organism cellular process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050863 | 0 | 41.3004 | 0.2439 | 6 | 249 | regulation of T cell activation |
| GO:0022407 | 0 | 30.6155 | 0.3252 | 6 | 332 | regulation of cell-cell adhesion |
| GO:0031295 | 0 | 86.5511 | 0.0666 | 4 | 68 | T cell costimulation |
| GO:0002694 | 0 | 26.8212 | 0.3693 | 6 | 377 | regulation of leukocyte activation |
| GO:0070489 | 0 | 25.753 | 0.384 | 6 | 392 | T cell aggregation |
| GO:0070486 | 0 | 25.2166 | 0.3918 | 6 | 400 | leukocyte aggregation |
| GO:0050867 | 0 | 29.7312 | 0.2527 | 5 | 258 | positive regulation of cell activation |
| GO:1903039 | 0 | 31.2417 | 0.1763 | 4 | 180 | positive regulation of leukocyte cell-cell adhesion |
| GO:0034112 | 0 | 30.8866 | 0.1783 | 4 | 182 | positive regulation of homotypic cell-cell adhesion |
| GO:0098602 | 0 | 14.2209 | 0.6769 | 6 | 691 | single organism cell adhesion |
| GO:0051251 | 1e-04 | 24.6929 | 0.2214 | 4 | 226 | positive regulation of lymphocyte activation |
| GO:0045785 | 2e-04 | 16.6472 | 0.3243 | 4 | 331 | positive regulation of cell adhesion |
| GO:0002684 | 5e-04 | 9.8498 | 0.7288 | 5 | 744 | positive regulation of immune system process |
| GO:0030887 | 0.001 | Inf | 0.001 | 1 | 1 | positive regulation of myeloid dendritic cell activation |
| GO:0022610 | 0.001 | 7.1121 | 1.2902 | 6 | 1317 | biological adhesion |
| GO:0070228 | 0.001 | 49.9182 | 0.048 | 2 | 49 | regulation of lymphocyte apoptotic process |
| GO:0046649 | 0.0013 | 17.9793 | 0.2268 | 3 | 311 | lymphocyte activation |
| GO:0043553 | 0.002 | 1092.5714 | 0.002 | 1 | 2 | negative regulation of phosphatidylinositol 3-kinase activity |
| GO:0071887 | 0.0036 | 25.9949 | 0.0901 | 2 | 92 | leukocyte apoptotic process |
| GO:0001766 | 0.0039 | 364.1429 | 0.0039 | 1 | 4 | membrane raft polarization |
| GO:0060564 | 0.0039 | 364.1429 | 0.0039 | 1 | 4 | negative regulation of APC-Cdc20 complex activity |
| GO:1902715 | 0.0039 | 364.1429 | 0.0039 | 1 | 4 | positive regulation of interferon-gamma secretion |
| GO:0050852 | 0.0045 | 22.9186 | 0.1019 | 2 | 104 | T cell receptor signaling pathway |
| GO:0000730 | 0.0049 | 273.0893 | 0.0049 | 1 | 5 | DNA recombinase assembly |
| GO:0006689 | 0.0049 | 273.0893 | 0.0049 | 1 | 5 | ganglioside catabolic process |
| GO:0051665 | 0.0049 | 273.0893 | 0.0049 | 1 | 5 | membrane raft localization |
| GO:0002521 | 0.0071 | 9.0097 | 0.4075 | 3 | 416 | leukocyte differentiation |
| GO:0009313 | 0.0078 | 156.0204 | 0.0078 | 1 | 8 | oligosaccharide catabolic process |
| GO:0051716 | 0.0082 | 4.2367 | 5.9091 | 11 | 6032 | cellular response to stimulus |
| GO:0045059 | 0.0098 | 121.3333 | 0.0098 | 1 | 10 | positive thymic T cell selection |
| GO:2000484 | 0.0098 | 121.3333 | 0.0098 | 1 | 10 | positive regulation of interleukin-8 secretion |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:1903037 | 0 | 44.3018 | 0.3164 | 8 | 255 | regulation of leukocyte cell-cell adhesion |
| GO:0034110 | 0 | 42.7188 | 0.3276 | 8 | 264 | regulation of homotypic cell-cell adhesion |
| GO:0050852 | 0 | 71.562 | 0.129 | 6 | 104 | T cell receptor signaling pathway |
| GO:0051249 | 0 | 33.9213 | 0.4082 | 8 | 329 | regulation of lymphocyte activation |
| GO:0002429 | 0 | 45.4008 | 0.2494 | 7 | 201 | immune response-activating cell surface receptor signaling pathway |
| GO:0022409 | 0 | 42.9333 | 0.2631 | 7 | 212 | positive regulation of cell-cell adhesion |
| GO:0070489 | 0 | 28.2367 | 0.4864 | 8 | 392 | T cell aggregation |
| GO:0002696 | 0 | 36.5872 | 0.3065 | 7 | 247 | positive regulation of leukocyte activation |
| GO:0070486 | 0 | 27.6456 | 0.4963 | 8 | 400 | leukocyte aggregation |
| GO:0050865 | 0 | 27.0782 | 0.5063 | 8 | 408 | regulation of cell activation |
| GO:0031295 | 0 | 86.3379 | 0.0844 | 5 | 68 | T cell costimulation |
| GO:0030155 | 0 | 19.8313 | 0.6812 | 8 | 549 | regulation of cell adhesion |
| GO:0002253 | 0 | 22.8928 | 0.4802 | 7 | 387 | activation of immune response |
| GO:0002682 | 0 | 13.9529 | 1.4121 | 10 | 1138 | regulation of immune system process |
| GO:0002764 | 0 | 19.7377 | 0.5534 | 7 | 446 | immune response-regulating signaling pathway |
| GO:0098602 | 0 | 15.557 | 0.8574 | 8 | 691 | single organism cell adhesion |
| GO:0045059 | 1e-04 | 224.7794 | 0.0124 | 2 | 10 | positive thymic T cell selection |
| GO:0048584 | 1e-04 | 7.3368 | 2.0846 | 9 | 1680 | positive regulation of response to stimulus |
| GO:0022610 | 1e-04 | 7.7694 | 1.6342 | 8 | 1317 | biological adhesion |
| GO:1903564 | 0.0012 | Inf | 0.0012 | 1 | 1 | regulation of protein localization to cilium |
| GO:1903568 | 0.0012 | Inf | 0.0012 | 1 | 1 | negative regulation of protein localization to ciliary membrane |
| GO:0038093 | 0.0022 | 13.3381 | 0.2668 | 3 | 215 | Fc receptor signaling pathway |
| GO:0007166 | 0.0023 | 4.2073 | 3.9769 | 10 | 3205 | cell surface receptor signaling pathway |
| GO:0043366 | 0.0025 | 849.5556 | 0.0025 | 1 | 2 | beta selection |
| GO:0038096 | 0.0034 | 26.3408 | 0.0869 | 2 | 70 | Fc-gamma receptor signaling pathway involved in phagocytosis |
| GO:0045087 | 0.0034 | 6.016 | 1.0696 | 5 | 862 | innate immune response |
| GO:0048522 | 0.0034 | 3.882 | 4.9771 | 11 | 4011 | positive regulation of cellular process |
| GO:0033077 | 0.0035 | 25.5849 | 0.0893 | 2 | 72 | T cell differentiation in thymus |
| GO:0044700 | 0.0037 | 3.9232 | 6.7676 | 13 | 5454 | single organism signaling |
| GO:0007154 | 0.0044 | 3.8208 | 6.883 | 13 | 5547 | cell communication |
| GO:0050870 | 0.0044 | 23.3364 | 0.101 | 2 | 110 | positive regulation of T cell activation |
| GO:0071896 | 0.005 | 283.1481 | 0.005 | 1 | 4 | protein localization to adherens junction |
| GO:0001574 | 0.0087 | 141.5463 | 0.0087 | 1 | 7 | ganglioside biosynthetic process |
| GO:0008037 | 0.0088 | 15.8043 | 0.1427 | 2 | 115 | cell recognition |
| GO:0051901 | 0.0099 | 121.3175 | 0.0099 | 1 | 8 | positive regulation of mitochondrial depolarization |
| GO:0051716 | 0.0099 | 3.3384 | 7.4848 | 13 | 6032 | cellular response to stimulus |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0009954 | 0 | 44.7014 | 0.1099 | 4 | 33 | proximal/distal pattern formation |
| GO:0072272 | 0 | Inf | 0.0067 | 2 | 2 | proximal/distal pattern formation involved in metanephric nephron development |
| GO:0021555 | 1e-04 | 311.4082 | 0.0133 | 2 | 4 | midbrain-hindbrain boundary morphogenesis |
| GO:0072086 | 1e-04 | 311.4082 | 0.0133 | 2 | 4 | specification of loop of Henle identity |
| GO:0021510 | 2e-04 | 14.6741 | 0.3064 | 4 | 92 | spinal cord development |
| GO:0048704 | 3e-04 | 14.3461 | 0.3131 | 4 | 94 | embryonic skeletal system morphogenesis |
| GO:0007389 | 3e-04 | 6.1687 | 1.3074 | 7 | 408 | pattern specification process |
| GO:0061004 | 4e-04 | 88.9446 | 0.03 | 2 | 9 | pattern specification involved in kidney development |
| GO:0048568 | 4e-04 | 5.8804 | 1.3623 | 7 | 409 | embryonic organ development |
| GO:0007338 | 5e-04 | 12.2845 | 0.363 | 4 | 109 | single fertilization |
| GO:0061303 | 5e-04 | 77.8214 | 0.0333 | 2 | 10 | cornea development in camera-type eye |
| GO:0019219 | 6e-04 | 2.6607 | 12.0672 | 23 | 3623 | regulation of nucleobase-containing compound metabolic process |
| GO:0072175 | 7e-04 | 11.0158 | 0.403 | 4 | 121 | epithelial tube formation |
| GO:0021903 | 7e-04 | 62.249 | 0.04 | 2 | 12 | rostrocaudal neural tube patterning |
| GO:0006355 | 7e-04 | 2.6827 | 10.5884 | 21 | 3179 | regulation of transcription, DNA-templated |
| GO:0048935 | 8e-04 | 56.5863 | 0.0433 | 2 | 13 | peripheral nervous system neuron development |
| GO:2001141 | 9e-04 | 2.6394 | 10.7249 | 21 | 3220 | regulation of RNA biosynthetic process |
| GO:0007423 | 0.0011 | 4.8885 | 1.6254 | 7 | 488 | sensory organ development |
| GO:0007156 | 0.0011 | 9.6804 | 0.4563 | 4 | 137 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0097659 | 0.0012 | 2.5649 | 10.9681 | 21 | 3293 | nucleic acid-templated transcription |
| GO:0048592 | 0.0013 | 9.3265 | 0.473 | 4 | 142 | eye morphogenesis |
| GO:0007379 | 0.0013 | 44.4519 | 0.0533 | 2 | 16 | segment specification |
| GO:0016331 | 0.0014 | 8.9975 | 0.4896 | 4 | 147 | morphogenesis of embryonic epithelium |
| GO:0035107 | 0.0015 | 8.8722 | 0.4963 | 4 | 149 | appendage morphogenesis |
| GO:0072079 | 0.0018 | 36.6002 | 0.0633 | 2 | 19 | nephron tubule formation |
| GO:0007268 | 0.0018 | 4.0016 | 2.2849 | 8 | 686 | synaptic transmission |
| GO:1902476 | 0.0021 | 13.0034 | 0.2531 | 3 | 76 | chloride transmembrane transport |
| GO:0021953 | 0.0021 | 8.0835 | 0.5429 | 4 | 163 | central nervous system neuron differentiation |
| GO:0060173 | 0.0023 | 7.8345 | 0.5596 | 4 | 168 | limb development |
| GO:0002089 | 0.0024 | 31.1041 | 0.0733 | 2 | 22 | lens morphogenesis in camera-type eye |
| GO:0034654 | 0.0027 | 2.3411 | 12.5135 | 22 | 3757 | nucleobase-containing compound biosynthetic process |
| GO:0009889 | 0.0031 | 2.3123 | 12.6301 | 22 | 3792 | regulation of biosynthetic process |
| GO:0021884 | 0.0031 | 27.0417 | 0.0833 | 2 | 25 | forebrain neuron development |
| GO:0021993 | 0.0033 | Inf | 0.0033 | 1 | 1 | initiation of neural tube closure |
| GO:0035332 | 0.0033 | Inf | 0.0033 | 1 | 1 | positive regulation of hippo signaling |
| GO:2001111 | 0.0033 | Inf | 0.0033 | 1 | 1 | positive regulation of lens epithelial cell proliferation |
| GO:0019953 | 0.0035 | 3.958 | 1.9961 | 7 | 622 | sexual reproduction |
| GO:0048596 | 0.0036 | 24.8751 | 0.0899 | 2 | 27 | embryonic camera-type eye morphogenesis |
| GO:0098609 | 0.0036 | 6.8977 | 0.6328 | 4 | 190 | cell-cell adhesion |
| GO:0015698 | 0.0044 | 6.5415 | 0.6661 | 4 | 200 | inorganic anion transport |
| GO:0019228 | 0.0045 | 22.2055 | 0.0999 | 2 | 30 | neuronal action potential |
| GO:0048665 | 0.0048 | 21.4384 | 0.1033 | 2 | 31 | neuron fate specification |
| GO:0007628 | 0.006 | 18.8349 | 0.1166 | 2 | 35 | adult walking behavior |
| GO:0035239 | 0.0063 | 4.6443 | 1.1791 | 5 | 354 | tube morphogenesis |
| GO:0021568 | 0.0067 | 305.2 | 0.0067 | 1 | 2 | rhombomere 2 development |
| GO:0021592 | 0.0067 | 305.2 | 0.0067 | 1 | 2 | fourth ventricle development |
| GO:0061386 | 0.0067 | 305.2 | 0.0067 | 1 | 2 | closure of optic fissure |
| GO:0070593 | 0.0067 | 305.2 | 0.0067 | 1 | 2 | dendrite self-avoidance |
| GO:0016070 | 0.0067 | 2.1328 | 13.4095 | 22 | 4026 | RNA metabolic process |
| GO:0009887 | 0.0068 | 3.4905 | 2.2586 | 7 | 729 | organ morphogenesis |
| GO:0044708 | 0.0068 | 4.5509 | 1.2024 | 5 | 361 | single-organism behavior |
| GO:0035137 | 0.0071 | 17.2619 | 0.1266 | 2 | 38 | hindlimb morphogenesis |
| GO:0034645 | 0.0075 | 2.0912 | 14.412 | 23 | 4327 | cellular macromolecule biosynthetic process |
| GO:0035136 | 0.0078 | 16.3512 | 0.1332 | 2 | 40 | forelimb morphogenesis |
| GO:0048598 | 0.008 | 4.3962 | 1.253 | 5 | 413 | embryonic morphogenesis |
| GO:0046483 | 0.0089 | 2.0269 | 17.3231 | 26 | 5201 | heterocycle metabolic process |
| GO:0007618 | 0.009 | 15.1518 | 0.1432 | 2 | 43 | mating |
| GO:0048483 | 0.009 | 15.1518 | 0.1432 | 2 | 43 | autonomic nervous system development |
| GO:0030326 | 0.0091 | 7.5074 | 0.4297 | 3 | 129 | embryonic limb morphogenesis |
| GO:0022414 | 0.0092 | 2.8081 | 3.6338 | 9 | 1091 | reproductive process |
| GO:0006725 | 0.0093 | 2.0175 | 17.3764 | 26 | 5217 | cellular aromatic compound metabolic process |
| GO:0043392 | 0.0094 | 14.7901 | 0.1466 | 2 | 44 | negative regulation of DNA binding |
| GO:0034641 | 0.0099 | 2.0023 | 18.3756 | 27 | 5517 | cellular nitrogen compound metabolic process |
| GO:0008344 | 0.0099 | 14.3574 | 0.1507 | 2 | 47 | adult locomotory behavior |
| GO:0002351 | 0.01 | 152.59 | 0.01 | 1 | 3 | serotonin production involved in inflammatory response |
| GO:0002554 | 0.01 | 152.59 | 0.01 | 1 | 3 | serotonin secretion by platelet |
| GO:0021678 | 0.01 | 152.59 | 0.01 | 1 | 3 | third ventricle development |
| GO:0060012 | 0.01 | 152.59 | 0.01 | 1 | 3 | synaptic transmission, glycinergic |
| GO:0060060 | 0.01 | 152.59 | 0.01 | 1 | 3 | post-embryonic retina morphogenesis in camera-type eye |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042636 | 0.0034 | 424.8889 | 0.0034 | 1 | 4 | negative regulation of hair cycle |
| GO:0051919 | 0.0034 | 424.8889 | 0.0034 | 1 | 4 | positive regulation of fibrinolysis |
| GO:0061589 | 0.0034 | 424.8889 | 0.0034 | 1 | 4 | calcium activated phosphatidylserine scrambling |
| GO:2000048 | 0.0034 | 424.8889 | 0.0034 | 1 | 4 | negative regulation of cell-cell adhesion mediated by cadherin |
| GO:0061590 | 0.0042 | 318.6458 | 0.0042 | 1 | 5 | calcium activated phosphatidylcholine scrambling |
| GO:0061591 | 0.0042 | 318.6458 | 0.0042 | 1 | 5 | calcium activated galactosylceramide scrambling |
| GO:0086073 | 0.0051 | 254.9 | 0.0051 | 1 | 6 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication |
| GO:0098911 | 0.0068 | 182.0476 | 0.0068 | 1 | 8 | regulation of ventricular cardiac muscle cell action potential |
| GO:0051918 | 0.0085 | 141.5741 | 0.0085 | 1 | 10 | negative regulation of fibrinolysis |
| GO:0017121 | 0.0093 | 127.4083 | 0.0093 | 1 | 11 | phospholipid scrambling |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050911 | 7e-04 | 25.2659 | 0.187 | 3 | 358 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0009593 | 0.0012 | 20.6065 | 0.2278 | 3 | 436 | detection of chemical stimulus |
| GO:0050906 | 0.0012 | 20.2218 | 0.232 | 3 | 444 | detection of stimulus involved in sensory perception |
| GO:0007606 | 0.0014 | 19.1471 | 0.2445 | 3 | 468 | sensory perception of chemical stimulus |
| GO:0070995 | 0.0021 | 728.619 | 0.0021 | 1 | 4 | NADPH oxidation |
| GO:0072592 | 0.0021 | 728.619 | 0.0021 | 1 | 4 | oxygen metabolic process |
| GO:0009404 | 0.0063 | 198.6104 | 0.0063 | 1 | 12 | toxin metabolic process |
| GO:0033141 | 0.0083 | 145.6095 | 0.0084 | 1 | 16 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006955 | 0 | 16.4628 | 0.7491 | 8 | 492 | immune response |
| GO:0019835 | 0 | 70.4215 | 0.053 | 3 | 29 | cytolysis |
| GO:0002429 | 0 | 16.7347 | 0.3676 | 5 | 201 | immune response-activating cell surface receptor signaling pathway |
| GO:0007166 | 1e-04 | 4.3745 | 5.8608 | 15 | 3205 | cell surface receptor signaling pathway |
| GO:0048584 | 5e-04 | 4.5289 | 3.0721 | 10 | 1680 | positive regulation of response to stimulus |
| GO:0002253 | 6e-04 | 8.4805 | 0.7077 | 5 | 387 | activation of immune response |
| GO:0050852 | 9e-04 | 18.0392 | 0.1902 | 3 | 104 | T cell receptor signaling pathway |
| GO:0002764 | 0.0012 | 7.3169 | 0.8156 | 5 | 446 | immune response-regulating signaling pathway |
| GO:1903564 | 0.0018 | Inf | 0.0018 | 1 | 1 | regulation of protein localization to cilium |
| GO:1903568 | 0.0018 | Inf | 0.0018 | 1 | 1 | negative regulation of protein localization to ciliary membrane |
| GO:0051716 | 0.0021 | 3.255 | 11.0303 | 19 | 6032 | cellular response to stimulus |
| GO:0043068 | 0.0026 | 6.0399 | 0.9801 | 5 | 536 | positive regulation of programmed cell death |
| GO:2001235 | 0.0035 | 10.9956 | 0.3072 | 3 | 168 | positive regulation of apoptotic signaling pathway |
| GO:0002682 | 0.0036 | 4.1712 | 2.081 | 7 | 1138 | regulation of immune system process |
| GO:0002357 | 0.0037 | 566.037 | 0.0037 | 1 | 2 | defense response to tumor cell |
| GO:0043366 | 0.0037 | 566.037 | 0.0037 | 1 | 2 | beta selection |
| GO:0070165 | 0.0037 | 566.037 | 0.0037 | 1 | 2 | positive regulation of adiponectin secretion |
| GO:0045087 | 0.0041 | 4.5969 | 1.5763 | 6 | 862 | innate immune response |
| GO:0006968 | 0.0044 | 22.5325 | 0.0987 | 2 | 54 | cellular defense response |
| GO:0009988 | 0.0053 | 20.1936 | 0.1097 | 2 | 60 | cell-cell recognition |
| GO:0048388 | 0.0055 | 283 | 0.0055 | 1 | 3 | endosomal lumen acidification |
| GO:0071638 | 0.0055 | 283 | 0.0055 | 1 | 3 | negative regulation of monocyte chemotactic protein-1 production |
| GO:0051607 | 0.0063 | 8.8267 | 0.3804 | 3 | 208 | defense response to virus |
| GO:0038096 | 0.0072 | 17.2127 | 0.128 | 2 | 70 | Fc-gamma receptor signaling pathway involved in phagocytosis |
| GO:0071896 | 0.0073 | 188.6543 | 0.0073 | 1 | 4 | protein localization to adherens junction |
| GO:0044700 | 0.0075 | 3.1928 | 6.195 | 12 | 4125 | single organism signaling |
| GO:0008625 | 0.0082 | 16.0285 | 0.1371 | 2 | 75 | extrinsic apoptotic signaling pathway via death domain receptors |
| GO:0023056 | 0.0085 | 3.5175 | 2.4321 | 7 | 1330 | positive regulation of signaling |
| GO:0010647 | 0.0089 | 3.4915 | 2.4485 | 7 | 1339 | positive regulation of cell communication |
| GO:0007154 | 0.009 | 3.0994 | 6.3252 | 12 | 4209 | cell communication |
| GO:0008626 | 0.0091 | 141.4815 | 0.0091 | 1 | 5 | granzyme-mediated apoptotic signaling pathway |
| GO:0030644 | 0.0091 | 141.4815 | 0.0091 | 1 | 5 | cellular chloride ion homeostasis |
| GO:1900165 | 0.0091 | 141.4815 | 0.0091 | 1 | 5 | negative regulation of interleukin-6 secretion |
| GO:0009966 | 0.0096 | 2.8835 | 4.5332 | 10 | 2479 | regulation of signal transduction |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001764 | 0 | 15.9712 | 0.4396 | 6 | 127 | neuron migration |
| GO:0021953 | 0 | 12.2797 | 0.5642 | 6 | 163 | central nervous system neuron differentiation |
| GO:0019219 | 0 | 3.1221 | 12.5404 | 26 | 3623 | regulation of nucleobase-containing compound metabolic process |
| GO:0006355 | 1e-04 | 3.175 | 11.0036 | 24 | 3179 | regulation of transcription, DNA-templated |
| GO:2001141 | 1e-04 | 3.1236 | 11.1455 | 24 | 3220 | regulation of RNA biosynthetic process |
| GO:0021884 | 1e-04 | 41.5555 | 0.0865 | 3 | 25 | forebrain neuron development |
| GO:0097659 | 1e-04 | 3.0354 | 11.3982 | 24 | 3293 | nucleic acid-templated transcription |
| GO:0034654 | 1e-04 | 2.9754 | 13.0042 | 26 | 3757 | nucleobase-containing compound biosynthetic process |
| GO:0009889 | 1e-04 | 2.9388 | 13.1254 | 26 | 3792 | regulation of biosynthetic process |
| GO:0007420 | 2e-04 | 5.0856 | 2.0733 | 9 | 599 | brain development |
| GO:0021510 | 3e-04 | 14.0733 | 0.3184 | 4 | 92 | spinal cord development |
| GO:0050767 | 4e-04 | 5.1622 | 1.7861 | 8 | 516 | regulation of neurogenesis |
| GO:0007399 | 5e-04 | 3.3552 | 5.3029 | 14 | 1701 | nervous system development |
| GO:0046113 | 5e-04 | 74.7598 | 0.0346 | 2 | 10 | nucleobase catabolic process |
| GO:0003207 | 6e-04 | 66.4488 | 0.0381 | 2 | 11 | cardiac chamber formation |
| GO:0051961 | 7e-04 | 7.8432 | 0.7096 | 5 | 205 | negative regulation of nervous system development |
| GO:0034645 | 0.0011 | 2.4534 | 14.9772 | 26 | 4327 | cellular macromolecule biosynthetic process |
| GO:0021872 | 0.0011 | 16.2889 | 0.2042 | 3 | 59 | forebrain generation of neurons |
| GO:0006725 | 0.0016 | 2.3456 | 18.0578 | 29 | 5217 | cellular aromatic compound metabolic process |
| GO:0090596 | 0.0016 | 6.4369 | 0.8584 | 5 | 248 | sensory organ morphogenesis |
| GO:0034641 | 0.0018 | 2.323 | 19.0962 | 30 | 5517 | cellular nitrogen compound metabolic process |
| GO:0071805 | 0.002 | 8.2226 | 0.533 | 4 | 154 | potassium ion transmembrane transport |
| GO:0016070 | 0.0022 | 2.3279 | 13.9353 | 24 | 4026 | RNA metabolic process |
| GO:0007411 | 0.0023 | 4.9189 | 1.3568 | 6 | 392 | axon guidance |
| GO:0002089 | 0.0026 | 29.8804 | 0.0761 | 2 | 22 | lens morphogenesis in camera-type eye |
| GO:0048562 | 0.0028 | 5.6548 | 0.9726 | 5 | 281 | embryonic organ morphogenesis |
| GO:0032502 | 0.0028 | 2.2317 | 17.7463 | 28 | 5127 | developmental process |
| GO:1901576 | 0.003 | 2.2194 | 18.7189 | 29 | 5408 | organic substance biosynthetic process |
| GO:1901360 | 0.0031 | 2.2099 | 18.7708 | 29 | 5423 | organic cyclic compound metabolic process |
| GO:0061564 | 0.0031 | 4.0241 | 1.9487 | 7 | 563 | axon development |
| GO:0035332 | 0.0035 | Inf | 0.0035 | 1 | 1 | positive regulation of hippo signaling |
| GO:0036306 | 0.0035 | Inf | 0.0035 | 1 | 1 | embryonic heart tube elongation |
| GO:0042404 | 0.0035 | Inf | 0.0035 | 1 | 1 | thyroid hormone catabolic process |
| GO:2001111 | 0.0035 | Inf | 0.0035 | 1 | 1 | positive regulation of lens epithelial cell proliferation |
| GO:0046483 | 0.0036 | 2.1837 | 18.0024 | 28 | 5201 | heterocycle metabolic process |
| GO:0035295 | 0.0036 | 3.9144 | 2.0007 | 7 | 578 | tube development |
| GO:0006813 | 0.0041 | 6.6515 | 0.6542 | 4 | 189 | potassium ion transport |
| GO:0048667 | 0.0046 | 3.7373 | 2.0906 | 7 | 604 | cell morphogenesis involved in neuron differentiation |
| GO:0060562 | 0.0046 | 5.0067 | 1.0938 | 5 | 316 | epithelial tube morphogenesis |
| GO:0042472 | 0.0049 | 9.4769 | 0.3427 | 3 | 99 | inner ear morphogenesis |
| GO:0048665 | 0.0051 | 20.595 | 0.1073 | 2 | 31 | neuron fate specification |
| GO:0048812 | 0.0051 | 3.6544 | 2.1356 | 7 | 617 | neuron projection morphogenesis |
| GO:0045595 | 0.0053 | 2.7542 | 4.6243 | 11 | 1336 | regulation of cell differentiation |
| GO:0014003 | 0.0055 | 19.9072 | 0.1108 | 2 | 32 | oligodendrocyte development |
| GO:0014014 | 0.0058 | 19.2638 | 0.1142 | 2 | 33 | negative regulation of gliogenesis |
| GO:0009953 | 0.0059 | 8.8287 | 0.3669 | 3 | 106 | dorsal/ventral pattern formation |
| GO:2000026 | 0.0061 | 2.6984 | 4.7109 | 11 | 1361 | regulation of multicellular organismal development |
| GO:0006206 | 0.0061 | 18.6605 | 0.1177 | 2 | 34 | pyrimidine nucleobase metabolic process |
| GO:0072529 | 0.0065 | 18.0939 | 0.1211 | 2 | 35 | pyrimidine-containing compound catabolic process |
| GO:0003193 | 0.0069 | 293.4231 | 0.0069 | 1 | 2 | pulmonary valve formation |
| GO:0006212 | 0.0069 | 293.4231 | 0.0069 | 1 | 2 | uracil catabolic process |
| GO:0006682 | 0.0069 | 293.4231 | 0.0069 | 1 | 2 | galactosylceramide biosynthetic process |
| GO:0021568 | 0.0069 | 293.4231 | 0.0069 | 1 | 2 | rhombomere 2 development |
| GO:0030047 | 0.0069 | 293.4231 | 0.0069 | 1 | 2 | actin modification |
| GO:0035922 | 0.0069 | 293.4231 | 0.0069 | 1 | 2 | foramen ovale closure |
| GO:0042706 | 0.0069 | 293.4231 | 0.0069 | 1 | 2 | eye photoreceptor cell fate commitment |
| GO:0050925 | 0.0069 | 293.4231 | 0.0069 | 1 | 2 | negative regulation of negative chemotaxis |
| GO:0060577 | 0.0069 | 293.4231 | 0.0069 | 1 | 2 | pulmonary vein morphogenesis |
| GO:0061386 | 0.0069 | 293.4231 | 0.0069 | 1 | 2 | closure of optic fissure |
| GO:0072272 | 0.0069 | 293.4231 | 0.0069 | 1 | 2 | proximal/distal pattern formation involved in metanephric nephron development |
| GO:0001569 | 0.008 | 16.1335 | 0.135 | 2 | 39 | patterning of blood vessels |
| GO:0060429 | 0.0081 | 2.8614 | 3.5548 | 9 | 1027 | epithelium development |
| GO:0001838 | 0.0083 | 7.7651 | 0.4154 | 3 | 120 | embryonic epithelial tube formation |
| GO:0061351 | 0.0087 | 7.6336 | 0.4223 | 3 | 122 | neural precursor cell proliferation |
| GO:0010721 | 0.0087 | 5.3342 | 0.81 | 4 | 234 | negative regulation of cell development |
| GO:0001709 | 0.0088 | 15.3042 | 0.1419 | 2 | 41 | cell fate determination |
| GO:0010467 | 0.009 | 2.0192 | 15.4376 | 24 | 4460 | gene expression |
| GO:0050789 | 0.0096 | 2.2168 | 33.5611 | 42 | 9696 | regulation of biological process |
| GO:0048483 | 0.0097 | 14.5557 | 0.1488 | 2 | 43 | autonomic nervous system development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042789 | 2e-04 | 122.2 | 0.0212 | 2 | 12 | mRNA transcription from RNA polymerase II promoter |
| GO:0045646 | 0.0016 | 38.1325 | 0.06 | 2 | 34 | regulation of erythrocyte differentiation |
| GO:0030026 | 0.0018 | Inf | 0.0018 | 1 | 1 | cellular manganese ion homeostasis |
| GO:0032468 | 0.0018 | Inf | 0.0018 | 1 | 1 | Golgi calcium ion homeostasis |
| GO:0050853 | 0.002 | 33.8867 | 0.067 | 2 | 38 | B cell receptor signaling pathway |
| GO:0002682 | 0.0029 | 4.3801 | 2.0067 | 7 | 1138 | regulation of immune system process |
| GO:0007308 | 0.0035 | 587.8462 | 0.0035 | 1 | 2 | oocyte construction |
| GO:0007314 | 0.0035 | 587.8462 | 0.0035 | 1 | 2 | oocyte anterior/posterior axis specification |
| GO:0030719 | 0.0035 | 587.8462 | 0.0035 | 1 | 2 | P granule organization |
| GO:0032472 | 0.0035 | 587.8462 | 0.0035 | 1 | 2 | Golgi calcium ion transport |
| GO:0006968 | 0.004 | 23.4354 | 0.0952 | 2 | 54 | cellular defense response |
| GO:0010710 | 0.0053 | 293.9038 | 0.0053 | 1 | 3 | regulation of collagen catabolic process |
| GO:0048584 | 0.0068 | 3.4281 | 2.9624 | 8 | 1680 | positive regulation of response to stimulus |
| GO:0007161 | 0.007 | 195.9231 | 0.0071 | 1 | 4 | calcium-independent cell-matrix adhesion |
| GO:0021943 | 0.007 | 195.9231 | 0.0071 | 1 | 4 | formation of radial glial scaffolds |
| GO:0006306 | 0.0085 | 15.8005 | 0.1393 | 2 | 79 | DNA methylation |
| GO:0007386 | 0.0088 | 146.9327 | 0.0088 | 1 | 5 | compartment pattern specification |
| GO:0071421 | 0.0088 | 146.9327 | 0.0088 | 1 | 5 | manganese ion transmembrane transport |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006955 | 0 | 6.9162 | 2.2107 | 10 | 1354 | immune response |
| GO:0032760 | 0 | 50.7073 | 0.0718 | 3 | 44 | positive regulation of tumor necrosis factor production |
| GO:0050715 | 2e-04 | 31.9664 | 0.1113 | 3 | 71 | positive regulation of cytokine secretion |
| GO:0006954 | 2e-04 | 8.7307 | 0.8906 | 6 | 568 | inflammatory response |
| GO:0001816 | 2e-04 | 8.5746 | 0.8964 | 6 | 549 | cytokine production |
| GO:1903555 | 3e-04 | 25.5993 | 0.1371 | 3 | 84 | regulation of tumor necrosis factor superfamily cytokine production |
| GO:0045671 | 5e-04 | 69.8764 | 0.0343 | 2 | 21 | negative regulation of osteoclast differentiation |
| GO:1903532 | 9e-04 | 10.7975 | 0.4392 | 4 | 269 | positive regulation of secretion by cell |
| GO:0071219 | 0.0012 | 16.2777 | 0.2123 | 3 | 130 | cellular response to molecule of bacterial origin |
| GO:0006051 | 0.0016 | Inf | 0.0016 | 1 | 1 | N-acetylmannosamine metabolic process |
| GO:0030887 | 0.0016 | Inf | 0.0016 | 1 | 1 | positive regulation of myeloid dendritic cell activation |
| GO:0050708 | 0.0019 | 8.687 | 0.5421 | 4 | 332 | regulation of protein secretion |
| GO:0008285 | 0.0024 | 6.2606 | 0.9666 | 5 | 592 | negative regulation of cell proliferation |
| GO:0031663 | 0.0024 | 30.8271 | 0.0735 | 2 | 45 | lipopolysaccharide-mediated signaling pathway |
| GO:0051222 | 0.0025 | 8.0583 | 0.5829 | 4 | 357 | positive regulation of protein transport |
| GO:0015993 | 0.0033 | 636.9167 | 0.0033 | 1 | 2 | molecular hydrogen transport |
| GO:0070904 | 0.0033 | 636.9167 | 0.0033 | 1 | 2 | transepithelial L-ascorbic acid transport |
| GO:0006950 | 0.0034 | 3.3107 | 5.4614 | 12 | 3345 | response to stress |
| GO:0042330 | 0.0038 | 5.5758 | 1.0792 | 5 | 661 | taxis |
| GO:0060326 | 0.0046 | 10.0324 | 0.3396 | 3 | 208 | cell chemotaxis |
| GO:0019262 | 0.0049 | 318.4375 | 0.0049 | 1 | 3 | N-acetylneuraminate catabolic process |
| GO:0001766 | 0.0065 | 212.2778 | 0.0065 | 1 | 4 | membrane raft polarization |
| GO:0002248 | 0.0065 | 212.2778 | 0.0065 | 1 | 4 | connective tissue replacement involved in inflammatory response wound healing |
| GO:1902715 | 0.0065 | 212.2778 | 0.0065 | 1 | 4 | positive regulation of interferon-gamma secretion |
| GO:1902106 | 0.0066 | 18.1227 | 0.1225 | 2 | 75 | negative regulation of leukocyte differentiation |
| GO:0032649 | 0.0073 | 17.1767 | 0.129 | 2 | 79 | regulation of interferon-gamma production |
| GO:0045638 | 0.0075 | 16.9554 | 0.1306 | 2 | 80 | negative regulation of myeloid cell differentiation |
| GO:1903901 | 0.0077 | 16.7397 | 0.1322 | 2 | 81 | negative regulation of viral life cycle |
| GO:0032496 | 0.0081 | 8.1031 | 0.418 | 3 | 256 | response to lipopolysaccharide |
| GO:0043308 | 0.0081 | 159.1979 | 0.0082 | 1 | 5 | eosinophil degranulation |
| GO:0051665 | 0.0081 | 159.1979 | 0.0082 | 1 | 5 | membrane raft localization |
| GO:2000503 | 0.0081 | 159.1979 | 0.0082 | 1 | 5 | positive regulation of natural killer cell chemotaxis |
| GO:0015851 | 0.0098 | 127.35 | 0.0098 | 1 | 6 | nucleobase transport |
| GO:0043307 | 0.0098 | 127.35 | 0.0098 | 1 | 6 | eosinophil activation |
| GO:0043615 | 0.0098 | 127.35 | 0.0098 | 1 | 6 | astrocyte cell migration |
| GO:0060700 | 0.0098 | 127.35 | 0.0098 | 1 | 6 | regulation of ribonuclease activity |
| GO:0090594 | 0.0098 | 127.35 | 0.0098 | 1 | 6 | inflammatory response to wounding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0032760 | 1e-04 | 41.3035 | 0.0862 | 3 | 44 | positive regulation of tumor necrosis factor production |
| GO:0006955 | 2e-04 | 5.1853 | 2.6528 | 10 | 1354 | immune response |
| GO:1903555 | 6e-04 | 20.8519 | 0.1646 | 3 | 84 | regulation of tumor necrosis factor superfamily cytokine production |
| GO:0032609 | 7e-04 | 19.6331 | 0.1744 | 3 | 89 | interferon-gamma production |
| GO:0006954 | 7e-04 | 6.4762 | 1.1246 | 6 | 574 | inflammatory response |
| GO:0045671 | 8e-04 | 57.3797 | 0.0411 | 2 | 21 | negative regulation of osteoclast differentiation |
| GO:0050863 | 0.0013 | 9.4424 | 0.4879 | 4 | 249 | regulation of T cell activation |
| GO:0042330 | 0.0015 | 5.5828 | 1.2951 | 6 | 661 | taxis |
| GO:0006051 | 0.002 | Inf | 0.002 | 1 | 1 | N-acetylmannosamine metabolic process |
| GO:0030887 | 0.002 | Inf | 0.002 | 1 | 1 | positive regulation of myeloid dendritic cell activation |
| GO:0034612 | 0.002 | 13.3651 | 0.2527 | 3 | 129 | response to tumor necrosis factor |
| GO:0071219 | 0.0021 | 13.259 | 0.2547 | 3 | 130 | cellular response to molecule of bacterial origin |
| GO:0031663 | 0.0035 | 25.314 | 0.0882 | 2 | 45 | lipopolysaccharide-mediated signaling pathway |
| GO:0022407 | 0.0038 | 7.0141 | 0.6505 | 4 | 332 | regulation of cell-cell adhesion |
| GO:0015993 | 0.0039 | 526.931 | 0.0039 | 1 | 2 | molecular hydrogen transport |
| GO:0070904 | 0.0039 | 526.931 | 0.0039 | 1 | 2 | transepithelial L-ascorbic acid transport |
| GO:0019262 | 0.0059 | 263.4483 | 0.0059 | 1 | 3 | N-acetylneuraminate catabolic process |
| GO:0002694 | 0.006 | 6.1493 | 0.7386 | 4 | 377 | regulation of leukocyte activation |
| GO:0002376 | 0.0068 | 4.9946 | 1.2566 | 5 | 877 | immune system process |
| GO:0070489 | 0.0068 | 5.9056 | 0.768 | 4 | 392 | T cell aggregation |
| GO:0070486 | 0.0073 | 5.7832 | 0.7837 | 4 | 400 | leukocyte aggregation |
| GO:0060326 | 0.0077 | 8.1718 | 0.4075 | 3 | 208 | cell chemotaxis |
| GO:0031295 | 0.0078 | 16.4675 | 0.1332 | 2 | 68 | T cell costimulation |
| GO:0001766 | 0.0078 | 175.6207 | 0.0078 | 1 | 4 | membrane raft polarization |
| GO:1902715 | 0.0078 | 175.6207 | 0.0078 | 1 | 4 | positive regulation of interferon-gamma secretion |
| GO:0050715 | 0.0079 | 16.3285 | 0.1345 | 2 | 71 | positive regulation of cytokine secretion |
| GO:1902106 | 0.0094 | 14.8816 | 0.1469 | 2 | 75 | negative regulation of leukocyte differentiation |
| GO:0043308 | 0.0098 | 131.7069 | 0.0098 | 1 | 5 | eosinophil degranulation |
| GO:0051665 | 0.0098 | 131.7069 | 0.0098 | 1 | 5 | membrane raft localization |
| GO:2000503 | 0.0098 | 131.7069 | 0.0098 | 1 | 5 | positive regulation of natural killer cell chemotaxis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050715 | 2e-04 | 30.1905 | 0.1176 | 3 | 75 | positive regulation of cytokine secretion |
| GO:0010818 | 3e-04 | 92.5636 | 0.0266 | 2 | 17 | T cell chemotaxis |
| GO:1901623 | 4e-04 | 81.6631 | 0.0298 | 2 | 19 | regulation of lymphocyte chemotaxis |
| GO:0006955 | 7e-04 | 5.179 | 2.1223 | 8 | 1354 | immune response |
| GO:0070374 | 9e-04 | 18.0571 | 0.1928 | 3 | 123 | positive regulation of ERK1 and ERK2 cascade |
| GO:0071219 | 0.0011 | 17.054 | 0.2038 | 3 | 130 | cellular response to molecule of bacterial origin |
| GO:0002548 | 0.0011 | 47.8339 | 0.0486 | 2 | 31 | monocyte chemotaxis |
| GO:0006954 | 0.0013 | 7.2627 | 0.8535 | 5 | 568 | inflammatory response |
| GO:0006051 | 0.0016 | Inf | 0.0016 | 1 | 1 | N-acetylmannosamine metabolic process |
| GO:0009967 | 0.002 | 4.8037 | 1.9028 | 7 | 1214 | positive regulation of signal transduction |
| GO:0031663 | 0.0022 | 32.2304 | 0.0705 | 2 | 45 | lipopolysaccharide-mediated signaling pathway |
| GO:0015993 | 0.0031 | 664.6522 | 0.0031 | 1 | 2 | molecular hydrogen transport |
| GO:0070904 | 0.0031 | 664.6522 | 0.0031 | 1 | 2 | transepithelial L-ascorbic acid transport |
| GO:0072676 | 0.0032 | 26.6364 | 0.0846 | 2 | 54 | lymphocyte migration |
| GO:0009306 | 0.0039 | 7.1148 | 0.6614 | 4 | 422 | protein secretion |
| GO:0034605 | 0.0045 | 22.3255 | 0.1003 | 2 | 64 | cellular response to heat |
| GO:0032103 | 0.0047 | 9.9683 | 0.3433 | 3 | 219 | positive regulation of response to external stimulus |
| GO:0019262 | 0.0047 | 332.3043 | 0.0047 | 1 | 3 | N-acetylneuraminate catabolic process |
| GO:1901509 | 0.0047 | 332.3043 | 0.0047 | 1 | 3 | regulation of endothelial tube morphogenesis |
| GO:1901740 | 0.0047 | 332.3043 | 0.0047 | 1 | 3 | negative regulation of myoblast fusion |
| GO:0007588 | 0.0049 | 21.2909 | 0.105 | 2 | 67 | excretion |
| GO:0002248 | 0.0063 | 221.5217 | 0.0063 | 1 | 4 | connective tissue replacement involved in inflammatory response wound healing |
| GO:1903901 | 0.0071 | 17.5017 | 0.127 | 2 | 81 | negative regulation of viral life cycle |
| GO:0032496 | 0.0072 | 8.4896 | 0.4013 | 3 | 256 | response to lipopolysaccharide |
| GO:0002322 | 0.0078 | 166.1304 | 0.0078 | 1 | 5 | B cell proliferation involved in immune response |
| GO:0043308 | 0.0078 | 166.1304 | 0.0078 | 1 | 5 | eosinophil degranulation |
| GO:2000503 | 0.0078 | 166.1304 | 0.0078 | 1 | 5 | positive regulation of natural killer cell chemotaxis |
| GO:0051209 | 0.0079 | 16.4545 | 0.1348 | 2 | 86 | release of sequestered calcium ion into cytosol |
| GO:0051282 | 0.0081 | 16.2599 | 0.1364 | 2 | 87 | regulation of sequestering of calcium ion |
| GO:1903532 | 0.0083 | 8.0677 | 0.4216 | 3 | 269 | positive regulation of secretion by cell |
| GO:0002687 | 0.0085 | 15.884 | 0.1395 | 2 | 89 | positive regulation of leukocyte migration |
| GO:0051928 | 0.009 | 15.3515 | 0.1442 | 2 | 92 | positive regulation of calcium ion transport |
| GO:0015851 | 0.0094 | 132.8957 | 0.0094 | 1 | 6 | nucleobase transport |
| GO:0043307 | 0.0094 | 132.8957 | 0.0094 | 1 | 6 | eosinophil activation |
| GO:0043615 | 0.0094 | 132.8957 | 0.0094 | 1 | 6 | astrocyte cell migration |
| GO:0060700 | 0.0094 | 132.8957 | 0.0094 | 1 | 6 | regulation of ribonuclease activity |
| GO:0090594 | 0.0094 | 132.8957 | 0.0094 | 1 | 6 | inflammatory response to wounding |
| GO:0071345 | 0.0097 | 5.4309 | 0.8574 | 4 | 547 | cellular response to cytokine stimulus |
| GO:0001816 | 0.0098 | 5.4103 | 0.8605 | 4 | 549 | cytokine production |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0044723 | 9e-04 | 6.3919 | 1.1638 | 6 | 660 | single-organism carbohydrate metabolic process |
| GO:0006049 | 0.0018 | Inf | 0.0018 | 1 | 1 | UDP-N-acetylglucosamine catabolic process |
| GO:0006127 | 0.0018 | Inf | 0.0018 | 1 | 1 | glycerophosphate shuttle |
| GO:0036399 | 0.0018 | Inf | 0.0018 | 1 | 1 | TCR signalosome assembly |
| GO:0010623 | 0.0022 | 32.0989 | 0.0705 | 2 | 40 | developmental programmed cell death |
| GO:0001869 | 0.0035 | 587.8462 | 0.0035 | 1 | 2 | negative regulation of complement activation, lectin pathway |
| GO:0046168 | 0.0035 | 587.8462 | 0.0035 | 1 | 2 | glycerol-3-phosphate catabolic process |
| GO:0016266 | 0.0038 | 24.376 | 0.0917 | 2 | 52 | O-glycan processing |
| GO:0010676 | 0.0045 | 22.1527 | 0.1005 | 2 | 57 | positive regulation of cellular carbohydrate metabolic process |
| GO:0006096 | 0.005 | 21.0028 | 0.1058 | 2 | 60 | glycolytic process |
| GO:0006116 | 0.0053 | 293.9038 | 0.0053 | 1 | 3 | NADH oxidation |
| GO:0002248 | 0.007 | 195.9231 | 0.0071 | 1 | 4 | connective tissue replacement involved in inflammatory response wound healing |
| GO:0044027 | 0.007 | 195.9231 | 0.0071 | 1 | 4 | hypermethylation of CpG island |
| GO:0006955 | 0.0076 | 3.6216 | 2.3875 | 7 | 1354 | immune response |
| GO:0006094 | 0.0077 | 16.6707 | 0.1322 | 2 | 75 | gluconeogenesis |
| GO:0043687 | 0.0086 | 7.8692 | 0.4267 | 3 | 242 | post-translational protein modification |
| GO:0030311 | 0.0088 | 146.9327 | 0.0088 | 1 | 5 | poly-N-acetyllactosamine biosynthetic process |
| GO:0090241 | 0.0088 | 146.9327 | 0.0088 | 1 | 5 | negative regulation of histone H4 acetylation |
| GO:0050727 | 0.009 | 7.7377 | 0.4338 | 3 | 246 | regulation of inflammatory response |
| GO:0046364 | 0.0093 | 15.0163 | 0.1464 | 2 | 83 | monosaccharide biosynthetic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:1901642 | 4e-04 | 80.7354 | 0.0316 | 2 | 11 | nucleoside transmembrane transport |
| GO:0043123 | 0.0013 | 9.3832 | 0.4741 | 4 | 165 | positive regulation of I-kappaB kinase/NF-kappaB signaling |
| GO:0045742 | 0.0018 | 36.3048 | 0.0632 | 2 | 22 | positive regulation of epidermal growth factor receptor signaling pathway |
| GO:0015862 | 0.0029 | Inf | 0.0029 | 1 | 1 | uridine transport |
| GO:0035048 | 0.0029 | Inf | 0.0029 | 1 | 1 | splicing factor protein import into nucleus |
| GO:0035350 | 0.0029 | Inf | 0.0029 | 1 | 1 | FAD transmembrane transport |
| GO:0035491 | 0.0029 | Inf | 0.0029 | 1 | 1 | positive regulation of leukotriene production involved in inflammatory response |
| GO:0061044 | 0.0029 | Inf | 0.0029 | 1 | 1 | negative regulation of vascular wound healing |
| GO:0002685 | 0.0049 | 9.4753 | 0.3448 | 3 | 120 | regulation of leukocyte migration |
| GO:0001300 | 0.0057 | 355.0465 | 0.0057 | 1 | 2 | chronological cell aging |
| GO:0002538 | 0.0057 | 355.0465 | 0.0057 | 1 | 2 | arachidonic acid metabolite production involved in inflammatory response |
| GO:0015866 | 0.0057 | 355.0465 | 0.0057 | 1 | 2 | ADP transport |
| GO:0019303 | 0.0057 | 355.0465 | 0.0057 | 1 | 2 | D-ribose catabolic process |
| GO:0035349 | 0.0057 | 355.0465 | 0.0057 | 1 | 2 | coenzyme A transmembrane transport |
| GO:0043132 | 0.0057 | 355.0465 | 0.0057 | 1 | 2 | NAD transport |
| GO:0060545 | 0.0057 | 355.0465 | 0.0057 | 1 | 2 | positive regulation of necroptotic process |
| GO:0080121 | 0.0057 | 355.0465 | 0.0057 | 1 | 2 | AMP transport |
| GO:2000098 | 0.0057 | 355.0465 | 0.0057 | 1 | 2 | negative regulation of smooth muscle cell-matrix adhesion |
| GO:2000452 | 0.0057 | 355.0465 | 0.0057 | 1 | 2 | regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation |
| GO:0033344 | 0.0062 | 18.5946 | 0.1178 | 2 | 41 | cholesterol efflux |
| GO:1901264 | 0.0062 | 18.5946 | 0.1178 | 2 | 41 | carbohydrate derivative transport |
| GO:0042059 | 0.0065 | 18.1286 | 0.1207 | 2 | 42 | negative regulation of epidermal growth factor receptor signaling pathway |
| GO:0060079 | 0.0077 | 16.4762 | 0.1322 | 2 | 46 | regulation of excitatory postsynaptic membrane potential |
| GO:0051865 | 0.008 | 16.109 | 0.1351 | 2 | 47 | protein autoubiquitination |
| GO:0006869 | 0.0082 | 5.4723 | 0.7989 | 4 | 278 | lipid transport |
| GO:0035697 | 0.0086 | 177.5116 | 0.0086 | 1 | 3 | CD8-positive, alpha-beta T cell extravasation |
| GO:0042427 | 0.0086 | 177.5116 | 0.0086 | 1 | 3 | serotonin biosynthetic process |
| GO:1900127 | 0.0086 | 177.5116 | 0.0086 | 1 | 3 | positive regulation of hyaluronan biosynthetic process |
| GO:2000407 | 0.0086 | 177.5116 | 0.0086 | 1 | 3 | regulation of T cell extravasation |
| GO:0044242 | 0.0099 | 7.2766 | 0.4454 | 3 | 155 | cellular lipid catabolic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007321 | 0.0013 | Inf | 0.0013 | 1 | 1 | sperm displacement |
| GO:0001887 | 0.0026 | 804.7895 | 0.0026 | 1 | 2 | selenium compound metabolic process |
| GO:0007181 | 0.0039 | 402.3684 | 0.0039 | 1 | 3 | transforming growth factor beta receptor complex assembly |
| GO:0015747 | 0.0039 | 402.3684 | 0.0039 | 1 | 3 | urate transport |
| GO:0015760 | 0.0052 | 268.2281 | 0.0052 | 1 | 4 | glucose-6-phosphate transport |
| GO:0001957 | 0.0078 | 160.9158 | 0.0078 | 1 | 6 | intramembranous ossification |
| GO:2001275 | 0.0078 | 160.9158 | 0.0078 | 1 | 6 | positive regulation of glucose import in response to insulin stimulus |
| GO:0010759 | 0.0091 | 134.0877 | 0.0091 | 1 | 7 | positive regulation of macrophage chemotaxis |
| GO:0019953 | 0.0098 | 5.5337 | 0.8686 | 4 | 665 | sexual reproduction |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006955 | 0 | 22.6306 | 0.3068 | 5 | 242 | immune response |
| GO:0006968 | 1e-04 | 40.738 | 0.0882 | 3 | 54 | cellular defense response |
| GO:0002275 | 1e-04 | 37.7653 | 0.0947 | 3 | 58 | myeloid cell activation involved in immune response |
| GO:0070493 | 1e-04 | 166.0761 | 0.0163 | 2 | 10 | thrombin receptor signaling pathway |
| GO:0002263 | 2e-04 | 16.4484 | 0.2923 | 4 | 179 | cell activation involved in immune response |
| GO:0050715 | 2e-04 | 28.8163 | 0.1225 | 3 | 75 | positive regulation of cytokine secretion |
| GO:0007229 | 3e-04 | 25.2855 | 0.1388 | 3 | 85 | integrin-mediated signaling pathway |
| GO:0045321 | 5e-04 | 7.3347 | 1.04 | 6 | 637 | leukocyte activation |
| GO:0009611 | 7e-04 | 5.8558 | 1.5658 | 7 | 959 | response to wounding |
| GO:0002715 | 9e-04 | 53.0852 | 0.0441 | 2 | 27 | regulation of natural killer cell mediated immunity |
| GO:0044700 | 0.001 | 3.8498 | 8.9048 | 17 | 5454 | single organism signaling |
| GO:0007154 | 0.0012 | 3.7493 | 9.0566 | 17 | 5547 | cell communication |
| GO:0031347 | 0.0013 | 7.1709 | 0.849 | 5 | 520 | regulation of defense response |
| GO:0007596 | 0.0015 | 7.0157 | 0.867 | 5 | 531 | blood coagulation |
| GO:0010920 | 0.0016 | Inf | 0.0016 | 1 | 1 | negative regulation of inositol phosphate biosynthetic process |
| GO:0010925 | 0.0016 | Inf | 0.0016 | 1 | 1 | positive regulation of inositol-polyphosphate 5-phosphatase activity |
| GO:0030845 | 0.0016 | Inf | 0.0016 | 1 | 1 | phospholipase C-inhibiting G-protein coupled receptor signaling pathway |
| GO:0060305 | 0.0016 | Inf | 0.0016 | 1 | 1 | regulation of cell diameter |
| GO:0050848 | 0.0019 | 34.8947 | 0.0653 | 2 | 40 | regulation of calcium-mediated signaling |
| GO:0045087 | 0.0022 | 5.3238 | 1.4074 | 6 | 862 | innate immune response |
| GO:0042267 | 0.0028 | 28.811 | 0.0784 | 2 | 48 | natural killer cell mediated cytotoxicity |
| GO:0045912 | 0.0028 | 28.811 | 0.0784 | 2 | 48 | negative regulation of carbohydrate metabolic process |
| GO:0001775 | 0.0028 | 12.3596 | 0.2874 | 3 | 222 | cell activation |
| GO:0070165 | 0.0033 | 636.9167 | 0.0033 | 1 | 2 | positive regulation of adiponectin secretion |
| GO:0070560 | 0.0033 | 636.9167 | 0.0033 | 1 | 2 | protein secretion by platelet |
| GO:0002449 | 0.0035 | 11.0711 | 0.3086 | 3 | 189 | lymphocyte mediated immunity |
| GO:0051716 | 0.0036 | 3.2756 | 9.8485 | 17 | 6032 | cellular response to stimulus |
| GO:0050878 | 0.0041 | 5.4712 | 1.0988 | 5 | 673 | regulation of body fluid levels |
| GO:0002351 | 0.0049 | 318.4375 | 0.0049 | 1 | 3 | serotonin production involved in inflammatory response |
| GO:0002554 | 0.0049 | 318.4375 | 0.0049 | 1 | 3 | serotonin secretion by platelet |
| GO:0060741 | 0.0049 | 318.4375 | 0.0049 | 1 | 3 | prostate gland stromal morphogenesis |
| GO:0071638 | 0.0049 | 318.4375 | 0.0049 | 1 | 3 | negative regulation of monocyte chemotactic protein-1 production |
| GO:0002444 | 0.0053 | 20.3639 | 0.1094 | 2 | 67 | myeloid leukocyte mediated immunity |
| GO:0035556 | 0.0053 | 3.4277 | 3.5332 | 9 | 2164 | intracellular signal transduction |
| GO:0045055 | 0.0061 | 18.9031 | 0.1176 | 2 | 72 | regulated secretory pathway |
| GO:0050776 | 0.0064 | 4.9076 | 1.218 | 5 | 746 | regulation of immune response |
| GO:0003056 | 0.0065 | 212.2778 | 0.0065 | 1 | 4 | regulation of vascular smooth muscle contraction |
| GO:0033625 | 0.0065 | 212.2778 | 0.0065 | 1 | 4 | positive regulation of integrin activation |
| GO:0043255 | 0.0068 | 17.8766 | 0.1241 | 2 | 76 | regulation of carbohydrate biosynthetic process |
| GO:0051050 | 0.0071 | 4.7786 | 1.249 | 5 | 765 | positive regulation of transport |
| GO:0002705 | 0.0077 | 16.7397 | 0.1322 | 2 | 81 | positive regulation of leukocyte mediated immunity |
| GO:0030316 | 0.0077 | 16.7397 | 0.1322 | 2 | 81 | osteoclast differentiation |
| GO:0008626 | 0.0081 | 159.1979 | 0.0082 | 1 | 5 | granzyme-mediated apoptotic signaling pathway |
| GO:0043308 | 0.0081 | 159.1979 | 0.0082 | 1 | 5 | eosinophil degranulation |
| GO:1900165 | 0.0081 | 159.1979 | 0.0082 | 1 | 5 | negative regulation of interleukin-6 secretion |
| GO:2000503 | 0.0081 | 159.1979 | 0.0082 | 1 | 5 | positive regulation of natural killer cell chemotaxis |
| GO:1903532 | 0.0093 | 7.7004 | 0.4392 | 3 | 269 | positive regulation of secretion by cell |
| GO:0002697 | 0.0094 | 7.6711 | 0.4408 | 3 | 270 | regulation of immune effector process |
| GO:0010572 | 0.0098 | 127.35 | 0.0098 | 1 | 6 | positive regulation of platelet activation |
| GO:0035356 | 0.0098 | 127.35 | 0.0098 | 1 | 6 | cellular triglyceride homeostasis |
| GO:0043307 | 0.0098 | 127.35 | 0.0098 | 1 | 6 | eosinophil activation |
| GO:0043615 | 0.0098 | 127.35 | 0.0098 | 1 | 6 | astrocyte cell migration |
| GO:2001204 | 0.0098 | 127.35 | 0.0098 | 1 | 6 | regulation of osteoclast development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0045321 | 0 | 13.1301 | 1.04 | 9 | 637 | leukocyte activation |
| GO:0042113 | 0 | 19.7592 | 0.32 | 5 | 196 | B cell activation |
| GO:0002322 | 0 | 443.0145 | 0.0082 | 2 | 5 | B cell proliferation involved in immune response |
| GO:0008360 | 0 | 23.8741 | 0.2041 | 4 | 125 | regulation of cell shape |
| GO:0031666 | 1e-04 | 265.7739 | 0.0114 | 2 | 7 | positive regulation of lipopolysaccharide-mediated signaling pathway |
| GO:0006959 | 1e-04 | 20.6082 | 0.2351 | 4 | 144 | humoral immune response |
| GO:0002263 | 2e-04 | 16.4484 | 0.2923 | 4 | 179 | cell activation involved in immune response |
| GO:0045087 | 3e-04 | 6.5643 | 1.4074 | 7 | 862 | innate immune response |
| GO:0071222 | 0.001 | 17.2352 | 0.2008 | 3 | 123 | cellular response to lipopolysaccharide |
| GO:0002520 | 0.0011 | 6.1208 | 1.2343 | 6 | 756 | immune system development |
| GO:0035611 | 0.0016 | Inf | 0.0016 | 1 | 1 | protein branching point deglutamylation |
| GO:0071216 | 0.0017 | 14.4412 | 0.2384 | 3 | 146 | cellular response to biotic stimulus |
| GO:0050853 | 0.0017 | 36.8382 | 0.062 | 2 | 38 | B cell receptor signaling pathway |
| GO:0071310 | 0.0018 | 4.1185 | 3.014 | 9 | 1846 | cellular response to organic substance |
| GO:0038083 | 0.002 | 33.9978 | 0.0669 | 2 | 41 | peptidyl-tyrosine autophosphorylation |
| GO:0006954 | 0.0021 | 6.4666 | 0.9372 | 5 | 574 | inflammatory response |
| GO:0070098 | 0.0034 | 25.9778 | 0.0865 | 2 | 53 | chemokine-mediated signaling pathway |
| GO:0006968 | 0.0035 | 25.4766 | 0.0882 | 2 | 54 | cellular defense response |
| GO:0002275 | 0.004 | 23.6506 | 0.0947 | 2 | 58 | myeloid cell activation involved in immune response |
| GO:0002429 | 0.0041 | 10.3919 | 0.3282 | 3 | 201 | immune response-activating cell surface receptor signaling pathway |
| GO:0030097 | 0.0043 | 5.4119 | 1.1102 | 5 | 680 | hemopoiesis |
| GO:0007204 | 0.0048 | 9.8378 | 0.3461 | 3 | 212 | positive regulation of cytosolic calcium ion concentration |
| GO:0002351 | 0.0049 | 318.4375 | 0.0049 | 1 | 3 | serotonin production involved in inflammatory response |
| GO:0002554 | 0.0049 | 318.4375 | 0.0049 | 1 | 3 | serotonin secretion by platelet |
| GO:0002444 | 0.0053 | 20.3639 | 0.1094 | 2 | 67 | myeloid leukocyte mediated immunity |
| GO:0046651 | 0.006 | 9.0875 | 0.3739 | 3 | 229 | lymphocyte proliferation |
| GO:0045055 | 0.0061 | 18.9031 | 0.1176 | 2 | 72 | regulated secretory pathway |
| GO:0003056 | 0.0065 | 212.2778 | 0.0065 | 1 | 4 | regulation of vascular smooth muscle contraction |
| GO:0044027 | 0.0065 | 212.2778 | 0.0065 | 1 | 4 | hypermethylation of CpG island |
| GO:0050715 | 0.0066 | 18.1227 | 0.1225 | 2 | 75 | positive regulation of cytokine secretion |
| GO:0070661 | 0.0069 | 8.5858 | 0.3951 | 3 | 242 | leukocyte proliferation |
| GO:0051050 | 0.0071 | 4.7786 | 1.249 | 5 | 765 | positive regulation of transport |
| GO:0007169 | 0.0072 | 4.7523 | 1.2556 | 5 | 769 | transmembrane receptor protein tyrosine kinase signaling pathway |
| GO:0007166 | 0.0079 | 2.9748 | 5.2328 | 11 | 3205 | cell surface receptor signaling pathway |
| GO:0043308 | 0.0081 | 159.1979 | 0.0082 | 1 | 5 | eosinophil degranulation |
| GO:0090241 | 0.0081 | 159.1979 | 0.0082 | 1 | 5 | negative regulation of histone H4 acetylation |
| GO:2000503 | 0.0081 | 159.1979 | 0.0082 | 1 | 5 | positive regulation of natural killer cell chemotaxis |
| GO:0051209 | 0.0086 | 15.7381 | 0.1404 | 2 | 86 | release of sequestered calcium ion into cytosol |
| GO:0051282 | 0.0088 | 15.5519 | 0.142 | 2 | 87 | regulation of sequestering of calcium ion |
| GO:0002237 | 0.0093 | 7.7004 | 0.4392 | 3 | 269 | response to molecule of bacterial origin |
| GO:1903532 | 0.0093 | 7.7004 | 0.4392 | 3 | 269 | positive regulation of secretion by cell |
| GO:0010959 | 0.0097 | 7.5559 | 0.4474 | 3 | 274 | regulation of metal ion transport |
| GO:0030098 | 0.0097 | 7.5559 | 0.4474 | 3 | 274 | lymphocyte differentiation |
| GO:0043307 | 0.0098 | 127.35 | 0.0098 | 1 | 6 | eosinophil activation |
| GO:0043615 | 0.0098 | 127.35 | 0.0098 | 1 | 6 | astrocyte cell migration |
| GO:0045347 | 0.0098 | 127.35 | 0.0098 | 1 | 6 | negative regulation of MHC class II biosynthetic process |
| GO:1902262 | 0.0098 | 127.35 | 0.0098 | 1 | 6 | apoptotic process involved in patterning of blood vessels |
| GO:0051928 | 0.0098 | 14.6831 | 0.1502 | 2 | 92 | positive regulation of calcium ion transport |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0070493 | 1e-04 | 224.7794 | 0.0124 | 2 | 10 | thrombin receptor signaling pathway |
| GO:0043068 | 4e-04 | 9.9287 | 0.6651 | 5 | 536 | positive regulation of programmed cell death |
| GO:0001775 | 4e-04 | 7.8035 | 1.0671 | 6 | 860 | cell activation |
| GO:0045851 | 6e-04 | 66.5185 | 0.036 | 2 | 29 | pH reduction |
| GO:0052548 | 8e-04 | 11.6927 | 0.4281 | 4 | 345 | regulation of endopeptidase activity |
| GO:0006955 | 8e-04 | 6.0395 | 1.6801 | 7 | 1354 | immune response |
| GO:0002737 | 0.0012 | Inf | 0.0012 | 1 | 1 | negative regulation of plasmacytoid dendritic cell cytokine production |
| GO:0010920 | 0.0012 | Inf | 0.0012 | 1 | 1 | negative regulation of inositol phosphate biosynthetic process |
| GO:0010925 | 0.0012 | Inf | 0.0012 | 1 | 1 | positive regulation of inositol-polyphosphate 5-phosphatase activity |
| GO:0030845 | 0.0012 | Inf | 0.0012 | 1 | 1 | phospholipase C-inhibiting G-protein coupled receptor signaling pathway |
| GO:0060305 | 0.0012 | Inf | 0.0012 | 1 | 1 | regulation of cell diameter |
| GO:0051453 | 0.0014 | 41.7237 | 0.0558 | 2 | 45 | regulation of intracellular pH |
| GO:0043525 | 0.0015 | 39.8641 | 0.0583 | 2 | 47 | positive regulation of neuron apoptotic process |
| GO:0007267 | 0.0021 | 5.6655 | 1.4369 | 6 | 1158 | cell-cell signaling |
| GO:0035087 | 0.0025 | 849.5556 | 0.0025 | 1 | 2 | siRNA loading onto RISC involved in RNA interference |
| GO:0044334 | 0.0025 | 849.5556 | 0.0025 | 1 | 2 | canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition |
| GO:0070560 | 0.0025 | 849.5556 | 0.0025 | 1 | 2 | protein secretion by platelet |
| GO:1901253 | 0.0025 | 849.5556 | 0.0025 | 1 | 2 | negative regulation of intracellular transport of viral material |
| GO:0030004 | 0.0026 | 29.8686 | 0.0769 | 2 | 62 | cellular monovalent inorganic cation homeostasis |
| GO:0009967 | 0.0027 | 5.3814 | 1.5064 | 6 | 1214 | positive regulation of signal transduction |
| GO:0035556 | 0.0028 | 4.4314 | 2.6852 | 8 | 2164 | intracellular signal transduction |
| GO:0051241 | 0.0032 | 6.1065 | 1.0547 | 5 | 850 | negative regulation of multicellular organismal process |
| GO:1904019 | 0.0032 | 27.1426 | 0.0844 | 2 | 68 | epithelial cell apoptotic process |
| GO:0002443 | 0.0036 | 11.2366 | 0.3152 | 3 | 254 | leukocyte mediated immunity |
| GO:0002351 | 0.0037 | 424.75 | 0.0037 | 1 | 3 | serotonin production involved in inflammatory response |
| GO:0002554 | 0.0037 | 424.75 | 0.0037 | 1 | 3 | serotonin secretion by platelet |
| GO:0002730 | 0.0037 | 424.75 | 0.0037 | 1 | 3 | regulation of dendritic cell cytokine production |
| GO:0010909 | 0.0037 | 424.75 | 0.0037 | 1 | 3 | positive regulation of heparan sulfate proteoglycan biosynthetic process |
| GO:0030423 | 0.0037 | 424.75 | 0.0037 | 1 | 3 | targeting of mRNA for destruction involved in RNA interference |
| GO:0048388 | 0.0037 | 424.75 | 0.0037 | 1 | 3 | endosomal lumen acidification |
| GO:0043255 | 0.0039 | 24.1955 | 0.0943 | 2 | 76 | regulation of carbohydrate biosynthetic process |
| GO:0051897 | 0.0041 | 23.5557 | 0.0968 | 2 | 78 | positive regulation of protein kinase B signaling |
| GO:0055082 | 0.0044 | 7.0946 | 0.6924 | 4 | 558 | cellular chemical homeostasis |
| GO:0048525 | 0.0047 | 22.0944 | 0.103 | 2 | 83 | negative regulation of viral process |
| GO:0003056 | 0.005 | 283.1481 | 0.005 | 1 | 4 | regulation of vascular smooth muscle contraction |
| GO:0030538 | 0.005 | 283.1481 | 0.005 | 1 | 4 | embryonic genitalia morphogenesis |
| GO:0032252 | 0.005 | 283.1481 | 0.005 | 1 | 4 | secretory granule localization |
| GO:0033625 | 0.005 | 283.1481 | 0.005 | 1 | 4 | positive regulation of integrin activation |
| GO:0043570 | 0.005 | 283.1481 | 0.005 | 1 | 4 | maintenance of DNA repeat elements |
| GO:0048619 | 0.005 | 283.1481 | 0.005 | 1 | 4 | embryonic hindgut morphogenesis |
| GO:0006919 | 0.0052 | 20.803 | 0.1092 | 2 | 88 | activation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0030282 | 0.0056 | 20.0978 | 0.1129 | 2 | 91 | bone mineralization |
| GO:0051128 | 0.0059 | 4.1218 | 2.3614 | 7 | 1903 | regulation of cellular component organization |
| GO:0008626 | 0.0062 | 212.3472 | 0.0062 | 1 | 5 | granzyme-mediated apoptotic signaling pathway |
| GO:0030644 | 0.0062 | 212.3472 | 0.0062 | 1 | 5 | cellular chloride ion homeostasis |
| GO:0043308 | 0.0062 | 212.3472 | 0.0062 | 1 | 5 | eosinophil degranulation |
| GO:0048625 | 0.0062 | 212.3472 | 0.0062 | 1 | 5 | myoblast fate commitment |
| GO:0090383 | 0.0062 | 212.3472 | 0.0062 | 1 | 5 | phagosome acidification |
| GO:2000503 | 0.0062 | 212.3472 | 0.0062 | 1 | 5 | positive regulation of natural killer cell chemotaxis |
| GO:0042552 | 0.0068 | 18.0559 | 0.1253 | 2 | 101 | myelination |
| GO:0007272 | 0.0072 | 17.5213 | 0.129 | 2 | 104 | ensheathment of neurons |
| GO:0030162 | 0.0074 | 6.0658 | 0.8041 | 4 | 648 | regulation of proteolysis |
| GO:0010572 | 0.0074 | 169.8667 | 0.0074 | 1 | 6 | positive regulation of platelet activation |
| GO:0043307 | 0.0074 | 169.8667 | 0.0074 | 1 | 6 | eosinophil activation |
| GO:0043615 | 0.0074 | 169.8667 | 0.0074 | 1 | 6 | astrocyte cell migration |
| GO:0046666 | 0.0074 | 169.8667 | 0.0074 | 1 | 6 | retinal cell programmed cell death |
| GO:0097527 | 0.0074 | 169.8667 | 0.0074 | 1 | 6 | necroptotic signaling pathway |
| GO:2000675 | 0.0074 | 169.8667 | 0.0074 | 1 | 6 | negative regulation of type B pancreatic cell apoptotic process |
| GO:0050790 | 0.0082 | 3.8461 | 2.5078 | 7 | 2021 | regulation of catalytic activity |
| GO:0006996 | 0.0083 | 3.4625 | 3.9261 | 9 | 3164 | organelle organization |
| GO:0006887 | 0.0086 | 8.1239 | 0.4318 | 3 | 348 | exocytosis |
| GO:0033860 | 0.0087 | 141.5463 | 0.0087 | 1 | 7 | regulation of NAD(P)H oxidase activity |
| GO:0050849 | 0.0087 | 141.5463 | 0.0087 | 1 | 7 | negative regulation of calcium-mediated signaling |
| GO:1901142 | 0.0087 | 141.5463 | 0.0087 | 1 | 7 | insulin metabolic process |
| GO:0031638 | 0.0089 | 15.6646 | 0.1439 | 2 | 116 | zymogen activation |
| GO:0007166 | 0.009 | 3.4065 | 3.9769 | 9 | 3205 | cell surface receptor signaling pathway |
| GO:0051707 | 0.0091 | 5.6955 | 0.8537 | 4 | 688 | response to other organism |
| GO:2001233 | 0.0092 | 7.9126 | 0.443 | 3 | 357 | regulation of apoptotic signaling pathway |
| GO:0030836 | 0.0099 | 121.3175 | 0.0099 | 1 | 8 | positive regulation of actin filament depolymerization |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0009954 | 0 | 37.4951 | 0.1293 | 4 | 33 | proximal/distal pattern formation |
| GO:0072272 | 0 | Inf | 0.0078 | 2 | 2 | proximal/distal pattern formation involved in metanephric nephron development |
| GO:0007156 | 0 | 12.8253 | 0.5368 | 6 | 137 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0007626 | 1e-04 | 9.6284 | 0.7053 | 6 | 180 | locomotory behavior |
| GO:0003056 | 1e-04 | 262.931 | 0.0157 | 2 | 4 | regulation of vascular smooth muscle contraction |
| GO:0021555 | 1e-04 | 262.931 | 0.0157 | 2 | 4 | midbrain-hindbrain boundary morphogenesis |
| GO:0072086 | 1e-04 | 262.931 | 0.0157 | 2 | 4 | specification of loop of Henle identity |
| GO:0098609 | 1e-04 | 9.099 | 0.7445 | 6 | 190 | cell-cell adhesion |
| GO:0009887 | 1e-04 | 4.1889 | 3.413 | 12 | 871 | organ morphogenesis |
| GO:0007389 | 1e-04 | 5.9336 | 1.5475 | 8 | 408 | pattern specification process |
| GO:0007187 | 4e-04 | 8.6847 | 0.6387 | 5 | 163 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
| GO:0048704 | 5e-04 | 12.0333 | 0.3683 | 4 | 94 | embryonic skeletal system morphogenesis |
| GO:0022008 | 5e-04 | 3.2229 | 5.2116 | 14 | 1330 | neurogenesis |
| GO:0061004 | 5e-04 | 75.0985 | 0.0353 | 2 | 9 | pattern specification involved in kidney development |
| GO:0021903 | 0.001 | 52.5586 | 0.047 | 2 | 12 | rostrocaudal neural tube patterning |
| GO:0048568 | 0.0011 | 4.8789 | 1.6027 | 7 | 409 | embryonic organ development |
| GO:0048935 | 0.0011 | 47.7774 | 0.0509 | 2 | 13 | peripheral nervous system neuron development |
| GO:0048598 | 0.0012 | 4.2683 | 2.118 | 8 | 559 | embryonic morphogenesis |
| GO:0060562 | 0.0014 | 5.3556 | 1.2382 | 6 | 316 | epithelial tube morphogenesis |
| GO:0030182 | 0.0014 | 3.1036 | 4.5024 | 12 | 1149 | neuron differentiation |
| GO:0019219 | 0.0015 | 2.3136 | 14.1967 | 25 | 3623 | regulation of nucleobase-containing compound metabolic process |
| GO:0030534 | 0.0017 | 8.5067 | 0.5133 | 4 | 131 | adult behavior |
| GO:0007379 | 0.0017 | 37.532 | 0.0627 | 2 | 16 | segment specification |
| GO:0072079 | 0.0025 | 30.9026 | 0.0745 | 2 | 19 | nephron tubule formation |
| GO:0035107 | 0.0028 | 7.4419 | 0.5839 | 4 | 149 | appendage morphogenesis |
| GO:0007422 | 0.003 | 11.2535 | 0.29 | 3 | 74 | peripheral nervous system development |
| GO:0007399 | 0.0031 | 4.0639 | 1.9624 | 7 | 596 | nervous system development |
| GO:0006355 | 0.0033 | 2.218 | 12.4569 | 22 | 3179 | regulation of transcription, DNA-templated |
| GO:2001141 | 0.0039 | 2.1822 | 12.6176 | 22 | 3220 | regulation of RNA biosynthetic process |
| GO:0021993 | 0.0039 | Inf | 0.0039 | 1 | 1 | initiation of neural tube closure |
| GO:0036065 | 0.0039 | 23.8715 | 0.094 | 2 | 24 | fucosylation |
| GO:0019953 | 0.0042 | 3.4176 | 2.6058 | 8 | 665 | sexual reproduction |
| GO:0060173 | 0.0042 | 6.5714 | 0.6583 | 4 | 168 | limb development |
| GO:0032501 | 0.0048 | 2.0258 | 24.5611 | 35 | 6268 | multicellular organismal process |
| GO:0097659 | 0.0051 | 2.1206 | 12.9036 | 22 | 3293 | nucleic acid-templated transcription |
| GO:0021510 | 0.0056 | 8.9669 | 0.3605 | 3 | 92 | spinal cord development |
| GO:0034654 | 0.0058 | 2.0571 | 14.7218 | 24 | 3757 | nucleobase-containing compound biosynthetic process |
| GO:0019228 | 0.0061 | 18.7488 | 0.1176 | 2 | 30 | neuronal action potential |
| GO:0009187 | 0.0062 | 5.8817 | 0.7328 | 4 | 187 | cyclic nucleotide metabolic process |
| GO:0009889 | 0.0065 | 2.0318 | 14.8589 | 24 | 3792 | regulation of biosynthetic process |
| GO:0048665 | 0.0065 | 18.1011 | 0.1215 | 2 | 31 | neuron fate specification |
| GO:0048729 | 0.007 | 3.4144 | 2.2531 | 7 | 575 | tissue morphogenesis |
| GO:0021522 | 0.0078 | 16.4009 | 0.1332 | 2 | 34 | spinal cord motor neuron differentiation |
| GO:0021568 | 0.0078 | 258.4915 | 0.0078 | 1 | 2 | rhombomere 2 development |
| GO:0021592 | 0.0078 | 258.4915 | 0.0078 | 1 | 2 | fourth ventricle development |
| GO:0070593 | 0.0078 | 258.4915 | 0.0078 | 1 | 2 | dendrite self-avoidance |
| GO:0007628 | 0.0083 | 15.9028 | 0.1371 | 2 | 35 | adult walking behavior |
| GO:0034332 | 0.0087 | 7.5925 | 0.4232 | 3 | 108 | adherens junction organization |
| GO:0007338 | 0.0089 | 7.5204 | 0.4271 | 3 | 109 | single fertilization |
| GO:0035137 | 0.0097 | 14.5747 | 0.1489 | 2 | 38 | hindlimb morphogenesis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0000042 | 7e-04 | 59.6172 | 0.04 | 2 | 18 | protein targeting to Golgi |
| GO:0048813 | 9e-04 | 17.5046 | 0.1932 | 3 | 87 | dendrite morphogenesis |
| GO:0048869 | 0.0018 | 2.9681 | 7.8538 | 16 | 3537 | cellular developmental process |
| GO:0003144 | 0.0022 | Inf | 0.0022 | 1 | 1 | embryonic heart tube formation |
| GO:0051615 | 0.0022 | Inf | 0.0022 | 1 | 1 | histamine uptake |
| GO:0006891 | 0.0037 | 24.4215 | 0.091 | 2 | 41 | intra-Golgi vesicle-mediated transport |
| GO:0045597 | 0.0041 | 4.4828 | 1.561 | 6 | 703 | positive regulation of cell differentiation |
| GO:0002876 | 0.0044 | 462.9394 | 0.0044 | 1 | 2 | positive regulation of chronic inflammatory response to antigenic stimulus |
| GO:0003218 | 0.0044 | 462.9394 | 0.0044 | 1 | 2 | cardiac left ventricle formation |
| GO:1903026 | 0.0044 | 462.9394 | 0.0044 | 1 | 2 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding |
| GO:0048699 | 0.0053 | 3.4621 | 2.7867 | 8 | 1255 | generation of neurons |
| GO:0016358 | 0.0054 | 20.0822 | 0.11 | 2 | 54 | dendrite development |
| GO:0007399 | 0.0076 | 2.8868 | 4.3011 | 10 | 1937 | nervous system development |
| GO:0003219 | 0.0089 | 154.2929 | 0.0089 | 1 | 4 | cardiac right ventricle formation |
| GO:0006651 | 0.0089 | 154.2929 | 0.0089 | 1 | 4 | diacylglycerol biosynthetic process |
| GO:0031536 | 0.0089 | 154.2929 | 0.0089 | 1 | 4 | positive regulation of exit from mitosis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006955 | 0 | 7.4107 | 2.1223 | 10 | 1354 | immune response |
| GO:0050853 | 0 | 62.2571 | 0.0596 | 3 | 38 | B cell receptor signaling pathway |
| GO:0045321 | 0 | 9.5804 | 0.9984 | 7 | 637 | leukocyte activation |
| GO:0031666 | 0 | 277.8727 | 0.011 | 2 | 7 | positive regulation of lipopolysaccharide-mediated signaling pathway |
| GO:0042113 | 2e-04 | 15.725 | 0.3072 | 4 | 196 | B cell activation |
| GO:0030851 | 8e-04 | 55.5018 | 0.0423 | 2 | 27 | granulocyte differentiation |
| GO:0002520 | 9e-04 | 6.4613 | 1.185 | 6 | 756 | immune system development |
| GO:0035611 | 0.0016 | Inf | 0.0016 | 1 | 1 | protein branching point deglutamylation |
| GO:0008616 | 0.0031 | 664.6522 | 0.0031 | 1 | 2 | queuosine biosynthetic process |
| GO:0030097 | 0.0036 | 5.6971 | 1.0658 | 5 | 680 | hemopoiesis |
| GO:0002429 | 0.0037 | 10.8874 | 0.315 | 3 | 201 | immune response-activating cell surface receptor signaling pathway |
| GO:0002764 | 0.0048 | 6.7176 | 0.6991 | 4 | 446 | immune response-regulating signaling pathway |
| GO:0048518 | 0.0048 | 3.1432 | 7.406 | 14 | 4725 | positive regulation of biological process |
| GO:0044027 | 0.0063 | 221.5217 | 0.0063 | 1 | 4 | hypermethylation of CpG island |
| GO:0002322 | 0.0078 | 166.1304 | 0.0078 | 1 | 5 | B cell proliferation involved in immune response |
| GO:0090241 | 0.0078 | 166.1304 | 0.0078 | 1 | 5 | negative regulation of histone H4 acetylation |
| GO:0030098 | 0.0087 | 7.9162 | 0.4295 | 3 | 274 | lymphocyte differentiation |
| GO:0045347 | 0.0094 | 132.8957 | 0.0094 | 1 | 6 | negative regulation of MHC class II biosynthetic process |
| GO:0046642 | 0.0094 | 132.8957 | 0.0094 | 1 | 6 | negative regulation of alpha-beta T cell proliferation |
| GO:1902262 | 0.0094 | 132.8957 | 0.0094 | 1 | 6 | apoptotic process involved in patterning of blood vessels |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0022803 | 0 | 8.8194 | 1.387 | 10 | 395 | passive transmembrane transporter activity |
| GO:0022838 | 0 | 8.1743 | 1.3167 | 9 | 375 | substrate-specific channel activity |
| GO:0022836 | 0 | 9.0165 | 1.0464 | 8 | 298 | gated channel activity |
| GO:0015077 | 2e-04 | 6.874 | 1.1657 | 7 | 332 | monovalent inorganic cation transmembrane transporter activity |
| GO:0046873 | 3e-04 | 5.9867 | 1.3308 | 7 | 379 | metal ion transmembrane transporter activity |
| GO:0005244 | 4e-04 | 9.1511 | 0.611 | 5 | 174 | voltage-gated ion channel activity |
| GO:0015459 | 5e-04 | 21.9283 | 0.1545 | 3 | 44 | potassium channel regulator activity |
| GO:0008324 | 7e-04 | 4.6985 | 1.9488 | 8 | 555 | cation transmembrane transporter activity |
| GO:0004890 | 0.0014 | 42.0632 | 0.0562 | 2 | 16 | GABA-A receptor activity |
| GO:0022892 | 0.0015 | 3.4938 | 3.3217 | 10 | 946 | substrate-specific transporter activity |
| GO:0004653 | 0.002 | 34.6335 | 0.0667 | 2 | 19 | polypeptide N-acetylgalactosaminyltransferase activity |
| GO:0005217 | 0.0027 | 29.4327 | 0.0772 | 2 | 22 | intracellular ligand-gated ion channel activity |
| GO:0005249 | 0.0031 | 11.2096 | 0.2914 | 3 | 83 | voltage-gated potassium channel activity |
| GO:0038048 | 0.0035 | Inf | 0.0035 | 1 | 1 | dynorphin receptor activity |
| GO:0043924 | 0.0035 | Inf | 0.0035 | 1 | 1 | suramin binding |
| GO:0005267 | 0.0051 | 20.7007 | 0.1067 | 2 | 32 | potassium channel activity |
| GO:0015276 | 0.0063 | 8.6151 | 0.3759 | 3 | 111 | ligand-gated ion channel activity |
| GO:0005272 | 0.0063 | 18.381 | 0.1194 | 2 | 34 | sodium channel activity |
| GO:0005006 | 0.007 | 289.1321 | 0.007 | 1 | 2 | epidermal growth factor-activated receptor activity |
| GO:0008281 | 0.007 | 289.1321 | 0.007 | 1 | 2 | sulfonylurea receptor activity |
| GO:0050682 | 0.007 | 289.1321 | 0.007 | 1 | 2 | AF-2 domain binding |
| GO:0015103 | 0.0098 | 7.2702 | 0.4424 | 3 | 126 | inorganic anion transmembrane transporter activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0098772 | 0.0013 | 3.9532 | 2.7667 | 9 | 1091 | molecular function regulator |
| GO:0005096 | 0.0023 | 8.0021 | 0.5579 | 4 | 220 | GTPase activator activity |
| GO:0001532 | 0.0025 | Inf | 0.0025 | 1 | 1 | interleukin-21 receptor activity |
| GO:0003692 | 0.0025 | Inf | 0.0025 | 1 | 1 | left-handed Z-DNA binding |
| GO:0005147 | 0.0025 | Inf | 0.0025 | 1 | 1 | oncostatin-M receptor binding |
| GO:0060589 | 0.0045 | 6.5517 | 0.6771 | 4 | 267 | nucleoside-triphosphatase regulator activity |
| GO:0030156 | 0.0051 | 403.6579 | 0.0051 | 1 | 2 | benzodiazepine receptor binding |
| GO:0042498 | 0.0051 | 403.6579 | 0.0051 | 1 | 2 | diacyl lipopeptide binding |
| GO:0003726 | 0.0076 | 201.8158 | 0.0076 | 1 | 3 | double-stranded RNA adenosine deaminase activity |
| GO:0030414 | 0.0079 | 7.9565 | 0.4108 | 3 | 162 | peptidase inhibitor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0016788 | 0.0025 | 4.2432 | 1.8873 | 7 | 645 | hydrolase activity, acting on ester bonds |
| GO:0001872 | 0.0029 | Inf | 0.0029 | 1 | 1 | (1->3)-beta-D-glucan binding |
| GO:0002055 | 0.0029 | Inf | 0.0029 | 1 | 1 | adenine binding |
| GO:0003999 | 0.0029 | Inf | 0.0029 | 1 | 1 | adenine phosphoribosyltransferase activity |
| GO:0030377 | 0.0029 | Inf | 0.0029 | 1 | 1 | urokinase plasminogen activator receptor activity |
| GO:0042947 | 0.0029 | Inf | 0.0029 | 1 | 1 | glucoside transmembrane transporter activity |
| GO:0050528 | 0.0029 | Inf | 0.0029 | 1 | 1 | acyloxyacyl hydrolase activity |
| GO:0097573 | 0.0029 | Inf | 0.0029 | 1 | 1 | glutathione oxidoreductase activity |
| GO:0004119 | 0.0058 | 348.4773 | 0.0059 | 1 | 2 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity |
| GO:0042281 | 0.0058 | 348.4773 | 0.0059 | 1 | 2 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity |
| GO:0030246 | 0.0067 | 5.7922 | 0.7549 | 4 | 258 | carbohydrate binding |
| GO:0000033 | 0.0088 | 174.2273 | 0.0088 | 1 | 3 | alpha-1,3-mannosyltransferase activity |
| GO:0004465 | 0.0088 | 174.2273 | 0.0088 | 1 | 3 | lipoprotein lipase activity |
| GO:0016936 | 0.0088 | 174.2273 | 0.0088 | 1 | 3 | galactoside binding |
| GO:0030395 | 0.0088 | 174.2273 | 0.0088 | 1 | 3 | lactose binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0051736 | 0.0023 | Inf | 0.0023 | 1 | 1 | ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity |
| GO:0001641 | 0.0047 | 438.3429 | 0.0047 | 1 | 2 | group II metabotropic glutamate receptor activity |
| GO:0046811 | 0.0047 | 438.3429 | 0.0047 | 1 | 2 | histone deacetylase inhibitor activity |
| GO:0005044 | 0.0052 | 20.4532 | 0.1077 | 2 | 46 | scavenger receptor activity |
| GO:0046404 | 0.007 | 219.1571 | 0.007 | 1 | 3 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity |
| GO:0001733 | 0.0093 | 146.0952 | 0.0094 | 1 | 4 | galactosylceramide sulfotransferase activity |
| GO:0017089 | 0.0093 | 146.0952 | 0.0094 | 1 | 4 | glycolipid transporter activity |
| GO:0051430 | 0.0093 | 146.0952 | 0.0094 | 1 | 4 | corticotropin-releasing hormone receptor 1 binding |
| GO:0051431 | 0.0093 | 146.0952 | 0.0094 | 1 | 4 | corticotropin-releasing hormone receptor 2 binding |
| GO:0051731 | 0.0093 | 146.0952 | 0.0094 | 1 | 4 | polynucleotide 5'-hydroxyl-kinase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0016810 | 3e-04 | 26.5148 | 0.1381 | 3 | 118 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds |
| GO:0004053 | 0.0023 | 903.5294 | 0.0023 | 1 | 2 | arginase activity |
| GO:0071558 | 0.0023 | 903.5294 | 0.0023 | 1 | 2 | histone demethylase activity (H3-K27 specific) |
| GO:0035662 | 0.0035 | 451.7353 | 0.0035 | 1 | 3 | Toll-like receptor 4 binding |
| GO:0047844 | 0.0035 | 451.7353 | 0.0035 | 1 | 3 | deoxycytidine deaminase activity |
| GO:0008745 | 0.0047 | 301.1373 | 0.0047 | 1 | 4 | N-acetylmuramoyl-L-alanine amidase activity |
| GO:0016019 | 0.0058 | 225.8382 | 0.0059 | 1 | 5 | peptidoglycan receptor activity |
| GO:0042289 | 0.0058 | 225.8382 | 0.0059 | 1 | 5 | MHC class II protein binding |
| GO:0050544 | 0.0058 | 225.8382 | 0.0059 | 1 | 5 | arachidonic acid binding |
| GO:1901567 | 0.007 | 180.6588 | 0.007 | 1 | 6 | fatty acid derivative binding |
| GO:0004126 | 0.0093 | 129.0252 | 0.0094 | 1 | 8 | cytidine deaminase activity |
| GO:0008061 | 0.0093 | 129.0252 | 0.0094 | 1 | 8 | chitin binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0016810 | 3e-04 | 26.5148 | 0.1381 | 3 | 118 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds |
| GO:0004053 | 0.0023 | 903.5294 | 0.0023 | 1 | 2 | arginase activity |
| GO:0071558 | 0.0023 | 903.5294 | 0.0023 | 1 | 2 | histone demethylase activity (H3-K27 specific) |
| GO:0035662 | 0.0035 | 451.7353 | 0.0035 | 1 | 3 | Toll-like receptor 4 binding |
| GO:0047844 | 0.0035 | 451.7353 | 0.0035 | 1 | 3 | deoxycytidine deaminase activity |
| GO:0051381 | 0.0035 | 451.7353 | 0.0035 | 1 | 3 | histamine binding |
| GO:0008745 | 0.0047 | 301.1373 | 0.0047 | 1 | 4 | N-acetylmuramoyl-L-alanine amidase activity |
| GO:0016019 | 0.0058 | 225.8382 | 0.0059 | 1 | 5 | peptidoglycan receptor activity |
| GO:0042289 | 0.0058 | 225.8382 | 0.0059 | 1 | 5 | MHC class II protein binding |
| GO:0050544 | 0.0058 | 225.8382 | 0.0059 | 1 | 5 | arachidonic acid binding |
| GO:0004969 | 0.007 | 180.6588 | 0.007 | 1 | 6 | histamine receptor activity |
| GO:1901567 | 0.007 | 180.6588 | 0.007 | 1 | 6 | fatty acid derivative binding |
| GO:0004126 | 0.0093 | 129.0252 | 0.0094 | 1 | 8 | cytidine deaminase activity |
| GO:0008061 | 0.0093 | 129.0252 | 0.0094 | 1 | 8 | chitin binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004869 | 0.0017 | 37.5245 | 0.062 | 2 | 53 | cysteine-type endopeptidase inhibitor activity |
| GO:0004053 | 0.0023 | 903.5294 | 0.0023 | 1 | 2 | arginase activity |
| GO:0071558 | 0.0023 | 903.5294 | 0.0023 | 1 | 2 | histone demethylase activity (H3-K27 specific) |
| GO:0008745 | 0.0047 | 301.1373 | 0.0047 | 1 | 4 | N-acetylmuramoyl-L-alanine amidase activity |
| GO:0016019 | 0.0058 | 225.8382 | 0.0059 | 1 | 5 | peptidoglycan receptor activity |
| GO:0042289 | 0.0058 | 225.8382 | 0.0059 | 1 | 5 | MHC class II protein binding |
| GO:0016810 | 0.0082 | 16.4278 | 0.1381 | 2 | 118 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004336 | 0.0026 | Inf | 0.0026 | 1 | 1 | galactosylceramidase activity |
| GO:0001632 | 0.0052 | 393.2821 | 0.0052 | 1 | 2 | leukotriene B4 receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008579 | 0.0021 | Inf | 0.0021 | 1 | 1 | JUN kinase phosphatase activity |
| GO:0005044 | 0.0041 | 23.1864 | 0.0957 | 2 | 46 | scavenger receptor activity |
| GO:0001632 | 0.0042 | 495.0323 | 0.0042 | 1 | 2 | leukotriene B4 receptor activity |
| GO:0004911 | 0.0042 | 495.0323 | 0.0042 | 1 | 2 | interleukin-2 receptor activity |
| GO:0019976 | 0.0042 | 495.0323 | 0.0042 | 1 | 2 | interleukin-2 binding |
| GO:0005539 | 0.007 | 8.4321 | 0.3933 | 3 | 189 | glycosaminoglycan binding |
| GO:0004860 | 0.0071 | 17.2746 | 0.1269 | 2 | 61 | protein kinase inhibitor activity |
| GO:0004872 | 0.0072 | 3.2948 | 2.9505 | 8 | 1418 | receptor activity |
| GO:0035591 | 0.008 | 16.1735 | 0.1352 | 2 | 65 | signaling adaptor activity |
| GO:0008330 | 0.0083 | 164.9892 | 0.0083 | 1 | 4 | protein tyrosine/threonine phosphatase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004336 | 0.0026 | Inf | 0.0026 | 1 | 1 | galactosylceramidase activity |
| GO:0001632 | 0.0052 | 393.2821 | 0.0052 | 1 | 2 | leukotriene B4 receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031014 | 0 | 853.1667 | 0.0052 | 2 | 4 | troponin T binding |
| GO:0000210 | 0.0013 | Inf | 0.0013 | 1 | 1 | NAD+ diphosphatase activity |
| GO:0015143 | 0.0026 | 808.3158 | 0.0026 | 1 | 2 | urate transmembrane transporter activity |
| GO:0035591 | 0.0032 | 26.9771 | 0.0845 | 2 | 65 | signaling adaptor activity |
| GO:0030172 | 0.0039 | 404.1316 | 0.0039 | 1 | 3 | troponin C binding |
| GO:0030369 | 0.0039 | 404.1316 | 0.0039 | 1 | 3 | ICAM-3 receptor activity |
| GO:0035529 | 0.0039 | 404.1316 | 0.0039 | 1 | 3 | NADH pyrophosphatase activity |
| GO:0015562 | 0.0052 | 269.4035 | 0.0052 | 1 | 4 | efflux transmembrane transporter activity |
| GO:0004523 | 0.0078 | 161.6211 | 0.0078 | 1 | 6 | RNA-DNA hybrid ribonuclease activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004489 | 0.0013 | Inf | 0.0013 | 1 | 1 | methylenetetrahydrofolate reductase (NAD(P)H) activity |
| GO:0016165 | 0.0026 | 808.3158 | 0.0026 | 1 | 2 | linoleate 13S-lipoxygenase activity |
| GO:0047977 | 0.0026 | 808.3158 | 0.0026 | 1 | 2 | hepoxilin-epoxide hydrolase activity |
| GO:0004052 | 0.0039 | 404.1316 | 0.0039 | 1 | 3 | arachidonate 12-lipoxygenase activity |
| GO:0051120 | 0.0039 | 404.1316 | 0.0039 | 1 | 3 | hepoxilin A3 synthase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0016165 | 0.0023 | 903.5294 | 0.0023 | 1 | 2 | linoleate 13S-lipoxygenase activity |
| GO:0016509 | 0.0023 | 903.5294 | 0.0023 | 1 | 2 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity |
| GO:0047977 | 0.0023 | 903.5294 | 0.0023 | 1 | 2 | hepoxilin-epoxide hydrolase activity |
| GO:0004052 | 0.0035 | 451.7353 | 0.0035 | 1 | 3 | arachidonate 12-lipoxygenase activity |
| GO:0016508 | 0.0035 | 451.7353 | 0.0035 | 1 | 3 | long-chain-enoyl-CoA hydratase activity |
| GO:0047223 | 0.0035 | 451.7353 | 0.0035 | 1 | 3 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity |
| GO:0051120 | 0.0035 | 451.7353 | 0.0035 | 1 | 3 | hepoxilin A3 synthase activity |
| GO:0001085 | 0.0047 | 22.202 | 0.103 | 2 | 88 | RNA polymerase II transcription factor binding |
| GO:0008532 | 0.0047 | 301.1373 | 0.0047 | 1 | 4 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity |
| GO:0004300 | 0.0058 | 225.8382 | 0.0059 | 1 | 5 | enoyl-CoA hydratase activity |
| GO:0003988 | 0.007 | 180.6588 | 0.007 | 1 | 6 | acetyl-CoA C-acyltransferase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0051424 | 0.0035 | 590.4231 | 0.0035 | 1 | 2 | corticotropin-releasing hormone binding |
| GO:0030395 | 0.0053 | 295.1923 | 0.0053 | 1 | 3 | lactose binding |
| GO:0033829 | 0.0053 | 295.1923 | 0.0053 | 1 | 3 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity |
| GO:0000104 | 0.007 | 196.7821 | 0.007 | 1 | 4 | succinate dehydrogenase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004872 | 5e-04 | 5.6523 | 2.0285 | 8 | 1418 | receptor activity |
| GO:0005456 | 0.0014 | Inf | 0.0014 | 1 | 1 | CMP-N-acetylneuraminate transmembrane transporter activity |
| GO:0022894 | 0.0014 | Inf | 0.0014 | 1 | 1 | Intermediate conductance calcium-activated potassium channel activity |
| GO:0050840 | 0.002 | 34.0267 | 0.0672 | 2 | 47 | extracellular matrix binding |
| GO:0008476 | 0.0029 | 731.2381 | 0.0029 | 1 | 2 | protein-tyrosine sulfotransferase activity |
| GO:0004871 | 0.0042 | 4.2544 | 2.1815 | 7 | 1525 | signal transducer activity |
| GO:0005338 | 0.01 | 121.8333 | 0.01 | 1 | 7 | nucleotide-sugar transmembrane transporter activity |
| GO:0005351 | 0.01 | 121.8333 | 0.01 | 1 | 7 | sugar:proton symporter activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0032428 | 0.001 | Inf | 0.001 | 1 | 1 | beta-N-acetylgalactosaminidase activity |
| GO:0036313 | 0.001 | Inf | 0.001 | 1 | 1 | phosphatidylinositol 3-kinase catalytic subunit binding |
| GO:0004872 | 0.0022 | 5.9282 | 1.4753 | 6 | 1418 | receptor activity |
| GO:0050698 | 0.0031 | 512.0333 | 0.0031 | 1 | 3 | proteoglycan sulfotransferase activity |
| GO:0004871 | 0.0031 | 5.4683 | 1.5866 | 6 | 1525 | signal transducer activity |
| GO:0001733 | 0.0042 | 341.3333 | 0.0042 | 1 | 4 | galactosylceramide sulfotransferase activity |
| GO:0004888 | 0.0043 | 5.8594 | 1.1559 | 5 | 1111 | transmembrane signaling receptor activity |
| GO:0050656 | 0.0062 | 204.7733 | 0.0062 | 1 | 6 | 3'-phosphoadenosine 5'-phosphosulfate binding |
| GO:0042608 | 0.0073 | 170.6333 | 0.0073 | 1 | 7 | T cell receptor binding |
| GO:0046982 | 0.0084 | 8.3953 | 0.4307 | 3 | 414 | protein heterodimerization activity |
| GO:0016004 | 0.0093 | 127.9583 | 0.0094 | 1 | 9 | phospholipase activator activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0032947 | 0.0027 | 29.3123 | 0.078 | 2 | 60 | protein complex scaffold |
| GO:0035591 | 0.0032 | 26.9771 | 0.0845 | 2 | 65 | signaling adaptor activity |
| GO:0001665 | 0.0039 | 404.1316 | 0.0039 | 1 | 3 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity |
| GO:0042608 | 0.0091 | 134.6754 | 0.0091 | 1 | 7 | T cell receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0036313 | 0.0012 | Inf | 0.0012 | 1 | 1 | phosphatidylinositol 3-kinase catalytic subunit binding |
| GO:0015143 | 0.0023 | 903.5294 | 0.0023 | 1 | 2 | urate transmembrane transporter activity |
| GO:0003823 | 0.0033 | 26.5434 | 0.0866 | 2 | 74 | antigen binding |
| GO:0050698 | 0.0035 | 451.7353 | 0.0035 | 1 | 3 | proteoglycan sulfotransferase activity |
| GO:0001733 | 0.0047 | 301.1373 | 0.0047 | 1 | 4 | galactosylceramide sulfotransferase activity |
| GO:0015562 | 0.0047 | 301.1373 | 0.0047 | 1 | 4 | efflux transmembrane transporter activity |
| GO:0030883 | 0.0058 | 225.8382 | 0.0059 | 1 | 5 | endogenous lipid antigen binding |
| GO:0030884 | 0.0058 | 225.8382 | 0.0059 | 1 | 5 | exogenous lipid antigen binding |
| GO:0050656 | 0.007 | 180.6588 | 0.007 | 1 | 6 | 3'-phosphoadenosine 5'-phosphosulfate binding |
| GO:0042608 | 0.0082 | 150.5392 | 0.0082 | 1 | 7 | T cell receptor binding |
| GO:0071723 | 0.0082 | 150.5392 | 0.0082 | 1 | 7 | lipopeptide binding |
| GO:0005436 | 0.0093 | 129.0252 | 0.0094 | 1 | 8 | sodium:phosphate symporter activity |
| GO:0019534 | 0.0093 | 129.0252 | 0.0094 | 1 | 8 | toxin transporter activity |
| GO:0030881 | 0.0093 | 129.0252 | 0.0094 | 1 | 8 | beta-2-microglobulin binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050698 | 0.0031 | 512.0333 | 0.0031 | 1 | 3 | proteoglycan sulfotransferase activity |
| GO:0001733 | 0.0042 | 341.3333 | 0.0042 | 1 | 4 | galactosylceramide sulfotransferase activity |
| GO:0050656 | 0.0062 | 204.7733 | 0.0062 | 1 | 6 | 3'-phosphoadenosine 5'-phosphosulfate binding |
| GO:0042608 | 0.0073 | 170.6333 | 0.0073 | 1 | 7 | T cell receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008502 | 0 | Inf | 0.0061 | 2 | 2 | melatonin receptor activity |
| GO:0043565 | 0 | 5.6929 | 2.4204 | 11 | 792 | sequence-specific DNA binding |
| GO:0003700 | 0 | 4.8413 | 3.1356 | 12 | 1026 | sequence-specific DNA binding transcription factor activity |
| GO:0022834 | 7e-04 | 10.963 | 0.4065 | 4 | 133 | ligand-gated channel activity |
| GO:0004890 | 0.0011 | 48.6286 | 0.0489 | 2 | 16 | GABA-A receptor activity |
| GO:0005253 | 0.0013 | 15.5343 | 0.2139 | 3 | 70 | anion channel activity |
| GO:0015108 | 0.0016 | 14.2519 | 0.2323 | 3 | 76 | chloride transmembrane transporter activity |
| GO:0097159 | 0.0017 | 2.4632 | 16.6711 | 27 | 5455 | organic cyclic compound binding |
| GO:0005230 | 0.0017 | 37.3782 | 0.0616 | 2 | 21 | extracellular ligand-gated ion channel activity |
| GO:0003677 | 0.0024 | 3.4303 | 3.6452 | 10 | 1477 | DNA binding |
| GO:1901363 | 0.0034 | 2.3041 | 16.4572 | 26 | 5385 | heterocyclic compound binding |
| GO:0004119 | 0.0061 | 333.2826 | 0.0061 | 1 | 2 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity |
| GO:0005231 | 0.0087 | 15.4424 | 0.1406 | 2 | 46 | excitatory extracellular ligand-gated ion channel activity |
| GO:0016934 | 0.0091 | 166.6304 | 0.0092 | 1 | 3 | extracellular-glycine-gated chloride channel activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0051015 | 0.0021 | 36.3429 | 0.0696 | 2 | 107 | actin filament binding |
| GO:0032027 | 0.0026 | 569.1111 | 0.0026 | 1 | 4 | myosin light chain binding |
| GO:0086083 | 0.0039 | 341.4222 | 0.0039 | 1 | 6 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication |
| GO:0017128 | 0.0058 | 213.3472 | 0.0059 | 1 | 9 | phospholipid scramblase activity |
| GO:0098632 | 0.0065 | 189.6296 | 0.0065 | 1 | 10 | protein binding involved in cell-cell adhesion |
| GO:0005229 | 0.0091 | 131.2479 | 0.0091 | 1 | 14 | intracellular calcium activated chloride channel activity |
| GO:0034185 | 0.0097 | 121.8651 | 0.0098 | 1 | 15 | apolipoprotein binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0.0018 | 15.9047 | 0.2553 | 3 | 357 | olfactory receptor activity |
| GO:0004499 | 0.0036 | 384.1 | 0.0036 | 1 | 5 | N,N-dimethylaniline monooxygenase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004252 | 0.0033 | 11.077 | 0.3017 | 3 | 145 | serine-type endopeptidase activity |
| GO:0017171 | 0.005 | 9.5185 | 0.3496 | 3 | 168 | serine hydrolase activity |
| GO:0001665 | 0.0062 | 247.5 | 0.0062 | 1 | 3 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0060089 | 2e-04 | 7.0363 | 1.9135 | 8 | 1731 | molecular transducer activity |
| GO:0038023 | 0.0014 | 6.4199 | 1.3364 | 6 | 1209 | signaling receptor activity |
| GO:0019911 | 0.0044 | 319.9792 | 0.0044 | 1 | 4 | structural constituent of myelin sheath |
| GO:0035197 | 0.0044 | 319.9792 | 0.0044 | 1 | 4 | siRNA binding |
| GO:0004984 | 0.0066 | 9.0847 | 0.3946 | 3 | 357 | olfactory receptor activity |
| GO:0030368 | 0.0077 | 159.9583 | 0.0077 | 1 | 7 | interleukin-17 receptor activity |
| GO:0004930 | 0.0086 | 5.9117 | 0.8445 | 4 | 764 | G-protein coupled receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0043565 | 0 | 8.2631 | 2.5234 | 15 | 792 | sequence-specific DNA binding |
| GO:0003700 | 0 | 6.2485 | 3.269 | 15 | 1026 | sequence-specific DNA binding transcription factor activity |
| GO:0015459 | 4e-04 | 24.3197 | 0.1402 | 3 | 44 | potassium channel regulator activity |
| GO:0001105 | 0.0026 | 29.6093 | 0.0765 | 2 | 24 | RNA polymerase II transcription coactivator activity |
| GO:0002058 | 0.0032 | Inf | 0.0032 | 1 | 1 | uracil binding |
| GO:0002059 | 0.0032 | Inf | 0.0032 | 1 | 1 | thymine binding |
| GO:0033798 | 0.0032 | Inf | 0.0032 | 1 | 1 | thyroxine 5-deiodinase activity |
| GO:0005267 | 0.0058 | 8.8614 | 0.3664 | 3 | 115 | potassium channel activity |
| GO:0005216 | 0.0059 | 4.7254 | 1.1629 | 5 | 365 | ion channel activity |
| GO:0000977 | 0.006 | 4.712 | 1.1661 | 5 | 366 | RNA polymerase II regulatory region sequence-specific DNA binding |
| GO:0001641 | 0.0064 | 319.3542 | 0.0064 | 1 | 2 | group II metabotropic glutamate receptor activity |
| GO:0004157 | 0.0064 | 319.3542 | 0.0064 | 1 | 2 | dihydropyrimidinase activity |
| GO:0008281 | 0.0064 | 319.3542 | 0.0064 | 1 | 2 | sulfonylurea receptor activity |
| GO:0008502 | 0.0064 | 319.3542 | 0.0064 | 1 | 2 | melatonin receptor activity |
| GO:0030305 | 0.0064 | 319.3542 | 0.0064 | 1 | 2 | heparanase activity |
| GO:0050682 | 0.0064 | 319.3542 | 0.0064 | 1 | 2 | AF-2 domain binding |
| GO:0001228 | 0.0071 | 5.6851 | 0.7647 | 4 | 240 | RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription |
| GO:0015267 | 0.0082 | 4.3531 | 1.2585 | 5 | 395 | channel activity |
| GO:0097159 | 0.0086 | 2.0616 | 17.3805 | 26 | 5455 | organic cyclic compound binding |
| GO:0044212 | 0.0093 | 3.6397 | 1.8225 | 6 | 572 | transcription regulatory region DNA binding |
| GO:0004800 | 0.0095 | 159.6667 | 0.0096 | 1 | 3 | thyroxine 5'-deiodinase activity |
| GO:0001067 | 0.0096 | 3.6132 | 1.8352 | 6 | 576 | regulatory region nucleic acid binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004872 | 1e-04 | 8.7956 | 1.5675 | 8 | 1418 | receptor activity |
| GO:0004871 | 1e-04 | 8.1125 | 1.6857 | 8 | 1525 | signal transducer activity |
| GO:0023026 | 1e-04 | 146.1714 | 0.0177 | 2 | 16 | MHC class II protein complex binding |
| GO:0004888 | 6e-04 | 7.763 | 1.153 | 6 | 1108 | transmembrane signaling receptor activity |
| GO:0016517 | 0.0011 | Inf | 0.0011 | 1 | 1 | interleukin-12 receptor activity |
| GO:0042019 | 0.0022 | 960.0625 | 0.0022 | 1 | 2 | interleukin-23 binding |
| GO:0042020 | 0.0022 | 960.0625 | 0.0022 | 1 | 2 | interleukin-23 receptor activity |
| GO:0003823 | 0.003 | 28.3148 | 0.0818 | 2 | 74 | antigen binding |
| GO:0030369 | 0.0033 | 480 | 0.0033 | 1 | 3 | ICAM-3 receptor activity |
| GO:0004720 | 0.0044 | 319.9792 | 0.0044 | 1 | 4 | protein-lysine 6-oxidase activity |
| GO:0005143 | 0.0055 | 239.9688 | 0.0055 | 1 | 5 | interleukin-12 receptor binding |
| GO:0038036 | 0.0066 | 191.9625 | 0.0066 | 1 | 6 | sphingosine-1-phosphate receptor activity |
| GO:0004126 | 0.0088 | 137.0982 | 0.0088 | 1 | 8 | cytidine deaminase activity |
| GO:0070492 | 0.0088 | 137.0982 | 0.0088 | 1 | 8 | oligosaccharide binding |
| GO:0044877 | 0.0098 | 4.6917 | 1.3906 | 5 | 1258 | macromolecular complex binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005001 | 8e-04 | 55.2252 | 0.0431 | 2 | 17 | transmembrane receptor protein tyrosine phosphatase activity |
| GO:0003823 | 9e-04 | 17.9214 | 0.1877 | 3 | 74 | antigen binding |
| GO:0043325 | 9e-04 | 51.7703 | 0.0456 | 2 | 18 | phosphatidylinositol-3,4-bisphosphate binding |
| GO:0005164 | 0.0023 | 31.8378 | 0.071 | 2 | 28 | tumor necrosis factor receptor binding |
| GO:0005547 | 0.0024 | 30.6567 | 0.0735 | 2 | 29 | phosphatidylinositol-3,4,5-trisphosphate binding |
| GO:0001631 | 0.0025 | Inf | 0.0025 | 1 | 1 | cysteinyl leukotriene receptor activity |
| GO:0005147 | 0.0025 | Inf | 0.0025 | 1 | 1 | oncostatin-M receptor binding |
| GO:0042498 | 0.0051 | 403.6579 | 0.0051 | 1 | 2 | diacyl lipopeptide binding |
| GO:0004721 | 0.0075 | 8.1111 | 0.4032 | 3 | 159 | phosphoprotein phosphatase activity |
| GO:0004872 | 0.0078 | 2.9661 | 3.5959 | 9 | 1418 | receptor activity |
| GO:0003725 | 0.0085 | 15.591 | 0.1395 | 2 | 55 | double-stranded RNA binding |
| GO:0035091 | 0.0094 | 7.4808 | 0.4362 | 3 | 172 | phosphatidylinositol binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004874 | 0.0017 | Inf | 0.0017 | 1 | 1 | aryl hydrocarbon receptor activity |
| GO:0004910 | 0.0017 | Inf | 0.0017 | 1 | 1 | interleukin-1, Type II, blocking receptor activity |
| GO:0015410 | 0.0017 | Inf | 0.0017 | 1 | 1 | manganese-transporting ATPase activity |
| GO:0035755 | 0.0017 | Inf | 0.0017 | 1 | 1 | cardiolipin hydrolase activity |
| GO:0004872 | 0.0018 | 4.395 | 2.3973 | 8 | 1418 | receptor activity |
| GO:0046982 | 0.0048 | 6.6266 | 0.6999 | 4 | 414 | protein heterodimerization activity |
| GO:0017162 | 0.0051 | 307.02 | 0.0051 | 1 | 3 | aryl hydrocarbon receptor binding |
| GO:0033829 | 0.0051 | 307.02 | 0.0051 | 1 | 3 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity |
| GO:0015057 | 0.0084 | 153.49 | 0.0085 | 1 | 5 | thrombin receptor activity |
| GO:0045159 | 0.0084 | 153.49 | 0.0085 | 1 | 5 | myosin II binding |
| GO:0098639 | 0.0084 | 153.49 | 0.0085 | 1 | 5 | collagen binding involved in cell-matrix adhesion |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008009 | 0 | 53.4174 | 0.0688 | 3 | 46 | chemokine activity |
| GO:0005126 | 4e-04 | 13.2038 | 0.3664 | 4 | 245 | cytokine receptor binding |
| GO:0045127 | 0.0015 | Inf | 0.0015 | 1 | 1 | N-acetylglucosamine kinase activity |
| GO:0008520 | 0.003 | 697.9545 | 0.003 | 1 | 2 | L-ascorbate:sodium symporter activity |
| GO:0008523 | 0.003 | 697.9545 | 0.003 | 1 | 2 | sodium-dependent multivitamin transmembrane transporter activity |
| GO:0009384 | 0.003 | 697.9545 | 0.003 | 1 | 2 | N-acylmannosamine kinase activity |
| GO:0070890 | 0.003 | 697.9545 | 0.003 | 1 | 2 | sodium-dependent L-ascorbate transmembrane transporter activity |
| GO:0004872 | 0.0036 | 4.3238 | 2.1207 | 7 | 1418 | receptor activity |
| GO:0001730 | 0.0045 | 348.9545 | 0.0045 | 1 | 3 | 2'-5'-oligoadenylate synthetase activity |
| GO:0001847 | 0.0045 | 348.9545 | 0.0045 | 1 | 3 | opsonin receptor activity |
| GO:0004698 | 0.0045 | 348.9545 | 0.0045 | 1 | 3 | calcium-dependent protein kinase C activity |
| GO:0004965 | 0.0045 | 348.9545 | 0.0045 | 1 | 3 | G-protein coupled GABA receptor activity |
| GO:0004982 | 0.0045 | 348.9545 | 0.0045 | 1 | 3 | N-formyl peptide receptor activity |
| GO:0001664 | 0.0049 | 9.8214 | 0.35 | 3 | 234 | G-protein coupled receptor binding |
| GO:0070891 | 0.006 | 232.6212 | 0.006 | 1 | 4 | lipoteichoic acid binding |
| GO:0015205 | 0.0075 | 174.4545 | 0.0075 | 1 | 5 | nucleobase transmembrane transporter activity |
| GO:0016019 | 0.0075 | 174.4545 | 0.0075 | 1 | 5 | peptidoglycan receptor activity |
| GO:0031726 | 0.0089 | 139.5545 | 0.009 | 1 | 6 | CCR1 chemokine receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008009 | 1e-04 | 44.5029 | 0.0808 | 3 | 46 | chemokine activity |
| GO:0005126 | 8e-04 | 10.9046 | 0.4301 | 4 | 245 | cytokine receptor binding |
| GO:0045127 | 0.0018 | Inf | 0.0018 | 1 | 1 | N-acetylglucosamine kinase activity |
| GO:0008520 | 0.0035 | 590.4231 | 0.0035 | 1 | 2 | L-ascorbate:sodium symporter activity |
| GO:0008523 | 0.0035 | 590.4231 | 0.0035 | 1 | 2 | sodium-dependent multivitamin transmembrane transporter activity |
| GO:0009384 | 0.0035 | 590.4231 | 0.0035 | 1 | 2 | N-acylmannosamine kinase activity |
| GO:0070890 | 0.0035 | 590.4231 | 0.0035 | 1 | 2 | sodium-dependent L-ascorbate transmembrane transporter activity |
| GO:0001847 | 0.0053 | 295.1923 | 0.0053 | 1 | 3 | opsonin receptor activity |
| GO:0004698 | 0.0053 | 295.1923 | 0.0053 | 1 | 3 | calcium-dependent protein kinase C activity |
| GO:0004965 | 0.0053 | 295.1923 | 0.0053 | 1 | 3 | G-protein coupled GABA receptor activity |
| GO:0004982 | 0.0053 | 295.1923 | 0.0053 | 1 | 3 | N-formyl peptide receptor activity |
| GO:0047374 | 0.0053 | 295.1923 | 0.0053 | 1 | 3 | methylumbelliferyl-acetate deacetylase activity |
| GO:0070891 | 0.007 | 196.7821 | 0.007 | 1 | 4 | lipoteichoic acid binding |
| GO:0001664 | 0.0078 | 8.1824 | 0.4108 | 3 | 234 | G-protein coupled receptor binding |
| GO:0015205 | 0.0087 | 147.5769 | 0.0088 | 1 | 5 | nucleobase transmembrane transporter activity |
| GO:0016019 | 0.0087 | 147.5769 | 0.0088 | 1 | 5 | peptidoglycan receptor activity |
| GO:0004872 | 0.0095 | 3.4581 | 2.4895 | 7 | 1418 | receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0045127 | 0.0015 | Inf | 0.0015 | 1 | 1 | N-acetylglucosamine kinase activity |
| GO:0008009 | 0.0021 | 33.1429 | 0.0688 | 2 | 46 | chemokine activity |
| GO:0008520 | 0.003 | 697.9545 | 0.003 | 1 | 2 | L-ascorbate:sodium symporter activity |
| GO:0008523 | 0.003 | 697.9545 | 0.003 | 1 | 2 | sodium-dependent multivitamin transmembrane transporter activity |
| GO:0009384 | 0.003 | 697.9545 | 0.003 | 1 | 2 | N-acylmannosamine kinase activity |
| GO:0070890 | 0.003 | 697.9545 | 0.003 | 1 | 2 | sodium-dependent L-ascorbate transmembrane transporter activity |
| GO:0001730 | 0.0045 | 348.9545 | 0.0045 | 1 | 3 | 2'-5'-oligoadenylate synthetase activity |
| GO:0004698 | 0.0045 | 348.9545 | 0.0045 | 1 | 3 | calcium-dependent protein kinase C activity |
| GO:0004965 | 0.0045 | 348.9545 | 0.0045 | 1 | 3 | G-protein coupled GABA receptor activity |
| GO:0004982 | 0.0045 | 348.9545 | 0.0045 | 1 | 3 | N-formyl peptide receptor activity |
| GO:0005126 | 0.0056 | 9.3682 | 0.3664 | 3 | 245 | cytokine receptor binding |
| GO:0004095 | 0.006 | 232.6212 | 0.006 | 1 | 4 | carnitine O-palmitoyltransferase activity |
| GO:0015205 | 0.0075 | 174.4545 | 0.0075 | 1 | 5 | nucleobase transmembrane transporter activity |
| GO:0048248 | 0.0075 | 174.4545 | 0.0075 | 1 | 5 | CXCR3 chemokine receptor binding |
| GO:0031726 | 0.0089 | 139.5545 | 0.009 | 1 | 6 | CCR1 chemokine receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030246 | 5e-04 | 12.5172 | 0.3859 | 4 | 258 | carbohydrate binding |
| GO:0003839 | 0.003 | 697.9545 | 0.003 | 1 | 2 | gamma-glutamylcyclotransferase activity |
| GO:0002039 | 0.0031 | 26.9877 | 0.0838 | 2 | 56 | p53 binding |
| GO:0031698 | 0.006 | 232.6212 | 0.006 | 1 | 4 | beta-2 adrenergic receptor binding |
| GO:0016176 | 0.0075 | 174.4545 | 0.0075 | 1 | 5 | superoxide-generating NADPH oxidase activator activity |
| GO:1901981 | 0.0081 | 16.3371 | 0.1361 | 2 | 91 | phosphatidylinositol phosphate binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0003839 | 0.0032 | 639.7083 | 0.0033 | 1 | 2 | gamma-glutamylcyclotransferase activity |
| GO:0004464 | 0.0032 | 639.7083 | 0.0033 | 1 | 2 | leukotriene-C4 synthase activity |
| GO:0005332 | 0.0065 | 213.2083 | 0.0065 | 1 | 4 | gamma-aminobutyric acid:sodium symporter activity |
| GO:0031698 | 0.0065 | 213.2083 | 0.0065 | 1 | 4 | beta-2 adrenergic receptor binding |
| GO:0051525 | 0.0065 | 213.2083 | 0.0065 | 1 | 4 | NFAT protein binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030246 | 5e-04 | 12.5172 | 0.3859 | 4 | 258 | carbohydrate binding |
| GO:0003839 | 0.003 | 697.9545 | 0.003 | 1 | 2 | gamma-glutamylcyclotransferase activity |
| GO:0002039 | 0.0031 | 26.9877 | 0.0838 | 2 | 56 | p53 binding |
| GO:0031698 | 0.006 | 232.6212 | 0.006 | 1 | 4 | beta-2 adrenergic receptor binding |
| GO:0016176 | 0.0075 | 174.4545 | 0.0075 | 1 | 5 | superoxide-generating NADPH oxidase activator activity |
| GO:1901981 | 0.0081 | 16.3371 | 0.1361 | 2 | 91 | phosphatidylinositol phosphate binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008194 | 0.0014 | 15.3508 | 0.223 | 3 | 127 | UDP-glycosyltransferase activity |
| GO:0003827 | 0.0018 | Inf | 0.0018 | 1 | 1 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity |
| GO:0043843 | 0.0018 | Inf | 0.0018 | 1 | 1 | ADP-specific glucokinase activity |
| GO:0051287 | 0.0031 | 27.2124 | 0.0825 | 2 | 47 | NAD binding |
| GO:0005507 | 0.0033 | 26.0511 | 0.086 | 2 | 49 | copper ion binding |
| GO:0003839 | 0.0035 | 590.4231 | 0.0035 | 1 | 2 | gamma-glutamylcyclotransferase activity |
| GO:0004367 | 0.0035 | 590.4231 | 0.0035 | 1 | 2 | glycerol-3-phosphate dehydrogenase [NAD+] activity |
| GO:0004368 | 0.0035 | 590.4231 | 0.0035 | 1 | 2 | glycerol-3-phosphate dehydrogenase activity |
| GO:0016509 | 0.0035 | 590.4231 | 0.0035 | 1 | 2 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity |
| GO:0043120 | 0.0035 | 590.4231 | 0.0035 | 1 | 2 | tumor necrosis factor binding |
| GO:0016758 | 0.0043 | 10.1922 | 0.3318 | 3 | 189 | transferase activity, transferring hexosyl groups |
| GO:0042379 | 0.0045 | 22.2502 | 0.1001 | 2 | 57 | chemokine receptor binding |
| GO:0016740 | 0.0048 | 3.4263 | 3.4481 | 9 | 1964 | transferase activity |
| GO:0016508 | 0.0053 | 295.1923 | 0.0053 | 1 | 3 | long-chain-enoyl-CoA hydratase activity |
| GO:0019959 | 0.0053 | 295.1923 | 0.0053 | 1 | 3 | interleukin-8 binding |
| GO:0047223 | 0.0053 | 295.1923 | 0.0053 | 1 | 3 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity |
| GO:0008532 | 0.007 | 196.7821 | 0.007 | 1 | 4 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity |
| GO:0051525 | 0.007 | 196.7821 | 0.007 | 1 | 4 | NFAT protein binding |
| GO:0004300 | 0.0087 | 147.5769 | 0.0088 | 1 | 5 | enoyl-CoA hydratase activity |
| GO:0016176 | 0.0087 | 147.5769 | 0.0088 | 1 | 5 | superoxide-generating NADPH oxidase activator activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0015143 | 0.0022 | 960.0625 | 0.0022 | 1 | 2 | urate transmembrane transporter activity |
| GO:0032182 | 0.0043 | 23.41 | 0.0984 | 2 | 89 | ubiquitin-like protein binding |
| GO:0015562 | 0.0044 | 319.9792 | 0.0044 | 1 | 4 | efflux transmembrane transporter activity |
| GO:0005436 | 0.0088 | 137.0982 | 0.0088 | 1 | 8 | sodium:phosphate symporter activity |
| GO:0019534 | 0.0088 | 137.0982 | 0.0088 | 1 | 8 | toxin transporter activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0035717 | 0.0016 | Inf | 0.0016 | 1 | 1 | chemokine (C-C motif) ligand 7 binding |
| GO:0004342 | 0.0032 | 639.7083 | 0.0033 | 1 | 2 | glucosamine-6-phosphate deaminase activity |
| GO:0015143 | 0.0032 | 639.7083 | 0.0033 | 1 | 2 | urate transmembrane transporter activity |
| GO:0071791 | 0.0032 | 639.7083 | 0.0033 | 1 | 2 | chemokine (C-C motif) ligand 5 binding |
| GO:0042799 | 0.0049 | 319.8333 | 0.0049 | 1 | 3 | histone methyltransferase activity (H4-K20 specific) |
| GO:0015562 | 0.0065 | 213.2083 | 0.0065 | 1 | 4 | efflux transmembrane transporter activity |
| GO:0046975 | 0.0065 | 213.2083 | 0.0065 | 1 | 4 | histone methyltransferase activity (H3-K36 specific) |
| GO:0016787 | 0.0068 | 3.288 | 3.6608 | 9 | 2252 | hydrolase activity |
| GO:0004620 | 0.0089 | 15.4378 | 0.1431 | 2 | 88 | phospholipase activity |
| GO:0004523 | 0.0097 | 127.9083 | 0.0098 | 1 | 6 | RNA-DNA hybrid ribonuclease activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0019534 | 0 | 393.7949 | 0.0078 | 2 | 8 | toxin transporter activity |
| GO:0001631 | 0.001 | Inf | 0.001 | 1 | 1 | cysteinyl leukotriene receptor activity |
| GO:0034041 | 0.001 | Inf | 0.001 | 1 | 1 | sterol-transporting ATPase activity |
| GO:0071886 | 0.001 | Inf | 0.001 | 1 | 1 | 1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding |
| GO:0015143 | 0.0019 | 1097.3571 | 0.002 | 1 | 2 | urate transmembrane transporter activity |
| GO:0034437 | 0.0019 | 1097.3571 | 0.002 | 1 | 2 | glycoprotein transporter activity |
| GO:0004888 | 0.0032 | 6.4458 | 1.0836 | 5 | 1111 | transmembrane signaling receptor activity |
| GO:0015562 | 0.0039 | 365.7381 | 0.0039 | 1 | 4 | efflux transmembrane transporter activity |
| GO:0051864 | 0.0058 | 219.4143 | 0.0059 | 1 | 6 | histone demethylase activity (H3-K36 specific) |
| GO:0030274 | 0.0068 | 182.8333 | 0.0068 | 1 | 7 | LIM domain binding |
| GO:0051378 | 0.0068 | 182.8333 | 0.0068 | 1 | 7 | serotonin binding |
| GO:0005436 | 0.0078 | 156.7041 | 0.0078 | 1 | 8 | sodium:phosphate symporter activity |
| GO:0048156 | 0.0078 | 156.7041 | 0.0078 | 1 | 8 | tau protein binding |
| GO:0005068 | 0.0087 | 137.1071 | 0.0088 | 1 | 9 | transmembrane receptor protein tyrosine kinase adaptor activity |
| GO:0004872 | 0.009 | 4.9367 | 1.3831 | 5 | 1418 | receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0034988 | 0.0016 | Inf | 0.0016 | 1 | 1 | Fc-gamma receptor I complex binding |
| GO:0004871 | 0.0021 | 4.2924 | 2.479 | 8 | 1525 | signal transducer activity |
| GO:0004698 | 0.0049 | 319.8333 | 0.0049 | 1 | 3 | calcium-dependent protein kinase C activity |
| GO:0004872 | 0.0061 | 3.8429 | 2.3051 | 7 | 1418 | receptor activity |
| GO:0004888 | 0.0075 | 4.0721 | 1.806 | 6 | 1111 | transmembrane signaling receptor activity |
| GO:0015057 | 0.0081 | 159.8958 | 0.0081 | 1 | 5 | thrombin receptor activity |
| GO:0003680 | 0.0097 | 127.9083 | 0.0098 | 1 | 6 | AT DNA binding |
| GO:0031726 | 0.0097 | 127.9083 | 0.0098 | 1 | 6 | CCR1 chemokine receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001637 | 5e-04 | 74.087 | 0.0325 | 2 | 25 | G-protein coupled chemoattractant receptor activity |
| GO:0034988 | 0.0013 | Inf | 0.0013 | 1 | 1 | Fc-gamma receptor I complex binding |
| GO:0004715 | 0.0015 | 40.5212 | 0.0572 | 2 | 44 | non-membrane spanning protein tyrosine kinase activity |
| GO:0004698 | 0.0039 | 404.1316 | 0.0039 | 1 | 3 | calcium-dependent protein kinase C activity |
| GO:0030395 | 0.0039 | 404.1316 | 0.0039 | 1 | 3 | lactose binding |
| GO:0004896 | 0.0049 | 21.4909 | 0.1053 | 2 | 81 | cytokine receptor activity |
| GO:0051525 | 0.0052 | 269.4035 | 0.0052 | 1 | 4 | NFAT protein binding |
| GO:0070290 | 0.0065 | 202.0395 | 0.0065 | 1 | 5 | N-acylphosphatidylethanolamine-specific phospholipase D activity |
| GO:0004630 | 0.0078 | 161.6211 | 0.0078 | 1 | 6 | phospholipase D activity |
| GO:0031726 | 0.0078 | 161.6211 | 0.0078 | 1 | 6 | CCR1 chemokine receptor binding |
| GO:0004931 | 0.0091 | 134.6754 | 0.0091 | 1 | 7 | extracellular ATP-gated cation channel activity |
| GO:0016494 | 0.0091 | 134.6754 | 0.0091 | 1 | 7 | C-X-C chemokine receptor activity |
| GO:0031730 | 0.0091 | 134.6754 | 0.0091 | 1 | 7 | CCR5 chemokine receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008476 | 0.0029 | 731.2381 | 0.0029 | 1 | 2 | protein-tyrosine sulfotransferase activity |
| GO:0004698 | 0.0043 | 365.5952 | 0.0043 | 1 | 3 | calcium-dependent protein kinase C activity |
| GO:0060089 | 0.0084 | 3.6903 | 2.4762 | 7 | 1731 | molecular transducer activity |
| GO:0031726 | 0.0086 | 146.2095 | 0.0086 | 1 | 6 | CCR1 chemokine receptor binding |
| GO:0031730 | 0.01 | 121.8333 | 0.01 | 1 | 7 | CCR5 chemokine receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0051736 | 0.0014 | Inf | 0.0014 | 1 | 1 | ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity |
| GO:0004698 | 0.0041 | 383.9 | 0.0041 | 1 | 3 | calcium-dependent protein kinase C activity |
| GO:0030395 | 0.0041 | 383.9 | 0.0041 | 1 | 3 | lactose binding |
| GO:0046404 | 0.0041 | 383.9 | 0.0041 | 1 | 3 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity |
| GO:0030246 | 0.005 | 9.8712 | 0.3523 | 3 | 258 | carbohydrate binding |
| GO:0019911 | 0.0055 | 255.9167 | 0.0055 | 1 | 4 | structural constituent of myelin sheath |
| GO:0051731 | 0.0055 | 255.9167 | 0.0055 | 1 | 4 | polynucleotide 5'-hydroxyl-kinase activity |
| GO:0060089 | 0.0063 | 3.9542 | 2.3637 | 7 | 1731 | molecular transducer activity |
| GO:0004565 | 0.0068 | 191.925 | 0.0068 | 1 | 5 | beta-galactosidase activity |
| GO:0015057 | 0.0068 | 191.925 | 0.0068 | 1 | 5 | thrombin receptor activity |
| GO:0001849 | 0.0082 | 153.53 | 0.0082 | 1 | 6 | complement component C1q binding |
| GO:0031726 | 0.0082 | 153.53 | 0.0082 | 1 | 6 | CCR1 chemokine receptor binding |
| GO:0004931 | 0.0095 | 127.9333 | 0.0096 | 1 | 7 | extracellular ATP-gated cation channel activity |
| GO:0031730 | 0.0095 | 127.9333 | 0.0096 | 1 | 7 | CCR5 chemokine receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0043027 | 1e-04 | 208.8299 | 0.0135 | 2 | 23 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process |
| GO:0005125 | 2e-04 | 36.8058 | 0.1223 | 3 | 209 | cytokine activity |
| GO:0045523 | 0.0012 | 1921.125 | 0.0012 | 1 | 2 | interleukin-27 receptor binding |
| GO:0030883 | 0.0029 | 480.1875 | 0.0029 | 1 | 5 | endogenous lipid antigen binding |
| GO:0030884 | 0.0029 | 480.1875 | 0.0029 | 1 | 5 | exogenous lipid antigen binding |
| GO:0004866 | 0.0035 | 28.2301 | 0.0913 | 2 | 156 | endopeptidase inhibitor activity |
| GO:0071723 | 0.0041 | 320.0833 | 0.0041 | 1 | 7 | lipopeptide binding |
| GO:0030881 | 0.0047 | 274.3393 | 0.0047 | 1 | 8 | beta-2-microglobulin binding |
| GO:0017128 | 0.0053 | 240.0312 | 0.0053 | 1 | 9 | phospholipid scramblase activity |
| GO:0061134 | 0.0055 | 22.2344 | 0.1153 | 2 | 197 | peptidase regulator activity |
| GO:0005126 | 0.0065 | 20.9239 | 0.1264 | 2 | 243 | cytokine receptor binding |
| GO:0001664 | 0.0077 | 18.6429 | 0.1369 | 2 | 234 | G-protein coupled receptor binding |
| GO:0005229 | 0.0082 | 147.6635 | 0.0082 | 1 | 14 | intracellular calcium activated chloride channel activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008502 | 0 | Inf | 0.007 | 2 | 2 | melatonin receptor activity |
| GO:0043565 | 1e-04 | 4.7638 | 2.7809 | 11 | 792 | sequence-specific DNA binding |
| GO:0005509 | 0.0017 | 4.0233 | 2.2578 | 8 | 643 | calcium ion binding |
| GO:0003700 | 0.0027 | 3.2008 | 3.6026 | 10 | 1026 | sequence-specific DNA binding transcription factor activity |
| GO:0008144 | 0.004 | 10.1852 | 0.3195 | 3 | 91 | drug binding |
| GO:0004119 | 0.007 | 289.1321 | 0.007 | 1 | 2 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042610 | 0.0039 | 529.2414 | 0.0039 | 1 | 2 | CD8 receptor binding |
| GO:0008237 | 0.0049 | 9.6343 | 0.3472 | 3 | 178 | metallopeptidase activity |
| GO:0005329 | 0.0058 | 264.6034 | 0.0059 | 1 | 3 | dopamine transmembrane transporter activity |
| GO:0004144 | 0.0078 | 176.3908 | 0.0078 | 1 | 4 | diacylglycerol O-acyltransferase activity |
| GO:0005096 | 0.0088 | 7.7481 | 0.4292 | 3 | 220 | GTPase activator activity |
| GO:0001537 | 0.0097 | 132.2845 | 0.0098 | 1 | 5 | N-acetylgalactosamine 4-O-sulfotransferase activity |
| GO:0003846 | 0.0097 | 132.2845 | 0.0098 | 1 | 5 | 2-acylglycerol O-acyltransferase activity |
| GO:0042609 | 0.0097 | 132.2845 | 0.0098 | 1 | 5 | CD4 receptor binding |
| GO:0070290 | 0.0097 | 132.2845 | 0.0098 | 1 | 5 | N-acylphosphatidylethanolamine-specific phospholipase D activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008479 | 0.0025 | 853.2778 | 0.0025 | 1 | 2 | queuine tRNA-ribosyltransferase activity |
| GO:0051525 | 0.0049 | 284.3889 | 0.0049 | 1 | 4 | NFAT protein binding |
| GO:0070290 | 0.0062 | 213.2778 | 0.0062 | 1 | 5 | N-acylphosphatidylethanolamine-specific phospholipase D activity |
| GO:0004630 | 0.0074 | 170.6111 | 0.0074 | 1 | 6 | phospholipase D activity |
| GO:0038036 | 0.0074 | 170.6111 | 0.0074 | 1 | 6 | sphingosine-1-phosphate receptor activity |
| GO:0016494 | 0.0086 | 142.1667 | 0.0086 | 1 | 7 | C-X-C chemokine receptor activity |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007268 | 0 | 10.307 | 2.3726 | 17 | 686 | synaptic transmission |
| GO:0071805 | 0 | 13.0446 | 0.5326 | 6 | 154 | potassium ion transmembrane transport |
| GO:0006813 | 0 | 10.4674 | 0.6571 | 6 | 190 | potassium ion transport |
| GO:0034765 | 1e-04 | 7.2018 | 1.1171 | 7 | 323 | regulation of ion transmembrane transport |
| GO:0098655 | 1e-04 | 5.3142 | 1.9887 | 9 | 575 | cation transmembrane transport |
| GO:0098660 | 2e-04 | 5.8747 | 1.5914 | 8 | 484 | inorganic ion transmembrane transport |
| GO:0001508 | 5e-04 | 11.905 | 0.3735 | 4 | 108 | action potential |
| GO:0048167 | 8e-04 | 10.5732 | 0.4185 | 4 | 121 | regulation of synaptic plasticity |
| GO:0051049 | 0.0016 | 2.9662 | 5.2606 | 13 | 1521 | regulation of transport |
| GO:0044700 | 0.0034 | 2.193 | 18.8634 | 29 | 5454 | single organism signaling |
| GO:0003220 | 0.0035 | Inf | 0.0035 | 1 | 1 | left ventricular cardiac muscle tissue morphogenesis |
| GO:0019694 | 0.0035 | Inf | 0.0035 | 1 | 1 | alkanesulfonate metabolic process |
| GO:0035332 | 0.0035 | Inf | 0.0035 | 1 | 1 | positive regulation of hippo signaling |
| GO:0048561 | 0.0035 | Inf | 0.0035 | 1 | 1 | establishment of organ orientation |
| GO:0051615 | 0.0035 | Inf | 0.0035 | 1 | 1 | histamine uptake |
| GO:0086094 | 0.0035 | Inf | 0.0035 | 1 | 1 | positive regulation of ryanodine-sensitive calcium-release channel activity by adrenergic receptor signaling pathway involved in positive regulation of cardiac muscle contraction |
| GO:1901896 | 0.0035 | Inf | 0.0035 | 1 | 1 | positive regulation of calcium-transporting ATPase activity |
| GO:2001111 | 0.0035 | Inf | 0.0035 | 1 | 1 | positive regulation of lens epithelial cell proliferation |
| GO:0007611 | 0.0043 | 6.5847 | 0.6606 | 4 | 191 | learning or memory |
| GO:0007154 | 0.0044 | 2.1363 | 19.1815 | 29 | 5546 | cell communication |
| GO:0002090 | 0.0045 | 22.1409 | 0.1003 | 2 | 29 | regulation of receptor internalization |
| GO:0071407 | 0.0049 | 4.9298 | 1.1102 | 5 | 321 | cellular response to organic cyclic compound |
| GO:0007610 | 0.0055 | 3.602 | 2.1651 | 7 | 626 | behavior |
| GO:0031635 | 0.0069 | 293.6538 | 0.0069 | 1 | 2 | adenylate cyclase-inhibiting opioid receptor signaling pathway |
| GO:0033590 | 0.0069 | 293.6538 | 0.0069 | 1 | 2 | response to cobalamin |
| GO:0043006 | 0.0069 | 293.6538 | 0.0069 | 1 | 2 | activation of phospholipase A2 activity by calcium-mediated signaling |
| GO:0048143 | 0.0069 | 293.6538 | 0.0069 | 1 | 2 | astrocyte activation |
| GO:0051284 | 0.0069 | 293.6538 | 0.0069 | 1 | 2 | positive regulation of sequestering of calcium ion |
| GO:0061386 | 0.0069 | 293.6538 | 0.0069 | 1 | 2 | closure of optic fissure |
| GO:0098904 | 0.0069 | 293.6538 | 0.0069 | 1 | 2 | regulation of AV node cell action potential |
| GO:0098907 | 0.0069 | 293.6538 | 0.0069 | 1 | 2 | regulation of SA node cell action potential |
| GO:1900452 | 0.0069 | 293.6538 | 0.0069 | 1 | 2 | regulation of long term synaptic depression |
| GO:0098661 | 0.0077 | 7.9774 | 0.4047 | 3 | 117 | inorganic anion transmembrane transport |
| GO:0051896 | 0.0079 | 7.9075 | 0.4081 | 3 | 118 | regulation of protein kinase B signaling |
| GO:0044765 | 0.0089 | 2.0867 | 11.9565 | 20 | 3457 | single-organism transport |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008347 | 0.002 | 34.2581 | 0.0662 | 2 | 29 | glial cell migration |
| GO:0015862 | 0.0023 | Inf | 0.0023 | 1 | 1 | uridine transport |
| GO:1901264 | 0.0039 | 23.6985 | 0.0936 | 2 | 41 | carbohydrate derivative transport |
| GO:0051966 | 0.0041 | 23.1045 | 0.0959 | 2 | 42 | regulation of synaptic transmission, glutamatergic |
| GO:0006682 | 0.0046 | 449.6471 | 0.0046 | 1 | 2 | galactosylceramide biosynthetic process |
| GO:0021568 | 0.0046 | 449.6471 | 0.0046 | 1 | 2 | rhombomere 2 development |
| GO:0021658 | 0.0046 | 449.6471 | 0.0046 | 1 | 2 | rhombomere 3 morphogenesis |
| GO:0035087 | 0.0046 | 449.6471 | 0.0046 | 1 | 2 | siRNA loading onto RISC involved in RNA interference |
| GO:0035483 | 0.0046 | 449.6471 | 0.0046 | 1 | 2 | gastric emptying |
| GO:0030423 | 0.0068 | 224.8088 | 0.0069 | 1 | 3 | targeting of mRNA for destruction involved in RNA interference |
| GO:0032513 | 0.0068 | 224.8088 | 0.0069 | 1 | 3 | negative regulation of protein phosphatase type 2B activity |
| GO:0035284 | 0.0068 | 224.8088 | 0.0069 | 1 | 3 | brain segmentation |
| GO:1903365 | 0.0068 | 224.8088 | 0.0069 | 1 | 3 | regulation of fear response |
| GO:2000172 | 0.0068 | 224.8088 | 0.0069 | 1 | 3 | regulation of branching morphogenesis of a nerve |
| GO:2000766 | 0.0068 | 224.8088 | 0.0069 | 1 | 3 | negative regulation of cytoplasmic translation |
| GO:2000987 | 0.0068 | 224.8088 | 0.0069 | 1 | 3 | positive regulation of behavioral fear response |
| GO:0031064 | 0.0091 | 149.8627 | 0.0091 | 1 | 4 | negative regulation of histone deacetylation |
| GO:0051461 | 0.0091 | 149.8627 | 0.0091 | 1 | 4 | positive regulation of corticotropin secretion |
| GO:0060455 | 0.0091 | 149.8627 | 0.0091 | 1 | 4 | negative regulation of gastric acid secretion |
| GO:0070885 | 0.0091 | 149.8627 | 0.0091 | 1 | 4 | negative regulation of calcineurin-NFAT signaling cascade |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050832 | 0 | 122.248 | 0.0329 | 3 | 28 | defense response to fungus |
| GO:0051707 | 0 | 13.6664 | 0.8081 | 7 | 688 | response to other organism |
| GO:0009607 | 0 | 13.0245 | 0.8457 | 7 | 720 | response to biotic stimulus |
| GO:0045087 | 0 | 10.7557 | 1.0125 | 7 | 862 | innate immune response |
| GO:0006954 | 0 | 12.9736 | 0.6742 | 6 | 574 | inflammatory response |
| GO:0016045 | 2e-04 | 127.425 | 0.02 | 2 | 17 | detection of bacterium |
| GO:0098581 | 3e-04 | 90.9821 | 0.027 | 2 | 23 | detection of external biotic stimulus |
| GO:0002376 | 4e-04 | 5.8884 | 2.6206 | 9 | 2231 | immune system process |
| GO:0031640 | 5e-04 | 70.7361 | 0.0341 | 2 | 29 | killing of cells of other organism |
| GO:0019731 | 6e-04 | 65.8491 | 0.0364 | 2 | 31 | antibacterial humoral response |
| GO:0010043 | 9e-04 | 53.0208 | 0.0446 | 2 | 38 | response to zinc ion |
| GO:0051716 | 0.0011 | 5.4018 | 7.0854 | 14 | 6032 | cellular response to stimulus |
| GO:0009605 | 0.0011 | 5.3563 | 2.3457 | 8 | 1997 | response to external stimulus |
| GO:0010963 | 0.0012 | Inf | 0.0012 | 1 | 1 | regulation of L-arginine import |
| GO:0044356 | 0.0012 | Inf | 0.0012 | 1 | 1 | clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine |
| GO:0035872 | 0.0014 | 41.4674 | 0.0564 | 2 | 48 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway |
| GO:0070301 | 0.0017 | 37.3897 | 0.0623 | 2 | 53 | cellular response to hydrogen peroxide |
| GO:0070988 | 0.0021 | 34.0402 | 0.0681 | 2 | 58 | demethylation |
| GO:0070488 | 0.0023 | 900.2941 | 0.0023 | 1 | 2 | neutrophil aggregation |
| GO:0071557 | 0.0023 | 900.2941 | 0.0023 | 1 | 2 | histone H3-K27 demethylation |
| GO:0050830 | 0.0025 | 30.7339 | 0.0752 | 2 | 64 | defense response to Gram-positive bacterium |
| GO:0001816 | 0.0033 | 7.7384 | 0.6449 | 4 | 549 | cytokine production |
| GO:0090467 | 0.0035 | 450.1176 | 0.0035 | 1 | 3 | arginine import |
| GO:1902023 | 0.0035 | 450.1176 | 0.0035 | 1 | 3 | L-arginine transport |
| GO:0031349 | 0.0043 | 10.5789 | 0.3371 | 3 | 287 | positive regulation of defense response |
| GO:0035821 | 0.0045 | 22.6518 | 0.101 | 2 | 86 | modification of morphology or physiology of other organism |
| GO:0032827 | 0.0047 | 300.0588 | 0.0047 | 1 | 4 | negative regulation of natural killer cell differentiation involved in immune response |
| GO:0070269 | 0.0047 | 300.0588 | 0.0047 | 1 | 4 | pyroptosis |
| GO:0006919 | 0.0047 | 22.1221 | 0.1034 | 2 | 88 | activation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0006950 | 0.0047 | 4.0482 | 3.7028 | 9 | 3336 | response to stress |
| GO:1901565 | 0.0054 | 9.739 | 0.3653 | 3 | 311 | organonitrogen compound catabolic process |
| GO:0042742 | 0.0058 | 20.0517 | 0.1161 | 2 | 118 | defense response to bacterium |
| GO:0010269 | 0.0059 | 225.0294 | 0.0059 | 1 | 5 | response to selenium ion |
| GO:0070383 | 0.0059 | 225.0294 | 0.0059 | 1 | 5 | DNA cytosine deamination |
| GO:0030307 | 0.0069 | 18.0964 | 0.1257 | 2 | 107 | positive regulation of cell growth |
| GO:0032815 | 0.007 | 180.0118 | 0.007 | 1 | 6 | negative regulation of natural killer cell activation |
| GO:0031638 | 0.008 | 16.6579 | 0.1363 | 2 | 116 | zymogen activation |
| GO:0009253 | 0.0082 | 150 | 0.0082 | 1 | 7 | peptidoglycan catabolic process |
| GO:0051092 | 0.0083 | 16.3685 | 0.1386 | 2 | 118 | positive regulation of NF-kappaB transcription factor activity |
| GO:2001056 | 0.0093 | 15.4299 | 0.1468 | 2 | 125 | positive regulation of cysteine-type endopeptidase activity |
| GO:0009635 | 0.0094 | 128.563 | 0.0094 | 1 | 8 | response to herbicide |
| GO:0032119 | 0.0094 | 128.563 | 0.0094 | 1 | 8 | sequestering of zinc ion |
| GO:0051597 | 0.0094 | 128.563 | 0.0094 | 1 | 8 | response to methylmercury |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050832 | 0 | 149.7941 | 0.0384 | 4 | 28 | defense response to fungus |
| GO:0051707 | 0 | 13.2335 | 0.9428 | 8 | 688 | response to other organism |
| GO:0009607 | 0 | 12.6111 | 0.9867 | 8 | 720 | response to biotic stimulus |
| GO:0006954 | 0 | 12.9947 | 0.7866 | 7 | 574 | inflammatory response |
| GO:0031640 | 0 | 97.9295 | 0.0397 | 3 | 29 | killing of cells of other organism |
| GO:0045087 | 1e-04 | 8.4491 | 1.1813 | 7 | 862 | innate immune response |
| GO:0035821 | 2e-04 | 30.5622 | 0.1179 | 3 | 86 | modification of morphology or physiology of other organism |
| GO:0016045 | 2e-04 | 107.2842 | 0.0233 | 2 | 17 | detection of bacterium |
| GO:0044110 | 3e-04 | 89.386 | 0.0274 | 2 | 20 | growth involved in symbiotic interaction |
| GO:0044117 | 3e-04 | 89.386 | 0.0274 | 2 | 20 | growth of symbiont in host |
| GO:0098581 | 4e-04 | 76.6015 | 0.0315 | 2 | 23 | detection of external biotic stimulus |
| GO:0006950 | 5e-04 | 4.7903 | 4.5826 | 12 | 3344 | response to stress |
| GO:0009605 | 7e-04 | 5.0233 | 2.7367 | 9 | 1997 | response to external stimulus |
| GO:0019731 | 8e-04 | 55.441 | 0.0425 | 2 | 31 | antibacterial humoral response |
| GO:0010043 | 0.0012 | 44.6404 | 0.0521 | 2 | 38 | response to zinc ion |
| GO:0010963 | 0.0014 | Inf | 0.0014 | 1 | 1 | regulation of L-arginine import |
| GO:0044356 | 0.0014 | Inf | 0.0014 | 1 | 1 | clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine |
| GO:0035872 | 0.0019 | 34.913 | 0.0658 | 2 | 48 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway |
| GO:0070301 | 0.0024 | 31.4799 | 0.0726 | 2 | 53 | cellular response to hydrogen peroxide |
| GO:0070488 | 0.0027 | 765.1 | 0.0027 | 1 | 2 | neutrophil aggregation |
| GO:0070946 | 0.0027 | 765.1 | 0.0027 | 1 | 2 | neutrophil mediated killing of gram-positive bacterium |
| GO:0071557 | 0.0027 | 765.1 | 0.0027 | 1 | 2 | histone H3-K27 demethylation |
| GO:0070988 | 0.0028 | 28.6598 | 0.0795 | 2 | 58 | demethylation |
| GO:0050830 | 0.0029 | 28.2259 | 0.0809 | 2 | 62 | defense response to Gram-positive bacterium |
| GO:0051716 | 0.0029 | 3.8582 | 8.2662 | 15 | 6032 | cellular response to stimulus |
| GO:0090467 | 0.0041 | 382.525 | 0.0041 | 1 | 3 | arginine import |
| GO:1902023 | 0.0041 | 382.525 | 0.0041 | 1 | 3 | L-arginine transport |
| GO:0032496 | 0.0049 | 9.9144 | 0.3508 | 3 | 256 | response to lipopolysaccharide |
| GO:0032827 | 0.0055 | 255 | 0.0055 | 1 | 4 | negative regulation of natural killer cell differentiation involved in immune response |
| GO:0070269 | 0.0055 | 255 | 0.0055 | 1 | 4 | pyroptosis |
| GO:0001816 | 0.006 | 6.3715 | 0.7523 | 4 | 549 | cytokine production |
| GO:0006919 | 0.0064 | 18.6255 | 0.1206 | 2 | 88 | activation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0031349 | 0.0067 | 8.814 | 0.3933 | 3 | 287 | positive regulation of defense response |
| GO:0010269 | 0.0068 | 191.2375 | 0.0069 | 1 | 5 | response to selenium ion |
| GO:0070383 | 0.0068 | 191.2375 | 0.0069 | 1 | 5 | DNA cytosine deamination |
| GO:0042742 | 0.0075 | 17.3759 | 0.1315 | 2 | 118 | defense response to bacterium |
| GO:0002252 | 0.0076 | 5.9409 | 0.8044 | 4 | 587 | immune effector process |
| GO:0002376 | 0.008 | 4.3563 | 1.8965 | 6 | 1644 | immune system process |
| GO:0032815 | 0.0082 | 152.98 | 0.0082 | 1 | 6 | negative regulation of natural killer cell activation |
| GO:0070943 | 0.0082 | 152.98 | 0.0082 | 1 | 6 | neutrophil mediated killing of symbiont cell |
| GO:1901565 | 0.0084 | 8.1142 | 0.4262 | 3 | 311 | organonitrogen compound catabolic process |
| GO:0030307 | 0.0093 | 15.2361 | 0.1466 | 2 | 107 | positive regulation of cell growth |
| GO:0009253 | 0.0096 | 127.475 | 0.0096 | 1 | 7 | peptidoglycan catabolic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0070301 | 0 | 61.024 | 0.0623 | 3 | 53 | cellular response to hydrogen peroxide |
| GO:0009635 | 0 | 318.75 | 0.0094 | 2 | 8 | response to herbicide |
| GO:0016045 | 2e-04 | 127.425 | 0.02 | 2 | 17 | detection of bacterium |
| GO:0070207 | 2e-04 | 127.425 | 0.02 | 2 | 17 | protein homotrimerization |
| GO:0098581 | 3e-04 | 90.9821 | 0.027 | 2 | 23 | detection of external biotic stimulus |
| GO:0051707 | 9e-04 | 8.2346 | 0.8081 | 5 | 688 | response to other organism |
| GO:0000302 | 0.001 | 18.0214 | 0.2009 | 3 | 171 | response to reactive oxygen species |
| GO:0034599 | 0.0011 | 17.4948 | 0.2067 | 3 | 176 | cellular response to oxidative stress |
| GO:0009607 | 0.0012 | 7.8488 | 0.8457 | 5 | 720 | response to biotic stimulus |
| GO:0010963 | 0.0012 | Inf | 0.0012 | 1 | 1 | regulation of L-arginine import |
| GO:0061015 | 0.0012 | Inf | 0.0012 | 1 | 1 | snRNA import into nucleus |
| GO:0042742 | 0.0014 | 15.9968 | 0.2255 | 3 | 192 | defense response to bacterium |
| GO:0035872 | 0.0014 | 41.4674 | 0.0564 | 2 | 48 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway |
| GO:0071557 | 0.0023 | 900.2941 | 0.0023 | 1 | 2 | histone H3-K27 demethylation |
| GO:0045087 | 0.0026 | 6.4846 | 1.0125 | 5 | 862 | innate immune response |
| GO:0015891 | 0.0035 | 450.1176 | 0.0035 | 1 | 3 | siderophore transport |
| GO:0070682 | 0.0035 | 450.1176 | 0.0035 | 1 | 3 | proteasome regulatory particle assembly |
| GO:0090467 | 0.0035 | 450.1176 | 0.0035 | 1 | 3 | arginine import |
| GO:1902023 | 0.0035 | 450.1176 | 0.0035 | 1 | 3 | L-arginine transport |
| GO:0006954 | 0.0039 | 7.3865 | 0.6742 | 4 | 574 | inflammatory response |
| GO:0032827 | 0.0047 | 300.0588 | 0.0047 | 1 | 4 | negative regulation of natural killer cell differentiation involved in immune response |
| GO:0070269 | 0.0047 | 300.0588 | 0.0047 | 1 | 4 | pyroptosis |
| GO:0010269 | 0.0059 | 225.0294 | 0.0059 | 1 | 5 | response to selenium ion |
| GO:0032815 | 0.007 | 180.0118 | 0.007 | 1 | 6 | negative regulation of natural killer cell activation |
| GO:0009253 | 0.0082 | 150 | 0.0082 | 1 | 7 | peptidoglycan catabolic process |
| GO:0071222 | 0.009 | 15.687 | 0.1445 | 2 | 123 | cellular response to lipopolysaccharide |
| GO:0051597 | 0.0094 | 128.563 | 0.0094 | 1 | 8 | response to methylmercury |
| GO:0043933 | 0.0094 | 3.795 | 2.5901 | 7 | 2205 | macromolecular complex subunit organization |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030049 | 0.0013 | 42.4056 | 0.0546 | 2 | 38 | muscle filament sliding |
| GO:0019677 | 0.0014 | Inf | 0.0014 | 1 | 1 | NAD catabolic process |
| GO:0071412 | 0.0014 | Inf | 0.0014 | 1 | 1 | cellular response to genistein |
| GO:1903039 | 0.0021 | 13.4924 | 0.2584 | 3 | 180 | positive regulation of leukocyte cell-cell adhesion |
| GO:0034112 | 0.0021 | 13.3399 | 0.2613 | 3 | 182 | positive regulation of homotypic cell-cell adhesion |
| GO:0001980 | 0.0029 | 728.619 | 0.0029 | 1 | 2 | regulation of systemic arterial blood pressure by ischemic conditions |
| GO:0006742 | 0.0029 | 728.619 | 0.0029 | 1 | 2 | NADP catabolic process |
| GO:0031444 | 0.0029 | 728.619 | 0.0029 | 1 | 2 | slow-twitch skeletal muscle fiber contraction |
| GO:0070252 | 0.0031 | 27.225 | 0.0833 | 2 | 58 | actin-mediated cell contraction |
| GO:0051251 | 0.004 | 10.6767 | 0.3245 | 3 | 226 | positive regulation of lymphocyte activation |
| GO:0031295 | 0.0042 | 23.0848 | 0.0976 | 2 | 68 | T cell costimulation |
| GO:0003010 | 0.0043 | 364.2857 | 0.0043 | 1 | 3 | voluntary skeletal muscle contraction |
| GO:0007181 | 0.0043 | 364.2857 | 0.0043 | 1 | 3 | transforming growth factor beta receptor complex assembly |
| GO:0015747 | 0.0043 | 364.2857 | 0.0043 | 1 | 3 | urate transport |
| GO:0050863 | 0.0052 | 9.6637 | 0.3575 | 3 | 249 | regulation of T cell activation |
| GO:0015760 | 0.0057 | 242.8413 | 0.0057 | 1 | 4 | glucose-6-phosphate transport |
| GO:0033594 | 0.0057 | 242.8413 | 0.0057 | 1 | 4 | response to hydroxyisoflavone |
| GO:0071896 | 0.0057 | 242.8413 | 0.0057 | 1 | 4 | protein localization to adherens junction |
| GO:0050867 | 0.0057 | 9.317 | 0.3704 | 3 | 258 | positive regulation of cell activation |
| GO:0042102 | 0.006 | 19.2696 | 0.1163 | 2 | 81 | positive regulation of T cell proliferation |
| GO:0050688 | 0.006 | 19.2696 | 0.1163 | 2 | 81 | regulation of defense response to virus |
| GO:0000730 | 0.0072 | 182.119 | 0.0072 | 1 | 5 | DNA recombinase assembly |
| GO:0002291 | 0.0072 | 182.119 | 0.0072 | 1 | 5 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
| GO:0072526 | 0.0072 | 182.119 | 0.0072 | 1 | 5 | pyridine-containing compound catabolic process |
| GO:0048304 | 0.0086 | 145.6857 | 0.0086 | 1 | 6 | positive regulation of isotype switching to IgG isotypes |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:2000502 | 0 | 1913.125 | 0.0035 | 2 | 3 | negative regulation of natural killer cell chemotaxis |
| GO:2000402 | 0 | 382.525 | 0.0082 | 2 | 7 | negative regulation of lymphocyte migration |
| GO:0002689 | 1e-04 | 239.0312 | 0.0117 | 2 | 10 | negative regulation of leukocyte chemotaxis |
| GO:0030101 | 1e-04 | 46.8954 | 0.0799 | 3 | 68 | natural killer cell activation |
| GO:0045954 | 2e-04 | 136.5357 | 0.0188 | 2 | 16 | positive regulation of natural killer cell mediated cytotoxicity |
| GO:0034260 | 2e-04 | 112.4191 | 0.0223 | 2 | 19 | negative regulation of GTPase activity |
| GO:1901623 | 2e-04 | 112.4191 | 0.0223 | 2 | 19 | regulation of lymphocyte chemotaxis |
| GO:0002685 | 4e-04 | 25.9641 | 0.141 | 3 | 120 | regulation of leukocyte migration |
| GO:0002715 | 4e-04 | 76.405 | 0.0317 | 2 | 27 | regulation of natural killer cell mediated immunity |
| GO:0050920 | 5e-04 | 22.8165 | 0.1597 | 3 | 136 | regulation of chemotaxis |
| GO:0031343 | 0.001 | 48.9327 | 0.0482 | 2 | 41 | positive regulation of cell killing |
| GO:0048521 | 0.0011 | 47.7062 | 0.0493 | 2 | 42 | negative regulation of behavior |
| GO:0035644 | 0.0012 | Inf | 0.0012 | 1 | 1 | phosphoanandamide dephosphorylation |
| GO:1901751 | 0.0012 | Inf | 0.0012 | 1 | 1 | leukotriene A4 metabolic process |
| GO:2001306 | 0.0012 | Inf | 0.0012 | 1 | 1 | lipoxin B4 biosynthetic process |
| GO:0001910 | 0.0014 | 41.4674 | 0.0564 | 2 | 48 | regulation of leukocyte mediated cytotoxicity |
| GO:0034109 | 0.0017 | 9.3468 | 0.538 | 4 | 458 | homotypic cell-cell adhesion |
| GO:0060326 | 0.0017 | 14.7327 | 0.2443 | 3 | 208 | cell chemotaxis |
| GO:0032102 | 0.0021 | 13.6516 | 0.2631 | 3 | 224 | negative regulation of response to external stimulus |
| GO:0033274 | 0.0023 | 900.2941 | 0.0023 | 1 | 2 | response to vitamin B2 |
| GO:0070829 | 0.0023 | 900.2941 | 0.0023 | 1 | 2 | heterochromatin maintenance |
| GO:2001303 | 0.0023 | 900.2941 | 0.0023 | 1 | 2 | lipoxin A4 biosynthetic process |
| GO:0002708 | 0.0028 | 29.3096 | 0.0787 | 2 | 67 | positive regulation of lymphocyte mediated immunity |
| GO:0031295 | 0.0028 | 28.8636 | 0.0799 | 2 | 68 | T cell costimulation |
| GO:0050863 | 0.0029 | 12.2439 | 0.2925 | 3 | 249 | regulation of T cell activation |
| GO:2000145 | 0.0039 | 7.3865 | 0.6742 | 4 | 574 | regulation of cell motility |
| GO:0032237 | 0.0059 | 225.0294 | 0.0059 | 1 | 5 | activation of store-operated calcium channel activity |
| GO:0051122 | 0.0059 | 225.0294 | 0.0059 | 1 | 5 | hepoxilin biosynthetic process |
| GO:0002683 | 0.0063 | 9.1902 | 0.3865 | 3 | 329 | negative regulation of immune system process |
| GO:0045785 | 0.0064 | 9.1329 | 0.3888 | 3 | 331 | positive regulation of cell adhesion |
| GO:0043045 | 0.007 | 180.0118 | 0.007 | 1 | 6 | DNA methylation involved in embryo development |
| GO:1901339 | 0.007 | 180.0118 | 0.007 | 1 | 6 | regulation of store-operated calcium channel activity |
| GO:0098602 | 0.0076 | 6.0799 | 0.8117 | 4 | 691 | single organism cell adhesion |
| GO:0006950 | 0.0078 | 3.5895 | 3.928 | 9 | 3344 | response to stress |
| GO:0022408 | 0.0082 | 16.512 | 0.1374 | 2 | 117 | negative regulation of cell-cell adhesion |
| GO:0032817 | 0.0082 | 150 | 0.0082 | 1 | 7 | regulation of natural killer cell proliferation |
| GO:0035999 | 0.0082 | 150 | 0.0082 | 1 | 7 | tetrahydrofolate interconversion |
| GO:0090331 | 0.0082 | 150 | 0.0082 | 1 | 7 | negative regulation of platelet aggregation |
| GO:2001300 | 0.0082 | 150 | 0.0082 | 1 | 7 | lipoxin metabolic process |
| GO:0051674 | 0.0085 | 4.8021 | 1.3391 | 5 | 1140 | localization of cell |
| GO:0002694 | 0.0092 | 7.985 | 0.4428 | 3 | 377 | regulation of leukocyte activation |
| GO:0051901 | 0.0094 | 128.563 | 0.0094 | 1 | 8 | positive regulation of mitochondrial depolarization |
| GO:0002684 | 0.0098 | 5.6239 | 0.8739 | 4 | 744 | positive regulation of immune system process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0002322 | 0 | 850.3889 | 0.0046 | 2 | 5 | B cell proliferation involved in immune response |
| GO:1901751 | 9e-04 | Inf | 9e-04 | 1 | 1 | leukotriene A4 metabolic process |
| GO:2001306 | 9e-04 | Inf | 9e-04 | 1 | 1 | lipoxin B4 biosynthetic process |
| GO:0044334 | 0.0018 | 1177.6154 | 0.0018 | 1 | 2 | canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition |
| GO:2001303 | 0.0018 | 1177.6154 | 0.0018 | 1 | 2 | lipoxin A4 biosynthetic process |
| GO:0048660 | 0.0023 | 32.9719 | 0.0722 | 2 | 79 | regulation of smooth muscle cell proliferation |
| GO:0019395 | 0.0024 | 32.1329 | 0.074 | 2 | 81 | fatty acid oxidation |
| GO:0046486 | 0.0026 | 13.2839 | 0.2841 | 3 | 311 | glycerolipid metabolic process |
| GO:0010909 | 0.0027 | 588.7692 | 0.0027 | 1 | 3 | positive regulation of heparan sulfate proteoglycan biosynthetic process |
| GO:0044264 | 0.0032 | 27.8736 | 0.085 | 2 | 93 | cellular polysaccharide metabolic process |
| GO:0030538 | 0.0036 | 392.4872 | 0.0037 | 1 | 4 | embryonic genitalia morphogenesis |
| GO:0032252 | 0.0036 | 392.4872 | 0.0037 | 1 | 4 | secretory granule localization |
| GO:0043570 | 0.0036 | 392.4872 | 0.0037 | 1 | 4 | maintenance of DNA repeat elements |
| GO:0048619 | 0.0036 | 392.4872 | 0.0037 | 1 | 4 | embryonic hindgut morphogenesis |
| GO:0006641 | 0.0041 | 24.3686 | 0.0968 | 2 | 106 | triglyceride metabolic process |
| GO:0006824 | 0.0046 | 294.3462 | 0.0046 | 1 | 5 | cobalt ion transport |
| GO:0015889 | 0.0046 | 294.3462 | 0.0046 | 1 | 5 | cobalamin transport |
| GO:0030311 | 0.0046 | 294.3462 | 0.0046 | 1 | 5 | poly-N-acetyllactosamine biosynthetic process |
| GO:0048625 | 0.0046 | 294.3462 | 0.0046 | 1 | 5 | myoblast fate commitment |
| GO:0051122 | 0.0046 | 294.3462 | 0.0046 | 1 | 5 | hepoxilin biosynthetic process |
| GO:0006638 | 0.0047 | 22.6161 | 0.1042 | 2 | 114 | neutral lipid metabolic process |
| GO:0002285 | 0.0054 | 21.0972 | 0.1115 | 2 | 122 | lymphocyte activation involved in immune response |
| GO:0035965 | 0.0055 | 235.4615 | 0.0055 | 1 | 6 | cardiolipin acyl-chain remodeling |
| GO:2000675 | 0.0055 | 235.4615 | 0.0055 | 1 | 6 | negative regulation of type B pancreatic cell apoptotic process |
| GO:0033002 | 0.0057 | 20.4113 | 0.1151 | 2 | 126 | muscle cell proliferation |
| GO:0009605 | 0.0057 | 5.0172 | 1.8245 | 6 | 1997 | response to external stimulus |
| GO:0031666 | 0.0064 | 196.2051 | 0.0064 | 1 | 7 | positive regulation of lipopolysaccharide-mediated signaling pathway |
| GO:0090331 | 0.0064 | 196.2051 | 0.0064 | 1 | 7 | negative regulation of platelet aggregation |
| GO:1901142 | 0.0064 | 196.2051 | 0.0064 | 1 | 7 | insulin metabolic process |
| GO:2001300 | 0.0064 | 196.2051 | 0.0064 | 1 | 7 | lipoxin metabolic process |
| GO:0051901 | 0.0073 | 168.1648 | 0.0073 | 1 | 8 | positive regulation of mitochondrial depolarization |
| GO:0061525 | 0.0082 | 147.1346 | 0.0082 | 1 | 9 | hindgut development |
| GO:0044242 | 0.0085 | 16.5109 | 0.1416 | 2 | 155 | cellular lipid catabolic process |
| GO:0030258 | 0.0089 | 16.1902 | 0.1443 | 2 | 158 | lipid modification |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0051460 | 0.0019 | Inf | 0.0019 | 1 | 1 | negative regulation of corticotropin secretion |
| GO:1900011 | 0.0019 | Inf | 0.0019 | 1 | 1 | negative regulation of corticotropin-releasing hormone receptor activity |
| GO:0030999 | 0.0038 | 546.2143 | 0.0038 | 1 | 2 | linear element assembly |
| GO:0070946 | 0.0038 | 546.2143 | 0.0038 | 1 | 2 | neutrophil mediated killing of gram-positive bacterium |
| GO:0071314 | 0.0038 | 546.2143 | 0.0038 | 1 | 2 | cellular response to cocaine |
| GO:0060359 | 0.0073 | 17.092 | 0.1287 | 2 | 68 | response to ammonium ion |
| GO:0002125 | 0.0075 | 182.0476 | 0.0076 | 1 | 4 | maternal aggressive behavior |
| GO:0050886 | 0.0079 | 16.3457 | 0.1344 | 2 | 71 | endocrine process |
| GO:0002322 | 0.0094 | 136.5268 | 0.0095 | 1 | 5 | B cell proliferation involved in immune response |
| GO:0006824 | 0.0094 | 136.5268 | 0.0095 | 1 | 5 | cobalt ion transport |
| GO:0007386 | 0.0094 | 136.5268 | 0.0095 | 1 | 5 | compartment pattern specification |
| GO:0014719 | 0.0094 | 136.5268 | 0.0095 | 1 | 5 | skeletal muscle satellite cell activation |
| GO:0015889 | 0.0094 | 136.5268 | 0.0095 | 1 | 5 | cobalamin transport |
| GO:0097211 | 0.0094 | 136.5268 | 0.0095 | 1 | 5 | cellular response to gonadotropin-releasing hormone |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0002418 | 1e-04 | 201.25 | 0.0137 | 2 | 10 | immune response to tumor cell |
| GO:0002717 | 3e-04 | 100.5724 | 0.0247 | 2 | 18 | positive regulation of natural killer cell mediated immunity |
| GO:0042269 | 6e-04 | 67.0132 | 0.0356 | 2 | 26 | regulation of natural killer cell mediated cytotoxicity |
| GO:0001912 | 0.0011 | 47.2724 | 0.0493 | 2 | 36 | positive regulation of leukocyte mediated cytotoxicity |
| GO:0002355 | 0.0014 | Inf | 0.0014 | 1 | 1 | detection of tumor cell |
| GO:0015782 | 0.0014 | Inf | 0.0014 | 1 | 1 | CMP-N-acetylneuraminate transport |
| GO:0045321 | 0.0014 | 7.2543 | 0.8729 | 5 | 637 | leukocyte activation |
| GO:0006952 | 0.0016 | 5.2154 | 1.8783 | 7 | 1439 | defense response |
| GO:0042110 | 0.0018 | 9.0449 | 0.5372 | 4 | 392 | T cell activation |
| GO:0071593 | 0.0018 | 8.9973 | 0.5399 | 4 | 394 | lymphocyte aggregation |
| GO:0009607 | 0.0025 | 6.3759 | 0.9867 | 5 | 720 | response to biotic stimulus |
| GO:0007159 | 0.0025 | 8.237 | 0.5879 | 4 | 429 | leukocyte cell-cell adhesion |
| GO:0031341 | 0.0025 | 30.288 | 0.0754 | 2 | 55 | regulation of cell killing |
| GO:0002357 | 0.0027 | 765.1 | 0.0027 | 1 | 2 | defense response to tumor cell |
| GO:0006478 | 0.0027 | 765.1 | 0.0027 | 1 | 2 | peptidyl-tyrosine sulfation |
| GO:0071393 | 0.0027 | 765.1 | 0.0027 | 1 | 2 | cellular response to progesterone stimulus |
| GO:0086098 | 0.0027 | 765.1 | 0.0027 | 1 | 2 | angiotensin-activated signaling pathway involved in heart process |
| GO:0034109 | 0.0031 | 7.6958 | 0.6276 | 4 | 458 | homotypic cell-cell adhesion |
| GO:0031295 | 0.0039 | 24.3014 | 0.0932 | 2 | 68 | T cell costimulation |
| GO:0010641 | 0.0041 | 382.525 | 0.0041 | 1 | 3 | positive regulation of platelet-derived growth factor receptor signaling pathway |
| GO:0045065 | 0.0041 | 382.525 | 0.0041 | 1 | 3 | cytotoxic T cell differentiation |
| GO:0060468 | 0.0041 | 382.525 | 0.0041 | 1 | 3 | prevention of polyspermy |
| GO:2000502 | 0.0041 | 382.525 | 0.0041 | 1 | 3 | negative regulation of natural killer cell chemotaxis |
| GO:0015748 | 0.0043 | 22.9068 | 0.0987 | 2 | 72 | organophosphate ester transport |
| GO:0050778 | 0.0047 | 6.8667 | 0.7003 | 4 | 511 | positive regulation of immune response |
| GO:0050715 | 0.0047 | 21.9611 | 0.1028 | 2 | 75 | positive regulation of cytokine secretion |
| GO:0002443 | 0.0048 | 9.9947 | 0.3481 | 3 | 254 | leukocyte mediated immunity |
| GO:0007165 | 0.0055 | 3.3674 | 6.8438 | 13 | 4994 | signal transduction |
| GO:0002051 | 0.0055 | 255 | 0.0055 | 1 | 4 | osteoblast fate commitment |
| GO:0033625 | 0.0055 | 255 | 0.0055 | 1 | 4 | positive regulation of integrin activation |
| GO:0051902 | 0.0055 | 255 | 0.0055 | 1 | 4 | negative regulation of mitochondrial depolarization |
| GO:1903532 | 0.0056 | 9.4217 | 0.3686 | 3 | 269 | positive regulation of secretion by cell |
| GO:0009615 | 0.0064 | 9.0078 | 0.3851 | 3 | 281 | response to virus |
| GO:0090383 | 0.0068 | 191.2375 | 0.0069 | 1 | 5 | phagosome acidification |
| GO:2001223 | 0.0068 | 191.2375 | 0.0069 | 1 | 5 | negative regulation of neuron migration |
| GO:2001286 | 0.0068 | 191.2375 | 0.0069 | 1 | 5 | regulation of caveolin-mediated endocytosis |
| GO:0002706 | 0.0079 | 16.6743 | 0.1343 | 2 | 98 | regulation of lymphocyte mediated immunity |
| GO:0002855 | 0.0082 | 152.98 | 0.0082 | 1 | 6 | regulation of natural killer cell mediated immune response to tumor cell |
| GO:0002860 | 0.0082 | 152.98 | 0.0082 | 1 | 6 | positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target |
| GO:0015780 | 0.0082 | 152.98 | 0.0082 | 1 | 6 | nucleotide-sugar transport |
| GO:0032463 | 0.0082 | 152.98 | 0.0082 | 1 | 6 | negative regulation of protein homooligomerization |
| GO:0050847 | 0.0082 | 152.98 | 0.0082 | 1 | 6 | progesterone receptor signaling pathway |
| GO:0071803 | 0.0082 | 152.98 | 0.0082 | 1 | 6 | positive regulation of podosome assembly |
| GO:0051606 | 0.0094 | 5.5629 | 0.8565 | 4 | 625 | detection of stimulus |
| GO:0033860 | 0.0096 | 127.475 | 0.0096 | 1 | 7 | regulation of NAD(P)H oxidase activity |
| GO:0050862 | 0.0096 | 127.475 | 0.0096 | 1 | 7 | positive regulation of T cell receptor signaling pathway |
| GO:2000402 | 0.0096 | 127.475 | 0.0096 | 1 | 7 | negative regulation of lymphocyte migration |
| GO:0045785 | 0.01 | 7.6092 | 0.4536 | 3 | 331 | positive regulation of cell adhesion |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050863 | 0 | 41.3333 | 0.2437 | 6 | 249 | regulation of T cell activation |
| GO:0022407 | 0 | 30.6401 | 0.325 | 6 | 332 | regulation of cell-cell adhesion |
| GO:0031295 | 0 | 86.6193 | 0.0666 | 4 | 68 | T cell costimulation |
| GO:0002694 | 0 | 26.8428 | 0.369 | 6 | 377 | regulation of leukocyte activation |
| GO:0070489 | 0 | 25.7737 | 0.3837 | 6 | 392 | T cell aggregation |
| GO:0070486 | 0 | 25.2369 | 0.3915 | 6 | 400 | leukocyte aggregation |
| GO:0050867 | 0 | 29.7549 | 0.2525 | 5 | 258 | positive regulation of cell activation |
| GO:1903039 | 0 | 31.2665 | 0.1762 | 4 | 180 | positive regulation of leukocyte cell-cell adhesion |
| GO:0034112 | 0 | 30.9111 | 0.1782 | 4 | 182 | positive regulation of homotypic cell-cell adhesion |
| GO:0098602 | 0 | 14.2326 | 0.6764 | 6 | 691 | single organism cell adhesion |
| GO:0051251 | 1e-04 | 24.7125 | 0.2212 | 4 | 226 | positive regulation of lymphocyte activation |
| GO:0045785 | 2e-04 | 16.6606 | 0.324 | 4 | 331 | positive regulation of cell adhesion |
| GO:0002684 | 5e-04 | 9.8579 | 0.7283 | 5 | 744 | positive regulation of immune system process |
| GO:0030887 | 0.001 | Inf | 0.001 | 1 | 1 | positive regulation of myeloid dendritic cell activation |
| GO:0022610 | 0.001 | 7.1182 | 1.2892 | 6 | 1317 | biological adhesion |
| GO:0070228 | 0.001 | 49.9574 | 0.048 | 2 | 49 | regulation of lymphocyte apoptotic process |
| GO:0046649 | 0.0013 | 17.9939 | 0.2266 | 3 | 311 | lymphocyte activation |
| GO:0043553 | 0.002 | 1093.4286 | 0.002 | 1 | 2 | negative regulation of phosphatidylinositol 3-kinase activity |
| GO:0071887 | 0.0036 | 26.0154 | 0.0901 | 2 | 92 | leukocyte apoptotic process |
| GO:0001766 | 0.0039 | 364.4286 | 0.0039 | 1 | 4 | membrane raft polarization |
| GO:0060564 | 0.0039 | 364.4286 | 0.0039 | 1 | 4 | negative regulation of APC-Cdc20 complex activity |
| GO:1902715 | 0.0039 | 364.4286 | 0.0039 | 1 | 4 | positive regulation of interferon-gamma secretion |
| GO:0050852 | 0.0045 | 22.9367 | 0.1018 | 2 | 104 | T cell receptor signaling pathway |
| GO:0000730 | 0.0049 | 273.3036 | 0.0049 | 1 | 5 | DNA recombinase assembly |
| GO:0006689 | 0.0049 | 273.3036 | 0.0049 | 1 | 5 | ganglioside catabolic process |
| GO:0051665 | 0.0049 | 273.3036 | 0.0049 | 1 | 5 | membrane raft localization |
| GO:0002521 | 0.0071 | 9.0169 | 0.4072 | 3 | 416 | leukocyte differentiation |
| GO:0009313 | 0.0078 | 156.1429 | 0.0078 | 1 | 8 | oligosaccharide catabolic process |
| GO:0051716 | 0.0081 | 4.2422 | 5.9045 | 11 | 6032 | cellular response to stimulus |
| GO:0045059 | 0.0097 | 121.4286 | 0.0098 | 1 | 10 | positive thymic T cell selection |
| GO:2000484 | 0.0097 | 121.4286 | 0.0098 | 1 | 10 | positive regulation of interleukin-8 secretion |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:1903037 | 0 | 44.3371 | 0.3162 | 8 | 255 | regulation of leukocyte cell-cell adhesion |
| GO:0034110 | 0 | 42.7528 | 0.3273 | 8 | 264 | regulation of homotypic cell-cell adhesion |
| GO:0050852 | 0 | 71.6185 | 0.1289 | 6 | 104 | T cell receptor signaling pathway |
| GO:0051249 | 0 | 33.9485 | 0.4079 | 8 | 329 | regulation of lymphocyte activation |
| GO:0002429 | 0 | 45.4369 | 0.2492 | 7 | 201 | immune response-activating cell surface receptor signaling pathway |
| GO:0022409 | 0 | 42.9675 | 0.2629 | 7 | 212 | positive regulation of cell-cell adhesion |
| GO:0070489 | 0 | 28.2595 | 0.486 | 8 | 392 | T cell aggregation |
| GO:0002696 | 0 | 36.6163 | 0.3063 | 7 | 247 | positive regulation of leukocyte activation |
| GO:0070486 | 0 | 27.6679 | 0.496 | 8 | 400 | leukocyte aggregation |
| GO:0050865 | 0 | 27.1 | 0.5059 | 8 | 408 | regulation of cell activation |
| GO:0031295 | 0 | 86.4059 | 0.0843 | 5 | 68 | T cell costimulation |
| GO:0030155 | 0 | 19.8474 | 0.6807 | 8 | 549 | regulation of cell adhesion |
| GO:0002253 | 0 | 22.9112 | 0.4798 | 7 | 387 | activation of immune response |
| GO:0002682 | 0 | 13.9647 | 1.411 | 10 | 1138 | regulation of immune system process |
| GO:0002764 | 0 | 19.7536 | 0.553 | 7 | 446 | immune response-regulating signaling pathway |
| GO:0098602 | 0 | 15.5698 | 0.8568 | 8 | 691 | single organism cell adhesion |
| GO:0045059 | 1e-04 | 224.9559 | 0.0124 | 2 | 10 | positive thymic T cell selection |
| GO:0048584 | 1e-04 | 7.3433 | 2.083 | 9 | 1680 | positive regulation of response to stimulus |
| GO:0022610 | 1e-04 | 7.7761 | 1.6329 | 8 | 1317 | biological adhesion |
| GO:1903564 | 0.0012 | Inf | 0.0012 | 1 | 1 | regulation of protein localization to cilium |
| GO:1903568 | 0.0012 | Inf | 0.0012 | 1 | 1 | negative regulation of protein localization to ciliary membrane |
| GO:0038093 | 0.0022 | 13.3488 | 0.2666 | 3 | 215 | Fc receptor signaling pathway |
| GO:0007166 | 0.0022 | 4.2114 | 3.9738 | 10 | 3205 | cell surface receptor signaling pathway |
| GO:0043366 | 0.0025 | 850.2222 | 0.0025 | 1 | 2 | beta selection |
| GO:0045087 | 0.0033 | 6.021 | 1.0688 | 5 | 862 | innate immune response |
| GO:0038096 | 0.0033 | 26.3616 | 0.0868 | 2 | 70 | Fc-gamma receptor signaling pathway involved in phagocytosis |
| GO:0048522 | 0.0034 | 3.8861 | 4.9732 | 11 | 4011 | positive regulation of cellular process |
| GO:0033077 | 0.0035 | 25.605 | 0.0893 | 2 | 72 | T cell differentiation in thymus |
| GO:0044700 | 0.0036 | 3.928 | 6.7623 | 13 | 5454 | single organism signaling |
| GO:0007154 | 0.0043 | 3.8266 | 6.8764 | 13 | 5546 | cell communication |
| GO:0050870 | 0.0044 | 23.3549 | 0.1009 | 2 | 110 | positive regulation of T cell activation |
| GO:0071896 | 0.005 | 283.3704 | 0.005 | 1 | 4 | protein localization to adherens junction |
| GO:0001574 | 0.0086 | 141.6574 | 0.0087 | 1 | 7 | ganglioside biosynthetic process |
| GO:0008037 | 0.0088 | 15.8168 | 0.1426 | 2 | 115 | cell recognition |
| GO:0051716 | 0.0099 | 3.3427 | 7.479 | 13 | 6032 | cellular response to stimulus |
| GO:0051901 | 0.0099 | 121.4127 | 0.0099 | 1 | 8 | positive regulation of mitochondrial depolarization |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0009954 | 0 | 44.7366 | 0.1098 | 4 | 33 | proximal/distal pattern formation |
| GO:0072272 | 0 | Inf | 0.0067 | 2 | 2 | proximal/distal pattern formation involved in metanephric nephron development |
| GO:0021555 | 1e-04 | 311.6531 | 0.0133 | 2 | 4 | midbrain-hindbrain boundary morphogenesis |
| GO:0072086 | 1e-04 | 311.6531 | 0.0133 | 2 | 4 | specification of loop of Henle identity |
| GO:0021510 | 2e-04 | 14.6857 | 0.3062 | 4 | 92 | spinal cord development |
| GO:0048704 | 3e-04 | 14.3574 | 0.3128 | 4 | 94 | embryonic skeletal system morphogenesis |
| GO:0007389 | 3e-04 | 6.1737 | 1.3063 | 7 | 408 | pattern specification process |
| GO:0048568 | 4e-04 | 5.8852 | 1.3612 | 7 | 409 | embryonic organ development |
| GO:0061004 | 4e-04 | 89.0146 | 0.03 | 2 | 9 | pattern specification involved in kidney development |
| GO:0007338 | 5e-04 | 12.2942 | 0.3628 | 4 | 109 | single fertilization |
| GO:0061303 | 5e-04 | 77.8827 | 0.0333 | 2 | 10 | cornea development in camera-type eye |
| GO:0019219 | 6e-04 | 2.6615 | 12.0644 | 23 | 3625 | regulation of nucleobase-containing compound metabolic process |
| GO:0072175 | 7e-04 | 11.0245 | 0.4027 | 4 | 121 | epithelial tube formation |
| GO:0021903 | 7e-04 | 62.298 | 0.0399 | 2 | 12 | rostrocaudal neural tube patterning |
| GO:0006355 | 7e-04 | 2.6833 | 10.5867 | 21 | 3181 | regulation of transcription, DNA-templated |
| GO:0048935 | 8e-04 | 56.6308 | 0.0433 | 2 | 13 | peripheral nervous system neuron development |
| GO:2001141 | 9e-04 | 2.6399 | 10.7232 | 21 | 3222 | regulation of RNA biosynthetic process |
| GO:0007423 | 0.0011 | 4.8925 | 1.6241 | 7 | 488 | sensory organ development |
| GO:0007156 | 0.0011 | 9.688 | 0.456 | 4 | 137 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0097659 | 0.0012 | 2.5645 | 10.9695 | 21 | 3296 | nucleic acid-templated transcription |
| GO:0048592 | 0.0013 | 9.334 | 0.4726 | 4 | 142 | eye morphogenesis |
| GO:0007379 | 0.0013 | 44.4869 | 0.0532 | 2 | 16 | segment specification |
| GO:0016331 | 0.0014 | 9.0046 | 0.4892 | 4 | 147 | morphogenesis of embryonic epithelium |
| GO:0035107 | 0.0015 | 8.8792 | 0.4959 | 4 | 149 | appendage morphogenesis |
| GO:0007268 | 0.0018 | 4.0049 | 2.2831 | 8 | 686 | synaptic transmission |
| GO:0072079 | 0.0018 | 36.6291 | 0.0632 | 2 | 19 | nephron tubule formation |
| GO:0021953 | 0.0021 | 8.0899 | 0.5425 | 4 | 163 | central nervous system neuron differentiation |
| GO:1902476 | 0.0021 | 12.837 | 0.2563 | 3 | 77 | chloride transmembrane transport |
| GO:0060173 | 0.0023 | 7.8407 | 0.5591 | 4 | 168 | limb development |
| GO:0002089 | 0.0024 | 31.1286 | 0.0732 | 2 | 22 | lens morphogenesis in camera-type eye |
| GO:0034654 | 0.0027 | 2.3402 | 12.517 | 22 | 3761 | nucleobase-containing compound biosynthetic process |
| GO:0009889 | 0.0031 | 2.3131 | 12.6269 | 22 | 3794 | regulation of biosynthetic process |
| GO:0021884 | 0.0031 | 27.063 | 0.0832 | 2 | 25 | forebrain neuron development |
| GO:0021993 | 0.0033 | Inf | 0.0033 | 1 | 1 | initiation of neural tube closure |
| GO:0035332 | 0.0033 | Inf | 0.0033 | 1 | 1 | positive regulation of hippo signaling |
| GO:2001111 | 0.0033 | Inf | 0.0033 | 1 | 1 | positive regulation of lens epithelial cell proliferation |
| GO:0019953 | 0.0035 | 3.9612 | 1.9945 | 7 | 622 | sexual reproduction |
| GO:0048596 | 0.0036 | 24.8947 | 0.0899 | 2 | 27 | embryonic camera-type eye morphogenesis |
| GO:0098609 | 0.0036 | 6.9032 | 0.6323 | 4 | 190 | cell-cell adhesion |
| GO:0015698 | 0.0044 | 6.513 | 0.669 | 4 | 201 | inorganic anion transport |
| GO:0019228 | 0.0045 | 22.223 | 0.0998 | 2 | 30 | neuronal action potential |
| GO:0048665 | 0.0047 | 21.4553 | 0.1032 | 2 | 31 | neuron fate specification |
| GO:0007628 | 0.006 | 18.8497 | 0.1165 | 2 | 35 | adult walking behavior |
| GO:0035239 | 0.0063 | 4.6481 | 1.1782 | 5 | 354 | tube morphogenesis |
| GO:0021568 | 0.0066 | 305.44 | 0.0067 | 1 | 2 | rhombomere 2 development |
| GO:0021592 | 0.0066 | 305.44 | 0.0067 | 1 | 2 | fourth ventricle development |
| GO:0061386 | 0.0066 | 305.44 | 0.0067 | 1 | 2 | closure of optic fissure |
| GO:0070593 | 0.0066 | 305.44 | 0.0067 | 1 | 2 | dendrite self-avoidance |
| GO:0016070 | 0.0067 | 2.1329 | 13.409 | 22 | 4029 | RNA metabolic process |
| GO:0009887 | 0.0067 | 3.4935 | 2.2568 | 7 | 729 | organ morphogenesis |
| GO:0044708 | 0.0068 | 4.5545 | 1.2014 | 5 | 361 | single-organism behavior |
| GO:0035137 | 0.0071 | 17.2755 | 0.1265 | 2 | 38 | hindlimb morphogenesis |
| GO:0034645 | 0.0075 | 2.0914 | 14.4107 | 23 | 4330 | cellular macromolecule biosynthetic process |
| GO:0035136 | 0.0078 | 16.3641 | 0.1331 | 2 | 40 | forelimb morphogenesis |
| GO:0048598 | 0.008 | 4.3998 | 1.252 | 5 | 413 | embryonic morphogenesis |
| GO:0046483 | 0.0089 | 2.027 | 17.3228 | 26 | 5205 | heterocycle metabolic process |
| GO:0007618 | 0.009 | 15.1638 | 0.1431 | 2 | 43 | mating |
| GO:0048483 | 0.009 | 15.1638 | 0.1431 | 2 | 43 | autonomic nervous system development |
| GO:0030326 | 0.009 | 7.5134 | 0.4293 | 3 | 129 | embryonic limb morphogenesis |
| GO:0022414 | 0.0092 | 2.8105 | 3.631 | 9 | 1091 | reproductive process |
| GO:0006725 | 0.0093 | 2.0175 | 17.3761 | 26 | 5221 | cellular aromatic compound metabolic process |
| GO:0043392 | 0.0094 | 14.8017 | 0.1464 | 2 | 44 | negative regulation of DNA binding |
| GO:0034641 | 0.0099 | 2.0024 | 18.3745 | 27 | 5521 | cellular nitrogen compound metabolic process |
| GO:0008344 | 0.0099 | 14.3688 | 0.1506 | 2 | 47 | adult locomotory behavior |
| GO:0002351 | 0.01 | 152.71 | 0.01 | 1 | 3 | serotonin production involved in inflammatory response |
| GO:0002554 | 0.01 | 152.71 | 0.01 | 1 | 3 | serotonin secretion by platelet |
| GO:0021678 | 0.01 | 152.71 | 0.01 | 1 | 3 | third ventricle development |
| GO:0060012 | 0.01 | 152.71 | 0.01 | 1 | 3 | synaptic transmission, glycinergic |
| GO:0060060 | 0.01 | 152.71 | 0.01 | 1 | 3 | post-embryonic retina morphogenesis in camera-type eye |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042636 | 0.0031 | 463.9091 | 0.0031 | 1 | 4 | negative regulation of hair cycle |
| GO:0051919 | 0.0031 | 463.9091 | 0.0031 | 1 | 4 | positive regulation of fibrinolysis |
| GO:0061589 | 0.0031 | 463.9091 | 0.0031 | 1 | 4 | calcium activated phosphatidylserine scrambling |
| GO:2000048 | 0.0031 | 463.9091 | 0.0031 | 1 | 4 | negative regulation of cell-cell adhesion mediated by cadherin |
| GO:0061590 | 0.0039 | 347.9091 | 0.0039 | 1 | 5 | calcium activated phosphatidylcholine scrambling |
| GO:0061591 | 0.0039 | 347.9091 | 0.0039 | 1 | 5 | calcium activated galactosylceramide scrambling |
| GO:0086073 | 0.0047 | 278.3091 | 0.0047 | 1 | 6 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication |
| GO:0098911 | 0.0062 | 198.7662 | 0.0063 | 1 | 8 | regulation of ventricular cardiac muscle cell action potential |
| GO:0003008 | 0.0074 | 5.6151 | 1.3571 | 5 | 1733 | system process |
| GO:0051918 | 0.0078 | 154.5758 | 0.0078 | 1 | 10 | negative regulation of fibrinolysis |
| GO:0017121 | 0.0086 | 139.1091 | 0.0086 | 1 | 11 | phospholipid scrambling |
| GO:0007162 | 0.009 | 16.3535 | 0.1464 | 2 | 187 | negative regulation of cell adhesion |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050911 | 6e-04 | 25.2862 | 0.1869 | 3 | 358 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0009593 | 0.0012 | 20.6231 | 0.2276 | 3 | 436 | detection of chemical stimulus |
| GO:0050906 | 0.0012 | 20.2381 | 0.2318 | 3 | 444 | detection of stimulus involved in sensory perception |
| GO:0007606 | 0.0014 | 19.1626 | 0.2443 | 3 | 468 | sensory perception of chemical stimulus |
| GO:0070995 | 0.0021 | 729.1905 | 0.0021 | 1 | 4 | NADPH oxidation |
| GO:0072592 | 0.0021 | 729.1905 | 0.0021 | 1 | 4 | oxygen metabolic process |
| GO:0009404 | 0.0062 | 198.7662 | 0.0063 | 1 | 12 | toxin metabolic process |
| GO:0033141 | 0.0083 | 145.7238 | 0.0084 | 1 | 16 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006955 | 0 | 16.477 | 0.7484 | 8 | 492 | immune response |
| GO:0019835 | 0 | 70.4769 | 0.053 | 3 | 29 | cytolysis |
| GO:0002429 | 0 | 16.748 | 0.3673 | 5 | 201 | immune response-activating cell surface receptor signaling pathway |
| GO:0007166 | 1e-04 | 4.3788 | 5.8562 | 15 | 3205 | cell surface receptor signaling pathway |
| GO:0048584 | 5e-04 | 4.5329 | 3.0697 | 10 | 1680 | positive regulation of response to stimulus |
| GO:0002253 | 6e-04 | 8.4874 | 0.7071 | 5 | 387 | activation of immune response |
| GO:0050852 | 9e-04 | 18.0535 | 0.19 | 3 | 104 | T cell receptor signaling pathway |
| GO:0002764 | 0.0012 | 7.3228 | 0.8149 | 5 | 446 | immune response-regulating signaling pathway |
| GO:1903564 | 0.0018 | Inf | 0.0018 | 1 | 1 | regulation of protein localization to cilium |
| GO:1903568 | 0.0018 | Inf | 0.0018 | 1 | 1 | negative regulation of protein localization to ciliary membrane |
| GO:0051716 | 0.0021 | 3.2592 | 11.0217 | 19 | 6032 | cellular response to stimulus |
| GO:0043068 | 0.0026 | 6.0448 | 0.9794 | 5 | 536 | positive regulation of programmed cell death |
| GO:2001235 | 0.0035 | 11.0044 | 0.307 | 3 | 168 | positive regulation of apoptotic signaling pathway |
| GO:0002682 | 0.0036 | 4.1748 | 2.0794 | 7 | 1138 | regulation of immune system process |
| GO:0002357 | 0.0037 | 566.4815 | 0.0037 | 1 | 2 | defense response to tumor cell |
| GO:0043366 | 0.0037 | 566.4815 | 0.0037 | 1 | 2 | beta selection |
| GO:0070165 | 0.0037 | 566.4815 | 0.0037 | 1 | 2 | positive regulation of adiponectin secretion |
| GO:0045087 | 0.004 | 4.6007 | 1.575 | 6 | 862 | innate immune response |
| GO:0006968 | 0.0043 | 22.5503 | 0.0987 | 2 | 54 | cellular defense response |
| GO:0009988 | 0.0053 | 20.2095 | 0.1096 | 2 | 60 | cell-cell recognition |
| GO:0048388 | 0.0055 | 283.2222 | 0.0055 | 1 | 3 | endosomal lumen acidification |
| GO:0071638 | 0.0055 | 283.2222 | 0.0055 | 1 | 3 | negative regulation of monocyte chemotactic protein-1 production |
| GO:0051607 | 0.0063 | 8.8338 | 0.3801 | 3 | 208 | defense response to virus |
| GO:0038096 | 0.0072 | 17.2262 | 0.1279 | 2 | 70 | Fc-gamma receptor signaling pathway involved in phagocytosis |
| GO:0071896 | 0.0073 | 188.8025 | 0.0073 | 1 | 4 | protein localization to adherens junction |
| GO:0044700 | 0.0075 | 3.1967 | 6.1897 | 12 | 4125 | single organism signaling |
| GO:0008625 | 0.0082 | 16.0411 | 0.137 | 2 | 75 | extrinsic apoptotic signaling pathway via death domain receptors |
| GO:0023056 | 0.0085 | 3.5205 | 2.4302 | 7 | 1330 | positive regulation of signaling |
| GO:0010647 | 0.0088 | 3.4945 | 2.4466 | 7 | 1339 | positive regulation of cell communication |
| GO:0007154 | 0.0089 | 3.1042 | 6.3183 | 12 | 4208 | cell communication |
| GO:0008626 | 0.0091 | 141.5926 | 0.0091 | 1 | 5 | granzyme-mediated apoptotic signaling pathway |
| GO:0030644 | 0.0091 | 141.5926 | 0.0091 | 1 | 5 | cellular chloride ion homeostasis |
| GO:1900165 | 0.0091 | 141.5926 | 0.0091 | 1 | 5 | negative regulation of interleukin-6 secretion |
| GO:0009966 | 0.0095 | 2.8862 | 4.5296 | 10 | 2479 | regulation of signal transduction |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001764 | 0 | 16.3324 | 0.431 | 6 | 127 | neuron migration |
| GO:0021953 | 0 | 12.5575 | 0.5531 | 6 | 163 | central nervous system neuron differentiation |
| GO:0021884 | 1e-04 | 42.4397 | 0.0848 | 3 | 25 | forebrain neuron development |
| GO:0021510 | 3e-04 | 14.3788 | 0.3122 | 4 | 92 | spinal cord development |
| GO:0019219 | 3e-04 | 2.778 | 12.301 | 24 | 3625 | regulation of nucleobase-containing compound metabolic process |
| GO:0050767 | 3e-04 | 5.2842 | 1.751 | 8 | 516 | regulation of neurogenesis |
| GO:0006355 | 3e-04 | 2.8119 | 10.7943 | 22 | 3181 | regulation of transcription, DNA-templated |
| GO:2001141 | 4e-04 | 2.7665 | 10.9334 | 22 | 3222 | regulation of RNA biosynthetic process |
| GO:0046113 | 5e-04 | 76.32 | 0.0339 | 2 | 10 | nucleobase catabolic process |
| GO:0034654 | 6e-04 | 2.6457 | 12.7625 | 24 | 3761 | nucleobase-containing compound biosynthetic process |
| GO:0061564 | 6e-04 | 4.8213 | 1.9105 | 8 | 563 | axon development |
| GO:0097659 | 6e-04 | 2.6874 | 11.1845 | 22 | 3296 | nucleic acid-templated transcription |
| GO:0003207 | 6e-04 | 67.8356 | 0.0373 | 2 | 11 | cardiac chamber formation |
| GO:0009889 | 6e-04 | 2.6151 | 12.8744 | 24 | 3794 | regulation of biosynthetic process |
| GO:0051961 | 6e-04 | 8.017 | 0.6956 | 5 | 205 | negative regulation of nervous system development |
| GO:0007420 | 9e-04 | 4.5165 | 2.0326 | 8 | 599 | brain development |
| GO:0048667 | 9e-04 | 4.4771 | 2.0496 | 8 | 604 | cell morphogenesis involved in neuron differentiation |
| GO:0048812 | 0.001 | 4.3777 | 2.0937 | 8 | 617 | neuron projection morphogenesis |
| GO:0021872 | 0.001 | 16.6356 | 0.2002 | 3 | 59 | forebrain generation of neurons |
| GO:0090596 | 0.0015 | 6.5795 | 0.8416 | 5 | 248 | sensory organ morphogenesis |
| GO:0071805 | 0.0018 | 8.4011 | 0.5226 | 4 | 154 | potassium ion transmembrane transport |
| GO:0007411 | 0.002 | 5.0302 | 1.3302 | 6 | 392 | axon guidance |
| GO:0002089 | 0.0025 | 30.504 | 0.0747 | 2 | 22 | lens morphogenesis in camera-type eye |
| GO:0048562 | 0.0026 | 5.7801 | 0.9535 | 5 | 281 | embryonic organ morphogenesis |
| GO:0035295 | 0.0032 | 4.0049 | 1.9614 | 7 | 578 | tube development |
| GO:0035332 | 0.0034 | Inf | 0.0034 | 1 | 1 | positive regulation of hippo signaling |
| GO:0036306 | 0.0034 | Inf | 0.0034 | 1 | 1 | embryonic heart tube elongation |
| GO:0042404 | 0.0034 | Inf | 0.0034 | 1 | 1 | thyroid hormone catabolic process |
| GO:2001111 | 0.0034 | Inf | 0.0034 | 1 | 1 | positive regulation of lens epithelial cell proliferation |
| GO:0006813 | 0.0039 | 6.759 | 0.6447 | 4 | 190 | potassium ion transport |
| GO:0060562 | 0.0042 | 5.1177 | 1.0723 | 5 | 316 | epithelial tube morphogenesis |
| GO:0034645 | 0.0045 | 2.1829 | 14.6933 | 24 | 4330 | cellular macromolecule biosynthetic process |
| GO:0032502 | 0.0045 | 2.1541 | 17.3978 | 27 | 5127 | developmental process |
| GO:0045595 | 0.0045 | 2.8241 | 4.5335 | 11 | 1336 | regulation of cell differentiation |
| GO:0042472 | 0.0046 | 9.6786 | 0.3359 | 3 | 99 | inner ear morphogenesis |
| GO:0048665 | 0.0049 | 21.0248 | 0.1052 | 2 | 31 | neuron fate specification |
| GO:0048869 | 0.005 | 2.2549 | 11.4375 | 20 | 3496 | cellular developmental process |
| GO:2000026 | 0.0052 | 2.7668 | 4.6184 | 11 | 1361 | regulation of multicellular organismal development |
| GO:0014003 | 0.0052 | 20.3227 | 0.1086 | 2 | 32 | oligodendrocyte development |
| GO:0032990 | 0.0055 | 3.2891 | 2.7418 | 8 | 808 | cell part morphogenesis |
| GO:0009953 | 0.0056 | 9.0166 | 0.3597 | 3 | 106 | dorsal/ventral pattern formation |
| GO:0014014 | 0.0056 | 19.6658 | 0.112 | 2 | 33 | negative regulation of gliogenesis |
| GO:0006206 | 0.0059 | 19.05 | 0.1154 | 2 | 34 | pyrimidine nucleobase metabolic process |
| GO:0006725 | 0.006 | 2.0955 | 17.7168 | 27 | 5221 | cellular aromatic compound metabolic process |
| GO:0072529 | 0.0063 | 18.4715 | 0.1188 | 2 | 35 | pyrimidine-containing compound catabolic process |
| GO:0034641 | 0.0064 | 2.077 | 18.7348 | 28 | 5521 | cellular nitrogen compound metabolic process |
| GO:0003193 | 0.0068 | 299.4314 | 0.0068 | 1 | 2 | pulmonary valve formation |
| GO:0006212 | 0.0068 | 299.4314 | 0.0068 | 1 | 2 | uracil catabolic process |
| GO:0006682 | 0.0068 | 299.4314 | 0.0068 | 1 | 2 | galactosylceramide biosynthetic process |
| GO:0021568 | 0.0068 | 299.4314 | 0.0068 | 1 | 2 | rhombomere 2 development |
| GO:0030047 | 0.0068 | 299.4314 | 0.0068 | 1 | 2 | actin modification |
| GO:0035922 | 0.0068 | 299.4314 | 0.0068 | 1 | 2 | foramen ovale closure |
| GO:0042706 | 0.0068 | 299.4314 | 0.0068 | 1 | 2 | eye photoreceptor cell fate commitment |
| GO:0050925 | 0.0068 | 299.4314 | 0.0068 | 1 | 2 | negative regulation of negative chemotaxis |
| GO:0060577 | 0.0068 | 299.4314 | 0.0068 | 1 | 2 | pulmonary vein morphogenesis |
| GO:0061386 | 0.0068 | 299.4314 | 0.0068 | 1 | 2 | closure of optic fissure |
| GO:0072272 | 0.0068 | 299.4314 | 0.0068 | 1 | 2 | proximal/distal pattern formation involved in metanephric nephron development |
| GO:0060429 | 0.0071 | 2.9306 | 3.485 | 9 | 1027 | epithelium development |
| GO:0006928 | 0.0074 | 2.5264 | 5.5414 | 12 | 1633 | movement of cell or subcellular component |
| GO:0001569 | 0.0077 | 16.4703 | 0.1323 | 2 | 39 | patterning of blood vessels |
| GO:0001838 | 0.0078 | 7.9304 | 0.4072 | 3 | 120 | embryonic epithelial tube formation |
| GO:0010721 | 0.0081 | 5.45 | 0.794 | 4 | 234 | negative regulation of cell development |
| GO:0061351 | 0.0082 | 7.7961 | 0.414 | 3 | 122 | neural precursor cell proliferation |
| GO:0001709 | 0.0085 | 15.6236 | 0.1391 | 2 | 41 | cell fate determination |
| GO:0016070 | 0.0087 | 2.0616 | 13.6719 | 22 | 4029 | RNA metabolic process |
| GO:0048483 | 0.0093 | 14.8595 | 0.1459 | 2 | 43 | autonomic nervous system development |
| GO:0022008 | 0.0096 | 3.272 | 2.4187 | 7 | 814 | neurogenesis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042789 | 2e-04 | 127.4 | 0.0204 | 2 | 12 | mRNA transcription from RNA polymerase II promoter |
| GO:0045646 | 0.0015 | 39.7552 | 0.0577 | 2 | 34 | regulation of erythrocyte differentiation |
| GO:0030026 | 0.0017 | Inf | 0.0017 | 1 | 1 | cellular manganese ion homeostasis |
| GO:0032468 | 0.0017 | Inf | 0.0017 | 1 | 1 | Golgi calcium ion homeostasis |
| GO:0050853 | 0.0019 | 35.3287 | 0.0645 | 2 | 38 | B cell receptor signaling pathway |
| GO:0002682 | 0.0023 | 4.6149 | 1.9308 | 7 | 1138 | regulation of immune system process |
| GO:0007308 | 0.0034 | 611.88 | 0.0034 | 1 | 2 | oocyte construction |
| GO:0007314 | 0.0034 | 611.88 | 0.0034 | 1 | 2 | oocyte anterior/posterior axis specification |
| GO:0030719 | 0.0034 | 611.88 | 0.0034 | 1 | 2 | P granule organization |
| GO:0032472 | 0.0034 | 611.88 | 0.0034 | 1 | 2 | Golgi calcium ion transport |
| GO:0006968 | 0.0038 | 24.4327 | 0.0916 | 2 | 54 | cellular defense response |
| GO:0010710 | 0.0051 | 305.92 | 0.0051 | 1 | 3 | regulation of collagen catabolic process |
| GO:0048584 | 0.0052 | 3.622 | 2.8504 | 8 | 1680 | positive regulation of response to stimulus |
| GO:0007161 | 0.0068 | 203.9333 | 0.0068 | 1 | 4 | calcium-independent cell-matrix adhesion |
| GO:0021943 | 0.0068 | 203.9333 | 0.0068 | 1 | 4 | formation of radial glial scaffolds |
| GO:0006306 | 0.0079 | 16.4729 | 0.134 | 2 | 79 | DNA methylation |
| GO:0007386 | 0.0085 | 152.94 | 0.0085 | 1 | 5 | compartment pattern specification |
| GO:0071421 | 0.0085 | 152.94 | 0.0085 | 1 | 5 | manganese ion transmembrane transport |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050715 | 2e-04 | 30.2143 | 0.1175 | 3 | 75 | positive regulation of cytokine secretion |
| GO:0010818 | 3e-04 | 92.6364 | 0.0266 | 2 | 17 | T cell chemotaxis |
| GO:1901623 | 4e-04 | 81.7273 | 0.0298 | 2 | 19 | regulation of lymphocyte chemotaxis |
| GO:0006955 | 7e-04 | 5.1835 | 2.1206 | 8 | 1354 | immune response |
| GO:0070374 | 9e-04 | 18.0714 | 0.1926 | 3 | 123 | positive regulation of ERK1 and ERK2 cascade |
| GO:0071219 | 0.0011 | 17.0675 | 0.2036 | 3 | 130 | cellular response to molecule of bacterial origin |
| GO:0002548 | 0.0011 | 47.8715 | 0.0486 | 2 | 31 | monocyte chemotaxis |
| GO:0006954 | 0.0013 | 7.2686 | 0.8529 | 5 | 568 | inflammatory response |
| GO:0006051 | 0.0016 | Inf | 0.0016 | 1 | 1 | N-acetylmannosamine metabolic process |
| GO:0009967 | 0.002 | 4.8078 | 1.9013 | 7 | 1214 | positive regulation of signal transduction |
| GO:0031663 | 0.0022 | 32.2558 | 0.0705 | 2 | 45 | lipopolysaccharide-mediated signaling pathway |
| GO:0015993 | 0.0031 | 665.1739 | 0.0031 | 1 | 2 | molecular hydrogen transport |
| GO:0070904 | 0.0031 | 665.1739 | 0.0031 | 1 | 2 | transepithelial L-ascorbic acid transport |
| GO:0072676 | 0.0032 | 26.6573 | 0.0846 | 2 | 54 | lymphocyte migration |
| GO:0009306 | 0.0039 | 7.1206 | 0.6609 | 4 | 422 | protein secretion |
| GO:0034605 | 0.0045 | 22.3431 | 0.1002 | 2 | 64 | cellular response to heat |
| GO:0032103 | 0.0047 | 9.9762 | 0.343 | 3 | 219 | positive regulation of response to external stimulus |
| GO:0019262 | 0.0047 | 332.5652 | 0.0047 | 1 | 3 | N-acetylneuraminate catabolic process |
| GO:1901509 | 0.0047 | 332.5652 | 0.0047 | 1 | 3 | regulation of endothelial tube morphogenesis |
| GO:1901740 | 0.0047 | 332.5652 | 0.0047 | 1 | 3 | negative regulation of myoblast fusion |
| GO:0007588 | 0.0049 | 21.3077 | 0.1049 | 2 | 67 | excretion |
| GO:0002248 | 0.0063 | 221.6957 | 0.0063 | 1 | 4 | connective tissue replacement involved in inflammatory response wound healing |
| GO:1903901 | 0.0071 | 17.5155 | 0.1269 | 2 | 81 | negative regulation of viral life cycle |
| GO:0032496 | 0.0072 | 8.4963 | 0.4009 | 3 | 256 | response to lipopolysaccharide |
| GO:0002322 | 0.0078 | 166.2609 | 0.0078 | 1 | 5 | B cell proliferation involved in immune response |
| GO:0043308 | 0.0078 | 166.2609 | 0.0078 | 1 | 5 | eosinophil degranulation |
| GO:2000503 | 0.0078 | 166.2609 | 0.0078 | 1 | 5 | positive regulation of natural killer cell chemotaxis |
| GO:0051209 | 0.0079 | 16.4675 | 0.1347 | 2 | 86 | release of sequestered calcium ion into cytosol |
| GO:0051282 | 0.0081 | 16.2727 | 0.1363 | 2 | 87 | regulation of sequestering of calcium ion |
| GO:1903532 | 0.0082 | 8.0741 | 0.4213 | 3 | 269 | positive regulation of secretion by cell |
| GO:0002687 | 0.0085 | 15.8966 | 0.1394 | 2 | 89 | positive regulation of leukocyte migration |
| GO:0051928 | 0.009 | 15.3636 | 0.1441 | 2 | 92 | positive regulation of calcium ion transport |
| GO:0015851 | 0.0094 | 133 | 0.0094 | 1 | 6 | nucleobase transport |
| GO:0043307 | 0.0094 | 133 | 0.0094 | 1 | 6 | eosinophil activation |
| GO:0043615 | 0.0094 | 133 | 0.0094 | 1 | 6 | astrocyte cell migration |
| GO:0060700 | 0.0094 | 133 | 0.0094 | 1 | 6 | regulation of ribonuclease activity |
| GO:0090594 | 0.0094 | 133 | 0.0094 | 1 | 6 | inflammatory response to wounding |
| GO:0071345 | 0.0097 | 5.4354 | 0.8567 | 4 | 547 | cellular response to cytokine stimulus |
| GO:0001816 | 0.0098 | 5.4147 | 0.8598 | 4 | 549 | cytokine production |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006049 | 0.0016 | Inf | 0.0016 | 1 | 1 | UDP-N-acetylglucosamine catabolic process |
| GO:0006127 | 0.0016 | Inf | 0.0016 | 1 | 1 | glycerophosphate shuttle |
| GO:0036399 | 0.0016 | Inf | 0.0016 | 1 | 1 | TCR signalosome assembly |
| GO:0010623 | 0.0019 | 34.9222 | 0.0653 | 2 | 40 | developmental programmed cell death |
| GO:0001869 | 0.0033 | 637.4167 | 0.0033 | 1 | 2 | negative regulation of complement activation, lectin pathway |
| GO:0046168 | 0.0033 | 637.4167 | 0.0033 | 1 | 2 | glycerol-3-phosphate catabolic process |
| GO:0044723 | 0.0038 | 5.5893 | 1.0767 | 5 | 660 | single-organism carbohydrate metabolic process |
| GO:0010676 | 0.0039 | 24.1012 | 0.093 | 2 | 57 | positive regulation of cellular carbohydrate metabolic process |
| GO:0006096 | 0.0043 | 22.8501 | 0.0979 | 2 | 60 | glycolytic process |
| GO:0006955 | 0.0048 | 4.028 | 2.209 | 7 | 1354 | immune response |
| GO:0006116 | 0.0049 | 318.6875 | 0.0049 | 1 | 3 | NADH oxidation |
| GO:0002248 | 0.0065 | 212.4444 | 0.0065 | 1 | 4 | connective tissue replacement involved in inflammatory response wound healing |
| GO:0044027 | 0.0065 | 212.4444 | 0.0065 | 1 | 4 | hypermethylation of CpG island |
| GO:0006094 | 0.0066 | 18.137 | 0.1224 | 2 | 75 | gluconeogenesis |
| GO:0006952 | 0.0068 | 3.7601 | 2.3509 | 7 | 1441 | defense response |
| GO:0046364 | 0.008 | 16.3371 | 0.1354 | 2 | 83 | monosaccharide biosynthetic process |
| GO:0090241 | 0.0081 | 159.3229 | 0.0082 | 1 | 5 | negative regulation of histone H4 acetylation |
| GO:0050729 | 0.0092 | 15.2044 | 0.1452 | 2 | 89 | positive regulation of inflammatory response |
| GO:0032787 | 0.0093 | 5.468 | 0.8467 | 4 | 519 | monocarboxylic acid metabolic process |
| GO:0035965 | 0.0098 | 127.45 | 0.0098 | 1 | 6 | cardiolipin acyl-chain remodeling |
| GO:0045347 | 0.0098 | 127.45 | 0.0098 | 1 | 6 | negative regulation of MHC class II biosynthetic process |
| GO:0090594 | 0.0098 | 127.45 | 0.0098 | 1 | 6 | inflammatory response to wounding |
| GO:1902262 | 0.0098 | 127.45 | 0.0098 | 1 | 6 | apoptotic process involved in patterning of blood vessels |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:1901642 | 4e-04 | 80.7989 | 0.0316 | 2 | 11 | nucleoside transmembrane transport |
| GO:0043123 | 0.0013 | 9.3907 | 0.4738 | 4 | 165 | positive regulation of I-kappaB kinase/NF-kappaB signaling |
| GO:0045742 | 0.0018 | 36.3333 | 0.0632 | 2 | 22 | positive regulation of epidermal growth factor receptor signaling pathway |
| GO:0015862 | 0.0029 | Inf | 0.0029 | 1 | 1 | uridine transport |
| GO:0035048 | 0.0029 | Inf | 0.0029 | 1 | 1 | splicing factor protein import into nucleus |
| GO:0035350 | 0.0029 | Inf | 0.0029 | 1 | 1 | FAD transmembrane transport |
| GO:0035491 | 0.0029 | Inf | 0.0029 | 1 | 1 | positive regulation of leukotriene production involved in inflammatory response |
| GO:0061044 | 0.0029 | Inf | 0.0029 | 1 | 1 | negative regulation of vascular wound healing |
| GO:0002685 | 0.0049 | 9.4828 | 0.3446 | 3 | 120 | regulation of leukocyte migration |
| GO:0001300 | 0.0057 | 355.3256 | 0.0057 | 1 | 2 | chronological cell aging |
| GO:0002538 | 0.0057 | 355.3256 | 0.0057 | 1 | 2 | arachidonic acid metabolite production involved in inflammatory response |
| GO:0015866 | 0.0057 | 355.3256 | 0.0057 | 1 | 2 | ADP transport |
| GO:0019303 | 0.0057 | 355.3256 | 0.0057 | 1 | 2 | D-ribose catabolic process |
| GO:0035349 | 0.0057 | 355.3256 | 0.0057 | 1 | 2 | coenzyme A transmembrane transport |
| GO:0043132 | 0.0057 | 355.3256 | 0.0057 | 1 | 2 | NAD transport |
| GO:0060545 | 0.0057 | 355.3256 | 0.0057 | 1 | 2 | positive regulation of necroptotic process |
| GO:0080121 | 0.0057 | 355.3256 | 0.0057 | 1 | 2 | AMP transport |
| GO:2000098 | 0.0057 | 355.3256 | 0.0057 | 1 | 2 | negative regulation of smooth muscle cell-matrix adhesion |
| GO:2000452 | 0.0057 | 355.3256 | 0.0057 | 1 | 2 | regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation |
| GO:0033344 | 0.0062 | 18.6093 | 0.1177 | 2 | 41 | cholesterol efflux |
| GO:1901264 | 0.0062 | 18.6093 | 0.1177 | 2 | 41 | carbohydrate derivative transport |
| GO:0042059 | 0.0064 | 18.1429 | 0.1206 | 2 | 42 | negative regulation of epidermal growth factor receptor signaling pathway |
| GO:0060079 | 0.0077 | 16.4892 | 0.1321 | 2 | 46 | regulation of excitatory postsynaptic membrane potential |
| GO:0051865 | 0.008 | 16.1217 | 0.135 | 2 | 47 | protein autoubiquitination |
| GO:0006869 | 0.0081 | 5.4766 | 0.7982 | 4 | 278 | lipid transport |
| GO:0035697 | 0.0086 | 177.6512 | 0.0086 | 1 | 3 | CD8-positive, alpha-beta T cell extravasation |
| GO:0042427 | 0.0086 | 177.6512 | 0.0086 | 1 | 3 | serotonin biosynthetic process |
| GO:1900127 | 0.0086 | 177.6512 | 0.0086 | 1 | 3 | positive regulation of hyaluronan biosynthetic process |
| GO:2000407 | 0.0086 | 177.6512 | 0.0086 | 1 | 3 | regulation of T cell extravasation |
| GO:0044242 | 0.0099 | 7.2824 | 0.4451 | 3 | 155 | cellular lipid catabolic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007321 | 0.0012 | Inf | 0.0012 | 1 | 1 | sperm displacement |
| GO:0001887 | 0.0025 | 850.2222 | 0.0025 | 1 | 2 | selenium compound metabolic process |
| GO:0007181 | 0.0037 | 425.0833 | 0.0037 | 1 | 3 | transforming growth factor beta receptor complex assembly |
| GO:0015747 | 0.0037 | 425.0833 | 0.0037 | 1 | 3 | urate transport |
| GO:0015760 | 0.005 | 283.3704 | 0.005 | 1 | 4 | glucose-6-phosphate transport |
| GO:0001957 | 0.0074 | 170 | 0.0074 | 1 | 6 | intramembranous ossification |
| GO:2001275 | 0.0074 | 170 | 0.0074 | 1 | 6 | positive regulation of glucose import in response to insulin stimulus |
| GO:0010759 | 0.0086 | 141.6574 | 0.0087 | 1 | 7 | positive regulation of macrophage chemotaxis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006955 | 0 | 22.6501 | 0.3065 | 5 | 242 | immune response |
| GO:0006968 | 1e-04 | 40.7701 | 0.0881 | 3 | 54 | cellular defense response |
| GO:0002275 | 1e-04 | 37.795 | 0.0946 | 3 | 58 | myeloid cell activation involved in immune response |
| GO:0070493 | 1e-04 | 166.2065 | 0.0163 | 2 | 10 | thrombin receptor signaling pathway |
| GO:0002263 | 2e-04 | 16.4615 | 0.292 | 4 | 179 | cell activation involved in immune response |
| GO:0050715 | 2e-04 | 28.839 | 0.1224 | 3 | 75 | positive regulation of cytokine secretion |
| GO:0007229 | 3e-04 | 25.3054 | 0.1387 | 3 | 85 | integrin-mediated signaling pathway |
| GO:0045321 | 5e-04 | 7.3407 | 1.0392 | 6 | 637 | leukocyte activation |
| GO:0009611 | 7e-04 | 5.8607 | 1.5645 | 7 | 959 | response to wounding |
| GO:0002715 | 9e-04 | 53.127 | 0.044 | 2 | 27 | regulation of natural killer cell mediated immunity |
| GO:0044700 | 0.001 | 3.8545 | 8.8978 | 17 | 5454 | single organism signaling |
| GO:0007154 | 0.0012 | 3.755 | 9.0479 | 17 | 5546 | cell communication |
| GO:0031347 | 0.0013 | 7.1767 | 0.8483 | 5 | 520 | regulation of defense response |
| GO:0007596 | 0.0015 | 7.0214 | 0.8663 | 5 | 531 | blood coagulation |
| GO:0010920 | 0.0016 | Inf | 0.0016 | 1 | 1 | negative regulation of inositol phosphate biosynthetic process |
| GO:0010925 | 0.0016 | Inf | 0.0016 | 1 | 1 | positive regulation of inositol-polyphosphate 5-phosphatase activity |
| GO:0030845 | 0.0016 | Inf | 0.0016 | 1 | 1 | phospholipase C-inhibiting G-protein coupled receptor signaling pathway |
| GO:0060305 | 0.0016 | Inf | 0.0016 | 1 | 1 | regulation of cell diameter |
| GO:0050848 | 0.0019 | 34.9222 | 0.0653 | 2 | 40 | regulation of calcium-mediated signaling |
| GO:0045087 | 0.0022 | 5.3282 | 1.4063 | 6 | 862 | innate immune response |
| GO:0042267 | 0.0028 | 28.8336 | 0.0783 | 2 | 48 | natural killer cell mediated cytotoxicity |
| GO:0045912 | 0.0028 | 28.8336 | 0.0783 | 2 | 48 | negative regulation of carbohydrate metabolic process |
| GO:0001775 | 0.0028 | 12.3699 | 0.2872 | 3 | 222 | cell activation |
| GO:0070165 | 0.0033 | 637.4167 | 0.0033 | 1 | 2 | positive regulation of adiponectin secretion |
| GO:0070560 | 0.0033 | 637.4167 | 0.0033 | 1 | 2 | protein secretion by platelet |
| GO:0002449 | 0.0035 | 11.0799 | 0.3083 | 3 | 189 | lymphocyte mediated immunity |
| GO:0051716 | 0.0035 | 3.2799 | 9.8408 | 17 | 6032 | cellular response to stimulus |
| GO:0050878 | 0.0041 | 5.4757 | 1.098 | 5 | 673 | regulation of body fluid levels |
| GO:0002351 | 0.0049 | 318.6875 | 0.0049 | 1 | 3 | serotonin production involved in inflammatory response |
| GO:0002554 | 0.0049 | 318.6875 | 0.0049 | 1 | 3 | serotonin secretion by platelet |
| GO:0060741 | 0.0049 | 318.6875 | 0.0049 | 1 | 3 | prostate gland stromal morphogenesis |
| GO:0071638 | 0.0049 | 318.6875 | 0.0049 | 1 | 3 | negative regulation of monocyte chemotactic protein-1 production |
| GO:0002444 | 0.0053 | 20.3799 | 0.1093 | 2 | 67 | myeloid leukocyte mediated immunity |
| GO:0035556 | 0.0053 | 3.4309 | 3.5304 | 9 | 2164 | intracellular signal transduction |
| GO:0045055 | 0.0061 | 18.918 | 0.1175 | 2 | 72 | regulated secretory pathway |
| GO:0050776 | 0.0064 | 4.9116 | 1.217 | 5 | 746 | regulation of immune response |
| GO:0003056 | 0.0065 | 212.4444 | 0.0065 | 1 | 4 | regulation of vascular smooth muscle contraction |
| GO:0033625 | 0.0065 | 212.4444 | 0.0065 | 1 | 4 | positive regulation of integrin activation |
| GO:0043255 | 0.0068 | 17.8907 | 0.124 | 2 | 76 | regulation of carbohydrate biosynthetic process |
| GO:0051050 | 0.0071 | 4.7826 | 1.248 | 5 | 765 | positive regulation of transport |
| GO:0002705 | 0.0077 | 16.7529 | 0.1321 | 2 | 81 | positive regulation of leukocyte mediated immunity |
| GO:0030316 | 0.0077 | 16.7529 | 0.1321 | 2 | 81 | osteoclast differentiation |
| GO:0008626 | 0.0081 | 159.3229 | 0.0082 | 1 | 5 | granzyme-mediated apoptotic signaling pathway |
| GO:0043308 | 0.0081 | 159.3229 | 0.0082 | 1 | 5 | eosinophil degranulation |
| GO:1900165 | 0.0081 | 159.3229 | 0.0082 | 1 | 5 | negative regulation of interleukin-6 secretion |
| GO:2000503 | 0.0081 | 159.3229 | 0.0082 | 1 | 5 | positive regulation of natural killer cell chemotaxis |
| GO:1903532 | 0.0092 | 7.7066 | 0.4389 | 3 | 269 | positive regulation of secretion by cell |
| GO:0002697 | 0.0093 | 7.6772 | 0.4405 | 3 | 270 | regulation of immune effector process |
| GO:0010572 | 0.0098 | 127.45 | 0.0098 | 1 | 6 | positive regulation of platelet activation |
| GO:0035356 | 0.0098 | 127.45 | 0.0098 | 1 | 6 | cellular triglyceride homeostasis |
| GO:0043307 | 0.0098 | 127.45 | 0.0098 | 1 | 6 | eosinophil activation |
| GO:0043615 | 0.0098 | 127.45 | 0.0098 | 1 | 6 | astrocyte cell migration |
| GO:2001204 | 0.0098 | 127.45 | 0.0098 | 1 | 6 | regulation of osteoclast development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0045321 | 0 | 14.0178 | 0.9977 | 9 | 637 | leukocyte activation |
| GO:0042113 | 0 | 20.817 | 0.307 | 5 | 196 | B cell activation |
| GO:0002322 | 0 | 463.5455 | 0.0078 | 2 | 5 | B cell proliferation involved in immune response |
| GO:0008360 | 0 | 25.0893 | 0.1958 | 4 | 125 | regulation of cell shape |
| GO:0031666 | 0 | 278.0909 | 0.011 | 2 | 7 | positive regulation of lipopolysaccharide-mediated signaling pathway |
| GO:0002263 | 2e-04 | 17.2857 | 0.2803 | 4 | 179 | cell activation involved in immune response |
| GO:0002520 | 9e-04 | 6.4667 | 1.184 | 6 | 756 | immune system development |
| GO:0071222 | 9e-04 | 18.0714 | 0.1926 | 3 | 123 | cellular response to lipopolysaccharide |
| GO:0006959 | 0.0014 | 15.3587 | 0.2255 | 3 | 144 | humoral immune response |
| GO:0071216 | 0.0015 | 15.1419 | 0.2287 | 3 | 146 | cellular response to biotic stimulus |
| GO:0035611 | 0.0016 | Inf | 0.0016 | 1 | 1 | protein branching point deglutamylation |
| GO:0050853 | 0.0016 | 38.5455 | 0.0595 | 2 | 38 | B cell receptor signaling pathway |
| GO:0006954 | 0.0017 | 6.813 | 0.899 | 5 | 574 | inflammatory response |
| GO:0045087 | 0.0017 | 5.6246 | 1.35 | 6 | 862 | innate immune response |
| GO:0038083 | 0.0019 | 35.5734 | 0.0642 | 2 | 41 | peptidyl-tyrosine autophosphorylation |
| GO:0030097 | 0.0036 | 5.7018 | 1.065 | 5 | 680 | hemopoiesis |
| GO:0002429 | 0.0037 | 10.8961 | 0.3148 | 3 | 201 | immune response-activating cell surface receptor signaling pathway |
| GO:0002275 | 0.0037 | 24.7468 | 0.0908 | 2 | 58 | myeloid cell activation involved in immune response |
| GO:0002351 | 0.0047 | 332.5652 | 0.0047 | 1 | 3 | serotonin production involved in inflammatory response |
| GO:0002554 | 0.0047 | 332.5652 | 0.0047 | 1 | 3 | serotonin secretion by platelet |
| GO:0002444 | 0.0049 | 21.3077 | 0.1049 | 2 | 67 | myeloid leukocyte mediated immunity |
| GO:0046651 | 0.0053 | 9.5284 | 0.3587 | 3 | 229 | lymphocyte proliferation |
| GO:0071310 | 0.0054 | 3.6621 | 2.8912 | 8 | 1846 | cellular response to organic substance |
| GO:0045055 | 0.0056 | 19.7792 | 0.1128 | 2 | 72 | regulated secretory pathway |
| GO:0051050 | 0.0059 | 5.0346 | 1.1981 | 5 | 765 | positive regulation of transport |
| GO:0007169 | 0.006 | 5.0069 | 1.2044 | 5 | 769 | transmembrane receptor protein tyrosine kinase signaling pathway |
| GO:0050715 | 0.0061 | 18.9626 | 0.1175 | 2 | 75 | positive regulation of cytokine secretion |
| GO:0070661 | 0.0062 | 9.0024 | 0.379 | 3 | 242 | leukocyte proliferation |
| GO:0003056 | 0.0063 | 221.6957 | 0.0063 | 1 | 4 | regulation of vascular smooth muscle contraction |
| GO:0044027 | 0.0063 | 221.6957 | 0.0063 | 1 | 4 | hypermethylation of CpG island |
| GO:0043308 | 0.0078 | 166.2609 | 0.0078 | 1 | 5 | eosinophil degranulation |
| GO:0090241 | 0.0078 | 166.2609 | 0.0078 | 1 | 5 | negative regulation of histone H4 acetylation |
| GO:2000503 | 0.0078 | 166.2609 | 0.0078 | 1 | 5 | positive regulation of natural killer cell chemotaxis |
| GO:0051209 | 0.0079 | 16.4675 | 0.1347 | 2 | 86 | release of sequestered calcium ion into cytosol |
| GO:0051282 | 0.0081 | 16.2727 | 0.1363 | 2 | 87 | regulation of sequestering of calcium ion |
| GO:0002237 | 0.0082 | 8.0741 | 0.4213 | 3 | 269 | response to molecule of bacterial origin |
| GO:1903532 | 0.0082 | 8.0741 | 0.4213 | 3 | 269 | positive regulation of secretion by cell |
| GO:0010959 | 0.0087 | 7.9225 | 0.4291 | 3 | 274 | regulation of metal ion transport |
| GO:0030098 | 0.0087 | 7.9225 | 0.4291 | 3 | 274 | lymphocyte differentiation |
| GO:0051928 | 0.009 | 15.3636 | 0.1441 | 2 | 92 | positive regulation of calcium ion transport |
| GO:0043307 | 0.0094 | 133 | 0.0094 | 1 | 6 | eosinophil activation |
| GO:0043615 | 0.0094 | 133 | 0.0094 | 1 | 6 | astrocyte cell migration |
| GO:0045347 | 0.0094 | 133 | 0.0094 | 1 | 6 | negative regulation of MHC class II biosynthetic process |
| GO:1902262 | 0.0094 | 133 | 0.0094 | 1 | 6 | apoptotic process involved in patterning of blood vessels |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0009954 | 0 | 37.5246 | 0.1292 | 4 | 33 | proximal/distal pattern formation |
| GO:0072272 | 0 | Inf | 0.0078 | 2 | 2 | proximal/distal pattern formation involved in metanephric nephron development |
| GO:0007156 | 0 | 12.8355 | 0.5364 | 6 | 137 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0007626 | 1e-04 | 9.636 | 0.7048 | 6 | 180 | locomotory behavior |
| GO:0003056 | 1e-04 | 263.1379 | 0.0157 | 2 | 4 | regulation of vascular smooth muscle contraction |
| GO:0021555 | 1e-04 | 263.1379 | 0.0157 | 2 | 4 | midbrain-hindbrain boundary morphogenesis |
| GO:0072086 | 1e-04 | 263.1379 | 0.0157 | 2 | 4 | specification of loop of Henle identity |
| GO:0098609 | 1e-04 | 9.1063 | 0.7439 | 6 | 190 | cell-cell adhesion |
| GO:0009887 | 1e-04 | 4.1924 | 3.4103 | 12 | 871 | organ morphogenesis |
| GO:0007389 | 1e-04 | 5.9384 | 1.5463 | 8 | 408 | pattern specification process |
| GO:0007187 | 4e-04 | 8.6916 | 0.6382 | 5 | 163 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
| GO:0022008 | 5e-04 | 3.2257 | 5.2075 | 14 | 1330 | neurogenesis |
| GO:0048704 | 5e-04 | 12.0429 | 0.3681 | 4 | 94 | embryonic skeletal system morphogenesis |
| GO:0061004 | 5e-04 | 75.1576 | 0.0352 | 2 | 9 | pattern specification involved in kidney development |
| GO:0021903 | 0.001 | 52.6 | 0.047 | 2 | 12 | rostrocaudal neural tube patterning |
| GO:0048568 | 0.001 | 4.8828 | 1.6014 | 7 | 409 | embryonic organ development |
| GO:0048935 | 0.0011 | 47.815 | 0.0509 | 2 | 13 | peripheral nervous system neuron development |
| GO:0048598 | 0.0011 | 4.2718 | 2.1163 | 8 | 559 | embryonic morphogenesis |
| GO:0030182 | 0.0014 | 3.1062 | 4.4988 | 12 | 1149 | neuron differentiation |
| GO:0060562 | 0.0014 | 5.3599 | 1.2373 | 6 | 316 | epithelial tube morphogenesis |
| GO:0019219 | 0.0015 | 2.3143 | 14.1934 | 25 | 3625 | regulation of nucleobase-containing compound metabolic process |
| GO:0030534 | 0.0017 | 8.5135 | 0.5129 | 4 | 131 | adult behavior |
| GO:0007379 | 0.0017 | 37.5616 | 0.0626 | 2 | 16 | segment specification |
| GO:0072079 | 0.0025 | 30.927 | 0.0744 | 2 | 19 | nephron tubule formation |
| GO:0035107 | 0.0027 | 7.4478 | 0.5834 | 4 | 149 | appendage morphogenesis |
| GO:0007422 | 0.003 | 11.2624 | 0.2897 | 3 | 74 | peripheral nervous system development |
| GO:0007399 | 0.0031 | 4.0676 | 1.9607 | 7 | 596 | nervous system development |
| GO:0006355 | 0.0033 | 2.2185 | 12.455 | 22 | 3181 | regulation of transcription, DNA-templated |
| GO:2001141 | 0.0039 | 2.1826 | 12.6155 | 22 | 3222 | regulation of RNA biosynthetic process |
| GO:0021993 | 0.0039 | Inf | 0.0039 | 1 | 1 | initiation of neural tube closure |
| GO:0036065 | 0.0039 | 23.8903 | 0.094 | 2 | 24 | fucosylation |
| GO:0019953 | 0.0042 | 3.4204 | 2.6038 | 8 | 665 | sexual reproduction |
| GO:0060173 | 0.0042 | 6.5767 | 0.6578 | 4 | 168 | limb development |
| GO:0032501 | 0.0047 | 2.0285 | 24.5419 | 35 | 6268 | multicellular organismal process |
| GO:0097659 | 0.0051 | 2.1202 | 12.9052 | 22 | 3296 | nucleic acid-templated transcription |
| GO:0021510 | 0.0056 | 8.974 | 0.3602 | 3 | 92 | spinal cord development |
| GO:0034654 | 0.0058 | 2.0564 | 14.7259 | 24 | 3761 | nucleobase-containing compound biosynthetic process |
| GO:0019228 | 0.0061 | 18.7635 | 0.1175 | 2 | 30 | neuronal action potential |
| GO:0009187 | 0.0062 | 5.8864 | 0.7322 | 4 | 187 | cyclic nucleotide metabolic process |
| GO:0009889 | 0.0065 | 2.0325 | 14.8551 | 24 | 3794 | regulation of biosynthetic process |
| GO:0048665 | 0.0065 | 18.1153 | 0.1214 | 2 | 31 | neuron fate specification |
| GO:0048729 | 0.007 | 3.4172 | 2.2514 | 7 | 575 | tissue morphogenesis |
| GO:0021522 | 0.0078 | 16.4138 | 0.1331 | 2 | 34 | spinal cord motor neuron differentiation |
| GO:0021568 | 0.0078 | 258.6949 | 0.0078 | 1 | 2 | rhombomere 2 development |
| GO:0021592 | 0.0078 | 258.6949 | 0.0078 | 1 | 2 | fourth ventricle development |
| GO:0070593 | 0.0078 | 258.6949 | 0.0078 | 1 | 2 | dendrite self-avoidance |
| GO:0007628 | 0.0083 | 15.9154 | 0.137 | 2 | 35 | adult walking behavior |
| GO:0034332 | 0.0087 | 7.5985 | 0.4229 | 3 | 108 | adherens junction organization |
| GO:0007338 | 0.0089 | 7.5263 | 0.4268 | 3 | 109 | single fertilization |
| GO:0035137 | 0.0097 | 14.5862 | 0.1488 | 2 | 38 | hindlimb morphogenesis |
| GO:0001501 | 0.01 | 3.5441 | 1.8403 | 6 | 470 | skeletal system development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006955 | 0 | 7.4171 | 2.1206 | 10 | 1354 | immune response |
| GO:0050853 | 0 | 62.3061 | 0.0595 | 3 | 38 | B cell receptor signaling pathway |
| GO:0045321 | 0 | 9.5882 | 0.9977 | 7 | 637 | leukocyte activation |
| GO:0031666 | 0 | 278.0909 | 0.011 | 2 | 7 | positive regulation of lipopolysaccharide-mediated signaling pathway |
| GO:0042113 | 2e-04 | 15.7375 | 0.307 | 4 | 196 | B cell activation |
| GO:0030851 | 8e-04 | 55.5455 | 0.0423 | 2 | 27 | granulocyte differentiation |
| GO:0002520 | 9e-04 | 6.4667 | 1.184 | 6 | 756 | immune system development |
| GO:0035611 | 0.0016 | Inf | 0.0016 | 1 | 1 | protein branching point deglutamylation |
| GO:0008616 | 0.0031 | 665.1739 | 0.0031 | 1 | 2 | queuosine biosynthetic process |
| GO:0030097 | 0.0036 | 5.7018 | 1.065 | 5 | 680 | hemopoiesis |
| GO:0002429 | 0.0037 | 10.8961 | 0.3148 | 3 | 201 | immune response-activating cell surface receptor signaling pathway |
| GO:0002764 | 0.0047 | 6.7231 | 0.6985 | 4 | 446 | immune response-regulating signaling pathway |
| GO:0048518 | 0.0048 | 3.1468 | 7.4002 | 14 | 4725 | positive regulation of biological process |
| GO:0044027 | 0.0063 | 221.6957 | 0.0063 | 1 | 4 | hypermethylation of CpG island |
| GO:0002322 | 0.0078 | 166.2609 | 0.0078 | 1 | 5 | B cell proliferation involved in immune response |
| GO:0090241 | 0.0078 | 166.2609 | 0.0078 | 1 | 5 | negative regulation of histone H4 acetylation |
| GO:0030098 | 0.0087 | 7.9225 | 0.4291 | 3 | 274 | lymphocyte differentiation |
| GO:0045347 | 0.0094 | 133 | 0.0094 | 1 | 6 | negative regulation of MHC class II biosynthetic process |
| GO:0046642 | 0.0094 | 133 | 0.0094 | 1 | 6 | negative regulation of alpha-beta T cell proliferation |
| GO:1902262 | 0.0094 | 133 | 0.0094 | 1 | 6 | apoptotic process involved in patterning of blood vessels |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0022803 | 0 | 8.8282 | 1.3856 | 10 | 395 | passive transmembrane transporter activity |
| GO:0022838 | 0 | 8.1825 | 1.3154 | 9 | 375 | substrate-specific channel activity |
| GO:0022836 | 0 | 9.0255 | 1.0453 | 8 | 298 | gated channel activity |
| GO:0015077 | 2e-04 | 6.8593 | 1.1681 | 7 | 333 | monovalent inorganic cation transmembrane transporter activity |
| GO:0046873 | 3e-04 | 5.9927 | 1.3295 | 7 | 379 | metal ion transmembrane transporter activity |
| GO:0005244 | 4e-04 | 9.1601 | 0.6104 | 5 | 174 | voltage-gated ion channel activity |
| GO:0015459 | 5e-04 | 21.9498 | 0.1543 | 3 | 44 | potassium channel regulator activity |
| GO:0008324 | 7e-04 | 4.6855 | 1.9539 | 8 | 557 | cation transmembrane transporter activity |
| GO:0004890 | 0.0014 | 42.1044 | 0.0561 | 2 | 16 | GABA-A receptor activity |
| GO:0022892 | 0.0015 | 3.4895 | 3.3255 | 10 | 948 | substrate-specific transporter activity |
| GO:0004653 | 0.002 | 34.6674 | 0.0666 | 2 | 19 | polypeptide N-acetylgalactosaminyltransferase activity |
| GO:0005217 | 0.0027 | 29.4615 | 0.0772 | 2 | 22 | intracellular ligand-gated ion channel activity |
| GO:0005249 | 0.0031 | 11.2206 | 0.2912 | 3 | 83 | voltage-gated potassium channel activity |
| GO:0038048 | 0.0035 | Inf | 0.0035 | 1 | 1 | dynorphin receptor activity |
| GO:0043924 | 0.0035 | Inf | 0.0035 | 1 | 1 | suramin binding |
| GO:0005267 | 0.0051 | 20.7211 | 0.1066 | 2 | 32 | potassium channel activity |
| GO:0015276 | 0.0063 | 8.6236 | 0.3755 | 3 | 111 | ligand-gated ion channel activity |
| GO:0005272 | 0.0063 | 18.399 | 0.1193 | 2 | 34 | sodium channel activity |
| GO:0005006 | 0.007 | 289.4151 | 0.007 | 1 | 2 | epidermal growth factor-activated receptor activity |
| GO:0008281 | 0.007 | 289.4151 | 0.007 | 1 | 2 | sulfonylurea receptor activity |
| GO:0050682 | 0.007 | 289.4151 | 0.007 | 1 | 2 | AF-2 domain binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0098772 | 0.0013 | 3.9574 | 2.764 | 9 | 1091 | molecular function regulator |
| GO:0005096 | 0.0023 | 8.0101 | 0.5574 | 4 | 220 | GTPase activator activity |
| GO:0001532 | 0.0025 | Inf | 0.0025 | 1 | 1 | interleukin-21 receptor activity |
| GO:0003692 | 0.0025 | Inf | 0.0025 | 1 | 1 | left-handed Z-DNA binding |
| GO:0005147 | 0.0025 | Inf | 0.0025 | 1 | 1 | oncostatin-M receptor binding |
| GO:0060589 | 0.0045 | 6.5582 | 0.6764 | 4 | 267 | nucleoside-triphosphatase regulator activity |
| GO:0030156 | 0.0051 | 404.0526 | 0.0051 | 1 | 2 | benzodiazepine receptor binding |
| GO:0042498 | 0.0051 | 404.0526 | 0.0051 | 1 | 2 | diacyl lipopeptide binding |
| GO:0003726 | 0.0076 | 202.0132 | 0.0076 | 1 | 3 | double-stranded RNA adenosine deaminase activity |
| GO:0030414 | 0.0079 | 7.9644 | 0.4104 | 3 | 162 | peptidase inhibitor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0016788 | 0.0025 | 4.2475 | 1.8855 | 7 | 645 | hydrolase activity, acting on ester bonds |
| GO:0001872 | 0.0029 | Inf | 0.0029 | 1 | 1 | (1->3)-beta-D-glucan binding |
| GO:0002055 | 0.0029 | Inf | 0.0029 | 1 | 1 | adenine binding |
| GO:0003999 | 0.0029 | Inf | 0.0029 | 1 | 1 | adenine phosphoribosyltransferase activity |
| GO:0030377 | 0.0029 | Inf | 0.0029 | 1 | 1 | urokinase plasminogen activator receptor activity |
| GO:0042947 | 0.0029 | Inf | 0.0029 | 1 | 1 | glucoside transmembrane transporter activity |
| GO:0050528 | 0.0029 | Inf | 0.0029 | 1 | 1 | acyloxyacyl hydrolase activity |
| GO:0097573 | 0.0029 | Inf | 0.0029 | 1 | 1 | glutathione oxidoreductase activity |
| GO:0004119 | 0.0058 | 348.8182 | 0.0058 | 1 | 2 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity |
| GO:0042281 | 0.0058 | 348.8182 | 0.0058 | 1 | 2 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity |
| GO:0030246 | 0.0067 | 5.798 | 0.7542 | 4 | 258 | carbohydrate binding |
| GO:0000033 | 0.0087 | 174.3977 | 0.0088 | 1 | 3 | alpha-1,3-mannosyltransferase activity |
| GO:0004465 | 0.0087 | 174.3977 | 0.0088 | 1 | 3 | lipoprotein lipase activity |
| GO:0016936 | 0.0087 | 174.3977 | 0.0088 | 1 | 3 | galactoside binding |
| GO:0030395 | 0.0087 | 174.3977 | 0.0088 | 1 | 3 | lactose binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0051736 | 0.0023 | Inf | 0.0023 | 1 | 1 | ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity |
| GO:0001641 | 0.0047 | 438.7714 | 0.0047 | 1 | 2 | group II metabotropic glutamate receptor activity |
| GO:0046811 | 0.0047 | 438.7714 | 0.0047 | 1 | 2 | histone deacetylase inhibitor activity |
| GO:0005044 | 0.0052 | 20.4733 | 0.1076 | 2 | 46 | scavenger receptor activity |
| GO:0046404 | 0.007 | 219.3714 | 0.007 | 1 | 3 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity |
| GO:0001733 | 0.0093 | 146.2381 | 0.0094 | 1 | 4 | galactosylceramide sulfotransferase activity |
| GO:0017089 | 0.0093 | 146.2381 | 0.0094 | 1 | 4 | glycolipid transporter activity |
| GO:0051430 | 0.0093 | 146.2381 | 0.0094 | 1 | 4 | corticotropin-releasing hormone receptor 1 binding |
| GO:0051431 | 0.0093 | 146.2381 | 0.0094 | 1 | 4 | corticotropin-releasing hormone receptor 2 binding |
| GO:0051731 | 0.0093 | 146.2381 | 0.0094 | 1 | 4 | polynucleotide 5'-hydroxyl-kinase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0016810 | 3e-04 | 28.4385 | 0.1303 | 3 | 118 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds |
| GO:0004053 | 0.0022 | 961 | 0.0022 | 1 | 2 | arginase activity |
| GO:0071558 | 0.0022 | 961 | 0.0022 | 1 | 2 | histone demethylase activity (H3-K27 specific) |
| GO:0035662 | 0.0033 | 480.4688 | 0.0033 | 1 | 3 | Toll-like receptor 4 binding |
| GO:0047844 | 0.0033 | 480.4688 | 0.0033 | 1 | 3 | deoxycytidine deaminase activity |
| GO:0008745 | 0.0044 | 320.2917 | 0.0044 | 1 | 4 | N-acetylmuramoyl-L-alanine amidase activity |
| GO:0016019 | 0.0055 | 240.2031 | 0.0055 | 1 | 5 | peptidoglycan receptor activity |
| GO:0042289 | 0.0055 | 240.2031 | 0.0055 | 1 | 5 | MHC class II protein binding |
| GO:0050544 | 0.0055 | 240.2031 | 0.0055 | 1 | 5 | arachidonic acid binding |
| GO:1901567 | 0.0066 | 192.15 | 0.0066 | 1 | 6 | fatty acid derivative binding |
| GO:0004126 | 0.0088 | 137.2321 | 0.0088 | 1 | 8 | cytidine deaminase activity |
| GO:0008061 | 0.0088 | 137.2321 | 0.0088 | 1 | 8 | chitin binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0016810 | 3e-04 | 26.5409 | 0.138 | 3 | 118 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds |
| GO:0004053 | 0.0023 | 904.4118 | 0.0023 | 1 | 2 | arginase activity |
| GO:0071558 | 0.0023 | 904.4118 | 0.0023 | 1 | 2 | histone demethylase activity (H3-K27 specific) |
| GO:0035662 | 0.0035 | 452.1765 | 0.0035 | 1 | 3 | Toll-like receptor 4 binding |
| GO:0047844 | 0.0035 | 452.1765 | 0.0035 | 1 | 3 | deoxycytidine deaminase activity |
| GO:0051381 | 0.0035 | 452.1765 | 0.0035 | 1 | 3 | histamine binding |
| GO:0008745 | 0.0047 | 301.4314 | 0.0047 | 1 | 4 | N-acetylmuramoyl-L-alanine amidase activity |
| GO:0016019 | 0.0058 | 226.0588 | 0.0058 | 1 | 5 | peptidoglycan receptor activity |
| GO:0042289 | 0.0058 | 226.0588 | 0.0058 | 1 | 5 | MHC class II protein binding |
| GO:0050544 | 0.0058 | 226.0588 | 0.0058 | 1 | 5 | arachidonic acid binding |
| GO:0004969 | 0.007 | 180.8353 | 0.007 | 1 | 6 | histamine receptor activity |
| GO:1901567 | 0.007 | 180.8353 | 0.007 | 1 | 6 | fatty acid derivative binding |
| GO:0004126 | 0.0093 | 129.1513 | 0.0094 | 1 | 8 | cytidine deaminase activity |
| GO:0008061 | 0.0093 | 129.1513 | 0.0094 | 1 | 8 | chitin binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004869 | 0.0017 | 37.5613 | 0.062 | 2 | 53 | cysteine-type endopeptidase inhibitor activity |
| GO:0004053 | 0.0023 | 904.4118 | 0.0023 | 1 | 2 | arginase activity |
| GO:0071558 | 0.0023 | 904.4118 | 0.0023 | 1 | 2 | histone demethylase activity (H3-K27 specific) |
| GO:0008745 | 0.0047 | 301.4314 | 0.0047 | 1 | 4 | N-acetylmuramoyl-L-alanine amidase activity |
| GO:0016019 | 0.0058 | 226.0588 | 0.0058 | 1 | 5 | peptidoglycan receptor activity |
| GO:0042289 | 0.0058 | 226.0588 | 0.0058 | 1 | 5 | MHC class II protein binding |
| GO:0016810 | 0.0082 | 16.444 | 0.138 | 2 | 118 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004336 | 0.0027 | Inf | 0.0027 | 1 | 1 | galactosylceramidase activity |
| GO:0001632 | 0.0053 | 383.8 | 0.0053 | 1 | 2 | leukotriene B4 receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008579 | 0.002 | Inf | 0.002 | 1 | 1 | JUN kinase phosphatase activity |
| GO:0005044 | 0.0038 | 24.011 | 0.0926 | 2 | 46 | scavenger receptor activity |
| GO:0001632 | 0.004 | 512.0667 | 0.004 | 1 | 2 | leukotriene B4 receptor activity |
| GO:0004911 | 0.004 | 512.0667 | 0.004 | 1 | 2 | interleukin-2 receptor activity |
| GO:0019976 | 0.004 | 512.0667 | 0.004 | 1 | 2 | interleukin-2 binding |
| GO:0004872 | 0.0058 | 3.442 | 2.8555 | 8 | 1418 | receptor activity |
| GO:0005539 | 0.0064 | 8.7425 | 0.3806 | 3 | 189 | glycosaminoglycan binding |
| GO:0004860 | 0.0067 | 17.889 | 0.1228 | 2 | 61 | protein kinase inhibitor activity |
| GO:0035591 | 0.0075 | 16.7488 | 0.1309 | 2 | 65 | signaling adaptor activity |
| GO:0008330 | 0.008 | 170.6667 | 0.0081 | 1 | 4 | protein tyrosine/threonine phosphatase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004336 | 0.0027 | Inf | 0.0027 | 1 | 1 | galactosylceramidase activity |
| GO:0001632 | 0.0053 | 383.8 | 0.0053 | 1 | 2 | leukotriene B4 receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031014 | 0 | 854 | 0.0052 | 2 | 4 | troponin T binding |
| GO:0000210 | 0.0013 | Inf | 0.0013 | 1 | 1 | NAD+ diphosphatase activity |
| GO:0015143 | 0.0026 | 809.1053 | 0.0026 | 1 | 2 | urate transmembrane transporter activity |
| GO:0035591 | 0.0032 | 27.0035 | 0.0844 | 2 | 65 | signaling adaptor activity |
| GO:0030172 | 0.0039 | 404.5263 | 0.0039 | 1 | 3 | troponin C binding |
| GO:0030369 | 0.0039 | 404.5263 | 0.0039 | 1 | 3 | ICAM-3 receptor activity |
| GO:0035529 | 0.0039 | 404.5263 | 0.0039 | 1 | 3 | NADH pyrophosphatase activity |
| GO:0015562 | 0.0052 | 269.6667 | 0.0052 | 1 | 4 | efflux transmembrane transporter activity |
| GO:0004523 | 0.0078 | 161.7789 | 0.0078 | 1 | 6 | RNA-DNA hybrid ribonuclease activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004489 | 0.0012 | Inf | 0.0012 | 1 | 1 | methylenetetrahydrofolate reductase (NAD(P)H) activity |
| GO:0016165 | 0.0025 | 854.1111 | 0.0025 | 1 | 2 | linoleate 13S-lipoxygenase activity |
| GO:0047977 | 0.0025 | 854.1111 | 0.0025 | 1 | 2 | hepoxilin-epoxide hydrolase activity |
| GO:0004052 | 0.0037 | 427.0278 | 0.0037 | 1 | 3 | arachidonate 12-lipoxygenase activity |
| GO:0051120 | 0.0037 | 427.0278 | 0.0037 | 1 | 3 | hepoxilin A3 synthase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0016165 | 0.0019 | 1098.4286 | 0.0019 | 1 | 2 | linoleate 13S-lipoxygenase activity |
| GO:0016509 | 0.0019 | 1098.4286 | 0.0019 | 1 | 2 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity |
| GO:0047977 | 0.0019 | 1098.4286 | 0.0019 | 1 | 2 | hepoxilin-epoxide hydrolase activity |
| GO:0004052 | 0.0029 | 549.1786 | 0.0029 | 1 | 3 | arachidonate 12-lipoxygenase activity |
| GO:0016508 | 0.0029 | 549.1786 | 0.0029 | 1 | 3 | long-chain-enoyl-CoA hydratase activity |
| GO:0047223 | 0.0029 | 549.1786 | 0.0029 | 1 | 3 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity |
| GO:0051120 | 0.0029 | 549.1786 | 0.0029 | 1 | 3 | hepoxilin A3 synthase activity |
| GO:0008532 | 0.0039 | 366.0952 | 0.0039 | 1 | 4 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity |
| GO:0004300 | 0.0049 | 274.5536 | 0.0049 | 1 | 5 | enoyl-CoA hydratase activity |
| GO:0003988 | 0.0058 | 219.6286 | 0.0058 | 1 | 6 | acetyl-CoA C-acyltransferase activity |
| GO:0035257 | 0.0071 | 18.0462 | 0.1286 | 2 | 132 | nuclear hormone receptor binding |
| GO:0016801 | 0.0087 | 137.2411 | 0.0088 | 1 | 9 | hydrolase activity, acting on ether bonds |
| GO:0031419 | 0.0087 | 137.2411 | 0.0088 | 1 | 9 | cobalamin binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0051424 | 0.0034 | 614.68 | 0.0034 | 1 | 2 | corticotropin-releasing hormone binding |
| GO:0030395 | 0.0051 | 307.32 | 0.0051 | 1 | 3 | lactose binding |
| GO:0033829 | 0.0051 | 307.32 | 0.0051 | 1 | 3 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity |
| GO:0000104 | 0.0067 | 204.8667 | 0.0068 | 1 | 4 | succinate dehydrogenase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005456 | 0.0014 | Inf | 0.0014 | 1 | 1 | CMP-N-acetylneuraminate transmembrane transporter activity |
| GO:0022894 | 0.0014 | Inf | 0.0014 | 1 | 1 | Intermediate conductance calcium-activated potassium channel activity |
| GO:0050840 | 0.0018 | 35.855 | 0.0641 | 2 | 47 | extracellular matrix binding |
| GO:0004872 | 0.002 | 4.9476 | 1.9344 | 7 | 1418 | receptor activity |
| GO:0008476 | 0.0027 | 768.6 | 0.0027 | 1 | 2 | protein-tyrosine sulfotransferase activity |
| GO:0005338 | 0.0095 | 128.0583 | 0.0095 | 1 | 7 | nucleotide-sugar transmembrane transporter activity |
| GO:0005351 | 0.0095 | 128.0583 | 0.0095 | 1 | 7 | sugar:proton symporter activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0032428 | 0.001 | Inf | 0.001 | 1 | 1 | beta-N-acetylgalactosaminidase activity |
| GO:0036313 | 0.001 | Inf | 0.001 | 1 | 1 | phosphatidylinositol 3-kinase catalytic subunit binding |
| GO:0004872 | 0.0022 | 5.9346 | 1.4738 | 6 | 1418 | receptor activity |
| GO:0050698 | 0.0031 | 512.5333 | 0.0031 | 1 | 3 | proteoglycan sulfotransferase activity |
| GO:0004871 | 0.0031 | 5.4743 | 1.585 | 6 | 1525 | signal transducer activity |
| GO:0001733 | 0.0042 | 341.6667 | 0.0042 | 1 | 4 | galactosylceramide sulfotransferase activity |
| GO:0004888 | 0.0043 | 5.8655 | 1.1547 | 5 | 1111 | transmembrane signaling receptor activity |
| GO:0050656 | 0.0062 | 204.9733 | 0.0062 | 1 | 6 | 3'-phosphoadenosine 5'-phosphosulfate binding |
| GO:0042608 | 0.0073 | 170.8 | 0.0073 | 1 | 7 | T cell receptor binding |
| GO:0046982 | 0.0083 | 8.4037 | 0.4303 | 3 | 414 | protein heterodimerization activity |
| GO:0016004 | 0.0093 | 128.0833 | 0.0094 | 1 | 9 | phospholipase activator activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0032947 | 0.0027 | 29.341 | 0.078 | 2 | 60 | protein complex scaffold |
| GO:0035591 | 0.0032 | 27.0035 | 0.0844 | 2 | 65 | signaling adaptor activity |
| GO:0001665 | 0.0039 | 404.5263 | 0.0039 | 1 | 3 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity |
| GO:0042608 | 0.0091 | 134.807 | 0.0091 | 1 | 7 | T cell receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0036313 | 0.0012 | Inf | 0.0012 | 1 | 1 | phosphatidylinositol 3-kinase catalytic subunit binding |
| GO:0015143 | 0.0023 | 904.4118 | 0.0023 | 1 | 2 | urate transmembrane transporter activity |
| GO:0003823 | 0.0033 | 26.5694 | 0.0865 | 2 | 74 | antigen binding |
| GO:0050698 | 0.0035 | 452.1765 | 0.0035 | 1 | 3 | proteoglycan sulfotransferase activity |
| GO:0001733 | 0.0047 | 301.4314 | 0.0047 | 1 | 4 | galactosylceramide sulfotransferase activity |
| GO:0015562 | 0.0047 | 301.4314 | 0.0047 | 1 | 4 | efflux transmembrane transporter activity |
| GO:0030883 | 0.0058 | 226.0588 | 0.0058 | 1 | 5 | endogenous lipid antigen binding |
| GO:0030884 | 0.0058 | 226.0588 | 0.0058 | 1 | 5 | exogenous lipid antigen binding |
| GO:0050656 | 0.007 | 180.8353 | 0.007 | 1 | 6 | 3'-phosphoadenosine 5'-phosphosulfate binding |
| GO:0042608 | 0.0082 | 150.6863 | 0.0082 | 1 | 7 | T cell receptor binding |
| GO:0071723 | 0.0082 | 150.6863 | 0.0082 | 1 | 7 | lipopeptide binding |
| GO:0005436 | 0.0093 | 129.1513 | 0.0094 | 1 | 8 | sodium:phosphate symporter activity |
| GO:0019534 | 0.0093 | 129.1513 | 0.0094 | 1 | 8 | toxin transporter activity |
| GO:0030881 | 0.0093 | 129.1513 | 0.0094 | 1 | 8 | beta-2-microglobulin binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050698 | 0.0031 | 512.5333 | 0.0031 | 1 | 3 | proteoglycan sulfotransferase activity |
| GO:0001733 | 0.0042 | 341.6667 | 0.0042 | 1 | 4 | galactosylceramide sulfotransferase activity |
| GO:0050656 | 0.0062 | 204.9733 | 0.0062 | 1 | 6 | 3'-phosphoadenosine 5'-phosphosulfate binding |
| GO:0042608 | 0.0073 | 170.8 | 0.0073 | 1 | 7 | T cell receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008502 | 0 | Inf | 0.0061 | 2 | 2 | melatonin receptor activity |
| GO:0043565 | 0 | 5.6987 | 2.4181 | 11 | 792 | sequence-specific DNA binding |
| GO:0003700 | 0 | 4.8412 | 3.1356 | 12 | 1027 | sequence-specific DNA binding transcription factor activity |
| GO:0022834 | 7e-04 | 10.9739 | 0.4061 | 4 | 133 | ligand-gated channel activity |
| GO:0004890 | 0.0011 | 48.6762 | 0.0489 | 2 | 16 | GABA-A receptor activity |
| GO:0005253 | 0.0013 | 15.5495 | 0.2137 | 3 | 70 | anion channel activity |
| GO:0015108 | 0.0017 | 14.0722 | 0.2351 | 3 | 77 | chloride transmembrane transporter activity |
| GO:0097159 | 0.0017 | 2.4627 | 16.6732 | 27 | 5461 | organic cyclic compound binding |
| GO:0005230 | 0.0017 | 37.4149 | 0.0616 | 2 | 21 | extracellular ligand-gated ion channel activity |
| GO:0003677 | 0.0024 | 3.4291 | 3.6463 | 10 | 1479 | DNA binding |
| GO:1901363 | 0.0034 | 2.3036 | 16.4595 | 26 | 5391 | heterocyclic compound binding |
| GO:0004119 | 0.0061 | 333.6087 | 0.0061 | 1 | 2 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity |
| GO:0005231 | 0.0087 | 15.4576 | 0.1404 | 2 | 46 | excitatory extracellular ligand-gated ion channel activity |
| GO:0016934 | 0.0091 | 166.7935 | 0.0092 | 1 | 3 | extracellular-glycine-gated chloride channel activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0051015 | 0.0021 | 36.3786 | 0.0695 | 2 | 107 | actin filament binding |
| GO:0032027 | 0.0026 | 569.6667 | 0.0026 | 1 | 4 | myosin light chain binding |
| GO:0086083 | 0.0039 | 341.7556 | 0.0039 | 1 | 6 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication |
| GO:0017128 | 0.0058 | 213.5556 | 0.0058 | 1 | 9 | phospholipid scramblase activity |
| GO:0098632 | 0.0065 | 189.8148 | 0.0065 | 1 | 10 | protein binding involved in cell-cell adhesion |
| GO:0005229 | 0.0091 | 131.3761 | 0.0091 | 1 | 14 | intracellular calcium activated chloride channel activity |
| GO:0034185 | 0.0097 | 121.9841 | 0.0097 | 1 | 15 | apolipoprotein binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0.0018 | 15.9206 | 0.2551 | 3 | 357 | olfactory receptor activity |
| GO:0004499 | 0.0036 | 384.475 | 0.0036 | 1 | 5 | N,N-dimethylaniline monooxygenase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004252 | 0.0035 | 10.9325 | 0.3056 | 3 | 147 | serine-type endopeptidase activity |
| GO:0017171 | 0.0052 | 9.4126 | 0.3534 | 3 | 170 | serine hydrolase activity |
| GO:0001665 | 0.0062 | 247.7419 | 0.0062 | 1 | 3 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0060089 | 2e-04 | 7.044 | 1.9116 | 8 | 1731 | molecular transducer activity |
| GO:0038023 | 0.0013 | 6.4267 | 1.3351 | 6 | 1209 | signaling receptor activity |
| GO:0019911 | 0.0044 | 320.2917 | 0.0044 | 1 | 4 | structural constituent of myelin sheath |
| GO:0035197 | 0.0044 | 320.2917 | 0.0044 | 1 | 4 | siRNA binding |
| GO:0004984 | 0.0066 | 9.0938 | 0.3942 | 3 | 357 | olfactory receptor activity |
| GO:0030368 | 0.0077 | 160.1146 | 0.0077 | 1 | 7 | interleukin-17 receptor activity |
| GO:0004930 | 0.0085 | 5.9178 | 0.8437 | 4 | 764 | G-protein coupled receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0043565 | 0 | 6.9456 | 2.4695 | 13 | 792 | sequence-specific DNA binding |
| GO:0003700 | 0 | 5.8261 | 3.2023 | 14 | 1027 | sequence-specific DNA binding transcription factor activity |
| GO:0015459 | 3e-04 | 24.8862 | 0.1372 | 3 | 44 | potassium channel regulator activity |
| GO:0001105 | 0.0025 | 30.2846 | 0.0748 | 2 | 24 | RNA polymerase II transcription coactivator activity |
| GO:0002058 | 0.0031 | Inf | 0.0031 | 1 | 1 | uracil binding |
| GO:0002059 | 0.0031 | Inf | 0.0031 | 1 | 1 | thymine binding |
| GO:0033798 | 0.0031 | Inf | 0.0031 | 1 | 1 | thyroxine 5-deiodinase activity |
| GO:0005216 | 0.0054 | 4.8404 | 1.1381 | 5 | 365 | ion channel activity |
| GO:0000977 | 0.0055 | 4.8267 | 1.1412 | 5 | 366 | RNA polymerase II regulatory region sequence-specific DNA binding |
| GO:0005267 | 0.0055 | 9.0679 | 0.3586 | 3 | 115 | potassium channel activity |
| GO:0001641 | 0.0062 | 326.4894 | 0.0062 | 1 | 2 | group II metabotropic glutamate receptor activity |
| GO:0004157 | 0.0062 | 326.4894 | 0.0062 | 1 | 2 | dihydropyrimidinase activity |
| GO:0008281 | 0.0062 | 326.4894 | 0.0062 | 1 | 2 | sulfonylurea receptor activity |
| GO:0008502 | 0.0062 | 326.4894 | 0.0062 | 1 | 2 | melatonin receptor activity |
| GO:0030305 | 0.0062 | 326.4894 | 0.0062 | 1 | 2 | heparanase activity |
| GO:0050682 | 0.0062 | 326.4894 | 0.0062 | 1 | 2 | AF-2 domain binding |
| GO:0001228 | 0.0066 | 5.8205 | 0.7483 | 4 | 240 | RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription |
| GO:0015267 | 0.0075 | 4.4592 | 1.2316 | 5 | 395 | channel activity |
| GO:0044212 | 0.0084 | 3.7304 | 1.7836 | 6 | 572 | transcription regulatory region DNA binding |
| GO:0001067 | 0.0086 | 3.7033 | 1.796 | 6 | 576 | regulatory region nucleic acid binding |
| GO:0004800 | 0.0093 | 163.234 | 0.0094 | 1 | 3 | thyroxine 5'-deiodinase activity |
| GO:0022843 | 0.0096 | 7.3469 | 0.4397 | 3 | 141 | voltage-gated cation channel activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004872 | 1e-04 | 7.924 | 1.658 | 8 | 1418 | receptor activity |
| GO:0023026 | 2e-04 | 137.1607 | 0.0187 | 2 | 16 | MHC class II protein complex binding |
| GO:0004871 | 2e-04 | 7.3086 | 1.7832 | 8 | 1525 | signal transducer activity |
| GO:0016517 | 0.0012 | Inf | 0.0012 | 1 | 1 | interleukin-12 receptor activity |
| GO:0030107 | 0.0012 | Inf | 0.0012 | 1 | 1 | HLA-A specific inhibitory MHC class I receptor activity |
| GO:0030109 | 0.0023 | 904.4118 | 0.0023 | 1 | 2 | HLA-B specific inhibitory MHC class I receptor activity |
| GO:0042019 | 0.0023 | 904.4118 | 0.0023 | 1 | 2 | interleukin-23 binding |
| GO:0042020 | 0.0023 | 904.4118 | 0.0023 | 1 | 2 | interleukin-23 receptor activity |
| GO:0003823 | 0.0033 | 26.5694 | 0.0865 | 2 | 74 | antigen binding |
| GO:0030369 | 0.0035 | 452.1765 | 0.0035 | 1 | 3 | ICAM-3 receptor activity |
| GO:0004888 | 0.0042 | 5.919 | 1.1451 | 5 | 1101 | transmembrane signaling receptor activity |
| GO:0004720 | 0.0047 | 301.4314 | 0.0047 | 1 | 4 | protein-lysine 6-oxidase activity |
| GO:0005143 | 0.0058 | 226.0588 | 0.0058 | 1 | 5 | interleukin-12 receptor binding |
| GO:0038036 | 0.007 | 180.8353 | 0.007 | 1 | 6 | sphingosine-1-phosphate receptor activity |
| GO:0032393 | 0.0082 | 150.6863 | 0.0082 | 1 | 7 | MHC class I receptor activity |
| GO:0004126 | 0.0093 | 129.1513 | 0.0094 | 1 | 8 | cytidine deaminase activity |
| GO:0070492 | 0.0093 | 129.1513 | 0.0094 | 1 | 8 | oligosaccharide binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005001 | 9e-04 | 53.8211 | 0.0442 | 2 | 17 | transmembrane receptor protein tyrosine phosphatase activity |
| GO:0003823 | 9e-04 | 17.453 | 0.1923 | 3 | 74 | antigen binding |
| GO:0043325 | 0.001 | 50.4539 | 0.0468 | 2 | 18 | phosphatidylinositol-3,4-bisphosphate binding |
| GO:0005164 | 0.0024 | 31.0283 | 0.0728 | 2 | 28 | tumor necrosis factor receptor binding |
| GO:0005547 | 0.0026 | 29.8772 | 0.0754 | 2 | 29 | phosphatidylinositol-3,4,5-trisphosphate binding |
| GO:0001631 | 0.0026 | Inf | 0.0026 | 1 | 1 | cysteinyl leukotriene receptor activity |
| GO:0005147 | 0.0026 | Inf | 0.0026 | 1 | 1 | oncostatin-M receptor binding |
| GO:0042498 | 0.0052 | 393.6667 | 0.0052 | 1 | 2 | diacyl lipopeptide binding |
| GO:0004721 | 0.0081 | 7.8992 | 0.4131 | 3 | 159 | phosphoprotein phosphatase activity |
| GO:0003725 | 0.009 | 15.1946 | 0.1429 | 2 | 55 | double-stranded RNA binding |
| GO:0004872 | 0.0092 | 2.8733 | 3.6846 | 9 | 1418 | receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004872 | 0.0013 | 4.6588 | 2.3028 | 8 | 1418 | receptor activity |
| GO:0004874 | 0.0016 | Inf | 0.0016 | 1 | 1 | aryl hydrocarbon receptor activity |
| GO:0004910 | 0.0016 | Inf | 0.0016 | 1 | 1 | interleukin-1, Type II, blocking receptor activity |
| GO:0015410 | 0.0016 | Inf | 0.0016 | 1 | 1 | manganese-transporting ATPase activity |
| GO:0035755 | 0.0016 | Inf | 0.0016 | 1 | 1 | cardiolipin hydrolase activity |
| GO:0046982 | 0.0042 | 6.9496 | 0.6723 | 4 | 414 | protein heterodimerization activity |
| GO:0017162 | 0.0049 | 320.1458 | 0.0049 | 1 | 3 | aryl hydrocarbon receptor binding |
| GO:0033829 | 0.0049 | 320.1458 | 0.0049 | 1 | 3 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity |
| GO:0015057 | 0.0081 | 160.0521 | 0.0081 | 1 | 5 | thrombin receptor activity |
| GO:0045159 | 0.0081 | 160.0521 | 0.0081 | 1 | 5 | myosin II binding |
| GO:0098639 | 0.0081 | 160.0521 | 0.0081 | 1 | 5 | collagen binding involved in cell-matrix adhesion |
| GO:0004871 | 0.009 | 3.5484 | 2.4766 | 7 | 1525 | signal transducer activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008009 | 0 | 50.9203 | 0.0717 | 3 | 46 | chemokine activity |
| GO:0005126 | 5e-04 | 12.5552 | 0.382 | 4 | 245 | cytokine receptor binding |
| GO:0004872 | 0.001 | 4.9504 | 2.2107 | 8 | 1418 | receptor activity |
| GO:0030107 | 0.0016 | Inf | 0.0016 | 1 | 1 | HLA-A specific inhibitory MHC class I receptor activity |
| GO:0045127 | 0.0016 | Inf | 0.0016 | 1 | 1 | N-acetylglucosamine kinase activity |
| GO:0008520 | 0.0031 | 668.2174 | 0.0031 | 1 | 2 | L-ascorbate:sodium symporter activity |
| GO:0008523 | 0.0031 | 668.2174 | 0.0031 | 1 | 2 | sodium-dependent multivitamin transmembrane transporter activity |
| GO:0009384 | 0.0031 | 668.2174 | 0.0031 | 1 | 2 | N-acylmannosamine kinase activity |
| GO:0030109 | 0.0031 | 668.2174 | 0.0031 | 1 | 2 | HLA-B specific inhibitory MHC class I receptor activity |
| GO:0070890 | 0.0031 | 668.2174 | 0.0031 | 1 | 2 | sodium-dependent L-ascorbate transmembrane transporter activity |
| GO:0001730 | 0.0047 | 334.087 | 0.0047 | 1 | 3 | 2'-5'-oligoadenylate synthetase activity |
| GO:0001847 | 0.0047 | 334.087 | 0.0047 | 1 | 3 | opsonin receptor activity |
| GO:0004698 | 0.0047 | 334.087 | 0.0047 | 1 | 3 | calcium-dependent protein kinase C activity |
| GO:0004965 | 0.0047 | 334.087 | 0.0047 | 1 | 3 | G-protein coupled GABA receptor activity |
| GO:0004982 | 0.0047 | 334.087 | 0.0047 | 1 | 3 | N-formyl peptide receptor activity |
| GO:0001664 | 0.0055 | 9.3624 | 0.3648 | 3 | 234 | G-protein coupled receptor binding |
| GO:0070891 | 0.0062 | 222.7101 | 0.0062 | 1 | 4 | lipoteichoic acid binding |
| GO:0015205 | 0.0078 | 167.0217 | 0.0078 | 1 | 5 | nucleobase transmembrane transporter activity |
| GO:0016019 | 0.0078 | 167.0217 | 0.0078 | 1 | 5 | peptidoglycan receptor activity |
| GO:0031726 | 0.0093 | 133.6087 | 0.0094 | 1 | 6 | CCR1 chemokine receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008009 | 1e-04 | 44.5465 | 0.0807 | 3 | 46 | chemokine activity |
| GO:0005126 | 8e-04 | 10.9154 | 0.4297 | 4 | 245 | cytokine receptor binding |
| GO:0030107 | 0.0018 | Inf | 0.0018 | 1 | 1 | HLA-A specific inhibitory MHC class I receptor activity |
| GO:0045127 | 0.0018 | Inf | 0.0018 | 1 | 1 | N-acetylglucosamine kinase activity |
| GO:0004872 | 0.0023 | 4.1678 | 2.4871 | 8 | 1418 | receptor activity |
| GO:0008520 | 0.0035 | 591 | 0.0035 | 1 | 2 | L-ascorbate:sodium symporter activity |
| GO:0008523 | 0.0035 | 591 | 0.0035 | 1 | 2 | sodium-dependent multivitamin transmembrane transporter activity |
| GO:0009384 | 0.0035 | 591 | 0.0035 | 1 | 2 | N-acylmannosamine kinase activity |
| GO:0030109 | 0.0035 | 591 | 0.0035 | 1 | 2 | HLA-B specific inhibitory MHC class I receptor activity |
| GO:0070890 | 0.0035 | 591 | 0.0035 | 1 | 2 | sodium-dependent L-ascorbate transmembrane transporter activity |
| GO:0001847 | 0.0053 | 295.4808 | 0.0053 | 1 | 3 | opsonin receptor activity |
| GO:0004698 | 0.0053 | 295.4808 | 0.0053 | 1 | 3 | calcium-dependent protein kinase C activity |
| GO:0004965 | 0.0053 | 295.4808 | 0.0053 | 1 | 3 | G-protein coupled GABA receptor activity |
| GO:0004982 | 0.0053 | 295.4808 | 0.0053 | 1 | 3 | N-formyl peptide receptor activity |
| GO:0047374 | 0.0053 | 295.4808 | 0.0053 | 1 | 3 | methylumbelliferyl-acetate deacetylase activity |
| GO:0070891 | 0.007 | 196.9744 | 0.007 | 1 | 4 | lipoteichoic acid binding |
| GO:0001664 | 0.0077 | 8.1905 | 0.4104 | 3 | 234 | G-protein coupled receptor binding |
| GO:0015205 | 0.0087 | 147.7212 | 0.0088 | 1 | 5 | nucleobase transmembrane transporter activity |
| GO:0016019 | 0.0087 | 147.7212 | 0.0088 | 1 | 5 | peptidoglycan receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0045127 | 0.0015 | Inf | 0.0015 | 1 | 1 | N-acetylglucosamine kinase activity |
| GO:0008009 | 0.0021 | 33.1753 | 0.0687 | 2 | 46 | chemokine activity |
| GO:0008520 | 0.003 | 698.6364 | 0.003 | 1 | 2 | L-ascorbate:sodium symporter activity |
| GO:0008523 | 0.003 | 698.6364 | 0.003 | 1 | 2 | sodium-dependent multivitamin transmembrane transporter activity |
| GO:0009384 | 0.003 | 698.6364 | 0.003 | 1 | 2 | N-acylmannosamine kinase activity |
| GO:0070890 | 0.003 | 698.6364 | 0.003 | 1 | 2 | sodium-dependent L-ascorbate transmembrane transporter activity |
| GO:0001730 | 0.0045 | 349.2955 | 0.0045 | 1 | 3 | 2'-5'-oligoadenylate synthetase activity |
| GO:0004698 | 0.0045 | 349.2955 | 0.0045 | 1 | 3 | calcium-dependent protein kinase C activity |
| GO:0004965 | 0.0045 | 349.2955 | 0.0045 | 1 | 3 | G-protein coupled GABA receptor activity |
| GO:0004982 | 0.0045 | 349.2955 | 0.0045 | 1 | 3 | N-formyl peptide receptor activity |
| GO:0005126 | 0.0056 | 9.3775 | 0.3661 | 3 | 245 | cytokine receptor binding |
| GO:0004095 | 0.006 | 232.8485 | 0.006 | 1 | 4 | carnitine O-palmitoyltransferase activity |
| GO:0015205 | 0.0074 | 174.625 | 0.0075 | 1 | 5 | nucleobase transmembrane transporter activity |
| GO:0048248 | 0.0074 | 174.625 | 0.0075 | 1 | 5 | CXCR3 chemokine receptor binding |
| GO:0031726 | 0.0089 | 139.6909 | 0.009 | 1 | 6 | CCR1 chemokine receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030107 | 0.0013 | Inf | 0.0013 | 1 | 1 | HLA-A specific inhibitory MHC class I receptor activity |
| GO:0002039 | 0.0024 | 31.5226 | 0.0728 | 2 | 56 | p53 binding |
| GO:0030109 | 0.0026 | 809.1053 | 0.0026 | 1 | 2 | HLA-B specific inhibitory MHC class I receptor activity |
| GO:0030246 | 0.0043 | 10.463 | 0.3352 | 3 | 258 | carbohydrate binding |
| GO:0031698 | 0.0052 | 269.6667 | 0.0052 | 1 | 4 | beta-2 adrenergic receptor binding |
| GO:0019904 | 0.0052 | 6.6877 | 0.725 | 4 | 558 | protein domain specific binding |
| GO:1901981 | 0.0061 | 19.0824 | 0.1182 | 2 | 91 | phosphatidylinositol phosphate binding |
| GO:0016176 | 0.0065 | 202.2368 | 0.0065 | 1 | 5 | superoxide-generating NADPH oxidase activator activity |
| GO:0004872 | 0.0076 | 4.2378 | 1.8423 | 6 | 1418 | receptor activity |
| GO:0032393 | 0.0091 | 134.807 | 0.0091 | 1 | 7 | MHC class I receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004464 | 0.003 | 698.6364 | 0.003 | 1 | 2 | leukotriene-C4 synthase activity |
| GO:0005332 | 0.006 | 232.8485 | 0.006 | 1 | 4 | gamma-aminobutyric acid:sodium symporter activity |
| GO:0031698 | 0.006 | 232.8485 | 0.006 | 1 | 4 | beta-2 adrenergic receptor binding |
| GO:0051525 | 0.006 | 232.8485 | 0.006 | 1 | 4 | NFAT protein binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030107 | 0.0013 | Inf | 0.0013 | 1 | 1 | HLA-A specific inhibitory MHC class I receptor activity |
| GO:0002039 | 0.0024 | 31.5226 | 0.0728 | 2 | 56 | p53 binding |
| GO:0030109 | 0.0026 | 809.1053 | 0.0026 | 1 | 2 | HLA-B specific inhibitory MHC class I receptor activity |
| GO:0030246 | 0.0043 | 10.463 | 0.3352 | 3 | 258 | carbohydrate binding |
| GO:0031698 | 0.0052 | 269.6667 | 0.0052 | 1 | 4 | beta-2 adrenergic receptor binding |
| GO:0019904 | 0.0052 | 6.6877 | 0.725 | 4 | 558 | protein domain specific binding |
| GO:1901981 | 0.0061 | 19.0824 | 0.1182 | 2 | 91 | phosphatidylinositol phosphate binding |
| GO:0016176 | 0.0065 | 202.2368 | 0.0065 | 1 | 5 | superoxide-generating NADPH oxidase activator activity |
| GO:0004872 | 0.0076 | 4.2378 | 1.8423 | 6 | 1418 | receptor activity |
| GO:0032393 | 0.0091 | 134.807 | 0.0091 | 1 | 7 | MHC class I receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0003827 | 0.0016 | Inf | 0.0016 | 1 | 1 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity |
| GO:0043843 | 0.0016 | Inf | 0.0016 | 1 | 1 | ADP-specific glucokinase activity |
| GO:0051287 | 0.0026 | 29.6116 | 0.0763 | 2 | 47 | NAD binding |
| GO:0005507 | 0.003 | 27.7554 | 0.0812 | 2 | 50 | copper ion binding |
| GO:0004367 | 0.0032 | 640.3333 | 0.0032 | 1 | 2 | glycerol-3-phosphate dehydrogenase [NAD+] activity |
| GO:0004368 | 0.0032 | 640.3333 | 0.0032 | 1 | 2 | glycerol-3-phosphate dehydrogenase activity |
| GO:0016509 | 0.0032 | 640.3333 | 0.0032 | 1 | 2 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity |
| GO:0043120 | 0.0032 | 640.3333 | 0.0032 | 1 | 2 | tumor necrosis factor binding |
| GO:0042379 | 0.0038 | 24.2119 | 0.0926 | 2 | 57 | chemokine receptor binding |
| GO:0016508 | 0.0049 | 320.1458 | 0.0049 | 1 | 3 | long-chain-enoyl-CoA hydratase activity |
| GO:0019959 | 0.0049 | 320.1458 | 0.0049 | 1 | 3 | interleukin-8 binding |
| GO:0051525 | 0.0065 | 213.4167 | 0.0065 | 1 | 4 | NFAT protein binding |
| GO:0004300 | 0.0081 | 160.0521 | 0.0081 | 1 | 5 | enoyl-CoA hydratase activity |
| GO:0016176 | 0.0081 | 160.0521 | 0.0081 | 1 | 5 | superoxide-generating NADPH oxidase activator activity |
| GO:0030246 | 0.0081 | 8.0824 | 0.419 | 3 | 258 | carbohydrate binding |
| GO:0003988 | 0.0097 | 128.0333 | 0.0097 | 1 | 6 | acetyl-CoA C-acyltransferase activity |
| GO:0019966 | 0.0097 | 128.0333 | 0.0097 | 1 | 6 | interleukin-1 binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0015143 | 0.0022 | 961 | 0.0022 | 1 | 2 | urate transmembrane transporter activity |
| GO:0032182 | 0.0042 | 23.433 | 0.0983 | 2 | 89 | ubiquitin-like protein binding |
| GO:0015562 | 0.0044 | 320.2917 | 0.0044 | 1 | 4 | efflux transmembrane transporter activity |
| GO:0005436 | 0.0088 | 137.2321 | 0.0088 | 1 | 8 | sodium:phosphate symporter activity |
| GO:0019534 | 0.0088 | 137.2321 | 0.0088 | 1 | 8 | toxin transporter activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0035717 | 0.0016 | Inf | 0.0016 | 1 | 1 | chemokine (C-C motif) ligand 7 binding |
| GO:0004342 | 0.0032 | 640.3333 | 0.0032 | 1 | 2 | glucosamine-6-phosphate deaminase activity |
| GO:0015143 | 0.0032 | 640.3333 | 0.0032 | 1 | 2 | urate transmembrane transporter activity |
| GO:0071791 | 0.0032 | 640.3333 | 0.0032 | 1 | 2 | chemokine (C-C motif) ligand 5 binding |
| GO:0042799 | 0.0049 | 320.1458 | 0.0049 | 1 | 3 | histone methyltransferase activity (H4-K20 specific) |
| GO:0015562 | 0.0065 | 213.4167 | 0.0065 | 1 | 4 | efflux transmembrane transporter activity |
| GO:0046975 | 0.0065 | 213.4167 | 0.0065 | 1 | 4 | histone methyltransferase activity (H3-K36 specific) |
| GO:0016787 | 0.0068 | 3.2866 | 3.6621 | 9 | 2255 | hydrolase activity |
| GO:0004620 | 0.0089 | 15.453 | 0.1429 | 2 | 88 | phospholipase activity |
| GO:0004523 | 0.0097 | 128.0333 | 0.0097 | 1 | 6 | RNA-DNA hybrid ribonuclease activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0019534 | 0 | 394.1795 | 0.0078 | 2 | 8 | toxin transporter activity |
| GO:0001631 | 0.001 | Inf | 0.001 | 1 | 1 | cysteinyl leukotriene receptor activity |
| GO:0034041 | 0.001 | Inf | 0.001 | 1 | 1 | sterol-transporting ATPase activity |
| GO:0071886 | 0.001 | Inf | 0.001 | 1 | 1 | 1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding |
| GO:0015143 | 0.0019 | 1098.4286 | 0.0019 | 1 | 2 | urate transmembrane transporter activity |
| GO:0034437 | 0.0019 | 1098.4286 | 0.0019 | 1 | 2 | glycoprotein transporter activity |
| GO:0004888 | 0.0032 | 6.4525 | 1.0826 | 5 | 1111 | transmembrane signaling receptor activity |
| GO:0015562 | 0.0039 | 366.0952 | 0.0039 | 1 | 4 | efflux transmembrane transporter activity |
| GO:0051864 | 0.0058 | 219.6286 | 0.0058 | 1 | 6 | histone demethylase activity (H3-K36 specific) |
| GO:0030274 | 0.0068 | 183.0119 | 0.0068 | 1 | 7 | LIM domain binding |
| GO:0051378 | 0.0068 | 183.0119 | 0.0068 | 1 | 7 | serotonin binding |
| GO:0005436 | 0.0078 | 156.8571 | 0.0078 | 1 | 8 | sodium:phosphate symporter activity |
| GO:0048156 | 0.0078 | 156.8571 | 0.0078 | 1 | 8 | tau protein binding |
| GO:0005068 | 0.0087 | 137.2411 | 0.0088 | 1 | 9 | transmembrane receptor protein tyrosine kinase adaptor activity |
| GO:0004872 | 0.009 | 4.942 | 1.3817 | 5 | 1418 | receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0034988 | 0.0016 | Inf | 0.0016 | 1 | 1 | Fc-gamma receptor I complex binding |
| GO:0004871 | 0.0021 | 4.297 | 2.4766 | 8 | 1525 | signal transducer activity |
| GO:0004698 | 0.0049 | 320.1458 | 0.0049 | 1 | 3 | calcium-dependent protein kinase C activity |
| GO:0004872 | 0.006 | 3.847 | 2.3028 | 7 | 1418 | receptor activity |
| GO:0004888 | 0.0075 | 4.0764 | 1.8043 | 6 | 1111 | transmembrane signaling receptor activity |
| GO:0015057 | 0.0081 | 160.0521 | 0.0081 | 1 | 5 | thrombin receptor activity |
| GO:0003680 | 0.0097 | 128.0333 | 0.0097 | 1 | 6 | AT DNA binding |
| GO:0031726 | 0.0097 | 128.0333 | 0.0097 | 1 | 6 | CCR1 chemokine receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0034988 | 0.0012 | Inf | 0.0012 | 1 | 1 | Fc-gamma receptor I complex binding |
| GO:0004715 | 0.0013 | 42.9496 | 0.0543 | 2 | 44 | non-membrane spanning protein tyrosine kinase activity |
| GO:0004698 | 0.0037 | 427.0278 | 0.0037 | 1 | 3 | calcium-dependent protein kinase C activity |
| GO:0030395 | 0.0037 | 427.0278 | 0.0037 | 1 | 3 | lactose binding |
| GO:0051525 | 0.0049 | 284.6667 | 0.0049 | 1 | 4 | NFAT protein binding |
| GO:0070290 | 0.0062 | 213.4861 | 0.0062 | 1 | 5 | N-acylphosphatidylethanolamine-specific phospholipase D activity |
| GO:0004630 | 0.0074 | 170.7778 | 0.0074 | 1 | 6 | phospholipase D activity |
| GO:0031726 | 0.0074 | 170.7778 | 0.0074 | 1 | 6 | CCR1 chemokine receptor binding |
| GO:0004931 | 0.0086 | 142.3056 | 0.0086 | 1 | 7 | extracellular ATP-gated cation channel activity |
| GO:0016494 | 0.0086 | 142.3056 | 0.0086 | 1 | 7 | C-X-C chemokine receptor activity |
| GO:0031730 | 0.0086 | 142.3056 | 0.0086 | 1 | 7 | CCR5 chemokine receptor binding |
| GO:0070492 | 0.0098 | 121.9683 | 0.0099 | 1 | 8 | oligosaccharide binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008476 | 0.003 | 698.6364 | 0.003 | 1 | 2 | protein-tyrosine sulfotransferase activity |
| GO:0004698 | 0.0045 | 349.2955 | 0.0045 | 1 | 3 | calcium-dependent protein kinase C activity |
| GO:0031726 | 0.0089 | 139.6909 | 0.009 | 1 | 6 | CCR1 chemokine receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0051736 | 0.0014 | Inf | 0.0014 | 1 | 1 | ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity |
| GO:0004698 | 0.0041 | 384.275 | 0.0041 | 1 | 3 | calcium-dependent protein kinase C activity |
| GO:0030395 | 0.0041 | 384.275 | 0.0041 | 1 | 3 | lactose binding |
| GO:0046404 | 0.0041 | 384.275 | 0.0041 | 1 | 3 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity |
| GO:0030246 | 0.0049 | 9.881 | 0.352 | 3 | 258 | carbohydrate binding |
| GO:0019911 | 0.0054 | 256.1667 | 0.0055 | 1 | 4 | structural constituent of myelin sheath |
| GO:0051731 | 0.0054 | 256.1667 | 0.0055 | 1 | 4 | polynucleotide 5'-hydroxyl-kinase activity |
| GO:0060089 | 0.0063 | 3.9585 | 2.3614 | 7 | 1731 | molecular transducer activity |
| GO:0004565 | 0.0068 | 192.1125 | 0.0068 | 1 | 5 | beta-galactosidase activity |
| GO:0015057 | 0.0068 | 192.1125 | 0.0068 | 1 | 5 | thrombin receptor activity |
| GO:0001849 | 0.0082 | 153.68 | 0.0082 | 1 | 6 | complement component C1q binding |
| GO:0031726 | 0.0082 | 153.68 | 0.0082 | 1 | 6 | CCR1 chemokine receptor binding |
| GO:0004931 | 0.0095 | 128.0583 | 0.0095 | 1 | 7 | extracellular ATP-gated cation channel activity |
| GO:0031730 | 0.0095 | 128.0583 | 0.0095 | 1 | 7 | CCR5 chemokine receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0043027 | 1e-04 | 243.8889 | 0.012 | 2 | 23 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process |
| GO:0005125 | 1e-04 | 44.2136 | 0.1086 | 3 | 209 | cytokine activity |
| GO:0045523 | 0.001 | 2197.8571 | 0.001 | 1 | 2 | interleukin-27 receptor binding |
| GO:0004866 | 0.0027 | 32.9697 | 0.0811 | 2 | 156 | endopeptidase inhibitor activity |
| GO:0061134 | 0.0043 | 25.9675 | 0.1024 | 2 | 197 | peptidase regulator activity |
| GO:0017128 | 0.0047 | 274.6071 | 0.0047 | 1 | 9 | phospholipid scramblase activity |
| GO:0005126 | 0.0049 | 25.1353 | 0.1105 | 2 | 243 | cytokine receptor binding |
| GO:0001664 | 0.0061 | 21.773 | 0.1216 | 2 | 234 | G-protein coupled receptor binding |
| GO:0005229 | 0.0073 | 168.9341 | 0.0073 | 1 | 14 | intracellular calcium activated chloride channel activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008502 | 0 | Inf | 0.007 | 2 | 2 | melatonin receptor activity |
| GO:0043565 | 1e-04 | 4.7688 | 2.7782 | 11 | 792 | sequence-specific DNA binding |
| GO:0005509 | 0.0017 | 4.0208 | 2.2591 | 8 | 644 | calcium ion binding |
| GO:0003700 | 0.0027 | 3.2008 | 3.6026 | 10 | 1027 | sequence-specific DNA binding transcription factor activity |
| GO:0008144 | 0.004 | 10.1952 | 0.3192 | 3 | 91 | drug binding |
| GO:0004119 | 0.007 | 289.4151 | 0.007 | 1 | 2 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042610 | 0.0042 | 495.5161 | 0.0042 | 1 | 2 | CD8 receptor binding |
| GO:0008237 | 0.0059 | 8.9775 | 0.37 | 3 | 178 | metallopeptidase activity |
| GO:0004937 | 0.0062 | 247.7419 | 0.0062 | 1 | 3 | alpha1-adrenergic receptor activity |
| GO:0005329 | 0.0062 | 247.7419 | 0.0062 | 1 | 3 | dopamine transmembrane transporter activity |
| GO:0004144 | 0.0083 | 165.1505 | 0.0083 | 1 | 4 | diacylglycerol O-acyltransferase activity |
| GO:0008047 | 0.009 | 5.413 | 0.8294 | 4 | 399 | enzyme activator activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008479 | 0.0025 | 854.1111 | 0.0025 | 1 | 2 | queuine tRNA-ribosyltransferase activity |
| GO:0051525 | 0.0049 | 284.6667 | 0.0049 | 1 | 4 | NFAT protein binding |
| GO:0070290 | 0.0062 | 213.4861 | 0.0062 | 1 | 5 | N-acylphosphatidylethanolamine-specific phospholipase D activity |
| GO:0004630 | 0.0074 | 170.7778 | 0.0074 | 1 | 6 | phospholipase D activity |
| GO:0038036 | 0.0074 | 170.7778 | 0.0074 | 1 | 6 | sphingosine-1-phosphate receptor activity |
| GO:0016494 | 0.0086 | 142.3056 | 0.0086 | 1 | 7 | C-X-C chemokine receptor activity |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:2001141 | 0 | 4.2897 | 42.333 | 106 | 3239 | regulation of RNA biosynthetic process |
| GO:0034654 | 0 | 3.8687 | 49.4037 | 111 | 3780 | nucleobase-containing compound biosynthetic process |
| GO:0019219 | 0 | 3.9901 | 44.3367 | 104 | 3477 | regulation of nucleobase-containing compound metabolic process |
| GO:0045944 | 0 | 5.7744 | 11.6974 | 51 | 895 | positive regulation of transcription from RNA polymerase II promoter |
| GO:1903508 | 0 | 4.7967 | 15.5138 | 56 | 1187 | positive regulation of nucleic acid-templated transcription |
| GO:0051254 | 0 | 4.6233 | 16.3895 | 57 | 1254 | positive regulation of RNA metabolic process |
| GO:0021517 | 0 | 35.4352 | 0.6012 | 14 | 46 | ventral spinal cord development |
| GO:0010628 | 0 | 4.1444 | 18.4414 | 58 | 1411 | positive regulation of gene expression |
| GO:0010557 | 0 | 4.173 | 17.9317 | 57 | 1372 | positive regulation of macromolecule biosynthetic process |
| GO:0060255 | 0 | 3.1318 | 66.1853 | 121 | 5064 | regulation of macromolecule metabolic process |
| GO:0051173 | 0 | 3.9853 | 19.5001 | 59 | 1492 | positive regulation of nitrogen compound metabolic process |
| GO:0031328 | 0 | 3.8964 | 19.4609 | 58 | 1489 | positive regulation of cellular biosynthetic process |
| GO:0021515 | 0 | 34.8802 | 0.5155 | 12 | 40 | cell differentiation in spinal cord |
| GO:0007420 | 0 | 5.4432 | 7.8549 | 35 | 601 | brain development |
| GO:0009889 | 0 | 3.5415 | 28.8298 | 69 | 2581 | regulation of biosynthetic process |
| GO:0048731 | 0 | 3.7918 | 21.4138 | 56 | 2124 | system development |
| GO:0046483 | 0 | 2.6888 | 68.3026 | 116 | 5226 | heterocycle metabolic process |
| GO:0009792 | 0 | 4.8973 | 7.8027 | 32 | 597 | embryo development ending in birth or egg hatching |
| GO:0006725 | 0 | 2.6577 | 66.0766 | 112 | 5156 | cellular aromatic compound metabolic process |
| GO:0048729 | 0 | 4.8961 | 7.5282 | 31 | 576 | tissue morphogenesis |
| GO:0021511 | 0 | 39.4792 | 0.3529 | 9 | 27 | spinal cord patterning |
| GO:0034641 | 0 | 2.5559 | 72.4457 | 118 | 5543 | cellular nitrogen compound metabolic process |
| GO:0022008 | 0 | 4.3553 | 9.4882 | 34 | 815 | neurogenesis |
| GO:0009952 | 0 | 10.0267 | 1.904 | 16 | 152 | anterior/posterior pattern specification |
| GO:1901576 | 0 | 2.4757 | 71.0734 | 115 | 5438 | organic substance biosynthetic process |
| GO:1901360 | 0 | 2.4996 | 68.7423 | 112 | 5364 | organic cyclic compound metabolic process |
| GO:0021953 | 0 | 13.9222 | 1.0541 | 12 | 84 | central nervous system neuron differentiation |
| GO:0048562 | 0 | 8.6348 | 2.1763 | 16 | 174 | embryonic organ morphogenesis |
| GO:1903507 | 0 | 3.5655 | 13.0567 | 39 | 999 | negative regulation of nucleic acid-templated transcription |
| GO:0000122 | 0 | 4.1543 | 8.43 | 30 | 645 | negative regulation of transcription from RNA polymerase II promoter |
| GO:0051172 | 0 | 3.2745 | 15.357 | 42 | 1175 | negative regulation of nitrogen compound metabolic process |
| GO:0009890 | 0 | 3.1961 | 16.1281 | 43 | 1234 | negative regulation of biosynthetic process |
| GO:0034645 | 0 | 2.6733 | 36.9887 | 71 | 3263 | cellular macromolecule biosynthetic process |
| GO:0009953 | 0 | 14.2401 | 0.9451 | 11 | 74 | dorsal/ventral pattern formation |
| GO:0051253 | 0 | 3.3663 | 13.7494 | 39 | 1052 | negative regulation of RNA metabolic process |
| GO:0090596 | 0 | 6.3926 | 3.2413 | 18 | 248 | sensory organ morphogenesis |
| GO:2000113 | 0 | 3.2392 | 14.233 | 39 | 1089 | negative regulation of cellular macromolecule biosynthetic process |
| GO:0007218 | 0 | 11.9795 | 1.0979 | 11 | 84 | neuropeptide signaling pathway |
| GO:0065007 | 0 | 2.6114 | 133.3117 | 168 | 10200 | biological regulation |
| GO:0060537 | 0 | 5.1423 | 4.1954 | 19 | 321 | muscle tissue development |
| GO:0010629 | 0 | 2.9527 | 15.919 | 40 | 1218 | negative regulation of gene expression |
| GO:0097659 | 0 | 3.1685 | 15.1338 | 38 | 1549 | nucleic acid-templated transcription |
| GO:2000026 | 0 | 2.958 | 15.9802 | 40 | 1265 | regulation of multicellular organismal development |
| GO:0021983 | 0 | 19.0234 | 0.5359 | 8 | 41 | pituitary gland development |
| GO:0051962 | 0 | 5.0569 | 4.2607 | 19 | 326 | positive regulation of nervous system development |
| GO:0010720 | 0 | 4.5742 | 4.9404 | 20 | 378 | positive regulation of cell development |
| GO:0001764 | 0 | 8.1033 | 1.6991 | 12 | 130 | neuron migration |
| GO:0060485 | 0 | 6.4476 | 2.4599 | 14 | 191 | mesenchyme development |
| GO:0009954 | 0 | 21.0278 | 0.4313 | 7 | 33 | proximal/distal pattern formation |
| GO:0006355 | 0 | 2.9814 | 15.4596 | 37 | 1616 | regulation of transcription, DNA-templated |
| GO:0014031 | 0 | 7.5848 | 1.8036 | 12 | 138 | mesenchymal cell development |
| GO:0045666 | 0 | 5.6391 | 2.993 | 15 | 229 | positive regulation of neuron differentiation |
| GO:0043583 | 0 | 6.0344 | 2.614 | 14 | 200 | ear development |
| GO:0009790 | 0 | 5.5684 | 3.0455 | 15 | 268 | embryo development |
| GO:0000904 | 0 | 3.7727 | 6.892 | 23 | 543 | cell morphogenesis involved in differentiation |
| GO:0044707 | 0 | 2.4304 | 43.623 | 71 | 4820 | single-multicellular organism process |
| GO:0048665 | 0 | 45.0416 | 0.175 | 5 | 14 | neuron fate specification |
| GO:0031018 | 0 | 13.0656 | 0.7319 | 8 | 56 | endocrine pancreas development |
| GO:0060173 | 0 | 6.7218 | 2.0126 | 12 | 157 | limb development |
| GO:0014033 | 0 | 12.2946 | 0.7711 | 8 | 59 | neural crest cell differentiation |
| GO:0035113 | 0 | 7.3889 | 1.686 | 11 | 129 | embryonic appendage morphogenesis |
| GO:0007517 | 0 | 4.4458 | 4.2607 | 17 | 326 | muscle organ development |
| GO:0001662 | 0 | 21.1972 | 0.366 | 6 | 28 | behavioral fear response |
| GO:0031175 | 0 | 3.0243 | 10.4427 | 28 | 799 | neuron projection development |
| GO:0033693 | 0 | Inf | 0.0392 | 3 | 3 | neurofilament bundle assembly |
| GO:0048663 | 0 | 18.6765 | 0.4001 | 6 | 33 | neuron fate commitment |
| GO:0033555 | 0 | 10.6219 | 0.8757 | 8 | 67 | multicellular organismal response to stress |
| GO:0032095 | 0 | 29.7586 | 0.2353 | 5 | 18 | regulation of response to food |
| GO:0007268 | 0 | 3.3159 | 7.7534 | 23 | 605 | synaptic transmission |
| GO:0014003 | 0 | 17.9314 | 0.4182 | 6 | 32 | oligodendrocyte development |
| GO:2000543 | 0 | 61.6162 | 0.1176 | 4 | 9 | positive regulation of gastrulation |
| GO:0051241 | 0 | 2.9421 | 10.319 | 27 | 816 | negative regulation of multicellular organismal process |
| GO:0035115 | 0 | 16.6484 | 0.4444 | 6 | 34 | embryonic forelimb morphogenesis |
| GO:0061333 | 0 | 9.6376 | 0.9541 | 8 | 73 | renal tubule morphogenesis |
| GO:0072088 | 0 | 9.6376 | 0.9541 | 8 | 73 | nephron epithelium morphogenesis |
| GO:0021520 | 0 | 51.8667 | 0.1294 | 4 | 10 | spinal cord motor neuron cell fate specification |
| GO:0042472 | 0 | 7.8583 | 1.2939 | 9 | 99 | inner ear morphogenesis |
| GO:0035282 | 0 | 9.2119 | 0.9924 | 8 | 77 | segmentation |
| GO:0048646 | 0 | 2.6887 | 12.5698 | 30 | 985 | anatomical structure formation involved in morphogenesis |
| GO:0003357 | 0 | 232.2857 | 0.0518 | 3 | 4 | noradrenergic neuron differentiation |
| GO:0021913 | 0 | 229.9545 | 0.0523 | 3 | 4 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
| GO:0021545 | 0 | 13.705 | 0.5228 | 6 | 40 | cranial nerve development |
| GO:0031324 | 0 | 2.1357 | 26.035 | 48 | 1992 | negative regulation of cellular metabolic process |
| GO:0032989 | 0 | 2.4196 | 15.8406 | 34 | 1212 | cellular component morphogenesis |
| GO:0048522 | 0 | 1.9855 | 39.5835 | 64 | 3270 | positive regulation of cellular process |
| GO:0061056 | 0 | 114.9697 | 0.0653 | 3 | 5 | sclerotome development |
| GO:0022603 | 0 | 2.7675 | 10.0114 | 25 | 766 | regulation of anatomical structure morphogenesis |
| GO:0060993 | 0 | 7.631 | 1.1763 | 8 | 90 | kidney morphogenesis |
| GO:0007409 | 0 | 3.1493 | 6.9888 | 20 | 540 | axonogenesis |
| GO:0072080 | 0 | 7.5385 | 1.1893 | 8 | 91 | nephron tubule development |
| GO:0071542 | 0 | 30.798 | 0.183 | 4 | 14 | dopaminergic neuron differentiation |
| GO:0060487 | 0 | 16.809 | 0.366 | 5 | 28 | lung epithelial cell differentiation |
| GO:0048704 | 0 | 7.19 | 1.2416 | 8 | 95 | embryonic skeletal system morphogenesis |
| GO:0098609 | 0 | 4.8788 | 2.4702 | 11 | 189 | cell-cell adhesion |
| GO:0016339 | 0 | 15.4622 | 0.3921 | 5 | 30 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
| GO:0035116 | 0 | 15.4622 | 0.3921 | 5 | 30 | embryonic hindlimb morphogenesis |
| GO:0014013 | 0 | 8.3895 | 0.941 | 7 | 72 | regulation of gliogenesis |
| GO:0021797 | 0 | 76.6414 | 0.0784 | 3 | 6 | forebrain anterior/posterior pattern specification |
| GO:0060022 | 0 | 76.6414 | 0.0784 | 3 | 6 | hard palate development |
| GO:0090185 | 0 | 25.6616 | 0.2091 | 4 | 16 | negative regulation of kidney development |
| GO:0048706 | 0 | 14.8385 | 0.4041 | 5 | 32 | embryonic skeletal system development |
| GO:0045995 | 1e-04 | 6.7235 | 1.32 | 8 | 101 | regulation of embryonic development |
| GO:0061138 | 1e-04 | 4.6664 | 2.5747 | 11 | 197 | morphogenesis of a branching epithelium |
| GO:0045109 | 1e-04 | 23.6861 | 0.2222 | 4 | 17 | intermediate filament organization |
| GO:0044767 | 1e-04 | 2.2865 | 22.3538 | 40 | 2755 | single-organism developmental process |
| GO:0060441 | 1e-04 | 13.8028 | 0.4313 | 5 | 33 | epithelial tube branching involved in lung morphogenesis |
| GO:0021521 | 1e-04 | 58.3577 | 0.0901 | 3 | 7 | ventral spinal cord interneuron specification |
| GO:0021902 | 1e-04 | 57.4773 | 0.0915 | 3 | 7 | commitment of neuronal cell to specific neuron type in forebrain |
| GO:0042756 | 1e-04 | 57.4773 | 0.0915 | 3 | 7 | drinking behavior |
| GO:0030878 | 1e-04 | 21.9927 | 0.2353 | 4 | 18 | thyroid gland development |
| GO:0007156 | 1e-04 | 5.5115 | 1.7906 | 9 | 137 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0022404 | 1e-04 | 7.4661 | 1.0456 | 7 | 80 | molting cycle process |
| GO:0023061 | 1e-04 | 3.2967 | 5.2802 | 16 | 404 | signal release |
| GO:0003156 | 1e-04 | 12.881 | 0.4574 | 5 | 35 | regulation of organ formation |
| GO:0007416 | 1e-04 | 7.3647 | 1.0587 | 7 | 81 | synapse assembly |
| GO:0060562 | 1e-04 | 5.401 | 1.824 | 9 | 146 | epithelial tube morphogenesis |
| GO:0072079 | 1e-04 | 20.5252 | 0.2483 | 4 | 19 | nephron tubule formation |
| GO:0007389 | 1e-04 | 12.3177 | 0.4666 | 5 | 44 | pattern specification process |
| GO:0050794 | 1e-04 | 2.0864 | 52.9264 | 73 | 5317 | regulation of cellular process |
| GO:0009887 | 1e-04 | 4.0425 | 3.2417 | 12 | 300 | organ morphogenesis |
| GO:0030182 | 1e-04 | 2.911 | 7.2068 | 19 | 671 | neuron differentiation |
| GO:0048858 | 1e-04 | 2.5441 | 10.3513 | 24 | 792 | cell projection morphogenesis |
| GO:0045665 | 1e-04 | 5.2626 | 1.869 | 9 | 143 | negative regulation of neuron differentiation |
| GO:0021854 | 1e-04 | 19.2411 | 0.2614 | 4 | 20 | hypothalamus development |
| GO:0021872 | 1e-04 | 8.7808 | 0.7711 | 6 | 59 | forebrain generation of neurons |
| GO:0016331 | 1e-04 | 5.1087 | 1.9213 | 9 | 147 | morphogenesis of embryonic epithelium |
| GO:0072089 | 1e-04 | 6.8463 | 1.1309 | 7 | 88 | stem cell proliferation |
| GO:0009880 | 1e-04 | 8.4604 | 0.7973 | 6 | 61 | embryonic pattern specification |
| GO:0042733 | 1e-04 | 8.4604 | 0.7973 | 6 | 61 | embryonic digit morphogenesis |
| GO:0019233 | 2e-04 | 6.7251 | 1.1501 | 7 | 88 | sensory perception of pain |
| GO:0015844 | 2e-04 | 8.3088 | 0.8103 | 6 | 62 | monoamine transport |
| GO:0048857 | 2e-04 | 8.3088 | 0.8103 | 6 | 62 | neural nucleus development |
| GO:0072171 | 2e-04 | 8.3088 | 0.8103 | 6 | 62 | mesonephric tubule morphogenesis |
| GO:0097154 | 2e-04 | Inf | 0.0258 | 2 | 2 | GABAergic neuron differentiation |
| GO:0035914 | 2e-04 | 8.1625 | 0.8234 | 6 | 63 | skeletal muscle cell differentiation |
| GO:0003326 | 2e-04 | Inf | 0.0261 | 2 | 2 | pancreatic A cell fate commitment |
| GO:0003329 | 2e-04 | Inf | 0.0261 | 2 | 2 | pancreatic PP cell fate commitment |
| GO:0007198 | 2e-04 | Inf | 0.0261 | 2 | 2 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
| GO:0043134 | 2e-04 | Inf | 0.0261 | 2 | 2 | regulation of hindgut contraction |
| GO:0043503 | 2e-04 | Inf | 0.0261 | 2 | 2 | skeletal muscle fiber adaptation |
| GO:0060516 | 2e-04 | Inf | 0.0261 | 2 | 2 | primary prostatic bud elongation |
| GO:0060738 | 2e-04 | Inf | 0.0261 | 2 | 2 | epithelial-mesenchymal signaling involved in prostate gland development |
| GO:0061032 | 2e-04 | Inf | 0.0261 | 2 | 2 | visceral serous pericardium development |
| GO:0072166 | 2e-04 | Inf | 0.0261 | 2 | 2 | posterior mesonephric tubule development |
| GO:0072272 | 2e-04 | Inf | 0.0261 | 2 | 2 | proximal/distal pattern formation involved in metanephric nephron development |
| GO:0023019 | 2e-04 | 17.101 | 0.2875 | 4 | 22 | signal transduction involved in regulation of gene expression |
| GO:0008343 | 2e-04 | 38.3131 | 0.1176 | 3 | 9 | adult feeding behavior |
| GO:0021892 | 2e-04 | 38.3131 | 0.1176 | 3 | 9 | cerebral cortex GABAergic interneuron differentiation |
| GO:0061004 | 2e-04 | 38.3131 | 0.1176 | 3 | 9 | pattern specification involved in kidney development |
| GO:0001655 | 2e-04 | 3.5252 | 3.9863 | 13 | 305 | urogenital system development |
| GO:0021915 | 2e-04 | 4.8262 | 2.0258 | 9 | 155 | neural tube development |
| GO:0002791 | 2e-04 | 4.338 | 2.4963 | 10 | 191 | regulation of peptide secretion |
| GO:0048468 | 2e-04 | 2.5488 | 9.5671 | 22 | 872 | cell development |
| GO:0050767 | 2e-04 | 3.6911 | 3.5173 | 12 | 288 | regulation of neurogenesis |
| GO:0048935 | 2e-04 | 33.1706 | 0.1294 | 3 | 10 | peripheral nervous system neuron development |
| GO:0050768 | 2e-04 | 10.0294 | 0.5671 | 5 | 45 | negative regulation of neurogenesis |
| GO:0022037 | 2e-04 | 6.1873 | 1.2416 | 7 | 95 | metencephalon development |
| GO:0003211 | 2e-04 | 32.8377 | 0.1307 | 3 | 10 | cardiac ventricle formation |
| GO:0032525 | 2e-04 | 32.8377 | 0.1307 | 3 | 10 | somite rostral/caudal axis specification |
| GO:0060174 | 2e-04 | 32.8377 | 0.1307 | 3 | 10 | limb bud formation |
| GO:0072203 | 2e-04 | 32.8377 | 0.1307 | 3 | 10 | cell proliferation involved in metanephros development |
| GO:0003279 | 3e-04 | 7.5017 | 0.8887 | 6 | 68 | cardiac septum development |
| GO:0001657 | 3e-04 | 6.1174 | 1.2547 | 7 | 96 | ureteric bud development |
| GO:0046887 | 3e-04 | 6.1174 | 1.2547 | 7 | 96 | positive regulation of hormone secretion |
| GO:0048565 | 3e-04 | 5.2454 | 1.6599 | 8 | 127 | digestive tract development |
| GO:0009888 | 3e-04 | 3.2531 | 4.6977 | 14 | 438 | tissue development |
| GO:0072163 | 3e-04 | 6.049 | 1.2678 | 7 | 97 | mesonephric epithelium development |
| GO:0010467 | 3e-04 | 2.0336 | 23.4475 | 40 | 2375 | gene expression |
| GO:0048545 | 3e-04 | 3.2093 | 4.7051 | 14 | 360 | response to steroid hormone |
| GO:0072006 | 3e-04 | 5.1581 | 1.686 | 8 | 129 | nephron development |
| GO:0008284 | 3e-04 | 2.4629 | 9.7215 | 22 | 751 | positive regulation of cell proliferation |
| GO:0035150 | 3e-04 | 5.1154 | 1.6991 | 8 | 130 | regulation of tube size |
| GO:0060041 | 3e-04 | 5.1154 | 1.6991 | 8 | 130 | retina development in camera-type eye |
| GO:0042633 | 3e-04 | 5.9167 | 1.2939 | 7 | 99 | hair cycle |
| GO:0007548 | 3e-04 | 3.7627 | 3.1498 | 11 | 241 | sex differentiation |
| GO:0032099 | 3e-04 | 28.7311 | 0.1438 | 3 | 11 | negative regulation of appetite |
| GO:0042755 | 3e-04 | 13.988 | 0.3398 | 4 | 26 | eating behavior |
| GO:0044708 | 4e-04 | 3.3011 | 4.2427 | 13 | 334 | single-organism behavior |
| GO:0061053 | 4e-04 | 6.943 | 0.953 | 6 | 74 | somite development |
| GO:0016070 | 4e-04 | 2.0388 | 21.3259 | 37 | 2183 | RNA metabolic process |
| GO:0035051 | 4e-04 | 5.6687 | 1.3462 | 7 | 103 | cardiocyte differentiation |
| GO:0007422 | 4e-04 | 6.8371 | 0.9672 | 6 | 74 | peripheral nervous system development |
| GO:0045687 | 5e-04 | 12.8206 | 0.366 | 4 | 28 | positive regulation of glial cell differentiation |
| GO:0003253 | 5e-04 | 152.5327 | 0.0392 | 2 | 3 | cardiac neural crest cell migration involved in outflow tract morphogenesis |
| GO:0003350 | 5e-04 | 152.5327 | 0.0392 | 2 | 3 | pulmonary myocardium development |
| GO:0003358 | 5e-04 | 152.5327 | 0.0392 | 2 | 3 | noradrenergic neuron development |
| GO:0014016 | 5e-04 | 152.5327 | 0.0392 | 2 | 3 | neuroblast differentiation |
| GO:0021530 | 5e-04 | 152.5327 | 0.0392 | 2 | 3 | spinal cord oligodendrocyte cell fate specification |
| GO:0021550 | 5e-04 | 152.5327 | 0.0392 | 2 | 3 | medulla oblongata development |
| GO:0021912 | 5e-04 | 152.5327 | 0.0392 | 2 | 3 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification |
| GO:0035993 | 5e-04 | 152.5327 | 0.0392 | 2 | 3 | deltoid tuberosity development |
| GO:0048936 | 5e-04 | 152.5327 | 0.0392 | 2 | 3 | peripheral nervous system neuron axonogenesis |
| GO:0055014 | 5e-04 | 152.5327 | 0.0392 | 2 | 3 | atrial cardiac muscle cell development |
| GO:0060166 | 5e-04 | 152.5327 | 0.0392 | 2 | 3 | olfactory pit development |
| GO:0060459 | 5e-04 | 152.5327 | 0.0392 | 2 | 3 | left lung development |
| GO:0061074 | 5e-04 | 152.5327 | 0.0392 | 2 | 3 | regulation of neural retina development |
| GO:0070253 | 5e-04 | 152.5327 | 0.0392 | 2 | 3 | somatostatin secretion |
| GO:0072190 | 5e-04 | 152.5327 | 0.0392 | 2 | 3 | ureter urothelium development |
| GO:0048863 | 5e-04 | 3.8537 | 2.7908 | 10 | 222 | stem cell differentiation |
| GO:0060412 | 5e-04 | 12.307 | 0.379 | 4 | 29 | ventricular septum morphogenesis |
| GO:1902692 | 5e-04 | 12.307 | 0.379 | 4 | 29 | regulation of neuroblast proliferation |
| GO:0048485 | 6e-04 | 23.2056 | 0.1683 | 3 | 13 | sympathetic nervous system development |
| GO:0021978 | 6e-04 | 22.9818 | 0.1699 | 3 | 13 | telencephalon regionalization |
| GO:0055015 | 6e-04 | 22.9818 | 0.1699 | 3 | 13 | ventricular cardiac muscle cell development |
| GO:0051101 | 6e-04 | 6.2802 | 1.0456 | 6 | 80 | regulation of DNA binding |
| GO:0061351 | 6e-04 | 5.2309 | 1.4502 | 7 | 112 | neural precursor cell proliferation |
| GO:0001755 | 7e-04 | 11.51 | 0.4012 | 4 | 31 | neural crest cell migration |
| GO:0061448 | 7e-04 | 3.7138 | 2.8884 | 10 | 221 | connective tissue development |
| GO:0061458 | 7e-04 | 2.9233 | 5.1364 | 14 | 393 | reproductive system development |
| GO:0003018 | 7e-04 | 4.4847 | 1.9213 | 8 | 147 | vascular process in circulatory system |
| GO:0003148 | 7e-04 | 20.8912 | 0.183 | 3 | 14 | outflow tract septum morphogenesis |
| GO:2000241 | 8e-04 | 6.0344 | 1.0848 | 6 | 83 | regulation of reproductive process |
| GO:0007601 | 8e-04 | 3.9727 | 2.431 | 9 | 186 | visual perception |
| GO:0008406 | 8e-04 | 3.9727 | 2.431 | 9 | 186 | gonad development |
| GO:0001658 | 9e-04 | 7.4205 | 0.745 | 5 | 57 | branching involved in ureteric bud morphogenesis |
| GO:0050885 | 9e-04 | 7.4205 | 0.745 | 5 | 57 | neuromuscular process controlling balance |
| GO:0060350 | 9e-04 | 7.4205 | 0.745 | 5 | 57 | endochondral bone morphogenesis |
| GO:0021527 | 9e-04 | 19.149 | 0.196 | 3 | 15 | spinal cord association neuron differentiation |
| GO:0072075 | 9e-04 | 19.149 | 0.196 | 3 | 15 | metanephric mesenchyme development |
| GO:0050877 | 9e-04 | 2.0493 | 14.8865 | 28 | 1139 | neurological system process |
| GO:0009914 | 9e-04 | 3.3039 | 3.5605 | 11 | 275 | hormone transport |
| GO:0060579 | 9e-04 | 78.6062 | 0.0508 | 2 | 4 | ventral spinal cord interneuron fate commitment |
| GO:0032100 | 0.001 | 76.2613 | 0.0523 | 2 | 4 | positive regulation of appetite |
| GO:0034287 | 0.001 | 76.2613 | 0.0523 | 2 | 4 | detection of monosaccharide stimulus |
| GO:0035811 | 0.001 | 76.2613 | 0.0523 | 2 | 4 | negative regulation of urine volume |
| GO:0048880 | 0.001 | 76.2613 | 0.0523 | 2 | 4 | sensory system development |
| GO:0051594 | 0.001 | 76.2613 | 0.0523 | 2 | 4 | detection of glucose |
| GO:0060455 | 0.001 | 76.2613 | 0.0523 | 2 | 4 | negative regulation of gastric acid secretion |
| GO:0060913 | 0.001 | 76.2613 | 0.0523 | 2 | 4 | cardiac cell fate determination |
| GO:0061031 | 0.001 | 76.2613 | 0.0523 | 2 | 4 | endodermal digestive tract morphogenesis |
| GO:0061325 | 0.001 | 76.2613 | 0.0523 | 2 | 4 | cell proliferation involved in outflow tract morphogenesis |
| GO:0072086 | 0.001 | 76.2613 | 0.0523 | 2 | 4 | specification of loop of Henle identity |
| GO:0072194 | 0.001 | 76.2613 | 0.0523 | 2 | 4 | kidney smooth muscle tissue development |
| GO:0072175 | 0.0011 | 4.768 | 1.5814 | 7 | 121 | epithelial tube formation |
| GO:0003215 | 0.0011 | 17.6748 | 0.2091 | 3 | 16 | cardiac right ventricle morphogenesis |
| GO:0007379 | 0.0011 | 17.6748 | 0.2091 | 3 | 16 | segment specification |
| GO:2000136 | 0.0011 | 17.6748 | 0.2091 | 3 | 16 | regulation of cell proliferation involved in heart morphogenesis |
| GO:0051952 | 0.0011 | 7.0144 | 0.7842 | 5 | 60 | regulation of amine transport |
| GO:0021536 | 0.0011 | 17.2329 | 0.2119 | 3 | 17 | diencephalon development |
| GO:0032104 | 0.0012 | 6.8887 | 0.7973 | 5 | 61 | regulation of response to extracellular stimulus |
| GO:0031128 | 0.0012 | 9.6104 | 0.4705 | 4 | 36 | developmental induction |
| GO:0048536 | 0.0012 | 9.6104 | 0.4705 | 4 | 36 | spleen development |
| GO:0030509 | 0.0013 | 4.6051 | 1.6337 | 7 | 125 | BMP signaling pathway |
| GO:0007368 | 0.0013 | 5.3996 | 1.2024 | 6 | 92 | determination of left/right symmetry |
| GO:0002070 | 0.0013 | 16.4113 | 0.2222 | 3 | 17 | epithelial cell maturation |
| GO:0003203 | 0.0013 | 16.4113 | 0.2222 | 3 | 17 | endocardial cushion morphogenesis |
| GO:0048486 | 0.0013 | 16.4113 | 0.2222 | 3 | 17 | parasympathetic nervous system development |
| GO:0060037 | 0.0013 | 16.4113 | 0.2222 | 3 | 17 | pharyngeal system development |
| GO:0002065 | 0.0013 | 4.5661 | 1.6468 | 7 | 126 | columnar/cuboidal epithelial cell differentiation |
| GO:0022600 | 0.0014 | 6.6014 | 0.8286 | 5 | 64 | digestive system process |
| GO:0010662 | 0.0016 | 15.3162 | 0.2353 | 3 | 18 | regulation of striated muscle cell apoptotic process |
| GO:0048643 | 0.0016 | 15.3162 | 0.2353 | 3 | 18 | positive regulation of skeletal muscle tissue development |
| GO:0003231 | 0.0016 | 5.1583 | 1.2547 | 6 | 96 | cardiac ventricle development |
| GO:0007626 | 0.0016 | 5.1518 | 1.2557 | 6 | 98 | locomotory behavior |
| GO:0045103 | 0.0016 | 8.7849 | 0.5097 | 4 | 39 | intermediate filament-based process |
| GO:0003278 | 0.0017 | 50.8375 | 0.0653 | 2 | 5 | apoptotic process involved in heart morphogenesis |
| GO:0014062 | 0.0017 | 50.8375 | 0.0653 | 2 | 5 | regulation of serotonin secretion |
| GO:0021779 | 0.0017 | 50.8375 | 0.0653 | 2 | 5 | oligodendrocyte cell fate commitment |
| GO:0021780 | 0.0017 | 50.8375 | 0.0653 | 2 | 5 | glial cell fate specification |
| GO:0031133 | 0.0017 | 50.8375 | 0.0653 | 2 | 5 | regulation of axon diameter |
| GO:0035881 | 0.0017 | 50.8375 | 0.0653 | 2 | 5 | amacrine cell differentiation |
| GO:0048865 | 0.0017 | 50.8375 | 0.0653 | 2 | 5 | stem cell fate commitment |
| GO:0060023 | 0.0017 | 50.8375 | 0.0653 | 2 | 5 | soft palate development |
| GO:0060040 | 0.0017 | 50.8375 | 0.0653 | 2 | 5 | retinal bipolar neuron differentiation |
| GO:0060729 | 0.0017 | 50.8375 | 0.0653 | 2 | 5 | intestinal epithelial structure maintenance |
| GO:0061009 | 0.0017 | 50.8375 | 0.0653 | 2 | 5 | common bile duct development |
| GO:0072193 | 0.0017 | 50.8375 | 0.0653 | 2 | 5 | ureter smooth muscle cell differentiation |
| GO:0050796 | 0.0017 | 3.8907 | 2.1957 | 8 | 168 | regulation of insulin secretion |
| GO:0021954 | 0.0017 | 8.6598 | 0.5158 | 4 | 40 | central nervous system neuron development |
| GO:0045599 | 0.0018 | 8.5403 | 0.5228 | 4 | 40 | negative regulation of fat cell differentiation |
| GO:0045776 | 0.0018 | 8.5403 | 0.5228 | 4 | 40 | negative regulation of blood pressure |
| GO:2000736 | 0.0019 | 4.9909 | 1.2939 | 6 | 99 | regulation of stem cell differentiation |
| GO:0048538 | 0.002 | 8.309 | 0.5359 | 4 | 41 | thymus development |
| GO:0003151 | 0.002 | 8.2933 | 0.5359 | 4 | 42 | outflow tract morphogenesis |
| GO:0048709 | 0.002 | 13.8925 | 0.2545 | 3 | 20 | oligodendrocyte differentiation |
| GO:0007519 | 0.002 | 6.0642 | 0.8952 | 5 | 71 | skeletal muscle tissue development |
| GO:1903522 | 0.002 | 3.4237 | 2.7969 | 9 | 214 | regulation of blood circulation |
| GO:0097485 | 0.0021 | 2.6856 | 5.1495 | 13 | 394 | neuron projection guidance |
| GO:0031290 | 0.0021 | 13.5125 | 0.2614 | 3 | 20 | retinal ganglion cell axon guidance |
| GO:0035813 | 0.0021 | 13.5125 | 0.2614 | 3 | 20 | regulation of renal sodium excretion |
| GO:0048557 | 0.0021 | 13.5125 | 0.2614 | 3 | 20 | embryonic digestive tract morphogenesis |
| GO:0007188 | 0.0022 | 4.1767 | 1.7906 | 7 | 137 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
| GO:0030324 | 0.0022 | 3.7196 | 2.2908 | 8 | 177 | lung development |
| GO:0009799 | 0.0022 | 4.834 | 1.3331 | 6 | 102 | specification of symmetry |
| GO:0042310 | 0.0023 | 5.8411 | 0.928 | 5 | 71 | vasoconstriction |
| GO:0071392 | 0.0025 | 12.7609 | 0.2745 | 3 | 21 | cellular response to estradiol stimulus |
| GO:0071773 | 0.0025 | 12.7609 | 0.2745 | 3 | 21 | cellular response to BMP stimulus |
| GO:0021523 | 0.0025 | 38.1256 | 0.0784 | 2 | 6 | somatic motor neuron differentiation |
| GO:0060406 | 0.0025 | 38.1256 | 0.0784 | 2 | 6 | positive regulation of penile erection |
| GO:0061308 | 0.0025 | 38.1256 | 0.0784 | 2 | 6 | cardiac neural crest cell development involved in heart development |
| GO:2000049 | 0.0025 | 38.1256 | 0.0784 | 2 | 6 | positive regulation of cell-cell adhesion mediated by cadherin |
| GO:2000288 | 0.0025 | 38.1256 | 0.0784 | 2 | 6 | positive regulation of myoblast proliferation |
| GO:0097285 | 0.0025 | 2.6289 | 5.254 | 13 | 402 | cell-type specific apoptotic process |
| GO:0001570 | 0.0025 | 5.7535 | 0.941 | 5 | 72 | vasculogenesis |
| GO:0007423 | 0.0026 | 4.0411 | 1.8467 | 7 | 157 | sensory organ development |
| GO:0001708 | 0.0027 | 7.5087 | 0.5849 | 4 | 48 | cell fate specification |
| GO:0006937 | 0.0027 | 3.9908 | 1.869 | 7 | 143 | regulation of muscle contraction |
| GO:0006357 | 0.0028 | 3.57 | 2.3935 | 8 | 240 | regulation of transcription from RNA polymerase II promoter |
| GO:0002089 | 0.0028 | 12.0885 | 0.2875 | 3 | 22 | lens morphogenesis in camera-type eye |
| GO:0010719 | 0.0028 | 12.0885 | 0.2875 | 3 | 22 | negative regulation of epithelial to mesenchymal transition |
| GO:0043586 | 0.0028 | 12.0885 | 0.2875 | 3 | 22 | tongue development |
| GO:0007623 | 0.0028 | 3.5536 | 2.3918 | 8 | 183 | circadian rhythm |
| GO:0021510 | 0.003 | 11.7908 | 0.2916 | 3 | 24 | spinal cord development |
| GO:0060021 | 0.003 | 5.5101 | 0.9791 | 5 | 76 | palate development |
| GO:0035050 | 0.003 | 5.5058 | 0.9802 | 5 | 75 | embryonic heart tube development |
| GO:0045778 | 0.0031 | 11.6784 | 0.2957 | 3 | 23 | positive regulation of ossification |
| GO:0010656 | 0.0032 | 11.4833 | 0.3006 | 3 | 23 | negative regulation of muscle cell apoptotic process |
| GO:0097305 | 0.0034 | 2.9464 | 3.5942 | 10 | 275 | response to alcohol |
| GO:0009719 | 0.0034 | 1.8147 | 17.8794 | 30 | 1368 | response to endogenous stimulus |
| GO:0014060 | 0.0034 | 30.4985 | 0.0915 | 2 | 7 | regulation of epinephrine secretion |
| GO:0021798 | 0.0034 | 30.4985 | 0.0915 | 2 | 7 | forebrain dorsal/ventral pattern formation |
| GO:2000020 | 0.0034 | 30.4985 | 0.0915 | 2 | 7 | positive regulation of male gonad development |
| GO:0030855 | 0.0035 | 2.627 | 4.8449 | 12 | 390 | epithelial cell differentiation |
| GO:0007620 | 0.0036 | 10.9358 | 0.3137 | 3 | 24 | copulation |
| GO:0021533 | 0.0036 | 10.9358 | 0.3137 | 3 | 24 | cell differentiation in hindbrain |
| GO:0035883 | 0.0036 | 10.9358 | 0.3137 | 3 | 24 | enteroendocrine cell differentiation |
| GO:0045686 | 0.0036 | 10.9358 | 0.3137 | 3 | 24 | negative regulation of glial cell differentiation |
| GO:0061217 | 0.0036 | 10.9358 | 0.3137 | 3 | 24 | regulation of mesonephros development |
| GO:0061311 | 0.0036 | 10.9358 | 0.3137 | 3 | 24 | cell surface receptor signaling pathway involved in heart development |
| GO:0042476 | 0.0037 | 4.3339 | 1.4769 | 6 | 113 | odontogenesis |
| GO:0046903 | 0.0037 | 1.9594 | 12.5731 | 23 | 962 | secretion |
| GO:0043588 | 0.0037 | 3.1152 | 3.0583 | 9 | 234 | skin development |
| GO:0001501 | 0.0037 | 2.7408 | 4.2526 | 11 | 345 | skeletal system development |
| GO:0010463 | 0.0038 | 6.8282 | 0.6404 | 4 | 49 | mesenchymal cell proliferation |
| GO:0001942 | 0.0039 | 6.7705 | 0.645 | 4 | 50 | hair follicle development |
| GO:0035270 | 0.0039 | 10.5209 | 0.3218 | 3 | 27 | endocrine system development |
| GO:0046546 | 0.004 | 4.2538 | 1.503 | 6 | 115 | development of primary male sexual characteristics |
| GO:0048589 | 0.004 | 2.581 | 4.9206 | 12 | 380 | developmental growth |
| GO:0048708 | 0.0041 | 6.6793 | 0.6535 | 4 | 50 | astrocyte differentiation |
| GO:0021884 | 0.0041 | 10.438 | 0.3267 | 3 | 25 | forebrain neuron development |
| GO:0032108 | 0.0041 | 10.438 | 0.3267 | 3 | 25 | negative regulation of response to nutrient levels |
| GO:0048870 | 0.0041 | 1.8648 | 14.978 | 26 | 1146 | cell motility |
| GO:0007187 | 0.0043 | 10.2606 | 0.3309 | 3 | 26 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
| GO:0045596 | 0.0043 | 2.5593 | 4.968 | 12 | 405 | negative regulation of cell differentiation |
| GO:0035137 | 0.0043 | 26.0258 | 0.1022 | 2 | 8 | hindlimb morphogenesis |
| GO:0008344 | 0.0044 | 5.003 | 1.0717 | 5 | 82 | adult locomotory behavior |
| GO:0015833 | 0.0044 | 2.8268 | 3.738 | 10 | 286 | peptide transport |
| GO:0003263 | 0.0045 | 25.4137 | 0.1046 | 2 | 8 | cardioblast proliferation |
| GO:0010667 | 0.0045 | 25.4137 | 0.1046 | 2 | 8 | negative regulation of cardiac muscle cell apoptotic process |
| GO:0035878 | 0.0045 | 25.4137 | 0.1046 | 2 | 8 | nail development |
| GO:0048664 | 0.0045 | 25.4137 | 0.1046 | 2 | 8 | neuron fate determination |
| GO:0060923 | 0.0045 | 25.4137 | 0.1046 | 2 | 8 | cardiac muscle cell fate commitment |
| GO:0006334 | 0.0045 | 4.139 | 1.5422 | 6 | 118 | nucleosome assembly |
| GO:0010226 | 0.0046 | 9.9835 | 0.3398 | 3 | 26 | response to lithium ion |
| GO:0021904 | 0.0046 | 9.9835 | 0.3398 | 3 | 26 | dorsal/ventral neural tube patterning |
| GO:0045880 | 0.0046 | 9.9835 | 0.3398 | 3 | 26 | positive regulation of smoothened signaling pathway |
| GO:0048593 | 0.0046 | 4.9452 | 1.083 | 5 | 84 | camera-type eye morphogenesis |
| GO:0006333 | 0.0048 | 3.5908 | 2.065 | 7 | 158 | chromatin assembly or disassembly |
| GO:0015696 | 0.0049 | 4.8757 | 1.0979 | 5 | 84 | ammonium transport |
| GO:0022414 | 0.005 | 1.9101 | 12.8887 | 23 | 1011 | reproductive process |
| GO:0060541 | 0.0051 | 9.5636 | 0.3519 | 3 | 28 | respiratory system development |
| GO:0045909 | 0.0051 | 9.5669 | 0.3529 | 3 | 27 | positive regulation of vasodilation |
| GO:0061036 | 0.0051 | 9.5669 | 0.3529 | 3 | 27 | positive regulation of cartilage development |
| GO:0018958 | 0.0051 | 4.8144 | 1.1109 | 5 | 85 | phenol-containing compound metabolic process |
| GO:0015850 | 0.0051 | 3.2015 | 2.6401 | 8 | 202 | organic hydroxy compound transport |
| GO:0008544 | 0.0051 | 2.7656 | 3.8164 | 10 | 292 | epidermis development |
| GO:0050806 | 0.0054 | 4.7547 | 1.124 | 5 | 86 | positive regulation of synaptic transmission |
| GO:0021766 | 0.0054 | 6.1434 | 0.7058 | 4 | 54 | hippocampus development |
| GO:0007631 | 0.0056 | 6.0606 | 0.7133 | 4 | 57 | feeding behavior |
| GO:0003170 | 0.0057 | 9.1836 | 0.366 | 3 | 28 | heart valve development |
| GO:0003209 | 0.0057 | 9.1836 | 0.366 | 3 | 28 | cardiac atrium morphogenesis |
| GO:0048713 | 0.0057 | 9.1836 | 0.366 | 3 | 28 | regulation of oligodendrocyte differentiation |
| GO:0001947 | 0.0057 | 6.0225 | 0.7188 | 4 | 55 | heart looping |
| GO:0003266 | 0.0058 | 21.7818 | 0.1176 | 2 | 9 | regulation of secondary heart field cardioblast proliferation |
| GO:0021546 | 0.0058 | 21.7818 | 0.1176 | 2 | 9 | rhombomere development |
| GO:0021930 | 0.0058 | 21.7818 | 0.1176 | 2 | 9 | cerebellar granule cell precursor proliferation |
| GO:0048241 | 0.0058 | 21.7818 | 0.1176 | 2 | 9 | epinephrine transport |
| GO:0060253 | 0.0058 | 21.7818 | 0.1176 | 2 | 9 | negative regulation of glial cell proliferation |
| GO:0060456 | 0.0058 | 21.7818 | 0.1176 | 2 | 9 | positive regulation of digestive system process |
| GO:0061549 | 0.0058 | 21.7818 | 0.1176 | 2 | 9 | sympathetic ganglion development |
| GO:0072239 | 0.0058 | 21.7818 | 0.1176 | 2 | 9 | metanephric glomerulus vasculature development |
| GO:2000679 | 0.0058 | 21.7818 | 0.1176 | 2 | 9 | positive regulation of transcription regulatory region DNA binding |
| GO:2001054 | 0.0058 | 21.7818 | 0.1176 | 2 | 9 | negative regulation of mesenchymal cell apoptotic process |
| GO:0030814 | 0.0058 | 3.927 | 1.6207 | 6 | 124 | regulation of cAMP metabolic process |
| GO:0006140 | 0.006 | 3.4301 | 2.1565 | 7 | 165 | regulation of nucleotide metabolic process |
| GO:0009948 | 0.006 | 8.958 | 0.3738 | 3 | 29 | anterior/posterior axis specification |
| GO:1901019 | 0.0061 | 5.9063 | 0.7319 | 4 | 56 | regulation of calcium ion transmembrane transporter activity |
| GO:0010769 | 0.0061 | 2.869 | 3.3067 | 9 | 253 | regulation of cell morphogenesis involved in differentiation |
| GO:0002062 | 0.0062 | 4.5839 | 1.1632 | 5 | 89 | chondrocyte differentiation |
| GO:0014902 | 0.0062 | 4.5839 | 1.1632 | 5 | 89 | myotube differentiation |
| GO:0051384 | 0.0062 | 3.861 | 1.6468 | 6 | 126 | response to glucocorticoid |
| GO:0001709 | 0.0065 | 8.673 | 0.3846 | 3 | 30 | cell fate determination |
| GO:0007204 | 0.0068 | 3.0426 | 2.7708 | 8 | 212 | positive regulation of cytosolic calcium ion concentration |
| GO:0031069 | 0.0069 | 8.5022 | 0.3921 | 3 | 30 | hair follicle morphogenesis |
| GO:0044253 | 0.0069 | 8.5022 | 0.3921 | 3 | 30 | positive regulation of multicellular organismal metabolic process |
| GO:0072207 | 0.0069 | 8.5022 | 0.3921 | 3 | 30 | metanephric epithelium development |
| GO:0045669 | 0.0069 | 5.6868 | 0.758 | 4 | 58 | positive regulation of osteoblast differentiation |
| GO:0030802 | 0.007 | 3.7661 | 1.686 | 6 | 129 | regulation of cyclic nucleotide biosynthetic process |
| GO:0043010 | 0.0071 | 4.4298 | 1.2003 | 5 | 96 | camera-type eye development |
| GO:0002118 | 0.0071 | 19.0578 | 0.1307 | 2 | 10 | aggressive behavior |
| GO:0021534 | 0.0071 | 19.0578 | 0.1307 | 2 | 10 | cell proliferation in hindbrain |
| GO:0033605 | 0.0071 | 19.0578 | 0.1307 | 2 | 10 | positive regulation of catecholamine secretion |
| GO:0070472 | 0.0071 | 19.0578 | 0.1307 | 2 | 10 | regulation of uterine smooth muscle contraction |
| GO:0090009 | 0.0071 | 19.0578 | 0.1307 | 2 | 10 | primitive streak formation |
| GO:0072358 | 0.0073 | 1.9273 | 11.0178 | 20 | 843 | cardiovascular system development |
| GO:0021700 | 0.0074 | 2.9979 | 2.81 | 8 | 215 | developmental maturation |
| GO:1902742 | 0.0076 | 8.1981 | 0.4052 | 3 | 31 | apoptotic process involved in development |
| GO:0060322 | 0.0076 | 8.1311 | 0.4044 | 3 | 36 | head development |
| GO:0031667 | 0.0079 | 2.4596 | 4.7069 | 11 | 365 | response to nutrient levels |
| GO:0008015 | 0.008 | 3.2383 | 2.278 | 7 | 180 | blood circulation |
| GO:1900371 | 0.0081 | 3.6465 | 1.7383 | 6 | 133 | regulation of purine nucleotide biosynthetic process |
| GO:0071824 | 0.0082 | 3.2238 | 2.2872 | 7 | 175 | protein-DNA complex subunit organization |
| GO:0060512 | 0.0083 | 7.9148 | 0.4182 | 3 | 32 | prostate gland morphogenesis |
| GO:0045165 | 0.0083 | 4.2466 | 1.2474 | 5 | 108 | cell fate commitment |
| GO:0006874 | 0.0084 | 2.5617 | 4.1039 | 10 | 314 | cellular calcium ion homeostasis |
| GO:0003002 | 0.0085 | 7.7505 | 0.4216 | 3 | 39 | regionalization |
| GO:0010454 | 0.0087 | 16.9391 | 0.1438 | 2 | 11 | negative regulation of cell fate commitment |
| GO:0048617 | 0.0087 | 16.9391 | 0.1438 | 2 | 11 | embryonic foregut morphogenesis |
| GO:0060736 | 0.0087 | 16.9391 | 0.1438 | 2 | 11 | prostate gland growth |
| GO:0060767 | 0.0087 | 16.9391 | 0.1438 | 2 | 11 | epithelial cell proliferation involved in prostate gland development |
| GO:0071300 | 0.0088 | 5.2932 | 0.8103 | 4 | 62 | cellular response to retinoic acid |
| GO:0021537 | 0.0088 | 3.1766 | 2.3194 | 7 | 180 | telencephalon development |
| GO:0043271 | 0.0089 | 4.1831 | 1.2678 | 5 | 97 | negative regulation of ion transport |
| GO:0030818 | 0.009 | 7.6505 | 0.4313 | 3 | 33 | negative regulation of cAMP biosynthetic process |
| GO:0030857 | 0.009 | 7.6505 | 0.4313 | 3 | 33 | negative regulation of epithelial cell differentiation |
| GO:0060349 | 0.0092 | 7.5689 | 0.4349 | 3 | 34 | bone morphogenesis |
| GO:0030178 | 0.0095 | 3.1296 | 2.3526 | 7 | 180 | negative regulation of Wnt signaling pathway |
| GO:0055123 | 0.0097 | 15.7581 | 0.1518 | 2 | 12 | digestive system development |
| GO:0048483 | 0.0097 | 15.6922 | 0.1525 | 2 | 12 | autonomic nervous system development |
| GO:0090278 | 0.0098 | 7.4032 | 0.4444 | 3 | 34 | negative regulation of peptide hormone secretion |
| GO:1903531 | 0.0099 | 3.4806 | 1.8167 | 6 | 139 | negative regulation of secretion by cell |
| GO:0007267 | 0.0099 | 2.8428 | 2.9635 | 8 | 260 | cell-cell signaling |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0044728 | 3e-04 | 13.5422 | 0.3301 | 4 | 94 | DNA methylation or demethylation |
| GO:0002376 | 4e-04 | 2.9423 | 7.8793 | 18 | 2244 | immune system process |
| GO:0006979 | 0.0011 | 5.7332 | 1.1693 | 6 | 333 | response to oxidative stress |
| GO:0070988 | 0.0012 | 15.7564 | 0.2107 | 3 | 60 | demethylation |
| GO:0035574 | 0.0012 | 45.3018 | 0.0527 | 2 | 15 | histone H4-K20 demethylation |
| GO:0015671 | 0.0014 | 42.0632 | 0.0562 | 2 | 16 | oxygen transport |
| GO:0071285 | 0.0014 | 42.0632 | 0.0562 | 2 | 16 | cellular response to lithium ion |
| GO:0045653 | 0.0018 | 36.8005 | 0.0632 | 2 | 18 | negative regulation of megakaryocyte differentiation |
| GO:0045932 | 0.002 | 34.6335 | 0.0667 | 2 | 19 | negative regulation of muscle contraction |
| GO:1902679 | 0.0025 | 3.2453 | 3.5569 | 10 | 1013 | negative regulation of RNA biosynthetic process |
| GO:0000723 | 0.0029 | 11.4985 | 0.2844 | 3 | 81 | telomere maintenance |
| GO:0006305 | 0.0029 | 11.4985 | 0.2844 | 3 | 81 | DNA alkylation |
| GO:0002149 | 0.0035 | Inf | 0.0035 | 1 | 1 | hypochlorous acid biosynthetic process |
| GO:0002502 | 0.0035 | Inf | 0.0035 | 1 | 1 | peptide antigen assembly with MHC class I protein complex |
| GO:0003061 | 0.0035 | Inf | 0.0035 | 1 | 1 | positive regulation of the force of heart contraction by norepinephrine |
| GO:0003108 | 0.0035 | Inf | 0.0035 | 1 | 1 | negative regulation of the force of heart contraction by chemical signal |
| GO:0032918 | 0.0035 | Inf | 0.0035 | 1 | 1 | spermidine acetylation |
| GO:0032919 | 0.0035 | Inf | 0.0035 | 1 | 1 | spermine acetylation |
| GO:0032920 | 0.0035 | Inf | 0.0035 | 1 | 1 | putrescine acetylation |
| GO:0033367 | 0.0035 | Inf | 0.0035 | 1 | 1 | protein localization to mast cell secretory granule |
| GO:0033371 | 0.0035 | Inf | 0.0035 | 1 | 1 | T cell secretory granule organization |
| GO:0033373 | 0.0035 | Inf | 0.0035 | 1 | 1 | maintenance of protease location in mast cell secretory granule |
| GO:0033375 | 0.0035 | Inf | 0.0035 | 1 | 1 | protease localization to T cell secretory granule |
| GO:0033377 | 0.0035 | Inf | 0.0035 | 1 | 1 | maintenance of protein location in T cell secretory granule |
| GO:0033382 | 0.0035 | Inf | 0.0035 | 1 | 1 | maintenance of granzyme B location in T cell secretory granule |
| GO:0046204 | 0.0035 | Inf | 0.0035 | 1 | 1 | nor-spermidine metabolic process |
| GO:0071228 | 0.0035 | Inf | 0.0035 | 1 | 1 | cellular response to tumor cell |
| GO:0097291 | 0.0035 | Inf | 0.0035 | 1 | 1 | renal phosphate ion absorption |
| GO:1902311 | 0.0035 | Inf | 0.0035 | 1 | 1 | regulation of copper ion transmembrane transport |
| GO:0006952 | 0.0037 | 2.7698 | 5.0738 | 12 | 1445 | defense response |
| GO:0002026 | 0.004 | 23.5385 | 0.0948 | 2 | 27 | regulation of the force of heart contraction |
| GO:0016577 | 0.0053 | 20.2865 | 0.1088 | 2 | 31 | histone demethylation |
| GO:0048523 | 0.0054 | 2.1524 | 13.1041 | 22 | 3732 | negative regulation of cellular process |
| GO:0030099 | 0.0055 | 4.7848 | 1.1412 | 5 | 325 | myeloid cell differentiation |
| GO:0006335 | 0.0056 | 19.609 | 0.1124 | 2 | 32 | DNA replication-dependent nucleosome assembly |
| GO:0008214 | 0.006 | 18.9752 | 0.1159 | 2 | 33 | protein dealkylation |
| GO:0045892 | 0.0061 | 2.996 | 3.3989 | 9 | 968 | negative regulation of transcription, DNA-templated |
| GO:0045934 | 0.0062 | 2.8199 | 4.0485 | 10 | 1153 | negative regulation of nucleobase-containing compound metabolic process |
| GO:0032776 | 0.0063 | 18.381 | 0.1194 | 2 | 34 | DNA methylation on cytosine |
| GO:0042592 | 0.0067 | 2.6568 | 4.7648 | 11 | 1357 | homeostatic process |
| GO:0009447 | 0.007 | 289.1321 | 0.007 | 1 | 2 | putrescine catabolic process |
| GO:0032416 | 0.007 | 289.1321 | 0.007 | 1 | 2 | negative regulation of sodium:proton antiporter activity |
| GO:0033274 | 0.007 | 289.1321 | 0.007 | 1 | 2 | response to vitamin B2 |
| GO:0034635 | 0.007 | 289.1321 | 0.007 | 1 | 2 | glutathione transport |
| GO:0061051 | 0.007 | 289.1321 | 0.007 | 1 | 2 | positive regulation of cell growth involved in cardiac muscle cell development |
| GO:1990268 | 0.007 | 289.1321 | 0.007 | 1 | 2 | response to gold nanoparticle |
| GO:0050873 | 0.0071 | 17.2975 | 0.1264 | 2 | 36 | brown fat cell differentiation |
| GO:0051290 | 0.0071 | 17.2975 | 0.1264 | 2 | 36 | protein heterotetramerization |
| GO:0000183 | 0.0078 | 16.3344 | 0.1334 | 2 | 38 | chromatin silencing at rDNA |
| GO:0050432 | 0.0078 | 16.3344 | 0.1334 | 2 | 38 | catecholamine secretion |
| GO:0034080 | 0.0087 | 15.4727 | 0.1405 | 2 | 40 | CENP-A containing nucleosome assembly |
| GO:1901532 | 0.0087 | 15.4727 | 0.1405 | 2 | 40 | regulation of hematopoietic progenitor cell differentiation |
| GO:0007568 | 0.0087 | 5.3209 | 0.8111 | 4 | 231 | aging |
| GO:0006996 | 0.0093 | 2.0948 | 11.1413 | 19 | 3173 | organelle organization |
| GO:0040029 | 0.0094 | 5.2045 | 0.8287 | 4 | 236 | regulation of gene expression, epigenetic |
| GO:0006120 | 0.0095 | 14.6971 | 0.1475 | 2 | 42 | mitochondrial electron transport, NADH to ubiquinone |
| GO:0009890 | 0.0099 | 2.6183 | 4.3329 | 10 | 1234 | negative regulation of biosynthetic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050878 | 0 | 4.6767 | 3.7802 | 15 | 676 | regulation of body fluid levels |
| GO:0007596 | 0 | 4.5887 | 2.9861 | 12 | 534 | blood coagulation |
| GO:0009611 | 8e-04 | 2.9837 | 5.3173 | 14 | 962 | response to wounding |
| GO:0042117 | 8e-04 | 60.6627 | 0.0447 | 2 | 8 | monocyte activation |
| GO:0060968 | 0.0011 | 16.7141 | 0.2013 | 3 | 36 | regulation of gene silencing |
| GO:2001273 | 0.0016 | 40.4339 | 0.0615 | 2 | 11 | regulation of glucose import in response to insulin stimulus |
| GO:0040011 | 0.0017 | 2.4269 | 8.5111 | 18 | 1522 | locomotion |
| GO:0043009 | 0.0017 | 3.3259 | 3.3105 | 10 | 592 | chordate embryonic development |
| GO:0032502 | 0.0022 | 1.9044 | 28.7878 | 42 | 5148 | developmental process |
| GO:0009790 | 0.0023 | 2.7253 | 5.318 | 13 | 951 | embryo development |
| GO:0044707 | 0.0026 | 2.0025 | 25.9797 | 38 | 5380 | single-multicellular organism process |
| GO:0048731 | 0.0036 | 1.8951 | 21.3336 | 33 | 3815 | system development |
| GO:0003151 | 0.0046 | 9.6614 | 0.3355 | 3 | 60 | outflow tract morphogenesis |
| GO:0051043 | 0.0055 | 20.205 | 0.1118 | 2 | 20 | regulation of membrane protein ectodomain proteolysis |
| GO:0002642 | 0.0056 | Inf | 0.0056 | 1 | 1 | positive regulation of immunoglobulin biosynthetic process |
| GO:0014876 | 0.0056 | Inf | 0.0056 | 1 | 1 | response to injury involved in regulation of muscle adaptation |
| GO:0021509 | 0.0056 | Inf | 0.0056 | 1 | 1 | roof plate formation |
| GO:0042502 | 0.0056 | Inf | 0.0056 | 1 | 1 | tyrosine phosphorylation of Stat2 protein |
| GO:0061301 | 0.0056 | Inf | 0.0056 | 1 | 1 | cerebellum vasculature morphogenesis |
| GO:0071881 | 0.0056 | Inf | 0.0056 | 1 | 1 | adenylate cyclase-inhibiting adrenergic receptor signaling pathway |
| GO:0071882 | 0.0056 | Inf | 0.0056 | 1 | 1 | phospholipase C-activating adrenergic receptor signaling pathway |
| GO:2001051 | 0.0056 | Inf | 0.0056 | 1 | 1 | positive regulation of tendon cell differentiation |
| GO:0007166 | 0.0071 | 1.8477 | 17.8722 | 28 | 3196 | cell surface receptor signaling pathway |
| GO:0048583 | 0.0071 | 1.8477 | 17.8722 | 28 | 3196 | regulation of response to stimulus |
| GO:0022414 | 0.0075 | 2.3413 | 6.1177 | 13 | 1094 | reproductive process |
| GO:0001570 | 0.0076 | 7.9749 | 0.4026 | 3 | 72 | vasculogenesis |
| GO:0050900 | 0.0084 | 3.6369 | 1.7615 | 6 | 315 | leukocyte migration |
| GO:0007194 | 0.0085 | 15.8075 | 0.1398 | 2 | 25 | negative regulation of adenylate cyclase activity |
| GO:0006928 | 0.0086 | 2.0752 | 9.1709 | 17 | 1640 | movement of cell or subcellular component |
| GO:0048869 | 0.0087 | 1.7898 | 19.8685 | 30 | 3553 | cellular developmental process |
| GO:0032869 | 0.0094 | 4.1339 | 1.2862 | 5 | 230 | cellular response to insulin stimulus |
| GO:0007266 | 0.0098 | 7.237 | 0.4418 | 3 | 79 | Rho protein signal transduction |
| GO:0045909 | 0.0099 | 14.541 | 0.151 | 2 | 27 | positive regulation of vasodilation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050832 | 0 | 57.7816 | 0.115 | 5 | 26 | defense response to fungus |
| GO:0006508 | 0 | 3.9812 | 6.0704 | 19 | 1353 | proteolysis |
| GO:0042742 | 0 | 11.6122 | 0.6941 | 7 | 159 | defense response to bacterium |
| GO:0031640 | 0 | 39.1949 | 0.1256 | 4 | 28 | killing of cells of other organism |
| GO:0070488 | 0 | Inf | 0.009 | 2 | 2 | neutrophil aggregation |
| GO:0051707 | 1e-04 | 4.5504 | 3.0913 | 12 | 689 | response to other organism |
| GO:0051235 | 1e-04 | 7.4025 | 1.0633 | 7 | 237 | maintenance of location |
| GO:0044110 | 1e-04 | 40.8904 | 0.0897 | 3 | 20 | growth involved in symbiotic interaction |
| GO:0016485 | 1e-04 | 4.7826 | 2.3959 | 10 | 534 | protein processing |
| GO:0032496 | 1e-04 | 6.8013 | 1.1531 | 7 | 257 | response to lipopolysaccharide |
| GO:0070942 | 2e-04 | 152.3085 | 0.0224 | 2 | 5 | neutrophil mediated cytotoxicity |
| GO:0071353 | 2e-04 | 30.2115 | 0.1167 | 3 | 26 | cellular response to interleukin-4 |
| GO:0006955 | 3e-04 | 3.1345 | 6.1063 | 16 | 1361 | immune response |
| GO:0051873 | 4e-04 | 91.3731 | 0.0314 | 2 | 7 | killing by host of symbiont cells |
| GO:0006952 | 5e-04 | 2.9325 | 6.4832 | 16 | 1445 | defense response |
| GO:0009635 | 5e-04 | 76.1393 | 0.0359 | 2 | 8 | response to herbicide |
| GO:0032119 | 5e-04 | 76.1393 | 0.0359 | 2 | 8 | sequestering of zinc ion |
| GO:0035821 | 6e-04 | 11.57 | 0.3814 | 4 | 85 | modification of morphology or physiology of other organism |
| GO:0030595 | 6e-04 | 8.0586 | 0.682 | 5 | 152 | leukocyte chemotaxis |
| GO:0010043 | 7e-04 | 19.8377 | 0.1705 | 3 | 38 | response to zinc ion |
| GO:0009607 | 7e-04 | 4.1535 | 2.4494 | 9 | 574 | response to biotic stimulus |
| GO:0016477 | 8e-04 | 3.1431 | 4.7828 | 13 | 1066 | cell migration |
| GO:0051818 | 0.0011 | 50.7496 | 0.0494 | 2 | 11 | disruption of cells of other organism involved in symbiotic interaction |
| GO:0032879 | 0.0012 | 2.5116 | 9.1124 | 19 | 2031 | regulation of localization |
| GO:0032602 | 0.0012 | 15.8906 | 0.2093 | 3 | 48 | chemokine production |
| GO:0002523 | 0.0013 | 45.6716 | 0.0538 | 2 | 12 | leukocyte migration involved in inflammatory response |
| GO:0032682 | 0.0013 | 45.6716 | 0.0538 | 2 | 12 | negative regulation of chemokine production |
| GO:0033197 | 0.0013 | 45.6716 | 0.0538 | 2 | 12 | response to vitamin E |
| GO:0045073 | 0.0013 | 45.6716 | 0.0538 | 2 | 12 | regulation of chemokine biosynthetic process |
| GO:0051674 | 0.0016 | 2.9048 | 5.1417 | 13 | 1146 | localization of cell |
| GO:0010035 | 0.0016 | 4.4843 | 1.7184 | 7 | 383 | response to inorganic substance |
| GO:0070301 | 0.0017 | 13.8727 | 0.2378 | 3 | 53 | cellular response to hydrogen peroxide |
| GO:0035967 | 0.0018 | 8.3505 | 0.5204 | 4 | 116 | cellular response to topologically incorrect protein |
| GO:0050764 | 0.0019 | 13.3374 | 0.2468 | 3 | 55 | regulation of phagocytosis |
| GO:0044259 | 0.002 | 8.1311 | 0.5339 | 4 | 119 | multicellular organismal macromolecule metabolic process |
| GO:0044130 | 0.0023 | 32.6141 | 0.0718 | 2 | 16 | negative regulation of growth of symbiont in host |
| GO:0044144 | 0.0023 | 32.6141 | 0.0718 | 2 | 16 | modulation of growth of symbiont involved in interaction with host |
| GO:0050755 | 0.0023 | 32.6141 | 0.0718 | 2 | 16 | chemokine metabolic process |
| GO:0051952 | 0.0025 | 12.1635 | 0.2692 | 3 | 60 | regulation of amine transport |
| GO:0009056 | 0.0025 | 2.3789 | 8.9553 | 18 | 1996 | catabolic process |
| GO:0051259 | 0.0026 | 4.1134 | 1.8664 | 7 | 416 | protein oligomerization |
| GO:0030593 | 0.0026 | 11.953 | 0.2737 | 3 | 61 | neutrophil chemotaxis |
| GO:0070207 | 0.0026 | 30.4378 | 0.0763 | 2 | 17 | protein homotrimerization |
| GO:0042330 | 0.0028 | 3.3561 | 2.9791 | 9 | 664 | taxis |
| GO:0032103 | 0.003 | 5.5111 | 0.9826 | 5 | 219 | positive regulation of response to external stimulus |
| GO:0019725 | 0.003 | 3.3086 | 3.0195 | 9 | 673 | cellular homeostasis |
| GO:0044765 | 0.0032 | 2.0848 | 15.5597 | 26 | 3468 | single-organism transport |
| GO:0006987 | 0.0032 | 11.0007 | 0.2961 | 3 | 66 | activation of signaling protein activity involved in unfolded protein response |
| GO:0050920 | 0.0032 | 7.076 | 0.6102 | 4 | 136 | regulation of chemotaxis |
| GO:0030866 | 0.0036 | 25.3599 | 0.0897 | 2 | 20 | cortical actin cytoskeleton organization |
| GO:0032456 | 0.0036 | 25.3599 | 0.0897 | 2 | 20 | endocytic recycling |
| GO:0055069 | 0.0036 | 25.3599 | 0.0897 | 2 | 20 | zinc ion homeostasis |
| GO:0072503 | 0.0036 | 4.3912 | 1.4851 | 6 | 331 | cellular divalent inorganic cation homeostasis |
| GO:0002544 | 0.0039 | 24.0236 | 0.0942 | 2 | 21 | chronic inflammatory response |
| GO:0006897 | 0.004 | 3.782 | 2.029 | 7 | 470 | endocytosis |
| GO:0060627 | 0.0043 | 4.2443 | 1.5344 | 6 | 342 | regulation of vesicle-mediated transport |
| GO:0071216 | 0.0043 | 6.5269 | 0.6595 | 4 | 147 | cellular response to biotic stimulus |
| GO:0006873 | 0.0045 | 3.7029 | 2.0639 | 7 | 460 | cellular ion homeostasis |
| GO:0002502 | 0.0045 | Inf | 0.0045 | 1 | 1 | peptide antigen assembly with MHC class I protein complex |
| GO:0003108 | 0.0045 | Inf | 0.0045 | 1 | 1 | negative regulation of the force of heart contraction by chemical signal |
| GO:0010963 | 0.0045 | Inf | 0.0045 | 1 | 1 | regulation of L-arginine import |
| GO:0015904 | 0.0045 | Inf | 0.0045 | 1 | 1 | tetracycline transport |
| GO:0032644 | 0.0045 | Inf | 0.0045 | 1 | 1 | regulation of fractalkine production |
| GO:0033367 | 0.0045 | Inf | 0.0045 | 1 | 1 | protein localization to mast cell secretory granule |
| GO:0033371 | 0.0045 | Inf | 0.0045 | 1 | 1 | T cell secretory granule organization |
| GO:0033373 | 0.0045 | Inf | 0.0045 | 1 | 1 | maintenance of protease location in mast cell secretory granule |
| GO:0033375 | 0.0045 | Inf | 0.0045 | 1 | 1 | protease localization to T cell secretory granule |
| GO:0033377 | 0.0045 | Inf | 0.0045 | 1 | 1 | maintenance of protein location in T cell secretory granule |
| GO:0033382 | 0.0045 | Inf | 0.0045 | 1 | 1 | maintenance of granzyme B location in T cell secretory granule |
| GO:0035782 | 0.0045 | Inf | 0.0045 | 1 | 1 | mature natural killer cell chemotaxis |
| GO:0044795 | 0.0045 | Inf | 0.0045 | 1 | 1 | trans-Golgi network to recycling endosome transport |
| GO:0050725 | 0.0045 | Inf | 0.0045 | 1 | 1 | positive regulation of interleukin-1 beta biosynthetic process |
| GO:0050754 | 0.0045 | Inf | 0.0045 | 1 | 1 | positive regulation of fractalkine biosynthetic process |
| GO:0060904 | 0.0045 | Inf | 0.0045 | 1 | 1 | regulation of protein folding in endoplasmic reticulum |
| GO:0070946 | 0.0045 | Inf | 0.0045 | 1 | 1 | neutrophil mediated killing of gram-positive bacterium |
| GO:0070947 | 0.0045 | Inf | 0.0045 | 1 | 1 | neutrophil mediated killing of fungus |
| GO:0071663 | 0.0045 | Inf | 0.0045 | 1 | 1 | positive regulation of granzyme B production |
| GO:2000513 | 0.0045 | Inf | 0.0045 | 1 | 1 | positive regulation of granzyme A production |
| GO:2000518 | 0.0045 | Inf | 0.0045 | 1 | 1 | negative regulation of T-helper 1 cell activation |
| GO:2000556 | 0.0045 | Inf | 0.0045 | 1 | 1 | positive regulation of T-helper 1 cell cytokine production |
| GO:2000558 | 0.0045 | Inf | 0.0045 | 1 | 1 | positive regulation of immunoglobulin production in mucosal tissue |
| GO:0030574 | 0.0046 | 9.6199 | 0.3365 | 3 | 75 | collagen catabolic process |
| GO:1903034 | 0.0049 | 4.1189 | 1.5793 | 6 | 352 | regulation of response to wounding |
| GO:0032069 | 0.005 | 9.3587 | 0.3455 | 3 | 77 | regulation of nuclease activity |
| GO:0055065 | 0.0057 | 3.5261 | 2.1626 | 7 | 482 | metal ion homeostasis |
| GO:0097530 | 0.0061 | 8.6534 | 0.3724 | 3 | 83 | granulocyte migration |
| GO:0032689 | 0.007 | 17.5476 | 0.1256 | 2 | 28 | negative regulation of interferon-gamma production |
| GO:0050728 | 0.0072 | 8.1417 | 0.3948 | 3 | 88 | negative regulation of inflammatory response |
| GO:0000302 | 0.0073 | 5.5801 | 0.7672 | 4 | 171 | response to reactive oxygen species |
| GO:0097305 | 0.0078 | 4.3519 | 1.2338 | 5 | 275 | response to alcohol |
| GO:0045807 | 0.0079 | 7.8626 | 0.4083 | 3 | 91 | positive regulation of endocytosis |
| GO:0046916 | 0.0079 | 7.8626 | 0.4083 | 3 | 91 | cellular transition metal ion homeostasis |
| GO:0019731 | 0.0085 | 15.7293 | 0.1391 | 2 | 31 | antibacterial humoral response |
| GO:0051050 | 0.0085 | 2.9958 | 2.927 | 8 | 678 | positive regulation of transport |
| GO:0021589 | 0.009 | 225.1324 | 0.009 | 1 | 2 | cerebellum structural organization |
| GO:0045113 | 0.009 | 225.1324 | 0.009 | 1 | 2 | regulation of integrin biosynthetic process |
| GO:0045360 | 0.009 | 225.1324 | 0.009 | 1 | 2 | regulation of interleukin-1 biosynthetic process |
| GO:0070165 | 0.009 | 225.1324 | 0.009 | 1 | 2 | positive regulation of adiponectin secretion |
| GO:1902463 | 0.009 | 225.1324 | 0.009 | 1 | 2 | protein localization to cell leading edge |
| GO:2000412 | 0.009 | 225.1324 | 0.009 | 1 | 2 | positive regulation of thymocyte migration |
| GO:2000538 | 0.009 | 225.1324 | 0.009 | 1 | 2 | positive regulation of B cell chemotaxis |
| GO:2000562 | 0.009 | 225.1324 | 0.009 | 1 | 2 | negative regulation of CD4-positive, alpha-beta T cell proliferation |
| GO:2000563 | 0.009 | 225.1324 | 0.009 | 1 | 2 | positive regulation of CD4-positive, alpha-beta T cell proliferation |
| GO:1900024 | 0.009 | 15.204 | 0.1436 | 2 | 32 | regulation of substrate adhesion-dependent cell spreading |
| GO:0002385 | 0.0096 | 14.7126 | 0.1481 | 2 | 33 | mucosal immune response |
| GO:1901998 | 0.0096 | 14.7126 | 0.1481 | 2 | 33 | toxin transport |
| GO:0042089 | 0.01 | 7.2036 | 0.4442 | 3 | 99 | cytokine biosynthetic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050832 | 0 | 61.7151 | 0.1082 | 5 | 26 | defense response to fungus |
| GO:0042742 | 0 | 12.4449 | 0.6527 | 7 | 159 | defense response to bacterium |
| GO:0031640 | 0 | 41.776 | 0.1183 | 4 | 28 | killing of cells of other organism |
| GO:0070488 | 0 | Inf | 0.0085 | 2 | 2 | neutrophil aggregation |
| GO:0051707 | 0 | 4.8952 | 2.9121 | 12 | 689 | response to other organism |
| GO:0006508 | 0 | 3.7055 | 5.7185 | 17 | 1353 | proteolysis |
| GO:0009607 | 0 | 4.664 | 3.0473 | 12 | 721 | response to biotic stimulus |
| GO:0016485 | 1e-04 | 5.1319 | 2.257 | 10 | 534 | protein processing |
| GO:0044110 | 1e-04 | 43.5398 | 0.0845 | 3 | 20 | growth involved in symbiotic interaction |
| GO:0032496 | 1e-04 | 7.2723 | 1.0862 | 7 | 257 | response to lipopolysaccharide |
| GO:0070942 | 2e-04 | 162.0212 | 0.0211 | 2 | 5 | neutrophil mediated cytotoxicity |
| GO:0051873 | 4e-04 | 97.2 | 0.0296 | 2 | 7 | killing by host of symbiont cells |
| GO:0006955 | 4e-04 | 3.1132 | 5.7523 | 15 | 1361 | immune response |
| GO:0035821 | 5e-04 | 12.3319 | 0.3593 | 4 | 85 | modification of morphology or physiology of other organism |
| GO:0009635 | 5e-04 | 80.9947 | 0.0338 | 2 | 8 | response to herbicide |
| GO:0032119 | 5e-04 | 80.9947 | 0.0338 | 2 | 8 | sequestering of zinc ion |
| GO:0010043 | 5e-04 | 21.123 | 0.1606 | 3 | 38 | response to zinc ion |
| GO:0006952 | 8e-04 | 2.9127 | 6.1074 | 15 | 1445 | defense response |
| GO:0051818 | 9e-04 | 53.9859 | 0.0465 | 2 | 11 | disruption of cells of other organism involved in symbiotic interaction |
| GO:0032602 | 0.001 | 16.9544 | 0.1968 | 3 | 48 | chemokine production |
| GO:0002523 | 0.0011 | 48.5841 | 0.0507 | 2 | 12 | leukocyte migration involved in inflammatory response |
| GO:0032682 | 0.0011 | 48.5841 | 0.0507 | 2 | 12 | negative regulation of chemokine production |
| GO:0033197 | 0.0011 | 48.5841 | 0.0507 | 2 | 12 | response to vitamin E |
| GO:0045073 | 0.0011 | 48.5841 | 0.0507 | 2 | 12 | regulation of chemokine biosynthetic process |
| GO:0006909 | 0.0012 | 6.9286 | 0.7904 | 5 | 187 | phagocytosis |
| GO:0070301 | 0.0015 | 14.7716 | 0.224 | 3 | 53 | cellular response to hydrogen peroxide |
| GO:0044259 | 0.0016 | 8.6666 | 0.503 | 4 | 119 | multicellular organismal macromolecule metabolic process |
| GO:0051259 | 0.0018 | 4.3982 | 1.7582 | 7 | 416 | protein oligomerization |
| GO:0044130 | 0.002 | 34.6939 | 0.0676 | 2 | 16 | negative regulation of growth of symbiont in host |
| GO:0044144 | 0.002 | 34.6939 | 0.0676 | 2 | 16 | modulation of growth of symbiont involved in interaction with host |
| GO:0050755 | 0.002 | 34.6939 | 0.0676 | 2 | 16 | chemokine metabolic process |
| GO:0051952 | 0.0021 | 12.9516 | 0.2536 | 3 | 60 | regulation of amine transport |
| GO:0030593 | 0.0022 | 12.7275 | 0.2578 | 3 | 61 | neutrophil chemotaxis |
| GO:0070207 | 0.0023 | 32.3788 | 0.0719 | 2 | 17 | protein homotrimerization |
| GO:0032456 | 0.0032 | 26.9771 | 0.0845 | 2 | 20 | endocytic recycling |
| GO:0055069 | 0.0032 | 26.9771 | 0.0845 | 2 | 20 | zinc ion homeostasis |
| GO:0051235 | 0.0032 | 5.4174 | 1.0017 | 5 | 237 | maintenance of location |
| GO:0002544 | 0.0035 | 25.5556 | 0.0888 | 2 | 21 | chronic inflammatory response |
| GO:1903034 | 0.0037 | 4.3993 | 1.4877 | 6 | 352 | regulation of response to wounding |
| GO:0030595 | 0.0039 | 6.7195 | 0.6424 | 4 | 152 | leukocyte chemotaxis |
| GO:0030574 | 0.0039 | 10.2433 | 0.317 | 3 | 75 | collagen catabolic process |
| GO:0003108 | 0.0042 | Inf | 0.0042 | 1 | 1 | negative regulation of the force of heart contraction by chemical signal |
| GO:0010963 | 0.0042 | Inf | 0.0042 | 1 | 1 | regulation of L-arginine import |
| GO:0015904 | 0.0042 | Inf | 0.0042 | 1 | 1 | tetracycline transport |
| GO:0032644 | 0.0042 | Inf | 0.0042 | 1 | 1 | regulation of fractalkine production |
| GO:0033367 | 0.0042 | Inf | 0.0042 | 1 | 1 | protein localization to mast cell secretory granule |
| GO:0033371 | 0.0042 | Inf | 0.0042 | 1 | 1 | T cell secretory granule organization |
| GO:0033373 | 0.0042 | Inf | 0.0042 | 1 | 1 | maintenance of protease location in mast cell secretory granule |
| GO:0033375 | 0.0042 | Inf | 0.0042 | 1 | 1 | protease localization to T cell secretory granule |
| GO:0033377 | 0.0042 | Inf | 0.0042 | 1 | 1 | maintenance of protein location in T cell secretory granule |
| GO:0033382 | 0.0042 | Inf | 0.0042 | 1 | 1 | maintenance of granzyme B location in T cell secretory granule |
| GO:0035782 | 0.0042 | Inf | 0.0042 | 1 | 1 | mature natural killer cell chemotaxis |
| GO:0044795 | 0.0042 | Inf | 0.0042 | 1 | 1 | trans-Golgi network to recycling endosome transport |
| GO:0050725 | 0.0042 | Inf | 0.0042 | 1 | 1 | positive regulation of interleukin-1 beta biosynthetic process |
| GO:0050754 | 0.0042 | Inf | 0.0042 | 1 | 1 | positive regulation of fractalkine biosynthetic process |
| GO:0070946 | 0.0042 | Inf | 0.0042 | 1 | 1 | neutrophil mediated killing of gram-positive bacterium |
| GO:0070947 | 0.0042 | Inf | 0.0042 | 1 | 1 | neutrophil mediated killing of fungus |
| GO:0071663 | 0.0042 | Inf | 0.0042 | 1 | 1 | positive regulation of granzyme B production |
| GO:2000513 | 0.0042 | Inf | 0.0042 | 1 | 1 | positive regulation of granzyme A production |
| GO:2000518 | 0.0042 | Inf | 0.0042 | 1 | 1 | negative regulation of T-helper 1 cell activation |
| GO:2000556 | 0.0042 | Inf | 0.0042 | 1 | 1 | positive regulation of T-helper 1 cell cytokine production |
| GO:2000558 | 0.0042 | Inf | 0.0042 | 1 | 1 | positive regulation of immunoglobulin production in mucosal tissue |
| GO:0016477 | 0.0047 | 2.7532 | 4.5055 | 11 | 1066 | cell migration |
| GO:0051050 | 0.0048 | 3.0777 | 3.2502 | 9 | 769 | positive regulation of transport |
| GO:0097530 | 0.0052 | 9.2141 | 0.3508 | 3 | 83 | granulocyte migration |
| GO:0071353 | 0.0054 | 20.2249 | 0.1099 | 2 | 26 | cellular response to interleukin-4 |
| GO:0010035 | 0.0055 | 4.0292 | 1.6188 | 6 | 383 | response to inorganic substance |
| GO:0030100 | 0.0055 | 6.0576 | 0.7101 | 4 | 168 | regulation of endocytosis |
| GO:0000302 | 0.0059 | 5.9476 | 0.7227 | 4 | 171 | response to reactive oxygen species |
| GO:0050728 | 0.0061 | 8.6693 | 0.3719 | 3 | 88 | negative regulation of inflammatory response |
| GO:0032689 | 0.0062 | 18.6667 | 0.1183 | 2 | 28 | negative regulation of interferon-gamma production |
| GO:0046916 | 0.0067 | 8.3721 | 0.3846 | 3 | 91 | cellular transition metal ion homeostasis |
| GO:0019731 | 0.0076 | 16.7323 | 0.131 | 2 | 31 | antibacterial humoral response |
| GO:0051674 | 0.0081 | 2.5448 | 4.8436 | 11 | 1146 | localization of cell |
| GO:0045113 | 0.0084 | 239.2656 | 0.0085 | 1 | 2 | regulation of integrin biosynthetic process |
| GO:0045360 | 0.0084 | 239.2656 | 0.0085 | 1 | 2 | regulation of interleukin-1 biosynthetic process |
| GO:0070165 | 0.0084 | 239.2656 | 0.0085 | 1 | 2 | positive regulation of adiponectin secretion |
| GO:1902463 | 0.0084 | 239.2656 | 0.0085 | 1 | 2 | protein localization to cell leading edge |
| GO:2000412 | 0.0084 | 239.2656 | 0.0085 | 1 | 2 | positive regulation of thymocyte migration |
| GO:2000538 | 0.0084 | 239.2656 | 0.0085 | 1 | 2 | positive regulation of B cell chemotaxis |
| GO:2000562 | 0.0084 | 239.2656 | 0.0085 | 1 | 2 | negative regulation of CD4-positive, alpha-beta T cell proliferation |
| GO:2000563 | 0.0084 | 239.2656 | 0.0085 | 1 | 2 | positive regulation of CD4-positive, alpha-beta T cell proliferation |
| GO:0042089 | 0.0085 | 7.6704 | 0.4184 | 3 | 99 | cytokine biosynthetic process |
| GO:0002385 | 0.0085 | 15.6508 | 0.1395 | 2 | 33 | mucosal immune response |
| GO:0050710 | 0.009 | 15.1607 | 0.1437 | 2 | 34 | negative regulation of cytokine secretion |
| GO:0055082 | 0.0091 | 3.2276 | 2.3626 | 7 | 559 | cellular chemical homeostasis |
| GO:0032879 | 0.0091 | 2.1551 | 8.5841 | 16 | 2031 | regulation of localization |
| GO:1901565 | 0.0099 | 4.1008 | 1.3102 | 5 | 310 | organonitrogen compound catabolic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042742 | 0 | 15.2512 | 0.556 | 7 | 190 | defense response to bacterium |
| GO:0051707 | 0 | 6.1666 | 2.0161 | 10 | 689 | response to other organism |
| GO:0044110 | 0 | 64.3571 | 0.0585 | 3 | 20 | growth involved in symbiotic interaction |
| GO:0031640 | 1e-04 | 43.74 | 0.0819 | 3 | 28 | killing of cells of other organism |
| GO:0070942 | 1e-04 | 237.6899 | 0.0146 | 2 | 5 | neutrophil mediated cytotoxicity |
| GO:0006508 | 1e-04 | 4.2426 | 3.959 | 13 | 1353 | proteolysis |
| GO:0051873 | 2e-04 | 142.5953 | 0.0205 | 2 | 7 | killing by host of symbiont cells |
| GO:0009635 | 2e-04 | 118.8217 | 0.0234 | 2 | 8 | response to herbicide |
| GO:0044259 | 4e-04 | 12.9111 | 0.3482 | 4 | 119 | multicellular organismal macromolecule metabolic process |
| GO:0051818 | 5e-04 | 79.199 | 0.0322 | 2 | 11 | disruption of cells of other organism involved in symbiotic interaction |
| GO:0033197 | 5e-04 | 71.2744 | 0.0351 | 2 | 12 | response to vitamin E |
| GO:0009607 | 9e-04 | 5.158 | 1.5827 | 7 | 574 | response to biotic stimulus |
| GO:0044130 | 0.001 | 50.897 | 0.0468 | 2 | 16 | negative regulation of growth of symbiont in host |
| GO:0044144 | 0.001 | 50.897 | 0.0468 | 2 | 16 | modulation of growth of symbiont involved in interaction with host |
| GO:0002237 | 0.0011 | 7.108 | 0.79 | 5 | 270 | response to molecule of bacterial origin |
| GO:0016045 | 0.0011 | 47.5008 | 0.0497 | 2 | 17 | detection of bacterium |
| GO:0070207 | 0.0011 | 47.5008 | 0.0497 | 2 | 17 | protein homotrimerization |
| GO:0051259 | 0.0013 | 5.6 | 1.2172 | 6 | 416 | protein oligomerization |
| GO:0030574 | 0.0014 | 15.1409 | 0.2195 | 3 | 75 | collagen catabolic process |
| GO:0035821 | 0.002 | 13.2857 | 0.2487 | 3 | 85 | modification of morphology or physiology of other organism |
| GO:0098581 | 0.002 | 33.9158 | 0.0673 | 2 | 23 | detection of external biotic stimulus |
| GO:0006909 | 0.0021 | 8.0773 | 0.5472 | 4 | 187 | phagocytosis |
| GO:0050728 | 0.0022 | 12.8143 | 0.2575 | 3 | 88 | negative regulation of inflammatory response |
| GO:0006952 | 0.0025 | 3.136 | 4.2282 | 11 | 1445 | defense response |
| GO:0050832 | 0.0025 | 30.377 | 0.0744 | 2 | 26 | defense response to fungus |
| GO:0010963 | 0.0029 | Inf | 0.0029 | 1 | 1 | regulation of L-arginine import |
| GO:0032644 | 0.0029 | Inf | 0.0029 | 1 | 1 | regulation of fractalkine production |
| GO:0050725 | 0.0029 | Inf | 0.0029 | 1 | 1 | positive regulation of interleukin-1 beta biosynthetic process |
| GO:0050754 | 0.0029 | Inf | 0.0029 | 1 | 1 | positive regulation of fractalkine biosynthetic process |
| GO:0070946 | 0.0029 | Inf | 0.0029 | 1 | 1 | neutrophil mediated killing of gram-positive bacterium |
| GO:0070947 | 0.0029 | Inf | 0.0029 | 1 | 1 | neutrophil mediated killing of fungus |
| GO:0032689 | 0.003 | 27.3846 | 0.0819 | 2 | 28 | negative regulation of interferon-gamma production |
| GO:0042089 | 0.003 | 11.3378 | 0.2897 | 3 | 99 | cytokine biosynthetic process |
| GO:0019882 | 0.0038 | 6.8284 | 0.6437 | 4 | 220 | antigen processing and presentation |
| GO:0016485 | 0.0044 | 4.3141 | 1.5625 | 6 | 534 | protein processing |
| GO:0009411 | 0.0048 | 9.5363 | 0.3423 | 3 | 117 | response to UV |
| GO:0022617 | 0.0057 | 8.9805 | 0.3628 | 3 | 124 | extracellular matrix disassembly |
| GO:0071222 | 0.0057 | 8.9805 | 0.3628 | 3 | 124 | cellular response to lipopolysaccharide |
| GO:0002437 | 0.0058 | 19.2294 | 0.1141 | 2 | 39 | inflammatory response to antigenic stimulus |
| GO:0045360 | 0.0058 | 348.4773 | 0.0059 | 1 | 2 | regulation of interleukin-1 biosynthetic process |
| GO:0070165 | 0.0058 | 348.4773 | 0.0059 | 1 | 2 | positive regulation of adiponectin secretion |
| GO:0002376 | 0.0058 | 2.6954 | 5.4742 | 12 | 2024 | immune system process |
| GO:0051851 | 0.0064 | 18.2409 | 0.12 | 2 | 41 | modification by host of symbiont morphology or physiology |
| GO:0043901 | 0.0076 | 8.0418 | 0.4038 | 3 | 138 | negative regulation of multi-organism process |
| GO:0015891 | 0.0088 | 174.2273 | 0.0088 | 1 | 3 | siderophore transport |
| GO:0045079 | 0.0088 | 174.2273 | 0.0088 | 1 | 3 | negative regulation of chemokine biosynthetic process |
| GO:0050756 | 0.0088 | 174.2273 | 0.0088 | 1 | 3 | fractalkine metabolic process |
| GO:0071638 | 0.0088 | 174.2273 | 0.0088 | 1 | 3 | negative regulation of monocyte chemotactic protein-1 production |
| GO:0090467 | 0.0088 | 174.2273 | 0.0088 | 1 | 3 | arginine import |
| GO:1902023 | 0.0088 | 174.2273 | 0.0088 | 1 | 3 | L-arginine transport |
| GO:2001137 | 0.0088 | 174.2273 | 0.0088 | 1 | 3 | positive regulation of endocytic recycling |
| GO:0071216 | 0.0091 | 7.5347 | 0.4301 | 3 | 147 | cellular response to biotic stimulus |
| GO:0032642 | 0.0097 | 14.5562 | 0.1488 | 2 | 52 | regulation of chemokine production |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042110 | 0 | 7.3042 | 1.952 | 12 | 395 | T cell activation |
| GO:0071593 | 0 | 7.2653 | 1.9619 | 12 | 397 | lymphocyte aggregation |
| GO:1903039 | 0 | 10.289 | 0.8945 | 8 | 181 | positive regulation of leukocyte cell-cell adhesion |
| GO:0034112 | 0 | 10.1701 | 0.9044 | 8 | 183 | positive regulation of homotypic cell-cell adhesion |
| GO:0022407 | 0 | 7.0269 | 1.6456 | 10 | 333 | regulation of cell-cell adhesion |
| GO:0050852 | 0 | 13.2988 | 0.5139 | 6 | 104 | T cell receptor signaling pathway |
| GO:0002694 | 0 | 6.1151 | 1.8779 | 10 | 380 | regulation of leukocyte activation |
| GO:0031295 | 0 | 16.7683 | 0.341 | 5 | 69 | T cell costimulation |
| GO:0098602 | 0 | 4.4238 | 3.4346 | 13 | 695 | single organism cell adhesion |
| GO:0050867 | 0 | 7.0266 | 1.2849 | 8 | 260 | positive regulation of cell activation |
| GO:0042326 | 1e-04 | 5.8939 | 1.7296 | 9 | 350 | negative regulation of phosphorylation |
| GO:0046426 | 1e-04 | 44.8796 | 0.084 | 3 | 17 | negative regulation of JAK-STAT cascade |
| GO:0010563 | 1e-04 | 5.0125 | 2.2683 | 10 | 459 | negative regulation of phosphorus metabolic process |
| GO:0060397 | 2e-04 | 29.9061 | 0.1186 | 3 | 24 | JAK-STAT cascade involved in growth hormone signaling pathway |
| GO:0006955 | 2e-04 | 5.5099 | 1.6458 | 8 | 370 | immune response |
| GO:0045785 | 2e-04 | 5.439 | 1.6407 | 8 | 332 | positive regulation of cell adhesion |
| GO:0046627 | 4e-04 | 24.147 | 0.1433 | 3 | 29 | negative regulation of insulin receptor signaling pathway |
| GO:0042129 | 4e-04 | 8.836 | 0.6227 | 5 | 126 | regulation of T cell proliferation |
| GO:0030098 | 4e-04 | 5.6698 | 1.3639 | 7 | 276 | lymphocyte differentiation |
| GO:0002429 | 5e-04 | 6.6409 | 0.9933 | 6 | 201 | immune response-activating cell surface receptor signaling pathway |
| GO:0002666 | 5e-04 | 82.6919 | 0.0346 | 2 | 7 | positive regulation of T cell tolerance induction |
| GO:0071378 | 5e-04 | 21.6448 | 0.1581 | 3 | 32 | cellular response to growth hormone stimulus |
| GO:0022610 | 6e-04 | 2.8604 | 6.5281 | 16 | 1321 | biological adhesion |
| GO:0044700 | 8e-04 | 2.1336 | 27.007 | 41 | 5465 | single organism signaling |
| GO:0003376 | 8e-04 | 59.0579 | 0.0445 | 2 | 9 | sphingosine-1-phosphate signaling pathway |
| GO:0045058 | 9e-04 | 17.9272 | 0.1878 | 3 | 38 | T cell selection |
| GO:0007166 | 9e-04 | 2.2345 | 15.794 | 28 | 3196 | cell surface receptor signaling pathway |
| GO:0002437 | 9e-04 | 17.4281 | 0.1927 | 3 | 39 | inflammatory response to antigenic stimulus |
| GO:0016265 | 0.001 | 2.5132 | 8.9496 | 19 | 1811 | death |
| GO:0050789 | 0.001 | 2.3669 | 48.1035 | 61 | 9734 | regulation of biological process |
| GO:0007154 | 0.0011 | 2.0779 | 27.4665 | 41 | 5558 | cell communication |
| GO:0048584 | 0.0012 | 2.5403 | 8.322 | 18 | 1684 | positive regulation of response to stimulus |
| GO:0034097 | 0.0012 | 3.4941 | 3.1924 | 10 | 646 | response to cytokine |
| GO:0045060 | 0.0013 | 45.9279 | 0.0544 | 2 | 11 | negative thymic T cell selection |
| GO:0019220 | 0.0013 | 2.6482 | 6.9976 | 16 | 1416 | regulation of phosphate metabolic process |
| GO:0017015 | 0.0015 | 8.8003 | 0.4942 | 4 | 100 | regulation of transforming growth factor beta receptor signaling pathway |
| GO:0032944 | 0.0015 | 6.4609 | 0.8401 | 5 | 170 | regulation of mononuclear cell proliferation |
| GO:0002643 | 0.0015 | 41.3324 | 0.0593 | 2 | 12 | regulation of tolerance induction |
| GO:0045576 | 0.0016 | 14.2519 | 0.2323 | 3 | 47 | mast cell activation |
| GO:0048661 | 0.0016 | 14.2519 | 0.2323 | 3 | 47 | positive regulation of smooth muscle cell proliferation |
| GO:0050790 | 0.0016 | 2.3592 | 10.0417 | 20 | 2032 | regulation of catalytic activity |
| GO:0010942 | 0.0017 | 3.61 | 2.7575 | 9 | 558 | positive regulation of cell death |
| GO:0051716 | 0.0017 | 2.0181 | 29.8831 | 43 | 6047 | cellular response to stimulus |
| GO:0045086 | 0.0018 | 37.5725 | 0.0642 | 2 | 13 | positive regulation of interleukin-2 biosynthetic process |
| GO:0002263 | 0.002 | 6.0527 | 0.8945 | 5 | 181 | cell activation involved in immune response |
| GO:1900076 | 0.002 | 13.0608 | 0.252 | 3 | 51 | regulation of cellular response to insulin stimulus |
| GO:0071346 | 0.0021 | 8.0413 | 0.5387 | 4 | 109 | cellular response to interferon-gamma |
| GO:0051251 | 0.0021 | 7.9931 | 0.5424 | 4 | 115 | positive regulation of lymphocyte activation |
| GO:0048523 | 0.0023 | 2.0437 | 18.4428 | 30 | 3732 | negative regulation of cellular process |
| GO:0050671 | 0.0024 | 7.7441 | 0.5584 | 4 | 113 | positive regulation of lymphocyte proliferation |
| GO:0043299 | 0.0024 | 12.2901 | 0.2669 | 3 | 54 | leukocyte degranulation |
| GO:0070665 | 0.0028 | 7.402 | 0.5831 | 4 | 118 | positive regulation of leukocyte proliferation |
| GO:0002275 | 0.0029 | 11.3933 | 0.2866 | 3 | 58 | myeloid cell activation involved in immune response |
| GO:0046634 | 0.0031 | 11.1891 | 0.2916 | 3 | 59 | regulation of alpha-beta T cell activation |
| GO:0046641 | 0.0031 | 27.5459 | 0.084 | 2 | 17 | positive regulation of alpha-beta T cell proliferation |
| GO:0006469 | 0.0032 | 5.4279 | 0.9933 | 5 | 201 | negative regulation of protein kinase activity |
| GO:0045087 | 0.0034 | 2.8597 | 4.2796 | 11 | 866 | innate immune response |
| GO:1990090 | 0.0035 | 25.8226 | 0.089 | 2 | 18 | cellular response to nerve growth factor stimulus |
| GO:0048706 | 0.0036 | 6.8564 | 0.6276 | 4 | 127 | embryonic skeletal system development |
| GO:0002684 | 0.0036 | 2.9945 | 3.6915 | 10 | 747 | positive regulation of immune system process |
| GO:0009966 | 0.0037 | 2.1147 | 12.3249 | 22 | 2494 | regulation of signal transduction |
| GO:0001932 | 0.0037 | 2.6933 | 4.9813 | 12 | 1008 | regulation of protein phosphorylation |
| GO:0031323 | 0.0038 | 1.9032 | 26.236 | 38 | 5309 | regulation of cellular metabolic process |
| GO:0051348 | 0.0039 | 4.3159 | 1.5023 | 6 | 304 | negative regulation of transferase activity |
| GO:0002520 | 0.0042 | 2.9318 | 3.7657 | 10 | 762 | immune system development |
| GO:0002444 | 0.0042 | 9.9413 | 0.3262 | 3 | 66 | myeloid leukocyte mediated immunity |
| GO:0043067 | 0.0043 | 2.4529 | 6.4441 | 14 | 1304 | regulation of programmed cell death |
| GO:0043434 | 0.0044 | 3.6943 | 2.0558 | 7 | 416 | response to peptide hormone |
| GO:0043065 | 0.0047 | 3.3116 | 2.634 | 8 | 533 | positive regulation of apoptotic process |
| GO:0009749 | 0.0047 | 6.3367 | 0.677 | 4 | 137 | response to glucose |
| GO:0002651 | 0.0049 | Inf | 0.0049 | 1 | 1 | positive regulation of tolerance induction to self antigen |
| GO:0003245 | 0.0049 | Inf | 0.0049 | 1 | 1 | cardiac muscle tissue growth involved in heart morphogenesis |
| GO:0014739 | 0.0049 | Inf | 0.0049 | 1 | 1 | positive regulation of muscle hyperplasia |
| GO:0050760 | 0.0049 | Inf | 0.0049 | 1 | 1 | negative regulation of thymidylate synthase biosynthetic process |
| GO:0071228 | 0.0049 | Inf | 0.0049 | 1 | 1 | cellular response to tumor cell |
| GO:0032673 | 0.0052 | 20.6527 | 0.1087 | 2 | 22 | regulation of interleukin-4 production |
| GO:0014066 | 0.0054 | 9.0733 | 0.3558 | 3 | 72 | regulation of phosphatidylinositol 3-kinase signaling |
| GO:0033077 | 0.0054 | 9.0733 | 0.3558 | 3 | 72 | T cell differentiation in thymus |
| GO:0002063 | 0.0057 | 19.668 | 0.1137 | 2 | 23 | chondrocyte development |
| GO:0045321 | 0.0059 | 4.6807 | 1.1529 | 5 | 262 | leukocyte activation |
| GO:0044092 | 0.0059 | 2.6396 | 4.6107 | 11 | 933 | negative regulation of molecular function |
| GO:0034284 | 0.006 | 5.8897 | 0.7264 | 4 | 147 | response to monosaccharide |
| GO:0010831 | 0.0062 | 18.7727 | 0.1186 | 2 | 24 | positive regulation of myotube differentiation |
| GO:0060334 | 0.0062 | 18.7727 | 0.1186 | 2 | 24 | regulation of interferon-gamma-mediated signaling pathway |
| GO:0048513 | 0.0064 | 1.9818 | 13.6987 | 23 | 2772 | organ development |
| GO:1901698 | 0.0065 | 2.7396 | 4.0127 | 10 | 812 | response to nitrogen compound |
| GO:0002764 | 0.0065 | 3.4269 | 2.209 | 7 | 447 | immune response-regulating signaling pathway |
| GO:0030097 | 0.0065 | 2.902 | 3.3901 | 9 | 686 | hemopoiesis |
| GO:0021884 | 0.0067 | 17.9553 | 0.1235 | 2 | 25 | forebrain neuron development |
| GO:0060351 | 0.0073 | 17.2061 | 0.1285 | 2 | 26 | cartilage development involved in endochondral bone morphogenesis |
| GO:0071495 | 0.0077 | 2.5435 | 4.7837 | 11 | 993 | cellular response to endogenous stimulus |
| GO:0009605 | 0.0078 | 2.0822 | 9.8984 | 18 | 2003 | response to external stimulus |
| GO:0071310 | 0.0078 | 2.1187 | 9.1374 | 17 | 1849 | cellular response to organic substance |
| GO:0034109 | 0.0081 | 4.3186 | 1.244 | 5 | 278 | homotypic cell-cell adhesion |
| GO:0090200 | 0.0084 | 15.8805 | 0.1384 | 2 | 28 | positive regulation of release of cytochrome c from mitochondria |
| GO:1901700 | 0.0089 | 2.3058 | 6.2761 | 13 | 1270 | response to oxygen-containing compound |
| GO:0090287 | 0.0098 | 5.097 | 0.8352 | 4 | 169 | regulation of cellular response to growth factor stimulus |
| GO:0000917 | 0.0099 | 204.0267 | 0.0099 | 1 | 2 | barrier septum assembly |
| GO:0002663 | 0.0099 | 204.0267 | 0.0099 | 1 | 2 | positive regulation of B cell tolerance induction |
| GO:0003430 | 0.0099 | 204.0267 | 0.0099 | 1 | 2 | growth plate cartilage chondrocyte growth |
| GO:0016598 | 0.0099 | 204.0267 | 0.0099 | 1 | 2 | protein arginylation |
| GO:0032796 | 0.0099 | 204.0267 | 0.0099 | 1 | 2 | uropod organization |
| GO:0036496 | 0.0099 | 204.0267 | 0.0099 | 1 | 2 | regulation of translational initiation by eIF2 alpha dephosphorylation |
| GO:0043553 | 0.0099 | 204.0267 | 0.0099 | 1 | 2 | negative regulation of phosphatidylinositol 3-kinase activity |
| GO:0060434 | 0.0099 | 204.0267 | 0.0099 | 1 | 2 | bronchus morphogenesis |
| GO:0071672 | 0.0099 | 204.0267 | 0.0099 | 1 | 2 | negative regulation of smooth muscle cell chemotaxis |
| GO:0071673 | 0.0099 | 204.0267 | 0.0099 | 1 | 2 | positive regulation of smooth muscle cell chemotaxis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0070489 | 0 | 9.7493 | 1.5411 | 12 | 395 | T cell aggregation |
| GO:0070486 | 0 | 9.5448 | 1.5723 | 12 | 403 | leukocyte aggregation |
| GO:0050865 | 0 | 8.3729 | 1.6035 | 11 | 411 | regulation of cell activation |
| GO:0050863 | 0 | 11.0408 | 0.9754 | 9 | 250 | regulation of T cell activation |
| GO:0046649 | 0 | 7.6896 | 1.7537 | 11 | 471 | lymphocyte activation |
| GO:0050852 | 0 | 17.2574 | 0.4057 | 6 | 104 | T cell receptor signaling pathway |
| GO:0002696 | 0 | 9.8556 | 0.9515 | 8 | 248 | positive regulation of leukocyte activation |
| GO:0022407 | 0 | 8.1672 | 1.2992 | 9 | 333 | regulation of cell-cell adhesion |
| GO:1903039 | 0 | 11.4959 | 0.7062 | 7 | 181 | positive regulation of leukocyte cell-cell adhesion |
| GO:0034112 | 0 | 11.3637 | 0.714 | 7 | 183 | positive regulation of homotypic cell-cell adhesion |
| GO:0031295 | 0 | 21.669 | 0.2692 | 5 | 69 | T cell costimulation |
| GO:0006955 | 0 | 4.1109 | 5.3098 | 17 | 1361 | immune response |
| GO:0098602 | 0 | 5.3572 | 2.7115 | 12 | 695 | single organism cell adhesion |
| GO:0048534 | 0 | 5.1364 | 2.8207 | 12 | 723 | hematopoietic or lymphoid organ development |
| GO:0030217 | 0 | 15.1623 | 0.3765 | 5 | 101 | T cell differentiation |
| GO:0002521 | 1e-04 | 8.8138 | 0.7716 | 6 | 209 | leukocyte differentiation |
| GO:0002429 | 1e-04 | 8.6177 | 0.7842 | 6 | 201 | immune response-activating cell surface receptor signaling pathway |
| GO:0051138 | 1e-04 | 176.046 | 0.0195 | 2 | 5 | positive regulation of NK T cell differentiation |
| GO:0002682 | 3e-04 | 3.6493 | 4.2876 | 13 | 1136 | regulation of immune system process |
| GO:0045785 | 3e-04 | 6.0934 | 1.2953 | 7 | 332 | positive regulation of cell adhesion |
| GO:0002666 | 3e-04 | 105.6138 | 0.0273 | 2 | 7 | positive regulation of T cell tolerance induction |
| GO:0045058 | 4e-04 | 22.9835 | 0.1483 | 3 | 38 | T cell selection |
| GO:0045060 | 8e-04 | 58.659 | 0.0429 | 2 | 11 | negative thymic T cell selection |
| GO:0002643 | 0.001 | 52.7897 | 0.0468 | 2 | 12 | regulation of tolerance induction |
| GO:0032729 | 0.001 | 16.7445 | 0.199 | 3 | 51 | positive regulation of interferon-gamma production |
| GO:0045086 | 0.0011 | 47.9875 | 0.0507 | 2 | 13 | positive regulation of interleukin-2 biosynthetic process |
| GO:0022610 | 0.0015 | 2.9628 | 5.1538 | 13 | 1321 | biological adhesion |
| GO:0046641 | 0.002 | 35.1816 | 0.0663 | 2 | 17 | positive regulation of alpha-beta T cell proliferation |
| GO:0032943 | 0.0022 | 5.964 | 0.9168 | 5 | 235 | mononuclear cell proliferation |
| GO:0002274 | 0.0023 | 7.8006 | 0.5579 | 4 | 143 | myeloid leukocyte activation |
| GO:0030101 | 0.0026 | 11.9811 | 0.2731 | 3 | 70 | natural killer cell activation |
| GO:0045621 | 0.0026 | 11.9811 | 0.2731 | 3 | 70 | positive regulation of lymphocyte differentiation |
| GO:0033077 | 0.0028 | 11.6323 | 0.2809 | 3 | 72 | T cell differentiation in thymus |
| GO:0042098 | 0.0033 | 7.0339 | 0.6164 | 4 | 158 | T cell proliferation |
| GO:0002063 | 0.0036 | 25.1199 | 0.0897 | 2 | 23 | chondrocyte development |
| GO:0002651 | 0.0039 | Inf | 0.0039 | 1 | 1 | positive regulation of tolerance induction to self antigen |
| GO:0030887 | 0.0039 | Inf | 0.0039 | 1 | 1 | positive regulation of myeloid dendritic cell activation |
| GO:0045660 | 0.0039 | Inf | 0.0039 | 1 | 1 | positive regulation of neutrophil differentiation |
| GO:0010831 | 0.0039 | 23.9765 | 0.0936 | 2 | 24 | positive regulation of myotube differentiation |
| GO:0002253 | 0.004 | 4.333 | 1.5177 | 6 | 389 | activation of immune response |
| GO:0060351 | 0.0046 | 21.9756 | 0.1014 | 2 | 26 | cartilage development involved in endochondral bone morphogenesis |
| GO:0048584 | 0.0046 | 2.4875 | 6.57 | 14 | 1684 | positive regulation of response to stimulus |
| GO:0046635 | 0.0046 | 21.8271 | 0.1019 | 2 | 27 | positive regulation of alpha-beta T cell activation |
| GO:0090200 | 0.0053 | 20.2825 | 0.1092 | 2 | 28 | positive regulation of release of cytochrome c from mitochondria |
| GO:0060349 | 0.0054 | 9.1094 | 0.355 | 3 | 91 | bone morphogenesis |
| GO:0050864 | 0.0057 | 8.9058 | 0.3628 | 3 | 93 | regulation of B cell activation |
| GO:0017015 | 0.007 | 8.2594 | 0.3901 | 3 | 100 | regulation of transforming growth factor beta receptor signaling pathway |
| GO:0030183 | 0.0072 | 8.1745 | 0.394 | 3 | 101 | B cell differentiation |
| GO:0044700 | 0.0075 | 1.9446 | 21.3213 | 31 | 5465 | single organism signaling |
| GO:0002764 | 0.0078 | 3.7486 | 1.7439 | 6 | 447 | immune response-regulating signaling pathway |
| GO:0002663 | 0.0078 | 259.6271 | 0.0078 | 1 | 2 | positive regulation of B cell tolerance induction |
| GO:0003430 | 0.0078 | 259.6271 | 0.0078 | 1 | 2 | growth plate cartilage chondrocyte growth |
| GO:0016598 | 0.0078 | 259.6271 | 0.0078 | 1 | 2 | protein arginylation |
| GO:0036496 | 0.0078 | 259.6271 | 0.0078 | 1 | 2 | regulation of translational initiation by eIF2 alpha dephosphorylation |
| GO:0060434 | 0.0078 | 259.6271 | 0.0078 | 1 | 2 | bronchus morphogenesis |
| GO:0002053 | 0.0087 | 15.502 | 0.1405 | 2 | 36 | positive regulation of mesenchymal cell proliferation |
| GO:1902105 | 0.0091 | 5.2403 | 0.8193 | 4 | 210 | regulation of leukocyte differentiation |
| GO:0019722 | 0.0093 | 7.4128 | 0.4331 | 3 | 111 | calcium-mediated signaling |
| GO:0042992 | 0.0096 | 14.6389 | 0.1483 | 2 | 38 | negative regulation of transcription factor import into nucleus |
| GO:0046637 | 0.0096 | 14.6389 | 0.1483 | 2 | 38 | regulation of alpha-beta T cell differentiation |
| GO:0050671 | 0.0098 | 7.277 | 0.4409 | 3 | 113 | positive regulation of lymphocyte proliferation |
| GO:0007154 | 0.0098 | 1.8939 | 21.6841 | 31 | 5558 | cell communication |
| GO:0050790 | 0.0098 | 2.1983 | 7.9277 | 15 | 2032 | regulation of catalytic activity |
| GO:0007186 | 0.01 | 2.5929 | 4.3189 | 10 | 1107 | G-protein coupled receptor signaling pathway |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042110 | 0 | 7.3042 | 1.952 | 12 | 395 | T cell activation |
| GO:0071593 | 0 | 7.2653 | 1.9619 | 12 | 397 | lymphocyte aggregation |
| GO:1903039 | 0 | 10.289 | 0.8945 | 8 | 181 | positive regulation of leukocyte cell-cell adhesion |
| GO:0034112 | 0 | 10.1701 | 0.9044 | 8 | 183 | positive regulation of homotypic cell-cell adhesion |
| GO:0022407 | 0 | 7.0269 | 1.6456 | 10 | 333 | regulation of cell-cell adhesion |
| GO:0050852 | 0 | 13.2988 | 0.5139 | 6 | 104 | T cell receptor signaling pathway |
| GO:0002694 | 0 | 6.1151 | 1.8779 | 10 | 380 | regulation of leukocyte activation |
| GO:0031295 | 0 | 16.7683 | 0.341 | 5 | 69 | T cell costimulation |
| GO:0098602 | 0 | 4.4238 | 3.4346 | 13 | 695 | single organism cell adhesion |
| GO:0050867 | 0 | 7.0266 | 1.2849 | 8 | 260 | positive regulation of cell activation |
| GO:0042326 | 1e-04 | 5.8939 | 1.7296 | 9 | 350 | negative regulation of phosphorylation |
| GO:0046426 | 1e-04 | 44.8796 | 0.084 | 3 | 17 | negative regulation of JAK-STAT cascade |
| GO:0010563 | 1e-04 | 5.0125 | 2.2683 | 10 | 459 | negative regulation of phosphorus metabolic process |
| GO:0060397 | 2e-04 | 29.9061 | 0.1186 | 3 | 24 | JAK-STAT cascade involved in growth hormone signaling pathway |
| GO:0006955 | 2e-04 | 5.5099 | 1.6458 | 8 | 370 | immune response |
| GO:0045785 | 2e-04 | 5.439 | 1.6407 | 8 | 332 | positive regulation of cell adhesion |
| GO:0046627 | 4e-04 | 24.147 | 0.1433 | 3 | 29 | negative regulation of insulin receptor signaling pathway |
| GO:0042129 | 4e-04 | 8.836 | 0.6227 | 5 | 126 | regulation of T cell proliferation |
| GO:0030098 | 4e-04 | 5.6698 | 1.3639 | 7 | 276 | lymphocyte differentiation |
| GO:0002429 | 5e-04 | 6.6409 | 0.9933 | 6 | 201 | immune response-activating cell surface receptor signaling pathway |
| GO:0002666 | 5e-04 | 82.6919 | 0.0346 | 2 | 7 | positive regulation of T cell tolerance induction |
| GO:0071378 | 5e-04 | 21.6448 | 0.1581 | 3 | 32 | cellular response to growth hormone stimulus |
| GO:0022610 | 6e-04 | 2.8604 | 6.5281 | 16 | 1321 | biological adhesion |
| GO:0044700 | 8e-04 | 2.1336 | 27.007 | 41 | 5465 | single organism signaling |
| GO:0003376 | 8e-04 | 59.0579 | 0.0445 | 2 | 9 | sphingosine-1-phosphate signaling pathway |
| GO:0045058 | 9e-04 | 17.9272 | 0.1878 | 3 | 38 | T cell selection |
| GO:0007166 | 9e-04 | 2.2345 | 15.794 | 28 | 3196 | cell surface receptor signaling pathway |
| GO:0002437 | 9e-04 | 17.4281 | 0.1927 | 3 | 39 | inflammatory response to antigenic stimulus |
| GO:0016265 | 0.001 | 2.5132 | 8.9496 | 19 | 1811 | death |
| GO:0050789 | 0.001 | 2.3669 | 48.1035 | 61 | 9734 | regulation of biological process |
| GO:0007154 | 0.0011 | 2.0779 | 27.4665 | 41 | 5558 | cell communication |
| GO:0048584 | 0.0012 | 2.5403 | 8.322 | 18 | 1684 | positive regulation of response to stimulus |
| GO:0034097 | 0.0012 | 3.4941 | 3.1924 | 10 | 646 | response to cytokine |
| GO:0045060 | 0.0013 | 45.9279 | 0.0544 | 2 | 11 | negative thymic T cell selection |
| GO:0019220 | 0.0013 | 2.6482 | 6.9976 | 16 | 1416 | regulation of phosphate metabolic process |
| GO:0017015 | 0.0015 | 8.8003 | 0.4942 | 4 | 100 | regulation of transforming growth factor beta receptor signaling pathway |
| GO:0032944 | 0.0015 | 6.4609 | 0.8401 | 5 | 170 | regulation of mononuclear cell proliferation |
| GO:0002643 | 0.0015 | 41.3324 | 0.0593 | 2 | 12 | regulation of tolerance induction |
| GO:0045576 | 0.0016 | 14.2519 | 0.2323 | 3 | 47 | mast cell activation |
| GO:0048661 | 0.0016 | 14.2519 | 0.2323 | 3 | 47 | positive regulation of smooth muscle cell proliferation |
| GO:0050790 | 0.0016 | 2.3592 | 10.0417 | 20 | 2032 | regulation of catalytic activity |
| GO:0010942 | 0.0017 | 3.61 | 2.7575 | 9 | 558 | positive regulation of cell death |
| GO:0051716 | 0.0017 | 2.0181 | 29.8831 | 43 | 6047 | cellular response to stimulus |
| GO:0045086 | 0.0018 | 37.5725 | 0.0642 | 2 | 13 | positive regulation of interleukin-2 biosynthetic process |
| GO:0002263 | 0.002 | 6.0527 | 0.8945 | 5 | 181 | cell activation involved in immune response |
| GO:1900076 | 0.002 | 13.0608 | 0.252 | 3 | 51 | regulation of cellular response to insulin stimulus |
| GO:0071346 | 0.0021 | 8.0413 | 0.5387 | 4 | 109 | cellular response to interferon-gamma |
| GO:0051251 | 0.0021 | 7.9931 | 0.5424 | 4 | 115 | positive regulation of lymphocyte activation |
| GO:0048523 | 0.0023 | 2.0437 | 18.4428 | 30 | 3732 | negative regulation of cellular process |
| GO:0050671 | 0.0024 | 7.7441 | 0.5584 | 4 | 113 | positive regulation of lymphocyte proliferation |
| GO:0043299 | 0.0024 | 12.2901 | 0.2669 | 3 | 54 | leukocyte degranulation |
| GO:0070665 | 0.0028 | 7.402 | 0.5831 | 4 | 118 | positive regulation of leukocyte proliferation |
| GO:0002275 | 0.0029 | 11.3933 | 0.2866 | 3 | 58 | myeloid cell activation involved in immune response |
| GO:0046634 | 0.0031 | 11.1891 | 0.2916 | 3 | 59 | regulation of alpha-beta T cell activation |
| GO:0046641 | 0.0031 | 27.5459 | 0.084 | 2 | 17 | positive regulation of alpha-beta T cell proliferation |
| GO:0006469 | 0.0032 | 5.4279 | 0.9933 | 5 | 201 | negative regulation of protein kinase activity |
| GO:0045087 | 0.0034 | 2.8597 | 4.2796 | 11 | 866 | innate immune response |
| GO:1990090 | 0.0035 | 25.8226 | 0.089 | 2 | 18 | cellular response to nerve growth factor stimulus |
| GO:0048706 | 0.0036 | 6.8564 | 0.6276 | 4 | 127 | embryonic skeletal system development |
| GO:0002684 | 0.0036 | 2.9945 | 3.6915 | 10 | 747 | positive regulation of immune system process |
| GO:0009966 | 0.0037 | 2.1147 | 12.3249 | 22 | 2494 | regulation of signal transduction |
| GO:0001932 | 0.0037 | 2.6933 | 4.9813 | 12 | 1008 | regulation of protein phosphorylation |
| GO:0031323 | 0.0038 | 1.9032 | 26.236 | 38 | 5309 | regulation of cellular metabolic process |
| GO:0051348 | 0.0039 | 4.3159 | 1.5023 | 6 | 304 | negative regulation of transferase activity |
| GO:0002520 | 0.0042 | 2.9318 | 3.7657 | 10 | 762 | immune system development |
| GO:0002444 | 0.0042 | 9.9413 | 0.3262 | 3 | 66 | myeloid leukocyte mediated immunity |
| GO:0043067 | 0.0043 | 2.4529 | 6.4441 | 14 | 1304 | regulation of programmed cell death |
| GO:0043434 | 0.0044 | 3.6943 | 2.0558 | 7 | 416 | response to peptide hormone |
| GO:0043065 | 0.0047 | 3.3116 | 2.634 | 8 | 533 | positive regulation of apoptotic process |
| GO:0009749 | 0.0047 | 6.3367 | 0.677 | 4 | 137 | response to glucose |
| GO:0002651 | 0.0049 | Inf | 0.0049 | 1 | 1 | positive regulation of tolerance induction to self antigen |
| GO:0003245 | 0.0049 | Inf | 0.0049 | 1 | 1 | cardiac muscle tissue growth involved in heart morphogenesis |
| GO:0014739 | 0.0049 | Inf | 0.0049 | 1 | 1 | positive regulation of muscle hyperplasia |
| GO:0050760 | 0.0049 | Inf | 0.0049 | 1 | 1 | negative regulation of thymidylate synthase biosynthetic process |
| GO:0071228 | 0.0049 | Inf | 0.0049 | 1 | 1 | cellular response to tumor cell |
| GO:0032673 | 0.0052 | 20.6527 | 0.1087 | 2 | 22 | regulation of interleukin-4 production |
| GO:0014066 | 0.0054 | 9.0733 | 0.3558 | 3 | 72 | regulation of phosphatidylinositol 3-kinase signaling |
| GO:0033077 | 0.0054 | 9.0733 | 0.3558 | 3 | 72 | T cell differentiation in thymus |
| GO:0002063 | 0.0057 | 19.668 | 0.1137 | 2 | 23 | chondrocyte development |
| GO:0045321 | 0.0059 | 4.6807 | 1.1529 | 5 | 262 | leukocyte activation |
| GO:0044092 | 0.0059 | 2.6396 | 4.6107 | 11 | 933 | negative regulation of molecular function |
| GO:0034284 | 0.006 | 5.8897 | 0.7264 | 4 | 147 | response to monosaccharide |
| GO:0010831 | 0.0062 | 18.7727 | 0.1186 | 2 | 24 | positive regulation of myotube differentiation |
| GO:0060334 | 0.0062 | 18.7727 | 0.1186 | 2 | 24 | regulation of interferon-gamma-mediated signaling pathway |
| GO:0048513 | 0.0064 | 1.9818 | 13.6987 | 23 | 2772 | organ development |
| GO:1901698 | 0.0065 | 2.7396 | 4.0127 | 10 | 812 | response to nitrogen compound |
| GO:0002764 | 0.0065 | 3.4269 | 2.209 | 7 | 447 | immune response-regulating signaling pathway |
| GO:0030097 | 0.0065 | 2.902 | 3.3901 | 9 | 686 | hemopoiesis |
| GO:0021884 | 0.0067 | 17.9553 | 0.1235 | 2 | 25 | forebrain neuron development |
| GO:0060351 | 0.0073 | 17.2061 | 0.1285 | 2 | 26 | cartilage development involved in endochondral bone morphogenesis |
| GO:0071495 | 0.0077 | 2.5435 | 4.7837 | 11 | 993 | cellular response to endogenous stimulus |
| GO:0009605 | 0.0078 | 2.0822 | 9.8984 | 18 | 2003 | response to external stimulus |
| GO:0071310 | 0.0078 | 2.1187 | 9.1374 | 17 | 1849 | cellular response to organic substance |
| GO:0034109 | 0.0081 | 4.3186 | 1.244 | 5 | 278 | homotypic cell-cell adhesion |
| GO:0090200 | 0.0084 | 15.8805 | 0.1384 | 2 | 28 | positive regulation of release of cytochrome c from mitochondria |
| GO:1901700 | 0.0089 | 2.3058 | 6.2761 | 13 | 1270 | response to oxygen-containing compound |
| GO:0090287 | 0.0098 | 5.097 | 0.8352 | 4 | 169 | regulation of cellular response to growth factor stimulus |
| GO:0000917 | 0.0099 | 204.0267 | 0.0099 | 1 | 2 | barrier septum assembly |
| GO:0002663 | 0.0099 | 204.0267 | 0.0099 | 1 | 2 | positive regulation of B cell tolerance induction |
| GO:0003430 | 0.0099 | 204.0267 | 0.0099 | 1 | 2 | growth plate cartilage chondrocyte growth |
| GO:0016598 | 0.0099 | 204.0267 | 0.0099 | 1 | 2 | protein arginylation |
| GO:0032796 | 0.0099 | 204.0267 | 0.0099 | 1 | 2 | uropod organization |
| GO:0036496 | 0.0099 | 204.0267 | 0.0099 | 1 | 2 | regulation of translational initiation by eIF2 alpha dephosphorylation |
| GO:0043553 | 0.0099 | 204.0267 | 0.0099 | 1 | 2 | negative regulation of phosphatidylinositol 3-kinase activity |
| GO:0060434 | 0.0099 | 204.0267 | 0.0099 | 1 | 2 | bronchus morphogenesis |
| GO:0071672 | 0.0099 | 204.0267 | 0.0099 | 1 | 2 | negative regulation of smooth muscle cell chemotaxis |
| GO:0071673 | 0.0099 | 204.0267 | 0.0099 | 1 | 2 | positive regulation of smooth muscle cell chemotaxis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050911 | 3e-04 | 10.4193 | 0.5883 | 5 | 348 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0009593 | 6e-04 | 8.4654 | 0.7185 | 5 | 425 | detection of chemical stimulus |
| GO:0050906 | 7e-04 | 8.3027 | 0.732 | 5 | 433 | detection of stimulus involved in sensory perception |
| GO:0007606 | 9e-04 | 7.8492 | 0.7726 | 5 | 457 | sensory perception of chemical stimulus |
| GO:0019428 | 0.0017 | Inf | 0.0017 | 1 | 1 | allantoin biosynthetic process |
| GO:0019628 | 0.0017 | Inf | 0.0017 | 1 | 1 | urate catabolic process |
| GO:0019677 | 0.0017 | Inf | 0.0017 | 1 | 1 | NAD catabolic process |
| GO:0007186 | 0.0019 | 4.7737 | 1.8715 | 7 | 1107 | G-protein coupled receptor signaling pathway |
| GO:0045576 | 0.0028 | 28.3481 | 0.0795 | 2 | 47 | mast cell activation |
| GO:0001980 | 0.0034 | 614.08 | 0.0034 | 1 | 2 | regulation of systemic arterial blood pressure by ischemic conditions |
| GO:0002506 | 0.0034 | 614.08 | 0.0034 | 1 | 2 | polysaccharide assembly with MHC class II protein complex |
| GO:0006742 | 0.0034 | 614.08 | 0.0034 | 1 | 2 | NADP catabolic process |
| GO:0071823 | 0.0034 | 614.08 | 0.0034 | 1 | 2 | protein-carbohydrate complex subunit organization |
| GO:0070489 | 0.0041 | 6.9575 | 0.6678 | 4 | 395 | T cell aggregation |
| GO:0070486 | 0.0044 | 6.8143 | 0.6813 | 4 | 403 | leukocyte aggregation |
| GO:0031295 | 0.006 | 19.0124 | 0.1167 | 2 | 69 | T cell costimulation |
| GO:0002503 | 0.0067 | 204.6667 | 0.0068 | 1 | 4 | peptide antigen assembly with MHC class II protein complex |
| GO:0030223 | 0.0067 | 204.6667 | 0.0068 | 1 | 4 | neutrophil differentiation |
| GO:0050863 | 0.0084 | 7.9771 | 0.4227 | 3 | 250 | regulation of T cell activation |
| GO:0002396 | 0.0084 | 153.49 | 0.0085 | 1 | 5 | MHC protein complex assembly |
| GO:0072526 | 0.0084 | 153.49 | 0.0085 | 1 | 5 | pyridine-containing compound catabolic process |
| GO:0002376 | 0.0088 | 3.1073 | 3.7937 | 9 | 2244 | immune system process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050911 | 0 | 23.5545 | 0.5204 | 8 | 348 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0009593 | 0 | 19.1066 | 0.6356 | 8 | 425 | detection of chemical stimulus |
| GO:0050906 | 0 | 18.7369 | 0.6476 | 8 | 433 | detection of stimulus involved in sensory perception |
| GO:0007606 | 0 | 17.7069 | 0.6835 | 8 | 457 | sensory perception of chemical stimulus |
| GO:0007186 | 0 | 9.9986 | 1.6556 | 10 | 1107 | G-protein coupled receptor signaling pathway |
| GO:0050877 | 0 | 8.0932 | 1.7034 | 9 | 1139 | neurological system process |
| GO:0044707 | 0.0033 | 3.5254 | 9.057 | 16 | 6056 | single-multicellular organism process |
| GO:0045918 | 0.006 | 232.6212 | 0.006 | 1 | 4 | negative regulation of cytolysis |
| GO:0043045 | 0.0089 | 139.5545 | 0.009 | 1 | 6 | DNA methylation involved in embryo development |
| GO:0045347 | 0.0089 | 139.5545 | 0.009 | 1 | 6 | negative regulation of MHC class II biosynthetic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042110 | 0 | 11.4514 | 0.899 | 8 | 395 | T cell activation |
| GO:0071593 | 0 | 11.391 | 0.9035 | 8 | 397 | lymphocyte aggregation |
| GO:0045954 | 0 | 110.5601 | 0.0364 | 3 | 16 | positive regulation of natural killer cell mediated cytotoxicity |
| GO:1901623 | 0 | 89.8125 | 0.0432 | 3 | 19 | regulation of lymphocyte chemotaxis |
| GO:0045321 | 0 | 11.1173 | 0.8052 | 7 | 393 | leukocyte activation |
| GO:2000502 | 0 | 929.8788 | 0.0068 | 2 | 3 | negative regulation of natural killer cell chemotaxis |
| GO:0002708 | 0 | 31.2975 | 0.1525 | 4 | 67 | positive regulation of lymphocyte mediated immunity |
| GO:0009607 | 0 | 7.1137 | 1.6409 | 9 | 721 | response to biotic stimulus |
| GO:0050776 | 0 | 12.2099 | 0.6128 | 6 | 305 | regulation of immune response |
| GO:0002715 | 0 | 59.8438 | 0.0614 | 3 | 27 | regulation of natural killer cell mediated immunity |
| GO:0060326 | 1e-04 | 12.3693 | 0.4756 | 5 | 209 | cell chemotaxis |
| GO:2000402 | 1e-04 | 185.9273 | 0.0159 | 2 | 7 | negative regulation of lymphocyte migration |
| GO:0031343 | 1e-04 | 37.7615 | 0.0933 | 3 | 41 | positive regulation of cell killing |
| GO:0098602 | 1e-04 | 6.3214 | 1.5817 | 8 | 695 | single organism cell adhesion |
| GO:0031347 | 2e-04 | 7.1697 | 1.1925 | 7 | 524 | regulation of defense response |
| GO:0045576 | 2e-04 | 32.5994 | 0.107 | 3 | 47 | mast cell activation |
| GO:0007159 | 2e-04 | 11.2316 | 0.5285 | 5 | 251 | leukocyte cell-cell adhesion |
| GO:0001910 | 2e-04 | 31.8729 | 0.1092 | 3 | 48 | regulation of leukocyte mediated cytotoxicity |
| GO:0002418 | 2e-04 | 116.1818 | 0.0228 | 2 | 10 | immune response to tumor cell |
| GO:0002689 | 2e-04 | 116.1818 | 0.0228 | 2 | 10 | negative regulation of leukocyte chemotaxis |
| GO:0002699 | 2e-04 | 14.87 | 0.3095 | 4 | 136 | positive regulation of immune effector process |
| GO:0002443 | 3e-04 | 10.1037 | 0.5781 | 5 | 254 | leukocyte mediated immunity |
| GO:0034109 | 3e-04 | 10.1011 | 0.5854 | 5 | 278 | homotypic cell-cell adhesion |
| GO:0031295 | 5e-04 | 21.7017 | 0.157 | 3 | 69 | T cell costimulation |
| GO:0022610 | 5e-04 | 4.2816 | 3.0064 | 10 | 1321 | biological adhesion |
| GO:0030101 | 5e-04 | 21.3764 | 0.1593 | 3 | 70 | natural killer cell activation |
| GO:0006952 | 6e-04 | 5.8657 | 1.5461 | 7 | 881 | defense response |
| GO:0051707 | 8e-04 | 5.3746 | 1.568 | 7 | 689 | response to other organism |
| GO:0034260 | 9e-04 | 51.6027 | 0.0455 | 2 | 20 | negative regulation of GTPase activity |
| GO:0002429 | 0.0011 | 9.9211 | 0.4574 | 4 | 201 | immune response-activating cell surface receptor signaling pathway |
| GO:0051607 | 0.0013 | 9.482 | 0.4779 | 4 | 210 | defense response to virus |
| GO:0045089 | 0.0013 | 9.3896 | 0.4825 | 4 | 212 | positive regulation of innate immune response |
| GO:0050850 | 0.0015 | 40.3715 | 0.0569 | 2 | 25 | positive regulation of calcium-mediated signaling |
| GO:0002253 | 0.0018 | 6.4931 | 0.8853 | 5 | 389 | activation of immune response |
| GO:0019835 | 0.002 | 34.3816 | 0.066 | 2 | 29 | cytolysis |
| GO:0001805 | 0.0023 | Inf | 0.0023 | 1 | 1 | positive regulation of type III hypersensitivity |
| GO:0002355 | 0.0023 | Inf | 0.0023 | 1 | 1 | detection of tumor cell |
| GO:1903488 | 0.0023 | Inf | 0.0023 | 1 | 1 | negative regulation of lactation |
| GO:0002696 | 0.0024 | 7.9521 | 0.5667 | 4 | 249 | positive regulation of leukocyte activation |
| GO:0002685 | 0.0025 | 12.2011 | 0.2731 | 3 | 120 | regulation of leukocyte migration |
| GO:0002764 | 0.0032 | 5.6192 | 1.0173 | 5 | 447 | immune response-regulating signaling pathway |
| GO:0048584 | 0.0034 | 3.2664 | 3.8325 | 10 | 1684 | positive regulation of response to stimulus |
| GO:0030098 | 0.0034 | 7.1499 | 0.6281 | 4 | 276 | lymphocyte differentiation |
| GO:0048870 | 0.0036 | 3.6988 | 2.6081 | 8 | 1146 | cell motility |
| GO:0050920 | 0.0036 | 10.722 | 0.3095 | 3 | 136 | regulation of chemotaxis |
| GO:0009605 | 0.0037 | 3.0721 | 4.5585 | 11 | 2003 | response to external stimulus |
| GO:0048521 | 0.0041 | 23.1879 | 0.0956 | 2 | 42 | negative regulation of behavior |
| GO:0001798 | 0.0045 | 451.2647 | 0.0046 | 1 | 2 | positive regulation of type IIa hypersensitivity |
| GO:0001812 | 0.0045 | 451.2647 | 0.0046 | 1 | 2 | positive regulation of type I hypersensitivity |
| GO:0002357 | 0.0045 | 451.2647 | 0.0046 | 1 | 2 | defense response to tumor cell |
| GO:0002361 | 0.0045 | 451.2647 | 0.0046 | 1 | 2 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation |
| GO:0002522 | 0.0045 | 451.2647 | 0.0046 | 1 | 2 | leukocyte migration involved in immune response |
| GO:0002892 | 0.0045 | 451.2647 | 0.0046 | 1 | 2 | regulation of type II hypersensitivity |
| GO:0032765 | 0.0045 | 451.2647 | 0.0046 | 1 | 2 | positive regulation of mast cell cytokine production |
| GO:1902530 | 0.0045 | 451.2647 | 0.0046 | 1 | 2 | positive regulation of protein linear polyubiquitination |
| GO:0038095 | 0.006 | 8.8969 | 0.371 | 3 | 163 | Fc-epsilon receptor signaling pathway |
| GO:0006968 | 0.0067 | 17.8228 | 0.1229 | 2 | 54 | cellular defense response |
| GO:0002351 | 0.0068 | 225.6176 | 0.0068 | 1 | 3 | serotonin production involved in inflammatory response |
| GO:0002554 | 0.0068 | 225.6176 | 0.0068 | 1 | 3 | serotonin secretion by platelet |
| GO:0033026 | 0.0068 | 225.6176 | 0.0068 | 1 | 3 | negative regulation of mast cell apoptotic process |
| GO:0045065 | 0.0068 | 225.6176 | 0.0068 | 1 | 3 | cytotoxic T cell differentiation |
| GO:0050911 | 0.0078 | 5.6264 | 0.792 | 4 | 348 | detection of chemical stimulus involved in sensory perception of smell |
| GO:1903039 | 0.008 | 7.9877 | 0.4119 | 3 | 181 | positive regulation of leukocyte cell-cell adhesion |
| GO:0034112 | 0.0082 | 7.8979 | 0.4165 | 3 | 183 | positive regulation of homotypic cell-cell adhesion |
| GO:0033023 | 0.0091 | 150.402 | 0.0091 | 1 | 4 | mast cell homeostasis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0097659 | 0 | 6.5379 | 37.2908 | 110 | 3315 | nucleic acid-templated transcription |
| GO:0034654 | 0 | 5.9263 | 42.5216 | 113 | 3780 | nucleobase-containing compound biosynthetic process |
| GO:1902680 | 0 | 7.1631 | 13.6789 | 64 | 1216 | positive regulation of RNA biosynthetic process |
| GO:0045944 | 0 | 7.751 | 10.0679 | 54 | 895 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0007389 | 0 | 20.9393 | 1.8916 | 28 | 199 | pattern specification process |
| GO:0016070 | 0 | 4.9926 | 45.5589 | 110 | 4050 | RNA metabolic process |
| GO:0009891 | 0 | 6.0194 | 17.0086 | 67 | 1512 | positive regulation of biosynthetic process |
| GO:0045935 | 0 | 5.9351 | 16.4799 | 65 | 1465 | positive regulation of nucleobase-containing compound metabolic process |
| GO:0010467 | 0 | 4.667 | 50.4522 | 113 | 4485 | gene expression |
| GO:0034645 | 0 | 4.6303 | 48.9449 | 111 | 4351 | cellular macromolecule biosynthetic process |
| GO:0009792 | 0 | 8.1841 | 6.7157 | 41 | 597 | embryo development ending in birth or egg hatching |
| GO:0006725 | 0 | 4.0031 | 58.9566 | 116 | 5241 | cellular aromatic compound metabolic process |
| GO:0046483 | 0 | 3.9162 | 58.7878 | 115 | 5226 | heterocycle metabolic process |
| GO:1901360 | 0 | 3.7676 | 61.2964 | 116 | 5449 | organic cyclic compound metabolic process |
| GO:0034641 | 0 | 3.7658 | 62.3538 | 117 | 5543 | cellular nitrogen compound metabolic process |
| GO:0010604 | 0 | 4.0561 | 26.3792 | 72 | 2345 | positive regulation of macromolecule metabolic process |
| GO:0090596 | 0 | 11.3494 | 2.7898 | 25 | 248 | sensory organ morphogenesis |
| GO:1901576 | 0 | 3.6813 | 61.1726 | 115 | 5438 | organic substance biosynthetic process |
| GO:0048562 | 0 | 15.099 | 1.7889 | 21 | 174 | embryonic organ morphogenesis |
| GO:0021510 | 0 | 21.9852 | 1.0349 | 17 | 92 | spinal cord development |
| GO:0009952 | 0 | 18.1072 | 1.2886 | 18 | 124 | anterior/posterior pattern specification |
| GO:1902679 | 0 | 5.0114 | 11.3953 | 44 | 1013 | negative regulation of RNA biosynthetic process |
| GO:0000122 | 0 | 6.0687 | 7.2557 | 35 | 645 | negative regulation of transcription from RNA polymerase II promoter |
| GO:0007156 | 0 | 14.723 | 1.5411 | 18 | 137 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0045934 | 0 | 4.6131 | 12.9702 | 46 | 1153 | negative regulation of nucleobase-containing compound metabolic process |
| GO:0098609 | 0 | 11.6309 | 2.1261 | 20 | 189 | cell-cell adhesion |
| GO:0044707 | 0 | 5.0866 | 26.9164 | 61 | 4042 | single-multicellular organism process |
| GO:0009890 | 0 | 4.2739 | 13.8814 | 46 | 1234 | negative regulation of biosynthetic process |
| GO:0009790 | 0 | 10.4549 | 2.3794 | 20 | 269 | embryo development |
| GO:0044767 | 0 | 9.8275 | 3.7372 | 23 | 710 | single-organism developmental process |
| GO:0035107 | 0 | 12.4445 | 1.6761 | 17 | 149 | appendage morphogenesis |
| GO:0022008 | 0 | 5.3459 | 7.8429 | 33 | 815 | neurogenesis |
| GO:0060173 | 0 | 11.6233 | 1.78 | 17 | 160 | limb development |
| GO:2001141 | 0 | 4.9364 | 10.4587 | 36 | 1434 | regulation of RNA biosynthetic process |
| GO:0006355 | 0 | 4.8837 | 10.5563 | 36 | 1454 | regulation of transcription, DNA-templated |
| GO:0051962 | 0 | 7.1419 | 3.6672 | 22 | 326 | positive regulation of nervous system development |
| GO:0009889 | 0 | 4.68 | 11.186 | 36 | 1562 | regulation of biosynthetic process |
| GO:0048665 | 0 | 96.1392 | 0.1504 | 7 | 14 | neuron fate specification |
| GO:0048729 | 0 | 6.155 | 4.4477 | 23 | 426 | tissue morphogenesis |
| GO:0019219 | 0 | 4.5761 | 10.8722 | 35 | 1499 | regulation of nucleobase-containing compound metabolic process |
| GO:0060581 | 0 | 80.1099 | 0.1687 | 7 | 15 | cell fate commitment involved in pattern specification |
| GO:0030900 | 0 | 13.5035 | 1.1667 | 13 | 112 | forebrain development |
| GO:0010720 | 0 | 6.0775 | 4.2522 | 22 | 378 | positive regulation of cell development |
| GO:0021514 | 0 | 64.0795 | 0.1912 | 7 | 17 | ventral spinal cord interneuron differentiation |
| GO:0009954 | 0 | 37.7267 | 0.3078 | 8 | 28 | proximal/distal pattern formation |
| GO:0043583 | 0 | 8.3201 | 2.2498 | 16 | 200 | ear development |
| GO:0042472 | 0 | 12.9527 | 1.1137 | 12 | 99 | inner ear morphogenesis |
| GO:2000026 | 0 | 3.6828 | 11.9735 | 36 | 1149 | regulation of multicellular organismal development |
| GO:0048522 | 0 | 2.868 | 30 | 61 | 3096 | positive regulation of cellular process |
| GO:0060255 | 0 | 4.0007 | 12.5213 | 35 | 1667 | regulation of macromolecule metabolic process |
| GO:0007399 | 0 | 6.4784 | 3.388 | 18 | 476 | nervous system development |
| GO:0045666 | 0 | 7.1735 | 2.576 | 16 | 229 | positive regulation of neuron differentiation |
| GO:0021513 | 0 | 35.581 | 0.2812 | 7 | 25 | spinal cord dorsal/ventral patterning |
| GO:0021913 | 0 | Inf | 0.045 | 4 | 4 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
| GO:0048565 | 0 | 9.7808 | 1.4286 | 12 | 127 | digestive tract development |
| GO:0001764 | 0 | 11.106 | 1.1626 | 11 | 105 | neuron migration |
| GO:0007517 | 0 | 5.6172 | 3.6672 | 18 | 326 | muscle organ development |
| GO:0016339 | 0 | 27.8368 | 0.3375 | 7 | 30 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
| GO:0060562 | 0 | 9.0242 | 1.536 | 12 | 146 | epithelial tube morphogenesis |
| GO:0030182 | 0 | 4.2218 | 6.7218 | 24 | 734 | neuron differentiation |
| GO:0035115 | 0 | 23.7066 | 0.3825 | 7 | 34 | embryonic forelimb morphogenesis |
| GO:0051241 | 0 | 3.5275 | 9.2101 | 28 | 832 | negative regulation of multicellular organismal process |
| GO:0060537 | 0 | 5.3419 | 3.611 | 17 | 321 | muscle tissue development |
| GO:0021797 | 0 | 179.929 | 0.0675 | 4 | 6 | forebrain anterior/posterior pattern specification |
| GO:0021983 | 0 | 18.8172 | 0.4612 | 7 | 41 | pituitary gland development |
| GO:0061138 | 0 | 6.6334 | 2.2161 | 13 | 197 | morphogenesis of a branching epithelium |
| GO:0010605 | 0 | 2.5627 | 21.6995 | 46 | 1929 | negative regulation of macromolecule metabolic process |
| GO:0009798 | 0 | 10.7825 | 0.9674 | 9 | 86 | axis specification |
| GO:0048870 | 0 | 3.9722 | 6.0352 | 21 | 569 | cell motility |
| GO:0048646 | 0 | 3.3874 | 8.8742 | 26 | 867 | anatomical structure formation involved in morphogenesis |
| GO:0048664 | 0 | 89.9527 | 0.09 | 4 | 8 | neuron fate determination |
| GO:0072175 | 0 | 8.343 | 1.3611 | 10 | 121 | epithelial tube formation |
| GO:0003231 | 0 | 9.5368 | 1.0799 | 9 | 96 | cardiac ventricle development |
| GO:0021912 | 0 | Inf | 0.0337 | 3 | 3 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification |
| GO:0009953 | 0 | 11.4005 | 0.812 | 8 | 76 | dorsal/ventral pattern formation |
| GO:0061564 | 0 | 3.7237 | 6.3557 | 21 | 565 | axon development |
| GO:0072048 | 0 | 71.9574 | 0.1012 | 4 | 9 | renal system pattern specification |
| GO:2000543 | 0 | 71.9574 | 0.1012 | 4 | 9 | positive regulation of gastrulation |
| GO:0045595 | 0 | 3.5737 | 7.0644 | 22 | 724 | regulation of cell differentiation |
| GO:0021915 | 0 | 13.644 | 0.6048 | 7 | 55 | neural tube development |
| GO:0001654 | 0 | 4.6538 | 3.5885 | 15 | 319 | eye development |
| GO:0016331 | 0 | 7.2565 | 1.5464 | 10 | 139 | morphogenesis of embryonic epithelium |
| GO:0023019 | 0 | 26.5914 | 0.2475 | 5 | 22 | signal transduction involved in regulation of gene expression |
| GO:0048667 | 0 | 3.4469 | 6.8282 | 21 | 607 | cell morphogenesis involved in neuron differentiation |
| GO:0045665 | 0 | 6.9528 | 1.6086 | 10 | 143 | negative regulation of neuron differentiation |
| GO:0050767 | 0 | 5.1261 | 2.8244 | 13 | 274 | regulation of neurogenesis |
| GO:0042733 | 0 | 11.8322 | 0.6862 | 7 | 61 | embryonic digit morphogenesis |
| GO:0034287 | 0 | 268.3235 | 0.045 | 3 | 4 | detection of monosaccharide stimulus |
| GO:0051594 | 0 | 268.3235 | 0.045 | 3 | 4 | detection of glucose |
| GO:0072086 | 0 | 268.3235 | 0.045 | 3 | 4 | specification of loop of Henle identity |
| GO:0048812 | 0 | 3.3749 | 6.9632 | 21 | 619 | neuron projection morphogenesis |
| GO:0061448 | 0 | 5.3483 | 2.4861 | 12 | 221 | connective tissue development |
| GO:0045165 | 0 | 7.4665 | 1.3473 | 9 | 139 | cell fate commitment |
| GO:0072080 | 0 | 8.8342 | 1.0237 | 8 | 91 | nephron tubule development |
| GO:0007368 | 0 | 8.7284 | 1.0349 | 8 | 92 | determination of left/right symmetry |
| GO:0061458 | 0 | 4.0086 | 4.4209 | 16 | 393 | reproductive system development |
| GO:0045596 | 0 | 3.817 | 4.9589 | 17 | 469 | negative regulation of cell differentiation |
| GO:0008284 | 0 | 3.2734 | 7.188 | 21 | 666 | positive regulation of cell proliferation |
| GO:0048935 | 0 | 39.9658 | 0.1462 | 4 | 13 | peripheral nervous system neuron development |
| GO:0002791 | 0 | 5.6682 | 2.1486 | 11 | 191 | regulation of peptide secretion |
| GO:0003279 | 0 | 10.4696 | 0.7649 | 7 | 68 | cardiac septum development |
| GO:0009887 | 0 | 5.6779 | 2.1656 | 11 | 260 | organ morphogenesis |
| GO:0072089 | 0 | 10.3429 | 0.7726 | 7 | 70 | stem cell proliferation |
| GO:0022414 | 0 | 2.674 | 12.3065 | 29 | 1094 | reproductive process |
| GO:0023061 | 0 | 3.892 | 4.5446 | 16 | 404 | signal release |
| GO:0003278 | 0 | 134.1529 | 0.0562 | 3 | 5 | apoptotic process involved in heart morphogenesis |
| GO:0021779 | 0 | 134.1529 | 0.0562 | 3 | 5 | oligodendrocyte cell fate commitment |
| GO:0021780 | 0 | 134.1529 | 0.0562 | 3 | 5 | glial cell fate specification |
| GO:0021846 | 0 | 18.8269 | 0.3262 | 5 | 29 | cell proliferation in forebrain |
| GO:0061333 | 0 | 9.6732 | 0.8212 | 7 | 73 | renal tubule morphogenesis |
| GO:0072088 | 0 | 9.6732 | 0.8212 | 7 | 73 | nephron epithelium morphogenesis |
| GO:0021527 | 0 | 32.695 | 0.1687 | 4 | 15 | spinal cord association neuron differentiation |
| GO:0072132 | 0 | 18.0726 | 0.3375 | 5 | 30 | mesenchyme morphogenesis |
| GO:0009799 | 0 | 7.7947 | 1.1474 | 8 | 102 | specification of symmetry |
| GO:0035050 | 0 | 9.3875 | 0.8437 | 7 | 75 | embryonic heart tube development |
| GO:0003206 | 0 | 9.1394 | 0.8638 | 7 | 78 | cardiac chamber morphogenesis |
| GO:0007379 | 0 | 29.9684 | 0.18 | 4 | 16 | segment specification |
| GO:0007519 | 0 | 9.0471 | 0.8717 | 7 | 79 | skeletal muscle tissue development |
| GO:0048663 | 0 | 16.6184 | 0.3581 | 5 | 35 | neuron fate commitment |
| GO:0060022 | 0 | 89.4294 | 0.0675 | 3 | 6 | hard palate development |
| GO:0007268 | 0 | 3.0021 | 7.7619 | 21 | 690 | synaptic transmission |
| GO:0007416 | 0 | 8.6229 | 0.9112 | 7 | 81 | synapse assembly |
| GO:0021549 | 0 | 8.3949 | 0.9337 | 7 | 83 | cerebellum development |
| GO:0030878 | 0 | 25.6839 | 0.2025 | 4 | 18 | thyroid gland development |
| GO:0021796 | 0 | 67.0676 | 0.0787 | 3 | 7 | cerebral cortex regionalization |
| GO:0021798 | 0 | 67.0676 | 0.0787 | 3 | 7 | forebrain dorsal/ventral pattern formation |
| GO:0072079 | 1e-04 | 23.97 | 0.2137 | 4 | 19 | nephron tubule formation |
| GO:0006935 | 1e-04 | 2.9558 | 7.4694 | 20 | 664 | chemotaxis |
| GO:0031290 | 1e-04 | 22.4704 | 0.225 | 4 | 20 | retinal ganglion cell axon guidance |
| GO:0048557 | 1e-04 | 22.4704 | 0.225 | 4 | 20 | embryonic digestive tract morphogenesis |
| GO:0060993 | 1e-04 | 7.6833 | 1.0124 | 7 | 90 | kidney morphogenesis |
| GO:0048704 | 1e-04 | 13.2119 | 0.4388 | 5 | 41 | embryonic skeletal system morphogenesis |
| GO:0072358 | 1e-04 | 2.6901 | 9.483 | 23 | 843 | cardiovascular system development |
| GO:0060415 | 1e-04 | 9.2238 | 0.7312 | 6 | 65 | muscle tissue morphogenesis |
| GO:0007548 | 1e-04 | 4.4213 | 2.711 | 11 | 241 | sex differentiation |
| GO:0003151 | 1e-04 | 12.5651 | 0.4593 | 5 | 42 | outflow tract morphogenesis |
| GO:0003309 | 1e-04 | 19.9711 | 0.2475 | 4 | 22 | type B pancreatic cell differentiation |
| GO:0050880 | 1e-04 | 6.0446 | 1.4511 | 8 | 129 | regulation of blood vessel size |
| GO:0021675 | 1e-04 | 8.9202 | 0.7537 | 6 | 67 | nerve development |
| GO:0060041 | 1e-04 | 5.9946 | 1.4624 | 8 | 130 | retina development in camera-type eye |
| GO:0048241 | 1e-04 | 44.7059 | 0.1012 | 3 | 9 | epinephrine transport |
| GO:0050768 | 1e-04 | 11.8932 | 0.4814 | 5 | 45 | negative regulation of neurogenesis |
| GO:0050796 | 1e-04 | 5.1934 | 1.8898 | 9 | 168 | regulation of insulin secretion |
| GO:0048468 | 1e-04 | 3.0071 | 6.7266 | 18 | 776 | cell development |
| GO:0003326 | 1e-04 | Inf | 0.0225 | 2 | 2 | pancreatic A cell fate commitment |
| GO:0003329 | 1e-04 | Inf | 0.0225 | 2 | 2 | pancreatic PP cell fate commitment |
| GO:0003404 | 1e-04 | Inf | 0.0225 | 2 | 2 | optic vesicle morphogenesis |
| GO:0007198 | 1e-04 | Inf | 0.0225 | 2 | 2 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
| GO:0043503 | 1e-04 | Inf | 0.0225 | 2 | 2 | skeletal muscle fiber adaptation |
| GO:0070473 | 1e-04 | Inf | 0.0225 | 2 | 2 | negative regulation of uterine smooth muscle contraction |
| GO:0072272 | 1e-04 | Inf | 0.0225 | 2 | 2 | proximal/distal pattern formation involved in metanephric nephron development |
| GO:0045893 | 1e-04 | 4.5816 | 2.3991 | 10 | 292 | positive regulation of transcription, DNA-templated |
| GO:0050789 | 2e-04 | 2.2051 | 48.0976 | 66 | 5668 | regulation of biological process |
| GO:0048869 | 2e-04 | 2.6439 | 10.2807 | 23 | 1386 | cellular developmental process |
| GO:0032525 | 2e-04 | 38.3168 | 0.1125 | 3 | 10 | somite rostral/caudal axis specification |
| GO:0061303 | 2e-04 | 38.3168 | 0.1125 | 3 | 10 | cornea development in camera-type eye |
| GO:0090009 | 2e-04 | 38.3168 | 0.1125 | 3 | 10 | primitive streak formation |
| GO:0021884 | 2e-04 | 17.1147 | 0.2812 | 4 | 25 | forebrain neuron development |
| GO:0060021 | 2e-04 | 7.9077 | 0.8406 | 6 | 76 | palate development |
| GO:2000027 | 2e-04 | 6.3575 | 1.2053 | 7 | 110 | regulation of organ morphogenesis |
| GO:0001501 | 2e-04 | 3.6944 | 3.5287 | 12 | 345 | skeletal system development |
| GO:0001656 | 2e-04 | 10.1483 | 0.5553 | 5 | 51 | metanephros development |
| GO:0009914 | 2e-04 | 3.914 | 3.0416 | 11 | 275 | hormone transport |
| GO:0007492 | 3e-04 | 7.448 | 0.8887 | 6 | 79 | endoderm development |
| GO:0030855 | 3e-04 | 3.8801 | 3.0742 | 11 | 298 | epithelial cell differentiation |
| GO:0060525 | 3e-04 | 29.798 | 0.135 | 3 | 12 | prostate glandular acinus development |
| GO:0097305 | 3e-04 | 3.8431 | 3.0935 | 11 | 275 | response to alcohol |
| GO:0042476 | 3e-04 | 6.007 | 1.2711 | 7 | 113 | odontogenesis |
| GO:0007224 | 3e-04 | 9.589 | 0.5849 | 5 | 53 | smoothened signaling pathway |
| GO:0060412 | 3e-04 | 14.3725 | 0.3262 | 4 | 29 | ventricular septum morphogenesis |
| GO:1902692 | 3e-04 | 14.3725 | 0.3262 | 4 | 29 | regulation of neuroblast proliferation |
| GO:0032990 | 3e-04 | 2.5245 | 9.1118 | 21 | 810 | cell part morphogenesis |
| GO:0001568 | 3e-04 | 2.9013 | 5.9845 | 16 | 532 | blood vessel development |
| GO:0022610 | 4e-04 | 2.1688 | 14.8601 | 29 | 1321 | biological adhesion |
| GO:0007218 | 4e-04 | 6.9682 | 0.9449 | 6 | 84 | neuropeptide signaling pathway |
| GO:0072047 | 4e-04 | 179.9408 | 0.0334 | 2 | 3 | proximal/distal pattern formation involved in nephron development |
| GO:0021903 | 4e-04 | 179.858 | 0.0334 | 2 | 3 | rostrocaudal neural tube patterning |
| GO:0055015 | 4e-04 | 26.8165 | 0.1462 | 3 | 13 | ventricular cardiac muscle cell development |
| GO:0060272 | 4e-04 | 26.8165 | 0.1462 | 3 | 13 | embryonic skeletal joint morphogenesis |
| GO:0001705 | 4e-04 | 177.8363 | 0.0337 | 2 | 3 | ectoderm formation |
| GO:0003253 | 4e-04 | 177.8363 | 0.0337 | 2 | 3 | cardiac neural crest cell migration involved in outflow tract morphogenesis |
| GO:0003350 | 4e-04 | 177.8363 | 0.0337 | 2 | 3 | pulmonary myocardium development |
| GO:0021530 | 4e-04 | 177.8363 | 0.0337 | 2 | 3 | spinal cord oligodendrocyte cell fate specification |
| GO:0021570 | 4e-04 | 177.8363 | 0.0337 | 2 | 3 | rhombomere 4 development |
| GO:0033693 | 4e-04 | 177.8363 | 0.0337 | 2 | 3 | neurofilament bundle assembly |
| GO:0055014 | 4e-04 | 177.8363 | 0.0337 | 2 | 3 | atrial cardiac muscle cell development |
| GO:0061074 | 4e-04 | 177.8363 | 0.0337 | 2 | 3 | regulation of neural retina development |
| GO:0070253 | 4e-04 | 177.8363 | 0.0337 | 2 | 3 | somatostatin secretion |
| GO:0071883 | 4e-04 | 177.8363 | 0.0337 | 2 | 3 | activation of MAPK activity by adrenergic receptor signaling pathway |
| GO:0001947 | 4e-04 | 9.0214 | 0.6187 | 5 | 55 | heart looping |
| GO:0048333 | 4e-04 | 13.3062 | 0.3487 | 4 | 31 | mesodermal cell differentiation |
| GO:1902742 | 4e-04 | 13.3062 | 0.3487 | 4 | 31 | apoptotic process involved in development |
| GO:0015833 | 4e-04 | 3.6867 | 3.2172 | 11 | 286 | peptide transport |
| GO:0021871 | 4e-04 | 25.1058 | 0.153 | 3 | 14 | forebrain regionalization |
| GO:0014032 | 4e-04 | 25.0628 | 0.1533 | 3 | 14 | neural crest cell development |
| GO:0014003 | 4e-04 | 12.8301 | 0.36 | 4 | 32 | oligodendrocyte development |
| GO:0048645 | 4e-04 | 24.9036 | 0.1543 | 3 | 14 | organ formation |
| GO:0050885 | 4e-04 | 8.6733 | 0.6412 | 5 | 57 | neuromuscular process controlling balance |
| GO:0003148 | 5e-04 | 24.377 | 0.1575 | 3 | 14 | outflow tract septum morphogenesis |
| GO:0048701 | 5e-04 | 12.5294 | 0.3671 | 4 | 33 | embryonic cranial skeleton morphogenesis |
| GO:0003013 | 5e-04 | 3.1959 | 4.3872 | 13 | 390 | circulatory system process |
| GO:0060441 | 5e-04 | 12.3869 | 0.3712 | 4 | 33 | epithelial tube branching involved in lung morphogenesis |
| GO:0031018 | 5e-04 | 12.2489 | 0.3742 | 4 | 34 | endocrine pancreas development |
| GO:0051094 | 5e-04 | 2.7941 | 6.2479 | 16 | 631 | positive regulation of developmental process |
| GO:0060349 | 6e-04 | 6.3914 | 1.0237 | 6 | 91 | bone morphogenesis |
| GO:0021542 | 6e-04 | 22.3441 | 0.1687 | 3 | 15 | dentate gyrus development |
| GO:2000678 | 6e-04 | 22.3441 | 0.1687 | 3 | 15 | negative regulation of transcription regulatory region DNA binding |
| GO:0009880 | 6e-04 | 8.0517 | 0.6862 | 5 | 61 | embryonic pattern specification |
| GO:0044238 | 6e-04 | 1.7186 | 102.0856 | 123 | 9075 | primary metabolic process |
| GO:0003156 | 6e-04 | 11.5862 | 0.3937 | 4 | 35 | regulation of organ formation |
| GO:0050433 | 6e-04 | 11.5862 | 0.3937 | 4 | 35 | regulation of catecholamine secretion |
| GO:0015844 | 7e-04 | 7.9099 | 0.6974 | 5 | 62 | monoamine transport |
| GO:0060850 | 7e-04 | 21.1209 | 0.1759 | 3 | 16 | regulation of transcription involved in cell fate commitment |
| GO:0048536 | 7e-04 | 11.2234 | 0.405 | 4 | 36 | spleen development |
| GO:0048532 | 7e-04 | 20.624 | 0.18 | 3 | 16 | anatomical structure arrangement |
| GO:0021546 | 7e-04 | 89.9467 | 0.0445 | 2 | 4 | rhombomere development |
| GO:0002865 | 7e-04 | 88.9123 | 0.045 | 2 | 4 | negative regulation of acute inflammatory response to antigenic stimulus |
| GO:0003219 | 7e-04 | 88.9123 | 0.045 | 2 | 4 | cardiac right ventricle formation |
| GO:0021569 | 7e-04 | 88.9123 | 0.045 | 2 | 4 | rhombomere 3 development |
| GO:0035625 | 7e-04 | 88.9123 | 0.045 | 2 | 4 | epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway |
| GO:0060743 | 7e-04 | 88.9123 | 0.045 | 2 | 4 | epithelial cell maturation involved in prostate gland development |
| GO:0060913 | 7e-04 | 88.9123 | 0.045 | 2 | 4 | cardiac cell fate determination |
| GO:0061031 | 7e-04 | 88.9123 | 0.045 | 2 | 4 | endodermal digestive tract morphogenesis |
| GO:0061325 | 7e-04 | 88.9123 | 0.045 | 2 | 4 | cell proliferation involved in outflow tract morphogenesis |
| GO:0002088 | 8e-04 | 7.6407 | 0.7199 | 5 | 64 | lens development in camera-type eye |
| GO:0072073 | 8e-04 | 10.8156 | 0.4178 | 4 | 38 | kidney epithelium development |
| GO:0021537 | 8e-04 | 7.5487 | 0.7266 | 5 | 68 | telencephalon development |
| GO:2000145 | 8e-04 | 2.6604 | 6.4907 | 16 | 577 | regulation of cell motility |
| GO:0008285 | 8e-04 | 2.659 | 6.4973 | 16 | 584 | negative regulation of cell proliferation |
| GO:0014015 | 8e-04 | 10.5618 | 0.4275 | 4 | 38 | positive regulation of gliogenesis |
| GO:0048486 | 8e-04 | 19.1496 | 0.1912 | 3 | 17 | parasympathetic nervous system development |
| GO:0060037 | 8e-04 | 19.1496 | 0.1912 | 3 | 17 | pharyngeal system development |
| GO:0015837 | 9e-04 | 7.3892 | 0.7424 | 5 | 66 | amine transport |
| GO:0072210 | 9e-04 | 10.3822 | 0.4337 | 4 | 39 | metanephric nephron development |
| GO:0048732 | 9e-04 | 3.3245 | 3.5527 | 11 | 334 | gland development |
| GO:0030030 | 9e-04 | 2.1472 | 12.7565 | 25 | 1134 | cell projection organization |
| GO:0050877 | 0.001 | 2.1368 | 12.8127 | 25 | 1139 | neurological system process |
| GO:0045995 | 0.001 | 5.7148 | 1.1362 | 6 | 101 | regulation of embryonic development |
| GO:0090277 | 0.001 | 7.1537 | 0.7649 | 5 | 68 | positive regulation of peptide hormone secretion |
| GO:0001829 | 0.001 | 17.8718 | 0.2025 | 3 | 18 | trophectodermal cell differentiation |
| GO:0010842 | 0.001 | 17.8718 | 0.2025 | 3 | 18 | retina layer formation |
| GO:0055010 | 0.001 | 9.9737 | 0.45 | 4 | 40 | ventricular cardiac muscle tissue morphogenesis |
| GO:0090066 | 0.001 | 3.0737 | 4.1847 | 12 | 372 | regulation of anatomical structure size |
| GO:0048545 | 0.001 | 3.796 | 2.5404 | 9 | 232 | response to steroid hormone |
| GO:0048332 | 0.0011 | 7.0415 | 0.7762 | 5 | 69 | mesoderm morphogenesis |
| GO:0035051 | 0.0011 | 5.5963 | 1.1587 | 6 | 103 | cardiocyte differentiation |
| GO:0009746 | 0.0011 | 4.7076 | 1.5974 | 7 | 142 | response to hexose |
| GO:0072087 | 0.0012 | 16.7537 | 0.2137 | 3 | 19 | renal vesicle development |
| GO:0014062 | 0.0012 | 59.271 | 0.0562 | 2 | 5 | regulation of serotonin secretion |
| GO:0021603 | 0.0012 | 59.271 | 0.0562 | 2 | 5 | cranial nerve formation |
| GO:0031133 | 0.0012 | 59.271 | 0.0562 | 2 | 5 | regulation of axon diameter |
| GO:0035881 | 0.0012 | 59.271 | 0.0562 | 2 | 5 | amacrine cell differentiation |
| GO:0060023 | 0.0012 | 59.271 | 0.0562 | 2 | 5 | soft palate development |
| GO:0072143 | 0.0012 | 59.271 | 0.0562 | 2 | 5 | mesangial cell development |
| GO:2000179 | 0.0012 | 9.4475 | 0.4725 | 4 | 42 | positive regulation of neural precursor cell proliferation |
| GO:0040007 | 0.0013 | 2.2845 | 9.483 | 20 | 843 | growth |
| GO:0021854 | 0.0014 | 15.7671 | 0.225 | 3 | 20 | hypothalamus development |
| GO:0035295 | 0.0014 | 4.0048 | 2.1414 | 8 | 225 | tube development |
| GO:0007422 | 0.0015 | 6.5291 | 0.8324 | 5 | 74 | peripheral nervous system development |
| GO:1903524 | 0.0015 | 6.5291 | 0.8324 | 5 | 74 | positive regulation of blood circulation |
| GO:0021522 | 0.0015 | 15.3333 | 0.2296 | 3 | 21 | spinal cord motor neuron differentiation |
| GO:0021879 | 0.0015 | 15.3172 | 0.2298 | 3 | 21 | forebrain neuron differentiation |
| GO:0044057 | 0.0015 | 2.9317 | 4.3759 | 12 | 389 | regulation of system process |
| GO:0071392 | 0.0016 | 14.8902 | 0.2362 | 3 | 21 | cellular response to estradiol stimulus |
| GO:0090303 | 0.0016 | 8.7545 | 0.5062 | 4 | 45 | positive regulation of wound healing |
| GO:0043279 | 0.0017 | 5.1181 | 1.2599 | 6 | 112 | response to alkaloid |
| GO:0002067 | 0.0018 | 14.3401 | 0.2436 | 3 | 22 | glandular epithelial cell differentiation |
| GO:0003211 | 0.0018 | 44.9704 | 0.0667 | 2 | 6 | cardiac ventricle formation |
| GO:0021937 | 0.0018 | 44.4503 | 0.0675 | 2 | 6 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation |
| GO:0032811 | 0.0018 | 44.4503 | 0.0675 | 2 | 6 | negative regulation of epinephrine secretion |
| GO:0061308 | 0.0018 | 44.4503 | 0.0675 | 2 | 6 | cardiac neural crest cell development involved in heart development |
| GO:0070092 | 0.0018 | 44.4503 | 0.0675 | 2 | 6 | regulation of glucagon secretion |
| GO:0072141 | 0.0018 | 44.4503 | 0.0675 | 2 | 6 | renal interstitial fibroblast development |
| GO:2000049 | 0.0018 | 44.4503 | 0.0675 | 2 | 6 | positive regulation of cell-cell adhesion mediated by cadherin |
| GO:2000288 | 0.0018 | 44.4503 | 0.0675 | 2 | 6 | positive regulation of myoblast proliferation |
| GO:2000675 | 0.0018 | 44.4503 | 0.0675 | 2 | 6 | negative regulation of type B pancreatic cell apoptotic process |
| GO:0010719 | 0.0018 | 14.1056 | 0.2475 | 3 | 22 | negative regulation of epithelial to mesenchymal transition |
| GO:0042474 | 0.0018 | 14.1056 | 0.2475 | 3 | 22 | middle ear morphogenesis |
| GO:0043586 | 0.0018 | 14.1056 | 0.2475 | 3 | 22 | tongue development |
| GO:0048485 | 0.0018 | 14.1056 | 0.2475 | 3 | 22 | sympathetic nervous system development |
| GO:0045778 | 0.002 | 13.6735 | 0.2537 | 3 | 23 | positive regulation of ossification |
| GO:0001942 | 0.0021 | 6.0044 | 0.8999 | 5 | 80 | hair follicle development |
| GO:0022404 | 0.0021 | 6.0044 | 0.8999 | 5 | 80 | molting cycle process |
| GO:0060560 | 0.0021 | 4.2043 | 1.7774 | 7 | 158 | developmental growth involved in morphogenesis |
| GO:0002068 | 0.0021 | 13.3994 | 0.2587 | 3 | 23 | glandular epithelial cell development |
| GO:0010656 | 0.0021 | 13.3994 | 0.2587 | 3 | 23 | negative regulation of muscle cell apoptotic process |
| GO:0031016 | 0.0021 | 13.343 | 0.2585 | 3 | 24 | pancreas development |
| GO:0072001 | 0.0023 | 4.1407 | 1.8035 | 7 | 167 | renal system development |
| GO:0045686 | 0.0024 | 12.7605 | 0.27 | 3 | 24 | negative regulation of glial cell differentiation |
| GO:0061311 | 0.0024 | 12.7605 | 0.27 | 3 | 24 | cell surface receptor signaling pathway involved in heart development |
| GO:0048844 | 0.0024 | 7.8004 | 0.5625 | 4 | 50 | artery morphogenesis |
| GO:0021521 | 0.0024 | 36.4096 | 0.0769 | 2 | 7 | ventral spinal cord interneuron specification |
| GO:0014031 | 0.0025 | 5.7473 | 0.9365 | 5 | 87 | mesenchymal cell development |
| GO:0003357 | 0.0025 | 35.5579 | 0.0787 | 2 | 7 | noradrenergic neuron differentiation |
| GO:0010700 | 0.0025 | 35.5579 | 0.0787 | 2 | 7 | negative regulation of norepinephrine secretion |
| GO:0021902 | 0.0025 | 35.5579 | 0.0787 | 2 | 7 | commitment of neuronal cell to specific neuron type in forebrain |
| GO:0060235 | 0.0025 | 35.5579 | 0.0787 | 2 | 7 | lens induction in camera-type eye |
| GO:0060527 | 0.0025 | 35.5579 | 0.0787 | 2 | 7 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis |
| GO:0061072 | 0.0025 | 35.5579 | 0.0787 | 2 | 7 | iris morphogenesis |
| GO:0072161 | 0.0025 | 35.5579 | 0.0787 | 2 | 7 | mesenchymal cell differentiation involved in kidney development |
| GO:0048596 | 0.0026 | 12.3247 | 0.278 | 3 | 25 | embryonic camera-type eye morphogenesis |
| GO:2001222 | 0.0027 | 12.1797 | 0.2812 | 3 | 25 | regulation of neuron migration |
| GO:0030335 | 0.0027 | 3.0483 | 3.4872 | 10 | 310 | positive regulation of cell migration |
| GO:0019229 | 0.0027 | 7.4744 | 0.585 | 4 | 52 | regulation of vasoconstriction |
| GO:0007411 | 0.0029 | 2.8437 | 4.1152 | 11 | 374 | axon guidance |
| GO:0043388 | 0.0029 | 11.7826 | 0.2893 | 3 | 26 | positive regulation of DNA binding |
| GO:0048519 | 0.0029 | 1.6977 | 31.4013 | 46 | 3212 | negative regulation of biological process |
| GO:0009743 | 0.0029 | 3.9405 | 1.8898 | 7 | 168 | response to carbohydrate |
| GO:0007420 | 0.0029 | 3.9425 | 1.8927 | 7 | 204 | brain development |
| GO:0007565 | 0.0031 | 3.8917 | 1.9123 | 7 | 170 | female pregnancy |
| GO:0019233 | 0.0031 | 5.4228 | 0.9899 | 5 | 88 | sensory perception of pain |
| GO:0021885 | 0.0032 | 7.1744 | 0.6075 | 4 | 54 | forebrain cell migration |
| GO:0030858 | 0.0032 | 7.1744 | 0.6075 | 4 | 54 | positive regulation of epithelial cell differentiation |
| GO:0001756 | 0.0032 | 7.1571 | 0.6084 | 4 | 55 | somitogenesis |
| GO:0071383 | 0.0033 | 4.4421 | 1.4399 | 6 | 128 | cellular response to steroid hormone stimulus |
| GO:0035137 | 0.0033 | 30.1052 | 0.0886 | 2 | 8 | hindlimb morphogenesis |
| GO:0007267 | 0.0033 | 3.4698 | 2.4575 | 8 | 254 | cell-cell signaling |
| GO:0002062 | 0.0033 | 5.3579 | 1.0012 | 5 | 89 | chondrocyte differentiation |
| GO:0000904 | 0.0033 | 3.8511 | 1.9345 | 7 | 188 | cell morphogenesis involved in differentiation |
| GO:0003197 | 0.0034 | 11.1632 | 0.3037 | 3 | 27 | endocardial cushion development |
| GO:2000826 | 0.0034 | 11.1632 | 0.3037 | 3 | 27 | regulation of heart morphogenesis |
| GO:0002072 | 0.0034 | 29.6296 | 0.09 | 2 | 8 | optic cup morphogenesis involved in camera-type eye development |
| GO:0003263 | 0.0034 | 29.6296 | 0.09 | 2 | 8 | cardioblast proliferation |
| GO:0010667 | 0.0034 | 29.6296 | 0.09 | 2 | 8 | negative regulation of cardiac muscle cell apoptotic process |
| GO:0021559 | 0.0034 | 29.6296 | 0.09 | 2 | 8 | trigeminal nerve development |
| GO:0021612 | 0.0034 | 29.6296 | 0.09 | 2 | 8 | facial nerve structural organization |
| GO:0031017 | 0.0034 | 29.6296 | 0.09 | 2 | 8 | exocrine pancreas development |
| GO:0035878 | 0.0034 | 29.6296 | 0.09 | 2 | 8 | nail development |
| GO:0048793 | 0.0034 | 29.6296 | 0.09 | 2 | 8 | pronephros development |
| GO:0072177 | 0.0034 | 29.6296 | 0.09 | 2 | 8 | mesonephric duct development |
| GO:0072178 | 0.0034 | 29.6296 | 0.09 | 2 | 8 | nephric duct morphogenesis |
| GO:0045892 | 0.0034 | 3.1733 | 3.0252 | 9 | 323 | negative regulation of transcription, DNA-templated |
| GO:0046887 | 0.0035 | 10.9949 | 0.3072 | 3 | 28 | positive regulation of hormone secretion |
| GO:0046883 | 0.0036 | 4.3507 | 1.4683 | 6 | 136 | regulation of hormone secretion |
| GO:0048731 | 0.0036 | 2.8921 | 4.3731 | 11 | 943 | system development |
| GO:0001678 | 0.0036 | 5.2326 | 1.0237 | 5 | 91 | cellular glucose homeostasis |
| GO:0030534 | 0.0036 | 4.3347 | 1.4736 | 6 | 131 | adult behavior |
| GO:0003209 | 0.0037 | 10.716 | 0.315 | 3 | 28 | cardiac atrium morphogenesis |
| GO:0060487 | 0.0037 | 10.716 | 0.315 | 3 | 28 | lung epithelial cell differentiation |
| GO:0051272 | 0.0039 | 2.8908 | 3.6672 | 10 | 326 | positive regulation of cellular component movement |
| GO:0033500 | 0.0039 | 3.7297 | 1.9911 | 7 | 177 | carbohydrate homeostasis |
| GO:0031128 | 0.004 | 10.4224 | 0.3226 | 3 | 29 | developmental induction |
| GO:0045669 | 0.0041 | 6.6412 | 0.6524 | 4 | 58 | positive regulation of osteoblast differentiation |
| GO:0051385 | 0.0041 | 10.3032 | 0.3262 | 3 | 29 | response to mineralocorticoid |
| GO:0061351 | 0.0041 | 6.6144 | 0.6542 | 4 | 60 | neural precursor cell proliferation |
| GO:0007631 | 0.0042 | 5.0552 | 1.0574 | 5 | 94 | feeding behavior |
| GO:0007626 | 0.0043 | 3.6643 | 2.0248 | 7 | 180 | locomotory behavior |
| GO:0030324 | 0.0043 | 3.6643 | 2.0248 | 7 | 180 | lung development |
| GO:0003266 | 0.0043 | 25.3952 | 0.1012 | 2 | 9 | regulation of secondary heart field cardioblast proliferation |
| GO:0003334 | 0.0043 | 25.3952 | 0.1012 | 2 | 9 | keratinocyte development |
| GO:0021561 | 0.0043 | 25.3952 | 0.1012 | 2 | 9 | facial nerve development |
| GO:0021892 | 0.0043 | 25.3952 | 0.1012 | 2 | 9 | cerebral cortex GABAergic interneuron differentiation |
| GO:0030917 | 0.0043 | 25.3952 | 0.1012 | 2 | 9 | midbrain-hindbrain boundary development |
| GO:0048703 | 0.0043 | 25.3952 | 0.1012 | 2 | 9 | embryonic viscerocranium morphogenesis |
| GO:0060253 | 0.0043 | 25.3952 | 0.1012 | 2 | 9 | negative regulation of glial cell proliferation |
| GO:2000679 | 0.0043 | 25.3952 | 0.1012 | 2 | 9 | positive regulation of transcription regulatory region DNA binding |
| GO:0048706 | 0.0044 | 10.0106 | 0.3329 | 3 | 32 | embryonic skeletal system development |
| GO:0040017 | 0.0045 | 2.8268 | 3.746 | 10 | 333 | positive regulation of locomotion |
| GO:0010092 | 0.0045 | 9.9209 | 0.3375 | 3 | 30 | specification of organ identity |
| GO:0035116 | 0.0045 | 9.9209 | 0.3375 | 3 | 30 | embryonic hindlimb morphogenesis |
| GO:0060740 | 0.0045 | 9.9209 | 0.3375 | 3 | 30 | prostate gland epithelium morphogenesis |
| GO:0001657 | 0.0046 | 4.9434 | 1.0799 | 5 | 96 | ureteric bud development |
| GO:0007623 | 0.0047 | 3.6011 | 2.0586 | 7 | 183 | circadian rhythm |
| GO:0060485 | 0.0047 | 9.7591 | 0.3405 | 3 | 33 | mesenchyme development |
| GO:0009719 | 0.0047 | 2.8147 | 3.7767 | 10 | 357 | response to endogenous stimulus |
| GO:0072163 | 0.0048 | 4.8894 | 1.0912 | 5 | 97 | mesonephric epithelium development |
| GO:0071495 | 0.0048 | 1.9839 | 11.3728 | 21 | 1011 | cellular response to endogenous stimulus |
| GO:0001755 | 0.0048 | 9.6792 | 0.3448 | 3 | 31 | neural crest cell migration |
| GO:0051240 | 0.0049 | 2.2748 | 7.0824 | 15 | 739 | positive regulation of multicellular organismal process |
| GO:0060429 | 0.005 | 4.0553 | 1.5732 | 6 | 180 | epithelium development |
| GO:0007601 | 0.0051 | 3.54 | 2.0923 | 7 | 186 | visual perception |
| GO:0008406 | 0.0051 | 3.54 | 2.0923 | 7 | 186 | gonad development |
| GO:0021520 | 0.0052 | 22.6161 | 0.1106 | 2 | 10 | spinal cord motor neuron cell fate specification |
| GO:0042633 | 0.0052 | 4.7847 | 1.1137 | 5 | 99 | hair cycle |
| GO:0048857 | 0.0052 | 6.1816 | 0.6974 | 4 | 62 | neural nucleus development |
| GO:0072171 | 0.0052 | 6.1816 | 0.6974 | 4 | 62 | mesonephric tubule morphogenesis |
| GO:0051969 | 0.0053 | 22.2193 | 0.1125 | 2 | 10 | regulation of transmission of nerve impulse |
| GO:0001841 | 0.0054 | 4.734 | 1.1249 | 5 | 100 | neural tube formation |
| GO:0042596 | 0.0055 | 9.2355 | 0.36 | 3 | 32 | fear response |
| GO:0060795 | 0.0055 | 9.2355 | 0.36 | 3 | 32 | cell fate commitment involved in formation of primary germ layer |
| GO:0035914 | 0.0055 | 6.0764 | 0.7087 | 4 | 63 | skeletal muscle cell differentiation |
| GO:0046903 | 0.0058 | 1.9794 | 10.8216 | 20 | 962 | secretion |
| GO:0097285 | 0.0059 | 2.5728 | 4.5221 | 11 | 402 | cell-type specific apoptotic process |
| GO:0030902 | 0.0061 | 8.8383 | 0.3734 | 3 | 35 | hindbrain development |
| GO:0014013 | 0.0061 | 8.8269 | 0.3746 | 3 | 34 | regulation of gliogenesis |
| GO:0010454 | 0.0065 | 19.7492 | 0.1237 | 2 | 11 | negative regulation of cell fate commitment |
| GO:0021702 | 0.0065 | 19.7492 | 0.1237 | 2 | 11 | cerebellar Purkinje cell differentiation |
| GO:0021936 | 0.0065 | 19.7492 | 0.1237 | 2 | 11 | regulation of cerebellar granule cell precursor proliferation |
| GO:0048617 | 0.0065 | 19.7492 | 0.1237 | 2 | 11 | embryonic foregut morphogenesis |
| GO:0061029 | 0.0065 | 19.7492 | 0.1237 | 2 | 11 | eyelid development in camera-type eye |
| GO:0021772 | 0.0065 | 8.6385 | 0.3825 | 3 | 34 | olfactory bulb development |
| GO:0008589 | 0.0065 | 5.7813 | 0.7424 | 4 | 66 | regulation of smoothened signaling pathway |
| GO:0007610 | 0.0065 | 2.6711 | 3.9601 | 10 | 372 | behavior |
| GO:1903034 | 0.0066 | 2.6664 | 3.9597 | 10 | 352 | regulation of response to wounding |
| GO:0048762 | 0.0067 | 19.0772 | 0.126 | 2 | 12 | mesenchymal cell differentiation |
| GO:0001824 | 0.0068 | 5.6891 | 0.7537 | 4 | 67 | blastocyst development |
| GO:2000648 | 0.0068 | 5.6891 | 0.7537 | 4 | 67 | positive regulation of stem cell proliferation |
| GO:0030326 | 0.0069 | 8.4281 | 0.3897 | 3 | 37 | embryonic limb morphogenesis |
| GO:0001738 | 0.007 | 8.368 | 0.3937 | 3 | 35 | morphogenesis of a polarized epithelium |
| GO:0035850 | 0.007 | 8.368 | 0.3937 | 3 | 35 | epithelial cell differentiation involved in kidney development |
| GO:0048730 | 0.007 | 8.368 | 0.3937 | 3 | 35 | epidermis morphogenesis |
| GO:0060325 | 0.007 | 8.368 | 0.3937 | 3 | 35 | face morphogenesis |
| GO:0051100 | 0.0072 | 4.4071 | 1.2037 | 5 | 107 | negative regulation of binding |
| GO:0022037 | 0.0072 | 18.439 | 0.1302 | 2 | 12 | metencephalon development |
| GO:0060359 | 0.0072 | 5.5999 | 0.7649 | 4 | 68 | response to ammonium ion |
| GO:0001655 | 0.0072 | 8.2501 | 0.3973 | 3 | 38 | urogenital system development |
| GO:0021543 | 0.0075 | 5.5273 | 0.7737 | 4 | 71 | pallium development |
| GO:0003215 | 0.0075 | 17.9811 | 0.1335 | 2 | 12 | cardiac right ventricle morphogenesis |
| GO:0007520 | 0.0076 | 8.1139 | 0.405 | 3 | 36 | myoblast fusion |
| GO:0035815 | 0.0077 | 17.7731 | 0.135 | 2 | 12 | positive regulation of renal sodium excretion |
| GO:0048714 | 0.0077 | 17.7731 | 0.135 | 2 | 12 | positive regulation of oligodendrocyte differentiation |
| GO:0060536 | 0.0077 | 17.7731 | 0.135 | 2 | 12 | cartilage morphogenesis |
| GO:0009991 | 0.0078 | 2.469 | 4.7021 | 11 | 418 | response to extracellular stimulus |
| GO:0008544 | 0.0079 | 2.96 | 2.8474 | 8 | 257 | epidermis development |
| GO:0043069 | 0.0082 | 2.0237 | 8.9318 | 17 | 794 | negative regulation of programmed cell death |
| GO:0071310 | 0.0084 | 1.6723 | 20.7996 | 32 | 1849 | cellular response to organic substance |
| GO:0051091 | 0.0088 | 3.18 | 2.3173 | 7 | 206 | positive regulation of sequence-specific DNA binding transcription factor activity |
| GO:0001570 | 0.0088 | 5.2691 | 0.8099 | 4 | 72 | vasculogenesis |
| GO:0035315 | 0.0088 | 7.6492 | 0.4275 | 3 | 38 | hair cell differentiation |
| GO:0002070 | 0.0089 | 16.3453 | 0.1446 | 2 | 13 | epithelial cell maturation |
| GO:0048593 | 0.009 | 5.2225 | 0.8161 | 4 | 75 | camera-type eye morphogenesis |
| GO:0003214 | 0.009 | 16.1563 | 0.1462 | 2 | 13 | cardiac left ventricle morphogenesis |
| GO:0007501 | 0.009 | 16.1563 | 0.1462 | 2 | 13 | mesodermal cell fate specification |
| GO:0010455 | 0.009 | 16.1563 | 0.1462 | 2 | 13 | positive regulation of cell fate commitment |
| GO:0021692 | 0.009 | 16.1563 | 0.1462 | 2 | 13 | cerebellar Purkinje cell layer morphogenesis |
| GO:0021794 | 0.009 | 16.1563 | 0.1462 | 2 | 13 | thalamus development |
| GO:0060707 | 0.009 | 16.1563 | 0.1462 | 2 | 13 | trophoblast giant cell differentiation |
| GO:0021766 | 0.0091 | 7.5639 | 0.4315 | 3 | 39 | hippocampus development |
| GO:1901654 | 0.0093 | 4.1222 | 1.2824 | 5 | 114 | response to ketone |
| GO:0001569 | 0.0095 | 7.4363 | 0.4387 | 3 | 39 | patterning of blood vessels |
| GO:0071385 | 0.0095 | 7.4363 | 0.4387 | 3 | 39 | cellular response to glucocorticoid stimulus |
| GO:0032989 | 0.0096 | 2.5196 | 4.1941 | 10 | 402 | cellular component morphogenesis |
| GO:0002064 | 0.0096 | 3.4998 | 1.8056 | 6 | 166 | epithelial cell development |
| GO:0048675 | 0.0097 | 5.1178 | 0.8324 | 4 | 74 | axon extension |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0009593 | 0 | 60.0321 | 0.4422 | 10 | 425 | detection of chemical stimulus |
| GO:0050906 | 0 | 58.8652 | 0.4505 | 10 | 433 | detection of stimulus involved in sensory perception |
| GO:0007606 | 0 | 55.6152 | 0.4755 | 10 | 457 | sensory perception of chemical stimulus |
| GO:0050911 | 0 | 56.981 | 0.3621 | 9 | 348 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0007186 | 0 | 21.6743 | 1.1517 | 10 | 1107 | G-protein coupled receptor signaling pathway |
| GO:0050877 | 0 | 21.0127 | 1.185 | 10 | 1139 | neurological system process |
| GO:0007165 | 0.0032 | 4.5719 | 5.204 | 11 | 5002 | signal transduction |
| GO:0044707 | 0.0042 | 4.6256 | 6.3005 | 12 | 6056 | single-multicellular organism process |
| GO:0050896 | 0.0063 | 4.7775 | 7.6156 | 13 | 7320 | response to stimulus |
| GO:0098542 | 0.007 | 8.954 | 0.4047 | 3 | 389 | defense response to other organism |
| GO:0023052 | 0.0071 | 3.9948 | 5.6878 | 11 | 5467 | signaling |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0097659 | 0 | 3.7196 | 42.2485 | 98 | 3315 | nucleic acid-templated transcription |
| GO:1902680 | 0 | 4.9619 | 15.4975 | 57 | 1216 | positive regulation of RNA biosynthetic process |
| GO:0007156 | 0 | 16.5665 | 1.746 | 22 | 137 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0098609 | 0 | 12.7002 | 2.4087 | 24 | 189 | cell-cell adhesion |
| GO:0045944 | 0 | 5.1776 | 11.4065 | 46 | 895 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0034654 | 0 | 3.3244 | 48.1748 | 101 | 3780 | nucleobase-containing compound biosynthetic process |
| GO:0045935 | 0 | 4.2199 | 18.6709 | 59 | 1465 | positive regulation of nucleobase-containing compound metabolic process |
| GO:0009891 | 0 | 4.172 | 19.2699 | 60 | 1512 | positive regulation of biosynthetic process |
| GO:0007389 | 0 | 9.3527 | 2.872 | 22 | 248 | pattern specification process |
| GO:0016070 | 0 | 2.9014 | 51.6158 | 99 | 4050 | RNA metabolic process |
| GO:0034645 | 0 | 2.7923 | 55.452 | 102 | 4351 | cellular macromolecule biosynthetic process |
| GO:0060322 | 0 | 4.8867 | 8.1183 | 33 | 637 | head development |
| GO:0010467 | 0 | 2.6738 | 57.1598 | 102 | 4485 | gene expression |
| GO:1902679 | 0 | 3.8673 | 12.9103 | 41 | 1013 | negative regulation of RNA biosynthetic process |
| GO:0010604 | 0 | 2.9423 | 29.8862 | 67 | 2345 | positive regulation of macromolecule metabolic process |
| GO:0009790 | 0 | 4.2696 | 9.5748 | 34 | 792 | embryo development |
| GO:0048729 | 0 | 4.6464 | 7.3409 | 29 | 576 | tissue morphogenesis |
| GO:0060581 | 0 | 70.2546 | 0.1912 | 7 | 15 | cell fate commitment involved in pattern specification |
| GO:0045934 | 0 | 3.4544 | 14.6946 | 42 | 1153 | negative regulation of nucleobase-containing compound metabolic process |
| GO:0000122 | 0 | 4.2809 | 8.2203 | 30 | 645 | negative regulation of transcription from RNA polymerase II promoter |
| GO:0021514 | 0 | 56.1963 | 0.2167 | 7 | 17 | ventral spinal cord interneuron differentiation |
| GO:0001764 | 0 | 9.9914 | 1.6568 | 14 | 130 | neuron migration |
| GO:0009890 | 0 | 3.2011 | 15.7269 | 42 | 1234 | negative regulation of biosynthetic process |
| GO:0006725 | 0 | 2.3279 | 64.391 | 103 | 5156 | cellular aromatic compound metabolic process |
| GO:0022008 | 0 | 3.7957 | 9.3237 | 30 | 815 | neurogenesis |
| GO:0046483 | 0 | 2.2671 | 66.6036 | 105 | 5226 | heterocycle metabolic process |
| GO:0010720 | 0 | 4.9835 | 4.8175 | 21 | 378 | positive regulation of cell development |
| GO:0021513 | 0 | 31.2037 | 0.3186 | 7 | 25 | spinal cord dorsal/ventral patterning |
| GO:2000026 | 0 | 3.0383 | 15.649 | 40 | 1265 | regulation of multicellular organismal development |
| GO:0060537 | 0 | 5.2894 | 4.091 | 19 | 321 | muscle tissue development |
| GO:0048562 | 0 | 7.5483 | 2.1307 | 14 | 174 | embryonic organ morphogenesis |
| GO:0051962 | 0 | 5.2015 | 4.1548 | 19 | 326 | positive regulation of nervous system development |
| GO:1901360 | 0 | 2.1896 | 66.9886 | 103 | 5364 | organic cyclic compound metabolic process |
| GO:0034641 | 0 | 2.1557 | 70.6436 | 107 | 5543 | cellular nitrogen compound metabolic process |
| GO:0009952 | 0 | 8.5506 | 1.6159 | 12 | 133 | anterior/posterior pattern specification |
| GO:0016339 | 0 | 24.4122 | 0.3823 | 7 | 30 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
| GO:0072009 | 0 | 9.3444 | 1.3637 | 11 | 107 | nephron epithelium development |
| GO:1901576 | 0 | 2.1311 | 69.3054 | 105 | 5438 | organic substance biosynthetic process |
| GO:0045666 | 0 | 5.7968 | 2.9185 | 15 | 229 | positive regulation of neuron differentiation |
| GO:0061326 | 0 | 9.7811 | 1.1853 | 10 | 93 | renal tubule development |
| GO:0000904 | 0 | 3.2683 | 10.132 | 29 | 795 | cell morphogenesis involved in differentiation |
| GO:0048665 | 0 | 46.0383 | 0.1713 | 5 | 14 | neuron fate specification |
| GO:0090596 | 0 | 5.3174 | 3.1607 | 15 | 248 | sensory organ morphogenesis |
| GO:0001654 | 0 | 4.6797 | 4.0655 | 17 | 319 | eye development |
| GO:0021983 | 0 | 16.5022 | 0.5225 | 7 | 41 | pituitary gland development |
| GO:0003357 | 0 | 105.4167 | 0.0892 | 4 | 7 | noradrenergic neuron differentiation |
| GO:0060485 | 0 | 6.0533 | 2.4102 | 13 | 191 | mesenchyme development |
| GO:0007517 | 0 | 4.5716 | 4.1548 | 17 | 326 | muscle organ development |
| GO:0048863 | 0 | 5.5034 | 2.8475 | 14 | 229 | stem cell differentiation |
| GO:0001705 | 0 | Inf | 0.0382 | 3 | 3 | ectoderm formation |
| GO:0001763 | 0 | 5.4601 | 2.6509 | 13 | 208 | morphogenesis of a branching structure |
| GO:2000543 | 0 | 63.2417 | 0.1147 | 4 | 9 | positive regulation of gastrulation |
| GO:0072028 | 0 | 9.6005 | 0.9558 | 8 | 75 | nephron morphogenesis |
| GO:0003151 | 0 | 11.56 | 0.7066 | 7 | 56 | outflow tract morphogenesis |
| GO:0031018 | 0 | 11.4392 | 0.7137 | 7 | 56 | endocrine pancreas development |
| GO:0048485 | 0 | 23.3539 | 0.2804 | 5 | 22 | sympathetic nervous system development |
| GO:0021913 | 0 | 235.9896 | 0.051 | 3 | 4 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
| GO:0001655 | 0 | 4.256 | 3.8871 | 15 | 305 | urogenital system development |
| GO:0022610 | 0 | 2.4335 | 16.8357 | 36 | 1321 | biological adhesion |
| GO:0035914 | 0 | 10.0046 | 0.8029 | 7 | 63 | skeletal muscle cell differentiation |
| GO:0048731 | 0 | 3.1649 | 8.1861 | 22 | 939 | system development |
| GO:0048522 | 0 | 2.0077 | 38.689 | 63 | 3270 | positive regulation of cellular process |
| GO:0007417 | 0 | 3.121 | 7.4752 | 21 | 639 | central nervous system development |
| GO:0003278 | 0 | 117.987 | 0.0637 | 3 | 5 | apoptotic process involved in heart morphogenesis |
| GO:0071542 | 0 | 31.6104 | 0.1784 | 4 | 14 | dopaminergic neuron differentiation |
| GO:0060173 | 0 | 5.6175 | 1.9615 | 10 | 157 | limb development |
| GO:0050768 | 0 | 5.041 | 2.396 | 11 | 188 | negative regulation of neurogenesis |
| GO:0021527 | 0 | 28.7348 | 0.1912 | 4 | 15 | spinal cord association neuron differentiation |
| GO:0021797 | 0 | 78.6528 | 0.0765 | 3 | 6 | forebrain anterior/posterior pattern specification |
| GO:0050880 | 0 | 6.0413 | 1.6441 | 9 | 129 | regulation of blood vessel size |
| GO:0045165 | 0 | 6.9528 | 1.2751 | 8 | 113 | cell fate commitment |
| GO:0048754 | 0 | 6.01 | 1.6515 | 9 | 132 | branching morphogenesis of an epithelial tube |
| GO:0050767 | 0 | 4.0849 | 3.4793 | 13 | 288 | regulation of neurogenesis |
| GO:0007586 | 0 | 5.8928 | 1.6823 | 9 | 132 | digestion |
| GO:0007519 | 1e-04 | 8.0422 | 0.9749 | 7 | 79 | skeletal muscle tissue development |
| GO:0022414 | 1e-04 | 2.3981 | 13.9426 | 30 | 1094 | reproductive process |
| GO:0009954 | 1e-04 | 14.1688 | 0.4206 | 5 | 33 | proximal/distal pattern formation |
| GO:0060429 | 1e-04 | 3.0496 | 6.8734 | 19 | 601 | epithelium development |
| GO:0009887 | 1e-04 | 3.3881 | 5.1878 | 16 | 468 | organ morphogenesis |
| GO:0021521 | 1e-04 | 59.9132 | 0.0879 | 3 | 7 | ventral spinal cord interneuron specification |
| GO:0001942 | 1e-04 | 7.6662 | 1.0196 | 7 | 80 | hair follicle development |
| GO:0022404 | 1e-04 | 7.6662 | 1.0196 | 7 | 80 | molting cycle process |
| GO:0040007 | 1e-04 | 2.5674 | 10.7437 | 25 | 843 | growth |
| GO:0060541 | 1e-04 | 4.5231 | 2.6509 | 11 | 208 | respiratory system development |
| GO:0072079 | 1e-04 | 21.0667 | 0.2421 | 4 | 19 | nephron tubule formation |
| GO:0019219 | 1e-04 | 2.4435 | 13.93 | 29 | 1499 | regulation of nucleobase-containing compound metabolic process |
| GO:0035107 | 1e-04 | 20.3311 | 0.2479 | 4 | 20 | appendage morphogenesis |
| GO:2001141 | 1e-04 | 2.4471 | 13.311 | 28 | 1434 | regulation of RNA biosynthetic process |
| GO:0021854 | 1e-04 | 19.7487 | 0.2549 | 4 | 20 | hypothalamus development |
| GO:0048664 | 1e-04 | 47.1855 | 0.102 | 3 | 8 | neuron fate determination |
| GO:0009798 | 1e-04 | 7.0811 | 1.096 | 7 | 86 | axis specification |
| GO:0060675 | 1e-04 | 8.6859 | 0.7774 | 6 | 61 | ureteric bud morphogenesis |
| GO:0071773 | 1e-04 | 18.5858 | 0.2676 | 4 | 21 | cellular response to BMP stimulus |
| GO:0045595 | 1e-04 | 2.7713 | 7.9446 | 20 | 688 | regulation of cell differentiation |
| GO:0032989 | 1e-04 | 2.2275 | 15.4465 | 31 | 1212 | cellular component morphogenesis |
| GO:0023019 | 2e-04 | 17.5521 | 0.2804 | 4 | 22 | signal transduction involved in regulation of gene expression |
| GO:0003326 | 2e-04 | Inf | 0.0255 | 2 | 2 | pancreatic A cell fate commitment |
| GO:0003329 | 2e-04 | Inf | 0.0255 | 2 | 2 | pancreatic PP cell fate commitment |
| GO:0043503 | 2e-04 | Inf | 0.0255 | 2 | 2 | skeletal muscle fiber adaptation |
| GO:0048866 | 2e-04 | Inf | 0.0255 | 2 | 2 | stem cell fate specification |
| GO:0070473 | 2e-04 | Inf | 0.0255 | 2 | 2 | negative regulation of uterine smooth muscle contraction |
| GO:0072272 | 2e-04 | Inf | 0.0255 | 2 | 2 | proximal/distal pattern formation involved in metanephric nephron development |
| GO:0048241 | 2e-04 | 39.3187 | 0.1147 | 3 | 9 | epinephrine transport |
| GO:0050789 | 2e-04 | 1.8003 | 124.0564 | 148 | 9734 | regulation of biological process |
| GO:0061351 | 2e-04 | 5.6249 | 1.5548 | 8 | 122 | neural precursor cell proliferation |
| GO:0002791 | 2e-04 | 4.4561 | 2.4342 | 10 | 191 | regulation of peptide secretion |
| GO:0051241 | 2e-04 | 2.5031 | 10.0711 | 23 | 813 | negative regulation of multicellular organismal process |
| GO:0007268 | 2e-04 | 2.6034 | 8.7938 | 21 | 690 | synaptic transmission |
| GO:0030509 | 2e-04 | 5.4795 | 1.5931 | 8 | 125 | BMP signaling pathway |
| GO:0044707 | 2e-04 | 1.9118 | 43.1443 | 63 | 4685 | single-multicellular organism process |
| GO:0048704 | 2e-04 | 6.3531 | 1.2107 | 7 | 95 | embryonic skeletal system morphogenesis |
| GO:0023061 | 2e-04 | 3.1517 | 5.1488 | 15 | 404 | signal release |
| GO:0021520 | 2e-04 | 34.0501 | 0.1262 | 3 | 10 | spinal cord motor neuron cell fate specification |
| GO:0021953 | 2e-04 | 5.364 | 1.6237 | 8 | 134 | central nervous system neuron differentiation |
| GO:0003211 | 2e-04 | 33.6995 | 0.1274 | 3 | 10 | cardiac ventricle formation |
| GO:0032525 | 2e-04 | 33.6995 | 0.1274 | 3 | 10 | somite rostral/caudal axis specification |
| GO:0090009 | 2e-04 | 33.6995 | 0.1274 | 3 | 10 | primitive streak formation |
| GO:0045893 | 2e-04 | 3.9577 | 3.024 | 11 | 292 | positive regulation of transcription, DNA-templated |
| GO:0072164 | 2e-04 | 6.2111 | 1.2362 | 7 | 97 | mesonephric tubule development |
| GO:0060041 | 3e-04 | 5.2532 | 1.6568 | 8 | 130 | retina development in camera-type eye |
| GO:0042633 | 3e-04 | 6.0753 | 1.2617 | 7 | 99 | hair cycle |
| GO:0048513 | 3e-04 | 2.3029 | 13.3312 | 27 | 1359 | organ development |
| GO:0044058 | 3e-04 | 14.357 | 0.3314 | 4 | 26 | regulation of digestive system process |
| GO:0001823 | 3e-04 | 5.9452 | 1.2872 | 7 | 101 | mesonephros development |
| GO:0045995 | 3e-04 | 5.9452 | 1.2872 | 7 | 101 | regulation of embryonic development |
| GO:0014013 | 3e-04 | 7.233 | 0.9176 | 6 | 72 | regulation of gliogenesis |
| GO:0022603 | 3e-04 | 2.4538 | 9.7624 | 22 | 766 | regulation of anatomical structure morphogenesis |
| GO:0010605 | 3e-04 | 1.9217 | 24.5844 | 42 | 1929 | negative regulation of macromolecule metabolic process |
| GO:0045823 | 4e-04 | 13.7319 | 0.3441 | 4 | 27 | positive regulation of heart contraction |
| GO:0035050 | 4e-04 | 6.9172 | 0.9558 | 6 | 75 | embryonic heart tube development |
| GO:0060487 | 4e-04 | 13.1589 | 0.3569 | 4 | 28 | lung epithelial cell differentiation |
| GO:0003206 | 4e-04 | 5.6431 | 1.3509 | 7 | 106 | cardiac chamber morphogenesis |
| GO:0021517 | 4e-04 | 13.101 | 0.3568 | 4 | 29 | ventral spinal cord development |
| GO:0009889 | 4e-04 | 2.2272 | 14.5181 | 28 | 1562 | regulation of biosynthetic process |
| GO:0060255 | 4e-04 | 2.1798 | 16.1385 | 30 | 1667 | regulation of macromolecule metabolic process |
| GO:0060412 | 5e-04 | 12.6317 | 0.3696 | 4 | 29 | ventricular septum morphogenesis |
| GO:1902692 | 5e-04 | 12.6317 | 0.3696 | 4 | 29 | regulation of neuroblast proliferation |
| GO:0003253 | 5e-04 | 156.5155 | 0.0382 | 2 | 3 | cardiac neural crest cell migration involved in outflow tract morphogenesis |
| GO:0003350 | 5e-04 | 156.5155 | 0.0382 | 2 | 3 | pulmonary myocardium development |
| GO:0021912 | 5e-04 | 156.5155 | 0.0382 | 2 | 3 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification |
| GO:0033693 | 5e-04 | 156.5155 | 0.0382 | 2 | 3 | neurofilament bundle assembly |
| GO:0035993 | 5e-04 | 156.5155 | 0.0382 | 2 | 3 | deltoid tuberosity development |
| GO:0055014 | 5e-04 | 156.5155 | 0.0382 | 2 | 3 | atrial cardiac muscle cell development |
| GO:0061074 | 5e-04 | 156.5155 | 0.0382 | 2 | 3 | regulation of neural retina development |
| GO:0070253 | 5e-04 | 156.5155 | 0.0382 | 2 | 3 | somatostatin secretion |
| GO:0071883 | 5e-04 | 156.5155 | 0.0382 | 2 | 3 | activation of MAPK activity by adrenergic receptor signaling pathway |
| GO:0007492 | 5e-04 | 6.5364 | 1.0068 | 6 | 79 | endoderm development |
| GO:0006357 | 5e-04 | 4.2276 | 2.308 | 9 | 240 | regulation of transcription from RNA polymerase II promoter |
| GO:0061458 | 5e-04 | 3.0047 | 5.0086 | 14 | 393 | reproductive system development |
| GO:0048935 | 5e-04 | 23.585 | 0.1657 | 3 | 13 | peripheral nervous system neuron development |
| GO:0055015 | 5e-04 | 23.585 | 0.1657 | 3 | 13 | ventricular cardiac muscle cell development |
| GO:0008284 | 5e-04 | 2.4026 | 9.4773 | 21 | 751 | positive regulation of cell proliferation |
| GO:0031175 | 6e-04 | 2.3442 | 10.183 | 22 | 799 | neuron projection development |
| GO:0007416 | 6e-04 | 6.3613 | 1.0323 | 6 | 81 | synapse assembly |
| GO:0030323 | 6e-04 | 4.1275 | 2.345 | 9 | 184 | respiratory tube development |
| GO:1902742 | 6e-04 | 11.6944 | 0.3951 | 4 | 31 | apoptotic process involved in development |
| GO:0021871 | 6e-04 | 21.8831 | 0.1749 | 3 | 14 | forebrain regionalization |
| GO:0030182 | 7e-04 | 2.49 | 8.3171 | 19 | 760 | neuron differentiation |
| GO:0048870 | 7e-04 | 2.0968 | 14.6054 | 28 | 1146 | cell motility |
| GO:0048593 | 7e-04 | 6.2057 | 1.0557 | 6 | 84 | camera-type eye morphogenesis |
| GO:0021761 | 7e-04 | 7.9249 | 0.7 | 5 | 56 | limbic system development |
| GO:0014003 | 7e-04 | 11.276 | 0.4078 | 4 | 32 | oligodendrocyte development |
| GO:0007218 | 7e-04 | 6.1154 | 1.0706 | 6 | 84 | neuropeptide signaling pathway |
| GO:0051094 | 7e-04 | 2.6032 | 7.0669 | 17 | 614 | positive regulation of developmental process |
| GO:0048663 | 8e-04 | 10.9677 | 0.4152 | 4 | 35 | neuron fate commitment |
| GO:0060350 | 8e-04 | 7.6173 | 0.7264 | 5 | 57 | endochondral bone morphogenesis |
| GO:0060441 | 8e-04 | 10.8865 | 0.4206 | 4 | 33 | epithelial tube branching involved in lung morphogenesis |
| GO:0021542 | 8e-04 | 19.6516 | 0.1912 | 3 | 15 | dentate gyrus development |
| GO:0042596 | 9e-04 | 79.3508 | 0.0503 | 2 | 4 | fear response |
| GO:0034287 | 0.001 | 78.2526 | 0.051 | 2 | 4 | detection of monosaccharide stimulus |
| GO:0035625 | 0.001 | 78.2526 | 0.051 | 2 | 4 | epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway |
| GO:0035990 | 0.001 | 78.2526 | 0.051 | 2 | 4 | tendon cell differentiation |
| GO:0051594 | 0.001 | 78.2526 | 0.051 | 2 | 4 | detection of glucose |
| GO:0060214 | 0.001 | 78.2526 | 0.051 | 2 | 4 | endocardium formation |
| GO:0061031 | 0.001 | 78.2526 | 0.051 | 2 | 4 | endodermal digestive tract morphogenesis |
| GO:0061325 | 0.001 | 78.2526 | 0.051 | 2 | 4 | cell proliferation involved in outflow tract morphogenesis |
| GO:0072086 | 0.001 | 78.2526 | 0.051 | 2 | 4 | specification of loop of Henle identity |
| GO:0097476 | 0.001 | 78.2526 | 0.051 | 2 | 4 | spinal cord motor neuron migration |
| GO:0006590 | 0.001 | 18.1387 | 0.2039 | 3 | 16 | thyroid hormone generation |
| GO:0043583 | 0.0011 | 3.7777 | 2.5489 | 9 | 200 | ear development |
| GO:0045892 | 0.0011 | 3.2427 | 3.6391 | 11 | 323 | negative regulation of transcription, DNA-templated |
| GO:0031128 | 0.0011 | 9.8639 | 0.4588 | 4 | 36 | developmental induction |
| GO:0021543 | 0.0011 | 4.7285 | 1.5931 | 7 | 125 | pallium development |
| GO:0002065 | 0.0012 | 4.6885 | 1.6058 | 7 | 126 | columnar/cuboidal epithelial cell differentiation |
| GO:0009653 | 0.0012 | 5.5084 | 1.1801 | 6 | 122 | anatomical structure morphogenesis |
| GO:0048565 | 0.0012 | 4.6491 | 1.6186 | 7 | 127 | digestive tract development |
| GO:0002070 | 0.0012 | 16.842 | 0.2167 | 3 | 17 | epithelial cell maturation |
| GO:0003203 | 0.0012 | 16.842 | 0.2167 | 3 | 17 | endocardial cushion morphogenesis |
| GO:0043009 | 0.0013 | 2.8467 | 4.8869 | 13 | 408 | chordate embryonic development |
| GO:0035113 | 0.0013 | 4.5723 | 1.6441 | 7 | 129 | embryonic appendage morphogenesis |
| GO:0008544 | 0.0013 | 3.1533 | 3.7214 | 11 | 292 | epidermis development |
| GO:0035137 | 0.0013 | 9.2825 | 0.4843 | 4 | 38 | hindlimb morphogenesis |
| GO:0022037 | 0.0013 | 5.3556 | 1.2107 | 6 | 95 | metencephalon development |
| GO:0050796 | 0.0014 | 3.9955 | 2.1411 | 8 | 168 | regulation of insulin secretion |
| GO:0003231 | 0.0014 | 5.2958 | 1.2235 | 6 | 96 | cardiac ventricle development |
| GO:0046887 | 0.0014 | 5.2958 | 1.2235 | 6 | 96 | positive regulation of hormone secretion |
| GO:0072210 | 0.0014 | 9.1116 | 0.492 | 4 | 39 | metanephric nephron development |
| GO:0010842 | 0.0014 | 15.7181 | 0.2294 | 3 | 18 | retina layer formation |
| GO:0030878 | 0.0014 | 15.7181 | 0.2294 | 3 | 18 | thyroid gland development |
| GO:0060008 | 0.0014 | 15.7181 | 0.2294 | 3 | 18 | Sertoli cell differentiation |
| GO:0046883 | 0.0016 | 4.4372 | 1.6908 | 7 | 136 | regulation of hormone secretion |
| GO:0035881 | 0.0016 | 52.1649 | 0.0637 | 2 | 5 | amacrine cell differentiation |
| GO:0046878 | 0.0016 | 52.1649 | 0.0637 | 2 | 5 | positive regulation of saliva secretion |
| GO:0060023 | 0.0016 | 52.1649 | 0.0637 | 2 | 5 | soft palate development |
| GO:0060729 | 0.0016 | 52.1649 | 0.0637 | 2 | 5 | intestinal epithelial structure maintenance |
| GO:0061009 | 0.0016 | 52.1649 | 0.0637 | 2 | 5 | common bile duct development |
| GO:0061056 | 0.0016 | 52.1649 | 0.0637 | 2 | 5 | sclerotome development |
| GO:0021545 | 0.0016 | 8.7656 | 0.5098 | 4 | 40 | cranial nerve development |
| GO:0035136 | 0.0016 | 8.7656 | 0.5098 | 4 | 40 | forelimb morphogenesis |
| GO:0007411 | 0.0017 | 2.7599 | 5.0214 | 13 | 394 | axon guidance |
| GO:0042472 | 0.0017 | 5.1239 | 1.2617 | 6 | 99 | inner ear morphogenesis |
| GO:2000736 | 0.0017 | 5.1239 | 1.2617 | 6 | 99 | regulation of stem cell differentiation |
| GO:0045932 | 0.0017 | 14.7348 | 0.2421 | 3 | 19 | negative regulation of muscle contraction |
| GO:0003279 | 0.0017 | 6.2827 | 0.8666 | 5 | 68 | cardiac septum development |
| GO:0048646 | 0.0018 | 2.1668 | 10.4642 | 21 | 882 | anatomical structure formation involved in morphogenesis |
| GO:0044767 | 0.0019 | 2.6058 | 6.5238 | 15 | 857 | single-organism developmental process |
| GO:0048557 | 0.002 | 13.8671 | 0.2549 | 3 | 20 | embryonic digestive tract morphogenesis |
| GO:0030900 | 0.002 | 3.7595 | 2.2681 | 8 | 190 | forebrain development |
| GO:0060425 | 0.0022 | 13.3474 | 0.2627 | 3 | 21 | lung morphogenesis |
| GO:0071392 | 0.0023 | 13.0959 | 0.2676 | 3 | 21 | cellular response to estradiol stimulus |
| GO:0090189 | 0.0023 | 13.0959 | 0.2676 | 3 | 21 | regulation of branching involved in ureteric bud morphogenesis |
| GO:0009953 | 0.0023 | 5.8393 | 0.9259 | 5 | 76 | dorsal/ventral pattern formation |
| GO:0021523 | 0.0023 | 39.1211 | 0.0765 | 2 | 6 | somatic motor neuron differentiation |
| GO:0032811 | 0.0023 | 39.1211 | 0.0765 | 2 | 6 | negative regulation of epinephrine secretion |
| GO:0035989 | 0.0023 | 39.1211 | 0.0765 | 2 | 6 | tendon development |
| GO:0038031 | 0.0023 | 39.1211 | 0.0765 | 2 | 6 | non-canonical Wnt signaling pathway via JNK cascade |
| GO:0060022 | 0.0023 | 39.1211 | 0.0765 | 2 | 6 | hard palate development |
| GO:0060836 | 0.0023 | 39.1211 | 0.0765 | 2 | 6 | lymphatic endothelial cell differentiation |
| GO:0060956 | 0.0023 | 39.1211 | 0.0765 | 2 | 6 | endocardial cell differentiation |
| GO:0061308 | 0.0023 | 39.1211 | 0.0765 | 2 | 6 | cardiac neural crest cell development involved in heart development |
| GO:2000049 | 0.0023 | 39.1211 | 0.0765 | 2 | 6 | positive regulation of cell-cell adhesion mediated by cadherin |
| GO:2000288 | 0.0023 | 39.1211 | 0.0765 | 2 | 6 | positive regulation of myoblast proliferation |
| GO:0007409 | 0.0024 | 4.1061 | 1.8196 | 7 | 149 | axonogenesis |
| GO:0001667 | 0.0024 | 3.0979 | 3.4283 | 10 | 269 | ameboidal-type cell migration |
| GO:0014032 | 0.0024 | 7.773 | 0.5679 | 4 | 45 | neural crest cell development |
| GO:0009914 | 0.0025 | 3.075 | 3.4532 | 10 | 275 | hormone transport |
| GO:0002089 | 0.0026 | 12.4058 | 0.2804 | 3 | 22 | lens morphogenesis in camera-type eye |
| GO:0010719 | 0.0026 | 12.4058 | 0.2804 | 3 | 22 | negative regulation of epithelial to mesenchymal transition |
| GO:0043586 | 0.0026 | 12.4058 | 0.2804 | 3 | 22 | tongue development |
| GO:0010721 | 0.0027 | 7.5148 | 0.5846 | 4 | 48 | negative regulation of cell development |
| GO:0048858 | 0.0028 | 2.1213 | 10.0938 | 20 | 792 | cell projection morphogenesis |
| GO:0016331 | 0.0028 | 3.9796 | 1.8735 | 7 | 147 | morphogenesis of embryonic epithelium |
| GO:0048588 | 0.0028 | 4.5786 | 1.4019 | 6 | 110 | developmental cell growth |
| GO:0090066 | 0.003 | 2.6853 | 4.741 | 12 | 372 | regulation of anatomical structure size |
| GO:0010656 | 0.003 | 11.7847 | 0.2931 | 3 | 23 | negative regulation of muscle cell apoptotic process |
| GO:0002027 | 0.003 | 5.4941 | 0.9813 | 5 | 77 | regulation of heart rate |
| GO:0008285 | 0.003 | 2.3118 | 7.3712 | 16 | 584 | negative regulation of cell proliferation |
| GO:0048869 | 0.003 | 2.0056 | 13.3229 | 24 | 1386 | cellular developmental process |
| GO:0043588 | 0.0031 | 3.1996 | 2.9822 | 9 | 234 | skin development |
| GO:0009996 | 0.0033 | 31.2948 | 0.0892 | 2 | 7 | negative regulation of cell fate specification |
| GO:0010700 | 0.0033 | 31.2948 | 0.0892 | 2 | 7 | negative regulation of norepinephrine secretion |
| GO:0021796 | 0.0033 | 31.2948 | 0.0892 | 2 | 7 | cerebral cortex regionalization |
| GO:0021798 | 0.0033 | 31.2948 | 0.0892 | 2 | 7 | forebrain dorsal/ventral pattern formation |
| GO:0060684 | 0.0033 | 31.2948 | 0.0892 | 2 | 7 | epithelial-mesenchymal cell signaling |
| GO:2000542 | 0.0033 | 31.2948 | 0.0892 | 2 | 7 | negative regulation of gastrulation |
| GO:0060562 | 0.0034 | 7.0483 | 0.6193 | 4 | 52 | epithelial tube morphogenesis |
| GO:0021533 | 0.0034 | 11.2228 | 0.3059 | 3 | 24 | cell differentiation in hindbrain |
| GO:0035883 | 0.0034 | 11.2228 | 0.3059 | 3 | 24 | enteroendocrine cell differentiation |
| GO:0045686 | 0.0034 | 11.2228 | 0.3059 | 3 | 24 | negative regulation of glial cell differentiation |
| GO:0061311 | 0.0034 | 11.2228 | 0.3059 | 3 | 24 | cell surface receptor signaling pathway involved in heart development |
| GO:0051101 | 0.0035 | 5.2733 | 1.0196 | 5 | 80 | regulation of DNA binding |
| GO:0021515 | 0.0037 | 10.7919 | 0.315 | 3 | 26 | cell differentiation in spinal cord |
| GO:0015833 | 0.0037 | 2.9038 | 3.645 | 10 | 286 | peptide transport |
| GO:0072078 | 0.0037 | 6.8452 | 0.6375 | 4 | 51 | nephron tubule morphogenesis |
| GO:0007548 | 0.0038 | 3.1016 | 3.0715 | 9 | 241 | sex differentiation |
| GO:0006355 | 0.0041 | 2.0864 | 10.5974 | 20 | 1202 | regulation of transcription, DNA-templated |
| GO:0060560 | 0.0042 | 3.687 | 2.0137 | 7 | 158 | developmental growth involved in morphogenesis |
| GO:0003179 | 0.0043 | 10.2456 | 0.3314 | 3 | 26 | heart valve morphogenesis |
| GO:0090092 | 0.0043 | 3.305 | 2.5617 | 8 | 201 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0019229 | 0.0043 | 6.569 | 0.6627 | 4 | 52 | regulation of vasoconstriction |
| GO:0010667 | 0.0043 | 26.0773 | 0.102 | 2 | 8 | negative regulation of cardiac muscle cell apoptotic process |
| GO:0035878 | 0.0043 | 26.0773 | 0.102 | 2 | 8 | nail development |
| GO:0009719 | 0.0045 | 1.7954 | 17.4347 | 29 | 1368 | response to endogenous stimulus |
| GO:0014031 | 0.0045 | 4.9624 | 1.0784 | 5 | 87 | mesenchymal cell development |
| GO:0072175 | 0.0045 | 4.1377 | 1.5421 | 6 | 121 | epithelial tube formation |
| GO:0018958 | 0.0046 | 4.9421 | 1.0833 | 5 | 85 | phenol-containing compound metabolic process |
| GO:0045909 | 0.0048 | 9.818 | 0.3441 | 3 | 27 | positive regulation of vasodilation |
| GO:0061036 | 0.0048 | 9.818 | 0.3441 | 3 | 27 | positive regulation of cartilage development |
| GO:2000826 | 0.0048 | 9.818 | 0.3441 | 3 | 27 | regulation of heart morphogenesis |
| GO:0070848 | 0.0048 | 2.1406 | 8.437 | 17 | 662 | response to growth factor |
| GO:0030858 | 0.0049 | 6.3054 | 0.6882 | 4 | 54 | positive regulation of epithelial cell differentiation |
| GO:0032835 | 0.0049 | 6.3054 | 0.6882 | 4 | 54 | glomerulus development |
| GO:0001756 | 0.005 | 6.2766 | 0.6907 | 4 | 55 | somitogenesis |
| GO:0001947 | 0.0053 | 6.1814 | 0.701 | 4 | 55 | heart looping |
| GO:0001662 | 0.0053 | 9.4247 | 0.3569 | 3 | 28 | behavioral fear response |
| GO:0045687 | 0.0053 | 9.4247 | 0.3569 | 3 | 28 | positive regulation of glial cell differentiation |
| GO:0003198 | 0.0055 | 22.3505 | 0.1147 | 2 | 9 | epithelial to mesenchymal transition involved in endocardial cushion formation |
| GO:0021892 | 0.0055 | 22.3505 | 0.1147 | 2 | 9 | cerebral cortex GABAergic interneuron differentiation |
| GO:0048703 | 0.0055 | 22.3505 | 0.1147 | 2 | 9 | embryonic viscerocranium morphogenesis |
| GO:0060253 | 0.0055 | 22.3505 | 0.1147 | 2 | 9 | negative regulation of glial cell proliferation |
| GO:0061004 | 0.0055 | 22.3505 | 0.1147 | 2 | 9 | pattern specification involved in kidney development |
| GO:2000679 | 0.0055 | 22.3505 | 0.1147 | 2 | 9 | positive regulation of transcription regulatory region DNA binding |
| GO:0055002 | 0.0055 | 3.9639 | 1.6058 | 6 | 126 | striated muscle cell development |
| GO:0014902 | 0.0056 | 4.7055 | 1.1343 | 5 | 89 | myotube differentiation |
| GO:0055006 | 0.0056 | 6.0621 | 0.7137 | 4 | 56 | cardiac cell development |
| GO:0030278 | 0.0056 | 3.4775 | 2.1284 | 7 | 167 | regulation of ossification |
| GO:0001825 | 0.0058 | 9.0616 | 0.3696 | 3 | 29 | blastocyst formation |
| GO:0050885 | 0.006 | 5.9473 | 0.7264 | 4 | 57 | neuromuscular process controlling balance |
| GO:0061448 | 0.006 | 3.1109 | 2.7132 | 8 | 215 | connective tissue development |
| GO:0044706 | 0.006 | 3.1091 | 2.7146 | 8 | 213 | multi-multicellular organism process |
| GO:0045669 | 0.0063 | 5.8368 | 0.7392 | 4 | 58 | positive regulation of osteoblast differentiation |
| GO:0003015 | 0.0064 | 3.3918 | 2.1793 | 7 | 171 | heart process |
| GO:0007368 | 0.0064 | 4.5423 | 1.1725 | 5 | 92 | determination of left/right symmetry |
| GO:0044253 | 0.0064 | 8.7254 | 0.3823 | 3 | 30 | positive regulation of multicellular organismal metabolic process |
| GO:0048545 | 0.0065 | 2.5273 | 4.5881 | 11 | 360 | response to steroid hormone |
| GO:0045596 | 0.0067 | 2.5239 | 4.6018 | 11 | 385 | negative regulation of cell differentiation |
| GO:0002064 | 0.0067 | 3.3604 | 2.1986 | 7 | 175 | epithelial cell development |
| GO:0021872 | 0.0067 | 5.7303 | 0.7519 | 4 | 59 | forebrain generation of neurons |
| GO:0051969 | 0.0068 | 19.5554 | 0.1274 | 2 | 10 | regulation of transmission of nerve impulse |
| GO:0060174 | 0.0068 | 19.5554 | 0.1274 | 2 | 10 | limb bud formation |
| GO:0061303 | 0.0068 | 19.5554 | 0.1274 | 2 | 10 | cornea development in camera-type eye |
| GO:0007631 | 0.007 | 4.4397 | 1.198 | 5 | 94 | feeding behavior |
| GO:0010453 | 0.007 | 8.4132 | 0.3951 | 3 | 31 | regulation of cell fate commitment |
| GO:0048706 | 0.0071 | 8.3793 | 0.3957 | 3 | 32 | embryonic skeletal system development |
| GO:0031497 | 0.0074 | 3.7142 | 1.7078 | 6 | 134 | chromatin assembly |
| GO:0072091 | 0.0075 | 5.5393 | 0.7755 | 4 | 62 | regulation of stem cell proliferation |
| GO:0042733 | 0.0076 | 5.5285 | 0.7774 | 4 | 61 | embryonic digit morphogenesis |
| GO:0030072 | 0.0076 | 2.9801 | 2.8262 | 8 | 224 | peptide hormone secretion |
| GO:0090257 | 0.0076 | 3.2708 | 2.2558 | 7 | 177 | regulation of muscle system process |
| GO:0060795 | 0.0077 | 8.1226 | 0.4078 | 3 | 32 | cell fate commitment involved in formation of primary germ layer |
| GO:0015844 | 0.008 | 5.4328 | 0.7902 | 4 | 62 | monoamine transport |
| GO:0048857 | 0.008 | 5.4328 | 0.7902 | 4 | 62 | neural nucleus development |
| GO:0071300 | 0.008 | 5.4328 | 0.7902 | 4 | 62 | cellular response to retinoic acid |
| GO:0032099 | 0.0082 | 17.3814 | 0.1402 | 2 | 11 | negative regulation of appetite |
| GO:0017145 | 0.0084 | 7.8513 | 0.4206 | 3 | 33 | stem cell division |
| GO:0048468 | 0.0086 | 2.1833 | 6.8345 | 14 | 655 | cell development |
| GO:0001709 | 0.0088 | 7.7149 | 0.4269 | 3 | 34 | cell fate determination |
| GO:0098801 | 0.0091 | 7.5975 | 0.4333 | 3 | 34 | regulation of renal system process |
| GO:0044708 | 0.0098 | 2.5019 | 4.1992 | 10 | 334 | single-organism behavior |
| GO:0003084 | 0.0098 | 15.6423 | 0.1529 | 2 | 12 | positive regulation of systemic arterial blood pressure |
| GO:0035815 | 0.0098 | 15.6423 | 0.1529 | 2 | 12 | positive regulation of renal sodium excretion |
| GO:0042789 | 0.0098 | 15.6423 | 0.1529 | 2 | 12 | mRNA transcription from RNA polymerase II promoter |
| GO:2001053 | 0.0098 | 15.6423 | 0.1529 | 2 | 12 | regulation of mesenchymal cell apoptotic process |
| GO:0009799 | 0.0098 | 4.0714 | 1.3 | 5 | 102 | specification of symmetry |
| GO:0008406 | 0.0099 | 3.1045 | 2.3705 | 7 | 186 | gonad development |
| GO:0050433 | 0.0099 | 7.3596 | 0.4461 | 3 | 35 | regulation of catecholamine secretion |
| GO:0060325 | 0.0099 | 7.3596 | 0.4461 | 3 | 35 | face morphogenesis |
| GO:0008589 | 0.01 | 5.081 | 0.8411 | 4 | 66 | regulation of smoothened signaling pathway |
| GO:0015837 | 0.01 | 5.081 | 0.8411 | 4 | 66 | amine transport |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0060326 | 0 | 10.7907 | 0.9785 | 9 | 209 | cell chemotaxis |
| GO:0002685 | 0 | 14.4803 | 0.5618 | 7 | 120 | regulation of leukocyte migration |
| GO:0070098 | 0 | 23.7236 | 0.2481 | 5 | 53 | chemokine-mediated signaling pathway |
| GO:1902531 | 0 | 3.6599 | 7.3456 | 21 | 1569 | regulation of intracellular signal transduction |
| GO:0071345 | 0 | 5.5009 | 2.5703 | 12 | 549 | cellular response to cytokine stimulus |
| GO:0023014 | 0 | 4.9685 | 3.104 | 13 | 663 | signal transduction by phosphorylation |
| GO:0002690 | 0 | 18.0573 | 0.3184 | 5 | 68 | positive regulation of leukocyte chemotaxis |
| GO:0006955 | 0 | 6.9129 | 1.5385 | 9 | 396 | immune response |
| GO:0044700 | 0 | 2.7033 | 25.5855 | 43 | 5465 | single organism signaling |
| GO:0032496 | 0 | 7.5592 | 1.2032 | 8 | 257 | response to lipopolysaccharide |
| GO:0009617 | 0 | 5.6478 | 2.0365 | 10 | 435 | response to bacterium |
| GO:0007186 | 0 | 3.7978 | 5.1021 | 16 | 1105 | G-protein coupled receptor signaling pathway |
| GO:0002684 | 0 | 4.3747 | 3.4972 | 13 | 747 | positive regulation of immune system process |
| GO:0050920 | 0 | 10.6133 | 0.6367 | 6 | 136 | regulation of chemotaxis |
| GO:0032695 | 0 | 55.4167 | 0.0702 | 3 | 15 | negative regulation of interleukin-12 production |
| GO:0048583 | 0 | 2.7391 | 14.9627 | 30 | 3196 | regulation of response to stimulus |
| GO:0010818 | 1e-04 | 47.4938 | 0.0796 | 3 | 17 | T cell chemotaxis |
| GO:0006954 | 1e-04 | 6.5823 | 1.3836 | 8 | 317 | inflammatory response |
| GO:0032103 | 1e-04 | 7.668 | 1.0253 | 7 | 219 | positive regulation of response to external stimulus |
| GO:0045937 | 1e-04 | 3.7791 | 4.368 | 14 | 933 | positive regulation of phosphate metabolic process |
| GO:0009967 | 1e-04 | 3.4199 | 5.6143 | 16 | 1216 | positive regulation of signal transduction |
| GO:0002761 | 1e-04 | 11.8245 | 0.4729 | 5 | 101 | regulation of myeloid leukocyte differentiation |
| GO:0002521 | 1e-04 | 5.1906 | 1.9616 | 9 | 419 | leukocyte differentiation |
| GO:0002275 | 2e-04 | 16.6155 | 0.2715 | 4 | 58 | myeloid cell activation involved in immune response |
| GO:0045087 | 2e-04 | 3.7336 | 4.0544 | 13 | 866 | innate immune response |
| GO:0006950 | 2e-04 | 2.857 | 10.1088 | 22 | 2389 | response to stress |
| GO:0002263 | 2e-04 | 7.8608 | 0.8474 | 6 | 181 | cell activation involved in immune response |
| GO:0050850 | 2e-04 | 30.2075 | 0.117 | 3 | 25 | positive regulation of calcium-mediated signaling |
| GO:0006887 | 2e-04 | 5.4697 | 1.6386 | 8 | 350 | exocytosis |
| GO:0051174 | 2e-04 | 3.0464 | 6.6808 | 17 | 1427 | regulation of phosphorus metabolic process |
| GO:0019932 | 3e-04 | 7.5132 | 0.8848 | 6 | 189 | second-messenger-mediated signaling |
| GO:0048520 | 3e-04 | 9.7729 | 0.5665 | 5 | 121 | positive regulation of behavior |
| GO:0070374 | 3e-04 | 9.606 | 0.5759 | 5 | 123 | positive regulation of ERK1 and ERK2 cascade |
| GO:0043207 | 3e-04 | 3.8909 | 3.2257 | 11 | 689 | response to external biotic stimulus |
| GO:0010033 | 4e-04 | 2.5673 | 11.1846 | 23 | 2389 | response to organic substance |
| GO:0046903 | 5e-04 | 3.3336 | 4.5038 | 13 | 962 | secretion |
| GO:0023051 | 5e-04 | 2.4267 | 13.0011 | 25 | 2777 | regulation of signaling |
| GO:0070887 | 6e-04 | 2.7303 | 8.6464 | 19 | 2082 | cellular response to chemical stimulus |
| GO:0010646 | 6e-04 | 2.4138 | 13.0573 | 25 | 2789 | regulation of cell communication |
| GO:0032720 | 6e-04 | 20.7541 | 0.1639 | 3 | 35 | negative regulation of tumor necrosis factor production |
| GO:0030335 | 6e-04 | 5.3327 | 1.4513 | 7 | 310 | positive regulation of cell migration |
| GO:1903555 | 6e-04 | 11.1963 | 0.3933 | 4 | 84 | regulation of tumor necrosis factor superfamily cytokine production |
| GO:0051674 | 8e-04 | 3.0226 | 5.3652 | 14 | 1146 | localization of cell |
| GO:0007253 | 8e-04 | 62.449 | 0.0421 | 2 | 9 | cytoplasmic sequestering of NF-kappaB |
| GO:0051272 | 8e-04 | 5.0599 | 1.5262 | 7 | 326 | positive regulation of cellular component movement |
| GO:0051591 | 8e-04 | 10.4111 | 0.4214 | 4 | 90 | response to cAMP |
| GO:0040017 | 9e-04 | 4.9489 | 1.559 | 7 | 333 | positive regulation of locomotion |
| GO:0045019 | 9e-04 | 54.6393 | 0.0468 | 2 | 10 | negative regulation of nitric oxide biosynthetic process |
| GO:0042325 | 0.0013 | 2.8402 | 5.6789 | 14 | 1213 | regulation of phosphorylation |
| GO:2000145 | 0.0014 | 3.707 | 2.7013 | 9 | 577 | regulation of cell motility |
| GO:0030502 | 0.0019 | 36.4167 | 0.0655 | 2 | 14 | negative regulation of bone mineralization |
| GO:0030889 | 0.0019 | 36.4167 | 0.0655 | 2 | 14 | negative regulation of B cell proliferation |
| GO:1901741 | 0.0019 | 36.4167 | 0.0655 | 2 | 14 | positive regulation of myoblast fusion |
| GO:0048534 | 0.0019 | 3.3014 | 3.3849 | 10 | 723 | hematopoietic or lymphoid organ development |
| GO:0006968 | 0.0021 | 13.006 | 0.2528 | 3 | 54 | cellular defense response |
| GO:0043299 | 0.0021 | 13.006 | 0.2528 | 3 | 54 | leukocyte degranulation |
| GO:0031349 | 0.0023 | 4.8436 | 1.3483 | 6 | 288 | positive regulation of defense response |
| GO:1903706 | 0.0023 | 4.8262 | 1.353 | 6 | 289 | regulation of hemopoiesis |
| GO:0045663 | 0.0028 | 29.1276 | 0.0796 | 2 | 17 | positive regulation of myoblast differentiation |
| GO:0045321 | 0.003 | 3.3117 | 3.0057 | 9 | 642 | leukocyte activation |
| GO:0071219 | 0.0033 | 7.031 | 0.6133 | 4 | 131 | cellular response to molecule of bacterial origin |
| GO:1901623 | 0.0035 | 25.6975 | 0.089 | 2 | 19 | regulation of lymphocyte chemotaxis |
| GO:0006928 | 0.0036 | 2.6301 | 5.674 | 13 | 1314 | movement of cell or subcellular component |
| GO:0002444 | 0.0036 | 10.5204 | 0.309 | 3 | 66 | myeloid leukocyte mediated immunity |
| GO:0010955 | 0.0037 | 4.3692 | 1.4888 | 6 | 318 | negative regulation of protein processing |
| GO:0031960 | 0.004 | 6.6607 | 0.6461 | 4 | 138 | response to corticosteroid |
| GO:0030099 | 0.0041 | 4.2713 | 1.5216 | 6 | 325 | myeloid cell differentiation |
| GO:0002544 | 0.0043 | 22.9895 | 0.0983 | 2 | 21 | chronic inflammatory response |
| GO:0045671 | 0.0043 | 22.9895 | 0.0983 | 2 | 21 | negative regulation of osteoclast differentiation |
| GO:0045672 | 0.0043 | 22.9895 | 0.0983 | 2 | 21 | positive regulation of osteoclast differentiation |
| GO:0040011 | 0.0045 | 2.6554 | 5.1366 | 12 | 1189 | locomotion |
| GO:0002683 | 0.0045 | 4.1908 | 1.5496 | 6 | 331 | negative regulation of immune system process |
| GO:0002875 | 0.0047 | Inf | 0.0047 | 1 | 1 | negative regulation of chronic inflammatory response to antigenic stimulus |
| GO:0006127 | 0.0047 | Inf | 0.0047 | 1 | 1 | glycerophosphate shuttle |
| GO:0015734 | 0.0047 | Inf | 0.0047 | 1 | 1 | taurine transport |
| GO:0045355 | 0.0047 | Inf | 0.0047 | 1 | 1 | negative regulation of interferon-alpha biosynthetic process |
| GO:0048160 | 0.0047 | Inf | 0.0047 | 1 | 1 | primary follicle stage |
| GO:0070392 | 0.0047 | Inf | 0.0047 | 1 | 1 | detection of lipoteichoic acid |
| GO:1903082 | 0.0047 | Inf | 0.0047 | 1 | 1 | positive regulation of C-C chemokine receptor CCR7 signaling pathway |
| GO:2000350 | 0.0047 | Inf | 0.0047 | 1 | 1 | positive regulation of CD40 signaling pathway |
| GO:0045742 | 0.0047 | 21.8386 | 0.103 | 2 | 22 | positive regulation of epidermal growth factor receptor signaling pathway |
| GO:0043154 | 0.0048 | 9.464 | 0.3418 | 3 | 73 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0009611 | 0.0049 | 2.7191 | 4.5085 | 11 | 963 | response to wounding |
| GO:0050790 | 0.005 | 2.2001 | 9.5132 | 18 | 2032 | regulation of catalytic activity |
| GO:0048246 | 0.0051 | 20.7973 | 0.1077 | 2 | 23 | macrophage chemotaxis |
| GO:2000403 | 0.0051 | 20.7973 | 0.1077 | 2 | 23 | positive regulation of lymphocyte migration |
| GO:0050715 | 0.0052 | 9.1999 | 0.3511 | 3 | 75 | positive regulation of cytokine secretion |
| GO:0007154 | 0.0056 | 2.2812 | 10.8056 | 19 | 2932 | cell communication |
| GO:0050727 | 0.006 | 4.6457 | 1.1564 | 5 | 247 | regulation of inflammatory response |
| GO:0060142 | 0.006 | 18.9863 | 0.117 | 2 | 25 | regulation of syncytium formation by plasma membrane fusion |
| GO:0036230 | 0.0065 | 18.194 | 0.1217 | 2 | 26 | granulocyte activation |
| GO:0051930 | 0.0065 | 18.194 | 0.1217 | 2 | 26 | regulation of sensory perception of pain |
| GO:0043410 | 0.0068 | 4.5071 | 1.1945 | 5 | 272 | positive regulation of MAPK cascade |
| GO:0030816 | 0.0069 | 8.2755 | 0.3886 | 3 | 83 | positive regulation of cAMP metabolic process |
| GO:0097530 | 0.0069 | 8.2755 | 0.3886 | 3 | 83 | granulocyte migration |
| GO:0071902 | 0.0078 | 4.3529 | 1.2313 | 5 | 263 | positive regulation of protein serine/threonine kinase activity |
| GO:0006935 | 0.0081 | 3.709 | 1.7564 | 6 | 422 | chemotaxis |
| GO:0060348 | 0.0084 | 5.3329 | 0.8006 | 4 | 171 | bone development |
| GO:1903532 | 0.0085 | 4.2523 | 1.2594 | 5 | 269 | positive regulation of secretion by cell |
| GO:0032715 | 0.0086 | 15.5908 | 0.1405 | 2 | 30 | negative regulation of interleukin-6 production |
| GO:0033003 | 0.0086 | 15.5908 | 0.1405 | 2 | 30 | regulation of mast cell activation |
| GO:0051928 | 0.0092 | 7.4343 | 0.4307 | 3 | 92 | positive regulation of calcium ion transport |
| GO:0002548 | 0.0092 | 15.0522 | 0.1451 | 2 | 31 | monocyte chemotaxis |
| GO:0043405 | 0.0093 | 4.1562 | 1.2875 | 5 | 275 | regulation of MAP kinase activity |
| GO:0001300 | 0.0093 | 215.5775 | 0.0094 | 1 | 2 | chronological cell aging |
| GO:0001550 | 0.0093 | 215.5775 | 0.0094 | 1 | 2 | ovarian cumulus expansion |
| GO:0002588 | 0.0093 | 215.5775 | 0.0094 | 1 | 2 | positive regulation of antigen processing and presentation of peptide antigen via MHC class II |
| GO:0015855 | 0.0093 | 215.5775 | 0.0094 | 1 | 2 | pyrimidine nucleobase transport |
| GO:0032499 | 0.0093 | 215.5775 | 0.0094 | 1 | 2 | detection of peptidoglycan |
| GO:0032929 | 0.0093 | 215.5775 | 0.0094 | 1 | 2 | negative regulation of superoxide anion generation |
| GO:0036273 | 0.0093 | 215.5775 | 0.0094 | 1 | 2 | response to statin |
| GO:0042700 | 0.0093 | 215.5775 | 0.0094 | 1 | 2 | luteinizing hormone signaling pathway |
| GO:0046108 | 0.0093 | 215.5775 | 0.0094 | 1 | 2 | uridine metabolic process |
| GO:0046168 | 0.0093 | 215.5775 | 0.0094 | 1 | 2 | glycerol-3-phosphate catabolic process |
| GO:0060302 | 0.0093 | 215.5775 | 0.0094 | 1 | 2 | negative regulation of cytokine activity |
| GO:0070483 | 0.0093 | 215.5775 | 0.0094 | 1 | 2 | detection of hypoxia |
| GO:0090024 | 0.0093 | 215.5775 | 0.0094 | 1 | 2 | negative regulation of neutrophil chemotaxis |
| GO:1902530 | 0.0093 | 215.5775 | 0.0094 | 1 | 2 | positive regulation of protein linear polyubiquitination |
| GO:0071622 | 0.0098 | 14.5495 | 0.1498 | 2 | 32 | regulation of granulocyte chemotaxis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0071345 | 0 | 7.5094 | 1.9991 | 12 | 549 | cellular response to cytokine stimulus |
| GO:0060326 | 0 | 12.539 | 0.761 | 8 | 209 | cell chemotaxis |
| GO:0006954 | 0 | 7.4186 | 1.8324 | 11 | 520 | inflammatory response |
| GO:0042330 | 0 | 6.1368 | 2.4178 | 12 | 664 | taxis |
| GO:0002685 | 0 | 16.0095 | 0.437 | 6 | 120 | regulation of leukocyte migration |
| GO:0043207 | 0 | 5.9001 | 2.5089 | 12 | 689 | response to external biotic stimulus |
| GO:0032103 | 0 | 10.1826 | 0.7975 | 7 | 219 | positive regulation of response to external stimulus |
| GO:0010033 | 0 | 3.5417 | 8.6991 | 22 | 2389 | response to organic substance |
| GO:0009617 | 0 | 6.6963 | 1.584 | 9 | 435 | response to bacterium |
| GO:0010818 | 0 | 61.8962 | 0.0619 | 3 | 17 | T cell chemotaxis |
| GO:0070098 | 0 | 23.978 | 0.193 | 4 | 53 | chemokine-mediated signaling pathway |
| GO:0002263 | 0 | 10.3872 | 0.6591 | 6 | 181 | cell activation involved in immune response |
| GO:0048520 | 1e-04 | 12.8524 | 0.4406 | 5 | 121 | positive regulation of behavior |
| GO:0030335 | 1e-04 | 7.0816 | 1.1288 | 7 | 310 | positive regulation of cell migration |
| GO:0050920 | 1e-04 | 11.3696 | 0.4952 | 5 | 136 | regulation of chemotaxis |
| GO:0051272 | 2e-04 | 6.7192 | 1.1871 | 7 | 326 | positive regulation of cellular component movement |
| GO:0071216 | 2e-04 | 10.4812 | 0.5353 | 5 | 147 | cellular response to biotic stimulus |
| GO:0045347 | 2e-04 | 141.8426 | 0.0218 | 2 | 6 | negative regulation of MHC class II biosynthetic process |
| GO:0040017 | 2e-04 | 6.5719 | 1.2126 | 7 | 333 | positive regulation of locomotion |
| GO:0032943 | 2e-04 | 7.9095 | 0.8557 | 6 | 235 | mononuclear cell proliferation |
| GO:2000145 | 2e-04 | 4.9743 | 2.101 | 9 | 577 | regulation of cell motility |
| GO:0002521 | 4e-04 | 5.9387 | 1.3411 | 7 | 381 | leukocyte differentiation |
| GO:0045321 | 4e-04 | 5.1014 | 1.8064 | 8 | 520 | leukocyte activation |
| GO:0070887 | 4e-04 | 3.1597 | 6.5877 | 16 | 2082 | cellular response to chemical stimulus |
| GO:0007166 | 4e-04 | 2.6688 | 11.6377 | 23 | 3196 | cell surface receptor signaling pathway |
| GO:0007253 | 5e-04 | 81.037 | 0.0328 | 2 | 9 | cytoplasmic sequestering of NF-kappaB |
| GO:0006950 | 5e-04 | 3.0713 | 7.4573 | 17 | 2389 | response to stress |
| GO:0048245 | 6e-04 | 70.9028 | 0.0364 | 2 | 10 | eosinophil chemotaxis |
| GO:0009611 | 6e-04 | 3.69 | 3.5066 | 11 | 963 | response to wounding |
| GO:0006638 | 8e-04 | 10.5419 | 0.4188 | 4 | 115 | neutral lipid metabolic process |
| GO:0090026 | 8e-04 | 56.7148 | 0.0437 | 2 | 12 | positive regulation of monocyte chemotaxis |
| GO:0006955 | 9e-04 | 6.0642 | 1.1315 | 6 | 370 | immune response |
| GO:0042592 | 0.001 | 3.1445 | 4.9413 | 13 | 1357 | homeostatic process |
| GO:0002690 | 0.001 | 16.9367 | 0.1968 | 3 | 56 | positive regulation of leukocyte chemotaxis |
| GO:0045087 | 0.001 | 3.6741 | 3.1534 | 10 | 866 | innate immune response |
| GO:0070374 | 0.001 | 9.8281 | 0.4479 | 4 | 123 | positive regulation of ERK1 and ERK2 cascade |
| GO:0045670 | 0.001 | 16.623 | 0.2003 | 3 | 55 | regulation of osteoclast differentiation |
| GO:0002285 | 0.0011 | 9.7455 | 0.4515 | 4 | 124 | lymphocyte activation involved in immune response |
| GO:0071222 | 0.0011 | 9.7455 | 0.4515 | 4 | 124 | cellular response to lipopolysaccharide |
| GO:0032496 | 0.0011 | 9.7377 | 0.4534 | 4 | 133 | response to lipopolysaccharide |
| GO:0048534 | 0.0011 | 3.918 | 2.6327 | 9 | 723 | hematopoietic or lymphoid organ development |
| GO:0030502 | 0.0012 | 47.2562 | 0.051 | 2 | 14 | negative regulation of bone mineralization |
| GO:0090280 | 0.0012 | 47.2562 | 0.051 | 2 | 14 | positive regulation of calcium ion import |
| GO:1901741 | 0.0012 | 47.2562 | 0.051 | 2 | 14 | positive regulation of myoblast fusion |
| GO:0002684 | 0.0014 | 3.7844 | 2.7201 | 9 | 747 | positive regulation of immune system process |
| GO:0045663 | 0.0017 | 37.7975 | 0.0619 | 2 | 17 | positive regulation of myoblast differentiation |
| GO:0002548 | 0.002 | 34.6063 | 0.0668 | 2 | 19 | monocyte chemotaxis |
| GO:1901623 | 0.0021 | 33.3464 | 0.0692 | 2 | 19 | regulation of lymphocyte chemotaxis |
| GO:0070838 | 0.0023 | 4.8766 | 1.3619 | 6 | 374 | divalent metal ion transport |
| GO:0050715 | 0.0026 | 11.9898 | 0.2731 | 3 | 75 | positive regulation of cytokine secretion |
| GO:0051928 | 0.0026 | 11.9498 | 0.2741 | 3 | 78 | positive regulation of calcium ion transport |
| GO:0002544 | 0.0026 | 29.8324 | 0.0765 | 2 | 21 | chronic inflammatory response |
| GO:0098542 | 0.0028 | 4.6809 | 1.4165 | 6 | 389 | defense response to other organism |
| GO:0043949 | 0.0029 | 28.3389 | 0.0801 | 2 | 22 | regulation of cAMP-mediated signaling |
| GO:0034764 | 0.0031 | 11.2075 | 0.2913 | 3 | 80 | positive regulation of transmembrane transport |
| GO:0048246 | 0.0031 | 26.9877 | 0.0838 | 2 | 23 | macrophage chemotaxis |
| GO:2000403 | 0.0031 | 26.9877 | 0.0838 | 2 | 23 | positive regulation of lymphocyte migration |
| GO:0010959 | 0.0032 | 5.4866 | 0.9977 | 5 | 274 | regulation of metal ion transport |
| GO:0042100 | 0.0034 | 10.7851 | 0.3022 | 3 | 83 | B cell proliferation |
| GO:0045637 | 0.0036 | 6.8976 | 0.6299 | 4 | 173 | regulation of myeloid cell differentiation |
| GO:0002875 | 0.0036 | Inf | 0.0036 | 1 | 1 | negative regulation of chronic inflammatory response to antigenic stimulus |
| GO:0006127 | 0.0036 | Inf | 0.0036 | 1 | 1 | glycerophosphate shuttle |
| GO:0035491 | 0.0036 | Inf | 0.0036 | 1 | 1 | positive regulation of leukotriene production involved in inflammatory response |
| GO:0045355 | 0.0036 | Inf | 0.0036 | 1 | 1 | negative regulation of interferon-alpha biosynthetic process |
| GO:0061044 | 0.0036 | Inf | 0.0036 | 1 | 1 | negative regulation of vascular wound healing |
| GO:0070392 | 0.0036 | Inf | 0.0036 | 1 | 1 | detection of lipoteichoic acid |
| GO:1903082 | 0.0036 | Inf | 0.0036 | 1 | 1 | positive regulation of C-C chemokine receptor CCR7 signaling pathway |
| GO:2000350 | 0.0036 | Inf | 0.0036 | 1 | 1 | positive regulation of CD40 signaling pathway |
| GO:2000521 | 0.0036 | Inf | 0.0036 | 1 | 1 | negative regulation of immunological synapse formation |
| GO:0050850 | 0.0037 | 24.6377 | 0.091 | 2 | 25 | positive regulation of calcium-mediated signaling |
| GO:0060142 | 0.0037 | 24.6377 | 0.091 | 2 | 25 | regulation of syncytium formation by plasma membrane fusion |
| GO:0031349 | 0.0039 | 5.2103 | 1.0487 | 5 | 288 | positive regulation of defense response |
| GO:0055082 | 0.004 | 3.8227 | 2.0355 | 7 | 559 | cellular chemical homeostasis |
| GO:0036230 | 0.004 | 23.6096 | 0.0947 | 2 | 26 | granulocyte activation |
| GO:0051930 | 0.004 | 23.6096 | 0.0947 | 2 | 26 | regulation of sensory perception of pain |
| GO:0001773 | 0.0046 | 21.7906 | 0.102 | 2 | 28 | myeloid dendritic cell activation |
| GO:0019932 | 0.0049 | 6.2944 | 0.6882 | 4 | 189 | second-messenger-mediated signaling |
| GO:0070328 | 0.0053 | 20.2315 | 0.1092 | 2 | 30 | triglyceride homeostasis |
| GO:0030003 | 0.0056 | 4.0401 | 1.6313 | 6 | 448 | cellular cation homeostasis |
| GO:0006874 | 0.0056 | 4.7636 | 1.1434 | 5 | 314 | cellular calcium ion homeostasis |
| GO:0046486 | 0.0056 | 4.7636 | 1.1434 | 5 | 314 | glycerolipid metabolic process |
| GO:0007154 | 0.0057 | 2.0445 | 20.2385 | 30 | 5558 | cell communication |
| GO:0046464 | 0.0057 | 19.5326 | 0.1129 | 2 | 31 | acylglycerol catabolic process |
| GO:0001959 | 0.0058 | 8.885 | 0.3641 | 3 | 100 | regulation of cytokine-mediated signaling pathway |
| GO:0030183 | 0.0059 | 8.7938 | 0.3678 | 3 | 101 | B cell differentiation |
| GO:0071407 | 0.0063 | 4.626 | 1.1761 | 5 | 323 | cellular response to organic cyclic compound |
| GO:0046425 | 0.0068 | 8.3642 | 0.386 | 3 | 106 | regulation of JAK-STAT cascade |
| GO:0030225 | 0.0068 | 17.6979 | 0.1238 | 2 | 34 | macrophage differentiation |
| GO:0051220 | 0.0068 | 17.6979 | 0.1238 | 2 | 34 | cytoplasmic sequestering of protein |
| GO:0006641 | 0.0069 | 8.2832 | 0.3896 | 3 | 107 | triglyceride metabolic process |
| GO:0050793 | 0.007 | 2.372 | 6.9258 | 14 | 1902 | regulation of developmental process |
| GO:0001300 | 0.0073 | 278.5818 | 0.0073 | 1 | 2 | chronological cell aging |
| GO:0002538 | 0.0073 | 278.5818 | 0.0073 | 1 | 2 | arachidonic acid metabolite production involved in inflammatory response |
| GO:0002588 | 0.0073 | 278.5818 | 0.0073 | 1 | 2 | positive regulation of antigen processing and presentation of peptide antigen via MHC class II |
| GO:0010902 | 0.0073 | 278.5818 | 0.0073 | 1 | 2 | positive regulation of very-low-density lipoprotein particle remodeling |
| GO:0015855 | 0.0073 | 278.5818 | 0.0073 | 1 | 2 | pyrimidine nucleobase transport |
| GO:0018153 | 0.0073 | 278.5818 | 0.0073 | 1 | 2 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine |
| GO:0032499 | 0.0073 | 278.5818 | 0.0073 | 1 | 2 | detection of peptidoglycan |
| GO:0046168 | 0.0073 | 278.5818 | 0.0073 | 1 | 2 | glycerol-3-phosphate catabolic process |
| GO:0060302 | 0.0073 | 278.5818 | 0.0073 | 1 | 2 | negative regulation of cytokine activity |
| GO:0060697 | 0.0073 | 278.5818 | 0.0073 | 1 | 2 | positive regulation of phospholipid catabolic process |
| GO:1901387 | 0.0073 | 278.5818 | 0.0073 | 1 | 2 | positive regulation of voltage-gated calcium channel activity |
| GO:1901491 | 0.0073 | 278.5818 | 0.0073 | 1 | 2 | negative regulation of lymphangiogenesis |
| GO:2000098 | 0.0073 | 278.5818 | 0.0073 | 1 | 2 | negative regulation of smooth muscle cell-matrix adhesion |
| GO:2000660 | 0.0073 | 278.5818 | 0.0073 | 1 | 2 | negative regulation of interleukin-1-mediated signaling pathway |
| GO:2001189 | 0.0073 | 278.5818 | 0.0073 | 1 | 2 | negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
| GO:0007204 | 0.0074 | 5.5899 | 0.772 | 4 | 212 | positive regulation of cytosolic calcium ion concentration |
| GO:0002682 | 0.0075 | 4.4687 | 1.2318 | 5 | 383 | regulation of immune system process |
| GO:0042345 | 0.008 | 16.1778 | 0.1347 | 2 | 37 | regulation of NF-kappaB import into nucleus |
| GO:0044765 | 0.0081 | 2.0672 | 12.6281 | 21 | 3468 | single-organism transport |
| GO:0042992 | 0.0084 | 15.7274 | 0.1384 | 2 | 38 | negative regulation of transcription factor import into nucleus |
| GO:0045806 | 0.0084 | 15.7274 | 0.1384 | 2 | 38 | negative regulation of endocytosis |
| GO:0097028 | 0.0084 | 15.7274 | 0.1384 | 2 | 38 | dendritic cell differentiation |
| GO:0008037 | 0.0087 | 7.619 | 0.4224 | 3 | 116 | cell recognition |
| GO:0048870 | 0.0088 | 3.6889 | 1.8067 | 6 | 569 | cell motility |
| GO:0002437 | 0.0089 | 15.3013 | 0.142 | 2 | 39 | inflammatory response to antigenic stimulus |
| GO:0072507 | 0.0089 | 4.2437 | 1.2781 | 5 | 351 | divalent inorganic cation homeostasis |
| GO:0022408 | 0.0089 | 7.5516 | 0.426 | 3 | 117 | negative regulation of cell-cell adhesion |
| GO:0051239 | 0.0091 | 2.2392 | 7.8908 | 15 | 2167 | regulation of multicellular organismal process |
| GO:0044700 | 0.0091 | 1.9535 | 19.8999 | 29 | 5465 | single organism signaling |
| GO:0008283 | 0.0097 | 2.3343 | 6.4452 | 13 | 1770 | cell proliferation |
| GO:0002695 | 0.0099 | 7.232 | 0.4442 | 3 | 122 | negative regulation of leukocyte activation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050911 | 0 | 12.3216 | 0.7241 | 7 | 348 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0009593 | 0 | 10.0003 | 0.8843 | 7 | 425 | detection of chemical stimulus |
| GO:0050906 | 0 | 9.8072 | 0.901 | 7 | 433 | detection of stimulus involved in sensory perception |
| GO:0007606 | 0 | 9.2692 | 0.9509 | 7 | 457 | sensory perception of chemical stimulus |
| GO:0021884 | 0.0012 | 44.4174 | 0.052 | 2 | 25 | forebrain neuron development |
| GO:0007186 | 0.0016 | 4.3215 | 2.3034 | 8 | 1107 | G-protein coupled receptor signaling pathway |
| GO:0014739 | 0.0021 | Inf | 0.0021 | 1 | 1 | positive regulation of muscle hyperplasia |
| GO:0071228 | 0.0021 | Inf | 0.0021 | 1 | 1 | cellular response to tumor cell |
| GO:0032653 | 0.0025 | 30.0255 | 0.0749 | 2 | 36 | regulation of interleukin-10 production |
| GO:0045608 | 0.0042 | 495.0323 | 0.0042 | 1 | 2 | negative regulation of auditory receptor cell differentiation |
| GO:0071672 | 0.0042 | 495.0323 | 0.0042 | 1 | 2 | negative regulation of smooth muscle cell chemotaxis |
| GO:0071673 | 0.0042 | 495.0323 | 0.0042 | 1 | 2 | positive regulation of smooth muscle cell chemotaxis |
| GO:0050896 | 0.0047 | 2.8193 | 15.2312 | 23 | 7320 | response to stimulus |
| GO:0045632 | 0.0062 | 247.5 | 0.0062 | 1 | 3 | negative regulation of mechanoreceptor differentiation |
| GO:0071315 | 0.0062 | 247.5 | 0.0062 | 1 | 3 | cellular response to morphine |
| GO:0021872 | 0.0067 | 17.883 | 0.1228 | 2 | 59 | forebrain generation of neurons |
| GO:0042446 | 0.0076 | 16.706 | 0.1311 | 2 | 63 | hormone biosynthetic process |
| GO:0050877 | 0.0078 | 3.5161 | 2.37 | 7 | 1139 | neurological system process |
| GO:0045087 | 0.0081 | 3.8874 | 1.8019 | 6 | 866 | innate immune response |
| GO:0001757 | 0.0083 | 164.9892 | 0.0083 | 1 | 4 | somite specification |
| GO:0002690 | 0.0088 | 15.4354 | 0.1415 | 2 | 68 | positive regulation of leukocyte chemotaxis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0090502 | 0.0014 | 41.6168 | 0.0562 | 2 | 48 | RNA phosphodiester bond hydrolysis, endonucleolytic |
| GO:2001275 | 0.007 | 180.6588 | 0.007 | 1 | 6 | positive regulation of glucose import in response to insulin stimulus |
| GO:0050911 | 0.0073 | 8.7049 | 0.4073 | 3 | 348 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0010759 | 0.0082 | 150.5392 | 0.0082 | 1 | 7 | positive regulation of macrophage chemotaxis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050865 | 0 | 10.1864 | 2.2716 | 18 | 411 | regulation of cell activation |
| GO:0006955 | 0 | 10.804 | 1.6718 | 14 | 376 | immune response |
| GO:0071593 | 0 | 8.365 | 2.1942 | 15 | 397 | lymphocyte aggregation |
| GO:0002682 | 0 | 4.96 | 6.345 | 24 | 1148 | regulation of immune system process |
| GO:1903037 | 0 | 10.1392 | 1.4149 | 12 | 256 | regulation of leukocyte cell-cell adhesion |
| GO:0034110 | 0 | 9.7727 | 1.4647 | 12 | 265 | regulation of homotypic cell-cell adhesion |
| GO:0002274 | 0 | 13.3975 | 0.7904 | 9 | 143 | myeloid leukocyte activation |
| GO:0051249 | 0 | 9.2519 | 1.2612 | 10 | 238 | regulation of lymphocyte activation |
| GO:0002696 | 0 | 9.1671 | 1.2694 | 10 | 235 | positive regulation of leukocyte activation |
| GO:0002366 | 0 | 10.473 | 0.9949 | 9 | 180 | leukocyte activation involved in immune response |
| GO:2000503 | 0 | 279.7317 | 0.0276 | 3 | 5 | positive regulation of natural killer cell chemotaxis |
| GO:0060326 | 0 | 8.9372 | 1.1551 | 9 | 209 | cell chemotaxis |
| GO:0002448 | 0 | 28.0515 | 0.2156 | 5 | 39 | mast cell mediated immunity |
| GO:1901623 | 0 | 50.3012 | 0.105 | 4 | 19 | regulation of lymphocyte chemotaxis |
| GO:0023052 | 0 | 2.7358 | 30.2162 | 51 | 5467 | signaling |
| GO:0045087 | 0 | 4.2535 | 4.7864 | 17 | 866 | innate immune response |
| GO:0030155 | 0 | 4.9617 | 3.0399 | 13 | 550 | regulation of cell adhesion |
| GO:0006968 | 0 | 19.4452 | 0.2985 | 5 | 54 | cellular defense response |
| GO:0043299 | 0 | 19.4452 | 0.2985 | 5 | 54 | leukocyte degranulation |
| GO:0072676 | 0 | 19.4452 | 0.2985 | 5 | 54 | lymphocyte migration |
| GO:0002429 | 0 | 8.1292 | 1.1109 | 8 | 201 | immune response-activating cell surface receptor signaling pathway |
| GO:0019835 | 0 | 30.161 | 0.1603 | 4 | 29 | cytolysis |
| GO:0010820 | 0 | 79.8972 | 0.0553 | 3 | 10 | positive regulation of T cell chemotaxis |
| GO:0022409 | 0 | 7.6473 | 1.1773 | 8 | 213 | positive regulation of cell-cell adhesion |
| GO:0048583 | 0 | 2.5579 | 17.6643 | 34 | 3196 | regulation of response to stimulus |
| GO:0002279 | 0 | 22.8373 | 0.2045 | 4 | 37 | mast cell activation involved in immune response |
| GO:0050868 | 1e-04 | 13.9945 | 0.4035 | 5 | 73 | negative regulation of T cell activation |
| GO:0002889 | 1e-04 | 22.1641 | 0.21 | 4 | 38 | regulation of immunoglobulin mediated immune response |
| GO:0045321 | 1e-04 | 9.6109 | 0.7044 | 6 | 164 | leukocyte activation |
| GO:0002705 | 1e-04 | 12.5148 | 0.4477 | 5 | 81 | positive regulation of leukocyte mediated immunity |
| GO:0050900 | 1e-04 | 7.4482 | 1.0482 | 7 | 200 | leukocyte migration |
| GO:0097530 | 1e-04 | 12.1923 | 0.4587 | 5 | 83 | granulocyte migration |
| GO:0043207 | 1e-04 | 3.9044 | 3.8081 | 13 | 689 | response to external biotic stimulus |
| GO:0032418 | 1e-04 | 18.8321 | 0.2432 | 4 | 44 | lysosome localization |
| GO:0030098 | 1e-04 | 5.8252 | 1.5255 | 8 | 276 | lymphocyte differentiation |
| GO:1902105 | 2e-04 | 6.6715 | 1.1607 | 7 | 210 | regulation of leukocyte differentiation |
| GO:0009615 | 2e-04 | 5.6533 | 1.5697 | 8 | 284 | response to virus |
| GO:2000404 | 2e-04 | 29.4127 | 0.1216 | 3 | 22 | regulation of T cell migration |
| GO:0001906 | 3e-04 | 9.7919 | 0.5638 | 5 | 102 | cell killing |
| GO:0032733 | 3e-04 | 27.9402 | 0.1271 | 3 | 23 | positive regulation of interleukin-10 production |
| GO:0048246 | 3e-04 | 27.9402 | 0.1271 | 3 | 23 | macrophage chemotaxis |
| GO:0042330 | 3e-04 | 3.6916 | 3.6699 | 12 | 664 | taxis |
| GO:0007155 | 3e-04 | 3.7195 | 3.7143 | 12 | 765 | cell adhesion |
| GO:0002253 | 3e-04 | 4.6477 | 2.15 | 9 | 389 | activation of immune response |
| GO:0008626 | 3e-04 | 122.8193 | 0.0276 | 2 | 5 | granzyme-mediated apoptotic signaling pathway |
| GO:0050859 | 3e-04 | 122.8193 | 0.0276 | 2 | 5 | negative regulation of B cell receptor signaling pathway |
| GO:0030278 | 3e-04 | 7.1388 | 0.923 | 6 | 167 | regulation of ossification |
| GO:0002714 | 3e-04 | 25.3969 | 0.1382 | 3 | 25 | positive regulation of B cell mediated immunity |
| GO:0032944 | 4e-04 | 7.0068 | 0.9396 | 6 | 170 | regulation of mononuclear cell proliferation |
| GO:0007165 | 4e-04 | 2.9836 | 7.7963 | 18 | 1751 | signal transduction |
| GO:0030097 | 4e-04 | 3.5657 | 3.7915 | 12 | 686 | hemopoiesis |
| GO:0043307 | 4e-04 | 92.1084 | 0.0332 | 2 | 6 | eosinophil activation |
| GO:0022408 | 5e-04 | 8.4721 | 0.6467 | 5 | 117 | negative regulation of cell-cell adhesion |
| GO:0070167 | 5e-04 | 11.9389 | 0.3703 | 4 | 67 | regulation of biomineral tissue development |
| GO:0048870 | 6e-04 | 3.8993 | 2.8831 | 10 | 569 | cell motility |
| GO:0031295 | 6e-04 | 11.57 | 0.3814 | 4 | 69 | T cell costimulation |
| GO:0002695 | 6e-04 | 8.1074 | 0.6743 | 5 | 122 | negative regulation of leukocyte activation |
| GO:0002281 | 8e-04 | 61.3976 | 0.0442 | 2 | 8 | macrophage activation involved in immune response |
| GO:0010533 | 8e-04 | 61.3976 | 0.0442 | 2 | 8 | regulation of activation of Janus kinase activity |
| GO:0012501 | 9e-04 | 2.4621 | 9.5009 | 20 | 1719 | programmed cell death |
| GO:0002520 | 9e-04 | 3.1877 | 4.2116 | 12 | 762 | immune system development |
| GO:0002576 | 0.001 | 9.7592 | 0.4477 | 4 | 81 | platelet degranulation |
| GO:0002252 | 0.0011 | 4.7756 | 1.6121 | 7 | 334 | immune effector process |
| GO:0007229 | 0.0013 | 9.2748 | 0.4698 | 4 | 85 | integrin-mediated signaling pathway |
| GO:2000145 | 0.0013 | 3.4631 | 3.1891 | 10 | 577 | regulation of cell motility |
| GO:0044763 | 0.0013 | 2.5185 | 61.9136 | 74 | 11202 | single-organism cellular process |
| GO:0002283 | 0.0013 | 46.0422 | 0.0553 | 2 | 10 | neutrophil activation involved in immune response |
| GO:0048245 | 0.0013 | 46.0422 | 0.0553 | 2 | 10 | eosinophil chemotaxis |
| GO:0070493 | 0.0013 | 46.0422 | 0.0553 | 2 | 10 | thrombin receptor signaling pathway |
| GO:0002687 | 0.0015 | 8.836 | 0.4919 | 4 | 89 | positive regulation of leukocyte migration |
| GO:0042119 | 0.0015 | 41.9122 | 0.0594 | 2 | 11 | neutrophil activation |
| GO:0043304 | 0.0015 | 41.9067 | 0.0594 | 2 | 11 | regulation of mast cell degranulation |
| GO:0061081 | 0.0016 | 40.9237 | 0.0608 | 2 | 11 | positive regulation of myeloid leukocyte cytokine production involved in immune response |
| GO:0016265 | 0.0017 | 2.3198 | 10.0094 | 20 | 1811 | death |
| GO:0050864 | 0.0017 | 8.4367 | 0.514 | 4 | 93 | regulation of B cell activation |
| GO:0032760 | 0.0018 | 13.6106 | 0.2432 | 3 | 44 | positive regulation of tumor necrosis factor production |
| GO:0030168 | 0.0019 | 4.9964 | 1.2988 | 6 | 235 | platelet activation |
| GO:0043306 | 0.0019 | 36.8289 | 0.0663 | 2 | 12 | positive regulation of mast cell degranulation |
| GO:0043922 | 0.0019 | 36.8289 | 0.0663 | 2 | 12 | negative regulation by host of viral transcription |
| GO:0045580 | 0.002 | 8.16 | 0.5306 | 4 | 96 | regulation of T cell differentiation |
| GO:0009611 | 0.0023 | 2.7262 | 5.3225 | 13 | 963 | response to wounding |
| GO:0002718 | 0.0024 | 12.3976 | 0.2653 | 3 | 48 | regulation of cytokine production involved in immune response |
| GO:0042267 | 0.0024 | 12.3976 | 0.2653 | 3 | 48 | natural killer cell mediated cytotoxicity |
| GO:0048518 | 0.0025 | 1.9063 | 26.2368 | 39 | 4747 | positive regulation of biological process |
| GO:1903305 | 0.0025 | 31.4053 | 0.0757 | 2 | 14 | regulation of regulated secretory pathway |
| GO:0050921 | 0.0026 | 7.5032 | 0.5748 | 4 | 104 | positive regulation of chemotaxis |
| GO:0030502 | 0.0026 | 30.6867 | 0.0774 | 2 | 14 | negative regulation of bone mineralization |
| GO:0033005 | 0.0026 | 30.6867 | 0.0774 | 2 | 14 | positive regulation of mast cell activation |
| GO:0033033 | 0.0026 | 30.6867 | 0.0774 | 2 | 14 | negative regulation of myeloid cell apoptotic process |
| GO:0070234 | 0.0026 | 30.6867 | 0.0774 | 2 | 14 | positive regulation of T cell apoptotic process |
| GO:0002702 | 0.0027 | 11.7639 | 0.2786 | 3 | 51 | positive regulation of production of molecular mediator of immune response |
| GO:0050870 | 0.0027 | 7.4114 | 0.582 | 4 | 110 | positive regulation of T cell activation |
| GO:0009617 | 0.0028 | 3.6174 | 2.4043 | 8 | 435 | response to bacterium |
| GO:0050817 | 0.0028 | 3.3118 | 2.968 | 9 | 537 | coagulation |
| GO:0007599 | 0.0028 | 3.3053 | 2.9735 | 9 | 538 | hemostasis |
| GO:0006887 | 0.003 | 4.5487 | 1.4243 | 6 | 269 | exocytosis |
| GO:0009607 | 0.0031 | 27.7867 | 0.0834 | 2 | 17 | response to biotic stimulus |
| GO:0071346 | 0.0031 | 7.1436 | 0.6024 | 4 | 109 | cellular response to interferon-gamma |
| GO:0050672 | 0.0031 | 11.1541 | 0.2929 | 3 | 53 | negative regulation of lymphocyte proliferation |
| GO:0002764 | 0.0033 | 3.5157 | 2.4706 | 8 | 447 | immune response-regulating signaling pathway |
| GO:0033003 | 0.0033 | 26.9277 | 0.0864 | 2 | 16 | regulation of mast cell activation |
| GO:0019722 | 0.0033 | 7.0091 | 0.6135 | 4 | 111 | calcium-mediated signaling |
| GO:0002703 | 0.0034 | 26.2736 | 0.088 | 2 | 17 | regulation of leukocyte mediated immunity |
| GO:0033630 | 0.0034 | 26.2995 | 0.0884 | 2 | 16 | positive regulation of cell adhesion mediated by integrin |
| GO:0014068 | 0.0035 | 10.7237 | 0.304 | 3 | 55 | positive regulation of phosphatidylinositol 3-kinase signaling |
| GO:0050764 | 0.0035 | 10.7237 | 0.304 | 3 | 55 | regulation of phagocytosis |
| GO:0050671 | 0.0035 | 6.8796 | 0.6246 | 4 | 113 | positive regulation of lymphocyte proliferation |
| GO:0070664 | 0.0037 | 10.5207 | 0.3095 | 3 | 56 | negative regulation of leukocyte proliferation |
| GO:0002443 | 0.0037 | 6.8163 | 0.6311 | 4 | 125 | leukocyte mediated immunity |
| GO:0006925 | 0.0039 | 24.5446 | 0.094 | 2 | 17 | inflammatory cell apoptotic process |
| GO:0070665 | 0.0041 | 6.5757 | 0.6522 | 4 | 118 | positive regulation of leukocyte proliferation |
| GO:0007166 | 0.0042 | 1.9664 | 16.4765 | 27 | 3111 | cell surface receptor signaling pathway |
| GO:0046634 | 0.0042 | 9.9551 | 0.3261 | 3 | 59 | regulation of alpha-beta T cell activation |
| GO:0043270 | 0.0043 | 5.0219 | 1.0667 | 5 | 193 | positive regulation of ion transport |
| GO:0042981 | 0.0046 | 2.3441 | 7.163 | 15 | 1296 | regulation of apoptotic process |
| GO:0050778 | 0.0046 | 9.6176 | 0.3369 | 3 | 68 | positive regulation of immune response |
| GO:0030593 | 0.0047 | 9.6106 | 0.3371 | 3 | 61 | neutrophil chemotaxis |
| GO:0071222 | 0.0049 | 6.2444 | 0.6854 | 4 | 124 | cellular response to lipopolysaccharide |
| GO:0006909 | 0.005 | 9.3476 | 0.346 | 3 | 66 | phagocytosis |
| GO:0051179 | 0.0052 | 1.7994 | 28.1712 | 40 | 5097 | localization |
| GO:0042129 | 0.0052 | 6.1413 | 0.6964 | 4 | 126 | regulation of T cell proliferation |
| GO:0071887 | 0.0055 | 9.0512 | 0.3568 | 3 | 66 | leukocyte apoptotic process |
| GO:0001805 | 0.0055 | Inf | 0.0055 | 1 | 1 | positive regulation of type III hypersensitivity |
| GO:0003335 | 0.0055 | Inf | 0.0055 | 1 | 1 | corneocyte development |
| GO:0010920 | 0.0055 | Inf | 0.0055 | 1 | 1 | negative regulation of inositol phosphate biosynthetic process |
| GO:0010925 | 0.0055 | Inf | 0.0055 | 1 | 1 | positive regulation of inositol-polyphosphate 5-phosphatase activity |
| GO:0030845 | 0.0055 | Inf | 0.0055 | 1 | 1 | phospholipase C-inhibiting G-protein coupled receptor signaling pathway |
| GO:0032078 | 0.0055 | Inf | 0.0055 | 1 | 1 | negative regulation of endodeoxyribonuclease activity |
| GO:0033367 | 0.0055 | Inf | 0.0055 | 1 | 1 | protein localization to mast cell secretory granule |
| GO:0033371 | 0.0055 | Inf | 0.0055 | 1 | 1 | T cell secretory granule organization |
| GO:0033373 | 0.0055 | Inf | 0.0055 | 1 | 1 | maintenance of protease location in mast cell secretory granule |
| GO:0033375 | 0.0055 | Inf | 0.0055 | 1 | 1 | protease localization to T cell secretory granule |
| GO:0033377 | 0.0055 | Inf | 0.0055 | 1 | 1 | maintenance of protein location in T cell secretory granule |
| GO:0033382 | 0.0055 | Inf | 0.0055 | 1 | 1 | maintenance of granzyme B location in T cell secretory granule |
| GO:0035782 | 0.0055 | Inf | 0.0055 | 1 | 1 | mature natural killer cell chemotaxis |
| GO:0043128 | 0.0055 | Inf | 0.0055 | 1 | 1 | positive regulation of 1-phosphatidylinositol 4-kinase activity |
| GO:0051134 | 0.0055 | Inf | 0.0055 | 1 | 1 | negative regulation of NK T cell activation |
| GO:0060101 | 0.0055 | Inf | 0.0055 | 1 | 1 | negative regulation of phagocytosis, engulfment |
| GO:0060305 | 0.0055 | Inf | 0.0055 | 1 | 1 | regulation of cell diameter |
| GO:0071663 | 0.0055 | Inf | 0.0055 | 1 | 1 | positive regulation of granzyme B production |
| GO:1902396 | 0.0055 | Inf | 0.0055 | 1 | 1 | protein localization to tight junction |
| GO:1902569 | 0.0055 | Inf | 0.0055 | 1 | 1 | negative regulation of activation of JAK2 kinase activity |
| GO:2000513 | 0.0055 | Inf | 0.0055 | 1 | 1 | positive regulation of granzyme A production |
| GO:2000518 | 0.0055 | Inf | 0.0055 | 1 | 1 | negative regulation of T-helper 1 cell activation |
| GO:2000556 | 0.0055 | Inf | 0.0055 | 1 | 1 | positive regulation of T-helper 1 cell cytokine production |
| GO:2000558 | 0.0055 | Inf | 0.0055 | 1 | 1 | positive regulation of immunoglobulin production in mucosal tissue |
| GO:0052472 | 0.0059 | 19.3722 | 0.1161 | 2 | 21 | modulation by host of symbiont transcription |
| GO:1903307 | 0.0059 | 19.3722 | 0.1161 | 2 | 21 | positive regulation of regulated secretory pathway |
| GO:0038096 | 0.0066 | 8.4412 | 0.3814 | 3 | 69 | Fc-gamma receptor signaling pathway involved in phagocytosis |
| GO:0032845 | 0.0066 | 5.716 | 0.7461 | 4 | 135 | negative regulation of homeostatic process |
| GO:0002706 | 0.0067 | 8.3829 | 0.3839 | 3 | 71 | regulation of lymphocyte mediated immunity |
| GO:0018108 | 0.007 | 3.7831 | 1.6968 | 6 | 307 | peptidyl-tyrosine phosphorylation |
| GO:0002821 | 0.0071 | 8.1919 | 0.3924 | 3 | 71 | positive regulation of adaptive immune response |
| GO:0051241 | 0.0072 | 2.5482 | 4.7201 | 11 | 854 | negative regulation of multicellular organismal process |
| GO:0043407 | 0.0074 | 8.0726 | 0.3979 | 3 | 72 | negative regulation of MAP kinase activity |
| GO:0016337 | 0.0077 | 3.727 | 1.7325 | 6 | 353 | single organismal cell-cell adhesion |
| GO:0050856 | 0.0077 | 16.7273 | 0.1326 | 2 | 24 | regulation of T cell receptor signaling pathway |
| GO:0010941 | 0.0078 | 2.2008 | 7.5831 | 15 | 1372 | regulation of cell death |
| GO:0031532 | 0.008 | 7.8442 | 0.409 | 3 | 74 | actin cytoskeleton reorganization |
| GO:0065007 | 0.0081 | 1.8958 | 56.3756 | 67 | 10200 | biological regulation |
| GO:0031347 | 0.0083 | 2.9755 | 2.8962 | 8 | 524 | regulation of defense response |
| GO:0030819 | 0.0086 | 7.6283 | 0.4201 | 3 | 76 | positive regulation of cAMP biosynthetic process |
| GO:0071216 | 0.0089 | 5.2322 | 0.8125 | 4 | 147 | cellular response to biotic stimulus |
| GO:0070229 | 0.009 | 15.3313 | 0.1437 | 2 | 26 | negative regulation of lymphocyte apoptotic process |
| GO:0051049 | 0.009 | 2.109 | 8.4619 | 16 | 1531 | regulation of transport |
| GO:0050852 | 0.0093 | 7.4002 | 0.4324 | 3 | 80 | T cell receptor signaling pathway |
| GO:0051272 | 0.0093 | 3.554 | 1.8018 | 6 | 326 | positive regulation of cellular component movement |
| GO:0042110 | 0.0094 | 5.165 | 0.8253 | 4 | 169 | T cell activation |
| GO:0051336 | 0.0095 | 2.2697 | 6.3008 | 13 | 1140 | regulation of hydrolase activity |
| GO:1903530 | 0.0097 | 2.8942 | 2.9735 | 8 | 538 | regulation of secretion by cell |
| GO:0002707 | 0.0097 | 14.7171 | 0.1492 | 2 | 27 | negative regulation of lymphocyte mediated immunity |
| GO:0002823 | 0.0097 | 14.7171 | 0.1492 | 2 | 27 | negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0050832 | 0.0097 | 14.7171 | 0.1492 | 2 | 27 | defense response to fungus |
| GO:0098751 | 0.0097 | 14.7171 | 0.1492 | 2 | 27 | bone cell development |
| GO:2000108 | 0.0097 | 14.7171 | 0.1492 | 2 | 27 | positive regulation of leukocyte apoptotic process |
| GO:0030193 | 0.0099 | 7.2301 | 0.4422 | 3 | 80 | regulation of blood coagulation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0097659 | 0 | 6.7834 | 40.5241 | 121 | 3315 | nucleic acid-templated transcription |
| GO:0034654 | 0 | 6.2623 | 46.2085 | 125 | 3780 | nucleobase-containing compound biosynthetic process |
| GO:0007389 | 0 | 19.747 | 2.402 | 33 | 225 | pattern specification process |
| GO:1902680 | 0 | 6.9318 | 14.8649 | 68 | 1216 | positive regulation of RNA biosynthetic process |
| GO:0016070 | 0 | 5.1766 | 49.5091 | 121 | 4050 | RNA metabolic process |
| GO:0045944 | 0 | 7.8534 | 10.9409 | 59 | 895 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0010467 | 0 | 4.9289 | 54.8267 | 125 | 4485 | gene expression |
| GO:0034645 | 0 | 4.9067 | 53.1886 | 123 | 4351 | cellular macromolecule biosynthetic process |
| GO:0045935 | 0 | 5.8667 | 17.9088 | 70 | 1465 | positive regulation of nucleobase-containing compound metabolic process |
| GO:0060322 | 0 | 8.4998 | 7.787 | 48 | 637 | head development |
| GO:0009891 | 0 | 5.7904 | 18.4834 | 71 | 1512 | positive regulation of biosynthetic process |
| GO:0006725 | 0 | 4.2049 | 64.0684 | 128 | 5241 | cellular aromatic compound metabolic process |
| GO:0046483 | 0 | 4.1207 | 63.885 | 127 | 5226 | heterocycle metabolic process |
| GO:0009792 | 0 | 7.5862 | 7.298 | 42 | 597 | embryo development ending in birth or egg hatching |
| GO:0007417 | 0 | 7.2773 | 7.942 | 43 | 710 | central nervous system development |
| GO:1901360 | 0 | 3.9572 | 66.6111 | 128 | 5449 | organic cyclic compound metabolic process |
| GO:0034641 | 0 | 3.9484 | 67.7602 | 129 | 5543 | cellular nitrogen compound metabolic process |
| GO:1901576 | 0 | 3.8731 | 66.4766 | 127 | 5438 | organic substance biosynthetic process |
| GO:1902679 | 0 | 5.3531 | 12.3834 | 50 | 1013 | negative regulation of RNA biosynthetic process |
| GO:0045934 | 0 | 5.0291 | 14.0948 | 53 | 1153 | negative regulation of nucleobase-containing compound metabolic process |
| GO:0000122 | 0 | 6.516 | 7.8848 | 40 | 645 | negative regulation of transcription from RNA polymerase II promoter |
| GO:0009890 | 0 | 4.7849 | 15.085 | 54 | 1234 | negative regulation of biosynthetic process |
| GO:0048562 | 0 | 14.3261 | 1.9712 | 22 | 174 | embryonic organ morphogenesis |
| GO:0010604 | 0 | 3.8645 | 28.6664 | 76 | 2345 | positive regulation of macromolecule metabolic process |
| GO:0021510 | 0 | 20.0368 | 1.1247 | 17 | 92 | spinal cord development |
| GO:0009952 | 0 | 16.4564 | 1.4021 | 18 | 124 | anterior/posterior pattern specification |
| GO:2000026 | 0 | 4.5557 | 13.7686 | 48 | 1182 | regulation of multicellular organismal development |
| GO:0022008 | 0 | 5.613 | 8.501 | 37 | 815 | neurogenesis |
| GO:0044707 | 0 | 4.895 | 28.4372 | 64 | 3983 | single-multicellular organism process |
| GO:2001141 | 0 | 5.1706 | 11.3038 | 40 | 1434 | regulation of RNA biosynthetic process |
| GO:0051962 | 0 | 7.5872 | 3.9852 | 25 | 326 | positive regulation of nervous system development |
| GO:0006355 | 0 | 5.1152 | 11.4094 | 40 | 1454 | regulation of transcription, DNA-templated |
| GO:0009889 | 0 | 4.9559 | 12.019 | 40 | 1562 | regulation of biosynthetic process |
| GO:0090596 | 0 | 15.231 | 1.2313 | 15 | 106 | sensory organ morphogenesis |
| GO:0019219 | 0 | 4.8721 | 11.6649 | 39 | 1499 | regulation of nucleobase-containing compound metabolic process |
| GO:0048731 | 0 | 7.766 | 4.1947 | 23 | 705 | system development |
| GO:0010720 | 0 | 6.3172 | 4.5009 | 24 | 372 | positive regulation of cell development |
| GO:0001764 | 0 | 13.5655 | 1.2651 | 14 | 105 | neuron migration |
| GO:0048522 | 0 | 2.9912 | 35.5581 | 73 | 3270 | positive regulation of cellular process |
| GO:0035107 | 0 | 10.5319 | 1.8214 | 16 | 149 | appendage morphogenesis |
| GO:0016339 | 0 | 36.3208 | 0.3667 | 9 | 30 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
| GO:0048665 | 0 | 88.2326 | 0.1631 | 7 | 14 | neuron fate specification |
| GO:0060173 | 0 | 9.8307 | 1.9361 | 16 | 160 | limb development |
| GO:0065007 | 0 | 3.348 | 124.6895 | 163 | 10200 | biological regulation |
| GO:0048704 | 0 | 13.6876 | 1.1613 | 13 | 95 | embryonic skeletal system morphogenesis |
| GO:0060255 | 0 | 4.2365 | 13.4952 | 39 | 1667 | regulation of macromolecule metabolic process |
| GO:0060581 | 0 | 73.3985 | 0.1834 | 7 | 15 | cell fate commitment involved in pattern specification |
| GO:0043583 | 0 | 8.1531 | 2.4449 | 17 | 200 | ear development |
| GO:0021514 | 0 | 58.711 | 0.2078 | 7 | 17 | ventral spinal cord interneuron differentiation |
| GO:0044767 | 0 | 7.2061 | 4.0888 | 20 | 812 | single-organism developmental process |
| GO:0030900 | 0 | 13.0245 | 1.1085 | 12 | 100 | forebrain development |
| GO:0007156 | 0 | 9.8566 | 1.6748 | 14 | 137 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0098609 | 0 | 8.0753 | 2.3104 | 16 | 189 | cell-cell adhesion |
| GO:0006928 | 0 | 3.0134 | 20.0481 | 49 | 1640 | movement of cell or subcellular component |
| GO:0045666 | 0 | 7.0242 | 2.7994 | 17 | 229 | positive regulation of neuron differentiation |
| GO:0051674 | 0 | 3.3301 | 14.0092 | 39 | 1146 | localization of cell |
| GO:0040011 | 0 | 3.0101 | 18.6056 | 46 | 1522 | locomotion |
| GO:0030182 | 0 | 4.2935 | 7.4997 | 27 | 754 | neuron differentiation |
| GO:0010605 | 0 | 2.7864 | 23.581 | 53 | 1929 | negative regulation of macromolecule metabolic process |
| GO:0000904 | 0 | 3.7286 | 9.7184 | 31 | 795 | cell morphogenesis involved in differentiation |
| GO:0007517 | 0 | 6.8421 | 2.6889 | 16 | 227 | muscle organ development |
| GO:0060537 | 0 | 6.7937 | 2.706 | 16 | 226 | muscle tissue development |
| GO:0021513 | 0 | 32.6001 | 0.3056 | 7 | 25 | spinal cord dorsal/ventral patterning |
| GO:0021913 | 0 | Inf | 0.0489 | 4 | 4 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
| GO:0009887 | 0 | 6.1238 | 3.2197 | 17 | 339 | organ morphogenesis |
| GO:0051241 | 0 | 3.623 | 9.647 | 30 | 813 | negative regulation of multicellular organismal process |
| GO:0021983 | 0 | 20.4148 | 0.5012 | 8 | 41 | pituitary gland development |
| GO:0009954 | 0 | 28.5669 | 0.3351 | 7 | 28 | proximal/distal pattern formation |
| GO:2000543 | 0 | 103.7363 | 0.11 | 5 | 9 | positive regulation of gastrulation |
| GO:0008284 | 0 | 3.6235 | 9.2539 | 29 | 757 | positive regulation of cell proliferation |
| GO:0048565 | 0 | 8.9383 | 1.5525 | 12 | 127 | digestive tract development |
| GO:0007416 | 0 | 11.9639 | 0.9902 | 10 | 81 | synapse assembly |
| GO:0021915 | 0 | 7.8727 | 1.8948 | 13 | 155 | neural tube development |
| GO:0048663 | 0 | 23.0854 | 0.3901 | 7 | 35 | neuron fate commitment |
| GO:0009888 | 0 | 3.8114 | 8.0782 | 26 | 841 | tissue development |
| GO:0072089 | 0 | 8.2178 | 1.6748 | 12 | 137 | stem cell proliferation |
| GO:0060562 | 0 | 8.1855 | 1.68 | 12 | 146 | epithelial tube morphogenesis |
| GO:0035115 | 0 | 21.7205 | 0.4156 | 7 | 34 | embryonic forelimb morphogenesis |
| GO:0001656 | 0 | 10.3515 | 1.1247 | 10 | 92 | metanephros development |
| GO:0045665 | 0 | 7.8383 | 1.7481 | 12 | 143 | negative regulation of neuron differentiation |
| GO:0023019 | 0 | 31.2672 | 0.2689 | 6 | 22 | signal transduction involved in regulation of gene expression |
| GO:0001655 | 0 | 5.1444 | 3.7285 | 17 | 305 | urogenital system development |
| GO:0021797 | 0 | 165.0978 | 0.0733 | 4 | 6 | forebrain anterior/posterior pattern specification |
| GO:0042472 | 0 | 9.5329 | 1.2102 | 10 | 99 | inner ear morphogenesis |
| GO:0021543 | 0 | 8.2192 | 1.5281 | 11 | 125 | pallium development |
| GO:0021796 | 0 | 110.058 | 0.0856 | 4 | 7 | cerebral cortex regionalization |
| GO:0009798 | 0 | 9.8691 | 1.0513 | 9 | 86 | axis specification |
| GO:0007268 | 0 | 3.3502 | 8.4349 | 25 | 690 | synaptic transmission |
| GO:0048592 | 0 | 7.1445 | 1.7359 | 11 | 142 | eye morphogenesis |
| GO:0048664 | 0 | 82.538 | 0.0978 | 4 | 8 | neuron fate determination |
| GO:0001763 | 0 | 5.7128 | 2.5427 | 13 | 208 | morphogenesis of a branching structure |
| GO:0021912 | 0 | Inf | 0.0367 | 3 | 3 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification |
| GO:0061326 | 0 | 9.0425 | 1.1369 | 9 | 93 | renal tubule development |
| GO:0048869 | 0 | 3.1461 | 11.015 | 28 | 1386 | cellular developmental process |
| GO:0072048 | 0 | 66.0261 | 0.11 | 4 | 9 | renal system pattern specification |
| GO:0003231 | 0 | 8.729 | 1.1735 | 9 | 96 | cardiac ventricle development |
| GO:0061448 | 0 | 5.3511 | 2.7016 | 13 | 221 | connective tissue development |
| GO:0072028 | 0 | 10.0325 | 0.9168 | 8 | 75 | nephron morphogenesis |
| GO:0032989 | 0 | 2.6263 | 14.816 | 34 | 1212 | cellular component morphogenesis |
| GO:0021879 | 0 | 26.449 | 0.2517 | 5 | 21 | forebrain neuron differentiation |
| GO:0042474 | 0 | 24.3877 | 0.2689 | 5 | 22 | middle ear morphogenesis |
| GO:0034287 | 0 | 246.3243 | 0.0489 | 3 | 4 | detection of monosaccharide stimulus |
| GO:0051594 | 0 | 246.3243 | 0.0489 | 3 | 4 | detection of glucose |
| GO:0072086 | 0 | 246.3243 | 0.0489 | 3 | 4 | specification of loop of Henle identity |
| GO:0045595 | 0 | 3.4797 | 6.4873 | 20 | 630 | regulation of cell differentiation |
| GO:0021549 | 0 | 8.9576 | 1.0146 | 8 | 83 | cerebellum development |
| GO:0042733 | 0 | 10.8409 | 0.7457 | 7 | 61 | embryonic digit morphogenesis |
| GO:0050767 | 0 | 4.7254 | 3.0416 | 13 | 274 | regulation of neurogenesis |
| GO:0060415 | 0 | 10.0906 | 0.7946 | 7 | 65 | muscle tissue morphogenesis |
| GO:0048935 | 0 | 36.6715 | 0.1589 | 4 | 13 | peripheral nervous system neuron development |
| GO:0031175 | 0 | 2.8568 | 9.7673 | 25 | 799 | neuron projection development |
| GO:0007368 | 0 | 7.9931 | 1.1247 | 8 | 92 | determination of left/right symmetry |
| GO:0003278 | 0 | 123.1541 | 0.0611 | 3 | 5 | apoptotic process involved in heart morphogenesis |
| GO:0021779 | 0 | 123.1541 | 0.0611 | 3 | 5 | oligodendrocyte cell fate commitment |
| GO:0021780 | 0 | 123.1541 | 0.0611 | 3 | 5 | glial cell fate specification |
| GO:0021871 | 0 | 33.9106 | 0.1667 | 4 | 14 | forebrain regionalization |
| GO:0003279 | 0 | 9.5924 | 0.8313 | 7 | 68 | cardiac septum development |
| GO:0021846 | 0 | 17.2666 | 0.3545 | 5 | 29 | cell proliferation in forebrain |
| GO:0022414 | 0 | 2.521 | 13.3736 | 30 | 1094 | reproductive process |
| GO:0021527 | 0 | 30 | 0.1834 | 4 | 15 | spinal cord association neuron differentiation |
| GO:0061458 | 0 | 3.6553 | 4.8042 | 16 | 393 | reproductive system development |
| GO:0072132 | 0 | 16.5749 | 0.3667 | 5 | 30 | mesenchyme morphogenesis |
| GO:0060022 | 0 | 82.0973 | 0.0733 | 3 | 6 | hard palate development |
| GO:0007379 | 0 | 27.4982 | 0.1956 | 4 | 16 | segment specification |
| GO:0009799 | 0 | 7.1381 | 1.2469 | 8 | 102 | specification of symmetry |
| GO:0035050 | 0 | 8.601 | 0.9168 | 7 | 75 | embryonic heart tube development |
| GO:0048598 | 0 | 4.8901 | 2.4753 | 11 | 252 | embryonic morphogenesis |
| GO:0035148 | 0 | 6.0601 | 1.6381 | 9 | 134 | tube formation |
| GO:0007548 | 0 | 4.4547 | 2.9461 | 12 | 241 | sex differentiation |
| GO:0003206 | 0 | 8.3609 | 0.94 | 7 | 78 | cardiac chamber morphogenesis |
| GO:0009953 | 0 | 10.4519 | 0.6544 | 6 | 57 | dorsal/ventral pattern formation |
| GO:0044238 | 0 | 1.8793 | 110.937 | 137 | 9075 | primary metabolic process |
| GO:0021761 | 1e-04 | 10.1966 | 0.6709 | 6 | 56 | limbic system development |
| GO:0030878 | 1e-04 | 23.5668 | 0.22 | 4 | 18 | thyroid gland development |
| GO:0003357 | 1e-04 | 61.5689 | 0.0856 | 3 | 7 | noradrenergic neuron differentiation |
| GO:0021798 | 1e-04 | 61.5689 | 0.0856 | 3 | 7 | forebrain dorsal/ventral pattern formation |
| GO:0021902 | 1e-04 | 61.5689 | 0.0856 | 3 | 7 | commitment of neuronal cell to specific neuron type in forebrain |
| GO:0072079 | 1e-04 | 21.9942 | 0.2323 | 4 | 19 | nephron tubule formation |
| GO:0007218 | 1e-04 | 7.5912 | 1.0269 | 7 | 84 | neuropeptide signaling pathway |
| GO:0022603 | 1e-04 | 2.7125 | 8.9283 | 22 | 741 | regulation of anatomical structure morphogenesis |
| GO:0021854 | 1e-04 | 20.6182 | 0.2445 | 4 | 20 | hypothalamus development |
| GO:0031290 | 1e-04 | 20.6182 | 0.2445 | 4 | 20 | retinal ganglion cell axon guidance |
| GO:0048557 | 1e-04 | 20.6182 | 0.2445 | 4 | 20 | embryonic digestive tract morphogenesis |
| GO:0072009 | 1e-04 | 7.3282 | 1.0599 | 7 | 88 | nephron epithelium development |
| GO:0048793 | 1e-04 | 49.2519 | 0.0978 | 3 | 8 | pronephros development |
| GO:0007224 | 1e-04 | 6.0933 | 1.4425 | 8 | 118 | smoothened signaling pathway |
| GO:0035914 | 1e-04 | 8.753 | 0.7701 | 6 | 63 | skeletal muscle cell differentiation |
| GO:0021545 | 1e-04 | 11.8314 | 0.489 | 5 | 40 | cranial nerve development |
| GO:0002791 | 1e-04 | 4.6589 | 2.3349 | 10 | 191 | regulation of peptide secretion |
| GO:0051094 | 1e-04 | 2.9519 | 6.7092 | 18 | 631 | positive regulation of developmental process |
| GO:0003309 | 1e-04 | 18.3249 | 0.2689 | 4 | 22 | type B pancreatic cell differentiation |
| GO:0023061 | 1e-04 | 3.2993 | 4.9387 | 15 | 404 | signal release |
| GO:0021546 | 1e-04 | 41.0405 | 0.11 | 3 | 9 | rhombomere development |
| GO:0048241 | 1e-04 | 41.0405 | 0.11 | 3 | 9 | epinephrine transport |
| GO:0003326 | 1e-04 | Inf | 0.0244 | 2 | 2 | pancreatic A cell fate commitment |
| GO:0003329 | 1e-04 | Inf | 0.0244 | 2 | 2 | pancreatic PP cell fate commitment |
| GO:0007198 | 1e-04 | Inf | 0.0244 | 2 | 2 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
| GO:0043503 | 1e-04 | Inf | 0.0244 | 2 | 2 | skeletal muscle fiber adaptation |
| GO:0070473 | 1e-04 | Inf | 0.0244 | 2 | 2 | negative regulation of uterine smooth muscle contraction |
| GO:0072272 | 1e-04 | Inf | 0.0244 | 2 | 2 | proximal/distal pattern formation involved in metanephric nephron development |
| GO:0050768 | 2e-04 | 10.9795 | 0.5198 | 5 | 45 | negative regulation of neurogenesis |
| GO:0030855 | 2e-04 | 4.8808 | 2.0052 | 9 | 178 | epithelial cell differentiation |
| GO:0048754 | 2e-04 | 5.5125 | 1.5827 | 8 | 132 | branching morphogenesis of an epithelial tube |
| GO:0021520 | 2e-04 | 35.7551 | 0.1203 | 3 | 10 | spinal cord motor neuron cell fate specification |
| GO:0032525 | 2e-04 | 35.1753 | 0.1222 | 3 | 10 | somite rostral/caudal axis specification |
| GO:0090009 | 2e-04 | 35.1753 | 0.1222 | 3 | 10 | primitive streak formation |
| GO:0045995 | 2e-04 | 6.2113 | 1.2347 | 7 | 101 | regulation of embryonic development |
| GO:0007519 | 3e-04 | 7.4202 | 0.8934 | 6 | 76 | skeletal muscle tissue development |
| GO:0048858 | 3e-04 | 2.4821 | 9.6818 | 22 | 792 | cell projection morphogenesis |
| GO:0048596 | 3e-04 | 14.3365 | 0.3301 | 4 | 27 | embryonic camera-type eye morphogenesis |
| GO:0060021 | 3e-04 | 7.2378 | 0.9148 | 6 | 76 | palate development |
| GO:0003013 | 3e-04 | 3.1702 | 4.7675 | 14 | 390 | circulatory system process |
| GO:0048513 | 3e-04 | 2.5954 | 9.3622 | 21 | 1288 | organ development |
| GO:0060412 | 4e-04 | 13.1878 | 0.3545 | 4 | 29 | ventricular septum morphogenesis |
| GO:0072047 | 4e-04 | 165.1087 | 0.0363 | 2 | 3 | proximal/distal pattern formation involved in nephron development |
| GO:0021903 | 4e-04 | 165.0326 | 0.0363 | 2 | 3 | rostrocaudal neural tube patterning |
| GO:0001705 | 4e-04 | 163.3333 | 0.0367 | 2 | 3 | ectoderm formation |
| GO:0002074 | 4e-04 | 163.3333 | 0.0367 | 2 | 3 | extraocular skeletal muscle development |
| GO:0003253 | 4e-04 | 163.3333 | 0.0367 | 2 | 3 | cardiac neural crest cell migration involved in outflow tract morphogenesis |
| GO:0003350 | 4e-04 | 163.3333 | 0.0367 | 2 | 3 | pulmonary myocardium development |
| GO:0021530 | 4e-04 | 163.3333 | 0.0367 | 2 | 3 | spinal cord oligodendrocyte cell fate specification |
| GO:0033693 | 4e-04 | 163.3333 | 0.0367 | 2 | 3 | neurofilament bundle assembly |
| GO:0036023 | 4e-04 | 163.3333 | 0.0367 | 2 | 3 | embryonic skeletal limb joint morphogenesis |
| GO:0055014 | 4e-04 | 163.3333 | 0.0367 | 2 | 3 | atrial cardiac muscle cell development |
| GO:0061074 | 4e-04 | 163.3333 | 0.0367 | 2 | 3 | regulation of neural retina development |
| GO:0070253 | 4e-04 | 163.3333 | 0.0367 | 2 | 3 | somatostatin secretion |
| GO:0071883 | 4e-04 | 163.3333 | 0.0367 | 2 | 3 | activation of MAPK activity by adrenergic receptor signaling pathway |
| GO:0021533 | 5e-04 | 24.8721 | 0.1573 | 3 | 13 | cell differentiation in hindbrain |
| GO:0035116 | 5e-04 | 12.6798 | 0.3667 | 4 | 30 | embryonic hindlimb morphogenesis |
| GO:0055015 | 5e-04 | 24.6178 | 0.1589 | 3 | 13 | ventricular cardiac muscle cell development |
| GO:0007498 | 5e-04 | 5.5038 | 1.3814 | 7 | 113 | mesoderm development |
| GO:0042476 | 5e-04 | 5.5038 | 1.3814 | 7 | 113 | odontogenesis |
| GO:0001755 | 5e-04 | 12.3427 | 0.375 | 4 | 31 | neural crest cell migration |
| GO:0006935 | 5e-04 | 2.5354 | 8.117 | 19 | 664 | chemotaxis |
| GO:0001756 | 5e-04 | 8.4078 | 0.662 | 5 | 55 | somitogenesis |
| GO:0044708 | 5e-04 | 3.1592 | 4.4253 | 13 | 362 | single-organism behavior |
| GO:1902742 | 5e-04 | 12.2093 | 0.379 | 4 | 31 | apoptotic process involved in development |
| GO:0014031 | 5e-04 | 6.4517 | 1.016 | 6 | 87 | mesenchymal cell development |
| GO:0014032 | 5e-04 | 23.0813 | 0.1661 | 3 | 14 | neural crest cell development |
| GO:0001947 | 5e-04 | 8.2738 | 0.6723 | 5 | 55 | heart looping |
| GO:0001501 | 6e-04 | 3.3214 | 3.8906 | 12 | 345 | skeletal system development |
| GO:0048645 | 6e-04 | 22.8172 | 0.1679 | 3 | 14 | organ formation |
| GO:0003148 | 6e-04 | 22.3784 | 0.1711 | 3 | 14 | outflow tract septum morphogenesis |
| GO:0071542 | 6e-04 | 22.3784 | 0.1711 | 3 | 14 | dopaminergic neuron differentiation |
| GO:1901741 | 6e-04 | 22.3784 | 0.1711 | 3 | 14 | positive regulation of myoblast fusion |
| GO:0014003 | 6e-04 | 11.7725 | 0.3912 | 4 | 32 | oligodendrocyte development |
| GO:0042596 | 6e-04 | 11.7725 | 0.3912 | 4 | 32 | fear response |
| GO:0040007 | 6e-04 | 2.3197 | 10.3052 | 22 | 843 | growth |
| GO:0072358 | 6e-04 | 2.3197 | 10.3052 | 22 | 843 | cardiovascular system development |
| GO:0050885 | 6e-04 | 7.9545 | 0.6968 | 5 | 57 | neuromuscular process controlling balance |
| GO:0060441 | 7e-04 | 11.3658 | 0.4034 | 4 | 33 | epithelial tube branching involved in lung morphogenesis |
| GO:0090066 | 7e-04 | 3.0691 | 4.5475 | 13 | 372 | regulation of anatomical structure size |
| GO:0031018 | 7e-04 | 11.217 | 0.4074 | 4 | 34 | endocrine pancreas development |
| GO:0019233 | 7e-04 | 6.0744 | 1.0758 | 6 | 88 | sensory perception of pain |
| GO:0021542 | 7e-04 | 20.5122 | 0.1834 | 3 | 15 | dentate gyrus development |
| GO:2000678 | 7e-04 | 20.5122 | 0.1834 | 3 | 15 | negative regulation of transcription regulatory region DNA binding |
| GO:0098801 | 8e-04 | 10.9862 | 0.4156 | 4 | 34 | regulation of renal system process |
| GO:0002062 | 8e-04 | 6.0008 | 1.088 | 6 | 89 | chondrocyte differentiation |
| GO:0060850 | 8e-04 | 19.3515 | 0.1915 | 3 | 16 | regulation of transcription involved in cell fate commitment |
| GO:0050433 | 8e-04 | 10.6311 | 0.4279 | 4 | 35 | regulation of catecholamine secretion |
| GO:0061351 | 9e-04 | 5.8757 | 1.1087 | 6 | 93 | neural precursor cell proliferation |
| GO:0060349 | 9e-04 | 5.8588 | 1.1124 | 6 | 91 | bone morphogenesis |
| GO:0003219 | 9e-04 | 81.6613 | 0.0489 | 2 | 4 | cardiac right ventricle formation |
| GO:0035625 | 9e-04 | 81.6613 | 0.0489 | 2 | 4 | epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway |
| GO:0035811 | 9e-04 | 81.6613 | 0.0489 | 2 | 4 | negative regulation of urine volume |
| GO:0048880 | 9e-04 | 81.6613 | 0.0489 | 2 | 4 | sensory system development |
| GO:0060913 | 9e-04 | 81.6613 | 0.0489 | 2 | 4 | cardiac cell fate determination |
| GO:0061031 | 9e-04 | 81.6613 | 0.0489 | 2 | 4 | endodermal digestive tract morphogenesis |
| GO:0061325 | 9e-04 | 81.6613 | 0.0489 | 2 | 4 | cell proliferation involved in outflow tract morphogenesis |
| GO:0097476 | 9e-04 | 81.6613 | 0.0489 | 2 | 4 | spinal cord motor neuron migration |
| GO:0072498 | 9e-04 | 18.9331 | 0.1956 | 3 | 16 | embryonic skeletal joint development |
| GO:0048536 | 9e-04 | 10.2982 | 0.4401 | 4 | 36 | spleen development |
| GO:0015844 | 0.001 | 7.2543 | 0.7579 | 5 | 62 | monoamine transport |
| GO:0071383 | 0.001 | 4.8167 | 1.5647 | 7 | 128 | cellular response to steroid hormone stimulus |
| GO:0007631 | 0.001 | 5.658 | 1.1491 | 6 | 94 | feeding behavior |
| GO:0002070 | 0.0011 | 17.5795 | 0.2078 | 3 | 17 | epithelial cell maturation |
| GO:0042693 | 0.0011 | 17.5795 | 0.2078 | 3 | 17 | muscle cell fate commitment |
| GO:0060037 | 0.0011 | 17.5795 | 0.2078 | 3 | 17 | pharyngeal system development |
| GO:0050796 | 0.0011 | 4.1753 | 2.0537 | 8 | 168 | regulation of insulin secretion |
| GO:0060041 | 0.0011 | 4.7377 | 1.5892 | 7 | 130 | retina development in camera-type eye |
| GO:0048468 | 0.0011 | 2.7923 | 5.4703 | 14 | 604 | cell development |
| GO:0021537 | 0.0011 | 6.9278 | 0.789 | 5 | 68 | telencephalon development |
| GO:0014015 | 0.0012 | 9.6912 | 0.4645 | 4 | 38 | positive regulation of gliogenesis |
| GO:0050880 | 0.0012 | 6.9013 | 0.7929 | 5 | 66 | regulation of blood vessel size |
| GO:0001707 | 0.0012 | 6.8903 | 0.7946 | 5 | 65 | mesoderm formation |
| GO:0007586 | 0.0012 | 4.6613 | 1.6136 | 7 | 132 | digestion |
| GO:0045893 | 0.0012 | 3.7293 | 2.6007 | 9 | 292 | positive regulation of transcription, DNA-templated |
| GO:0072163 | 0.0012 | 5.4704 | 1.1858 | 6 | 97 | mesonephric epithelium development |
| GO:0015837 | 0.0013 | 6.7769 | 0.8068 | 5 | 66 | amine transport |
| GO:0001829 | 0.0013 | 16.4065 | 0.22 | 3 | 18 | trophectodermal cell differentiation |
| GO:1903522 | 0.0013 | 3.6755 | 2.616 | 9 | 214 | regulation of blood circulation |
| GO:0055010 | 0.0014 | 9.1516 | 0.489 | 4 | 40 | ventricular cardiac muscle tissue morphogenesis |
| GO:0090277 | 0.0014 | 6.5608 | 0.8313 | 5 | 68 | positive regulation of peptide hormone secretion |
| GO:0014062 | 0.0015 | 54.4373 | 0.0611 | 2 | 5 | regulation of serotonin secretion |
| GO:0031133 | 0.0015 | 54.4373 | 0.0611 | 2 | 5 | regulation of axon diameter |
| GO:0035881 | 0.0015 | 54.4373 | 0.0611 | 2 | 5 | amacrine cell differentiation |
| GO:0046878 | 0.0015 | 54.4373 | 0.0611 | 2 | 5 | positive regulation of saliva secretion |
| GO:0060023 | 0.0015 | 54.4373 | 0.0611 | 2 | 5 | soft palate development |
| GO:0072143 | 0.0015 | 54.4373 | 0.0611 | 2 | 5 | mesangial cell development |
| GO:0045165 | 0.0015 | 5.221 | 1.2354 | 6 | 120 | cell fate commitment |
| GO:0001710 | 0.0015 | 15.3801 | 0.2323 | 3 | 19 | mesodermal cell fate commitment |
| GO:0045932 | 0.0015 | 15.3801 | 0.2323 | 3 | 19 | negative regulation of muscle contraction |
| GO:0072087 | 0.0015 | 15.3801 | 0.2323 | 3 | 19 | renal vesicle development |
| GO:0003151 | 0.0015 | 8.9033 | 0.5004 | 4 | 42 | outflow tract morphogenesis |
| GO:0045892 | 0.0016 | 3.3044 | 3.2445 | 10 | 323 | negative regulation of transcription, DNA-templated |
| GO:0055001 | 0.0016 | 4.4121 | 1.6992 | 7 | 139 | muscle cell development |
| GO:0051146 | 0.0017 | 3.5188 | 2.7261 | 9 | 223 | striated muscle cell differentiation |
| GO:0007409 | 0.0017 | 4.3564 | 1.7202 | 7 | 149 | axonogenesis |
| GO:0002052 | 0.0018 | 14.4744 | 0.2445 | 3 | 20 | positive regulation of neuroblast proliferation |
| GO:0048523 | 0.0018 | 1.7772 | 27.1863 | 42 | 2665 | negative regulation of cellular process |
| GO:0009746 | 0.0018 | 4.3132 | 1.7359 | 7 | 142 | response to hexose |
| GO:0010830 | 0.0018 | 8.4459 | 0.5257 | 4 | 43 | regulation of myotube differentiation |
| GO:0009914 | 0.0019 | 3.2173 | 3.31 | 10 | 275 | hormone transport |
| GO:0021522 | 0.0019 | 14.121 | 0.2487 | 3 | 21 | spinal cord motor neuron differentiation |
| GO:0007623 | 0.0019 | 3.8136 | 2.2371 | 8 | 183 | circadian rhythm |
| GO:2000145 | 0.002 | 2.4259 | 7.0535 | 16 | 577 | regulation of cell motility |
| GO:0001708 | 0.002 | 8.2368 | 0.5349 | 4 | 48 | cell fate specification |
| GO:0021697 | 0.002 | 13.6694 | 0.2567 | 3 | 21 | cerebellar cortex formation |
| GO:0071392 | 0.002 | 13.6694 | 0.2567 | 3 | 21 | cellular response to estradiol stimulus |
| GO:0090189 | 0.002 | 13.6694 | 0.2567 | 3 | 21 | regulation of branching involved in ureteric bud morphogenesis |
| GO:0010721 | 0.0021 | 8.1524 | 0.5403 | 4 | 48 | negative regulation of cell development |
| GO:0007601 | 0.0021 | 3.7486 | 2.2737 | 8 | 186 | visual perception |
| GO:0008406 | 0.0021 | 3.7486 | 2.2737 | 8 | 186 | gonad development |
| GO:0097305 | 0.0021 | 3.1643 | 3.3617 | 10 | 275 | response to alcohol |
| GO:0007422 | 0.0021 | 5.988 | 0.9046 | 5 | 74 | peripheral nervous system development |
| GO:0003211 | 0.0021 | 41.2636 | 0.0726 | 2 | 6 | cardiac ventricle formation |
| GO:0002009 | 0.0021 | 4.856 | 1.3239 | 6 | 123 | morphogenesis of an epithelium |
| GO:0021937 | 0.0022 | 40.8253 | 0.0733 | 2 | 6 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation |
| GO:0032811 | 0.0022 | 40.8253 | 0.0733 | 2 | 6 | negative regulation of epinephrine secretion |
| GO:0048743 | 0.0022 | 40.8253 | 0.0733 | 2 | 6 | positive regulation of skeletal muscle fiber development |
| GO:0048852 | 0.0022 | 40.8253 | 0.0733 | 2 | 6 | diencephalon morphogenesis |
| GO:0061308 | 0.0022 | 40.8253 | 0.0733 | 2 | 6 | cardiac neural crest cell development involved in heart development |
| GO:0070092 | 0.0022 | 40.8253 | 0.0733 | 2 | 6 | regulation of glucagon secretion |
| GO:0072141 | 0.0022 | 40.8253 | 0.0733 | 2 | 6 | renal interstitial fibroblast development |
| GO:2000049 | 0.0022 | 40.8253 | 0.0733 | 2 | 6 | positive regulation of cell-cell adhesion mediated by cadherin |
| GO:2000675 | 0.0022 | 40.8253 | 0.0733 | 2 | 6 | negative regulation of type B pancreatic cell apoptotic process |
| GO:0045844 | 0.0022 | 8.0329 | 0.5501 | 4 | 45 | positive regulation of striated muscle tissue development |
| GO:0090303 | 0.0022 | 8.0329 | 0.5501 | 4 | 45 | positive regulation of wound healing |
| GO:0002067 | 0.0022 | 13.1452 | 0.265 | 3 | 22 | glandular epithelial cell differentiation |
| GO:0001568 | 0.0023 | 2.461 | 6.5034 | 15 | 532 | blood vessel development |
| GO:0002089 | 0.0023 | 12.9491 | 0.2689 | 3 | 22 | lens morphogenesis in camera-type eye |
| GO:0010719 | 0.0023 | 12.9491 | 0.2689 | 3 | 22 | negative regulation of epithelial to mesenchymal transition |
| GO:0043586 | 0.0023 | 12.9491 | 0.2689 | 3 | 22 | tongue development |
| GO:0048485 | 0.0023 | 12.9491 | 0.2689 | 3 | 22 | sympathetic nervous system development |
| GO:0050877 | 0.0024 | 1.982 | 13.6523 | 25 | 1128 | neurological system process |
| GO:0043279 | 0.0025 | 4.6916 | 1.3691 | 6 | 112 | response to alkaloid |
| GO:0045778 | 0.0025 | 12.5279 | 0.2762 | 3 | 23 | positive regulation of ossification |
| GO:0002068 | 0.0027 | 12.3008 | 0.2812 | 3 | 23 | glandular epithelial cell development |
| GO:0010656 | 0.0027 | 12.3008 | 0.2812 | 3 | 23 | negative regulation of muscle cell apoptotic process |
| GO:0044062 | 0.0027 | 12.3008 | 0.2812 | 3 | 23 | regulation of excretion |
| GO:0016477 | 0.0027 | 2.1362 | 10.1025 | 20 | 910 | cell migration |
| GO:0031016 | 0.0027 | 12.2002 | 0.282 | 3 | 24 | pancreas development |
| GO:0015833 | 0.0028 | 3.0359 | 3.4962 | 10 | 286 | peptide transport |
| GO:0007492 | 0.0028 | 5.5815 | 0.9657 | 5 | 79 | endoderm development |
| GO:0021521 | 0.0029 | 33.3758 | 0.0838 | 2 | 7 | ventral spinal cord interneuron specification |
| GO:0071495 | 0.0029 | 2.0039 | 12.3589 | 23 | 1011 | cellular response to endogenous stimulus |
| GO:0001942 | 0.003 | 5.5067 | 0.978 | 5 | 80 | hair follicle development |
| GO:0022404 | 0.003 | 5.5067 | 0.978 | 5 | 80 | molting cycle process |
| GO:0010700 | 0.003 | 32.6581 | 0.0856 | 2 | 7 | negative regulation of norepinephrine secretion |
| GO:0061072 | 0.003 | 32.6581 | 0.0856 | 2 | 7 | iris morphogenesis |
| GO:0072161 | 0.003 | 32.6581 | 0.0856 | 2 | 7 | mesenchymal cell differentiation involved in kidney development |
| GO:0045686 | 0.003 | 11.7143 | 0.2934 | 3 | 24 | negative regulation of glial cell differentiation |
| GO:0061311 | 0.003 | 11.7143 | 0.2934 | 3 | 24 | cell surface receptor signaling pathway involved in heart development |
| GO:0072078 | 0.0032 | 7.1532 | 0.6109 | 4 | 51 | nephron tubule morphogenesis |
| GO:0060560 | 0.0033 | 3.852 | 1.9315 | 7 | 158 | developmental growth involved in morphogenesis |
| GO:0003016 | 0.0034 | 11.1811 | 0.3056 | 3 | 25 | respiratory system process |
| GO:0021884 | 0.0034 | 11.1811 | 0.3056 | 3 | 25 | forebrain neuron development |
| GO:0060142 | 0.0034 | 11.1811 | 0.3056 | 3 | 25 | regulation of syncytium formation by plasma membrane fusion |
| GO:2001222 | 0.0034 | 11.1811 | 0.3056 | 3 | 25 | regulation of neuron migration |
| GO:0046903 | 0.0034 | 2.0092 | 11.7599 | 22 | 962 | secretion |
| GO:0006949 | 0.0035 | 7.0046 | 0.6234 | 4 | 51 | syncytium formation |
| GO:0043388 | 0.0037 | 10.8061 | 0.3146 | 3 | 26 | positive regulation of DNA binding |
| GO:0021904 | 0.0038 | 10.6942 | 0.3178 | 3 | 26 | dorsal/ventral neural tube patterning |
| GO:0044058 | 0.0038 | 10.6942 | 0.3178 | 3 | 26 | regulation of digestive system process |
| GO:0035137 | 0.0038 | 27.7637 | 0.0959 | 2 | 8 | hindlimb morphogenesis |
| GO:0051091 | 0.0039 | 3.3654 | 2.5182 | 8 | 206 | positive regulation of sequence-specific DNA binding transcription factor activity |
| GO:0003263 | 0.004 | 27.2133 | 0.0978 | 2 | 8 | cardioblast proliferation |
| GO:0010667 | 0.004 | 27.2133 | 0.0978 | 2 | 8 | negative regulation of cardiac muscle cell apoptotic process |
| GO:0031017 | 0.004 | 27.2133 | 0.0978 | 2 | 8 | exocrine pancreas development |
| GO:0035878 | 0.004 | 27.2133 | 0.0978 | 2 | 8 | nail development |
| GO:0044848 | 0.004 | 27.2133 | 0.0978 | 2 | 8 | biological phase |
| GO:0072177 | 0.004 | 27.2133 | 0.0978 | 2 | 8 | mesonephric duct development |
| GO:0072178 | 0.004 | 27.2133 | 0.0978 | 2 | 8 | nephric duct morphogenesis |
| GO:0009653 | 0.0042 | 3.71 | 2.0262 | 7 | 269 | anatomical structure morphogenesis |
| GO:0048738 | 0.0042 | 3.6797 | 2.017 | 7 | 165 | cardiac muscle tissue development |
| GO:0003197 | 0.0042 | 10.248 | 0.3301 | 3 | 27 | endocardial cushion development |
| GO:0045823 | 0.0042 | 10.248 | 0.3301 | 3 | 27 | positive regulation of heart contraction |
| GO:0045907 | 0.0042 | 10.248 | 0.3301 | 3 | 27 | positive regulation of vasoconstriction |
| GO:2000826 | 0.0042 | 10.248 | 0.3301 | 3 | 27 | regulation of heart morphogenesis |
| GO:0021885 | 0.0042 | 6.583 | 0.6601 | 4 | 54 | forebrain cell migration |
| GO:0030858 | 0.0042 | 6.583 | 0.6601 | 4 | 54 | positive regulation of epithelial cell differentiation |
| GO:0046887 | 0.0044 | 10.0687 | 0.3347 | 3 | 28 | positive regulation of hormone secretion |
| GO:0051384 | 0.0045 | 4.1404 | 1.5403 | 6 | 126 | response to glucocorticoid |
| GO:0009743 | 0.0046 | 3.6104 | 2.0537 | 7 | 168 | response to carbohydrate |
| GO:0003209 | 0.0047 | 9.8374 | 0.3423 | 3 | 28 | cardiac atrium morphogenesis |
| GO:0060487 | 0.0047 | 9.8374 | 0.3423 | 3 | 28 | lung epithelial cell differentiation |
| GO:0048706 | 0.0048 | 9.7416 | 0.3435 | 3 | 30 | embryonic skeletal system development |
| GO:0055006 | 0.0048 | 6.329 | 0.6846 | 4 | 56 | cardiac cell development |
| GO:1902692 | 0.0049 | 23.6799 | 0.1084 | 2 | 9 | regulation of neuroblast proliferation |
| GO:0007565 | 0.0049 | 3.5656 | 2.0782 | 7 | 170 | female pregnancy |
| GO:0008285 | 0.005 | 2.2531 | 7.0673 | 15 | 584 | negative regulation of cell proliferation |
| GO:0050678 | 0.005 | 2.9687 | 3.2028 | 9 | 262 | regulation of epithelial cell proliferation |
| GO:0003266 | 0.0051 | 23.3241 | 0.11 | 2 | 9 | regulation of secondary heart field cardioblast proliferation |
| GO:0021892 | 0.0051 | 23.3241 | 0.11 | 2 | 9 | cerebral cortex GABAergic interneuron differentiation |
| GO:0030917 | 0.0051 | 23.3241 | 0.11 | 2 | 9 | midbrain-hindbrain boundary development |
| GO:0048703 | 0.0051 | 23.3241 | 0.11 | 2 | 9 | embryonic viscerocranium morphogenesis |
| GO:0060253 | 0.0051 | 23.3241 | 0.11 | 2 | 9 | negative regulation of glial cell proliferation |
| GO:2000679 | 0.0051 | 23.3241 | 0.11 | 2 | 9 | positive regulation of transcription regulatory region DNA binding |
| GO:0051147 | 0.0051 | 4.0386 | 1.577 | 6 | 129 | regulation of muscle cell differentiation |
| GO:0001678 | 0.0052 | 4.7989 | 1.1124 | 5 | 91 | cellular glucose homeostasis |
| GO:0014904 | 0.0052 | 9.4584 | 0.3545 | 3 | 29 | myotube cell development |
| GO:0051385 | 0.0052 | 9.4584 | 0.3545 | 3 | 29 | response to mineralocorticoid |
| GO:0042127 | 0.0052 | 4.0164 | 1.5874 | 6 | 154 | regulation of cell proliferation |
| GO:0030902 | 0.0052 | 9.3887 | 0.3552 | 3 | 31 | hindbrain development |
| GO:0002064 | 0.0053 | 3.5133 | 2.1075 | 7 | 175 | epithelial cell development |
| GO:0009991 | 0.0054 | 2.4829 | 5.1098 | 12 | 418 | response to extracellular stimulus |
| GO:0009913 | 0.0054 | 3.5005 | 2.1148 | 7 | 173 | epidermal cell differentiation |
| GO:0045669 | 0.0055 | 6.0938 | 0.709 | 4 | 58 | positive regulation of osteoblast differentiation |
| GO:0007411 | 0.0055 | 2.5945 | 4.4805 | 11 | 374 | axon guidance |
| GO:0048732 | 0.0055 | 2.7395 | 3.8579 | 10 | 334 | gland development |
| GO:0010092 | 0.0057 | 9.1075 | 0.3667 | 3 | 30 | specification of organ identity |
| GO:0060485 | 0.0058 | 8.9916 | 0.3687 | 3 | 33 | mesenchyme development |
| GO:0010001 | 0.0061 | 3.878 | 1.6386 | 6 | 136 | glial cell differentiation |
| GO:0033500 | 0.0061 | 3.4172 | 2.1637 | 7 | 177 | carbohydrate homeostasis |
| GO:1901861 | 0.0062 | 4.5844 | 1.1613 | 5 | 95 | regulation of muscle tissue development |
| GO:0051969 | 0.0063 | 20.4073 | 0.1222 | 2 | 10 | regulation of transmission of nerve impulse |
| GO:0061303 | 0.0063 | 20.4073 | 0.1222 | 2 | 10 | cornea development in camera-type eye |
| GO:0048634 | 0.0065 | 4.5337 | 1.1735 | 5 | 96 | regulation of muscle organ development |
| GO:0048545 | 0.0066 | 3.0648 | 2.7534 | 8 | 232 | response to steroid hormone |
| GO:0009880 | 0.0066 | 5.7719 | 0.7457 | 4 | 61 | embryonic pattern specification |
| GO:0060675 | 0.0066 | 5.7719 | 0.7457 | 4 | 61 | ureteric bud morphogenesis |
| GO:0030324 | 0.0067 | 3.3573 | 2.2004 | 7 | 180 | lung development |
| GO:0007188 | 0.0068 | 3.79 | 1.6748 | 6 | 137 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
| GO:0050794 | 0.0068 | 1.9171 | 23.8461 | 34 | 3584 | regulation of cellular process |
| GO:2001259 | 0.0069 | 8.4783 | 0.3912 | 3 | 32 | positive regulation of cation channel activity |
| GO:0043500 | 0.0069 | 5.672 | 0.7579 | 4 | 62 | muscle adaptation |
| GO:0048857 | 0.0069 | 5.672 | 0.7579 | 4 | 62 | neural nucleus development |
| GO:0001838 | 0.0073 | 4.3878 | 1.2099 | 5 | 101 | embryonic epithelial tube formation |
| GO:0042633 | 0.0073 | 4.3882 | 1.2102 | 5 | 99 | hair cycle |
| GO:2000736 | 0.0073 | 4.3882 | 1.2102 | 5 | 99 | regulation of stem cell differentiation |
| GO:0042311 | 0.0073 | 5.5755 | 0.7701 | 4 | 63 | vasodilation |
| GO:0030818 | 0.0075 | 8.1951 | 0.4034 | 3 | 33 | negative regulation of cAMP biosynthetic process |
| GO:0002087 | 0.0076 | 18.1386 | 0.1345 | 2 | 11 | regulation of respiratory gaseous exchange by neurological system process |
| GO:0010454 | 0.0076 | 18.1386 | 0.1345 | 2 | 11 | negative regulation of cell fate commitment |
| GO:0021702 | 0.0076 | 18.1386 | 0.1345 | 2 | 11 | cerebellar Purkinje cell differentiation |
| GO:0021936 | 0.0076 | 18.1386 | 0.1345 | 2 | 11 | regulation of cerebellar granule cell precursor proliferation |
| GO:0048617 | 0.0076 | 18.1386 | 0.1345 | 2 | 11 | embryonic foregut morphogenesis |
| GO:0061029 | 0.0076 | 18.1386 | 0.1345 | 2 | 11 | eyelid development in camera-type eye |
| GO:0014013 | 0.0077 | 8.0873 | 0.4078 | 3 | 34 | regulation of gliogenesis |
| GO:0048762 | 0.0078 | 17.6117 | 0.1362 | 2 | 12 | mesenchymal cell differentiation |
| GO:0051098 | 0.008 | 2.9562 | 2.8483 | 8 | 233 | regulation of binding |
| GO:0021772 | 0.0081 | 7.9303 | 0.4156 | 3 | 34 | olfactory bulb development |
| GO:0022037 | 0.0084 | 16.973 | 0.1412 | 2 | 12 | metencephalon development |
| GO:0001738 | 0.0088 | 7.6819 | 0.4279 | 3 | 35 | morphogenesis of a polarized epithelium |
| GO:0003156 | 0.0088 | 7.6819 | 0.4279 | 3 | 35 | regulation of organ formation |
| GO:0035850 | 0.0088 | 7.6819 | 0.4279 | 3 | 35 | epithelial cell differentiation involved in kidney development |
| GO:0003215 | 0.0089 | 16.4989 | 0.1452 | 2 | 12 | cardiac right ventricle morphogenesis |
| GO:0030326 | 0.0089 | 7.645 | 0.4284 | 3 | 37 | embryonic limb morphogenesis |
| GO:0045596 | 0.0089 | 2.5435 | 4.1456 | 10 | 378 | negative regulation of cell differentiation |
| GO:0003084 | 0.0091 | 16.3237 | 0.1467 | 2 | 12 | positive regulation of systemic arterial blood pressure |
| GO:0035815 | 0.0091 | 16.3237 | 0.1467 | 2 | 12 | positive regulation of renal sodium excretion |
| GO:0048714 | 0.0091 | 16.3237 | 0.1467 | 2 | 12 | positive regulation of oligodendrocyte differentiation |
| GO:0060525 | 0.0091 | 16.3237 | 0.1467 | 2 | 12 | prostate glandular acinus development |
| GO:0060536 | 0.0091 | 16.3237 | 0.1467 | 2 | 12 | cartilage morphogenesis |
| GO:0001824 | 0.0091 | 5.2202 | 0.819 | 4 | 67 | blastocyst development |
| GO:0051240 | 0.0093 | 2.0469 | 8.33 | 16 | 800 | positive regulation of multicellular organismal process |
| GO:0030809 | 0.0095 | 7.4486 | 0.4401 | 3 | 36 | negative regulation of nucleotide biosynthetic process |
| GO:0031128 | 0.0095 | 7.4486 | 0.4401 | 3 | 36 | developmental induction |
| GO:0060359 | 0.0096 | 5.1382 | 0.8313 | 4 | 68 | response to ammonium ion |
| GO:0030799 | 0.0097 | 3.4938 | 1.8092 | 6 | 148 | regulation of cyclic nucleotide metabolic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0032502 | 0 | 3.1098 | 32.47 | 59 | 5148 | developmental process |
| GO:0048545 | 0 | 6.661 | 2.2706 | 13 | 360 | response to steroid hormone |
| GO:0045944 | 0 | 4.2767 | 5.645 | 20 | 895 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0048699 | 0 | 3.5321 | 7.9409 | 23 | 1259 | generation of neurons |
| GO:0031328 | 0 | 3.2773 | 9.3916 | 25 | 1489 | positive regulation of cellular biosynthetic process |
| GO:0051173 | 0 | 3.2699 | 9.4105 | 25 | 1492 | positive regulation of nitrogen compound metabolic process |
| GO:0007625 | 0 | 46.9063 | 0.1135 | 4 | 18 | grooming behavior |
| GO:2000026 | 0 | 3.2259 | 8.6158 | 23 | 1366 | regulation of multicellular organismal development |
| GO:1903508 | 0 | 3.3452 | 7.4868 | 21 | 1187 | positive regulation of nucleic acid-templated transcription |
| GO:0030814 | 0 | 10.0812 | 0.7821 | 7 | 124 | regulation of cAMP metabolic process |
| GO:0045595 | 0 | 3.095 | 8.4833 | 22 | 1345 | regulation of cell differentiation |
| GO:0050789 | 0 | 2.7434 | 61.3953 | 80 | 9734 | regulation of biological process |
| GO:0051254 | 0 | 3.1484 | 7.9094 | 21 | 1254 | positive regulation of RNA metabolic process |
| GO:0021985 | 0 | Inf | 0.0126 | 2 | 2 | neurohypophysis development |
| GO:0015844 | 0 | 14.5166 | 0.3911 | 5 | 62 | monoamine transport |
| GO:0060322 | 0 | 3.9689 | 4.0178 | 14 | 637 | head development |
| GO:0009889 | 0 | 2.3294 | 24.0624 | 42 | 3815 | regulation of biosynthetic process |
| GO:0010628 | 1e-04 | 2.934 | 8.8996 | 22 | 1411 | positive regulation of gene expression |
| GO:0060429 | 1e-04 | 3.2197 | 6.4839 | 18 | 1028 | epithelium development |
| GO:0045777 | 1e-04 | 21.1599 | 0.2208 | 4 | 35 | positive regulation of blood pressure |
| GO:0048566 | 1e-04 | 20.4973 | 0.2271 | 4 | 36 | embryonic digestive tract development |
| GO:0044707 | 1e-04 | 2.4786 | 26.4528 | 43 | 5080 | single-multicellular organism process |
| GO:0051954 | 1e-04 | 45.249 | 0.0865 | 3 | 14 | positive regulation of amine transport |
| GO:0006140 | 1e-04 | 7.445 | 1.0407 | 7 | 165 | regulation of nucleotide metabolic process |
| GO:0048663 | 1e-04 | 12.5296 | 0.4478 | 5 | 71 | neuron fate commitment |
| GO:0048568 | 1e-04 | 4.9134 | 2.273 | 10 | 375 | embryonic organ development |
| GO:0030800 | 1e-04 | 19.2891 | 0.2397 | 4 | 38 | negative regulation of cyclic nucleotide metabolic process |
| GO:0010557 | 1e-04 | 2.8493 | 8.6536 | 21 | 1372 | positive regulation of macromolecule biosynthetic process |
| GO:0033693 | 1e-04 | 321.7053 | 0.0189 | 2 | 3 | neurofilament bundle assembly |
| GO:0010721 | 1e-04 | 5.9349 | 1.4885 | 8 | 236 | negative regulation of cell development |
| GO:0030802 | 2e-04 | 8.126 | 0.8136 | 6 | 129 | regulation of cyclic nucleotide biosynthetic process |
| GO:1900543 | 2e-04 | 16.3892 | 0.2775 | 4 | 44 | negative regulation of purine nucleotide metabolic process |
| GO:1900371 | 2e-04 | 7.868 | 0.8389 | 6 | 133 | regulation of purine nucleotide biosynthetic process |
| GO:0035270 | 2e-04 | 7.806 | 0.8452 | 6 | 134 | endocrine system development |
| GO:0034654 | 2e-04 | 2.1657 | 23.8416 | 40 | 3780 | nucleobase-containing compound biosynthetic process |
| GO:0002125 | 2e-04 | 160.8421 | 0.0252 | 2 | 4 | maternal aggressive behavior |
| GO:0035811 | 2e-04 | 160.8421 | 0.0252 | 2 | 4 | negative regulation of urine volume |
| GO:1903531 | 2e-04 | 7.51 | 0.8767 | 6 | 139 | negative regulation of secretion by cell |
| GO:0035813 | 3e-04 | 28.6577 | 0.1261 | 3 | 20 | regulation of renal sodium excretion |
| GO:0048729 | 3e-04 | 3.6841 | 3.633 | 12 | 576 | tissue morphogenesis |
| GO:0021510 | 3e-04 | 9.4921 | 0.5803 | 5 | 92 | spinal cord development |
| GO:0048704 | 3e-04 | 9.1739 | 0.5992 | 5 | 95 | embryonic skeletal system morphogenesis |
| GO:0051953 | 3e-04 | 25.6377 | 0.1388 | 3 | 22 | negative regulation of amine transport |
| GO:0052652 | 3e-04 | 7.0299 | 0.9335 | 6 | 148 | cyclic purine nucleotide metabolic process |
| GO:0006355 | 4e-04 | 2.1638 | 20.1644 | 35 | 3197 | regulation of transcription, DNA-templated |
| GO:0021766 | 4e-04 | 13.1028 | 0.3406 | 4 | 54 | hippocampus development |
| GO:0031133 | 4e-04 | 107.2211 | 0.0315 | 2 | 5 | regulation of axon diameter |
| GO:0035239 | 4e-04 | 4.4149 | 2.2391 | 9 | 355 | tube morphogenesis |
| GO:0007620 | 4e-04 | 23.193 | 0.1514 | 3 | 24 | copulation |
| GO:2001141 | 5e-04 | 2.128 | 20.4294 | 35 | 3239 | regulation of RNA biosynthetic process |
| GO:0051384 | 5e-04 | 8.509 | 0.6434 | 5 | 104 | response to glucocorticoid |
| GO:0045471 | 5e-04 | 8.508 | 0.6433 | 5 | 102 | response to ethanol |
| GO:0007417 | 5e-04 | 3.4003 | 3.9436 | 12 | 668 | central nervous system development |
| GO:0009887 | 6e-04 | 3.8751 | 2.8653 | 10 | 500 | organ morphogenesis |
| GO:0090066 | 6e-04 | 4.2033 | 2.3463 | 9 | 372 | regulation of anatomical structure size |
| GO:0042755 | 6e-04 | 21.1735 | 0.164 | 3 | 26 | eating behavior |
| GO:1903792 | 6e-04 | 21.1735 | 0.164 | 3 | 26 | negative regulation of anion transport |
| GO:0007187 | 6e-04 | 6.3519 | 1.0281 | 6 | 163 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
| GO:0021979 | 6e-04 | 80.4105 | 0.0378 | 2 | 6 | hypothalamus cell differentiation |
| GO:0060406 | 6e-04 | 80.4105 | 0.0378 | 2 | 6 | positive regulation of penile erection |
| GO:0045907 | 6e-04 | 20.2899 | 0.1703 | 3 | 27 | positive regulation of vasoconstriction |
| GO:0030431 | 8e-04 | 18.7267 | 0.1829 | 3 | 29 | sleep |
| GO:0042756 | 8e-04 | 64.3242 | 0.0442 | 2 | 7 | drinking behavior |
| GO:0043410 | 9e-04 | 3.9468 | 2.4914 | 9 | 395 | positive regulation of MAPK cascade |
| GO:0008284 | 9e-04 | 3.0241 | 4.7746 | 13 | 757 | positive regulation of cell proliferation |
| GO:0030900 | 9e-04 | 7.2529 | 0.7493 | 5 | 125 | forebrain development |
| GO:0048522 | 0.001 | 2.1969 | 16.6208 | 29 | 3074 | positive regulation of cellular process |
| GO:0007626 | 0.001 | 5.7249 | 1.1353 | 6 | 180 | locomotory behavior |
| GO:0023061 | 0.001 | 3.8545 | 2.5482 | 9 | 404 | signal release |
| GO:0051962 | 0.0011 | 4.2298 | 2.0562 | 8 | 326 | positive regulation of nervous system development |
| GO:0014003 | 0.0011 | 16.7861 | 0.2018 | 3 | 32 | oligodendrocyte development |
| GO:0048048 | 0.0011 | 16.7861 | 0.2018 | 3 | 32 | embryonic eye morphogenesis |
| GO:0071312 | 0.0011 | 16.7861 | 0.2018 | 3 | 32 | cellular response to alkaloid |
| GO:0042538 | 0.0011 | 53.6 | 0.0505 | 2 | 8 | hyperosmotic salinity response |
| GO:0045924 | 0.0011 | 53.6 | 0.0505 | 2 | 8 | regulation of female receptivity |
| GO:0048863 | 0.0011 | 4.2028 | 2.0688 | 8 | 328 | stem cell differentiation |
| GO:0090276 | 0.0011 | 5.5319 | 1.1732 | 6 | 186 | regulation of peptide hormone secretion |
| GO:0030818 | 0.0012 | 16.2255 | 0.2081 | 3 | 33 | negative regulation of cAMP biosynthetic process |
| GO:0050708 | 0.0012 | 4.1498 | 2.094 | 8 | 332 | regulation of protein secretion |
| GO:0043009 | 0.0012 | 3.2364 | 3.7339 | 11 | 592 | chordate embryonic development |
| GO:0009409 | 0.0013 | 15.7011 | 0.2144 | 3 | 34 | response to cold |
| GO:0003376 | 0.0014 | 45.9398 | 0.0568 | 2 | 9 | sphingosine-1-phosphate signaling pathway |
| GO:0048241 | 0.0014 | 45.9398 | 0.0568 | 2 | 9 | epinephrine transport |
| GO:0051957 | 0.0014 | 45.9398 | 0.0568 | 2 | 9 | positive regulation of amino acid transport |
| GO:0021537 | 0.0014 | 5.3223 | 1.2173 | 6 | 193 | telencephalon development |
| GO:0030534 | 0.0014 | 6.5373 | 0.8263 | 5 | 131 | adult behavior |
| GO:0030809 | 0.0015 | 14.7476 | 0.2271 | 3 | 36 | negative regulation of nucleotide biosynthetic process |
| GO:0042220 | 0.0015 | 14.7476 | 0.2271 | 3 | 36 | response to cocaine |
| GO:0050873 | 0.0015 | 14.7476 | 0.2271 | 3 | 36 | brown fat cell differentiation |
| GO:0051241 | 0.0015 | 3.1677 | 3.8323 | 11 | 646 | negative regulation of multicellular organismal process |
| GO:0060485 | 0.0015 | 5.2372 | 1.2362 | 6 | 196 | mesenchyme development |
| GO:0042063 | 0.0016 | 5.182 | 1.2488 | 6 | 198 | gliogenesis |
| GO:0035176 | 0.0016 | 14.3129 | 0.2334 | 3 | 37 | social behavior |
| GO:0048584 | 0.0016 | 2.2629 | 10.6215 | 21 | 1684 | positive regulation of response to stimulus |
| GO:0072507 | 0.0017 | 3.915 | 2.2139 | 8 | 351 | divalent inorganic cation homeostasis |
| GO:0045778 | 0.0017 | 8.4932 | 0.5109 | 4 | 81 | positive regulation of ossification |
| GO:0003211 | 0.0017 | 40.1947 | 0.0631 | 2 | 10 | cardiac ventricle formation |
| GO:0051969 | 0.0017 | 40.1947 | 0.0631 | 2 | 10 | regulation of transmission of nerve impulse |
| GO:0070472 | 0.0017 | 40.1947 | 0.0631 | 2 | 10 | regulation of uterine smooth muscle contraction |
| GO:0035094 | 0.0017 | 13.903 | 0.2397 | 3 | 38 | response to nicotine |
| GO:0015850 | 0.0017 | 5.0749 | 1.2741 | 6 | 202 | organic hydroxy compound transport |
| GO:0014031 | 0.0018 | 6.1903 | 0.8704 | 5 | 138 | mesenchymal cell development |
| GO:0051602 | 0.0019 | 13.516 | 0.246 | 3 | 39 | response to electrical stimulus |
| GO:0007218 | 0.002 | 8.1731 | 0.5298 | 4 | 84 | neuropeptide signaling pathway |
| GO:0051961 | 0.002 | 4.947 | 1.3056 | 6 | 207 | negative regulation of nervous system development |
| GO:0021795 | 0.002 | 13.1498 | 0.2523 | 3 | 40 | cerebral cortex cell migration |
| GO:0045776 | 0.002 | 13.1498 | 0.2523 | 3 | 40 | negative regulation of blood pressure |
| GO:0060255 | 0.0021 | 1.8449 | 31.9402 | 46 | 5064 | regulation of macromolecule metabolic process |
| GO:0002031 | 0.0021 | 35.7263 | 0.0694 | 2 | 11 | G-protein coupled receptor internalization |
| GO:0061029 | 0.0021 | 35.7263 | 0.0694 | 2 | 11 | eyelid development in camera-type eye |
| GO:0045937 | 0.0021 | 2.6362 | 5.8847 | 14 | 933 | positive regulation of phosphate metabolic process |
| GO:0045665 | 0.0021 | 5.9641 | 0.9019 | 5 | 143 | negative regulation of neuron differentiation |
| GO:0050806 | 0.0021 | 7.9727 | 0.5424 | 4 | 86 | positive regulation of synaptic transmission |
| GO:0045934 | 0.0022 | 2.4574 | 7.2723 | 16 | 1153 | negative regulation of nucleobase-containing compound metabolic process |
| GO:0007204 |